Final Programme - ERA-EDTA Congress 2012
Final Programme - ERA-EDTA Congress 2012
Final Programme - ERA-EDTA Congress 2012
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
49th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
MAY 24-27, <strong>2012</strong><br />
PARIS, France<br />
www. eraedta20<br />
12.org<br />
<strong>Final</strong> <strong>Programme</strong>
AMGEN is dedicated<br />
to creating a better<br />
future in nephrology.<br />
Come and see how<br />
at stand 2.48 level 2<br />
MN-IHQ-AMG-317-<strong>2012</strong>- April-P
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
CONTENTS page<br />
Welcome Address 4<br />
<strong>ERA</strong>-<strong>EDTA</strong> Council 6<br />
Organising and Scientific Committees 7<br />
Paper Selection Committee 8<br />
<strong>ERA</strong>-<strong>EDTA</strong> Information 16<br />
<strong>Congress</strong> Information 18<br />
Press/Media Information 22<br />
Accepted Abstracts 24<br />
<strong>ERA</strong>-<strong>EDTA</strong> Awards and Grants 26<br />
CME Credits 36<br />
Social <strong>Programme</strong> - Tours and Excursions 38<br />
Paris General Information 39<br />
Renal Run 43<br />
SCIENTIFIC PROGRAMME<br />
Thursday, May 24, <strong>2012</strong> 45<br />
Friday, May 25, <strong>2012</strong> 59<br />
Friday, May 25, <strong>2012</strong> - posters 105<br />
Saturday, May 26, <strong>2012</strong> 207<br />
Saturday, May 26, <strong>2012</strong> - posters 249<br />
Sunday, May 27, <strong>2012</strong> 349<br />
Industry Sponsored Symposia 373<br />
Industry Exhibition 391<br />
Cover:<br />
Les Nymphéas, Claude Monet, Musée de l’Orangerie, Paris<br />
photograph by Edoardo Terzolo<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
3
Dear Colleagues and Friends,<br />
4<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
W E L C O M E A D D R E S S<br />
We are very glad to welcome you to Paris for the 49 th<br />
congress of <strong>ERA</strong>-<strong>EDTA</strong>. We hope that the wonderful<br />
“Ville lumière” will charm you with its unique flavour<br />
of modernity and history. Paris is a megalopolis, with<br />
more than ten million inhabitants, a city as populated as<br />
some European States, full of contradictions and doubts,<br />
as well as potential and treasures.<br />
Twenty years after the last <strong>ERA</strong>-<strong>EDTA</strong> congress in Paris<br />
chaired by Prof. Claude Jacobs, this <strong>Congress</strong> inaugurates<br />
the 50 th year of European Nephrology while taking<br />
place in a moment of global crisis of the European and<br />
World economy; as difficult as they are, the moments of<br />
crisis are also opportunities to reflect on the motivations<br />
of our present to build our future. Past and present, keys<br />
for the future, will accompany you both during the <strong>Congress</strong><br />
and the time that we hope you’ll be able to enjoy in<br />
our beautiful city.<br />
The scientific programme, carefully prepared by Prof.<br />
Jürgen Floege and his Scientific Committee, was built<br />
with particular attention towards the clinics, a major<br />
strength of European medicine, and to the integration of<br />
basic science into the clinical context. The three plenary<br />
lectures that deal with cutting-edge topics of major interest<br />
to all nephrologists and the late breaking clinical<br />
trial session will be highlights of the congress. The intense<br />
activities of the different <strong>ERA</strong>-<strong>EDTA</strong> working groups<br />
will be presented on the day of the official opening together<br />
with CME sessions dedicated to diverse aspects of<br />
daily nephrology. The scientific congress further includes<br />
46 symposia and 17 mini-lectures covering all major<br />
areas of nephrology within eight main themes.<br />
Overall, a record-breaking number of 2672 abstracts<br />
were submitted, from 77 Countries all over the world.<br />
We warmly thank Prof. Markus Ketteler and the whole<br />
Paper Selection Committee and external referees for<br />
their hard work. The choice was more difficult than ever.<br />
We hope that the Authors of the oral communications<br />
and of the posters will be proud of their achievement,<br />
while those who could not be included in the programme<br />
due to the space constraints, will find a stimulating<br />
atmosphere for their future studies.<br />
Past and future will accompany us starting from the Opening<br />
Ceremony, as illustrated by the three prizes that will<br />
be awarded. Two will recognize the outstanding achievements<br />
of two great Masters of our discipline, Prof J.<br />
Stewart Cameron, the innovative, non-conventional<br />
genius of the early days of Nephrology, and Prof. Vincenzo<br />
Cambi, to whom we owe major contributions to<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
W E L C O M E A D D R E S S<br />
<strong>ERA</strong>-<strong>EDTA</strong> as well as the concept of “short dialysis”. Dr.<br />
Giovana Seno di Marco will be the recipient of the young<br />
investigator’s award.<br />
Memory is the refrain of the Opening Ceremony: memory<br />
in biology, through the lecture presented by Prof.<br />
Alain Prochiantz, and memory in the moving pictures of<br />
the Pioneers of Nephrology, who remind us of the adagio<br />
stating that only the one who knows the history does not<br />
risk reproducing its errors. The enlightened quotes on<br />
patient-physician relationship, on the sense of Medicine<br />
and Science, the wishes to the young physicians, in a<br />
kaleidoscope of languages, gain a special importance in<br />
this context of redefining our profession. We hope that<br />
the strength of the Masters will follow us as a most powerful<br />
wish.<br />
Paris is also joy, la joie de vivre. The young artists of the<br />
Ecole Nationale du Cirque will take you by the hand in the<br />
collective memory of the Circus, playing at the cosmopolitan<br />
music of Gilberto Richiero, merging artists and<br />
children, opera and rap.<br />
The search for perfection links science and art. The<br />
symbol of our <strong>Congress</strong>, the water lily, photographed in<br />
the marvelous pond of the Orangerie, is just one among<br />
thousands of water lilies, in over 250 oil paintings by<br />
Claude Monet. This simple flower, paradigm of the Impressionism,<br />
painted in all hues and nuances, may reflect<br />
the same research for perfection that is at the basis of the<br />
progress of our discipline.<br />
We hope that, in these days dedicated to the art of medicine,<br />
you’ll find some time not only for the great museums,<br />
as the Louvre and the Musée d’Orsay, but also<br />
for discovering some less known jewels, such as the Musée<br />
Marmottan, to see the small and marvelous painting<br />
which gave Impressionism its name, for living the experience<br />
out of time of the home-museum of Gustave Moreau,<br />
or for reflecting on the interactions between nature<br />
and art, looking at the inspiring water lilies in the oasis<br />
of Giverny, or for discovering the ever moving borders<br />
of the future in the City of Science.<br />
It is with great pleasure that we welcome you to this meeting<br />
in Paris, wishing that the search for perfection in<br />
Nephrology will never end.<br />
Raymond Vanholder Pierre Ronco<br />
<strong>ERA</strong>-<strong>EDTA</strong> President 49th <strong>Congress</strong> President<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
5
6<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
Registered Charity No. 1060134<br />
President<br />
Raymond Vanholder, Belgium<br />
Secretary-Treasurer<br />
Andrzej Więcek, Poland<br />
Chairperson of the Administrative Offices<br />
Rosanna Coppo, Italy<br />
Editor-in-Chief of “Nephrology Dialysis Transplantation”<br />
Carmine Zoccali, Italy<br />
Chairperson of the Registry<br />
Christoph Wanner, Germany<br />
Ordinary Council Members<br />
Peter Barany, Sweden<br />
Peter J. Blankestijn, The Netherlands<br />
Jonathan G. Fox, United Kingdom<br />
Markus Ketteler, Germany<br />
(Chairperson of the Paper Selection Committee)<br />
Marian Klinger, Poland<br />
Ziad Massy, France<br />
Kostas Siamopoulous, Greece<br />
Vladimir Tesar, Czech Republic<br />
<strong>Congress</strong> Presidents (Paris - France)<br />
Pierre Ronco, France<br />
Raymond Vanholder, Belgium<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
ORGANISING COMMITTEE<br />
<strong>ERA</strong>-<strong>EDTA</strong> President<br />
Raymond Vanholder, Belgium<br />
<strong>Congress</strong> President<br />
Pierre Ronco, France<br />
<strong>Congress</strong> Secretary<br />
Dominique Chauveau, France<br />
LOCAL COMMITTEE<br />
Maurice Laville<br />
President of Société de Néphrologie, France<br />
Thierry Hannedouche<br />
President of Société Francophone de Dialyse, France<br />
Jean-Paul Squifflet<br />
President of Société Francophone de Transplantation, Belgium<br />
Georges Deschênes<br />
President of Société de Néphrologie Pédiatrique, France<br />
SCIENTIFIC COMMITTEE<br />
Chair: Jürgen Floege, Germany<br />
Raymond Vanholder, Belgium<br />
Mustafa Arici, Turkey<br />
Bernard Canaud, France<br />
Giovambattista Capasso, Italy<br />
Pierre Cochat, France<br />
John Feehally, UK<br />
Bengt Fellstrom, Sweden<br />
Sandrine Florquin, Netherlands<br />
João M. Frazão, Portugal<br />
Markus Ketteler, Germany<br />
Nine Knoers, Netherlands<br />
Armin Kurtz, Germany<br />
Johannes Mann, Germany<br />
Patrick Maxwell, UK<br />
Klaus Olgaard, Denmark<br />
Manuel Praga, Spain<br />
Pierre Ronco, France<br />
Laszlo Rosivall, Hungary<br />
Francesco Paolo Schena, Italy<br />
Nicholas Topley, UK<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
7
8<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
PAPER SELECTION COMMITTEE<br />
<strong>ERA</strong>-<strong>EDTA</strong> is grateful to the following physicians for<br />
the work done in reviewing the abstracts submitted to<br />
this year’s congress.<br />
Chair<br />
Markus Ketteler, Germany<br />
Core group<br />
Dominique Chauveau, France<br />
Jürgen Floege, Germany<br />
Pierre Ronco, France<br />
Section Chairs<br />
Acid-base/Na, K, Cl. Proteins and cell physiology<br />
Carsten Wagner, Switzerland<br />
Cell signalling. Cell growth control and related alterations<br />
(hypertrophy, hyperplasia and apoptosis)<br />
including neoplasia<br />
Jesus Egido, Spain<br />
Renal development and cystic diseases<br />
Adrian S. Woolf, UK<br />
Genetic diseases and molecular genetics<br />
Olivier Devuyst, Switzerland<br />
Hormones<br />
Peter Gross, Germany<br />
Basic and clinical hypertension research<br />
and renal haemodynamics<br />
Roland E. Schmieder, Germany<br />
Acute Renal Failure - Human studies<br />
Norbert Lameire, Belgium<br />
Acute Renal Failure - Experimental models<br />
Andreas Kribben, Germany<br />
Lab methods, progression & risk factors for CKD, nutrition<br />
in CKD, renal diseases (except GNs and cystic diseases)<br />
Danilo Fliser, Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
General and Clinical Epidemiology and CKD 1-5<br />
Bénédicte Stengel, France<br />
Anaemia in CKD 1-5<br />
Goce Spasovski, F.Y.R. of Macedonia<br />
Bone disease in CKD 1-5<br />
Pieter Evenepoel, Belgium<br />
Pathophysiology and clinical studies in CKD 1-5<br />
Ivan Rychlik, Czech Republic<br />
Nutrition, inflammation and oxidative stress in CKD 1-5<br />
Denis Fouque, France<br />
Diabetes - Basic research<br />
Erwin Schleicher, Germany<br />
Diabetes - Clinical studies<br />
Peter Rossing, Denmark<br />
Acid Base and N/K related diseases, nephrolithiasis,<br />
divalent ions and divalent ions disorders<br />
Giovanni Gambaro, Italy<br />
Clinical Nephrology, primary and secondary<br />
glomerulonephritis<br />
Claudio Ponticelli, Italy<br />
Experimental pathology<br />
Peter Mathieson, UK<br />
Immune and inflammatory mechanisms<br />
Hans-Joachim Anders, Germany<br />
Renal histopathology<br />
Jan J. Weening, Netherlands<br />
Extracorporeal dialysis: techniques and adequacy<br />
Martin K. Kuhlmann, Germany<br />
Peritoneal dialysis<br />
Olof Heimbürger, Sweden<br />
Cardiovascular complications in CKD 5D<br />
Carmine Zoccali, Italy<br />
Vascular access in extracorporeal dialysis<br />
Pietro Ravani, Italy/Canada<br />
Anemia in CKD 5D<br />
Kai-Uwe Eckardt, Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
9
10<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
Bone disease in dialysis patients<br />
João M. Frazão, Portugal<br />
Pathophysiology and clinical studies in CKD 5D patients<br />
Raymond Vanholder, Belgium<br />
Epidemiology, outcome research,<br />
health services research in CKD 5D<br />
Friedo W. Dekker, Netherlands<br />
Protein-energy wasting,<br />
inflammation and oxidative stress in CKD 5D<br />
Peter Barany, Sweden<br />
Transplantation basic science and immunetolerance<br />
of allogenic and xenogenic transplants<br />
Bruno Watschinger, Austria<br />
Clinical epidemiology of renal transplantation<br />
Anders Hartmann, Norway<br />
Paediatric nephrology<br />
Christer Holmberg, Finland<br />
Reviewers<br />
Dwomoa Adu, Ghana/UK<br />
Alberto Albertazzi, Italy<br />
Kerstin Amann, Germany<br />
Alessandro Amore, Italy<br />
Björn Anderstam, Sweden<br />
Michele Andreucci, Italy<br />
Vittorio E. Andreucci, Italy<br />
Anders Åsberg, Norway<br />
Jan Aten, Netherlands<br />
Per-Ola Attman, Sweden<br />
Jonas Axelsson, Sweden<br />
Bert Bammens, Belgium<br />
Bernhard Banas, Germany<br />
Ali Basci, Turkey<br />
Carlo Basile, Italy<br />
Laurent Baud, France<br />
Joachim Beige, Germany<br />
Ariela Benigni, Italy<br />
Thomas Benzing, Germany<br />
Patrick Biggar, Germany<br />
Peter J. Blankestijn, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
Carsten Boeger, Germany<br />
Elisabeth W. Boeschoten, Netherlands<br />
Alessandra Boletta, Italy<br />
Jürgen Bommer, Germany<br />
Annette Bruchfeld, Sweden<br />
Philippe Brunet, France<br />
Klemens Budde, Germany<br />
Leonardo Cagnoli, Italy<br />
Bernard Canaud, France<br />
Giovanni Cancarini, Italy<br />
Jorge B. Cannata-Andía, Spain<br />
Giovambattista Capasso, Italy<br />
Cristina Stela Capusa, Romania<br />
Fernando Carrera, Portugal<br />
Juan Jesus Carrero, Sweden<br />
Francesco G. Casino, Italy<br />
Fergus Caskey, UK<br />
Michal Chmielewski, Poland<br />
Erik Ilsø Christensen, Denmark<br />
Jerzy Chudek, Poland<br />
Pierre Cochat, France<br />
Clemens D. Cohen, Switzerland<br />
Gerald Cohen, Austria<br />
Peter Joseph Conlon, Ireland<br />
Rosanna Coppo, Italy<br />
Maria Covic, Romania<br />
Mario Cozzolino, Italy<br />
Stanislaw Czekalski, Poland<br />
Andrew Davenport, UK<br />
Marc E. De Broe, Belgium<br />
Moniek de Goeij, Netherlands<br />
Dinanda J. de Jager, Netherlands<br />
Dick De Zeeuw, Netherlands<br />
Guy Decaux, Belgium<br />
Ljubica Djukanovic, Serbia<br />
Joerg Doetsch, Germany<br />
Michel Dracon, France<br />
Tilman B. Drueke, France<br />
Soner Duman, Turkey<br />
Tevfik Ecder, Turkey<br />
Frank Eitner, Germany<br />
Henrik Ekberg, Sweden<br />
Ekrem Erek, Turkey<br />
F. Fevzi Ersoy, Turkey<br />
Vincent L.M. Esnault, France<br />
Christopher K.T. Farmer, UK<br />
John Feehally, UK<br />
Bo Feldt-Rasmussen, Denmark<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
11
12<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
Robert Fenton, Denmark<br />
Franco Ferrario, Italy<br />
Anibal Ferreira, Portugal<br />
Patrick Finne, Finland<br />
Michael Fischereder, Germany<br />
Sandrine Florquin, Netherlands<br />
Joan Fort, Spain<br />
Ulrich Frei, Germany<br />
Gérard Friedlander, France<br />
Jan Galle, Germany<br />
Maurizio Gallieni, Italy<br />
Loreto Gesualdo, Italy<br />
Matthias Girndt, Germany<br />
Eric Goffin, Belgium<br />
Matthew D. Griffin, Ireland<br />
Megan Griffith, UK<br />
Josep M. Grinyó, Spain<br />
Hermann-Josef Groene, Germany<br />
Oliver Gross, Germany<br />
Paul Gusbeth-Tatomir, Romania<br />
Valsamakis E. Hadjiconstantinou, Greece<br />
Dieter Haffner, Germany<br />
Nynke Halbesma, Netherlands<br />
Hermann Haller, Germany<br />
Kevin Harris, UK<br />
Marion Haubitz, Germany<br />
Ingeborg A. Hauser, Germany<br />
James Heaf, Denmark<br />
Uwe Heemann, Germany<br />
Luuk Hilbrands, Netherlands<br />
Rachel Hilton, UK<br />
Eero Olavi Honkanen, Finland<br />
Eric Hoste, Belgium<br />
Tobias Huber, Germany<br />
Alastair James Hutchison, UK<br />
Helena Isoniemi, Finland<br />
Stefan Jacobson, Sweden<br />
Christian Jacquot, France<br />
Michel Jadoul, Belgium<br />
Philippe Jaeger, UK<br />
Alan Jardine, UK<br />
AnnCatherine Johansson, Sweden<br />
Achim Joerres, Germany<br />
Dontscho Kerjaschki, Austria<br />
Marian Klinger, Poland<br />
Anneke Kramer, Netherlands<br />
Bernhard K. Krämer, Germany<br />
Raymond T. Krediet, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
Matthias Kretzler, USA<br />
Wolfgang Kühn, Germany<br />
Ulrich Kunzendorf, Germany<br />
Armin Kurtz, Germany<br />
Maurice Laville, France<br />
Christophe Legendre, France<br />
Jens Leipziger, Denmark<br />
Ewa Lewin, Denmark<br />
Orfeas Liangos, Germany<br />
Carlo Lomonte, Italy<br />
Gérard M. London, France<br />
Merike Luman, Estonia<br />
Iain C. Macdougall, UK<br />
David Makanjuola, UK<br />
Francesca Mallamaci, Italy<br />
Marko Malovrh, Slovenia<br />
Jacek Manitius, Poland<br />
Johannes F.E. Mann, Germany<br />
Alejandro Martin-Malo, Spain<br />
Ziad Massy, France<br />
Patrick Maxwell, UK<br />
Gert Mayer, Austria<br />
Christopher W. McIntyre, UK<br />
Otto Mehls, Germany<br />
Paolo Mene’, Italy<br />
Peter Mertens, Germany<br />
Piergiorgio Messa, Italy<br />
Quentin Meulders, France<br />
Karsten Midtvedt, Norway<br />
Gabriel Mircescu, Romania<br />
Marcus Moeller, Germany<br />
Carl Erik Mogensen, Denmark<br />
Leo A.H. Monnens, Netherlands<br />
Daniela Monova, Bulgaria<br />
Eugen Mota, Romania<br />
Heini Murer, Switzerland<br />
Judit Nagy, Hungary<br />
Guy Nield, UK<br />
Hans Hellmut Neumayer, Germany<br />
Marlies Noordzij, Netherlands<br />
Marina Noris, Italy<br />
Michal Nowicki, Poland<br />
Gurbey Ocak, Turkey<br />
Klaus Olgaard, Denmark<br />
Michel Olmer, France<br />
Yvonne O’Meara, Ireland<br />
Ingrid Os, Norway<br />
Mai Ots-Rosenberg, Estonia<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
13
14<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
Antonello Pani, Italy<br />
Vincenzo Panichi, Italy<br />
Ulf Panzer, Germany<br />
Andreas Pasch, Switzerland<br />
Sonia Pasquali, Italy<br />
Hermann Pavenstädt, Germany<br />
E.B. Pedersen, Denmark<br />
Norberto Perico, Italy<br />
Manuel Pestana, Portugal<br />
Harm Peters, Germany<br />
Thierry Petitclerc, France<br />
Luis Piera, Spain<br />
Yves Pirson, Belgium<br />
Momir Polenakovic, F.Y.R. of Macedonia<br />
Claudio Pozzi, Italy<br />
Uwe Querfeld, Germany<br />
Abdul Rashid Qureshi, Sweden<br />
Ton J. Rabelink, Netherlands<br />
Maria Pia Rastaldi, Italy<br />
Helmut Reichel, Germany<br />
Bengt Rippe, Sweden<br />
Eberhard Ritz, Germany<br />
Ian Roberts, UK<br />
Paul Roderick, UK<br />
Anabela Soares Rodrigues, Portugal<br />
Mariano Rodriguez-Portillo, Spain<br />
Alexander Rosenkranz, Austria<br />
Joanna Rowinska Matrow, Poland<br />
Luis Ruilope, Spain<br />
Alan Salama, UK<br />
Moin A. Saleem, UK<br />
Kaija Salmela, Finland<br />
Antonio Santoro, Italy<br />
Francesco Paolo Schena, Italy<br />
Adalbert Schiller, Romania<br />
Ralf Schindler, Germany<br />
Georg Schlieper, Germany<br />
Vedat Schwenger, Germany<br />
Astrid Seeberger, Sweden<br />
Rafael Selgas, Spain<br />
Mehmet Sükrü Sever, Turkey<br />
Neil Sheerin, UK<br />
Kostas C. Siamopoulos, Greece<br />
João Manuel Graça Silva, Portugal<br />
Justin Silver, Israel<br />
Sandor Sonkodi, Hungary<br />
Søren Schwarz Sørensen, Denmark<br />
Jean-Paul Squifflet, Belgium<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
Coen Stehouwer, Netherlands<br />
Peter Stenvinkel, Sweden<br />
Dirk Struijk, Germany<br />
Frank Strutz, Germany<br />
Gultekin Süleymanlar, Turkey<br />
Wladyslaw Sulowicz, Poland<br />
Gere Sunder-Plassmann, Austria<br />
Maria Svensson, Sweden<br />
My Svensson, Denmark<br />
Pieter M. ter Wee, Netherlands<br />
Vladimir Tesar, Czech Republic<br />
Nicola Tessitore, Italy<br />
Daniel Teta, Switzerland<br />
Friedrich Thaiss, Germany<br />
Christian Tielemans, Belgium<br />
Burkhard Toenshoff, Germany<br />
Natalja Tomilina, Russia<br />
Rezan Topaloglu, Turkey<br />
Nicholas Topley, UK<br />
Dimitrios J. Tsakiris, Greece<br />
Photini-Effie C. Tsilibary, Greece<br />
Gunnar Tufveson, Sweden<br />
Robert Unwin, UK<br />
Cengiz Utas, Turkey<br />
Wim Van Biesen, Belgium<br />
Tessa van den Beukel, Netherlands<br />
Frank M. van der Sande, Netherlands<br />
Cees Van Kooten, Netherlands<br />
Karlijn van Stralen, Netherlands<br />
Roland Veelken, Germany<br />
Volker Vielhauer, Germany<br />
Andreas Vychytil, Austria<br />
Zofia Wankowicz, Poland<br />
Christoph Wanner, Germany<br />
Stefanie Weber, Germany<br />
Willem Weimar, Netherlands<br />
Ulrich O. Wenzel, Germany<br />
Ralf Westenfeld, Germany<br />
David Wheeler, UK<br />
Andrzej J. Wiecek, Poland<br />
Martin Wilkie, UK<br />
Christopher G. Winearls, UK<br />
Ralph Witzgall, Germany<br />
Rainer P. Woitas, Germany<br />
Rudolf Peter Wüthrich, Switzerland<br />
Mahmut Ilker Yilmaz, Turkey<br />
Martin Zeier, Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
15
16<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
Registered Charity No. 1060134<br />
<strong>ERA</strong>-<strong>EDTA</strong> Membership Office<br />
You will find the <strong>ERA</strong>-<strong>EDTA</strong> Membership Office in the<br />
Registration Area of the Palais des Congrès. It is possible<br />
to pay membership fees and become a new <strong>ERA</strong>-<strong>EDTA</strong><br />
member.<br />
How to vote for the new Ordinary Council Members<br />
All Full members of the <strong>ERA</strong>-<strong>EDTA</strong> will be able to vote<br />
for a maximum of three (3) candidates.<br />
Also this year, electronic voting online was possible<br />
(April 16th – May 16th).<br />
Only members who have not already voted online will be<br />
able to vote on-site. The voting station, next to the <strong>ERA</strong>-<br />
<strong>EDTA</strong> Membership Office, in the Registration Area will<br />
be open from 14:00 to 18:00 on May 24, <strong>2012</strong> (Thursday),<br />
from 7:00 to 19:00 on May 25, <strong>2012</strong> (Friday), from 7:00<br />
to 19:00 on May 26, <strong>2012</strong> (Saturday) and also before the<br />
start of the General Assembly on May 27, <strong>2012</strong> (Sunday)<br />
starting at 7:00 up to 10.00. A valid identification<br />
document (i.e. passport of national identity card) of the<br />
Full member who wishes to vote must be personally<br />
shown in order to vote. Vote by proxy is NOT possible.<br />
Only paper ballot voting will be possible.<br />
Candidates for Ordinary Council Membership (in alphabetical<br />
order according to last name):<br />
- Denis Fouque, France<br />
- Loreto Gesualdo, Italy<br />
- Gert Mayer, Austria<br />
- Alberto Ortiz, Spain<br />
- Mehmet Sever, Turkey<br />
A short curriculum for each candidate will be on display<br />
at the voting station and is also on the <strong>ERA</strong>-<strong>EDTA</strong>’s website<br />
(www.era-edta.org, section “About <strong>ERA</strong>-<strong>EDTA</strong>”,<br />
click on “Council Candidates”).<br />
General Assembly<br />
The General Assembly will be held on Sunday, May 27,<br />
<strong>2012</strong> starting at 10:30 am, in the “Amphitheatre Havane”<br />
on the 3 rd floor of the Palais de Congrès. The admission<br />
to the General Assembly is strictly reserved to <strong>ERA</strong>-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
<strong>EDTA</strong> Members only. Members should have their <strong>ERA</strong>-<br />
<strong>EDTA</strong> membership cards to show in order to enter the<br />
room for the General Assembly.<br />
Reasons to become an <strong>ERA</strong>-<strong>EDTA</strong> member<br />
1. Free paper and/or online subscription to the journals<br />
“Nephrology Dialysis Transplantation” (NDT) and<br />
“CKJ” (former NDT-Plus).<br />
2. Free password to access the Directory of <strong>ERA</strong>-<strong>EDTA</strong><br />
Members on Internet.<br />
3. Discounted registration fees at the annual <strong>ERA</strong>-<strong>EDTA</strong><br />
<strong>Congress</strong>es.<br />
4. Presentations of the <strong>ERA</strong>-<strong>EDTA</strong> CME Courses.<br />
5. 25% or more discount on Oxford University Press<br />
medical publications. Both lists of books and order forms<br />
are available at the <strong>ERA</strong>-<strong>EDTA</strong> Membership Office Desk<br />
or at the OUP booth in the exhibition area.<br />
Go and check out all the latest initiatives of the <strong>ERA</strong>-<br />
<strong>EDTA</strong> (including educational activities, grants, etc) on<br />
our website www.era-edta.org:<br />
1. Membership information<br />
2. Directory of all <strong>ERA</strong>-<strong>EDTA</strong> members<br />
3. Annual <strong>ERA</strong>-<strong>EDTA</strong> <strong>Congress</strong>es<br />
4. NDT and CKJ Journals<br />
5. <strong>ERA</strong>-<strong>EDTA</strong> Fellowship <strong>Programme</strong><br />
6. <strong>ERA</strong>-<strong>EDTA</strong> Grant <strong>Programme</strong><br />
7. <strong>ERA</strong>-<strong>EDTA</strong> Research <strong>Programme</strong><br />
8. European Renal Best Practice (ERBP)<br />
9. <strong>ERA</strong>-<strong>EDTA</strong> CME Courses<br />
10. <strong>ERA</strong>-<strong>EDTA</strong> Registry<br />
11. NDT-Educational<br />
12. European National Societies<br />
13. <strong>ERA</strong>-<strong>EDTA</strong> Working Groups<br />
To find out more about the <strong>ERA</strong>-<strong>EDTA</strong><br />
(more advantages, educational initiatives,<br />
CME Courses, grants, etc. )<br />
visit the society’s website<br />
www.era-edta.org<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
17
18<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
CONGRESS INFORMATION<br />
Abstract CD-ROM and Abstract Book<br />
A CD-ROM, with all the accepted abstracts, is in all delegates’<br />
bags. Only a few Abstract Books have been printed.<br />
Should you wish to receive one you can collect it<br />
at booth 1.102 NDT-ERBP-NDT-Educational located on<br />
Level 1/Paris.<br />
Certificate of attendance<br />
All regularly registered delegates can collect their certificate<br />
of attendance at the appropriate desk (“Certificate<br />
of Attendance”) located in the Registration Area starting<br />
May 25, <strong>2012</strong> after 15.00 hours. To obtain the certificate<br />
of attendance, it is mandatory to go to this desk and<br />
show the badge. A personalized certificate will be printed<br />
and will state exactly, and only, the days of the participation<br />
in the congress. For example, if you registered<br />
as a full congress member on May 24 and you request<br />
the certificate on May 25, you will receive it for May 24<br />
and 25. If you ask for it on May 27, you will receive it for<br />
May 24, 25, 26 and 27.<br />
If you are not able to go to this desk to collect your certificate<br />
due to other commitments, you can send a written<br />
request to the <strong>ERA</strong>-<strong>EDTA</strong> <strong>Congress</strong> Office after the congress<br />
(e-mail: registrations@era-edta.org), it will then be<br />
sent to you by e-mail.<br />
Children<br />
The participation to the <strong>ERA</strong>-<strong>EDTA</strong> <strong>Congress</strong> is not open<br />
to non healthcare professionals, particularly children.<br />
Children under 12 years of age are not admitted within<br />
the <strong>Congress</strong> limits, children who are at least 12 years<br />
old can be admitted but only to the Opening Ceremony<br />
and only if accompanied by regularly registered adults.<br />
Their number cannot exceed one child per registered<br />
adult. The accompanying adult will be responsible for<br />
the child’s safety and behaviour at all times. Access for<br />
non healthcare professionals, in particular children, to<br />
the exhibition/poster/session halls will be prohibited at<br />
all times.<br />
Coffee and tea break<br />
Complimentary coffee and tea will be served to registered<br />
delegates only in exchange of the coffee tickets received<br />
together with the congress badge, in the catering<br />
areas of the Exhibition Hall of the Palais des Congrès,<br />
during all coffee breaks.<br />
<strong>Congress</strong> membership<br />
Regularly registered participants are entitled to attend<br />
all Scientific and Poster Sessions, Opening Ceremony<br />
with Welcome Reception and Industrial Exhibition. On-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
site they will also receive a congress kit (including <strong>Final</strong><br />
<strong>Programme</strong> and Abstract CD-ROM).<br />
Accompanying guest registration is not available; however,<br />
all participants can take part, with their accompanying<br />
guests, in the Opening Ceremony and Welcome<br />
Reception on May 24, <strong>2012</strong>.<br />
All participants must wear their name badge when attending<br />
any congress or social event. Please note that<br />
only attendants wearing delegate badges are entitled to<br />
attend lecture and poster sessions. The information printed<br />
on the badges is exactly the one provided by participants<br />
when registering<br />
Recycle your badge! You will find special bins at the exit<br />
of the congress centre (registration area) where you can<br />
throw your badge as you leave the congress.<br />
A “Reprint desk” for lost or forgotten delegate badges<br />
will be available in the Registration Area. A personal picture<br />
ID (passport, driver’s licence, etc.) must be shown in<br />
order to receive a replacement delegate badge.<br />
CME Courses<br />
In order to participate in the CME Courses held on May<br />
24, <strong>2012</strong>, all regularly registered congress members must<br />
go to the session halls and have their badge scanned by<br />
the hostesses at the entrance (at participant’s own responsibility).<br />
Please note that the seat capacity of the conference rooms<br />
is limited, therefore participation in these courses will be<br />
on a “first come first served” basis.<br />
The courses are reserved to regularly registered congress<br />
members and are included in the registration fee.<br />
Facilities at the Palais des Congrès<br />
A Cloak Room is located on the mezzanine (Service<br />
Area) of the Grand Amphitheatre, between Level 1 and<br />
2; this service will be available for the entire duration of<br />
the congress.<br />
An internet point is available on the mezzanine (Service<br />
Area); there are also free wi-fi spots around the congress<br />
centre.<br />
Snack bars are available in the main Exhibition Area located<br />
on Level 1 and 2; there is another bar on Level 3<br />
between Amphitheatre Havane and Amphitheatre Bordeaux.<br />
On Level 0 and on the basement level there is a nice<br />
shopping mall.<br />
Grant policy<br />
All <strong>ERA</strong>-<strong>EDTA</strong> travel grants had to be applied for in<br />
advance and have already been assigned. No additional<br />
travel grants, reduced fees or financial support of any<br />
kind can be given to participants.<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
19
20<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
Insurance / Liability<br />
Participation in this <strong>Congress</strong> implies that persons/participants<br />
agree that the organizers do not assume any<br />
liability whatsoever. Upon registration, the participant<br />
accepts this proviso.<br />
Language of the <strong>Congress</strong><br />
The official language of the <strong>Congress</strong> is English. No simultaneous<br />
translation will be provided.<br />
Lunch<br />
Snack bars and catering areas will offer light food for<br />
purchase; they are located in the main Exhibition Area<br />
on Level 1 and 2; the same applies for the Bar located on<br />
Level 3.<br />
Most of the Companies that have arranged the Industry<br />
Sponsored Symposia will offer lunch to the participants.<br />
Post-<strong>Congress</strong> Correspondence<br />
If you wish to contact the <strong>ERA</strong>-<strong>EDTA</strong> after the <strong>Congress</strong>,<br />
the address is: <strong>ERA</strong>-<strong>EDTA</strong> <strong>Congress</strong> Office, Via I.<br />
Spolverini 2, 43126 Parma (Italy). Telephone: +39-0521-<br />
989078, fax: +39-0521-959242, e-mail: congress@era-edta.<br />
org or registrations@era-edta.org<br />
<strong>Programme</strong> changes<br />
The organisers cannot assume liability for changes in the<br />
programme due to external or unforeseen circumstances.<br />
Registration / Information<br />
A confirmation letter and congress materials (badge and<br />
coffee tickets) have been sent by post to regularly preregistered<br />
participants.<br />
The registration and information desks are situated in<br />
the Registration Area of the Palais des Congrès.<br />
The desks will be open at the following times:<br />
Thursday, May 24 07:00-18:00 hours<br />
Friday, May 25 07:00-18:45 hours<br />
Saturday, May 26 07:00-18:45 hours<br />
Sunday, May 27 07:00-13:45 hours<br />
Receipts<br />
Pre-registered delegates may request the receipt of the<br />
payment by personally giving their full address to the<br />
<strong>ERA</strong>-<strong>EDTA</strong> <strong>Congress</strong> Office or by sending a request to<br />
registrations@era-edta.org. Receipts will be sent upon<br />
request and only after the congress.<br />
On-site registered delegates may request the receipt of<br />
the payment by ticking the appropriate box in the onsite<br />
form or personally giving their full address to the<br />
<strong>ERA</strong>-<strong>EDTA</strong> <strong>Congress</strong> Office or by sending a request to<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
registrations@era-edta.org. Receipts will be sent after the<br />
congress.<br />
UEMS CME Credits<br />
The 49th <strong>ERA</strong>-<strong>EDTA</strong> <strong>Congress</strong> has been designated for a<br />
maximum of 21 hours of European external CME credits.<br />
Please refer to page 36 for further accreditation details.<br />
<strong>ERA</strong>-<strong>EDTA</strong> cannot be deemed responsible for forgotten, lost<br />
or stolen personal belongings and <strong>Congress</strong> materials.<br />
SPEAKERS INFORMATION<br />
The Speakers’ Preview Room is located on the second<br />
floor of the Palais des Congrès.<br />
All presentations need to be prepared as PowerPoint files<br />
and will be loaded on a central server in the Speakers’<br />
Preview Room.<br />
All speakers should bring their presentations stored on<br />
a CD-ROM, DVD or USB memory stick to this room no<br />
later than 2 hours before the start of their session (or the<br />
afternoon of the day before if the slides refer to the first<br />
morning session).<br />
The use of laptop computers and traditional slides will<br />
not be possible.<br />
The transparency declarations of all Invited Speakers<br />
and Chairs will be made available at the beginning of the<br />
sessions. Moreover, they have been posted on the Paris<br />
<strong>Congress</strong> website www.eraedta<strong>2012</strong>.org, under a special<br />
section.<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
21
22<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
INFORMATION<br />
FOR PRESS/MEDIA REPRESENTATIVES<br />
Media registration<br />
Pre-registered journalists can pick up their press passes<br />
in the press lounge (Room 135M, Level 1 Mezzanine/<br />
Neuilly). The press pass provides access to all sessions<br />
and symposia of this congress.<br />
Also for onsite registration, media representatives are<br />
kindly asked to come to the press room. The following<br />
identification will be required: press identification/press<br />
card and a letter of assignment from the news organization<br />
being represented.<br />
Please note: public relations personnel and exhibitors<br />
cannot register as Press!<br />
Press room<br />
<strong>ERA</strong>-<strong>EDTA</strong> will be providing a fully-equipped press<br />
lounge (computers with internet access/printer) in<br />
Room 135M, Level 1 Mezzanine/Neuilly. Press folders<br />
and other materials will be available. Opening hours:<br />
Thursday, May 24: 12:30-18:00<br />
Friday, May 25 and Saturday, May 26: 09:00-18:00<br />
Sunday, May 27: 09:00-12:30<br />
<strong>ERA</strong>-<strong>EDTA</strong> press events<br />
Main press conference: Friday, May 25, 11:45-12:45<br />
Room 134M, Level 1 Mezzanine/Neuilly<br />
Topics will be:<br />
1. Organ donation: how the kidney transplantation<br />
changed the life of a young man<br />
2. The often overlooked burden of kidney disease:<br />
when diagnosis comes too late for patients<br />
3. Born to be uremic? The research of the <strong>ERA</strong>-<strong>EDTA</strong><br />
Working Group on Inherited Kidney Diseases<br />
LBCT press briefing: Saturday, May 26, 11:00-12:00<br />
Room 134M, Level 1 Mezzanine/Neuilly<br />
Several late breaking clinical trials (LBCT) are to be presented<br />
at the <strong>ERA</strong>-<strong>EDTA</strong> congress in Paris. One press<br />
briefing featuring these late breaking trials will be held.<br />
Journalists will be informed about latest research find- fi nd-<br />
ings and will have the opportunity to speak to the principal<br />
investigators of the LBCT.<br />
Embargo policy<br />
All LBCT are confidential until officially released by<br />
<strong>ERA</strong>-<strong>EDTA</strong> in the LBCT sessions of the scientific programme.<br />
Unless otherwise noted, all abstracts presented<br />
at the <strong>ERA</strong>-<strong>EDTA</strong> are embargoed until the date and time<br />
of their presentation.<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
Press Office <strong>ERA</strong>-<strong>EDTA</strong> <strong>2012</strong><br />
albersconcept<br />
Dr. Bettina Albers<br />
Jakobstrasse 38 - 99423 Weimar, Germany<br />
Phone +49 3643/ 7764-23, Fax +49 3643/ 7764-52<br />
info@albersconcept.de<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
23
24<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
ACCEPTED ABSTRACTS<br />
Free Communications<br />
The presentation time for all free communication sessions<br />
is 10 minutes, followed by 5 minutes of discussion.<br />
The free communications which will be presented in the<br />
symposia, instead, will last 8 minutes and will be followed<br />
by a 4 minute discussion.<br />
All speakers are requested to keep to their allotted time.<br />
Please ensure that you are in your session hall at least 10<br />
minutes before the session starts, and remain until the<br />
end of the session.<br />
All presentations need to be prepared in PowerPoint.<br />
All speakers should bring their presentations stored on<br />
a CD-ROM, DVD or USB memory stick to the Speakers’<br />
Preview Room no later than 2 hours before the start of<br />
their session. The use of laptop computers and traditional<br />
slides will not be possible.<br />
Posters<br />
Posters will be displayed in the Poster Area located in<br />
the Hall Neuilly and Paris, level 1 of the Palais des ConCongrès. There will be two poster sessions, with the following<br />
timetable:<br />
Friday, May 25 09:30-10:45<br />
Saturday, May 26 09:30-10:45<br />
Authors should mount their poster on the day of their<br />
session starting at 07:30 and dismantle it after 17:00 hrs<br />
the same day. The poster panel measures 90 cm width<br />
x 200 cm height (portrait/vertical). The organisers will<br />
provide suitable fixing material during this period<br />
(07:30-17:00).<br />
The code number of each poster indicates both the position<br />
of the display board as well as the abstract number<br />
in the Abstract CD-ROM.<br />
Presenting authors are kindly requested to be present<br />
throughout the official poster viewing time (both timeslots)<br />
in order to explain their research and to answer<br />
questions from the delegates. There will be no guided<br />
formal discussion.<br />
<strong>ERA</strong>-<strong>EDTA</strong> cannot be deemed responsible for lost or stolen<br />
posters.<br />
Posters which are not dismounted by the end of each day<br />
will automatically be disposed of.<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
Abstract numbering system<br />
e.g. SAP313 = Satuday, poster number 313<br />
F = Friday<br />
SA = Saturday<br />
SU = Sunday<br />
O = free communication<br />
P = poster<br />
Number: Abstract number and reference<br />
number for the Abstract CD-ROM<br />
Publication<br />
All submitted abstracts which have been accepted for<br />
presentation will be published in NDT Volume 27, Supplement<br />
2, <strong>2012</strong>, as well as in the Abstract CD-ROM included<br />
in the delegates’ congress bags.<br />
In addition, authors are encouraged to submit their final<br />
manuscript to be peer reviewed for publication in Nephrology<br />
Dialysis Transplantation. All manuscripts should be<br />
submitted online at:<br />
http://mc.manuscriptcentral.com/ndt<br />
Poster service online<br />
<strong>ERA</strong>-<strong>EDTA</strong> will offer all delegates the chance of consulting<br />
the posters from the Poster Virtual Gallery stations<br />
located in the booth 1.04 of the Exhibition Level 1 - where<br />
10 computers will be provided for this viewing. This<br />
online service will start from Thursday, May 24 and will<br />
remain available online for twelve months.<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
25
26<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
<strong>ERA</strong>-<strong>EDTA</strong> AWARDS AND GRANTS<br />
Also this year the <strong>ERA</strong>-<strong>EDTA</strong> has decided to give up to<br />
90 travel grants for young nephrologists (under 40 years<br />
of age) to attend the Paris <strong>Congress</strong>. The total sum – EUR<br />
50,000 - has thus been allocated to the best rated abstracts<br />
in the various categories.<br />
All winners will receive:<br />
a) Free <strong>Congress</strong> Registration;<br />
b) A grant for EUR 500, except for the Presenting Authors<br />
of the best abstracts of each category whose grant<br />
will be of EUR 1,000.<br />
The Presenting Authors of the two best abstracts of each<br />
category will also receive a diploma, independently of<br />
age.<br />
The Paper Selection Committee has also selected the 8<br />
best abstracts overall, the authors of which will receive<br />
a diploma.<br />
How to receive your grant<br />
In case of free communications, a voucher will be given<br />
to the winner of the grant directly from the Chairpersons<br />
of his/her session. Instead, poster presenters will have to<br />
go directly to the Grant Desk in the Registration Hall of<br />
the Palais des Congrès.<br />
<strong>Congress</strong> awards will be given only to the presenting<br />
author of the successful abstract, who must show a valid<br />
identification picture ID, together with the voucher (if<br />
applicable), to the <strong>ERA</strong>-<strong>EDTA</strong> staff at the <strong>ERA</strong>-<strong>EDTA</strong><br />
Grant Desk after the presentation.<br />
Awards will not be given to co-authors/colleagues/<br />
friends/relatives; no exceptions will be made.<br />
No other grants or financial support of any kind, besides<br />
the grants mentioned above, will be given to<br />
<strong>Congress</strong> participants.<br />
¯ Eight Best Abstracts<br />
t Eight Best Abstracts presented by young<br />
Authors<br />
« Best Abstracts presented by young Authors<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
Eight Best Abstracts<br />
The authors of the abstracts below will receive a diploma.<br />
FO005<br />
MICROVESICLES DERIVED FROM ENDOTHELIAL PROGE-<br />
NITOR CELLS PROTECT KIDNEY FROM CISPLATIN-INDU-<br />
CED ACUTE TOXIC INJURY BY MICRORNA-DEPENDENT<br />
REPROGRAMMING AND INHIBITION OF APOPTOSIS OF<br />
TUBULAR CELLS<br />
Vincenzo Cantaluppi, Italy<br />
FO011<br />
MIR-148B UPREGULATION MODULATING CORE 1, Β1,3-<br />
GALACTOSYLTRANSF<strong>ERA</strong>SE 1 EXPRESSION EXPLAINS<br />
THE ABNORMAL GLYCOSYLATION PROCESS OF IGA1 IN<br />
IGA NEPHROPATHY<br />
Grazia Serino, Italy<br />
FO053<br />
GENOME-WIDE ASSOCIATION STUDY (GWAS) OF INCI-<br />
DENT CKD AND EGFR CHANGE: THE CKDGEN CONSOR-<br />
TIUM<br />
Carsten Böger, Germany<br />
SAO052<br />
GLUT9-MEDIATED RENAL URIC ACID HANDLING<br />
Muriel Auberson, Switzerland<br />
SAO055<br />
PARATHYROID HORMONE (PTH) LEVELS ROSE OVER<br />
TIME IN HEMODIALYSIS (HD) PATIENTS: RESULTS FROM<br />
THE DIALYSIS OUTCOMES AND PRACTICE PATTERNS<br />
STUDY (DOPPS)<br />
Francesca Tentori, USA<br />
SAO062<br />
10-YEAR CARDIOVASCULAR RISK IN TYPE 2 DIABETES IS<br />
PREDICTED BY MEASURABLE URINARY ALBUMIN EVEN<br />
IN THE NORMOALBUMINURIC RANGE<br />
Esteban Porrini, Spain<br />
SAP179<br />
BEST SUPPORTIVE CARE AND TH<strong>ERA</strong>PEUTIC PLASMA EX-<br />
CHANGE<br />
Jan Kielstein, Germany<br />
SAP719<br />
UK PAEDIATRIC RENAL TRANSPLANTATION: A REVIEW<br />
OF CHANGING PRACTICE AND IMPROVED OUTCOMES<br />
OVER 20 YEARS<br />
Lisa Mumford, UK<br />
SUO017<br />
ANGIOMYOLIPOMA RESPONSE TO EVEROLIMUS TREAT-<br />
MENT IN PATIENTS WITH TUBEROUS SCLEROSIS COM-<br />
PLEX OR SPORADIC LYMPHANGIOLEIOMYOMATOSIS:<br />
RESULTS FROM EXIST-2<br />
Bernard Zonnenberg, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
27
28<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
Eight Best Abstracts presented by Young Authors<br />
The authors of the abstracts below will receive a grant of EUR<br />
1,000, free congress registration and a diploma.<br />
FO005<br />
MICROVESICLES DERIVED FROM ENDOTHELIAL PROGE-<br />
NITOR CELLS PROTECT KIDNEY FROM CISPLATIN-INDU-<br />
CED ACUTE TOXIC INJURY BY MICRORNA-DEPENDENT<br />
REPROGRAMMING AND INHIBITION OF APOPTOSIS OF<br />
TUBULAR CELLS<br />
Vincenzo Cantaluppi, Italy<br />
FO011<br />
miR-148b UPREGULATION MODULATING CORE 1, β1,3-<br />
GALACTOSYLTRANSF<strong>ERA</strong>SE 1 EXPRESSION EXPLAINS<br />
THE ABNORMAL GLYCOSYLATION PROCESS OF IgA1 IN<br />
IgA NEPHROPATHY<br />
Grazia Serino, Italy<br />
SAO028<br />
NFAT5 CONTRIBUTES TO OSMOLALITY-INDUCED MCP-1<br />
EXPRESSION IN MESOTHELIAL CELLS<br />
Christoph Küper, Germany<br />
SAO029<br />
INTERLEUKIN L-17A: A NOVEL PLAYER IN PERITONEAL<br />
INJURY BY DIALYSIS<br />
Raquel Rodrigues-Díez, Spain<br />
SAO052<br />
GLUT9-MEDIATED RENAL URIC ACID HANDLING<br />
Muriel Auberson, Switzerland<br />
SAO062<br />
10-YEAR CARDIOVASCULAR RISK IN TYPE 2 DIABETES IS<br />
PREDICTED BY MEASURABLE URINARY ALBUMIN EVEN<br />
IN THE NORMOALBUMINURIC RANGE<br />
Esteban Porrini, Spain<br />
SAP719<br />
UK PAEDIATRIC RENAL TRANSPLANTATION: A REVIEW<br />
OF CHANGING PRACTICE AND IMPROVED OUTCOMES<br />
OVER 20 YEARS<br />
Lisa Mumford, UK<br />
SUO023<br />
ECULIZUMAB FOR AHUS RECURRENCE IN RENAL TRAN-<br />
SPLANTATION<br />
Julien Zuber, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
Best Abstracts presented by Young Authors<br />
The authors of the abstracts below will receive a grant of EUR<br />
500, free congress registration and a certificate.<br />
FO001<br />
BMP-2 INDUCES A PRO-FIBROTIC PHENOTYPE IN ADULT<br />
RENAL PROGENITOR CELLS THROUGH NOX4 ACTIVA-<br />
TION<br />
Simona Simone, Italy<br />
FO002<br />
ENDOTHELIAL-TO-MESENCHYMAL TRANSITION IN SWI-<br />
NE RENAL ISCHEMIA REPERFUSION INJURY IS MEDIA-<br />
TED BY COMPLEMENT AND AKT PATHWAY<br />
Giuseppe Castellano, Italy<br />
FO006<br />
H,K-ATPASE TYPE 2 IS REQUIRED FOR RENAL ADAPTA-<br />
TION TO PREGNANCY<br />
Gilles Crambert, France<br />
FO012<br />
SOLUBLE CD89-IGA1 COMPLEXES AGGRAVATE IGAN DE-<br />
VELOPMENT IN A MOUSE MODEL<br />
Christina Papista, France<br />
FO018<br />
CTGF: A LIGAND OF EPIDERMAL GROWTH FACTOR RE-<br />
CEPTOR (EGFR). OPENING NOVEL POTENTIAL TH<strong>ERA</strong>-<br />
PEUTIC TARGETS FOR RENAL DISEASES<br />
Sandra Rayego-Mateos, Spain<br />
FO021<br />
DEF-6 EXPRESSION AND LOCALIZATION IS CHANGED IN<br />
PKCΛ/Ι DEFICIENT MICE AND PODOCYTES<br />
Kirstin Worthmann, Germany<br />
FO030<br />
EPIDEMIOLOGY OF THE IDIOPATHIC NEPHROTIC SYN-<br />
DROME IN CHILDREN: ENDEMIC OR EPIDEMIC?<br />
Claire Dossier, France<br />
FO039<br />
BIRTHWEIGHT PREDICTS GLOMERULAR FILTRATION<br />
RATE<br />
Issa Salmi, Oman<br />
FO040<br />
SERUM URIC ACID AND RISK OF CHRONIC KIDNEY DISE-<br />
ASE: THE ROTTERDAM STUDY AND META-ANALYSIS<br />
Sanaz Sedaghat, Netherlands<br />
FO041<br />
RELATIVE ENERGY BALANCE, CHRONIC KIDNEY DISE-<br />
ASE AND RISK OF CARDIOVASCULAR AND ALL-CAUSE<br />
MORTALITY<br />
Samuel Iff, Australia<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
29
30<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
FO043<br />
FGF23 AND ASYMMETRICAL DIMETHYLARGININE (ADMA)<br />
ARE INT<strong>ERA</strong>CTIVE FACTORS IN THE HIGH RISK FOR CKD<br />
PROGRESSION IN STAGE 2-5 CKD PATIENTS<br />
Giovanni Tripepi, Italy<br />
FO044<br />
INTACT FIBROBLAST GROWTH FACTOR 23 LEVELS PRE-<br />
DICT INCIDENT CARDIOVASCULAR EVENT BEFORE BUT<br />
NOT AFTER THE START OF DIALYSIS<br />
Sayoko Yonemoto, Japan<br />
FO050<br />
HIGHER THROMBIN ACTIVATABLE FIBRINOLYSIS INHI-<br />
BITOR LEVELS ARE ASSOCIATED WITH INFLAMMATION<br />
AND GENETIC MUTATIONS IN ATTACK-FREE FAMILIAL<br />
MEDITERRANEAN FEVER PATIENTS<br />
Nuket Bavbek Ruzgaresen, Turkey<br />
FO052<br />
LINKAGE ANALYSIS DETECTES TWO ADDITIONAL RE-<br />
GIONS IN FAMILIAL IGA NEPHROPATHY<br />
Francesco Pesce, United Kingdom<br />
FO056<br />
DETERMINANTS OF THE COMMON CAROTID ARTERY<br />
SUBCLINICAL LESIONS IN HYPERTENSIVE SUBJECTS<br />
WITH RENAL FIBROMUSCULAR DYSPLASIA<br />
Luca Zanoli, France<br />
FP030<br />
ENDOTHELIAL DYSFUNCTION PROMOTES THE TRANSI-<br />
TION FROM COMPENSATORY RENAL HYPERTROPHY TO<br />
KIDNEY INJURY AFTER UNILAT<strong>ERA</strong>L NEPHRECTOMY IN<br />
MICE<br />
Hiroyuki Kadoya, Japan<br />
FP039<br />
ANGIOTENSIN II-INDUCED MITOCHONDRIAL NOX4 IS A<br />
MAJOR ENDOGENOUS SOURCE OF OXIDATIVE STRESS IN<br />
KIDNEY PROXIMAL TUBUALR CELLS<br />
Ju-Young Moon, Korea<br />
FP053<br />
COMPARATIVE EFFECTIVENESS OF VARIOUS AN-<br />
TIHYPERTENSIVE AGENTS IN DIABETIC PATIENTS: A<br />
SYSTEMATIC REVIEW AND BAYESIAN NETWORK META-<br />
ANALYSIS<br />
Hon-Yen Wu, Taiwan<br />
FP109<br />
REDUCED Γ-CARBOXYLASE ACTIVITY IN UREMIA- A POS-<br />
SIBLE MECHANISM OF UREMIC VASCULAR CALCIFICA-<br />
TION<br />
Nadine Kaesler, Germany<br />
FP150<br />
META-ANALYSIS: STATIN TH<strong>ERA</strong>PY TO PREVENT DE-<br />
ATH AND MAJOR CARDIOVASCULAR EVENTS IN PEOPLE<br />
WITH CHRONIC KIDNEY DISEASE<br />
Suetonia Palmer, New Zealand<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
FP166<br />
OSTEOPROTEGERIN REPLACES CORONARY ARTERY<br />
CALCIFICATION SCORE AS A PREDICTOR OF INCIDENT<br />
CARDIOVASCULAR EVENTS IN DIABETIC CHRONIC KID-<br />
NEY DISEASE<br />
Chikako Nakano, Japan<br />
FP212<br />
EARLY RECOMBINANT HUMAN ERYTHROPOIETIN TRE-<br />
ATMENT PROMOTES CARDIORENAL CYTOPROTECTION<br />
IN A RAT MODEL OF CHRONIC RENAL FAILURE<br />
Patrícia Garrido, Portugal<br />
FP259<br />
INVOLVEMENT OF IFN-Γ IN THE PATHOGENESIS OF<br />
TYPE2 DIABETIC NEPHROPATHY<br />
Miho Kimachi, Japan<br />
FP264<br />
PRESERVATION OF ENDOTHELIAL GTP CYCLOHYDRO-<br />
LASE I ACTIVITY AND IMPROVEMENT OF RENAL NITRIC<br />
OXIDE AVAILABILITY PREVENT THE DEVELOPMENT OF<br />
DIABETIC NEPHROPATHY<br />
Kengo Kidokoro, Japan<br />
FP353<br />
ACE INSERTION(I)/DELETION(D) POLYMORPHISM PRE-<br />
DICTED RENOPROTECTIVE EFFECTIVENESS OF RENIN-<br />
ANGIOTENSIN SYSTEM (RAS) BLOCKADE IN PATIENTS<br />
WITH IGA NEPHROPATHY<br />
Junya Teranishi, Japan<br />
FP375<br />
ASSESSMENT OF PODOCYTE DYSFUNCTION AND URINA-<br />
RY PODOCYTE LOSS IN CHRONIC GLOMERULONEPHRI-<br />
TIS (CGN): SIGNIFICANCE FOR ESTIMATION OF CLOME-<br />
RULAR DAMAGE AND GLOMERULOSCLEROSIS RISK<br />
Natalia Tchebotareva, Russian Federation<br />
FP476<br />
TRENDS IN THE INCIDENCE OF ATRIAL FIBRILLATION IN<br />
OLDER PATIENTS INITIATING DIALYSIS IN THE USA<br />
Benjamin Goldstein, USA<br />
FP485<br />
WHAT IS THE EFFECT OF A/V FISTULA FLOW ON RIGHT<br />
VENTRICULAR PERFORMANCE INDEX IN PATIENTS<br />
WITH ESRD; A THREE MONTH FOLLOW UP TISSUE DOP-<br />
PLER ECHOCARDIOGRAPHIC STUDY?<br />
Bahaa El-Din Zayed, Egypt<br />
FP508<br />
HYPERPHOSPHATAEMIA AND MICROVESICLE FORMA-<br />
TION: A NOVEL MECHANISM FOR CARDIOVASCULAR<br />
RISK IN CHRONIC KIDNEY DISEASE<br />
Nima Abbasian, United Kingdom<br />
FP594<br />
HIGHER DIALYSATE SODIUM IS ASSOCIATED WITH BET-<br />
TER HEMODIALYSIS PATIENT-REPORTED OUTCOMES:<br />
RESULTS FROM THE DOPPS<br />
Angelo Karaboyas, USA<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
31
32<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
FP714<br />
PERFORMANCE, LIMITATIONS AND UTILITY OF CYSTA-<br />
TIN C AS AN ENDOGENOUS GFR MARKER IN RENAL<br />
TRANSPLANTATION<br />
Ingrid Masson, France<br />
FP715<br />
SURVIVAL AFTER RENAL TRANSPLANT FAILURE: A UK<br />
RENAL REGISTRY ANALYSIS<br />
Lynsey Webb, United Kingdom<br />
FP718<br />
URINARY TRACT INFECTIONS DURING FIRST YEAR AF-<br />
TER RENAL TRANSPLANTATION<br />
Justyna Gołębiewska, Poland<br />
SAO004<br />
MTORC1 CONTRIBUTES TO THE PATHOGENESIS OF FSGS<br />
Stefan Zschiedrich, Germany<br />
SAO011<br />
THE SOLUBLE GUANYLATE CYCLASE ACTIVATOR CI-<br />
NACIGUAT ATTENUATES NEPHROPATHY IN DIABETIC<br />
RATS<br />
Gabor Kokeny, Hungary<br />
SAO015<br />
EFFECTS OF PHOSPHATE ON VASCULATURE CAN BE<br />
CORRECTED WITH A PHOSPHODIEST<strong>ERA</strong>SE 5 INHIBITOR<br />
Kathryn Stevens, United Kingdom<br />
SAO023<br />
THROMBIN MODULATE T CELLS RESPONSE INDUCED BY<br />
DENDRITIC CELLS (DC) IN KIDNEY TRANSPLANT RECI-<br />
PIENTS WITH DELAYED GRAFT FUNCTION (DGF)<br />
Paola Pontrelli, Italy<br />
SAO025<br />
A SPECIFIC B-CELL SUBSET AND FUNCTIONAL PROFILE<br />
IN THE CHRONIC HUMORAL REJECTION!<br />
Isabelle Segalen, France<br />
SAO030<br />
REFUTING A TABOO: OVERHYDRATION PREVALEN-<br />
CE DOES NOT INCREASE IN PERITONEAL DIALYSIS PA-<br />
TIENTS - A PROSPECTIVE LONGITUDINAL STUDY<br />
Aguiar Pedro Ventura, Portugal<br />
SAO031<br />
PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS IN AU-<br />
STRIA: EPIDEMIOLOGY, RISK FACTORS, AND THE ROLE<br />
OF ORAL ACTIVE VITAMIN D<br />
Julia Kerschbaum, Austria<br />
SAO032<br />
A DUTCH GUIDELINE FOR THE MANAGEMENT OF EN-<br />
CAPSULATING PERITONEAL SCLEROSIS<br />
Meelad Habib, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
SAO033<br />
ENCAPSULATING PERITONEAL SCLEROSIS IN PEDIATRIC<br />
PERITONEAL DIALYSIS PATIENTS: THE EXPERIENCE OF<br />
THE ITALIAN REGISTRY OF PEDIATRIC CHRONIC DIALYSIS<br />
Enrico Vidal, Italy<br />
SAO042<br />
PKD1 MUTATION INFLUENCES RENAL OUTCOME IN AU-<br />
TOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE:<br />
RESULTS FROM THE GENKYST REGISTRY<br />
Emilie Cornec Le Gall, France<br />
SAO044<br />
A LOOK BEYOND BLOOD IN THE UREMIC SYNDROME:<br />
COMPARATIVE ANALYSIS OF INTERSTITIAL FLUID AND<br />
PLASMA IN KIDNEY DISEASE<br />
Leonard Ebah, United Kingdom<br />
SAO053<br />
ENTERIC HYPEROXALURIA PREDISPOSING TO NEPHRO-<br />
LITHIASIS IS A COMPLICATION OF BARIATRIC SURGERY<br />
Leila Froeder, Brazil<br />
SAO056<br />
EFFECTIVENESS OF A MG-BASED PHOSPHATE BINDER<br />
ON THE DEVELOPMENT OF VASCULAR CALCIFICATIONS<br />
IN UREMIC RATS<br />
Tineke De Schutter, Belgium<br />
SAO059<br />
SEVELAMER ATTENUATES CV MORTALITY IN INCIDENT<br />
HEMODIALYSIS PATIENTS: OPEN LABEL, RANDOMIZED<br />
CLINICAL TRIAL OF EFFICACY AND SAFETY (INDEPEN-<br />
DENT STUDY)<br />
Antonio Bellasi, Italy<br />
SAP026<br />
THE JAK/STAT SIGNALING PATHWAY MODIFICATIONS<br />
BY GLUCOCORTICOSTEROIDS IN THE LEUKOCYTES OF<br />
CHILDREN WITH NEPHROTIC SYNDROME<br />
Katarzyna Lipkowska, Poland<br />
SAP053<br />
IS VASCULAR SMOOTH MUSCLE CELLS MIN<strong>ERA</strong>LOCOR-<br />
TICOID RECEPTOR INVOLVED IN CYCLOSPORINE A NE-<br />
PHROTOXICITY?<br />
Jean-Philippe Bertocchio, France<br />
SAP068<br />
CALCIUM-OXALATE CRYSTALS INDUCE RENAL INFLAM-<br />
MATION AND ACUTE KIDNEY INJURY BY ACTIVATING<br />
NLRP3 INFLAMMASOME-MEDIATED INTERLEUKIN-1Β<br />
SECRETION IN RENAL DENDRITIC CELLS<br />
Shrikant R. Mulay, Germany<br />
SAP073<br />
HYPOXIC RESPONSE IN MACROPHAGES IN RENAL<br />
ISCHEMIA REPERFUSION INJURY<br />
Alexander Weidemann, Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
33
34<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
SAP100<br />
EFFECT OF ERYTHROPOIETIN ON SHORT TERM I/R RE-<br />
PERFUSION INJURY IN RATS<br />
Massimo Torreggiani, Italy<br />
SAP184<br />
LUNG CONGESTION BY ULTRASOUND PREDICTS DE-<br />
ATH AND CARDIOVASCULAR COMPLICATIONS IN HE-<br />
MODIALYSIS (HD) PATIENTS: A MULTICENTRE COHORT<br />
STUDY<br />
Claudia Torino, Italy<br />
SAP232<br />
GEOGRAPHIC DISTRIBUTION OF SERVICES MAY BE A<br />
BARRIER TO HOME DIALYSIS IN THE USA<br />
Suma Prakash, USA<br />
SAP316<br />
DECREASING INCIDENCE IN RENAL AMYLOIDOSIS.<br />
DATA FROM LARGE REGISTRY OF KIDNEY BIOPSIES<br />
Nayara Panizo, Spain<br />
SAP429<br />
EFFECTS OF TRANSPLANTED MESOTHELIAL CELLS DU-<br />
RING PERITONEAL REPAIR USING TEMP<strong>ERA</strong>TURE-SEN-<br />
SITIVE SV40 LARGE T ANTIGEN GENE TRANSGENIC RAT<br />
MESOTHELIAL CELLS<br />
Reo Kanda, Japan<br />
SAP476<br />
THE EFFECT OF HMG-COA REDUCTASE INHIBITOR ON<br />
INSULIN RESISTANCE IN PATIENTS UNDERGOING PERI-<br />
TONEAL DIALYSIS<br />
Tae Ik Chang, Korea<br />
SAP563<br />
ACTIVATED VITAMIN D ALTERS THE T CELL DIFFEREN-<br />
TIATION IN CHRONIC HEMODIALYSIS PATIENTS WITH<br />
SECONDARY HYPERPARATHYROIDISM<br />
Cheng-Lin Lang, Taiwan<br />
SAP621<br />
“PROPE TOL<strong>ERA</strong>NCE” THE POSSIBILITY OF DONOR IN-<br />
TERLEUKIN-10-TRANSDUCTED FOETAL LIVER STEM CEL-<br />
LS IN MICE HEART ALLOGRAFT<br />
Masahide Matsuyama, Japan<br />
SAP625<br />
IMMUNOMODULATORY EFFECTS OF TNFΑ / TNF RECEP-<br />
TOR SYSTEM DEPENDENT ON ACTIVATION OF VIRAL<br />
RECEPTORS OF THE INNATE IMMUNE SYSTEM IN POLYO-<br />
MAVIRUS BK ASSOCIATED NEPHROPATHY<br />
Markus Wörnle, Germany<br />
SAP632<br />
MOLECULAR PREDICTORS OF DELAYED GRAFT FUN-<br />
CTION OF KIDNEY ALLOGRAFT<br />
Mariana Wohlfahrtova, Czech Republic<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
SAP641<br />
SYSTEMATIC HISTOLOGICAL ANALYSIS OF THROMBO-<br />
TIC MICROANGIOPATHY IN A PORCINE XENO-KIDNEY-<br />
TRANSPLANT-MODEL<br />
Clemens Bockmeyer, Germany<br />
SAP667<br />
SHORT-TERM EFFECTS OF AN Ω-3 (N-3) RICH DIET ON<br />
METABOLIC AND INFLAMMATORY MARKERS IN RENAL<br />
TRANSPLANT RECIPIENTS<br />
Luca Apicella, Italy<br />
SAP675<br />
ANALYSIS OF CHARACTERISTICS AND OUTCOMES OF A<br />
SINGLE CENTRE CLUSTER OF PNEUMOCYSTIS JIROVECII<br />
PNEUMONIA IN THE UK<br />
Sajeda Youssouf, United Kingdom<br />
SAP710<br />
CARPEDIEM: CARDIO-RENAL PEDIATRIC DIALYSIS<br />
EMERGENCY MACHINE. A NEW HOPE FOR INFANTS<br />
Francesco Garzotto, Italy<br />
SUO024<br />
UK STUDY OF LIVING KIDNEY DONOR-RECIPIENT RELA-<br />
TIONSHIPS: GENDER AND ETHNIC VARIATIONS<br />
Rishi Pruthi, United Kingdom<br />
SUO025<br />
EVIDENCE FOR A CAUSAL RELATIONSHIP BETWEEN<br />
NERVE DYSFUNCTION AND HYPERKALAEMIA IN END-<br />
STAGE KIDNEY DISEASE<br />
Ria Arnold, Australia<br />
SUO027<br />
PREDICTING ERYTHROPOIETIN RESISTANCE IN HEMO-<br />
DIALYSIS PATIENTS: POST HOC ANALYSES FROM THE 4D<br />
STUDY<br />
Andreas Schneider, Germany<br />
SUO029<br />
PATTERNS OF SYSTOLIC BLOOD PRESSURE, ALBUMIN,<br />
AND INTERDIALYTIC WEIGHT GAIN IN CHRONIC HEMO-<br />
DIALYSIS PATIENTS BEFORE HOSPITAL ADMISSION<br />
Len A Usvyat, USA<br />
SUO030<br />
RENAL CENTRE CHARACTERISTICS AND PRACTICE PAT-<br />
TERNS ASSOCIATED WITH RRT INCIDENCE IN THE UK<br />
Clare Castledine, United Kingdom<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
35
36<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
EUROPEAN UNION<br />
OF MEDICAL SPECIALISTS (UEMS)<br />
CME CREDITS<br />
The 49 th <strong>ERA</strong>-<strong>EDTA</strong> <strong>Congress</strong> (scientific sessions held<br />
between Friday, May 25, <strong>2012</strong> and Sunday, May 27,<br />
<strong>2012</strong>) has been designated for a maximum of 21 hours<br />
of European external CME credits.<br />
The 49 th <strong>ERA</strong>-<strong>EDTA</strong> <strong>Congress</strong> and pre-congress CME<br />
Courses are accredited by the European Accreditation<br />
Council for Continuing Medical Education (EACCME)<br />
to provide the following CME activity for medical specialists.<br />
The EACCME is an institution of the European<br />
Union of Medical Specialists (UEMS).<br />
EACCME credits<br />
Each medical specialist should claim only those hours of<br />
credit that he/she actually spent in the educational activity.<br />
The EACCME credit system is based on 1 ECMEC<br />
per hour with a maximum of 3 ECMECs for half a day<br />
and 6 ECMECs for a full-day event.<br />
Delegates attending only the 49 th <strong>ERA</strong>-<strong>EDTA</strong> <strong>Congress</strong><br />
(scientific sessions held between Friday, May 25, <strong>2012</strong><br />
and Sunday, May 27, <strong>2012</strong>), will receive a maximum of<br />
21 ECMECs credits.<br />
ECMECs credits are recognised in the following countries:<br />
Armenia, Austria, Croatia, Czech Republic, Denmark,<br />
Estonia, Finland, Georgia, Germany, Greece,<br />
Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg,<br />
Malta, Netherlands, Norway, Poland, Portugal, Romania,<br />
Slovakia, Slovenia, Spain, Sweden, Switzerland,<br />
Turkey and United Kingdom. Delegates receiving certificates<br />
for ECMEC credits must contact their National<br />
Accreditation Authority to have the credits recognised<br />
(or converted) in their country of practice.<br />
EACCME credits are recognised by the American Medical<br />
Association towards the Physician’s Recognition<br />
Award (PRA). To convert EACCME credit to AMA PRA<br />
category 1 credit, contact the AMA.<br />
For more information, visit www.uems.net.<br />
HOW TO RECEIVE UEMS CME CREDITS<br />
<strong>ERA</strong>-<strong>EDTA</strong> will track attendance of congress members<br />
during the congress in the Palais des Congrès each<br />
day. All regularly registered congress members must<br />
go to the session halls and have their badge scanned<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
by the hostesses at the entrance (at participant’s own<br />
responsibility). <strong>Congress</strong> members will then be awarded<br />
the number of credits towards the hours actually spent<br />
participating in the sessions of the congress. <strong>ERA</strong>-<strong>EDTA</strong><br />
will send UEMS CME Certificate only upon specific<br />
request. Regularly registered congress members can<br />
either request to receive it by post or e-mail at the UEMS<br />
CME desk (starting May 24, <strong>2012</strong>) during the congress<br />
or in writing to cmecredits@era-edta.org. The certificate<br />
will be then sent after the congress.<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
37
38<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
SOCIAL PROGRAMME<br />
Thursday, May 24 - 18:00-19:30 hrs.<br />
Palais des Congrès<br />
Grand Amphitheatre<br />
Opening Ceremony<br />
(see page 58)<br />
Welcome Cocktail in the Exhibition Level 1 and 2<br />
TOURS AND EXCURSIONS<br />
WIP - Colloquium will be available for booking tours<br />
and excursions to the most beautiful places of interest in<br />
Paris and surrounding areas.<br />
Desks are located on the mezzanine of the Palais des<br />
Congrès, near the entrance of the Grand Amphitheatre.<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
PARIS GEN<strong>ERA</strong>L INFORMATION<br />
Currency<br />
EUR (€) is the official currency in France. Money can be<br />
changed at the main train stations, international airports,<br />
major banks, exchange bureau, most large hotels and the<br />
post office.<br />
All major credit cards are accepted in most hotels, restaurants<br />
and shops.<br />
Restaurants<br />
Paris offers plenty of fine restaurants serving the traditional<br />
dishes that guarantee the reputation of French cuisine<br />
throughout the world.<br />
Dining in Paris is a culinary adventure and almost instantly<br />
connected with the famous “petits fours”, “foie<br />
gras”, “grenouilles” and “escargot”, but there is a range<br />
of other possibilities that start from traditional cuisine<br />
and go towards every gastronomic delight from all over<br />
the world. Paris has also a long tradition of brasseries<br />
and wine cellars. Parisians do not dine before 20:00. Prior<br />
to that, time is set aside for “l’apéritif”. But in very popular<br />
tourist areas, restaurants are open from 19:00 onwards.<br />
At the Palais des Congrès a choice of restaurants<br />
is available with something for every taste, such as Sushi,<br />
Sandwiches, and Mediterranean food.<br />
Tipping<br />
Tipping is optional, but normally 10% is customary in<br />
taxis and restaurants.<br />
Transports<br />
Travelling to the Palais des Congrès de Paris (Porte Maillot)<br />
The Porte Maillot is located in western Paris, easily accessible<br />
from the airport and railway station (“Porte<br />
Maillot” station) by underground, bus and RER.<br />
• Arriving by plane<br />
Paris has two international airports. Most international<br />
flights use the larger Roissy Charles de Gaulle Airport<br />
(airport code CDG), 30 km north-east of Paris. The<br />
other one is the Orly Airport (airport code ORY), 18 km<br />
south of the city. Most international airlines have direct<br />
connections to Paris from their respective hubs. Roissy<br />
Charles de Gaulle Airport and Orly Airport are both well<br />
connected by public transport to central Paris.<br />
From Roissy-Charles de Gaulle Airport:<br />
(approximate travel time: 75 minutes)<br />
- RER B, stop at “Chatelet Les Halles”<br />
- then take RER A to “Charles de Gaulle/Etoile”<br />
- then line 1 of the metro to “Porte Maillot/Palais des<br />
Congrès”<br />
By Air France or ADP shuttle bus: take line 2 (buses go<br />
directly to “Porte Maillot/Palais des Congrès” or to the<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
39
40<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
C O N G R E S S I N F O R M A T I O N<br />
“Opéra” in the city centre). Departure every 15 minutes<br />
from 05:45 to 23:00. Approximate travel time: 1 hour.<br />
Cost: € 15.00.<br />
From Orly Airport:<br />
(approximate travel time: 60 minutes)<br />
- High speed shuttle (Orlyval) to “Antony”<br />
- RER B, stop at “Chatelet Les Halles”<br />
- then take RER A to “Charles de Gaulle/Etoile”<br />
- then line 1 of the metro to “Porte Maillot/Palais des<br />
Congrès”<br />
By the “Cars Air France”:<br />
- go to “Terminus Etoile”<br />
- then line 1 of the metro to “Porte Maillot/Palais des<br />
Congrès”<br />
Departure every 30 minutes from 06:00 to 23:00. Approximate<br />
travel time: 40 minutes to 1 hour. Cost: € 11.50.<br />
By taxi: approximate travel time to central Paris is 40 minutes<br />
to 1 hour depending on traffic. Cost: approximately<br />
€ 50.00/60.00.<br />
• Arriving by car<br />
To Reach “Porte Maillot”, you need to drive on the inner/<br />
outer ring road and you should exit at “Boulevard<br />
Periphérique Ouest” (west beltway). Direct access to the<br />
underground parking of the Palais des Congrès via Porte<br />
Maillot. Open 24 hours a day.<br />
• Arriving by train<br />
Line C of the RER Commuter train provides direct access<br />
to the “Porte Maillot” station.<br />
Public transportation<br />
• Metro<br />
The metro is probably the best way to travel within the<br />
city. The Palais des Congrès is close to the “Porte Maillot”<br />
metro station. It runs from 05:30 to 01:00. You should<br />
keep your ticket until you leave the metro as you may<br />
need to show it /have it with you at some exit doors and<br />
in case of controls.<br />
Line 1 of the metro (La Défense-Château de Vincennes)<br />
crosses the city from east to west and provides direct access<br />
to the Palais des Congrès “Porte Maillot” station.<br />
• Bus<br />
They are slower than the metro at certain hours of the<br />
day depending on traffic, but the bus services are frequent<br />
during the day even if more irregular after 20:00<br />
on some lines. Lines to “Porte Maillot”: 82 (Luxembourg-<br />
Neuilly), 73 (Concorde-La Défense), and PC1, PC2, PC3<br />
(beltway lines).<br />
• Public transport tickets<br />
Paris public transport is operated by the RATP and includes<br />
the metro subway system, RER trains, buses, night<br />
buses, Montmartre bus, and the Montmartre funicular<br />
railway, all of which accept the same tickets and passes.<br />
You can purchase individual tickets, or a Paris Visite Metro<br />
Pass, available for 2, 3 or 5 consecutive days of unli-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
C O N G R E S S I N F O R M A T I O N<br />
mited travelling: these tickets were created especially for<br />
visitors they also include special offers and discounts of<br />
up to 35% at a variety of attractions in the Paris area. This<br />
makes travelling around the city very easy.<br />
Single tickets cost € 1.80. Tickets for public transport are<br />
available at subway stations, some bus terminals and registered<br />
retailers, usually tobacconists and bookshops,<br />
displaying the RATP sign.<br />
• Taxis<br />
There are approximately 500 taxi stations on the city’s<br />
major avenues and boulevards. There is an initial fee for<br />
each ride. The average fare from downtown to the Palais<br />
des Congrès is € 15.00. For your ride back, there is a taxi<br />
station located on the Avenue de la Grande Armée, right<br />
next to the Palais des Congrès: +33 (0)1 45 72 61 84.<br />
The Airports’ specialist is: +33 (0)6 08 57 75 83 available<br />
24 hours and 7/7 days (major credit cards accepted).<br />
Useful telephone numbers<br />
• Paris airports (Roissy CDG and Orly): 3950<br />
• Air France: 3654<br />
• SNCF (French National Railways): 3635<br />
• Taxi services:<br />
- Taxis G7: +33 (0)1 47 39 47 39<br />
- Taxis Bleus: +33 (0)1 49 36 10 10<br />
• Emergency: 15 or 112<br />
Useful websites<br />
• Venue: www.viparis.fr<br />
• Tourism: www.paris-touristoffice.com<br />
• Air France: www.airfrance.fr<br />
• National train network (SNCF): www.sncf.fr<br />
• Metro, bus in Paris (loadable map): www.ratp.fr<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
41
42<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
w w w . e r a e d t a 2 0 1 2 . o r g
nephrologists ists in motion<br />
2nd <strong>ERA</strong>-<strong>EDTA</strong> Renal Run<br />
<strong>2012</strong><br />
The organizing committee is very pleased<br />
to announce the second <strong>ERA</strong>-<strong>EDTA</strong> Renal<br />
Run, which will take place on<br />
Saturday, May 26, <strong>2012</strong> at 16.30.<br />
This year runners will enjoy a 6.5 km run<br />
(4 miles) through the Bois de Boulogne,<br />
West of Paris, within walking distance from<br />
the Palais des Congrès.<br />
The Bois de Boulogne is a part of what used<br />
to be the Forest of Rouvray that surrounded<br />
the Gallo-Roman city of Lutetia. You will<br />
admire its impressive variety of trees,<br />
including very old oaks. The race will loop<br />
the upper and lower lakes. Runners will<br />
defi nitely enjoy this part of the woods during<br />
this time of the year.<br />
The participation in the race is intended for<br />
<strong>Congress</strong> participants. They will be divided<br />
into categories according to age and gender.<br />
Registration is free, but must still be done<br />
for administrative purposes.<br />
On-site registration is possible at the<br />
Colloquium Desk in the Service Area of the<br />
Palais des Congrès. Registration to the Renal<br />
Run can be done up to Friday, May 25, 2011,<br />
at 15.00. Each participant will receive a<br />
number and a T-shirt. Refreshments and<br />
cloakrooms will be available.<br />
For further details,<br />
please see the <strong>Congress</strong> website<br />
eraedta<strong>2012</strong>.org<br />
We are looking forward<br />
to your participation and wish you<br />
a very enjoyable and fun experience!<br />
49th 4 <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
MAY M<br />
24-27, <strong>2012</strong> PARIS, France
44<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
Next <strong>Congress</strong>es of the <strong>ERA</strong>-<strong>EDTA</strong><br />
Istanbul, Turkey<br />
May 18-21, 2013<br />
Amsterdam, Netherlands<br />
May 31-June 3, 2014<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
DAY AT A GLANCE<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
page<br />
08:30 - 12:30 CME Courses<br />
Rheumatology for nephrologists 46<br />
Peritoneal Dialysis Workshop 47<br />
10:15 - 11.45 <strong>ERA</strong>-<strong>EDTA</strong> Working Group Symposium<br />
EURECA-m 48<br />
12:00 - 13.30 <strong>ERA</strong>-<strong>EDTA</strong> Working Group Symposium<br />
EUTox 49<br />
13:00 - 17:00 CME Courses<br />
Clinical questions for managing<br />
Nephrolithiasis 50<br />
Renal Pathology 51<br />
13:45 - 15.15 <strong>ERA</strong>-<strong>EDTA</strong> Working Group Symposia<br />
Inherited Kidney Disorders 52<br />
Immunonephrology 53<br />
15.00 - 17.00 Special Symposium<br />
Drug-induced renal injury:<br />
the quest for sensitive biomarkers 54<br />
15:30 - 17.00 <strong>ERA</strong>-<strong>EDTA</strong> Working Group Symposium<br />
EuDial 56<br />
Educational Symposium<br />
The Soft-Skill Masterclass 57<br />
18:00 - 19:30 Opening Ceremony 58<br />
Guest Lecture Alain Prochiantz<br />
“Building adaptive memories through evolution and<br />
development”<br />
Film: Pioneers of the European Nephrology<br />
Creation: Deep-Light-Light-Deep<br />
19:30 - 21:00 Welcome Cocktail<br />
in the Exhibition Level 1 and 2<br />
45<br />
THURSDAY, MAY 24
THURSDAY, MAY 24<br />
46<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
CME COURSE 1<br />
ROOM 252AB 08:30 - 12:30<br />
Rheumatology for nephrologists<br />
Chair: Hans-Joachim Anders, Munich, Germany<br />
David Jayne, Cambridge, UK<br />
Welcome and introduction<br />
Hans-Joachim Anders, Munich, Germany<br />
David Jayne, Cambridge, UK<br />
Joint pain in CKD patients: When do we need a joint<br />
aspirate?<br />
Hendrik Schulze-Koops, Munich, Germany<br />
Proteinuria in the patient with arthritis<br />
Volker Vielhauer, Munich, Germany<br />
The <strong>2012</strong> “standard of care” in lupus nephritis – referral,<br />
drugs and monitoring<br />
Frédéric A. Houssiau, Brussels, Belgium<br />
Non-renal flares in lupus nephritis patients – new options<br />
Falk Hiepe, Berlin, Germany<br />
Antiphospholipid antibodies and the kidney<br />
Ricard Cervera, Barcelona, Spain<br />
B cell targeted therapy in nephritis, all hype and no substance?<br />
David Jayne, Cambridge, UK<br />
ANCA-associated vasculitis - an update on therapeutic<br />
strategies<br />
Alan Salama, London, UK<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
CME COURSE 2<br />
ROOM 352AB 08:30 - 12:30<br />
Peritoneal Dialysis Workshop<br />
in cooperation with EuroPD<br />
Chair: Nicholas Topley, Cardiff, UK<br />
New insights in pharmacokinetics and pharmacodynamics<br />
of antibiotics: implications for the treatment of peritonitis<br />
An De Vriese, Bruges, Belgium<br />
Survival on PD and HD: what do we know?<br />
James Heaf, Herlev, Denmark<br />
Catheter placement: do’s and dont’s<br />
Alain Slingeneyer, Montpellier, France<br />
Optimal and individualised PD prescription: the ERBP<br />
viewpoint<br />
Wim Van Biesen, Ghent, Belgium<br />
Biocompatibility revisited: is it relevant in <strong>2012</strong>?<br />
Nicholas Topley, Cardiff, UK<br />
Membrane pathophysiology, EMT and MicroRNA’s as<br />
potential therapeutic targets<br />
Donald Fraser, Cardiff, UK<br />
Animal models revisited: what do they really tell us<br />
about the peritoneum<br />
Olivier Devuyst, Zurich, Switzerland<br />
Peritoneal membrane physiology and function: insights<br />
from cohort studies<br />
Simon Davies, Stoke-on-Trent, UK<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
47<br />
THURSDAY, MAY 24
THURSDAY, MAY 24<br />
48<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
<strong>ERA</strong>-<strong>EDTA</strong> WORKING GROUP SYMPOSIUM 1<br />
ROOM 351 10:15 - 11:45<br />
EURECA-m (EUropean REnal and CArdiovascular<br />
Medicine)<br />
Chair: Gérard M. London, Fleury-Mérogis, France<br />
Carmine Zoccali, Reggio Calabria, Italy<br />
Ultrafiltration in heart failure: experience or evidencebased?<br />
Enrico Fiaccadori, Parma, Italy<br />
The new dimension of hypertension: short term and visit<br />
to visit BP variability<br />
Gianfranco Parati, Milan, Italy<br />
Coronary calcium quantification: a useful surrogate in<br />
clinical research? A reasonable biomarker in clinical<br />
practice?<br />
Gérard M. London, Fleury-Mérogis, France<br />
Pulmonary hypertension in CKD: a neglected complication?<br />
Alan G. Jardine, Glasgow, UK<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
<strong>ERA</strong>-<strong>EDTA</strong> WORKING GROUP SYMPOSIUM 2<br />
ROOM 351 12:00 - 13:30<br />
EUTox<br />
Handling the patient with CKD: can we do more<br />
than dialyse?<br />
Chair: Angel Argiles, Montpellier, France<br />
Goce Spasovski, Skopje, F.Y.R. of Macedonia<br />
Improve early screening. CKD markers<br />
Harald Mischak, Hannover, Germany<br />
Prevent fibrosis and CKD progression. New pathways<br />
and putative therapeutic targets<br />
Alberto Ortiz, Madrid, Spain<br />
Alternative treatments in CKD<br />
Raymond Vanholder, Ghent, Belgium<br />
New methods to treat CKD: the application of hydrophobic<br />
media in extracorporeal systems for removal of<br />
uremic toxins<br />
Joachim Jankowski, Berlin, Germany<br />
Endothelial markers after transplantation<br />
Henri Vacher-Coponat, Marseille, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
49<br />
THURSDAY, MAY 24
THURSDAY, MAY 24<br />
50<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
CME COURSE 3<br />
ROOM 252AB 13:00 - 17:00<br />
Clinical questions for managing Nephrolithiasis<br />
in cooperation with the EAU Section of Urolithiasis<br />
(EULIS)<br />
Chair: Noor Buchholz, London, UK<br />
Giovanni Gambaro, Rome, Italy<br />
What do we ask the radiologist? - What can the radiologist<br />
tell us?<br />
Kim Hovgaard Andreassen, Fredericia, Denmark<br />
What do we learn from the stone’s analysis?<br />
Michel Daudon, Paris, France<br />
When and why do we suspect a genetic disorder in a<br />
patient with stones?<br />
Giovanni Gambaro, Rome, Italy<br />
When and why do we suspect a tubular disorder in a<br />
patient with stones?<br />
Robert Unwin, London, UK<br />
How do we interpret and manage hypercalciuria?<br />
Philippe Jaeger, London, UK<br />
How do we interpret the results of urine analysis?<br />
Martino Marangella, Turin, Italy<br />
How do we manage patients’ diet?<br />
Alberto Trinchieri, Lecco, Italy<br />
What does the urologist ask the nephrologist?<br />
Noor Buchholz, London, UK<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
CME COURSE 4<br />
ROOM 253 13:00 - 17:00<br />
Renal Pathology<br />
Chair: Kerstin Amann, Erlangen, Germany<br />
Sandrine Florquin, Amsterdam, Netherlands<br />
New insights in C3 glomerulopathy<br />
Terry Cook, London, UK<br />
Critical review of the ISN/RPS classification of lupus<br />
nephritis<br />
Ian Roberts, Oxford, UK<br />
Update in renal transplantation<br />
Heinz Regele, Vienna, Austria<br />
Monoclonal deposit diseases<br />
Eric Steenbergen, Nijmegen, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
51<br />
THURSDAY, MAY 24
THURSDAY, MAY 24<br />
52<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
<strong>ERA</strong>-<strong>EDTA</strong> WORKING GROUP SYMPOSIUM 3<br />
ROOM 351 13:45 - 15:15<br />
Inherited Kidney Disorders<br />
Chair: Olivier Devuyst, Zurich, Switzerland<br />
Remi Salomon, Paris, France<br />
New insights into inherited renal Fanconi syndrome<br />
Detlef Bockenhauer, London, UK<br />
Mendalian disorders of membrane trafficking<br />
Maria Antonietta De Matteis, Naples, Italy<br />
Uric acid: from GWAS to mendelian disorders<br />
Olivier Bonny, Lausanne, Switzerland<br />
The EuroCYST initiative<br />
Andreas Serra, Zurich, Switzerland<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
<strong>ERA</strong>-<strong>EDTA</strong> WORKING GROUP SYMPOSIUM 4<br />
ROOM CONCORDE 2 13:45 - 15:15<br />
Immunonephrology<br />
Chair: Rosanna Coppo, Turin, Italy<br />
Mohamed Daha, Leiden, Netherlands<br />
Introduction<br />
Mohamed Daha, Leiden, Netherlands<br />
Update on the ongoing programme: VALIGA<br />
Rosanna Coppo, Turin, Italy<br />
A multicentre trial for the treatment of membranous<br />
nephropathy: sequential therapy of tacrolimus and rituximab<br />
Manuel Praga, Madrid, Spain<br />
A European Registry for recurrent glomerular diseases<br />
after transplantation<br />
Jürgen Floege, Aachen, Germany<br />
<strong>ERA</strong>-<strong>EDTA</strong>/RPS immunopathology projects<br />
Loreto Gesualdo, Bari, Italy<br />
New prospectives for IWG<br />
Mohamed Daha, Leiden, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
53<br />
THURSDAY, MAY 24
THURSDAY, MAY 24<br />
54<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
SPECIAL SYMPOSIUM<br />
ROOM 352AB 15:00 - 17:00<br />
Drug-induced renal injury: the quest for sensitive<br />
biomarkers<br />
Organized in collaboration with Innovative Medicines<br />
Initiative (IMI)<br />
Chair: Michel Goldman, Brussels, Belgium<br />
Keynote introduction: Why do we need new biomarkers<br />
for drug-kidney interaction?<br />
Raymond Vanholder, Ghent, Belgium<br />
Preclinical approaches by the PSTC consortium to support<br />
translational drug-induced kidney injury monitoring<br />
in drug development<br />
Jonathan Phillips, Boehringer Ingelheim, Ridgefield,<br />
U.S.A.<br />
The Biomarkers Consortium: Prospective clinical trial<br />
design to qualify biomarkers for drug development<br />
Irene Nunes, Merck, West Point, USA<br />
Acute kidney injury biomarkers in clinical practice: current<br />
status<br />
Ralf Schindler, Berlin, Germany<br />
IMI project - SAFE-T: an European consortium approach<br />
to renal safety biomarkers<br />
Stefan Sultana, Novartis, UK<br />
Panel Discussion<br />
Moderator: Jean-Marc Vidal, European Medicines<br />
Agency, London, UK<br />
Nephrotoxicity is a serious problem for drug development<br />
and current clinical standards used for the detection<br />
of acute kidney injury, serum creatinine (sCr) and<br />
blood urea nitrogen (BUN), are suboptimal. Drugs can<br />
cause histopathological lesions and functional impairment<br />
in the kidney at doses and times where no measureable<br />
changes in sCR and BUN can be detected.<br />
This has important consequences both for patient care<br />
and the development of safe and innovative drugs. To<br />
address this issue, three public-private partnerships<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
have been formed: the Predictive Safety Testing Consortium<br />
Nephrotoxicity Working Group, the Drug Induced<br />
Kidney Injury (DIKI) working group of the Innovative<br />
Medicines Initiative (IMI) SAFE-T consortium and the<br />
Biomarkers Consortium Kidney Safety Project Team. All<br />
three partnerships conduct research designed to define<br />
thresholds and characterize the performance of the new<br />
DIKI biomarkers in order to enhance decision making in<br />
drug development. The research focuses on the various<br />
regions of the kidney, including injury to the proximal<br />
kidney tubule and the glomerulus. Clinical studies are<br />
being conducted in patients receiving standard of care<br />
treatment known to cause injuries to the kidney via<br />
different mechanisms. The data generated will be submitted<br />
to global health authorities for regulatory qualification<br />
of new biomarkers for monitoring early onset<br />
and reversal of drug-induced kidney injury. During this<br />
session, achievements and ongoing activities of the three<br />
partnerships will be presented and the complementary<br />
scope of their approaches will be discussed.<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
55<br />
THURSDAY, MAY 24
THURSDAY, MAY 24<br />
56<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
<strong>ERA</strong>-<strong>EDTA</strong> WORKING GROUP SYMPOSIUM 5<br />
ROOM 351 15:30 - 17:00<br />
EuDial (European Dialysis Working Group)<br />
Recommendations based on available evidence for hemodiafiltration<br />
therapy. Report of EuDial working meeting<br />
of October 2011.<br />
Chair: Peter Blankestijn, Utrecht, Netherlands<br />
Bernard Canaud, Montpellier, France<br />
Opening / welcome<br />
Bernard Canaud, Montpellier, France<br />
How to define and quantify hemodiafiltration?<br />
James Tattersall, Leeds, UK<br />
How to apply HDF in a safe way? Current safety standards,<br />
regulations and guidelines<br />
Richard Ward, Louisville, USA<br />
Available clinical evidence for HDF<br />
Peter Blankestijn, Utrecht, Netherlands<br />
Menso Nube, Amsterdam, Netherlands<br />
EuDial, where do we go from here?<br />
Bernard Canaud, Montpellier, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
EDUCATIONAL SYMPOSIUM<br />
ROOM CONCORDE 2 15:30 - 17:00<br />
The Soft-Skill Masterclass<br />
Chair: Jürgen Floege, Aachen, Germany<br />
Why did my grant application fail? Common mistakes<br />
you should avoid<br />
Frédéric Jaisser, Paris, France<br />
Common pitfalls in writing a paper<br />
Frank Eitner, Aachen, Germany<br />
Collaborations, intellectual property and patents - curse<br />
or blessing<br />
Steve Harper, Bristol, UK<br />
How to ruin your presentation?<br />
Jürgen Floege, Aachen, Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
57<br />
THURSDAY, MAY 24
THURSDAY, MAY 24<br />
58<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
OPENING CEREMONY<br />
Since 17:30 live performances by the young artists of the<br />
Ecole Nationale du Cirque<br />
GRAND AMPHITHEATRE 18:00 - 19:30<br />
Welcome address<br />
Gabriel Richet and Pierre Ronco, <strong>Congress</strong> President<br />
Introductory remarks<br />
Raymond Vanholder, <strong>ERA</strong>-<strong>EDTA</strong> President<br />
Presentation of the <strong>ERA</strong>-<strong>EDTA</strong> Award for outstanding scientific<br />
merits to John Stewart Cameron<br />
Presentation of the <strong>ERA</strong>-<strong>EDTA</strong> Award for outstanding contributions<br />
to the Society to Vincenzo Cambi<br />
Presentation of the <strong>ERA</strong>-<strong>EDTA</strong> young investigator Award to<br />
Giovana Seno di Marco<br />
Opening Lecture<br />
Building adaptive memories through evolution<br />
and development<br />
Alain Prochiantz (intr. Pierre Ronco)<br />
Professor at Collège de France (Chair of morphogenetic<br />
processes)<br />
Film: Pioneers of the European Nephrology<br />
Presented by Giorgina B. Piccoli<br />
Creation: Deep-Light-Light-Deep<br />
With the contribution of the Ecole Nationale du Cirque, the<br />
Corou de Berra (Provençal choir), Nadia Kuprina (opera<br />
singer).<br />
Music and videos: Gilberto Richiero<br />
Stage directors: Luc Richard and David Jauzion-Graverolles<br />
Welcome Cocktail in the Exhibition Level 1 and 2,<br />
accompanied by the artists of the Ecole Nationale du Cirque<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
DAY AT A GLANCE<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
page<br />
08:00 - 09:30 Symposia<br />
Late breaking clinical trials 60<br />
<strong>ERA</strong>-<strong>EDTA</strong> Registry 61<br />
CKD-mineral bone disorders 62<br />
Diagnostic approaches to tx kidney 63<br />
Renin-angiotensin system 64<br />
Free Communications + Mini Lectures<br />
AKI and stem cells 65<br />
Renal physiology 67<br />
IgA Nephropathy and urinary proteomics 69<br />
09:30 - 10:45 Poster session 105<br />
10:45 - 11:30 Plenary Lecture G. Karsenty<br />
The novel endocrinology of bone 71<br />
11:45 - 13:15 Symposia<br />
Sepsis and AKI 72<br />
What is “good dialysis”? 73<br />
Polycystic kidney disease 74<br />
Bone and mineral metabolism after tx 75<br />
Leukocytes and pro-inflammatory<br />
mediators in renal injury 76<br />
Free Communications + Mini Lectures<br />
Mechanisms and targets of glom. damage 77<br />
HUS and diabetic nephropathy 79<br />
Paediatric nephrology 81<br />
13:15 - 15:15 Industry Symposia 373<br />
15:15 - 16:45 Symposia<br />
Thrombotic microangiopathies<br />
and complement disorders 83<br />
Prehypertensive kidney 84<br />
Calcium sensing and PTH secretion 85<br />
Peritoneal dialysis 86<br />
Renal fibrosis 87<br />
Free Communications + Mini Lectures<br />
Vascular damage and access in CKD 88<br />
Clinical epidemiology and CKD 1-5 90<br />
AKI clinical studies 92<br />
17:00 - 18:30 Symposia<br />
DOPPS 93<br />
Vascular calcifications in CKD 94<br />
Paraneoplastic GN, monoclonal-IgG<br />
related disorders and amyloid 95<br />
Literature Updates<br />
Clinical nephrology 96<br />
Transplantation 97<br />
Free Communications + Mini Lectures<br />
Genetic studies in renal diseases 98<br />
Hypertension 100<br />
Anaemia 102<br />
59<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
60<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
GRAND AMPHITHEATRE 08:00 - 09:30<br />
Symposium 1<br />
Late breaking clinical trials<br />
Chair: Johannes Mann, Munich, Germany<br />
Giuseppe Remuzzi, Bergamo, Italy<br />
Effect of dual blockade of the renin angiotensin system<br />
on the progression of type 2 diabetic nephropathy<br />
José Luño, Madrid, Spain<br />
Olmesartan in dialysis patients: results of the OCTOPUS<br />
study<br />
Kunitoshi Iseki, Nishihara, Japan<br />
The impact of a low glucose peritoneal dialysis solution<br />
regimen on metabolic control in diabetic patients: the<br />
IMPENDIA and EDEN randomized, controlled clinical<br />
trials<br />
Joanne M. Bargman, Toronto, Canada<br />
The use of phosphate binding agents is associated with<br />
lower mortality: results from the COSMOS study<br />
Jorge B. Cannata-Andía, Oviedo, Spain<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 1 08:00 - 09:30<br />
Symposium 2<br />
<strong>ERA</strong>-<strong>EDTA</strong> Registry<br />
Chair: Raymond Vanholder, Ghent, Belgium<br />
Christoph Wanner, Würzburg, Germany<br />
The Registry in <strong>2012</strong>: a source for research and collaboration<br />
Christoph Wanner, Würzburg, Germany<br />
European nephrologists’ experience with the decision<br />
not to start RRT<br />
Moniek van de Luijtgaarden, Amsterdam, Netherlands<br />
EQUAL study - an international study in Stage 4 CKD<br />
Kitty Jager, Amsterdam, Netherlands<br />
Policies and practices of paediatric kidney transplantation<br />
across Europe<br />
Jérome Harambat, Bordeaux, France<br />
Pregnancy in chronic dialysis patients - a systematic review<br />
Marlies Noordzij, Amsterdam, Netherlands<br />
Timing and outcome of RRT in patients with congenital<br />
malformations of the kidney and the urinary tract<br />
Elke Wühl, Heidelberg, Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
61<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
62<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BLEU 08:00 - 09:30<br />
Symposium 3<br />
Current aspects of CKD-mineral bone disorders<br />
Chair: Marc De Broe, Antwerp, Belgium<br />
Marc Vervloet, Amsterdam, Netherlands<br />
Cardiovascular disease related mortality in CKD: revisiting<br />
the role of vitamin D, calcimimetics, alkaline phosphatase,<br />
and minerals<br />
Michal Nowicki, Lodz, Poland<br />
Not all phosphate is created equal: phosphate toxicity by<br />
food supplements?<br />
Markus Ketteler, Coburg, Germany<br />
Interaction between FGF23, PTH, P and calcitriol in<br />
CKD-MBD, which comes first?<br />
Justin Silver, Jerusalem, Israel<br />
Vitamin D, FGF23 and innate immunity in CKD<br />
Justine Bacchetta, Bron, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BORDEAUX 08:00 - 09:30<br />
Symposium 4<br />
Diagnostic approaches to the transplant kidney<br />
Chair: Maryvonne Hourmant, Nantes, France<br />
Francesco Paolo Schena, Bari, Italy<br />
Molecular phenotypes of renal allograft rejection<br />
Ondrej Viklicky, Prague, Czech Republic<br />
Towards personalized medicine in transplantation /<br />
Biomarkers in transplantation<br />
Josep M. Grinyó, Barcelona, Spain<br />
Antibodies against vascular receptors in transplant recipients<br />
Duska Dragun, Berlin, Germany<br />
The clinical relevance of HLA antibody detection<br />
Frans H.J. Claas, Leiden, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
63<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
64<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE HAVANE 08:00 - 09:30<br />
Symposium 5<br />
Advances in understanding the renin-angiotensin<br />
system<br />
Chair: Armin Kurtz, Regensburg, Germany<br />
Laszlo Rosivall, Budapest, Hungary<br />
Aldosterone synthase inhibition<br />
Michel Azizi, Paris, France<br />
Prorenin receptor function in the kidney<br />
Geneviève Nguyen, Paris, France<br />
Renin-Inhibitors: What is their current place in therapy?<br />
Jan Danser, Rotterdam, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 352AB 08:00 - 09:30<br />
Free Communication Session 1 + Mini Lecture<br />
AKI and stem cells<br />
Chair: Uta Kunter, Aachen, Germany<br />
Masaomi Nangaku, Tokyo, Japan<br />
FREE COMMUNICATIONS<br />
« FO001<br />
BMP-2 INDUCES A PRO-FIBROTIC PHENOTYPE IN ADULT<br />
RENAL PROGENITOR CELLS THROUGH Nox4 ACTIVA-<br />
TION<br />
Simona Simone | Marica Cariello | Carmela Cosola | Fabio<br />
Sallustio | Antonia Loverre | Francesco Paolo Schena | G Grandaliano<br />
| Loreto Gesualdo | Giovanni Pertosa<br />
Nephrology, Dialysis and Transpl Unit, DETO, Univ Bari, Italy|<br />
Dept Emergency and Organ Transpl, Univ Bari, Bari, Italy | Nephrology,<br />
Dialysis and Transpl Unit, Dept Biomedical Sciences,<br />
Univ Foggia, Italy<br />
« FO002<br />
ENDOTHELIAL-TO-MESENCHYMAL TRANSITION IN SWI-<br />
NE RENAL ISCHEMIA REPERFUSION INJURY IS MEDIA-<br />
TED BY COMPLEMENT AND AKT PATHWAY<br />
Giuseppe Castellano | Claudia Curci | Antonia Loverre |<br />
Alessandra Stasi | Simona Simone | Marica Cariello | Vincenzo<br />
Montinaro | Pasquale Ditonno | Michele Battaglia | Francesco<br />
Staffieri | Antonio Crovace | Beatrijs Oortwjin | Edwin<br />
van Amersfoort | Francesco Paolo Schena | Loreto Gesualdo |<br />
Giuseppe Grandaliano<br />
Dept Emergency and Organ Transpl, Univ Bari, Bari, Italy |<br />
Pharming Group NV, Leiden, Netherlands | Renal, Dialysis<br />
and Transpl Unit, Dept Biomedical Sciences, Univ Foggia, Foggia,<br />
Italy<br />
FO003<br />
RENOPROTECTIVE EFFECTS OF IN VIVO TREATMENT<br />
WITH DNASE IN A RAT MODEL OF ISCHEMIA-REPERFU-<br />
SION-INDUCED ACUTE KIDNEY INJURY<br />
Joshuah Weissgarten | Shai Efrati | Sylvia Berman | Ramzia<br />
Abu Hamad<br />
Assaf Harofeh Medical Center<br />
FO004<br />
THE EFFECT OF BONE MARROW MESENCHYMAL STEM<br />
CELLS (BMSC) OR CONDITIONED MEDIUM (CM) IN RATS<br />
WITH ACUTE KIDNEY INJURY (AKI) INDUCED BY LIPOPO-<br />
LYSACCHARIDE (LPS)<br />
Joelma Santina Christo | Luciana Aparecida Reis | Fernanda<br />
Borges | Manuel de Jesus Simões | Nestor Schor<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
65<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
66<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
Nephrology Division, Morphology Dept | Federal Univ São<br />
Paulo (UNIFESP), São Paulo, Brazil<br />
¯ t FO005<br />
MICROVESICLES DERIVED FROM ENDOTHELIAL PROGE-<br />
NITOR CELLS PROTECT KIDNEY FROM CISPLATIN-INDU-<br />
CED ACUTE TOXIC INJURY BY MICRORNA-DEPENDENT<br />
REPROGRAMMING AND INHIBITION OF APOPTOSIS OF<br />
TUBULAR CELLS<br />
Vincenzo Cantaluppi | Stefania Bruno | Federico Figliolini |<br />
Davide Medica | Ciro Tetta | Giovanni Camussi<br />
Univ Turin, Italy | Fresenius Medical Care, Bad Homburg, Germany<br />
Mini Lecture<br />
Stem cell therapy using MSC from human adipose tissues<br />
Shoichi Maruyama, Nagoya, Japan<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 342AB 08:00 - 09:30<br />
Free Communication Session 2 + Mini Lecture<br />
Renal physiology<br />
Chair: Giovambattista Capasso, Naples, Italy<br />
Pascal Houillier, Paris, France<br />
FREE COMMUNICATIONS<br />
« FO006<br />
H,K-ATPase TYPE 2 IS REQUIRED FOR RENAL ADAPTA-<br />
TION TO PREGNANCY<br />
Salhi Amel | Gilles Crambert | Doucet Alain<br />
INSERM-Cordelier Research Center, Paris, France<br />
FO007<br />
UNMASKING A CONSTITUTIVELY ACTIVE SALT-ABSOR-<br />
BING PATHWAY IN THE KIDNEY: A NOVEL TARGET FOR<br />
DIURETIC TH<strong>ERA</strong>PY<br />
Manoocher Soleimani | Hassane Amlal | Sharon Barone | Jie<br />
Xu | Kamyar Zahedi<br />
Univ Cincinnati, Cincinnati, USA<br />
FO008<br />
UP4A AFFECTING THE GLOMERULAR FILTRATION RATE<br />
Zidek Walter | Jankowski Joachim | Jankowski Vera<br />
Charité, Berlin, Germany<br />
Mini Lecture<br />
ATP and the kidney<br />
Robert Unwin, London, UK<br />
FREE COMMUNICATIONS<br />
FO009<br />
RENAL UPTAKE OF 99MTC-DMSA IS DEPENDENT ON EN-<br />
DOCYTOSIS BY THE MEGALIN/CUBILIN RECEPTOR COM-<br />
PLEX<br />
Kathrin Weyer | Rikke Nielsen | Erik Christensen | Michael<br />
Rehling | Henrik Birn<br />
Dept Biomedicine, Aarhus Univ | Dept Clinical Physiology and<br />
Nuclear Medicine, Aarhus Univ Hosp, Skejby, Aarhus, Denmark<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
67<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
68<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
FO010<br />
EXOSOME ISOLATION, COUNT AND CHARACTERIZA-<br />
TION FROM NORMAL URINE<br />
Veronica Dimuccio | Andrea Ranghino | Giovanni Camussi |<br />
Benedetta Bussolati<br />
Dept Internal Medicine, Univ Torino | Dept Internal Medicine,<br />
Torino, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 2 08:00 - 09:30<br />
Free Communication Session 3 + Mini Lecture<br />
IgA Nephropathy and urinary proteomics<br />
Chair: Rosanna Coppo, Turin, Italy<br />
Christophe Mariat, Saint-Etienne, France<br />
FREE COMMUNICATIONS<br />
¯ t FO011<br />
miR-148b UPREGULATION MODULATING CORE 1, β1,3-<br />
GALACTOSYLTRANSF<strong>ERA</strong>SE 1 EXPRESSION EXPLAINS<br />
THE ABNORMAL GLYCOSYLATION PROCESS OF IgA1 IN<br />
IgA NEPHROPATHY<br />
Grazia Serino | Fabio Sallustio | Sharon Natasha Cox | Francesco<br />
Pesce | Francesco Paolo Schena<br />
Dept Emergency and Organ Transpl, Nephrology Dialysis and<br />
Transpl Unit, Univ Bari, Bari, Italy<br />
« FO012<br />
SOLUBLE CD89-IGA1 COMPLEXES AGGRAVATE IGAN DE-<br />
VELOPMENT IN A MOUSE MODEL<br />
Christina Papista | Laureline Berthelot | Thiago T. Maciel |<br />
Martine Biarnes-Pelicot | Emilie Tissandie | Pamela H.M.<br />
Wang | Houda Tamouza | Agnès Jamin | Julie Bex-Coudrat |<br />
Aurelie Gestin | Ahmed Boumediene | Michelle Arcos-Fajardo|<br />
Patrick England | Evangéline Pillebout | Francine Walker|<br />
Eric Daugas | François Vrtosvnik | Marc Benhamou | Michel<br />
Cogné | Ivan C. Moura | Renato C Monteiro<br />
INSERM U699, Paris, France | CNRS UMR6101, Univ Limoges,<br />
Limoges, France | Inst Pasteur, Proteopole, Paris, France | Serv<br />
Anatomo-Pathologie, Hôp Bichat-Claude Bernard, Paris, France<br />
FO013<br />
WHAT ARE THE MOST IMPORTANT PROGNOSTIC FAC-<br />
TORS FOR RENAL SURVIVAL IN IgA NEPHROPATHY?<br />
Cristina Sarcina | Carmine Tinelli | Francesca Ferrario | Bianca<br />
Visciano | Veronica Terraneo | Antonello Pani | Giovanni<br />
Battista Fogazzi | Silvia Furiani | Elena Alberghini | Laura<br />
Buzzi | Claudio Pozzi<br />
Bassini Hosp, Cinisello Balsamo, Milan, Italy | S. Matteo Hosp,<br />
Pavia, Italy | Brotzu Hosp, Cagliari, Italy | Maggiore Hosp, Milan,<br />
Italy<br />
Mini Lecture<br />
Will urinary proteomics make the renal tissue biopsy redundant?<br />
Loreto Gesualdo, Bari, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
69<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
70<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
FREE COMMUNICATIONS<br />
FO014<br />
IGA NEPHROPATHY: ASSOCIATION BETWEEN HISTOLO-<br />
GICAL LESIONS AND BLOOD AND URINE PEPTIDE PRO-<br />
FILE<br />
Fredzzia Graterol | Maribel Navarro-Muñoz | Dolores López|<br />
Meritxell Ibernon | Maruja Navarro | Maribel Troya | Vanessa<br />
Pérez| Neus Sala | Assumpta Serra | Josep Bonet | Ramón<br />
Romero<br />
Hosp Univ Germans Trias i Pujol, Badalona, Spain<br />
FO015<br />
COMPLETE REMISSION PREDICTS A GOOD PROGNOSIS<br />
AFTER METHYLPREDNISOLONE PULSE TH<strong>ERA</strong>PY IN PA-<br />
TIENTS WITH IGA NEPHROPATHY<br />
Miho Tatematsu | Yoshinari Yasuda | Waichi Sato | Naotake<br />
Tsuboi | Shoichi Maruyama | Enyu Imai | Seiichi Matsuo<br />
Nagoya Univ Graduate School of Medicine, Nagoya, Japan<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
GRAND AMPHITHEATRE 10:45 - 11:30<br />
Plenary Lecture 1<br />
Chair: Pierre Ronco, Paris, France<br />
Raymond Vanholder, Ghent, Belgium<br />
The novel endocrinology of bone<br />
Gerard Karsenty, New York, USA<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
71<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
72<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
GRAND AMPHITHEATRE 11:45 - 13:15<br />
Symposium 6<br />
Sepsis and AKI<br />
Chair: Norbert Lameire, Ghent, Belgium<br />
Mehmet Sukru Sever, Istanbul, Turkey<br />
Diagnosis and treatment of hyponatremia in the ICU -<br />
the ERBP guideline<br />
Evi Nagler, Ghent, Belgium<br />
General, non-renal management of septic shock<br />
Eric Hoste, Ghent, Belgium<br />
CRRT in sepsis, does the anticogulant matter?<br />
Heleen M. Oudemans-van Straaten, Amsterdam, Netherlands<br />
SLED vs CRRT vs IHD in sepsis<br />
Achim Jörres, Berlin, Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 1 11:45 - 13:15<br />
Symposium 7<br />
What is “good dialysis”?<br />
Chair: Mustafa Arici, Ankara, Turkey<br />
Bernard Canaud, Montpellier, France<br />
What is early start and why it should not be systematic?<br />
Christian Combe, Bordeaux, France<br />
What is late start and why is it harmful?<br />
Charles Tomson, Bristol, UK<br />
When to start of dialysis: guideline and reality<br />
James Tattersal, Leeds, UK<br />
Target blood pressure in hemodialysis patients<br />
Thierry Hannedouche, Strasbourg, France<br />
Long dialysis sessions (daily, nocturnal etc)<br />
Ercan Ok, Izmir, Turkey<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
73<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
74<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BLEU 11:45 - 13:15<br />
Symposium 8<br />
Polycystic kidney disease: clinical studies<br />
Chair: Yves Pirson, Brussels, Belgium<br />
Andreas Serra, Zurich, Swizerland<br />
Vaptans in ADPKD<br />
Vicente Torres, Rochester, USA<br />
Somatostatin analogues in polycystic liver disease<br />
Joost P.H. Drenth, Nijmegen, Netherlands<br />
What is a reasonable endpoint in clinical PKD studies?<br />
Giuseppe Remuzzi, Bergamo, Italy<br />
The many masks of HNF1beta-related (kidney) diseases<br />
Dominique Chauveau, Toulouse, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BORDEAUX 11:45 - 13:15<br />
Symposium 9<br />
Bone and mineral metabolism after transplantation<br />
Chair: João M. Frazão, Porto, Portugal<br />
Rudolf Wüthrich, Zurich, Swizerland<br />
The use of cinacalcet after renal transplantation<br />
Andries Hoitsma, Nijmegen, Netherlands<br />
Bone metabolism in renal transplanted patients<br />
Pieter Evenepoel, Leuven, Belgium<br />
Post-transplant hypophosphatemia<br />
Wilfried Gwinner, Hanover, Germany<br />
FREE COMMUNICATIONS<br />
FO016<br />
A PROSPECTIVE COHORT STUDY OF PERSISTENT HYPER-<br />
PARATHYROIDISM IN KIDNEY TRANSPLANT RECIPIENTS<br />
F Vincenti | M Weir | J Von Visger | N Kopyt | RB Mannon |<br />
S Tseng | W Goodman | M Wolf<br />
UCSF Kidney Transplant Serv, San Francisco, USA | U Maryland,<br />
USA | Ohio State U Medical Center, USA | Lehigh Valley<br />
Hosp, USA | U Alabama Birmingham, USA | Amgen, San<br />
Francisco USA | Amgen, Thousand Oaks USA | U Miami Miller<br />
School of Medicine, USA<br />
FO017<br />
CHOLECALCIFEROL SUPPLEMENTATION REDUCES PRO-<br />
TEINURIA AND PARATHORMONE IN KIDNEY TRAN-<br />
SPLANT PATIENTS<br />
Ines Aires | Anibal Ferreira | Cecilia Silva | Francisco Remedio|<br />
Fernando Nolasco<br />
HCC, Lisbon, Portugal<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
75<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
76<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE HAVANE 11:45 - 13:15<br />
Symposium 10<br />
Leukocytes and pro-inflammatory mediators in<br />
renal injury<br />
Chair: Hans-Joachim Anders, Munich, Germany<br />
Loreto Gesualdo, Bari, Italy<br />
Genetic loci modulate macrophage activity in glomerulonephritis<br />
Terry Cook, London, UK<br />
Kidney dendritic cells in acute and chronic renal disease<br />
Christian Kurts, Bonn, Germany<br />
Kinase inhibitors in experimental glomerulonephritis<br />
Charles Pusey, London, UK<br />
NFκB in renal inflammation<br />
Alberto Ortiz, Madrid, Spain<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 352AB 11:45 - 13:15<br />
Free Communication Session 4 + Mini Lecture<br />
Mechanisms and targets of glomerular damage<br />
Chair: Jesus Egido, Madrid, Spain<br />
Maria Pia Rastaldi, Milan, Italy<br />
FREE COMMUNICATIONS<br />
« FO018<br />
CTGF: A LIGAND OF EPIDERMAL GROWTH FACTOR RE-<br />
CEPTOR (EGFR). OPENING NOVEL POTENTIAL TH<strong>ERA</strong>-<br />
PEUTIC TARGETS FOR RENAL DISEASES<br />
Sandra Rayego-Mateos | Raquel Rodrigues-Díez | Raul R.<br />
Rodrigues-Díez | Carolina Lavoz-Barria | Matilde Alique | Sebastian<br />
Mas | Janos Pato | Gyorgy Keri | Jesus Egido | Alberto<br />
Ortiz | Marta Ruiz-Ortega<br />
Cellular Biology Renal Diseases Lab Univ Autónoma Madrid,<br />
Spain | Renal Research Lab Fund Jiménez Díaz, Univ Autónoma<br />
Madrid, Spain | Vichem Chemie Ltd. Budapest, Hungary |<br />
Dialysis Unit, Fund Jiménez Díaz, Madrid Spain<br />
FO019<br />
BLOCKADE OF THE PROTEOGLYCAN SYNDECAN 4 AME-<br />
LIORATES PROTEINURIC KIDNEY DISEASE<br />
Liu Ying | Martin Tepel | Echtermeyer Frank | Thilo Florian |<br />
Theilmeier Gregor | Jensen Boye | Gollasch Maik<br />
SDU IMM Odense Denmark | MHH Hannover Germany |<br />
Charite Berlin Germany<br />
FO020<br />
DYNAMIN ACTIVATION RESCUES PKCe DEFICIENCY IN-<br />
DUCED ACTIN DYSREGULATION IN PODOCYTES<br />
Beina Teng | Changkyu Gu | Hermann Haller | Sanja Sever |<br />
Mario Schiffer<br />
Medical School Hannover | Nephrology Div, Dept Medicine,<br />
Massachusetts Gerneral Hosp, Charlestown, Massachusetts,<br />
USA<br />
« FO021<br />
DEF-6 EXPRESSION AND LOCALIZATION IS CHANGED IN<br />
PKCλ/ι DEFICIENT MICE AND PODOCYTES<br />
Kirstin Worthmann | Michael Leitges | Oliver Dittrich-<br />
Breiholz | Michael Kracht | Hermann Haller | Mario Schiffer<br />
Medical School Hannover, Hannover, Germany | Biotechnology<br />
Centre Oslo, Oslo, Norway<br />
FO022<br />
PROTEINURIA IMPAIRS PODOCYTE REGEN<strong>ERA</strong>TION IN<br />
GLOMERULAR DISORDERS<br />
Anna Peired | Maria Lucia Angelotti | Elisa Ronconi | Elena<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
77<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
78<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
Lazzeri | Alessandro Sisti | Laura Lasagni | Paola Romagnani<br />
Univ Florence, Florence, Italy<br />
Mini Lecture<br />
Podocyte cell communication through glutamate receptors<br />
and co<br />
Maria Pia Rastaldi, Milan, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 342AB 11:45 - 13:15<br />
Free Communication Session 5 + Mini Lecture<br />
HUS and diabetic nephropathy<br />
Chair: Ivan Rychlik, Prague, Czech Republic<br />
Franz Schaefer, Heidelberg, Germany<br />
FREE COMMUNICATIONS<br />
FO023<br />
aHUS SUPERIMPOSED TO UNDERLYING GLOMERULOPA-<br />
THY: AN UNDERPINNED ASSOCIATION?<br />
Lucio Manenti | Marco Allinovi | Augusto Vaglio | Lando Allegri<br />
| Elisa Gnappi<br />
Dept Nephrology, Univ Parma<br />
FO024<br />
EFFICACY AND SAFETY OF ECULIZUMAB TREATMENT<br />
FOR ATYPICAL HAEMOLYTIC UREMIC SYNDROME<br />
(aHUS) IN PAEDIATRIC PATIENTS: SUBGROUP ANALYSIS<br />
OF A RETROSPECTIVE STUDY<br />
Giacomo Simonetti | Ramon Vilalta | Anne-Laure Lapeyraque|<br />
Ralph Gruppo | Julius Sherwinter | Jodi Smith | Courtney<br />
Thornburg | Therese Jungraithmayr | Elke Wuehl |<br />
Samhar Al-Akash | J.C. Davin | Marie Alice Macher | Craig<br />
Langman | Juan Antonio Camacho Diaz<br />
Bern Univ Hosp, Bern, Switzerland | Hosp Vall d’Hebron,<br />
Barcelona, Spain | CHU Sainte-Justine, Montréal, Canada |<br />
Cincinnati Children’s Hosp Medical Center, Cincinnati, USA|<br />
Children’s Healthcare Atlanta, Atlanta, USA | Children’s Hosp<br />
and Regional Medical Center, Seattle, USA | Duke Univ Medical<br />
Center, Durham, USA | Innsbruck Medical Univ, Innsbruck,<br />
Austria | Center Pediatric and Adolescent Medicine,<br />
Univ Heidelberg, Heidelberg, Germany | Driscoll Children’s<br />
Kidney Center, Corpus Christi, USA | Emma Children’s Hosp,<br />
Amsterdam, Netherlands | Hôp Robert Debré, Paris, France |<br />
Children’s Memorial Hosp, Chicago, USA | Hosp Infantil Sant<br />
Joan de Déu, Barcelona, Spain<br />
FO025<br />
BARDOXOLONE METHYL ACUTELY REDUCES SERUM<br />
MAGNESIUM IN STAGE 3B AND 4 CKD PATIENTS WITH<br />
TYPE 2 DIABETES WITHOUT ANY ADVERSE EFFECT ON<br />
QT INTERVAL<br />
Melanie Chin | Angie Goldsberry, MS | Sudarshan Hebbar |<br />
Colin Meyer | Paul Audhya | Robert Toto | David Warnock<br />
Reata Pharmaceuticals, Irving TX, USA | Univ Texas Southwestern,<br />
Dallas TX, USA | Univ Alabama Birmingham, Birmingham,<br />
AL USA<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
79<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
80<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
FO026<br />
WEIGHT LOSS IN OBESE, STAGE 3B AND 4 CKD PATIENTS<br />
WITH TYPE 2 DIABETES GIVEN BARDOXOLONE METHYL<br />
Pablo Pergola | Melanie Chin | Angie Goldsberry, MS | Sudarshan<br />
Hebbar | Colin Meyer | Paul Audhya<br />
Renal Associates, San Antonio TX, USA | Reata Pharmaceuticals,<br />
Irving TX, USA<br />
FO027<br />
PROTEINURIA IS A TH<strong>ERA</strong>PEUTIC TARGET FOR RENO-<br />
PROTECTION IN PATIENTS WITH TYPE 2 DIABETES WITH<br />
OVERT NEPHROPATHY: A SUB-ANALYSIS OF ORIENT<br />
STUDY<br />
Enyu Imai | Masakazu Haneda | Sadayoshi Ito | Fumiaki Kobayashi<br />
| Tetsu Yamasaki | Juliana Chan | Hirofumi Makino<br />
Nagoya Univ, Nagoya, Japan | Asahikawa Medical Univ, Asahikawa,<br />
Japan | Tohoku Univ, Sendai, Japan | Daiichi-Sankyo<br />
Co.Ltd. Tokyo Japan | Chinese Univ Hong Kong, Hong Kong,<br />
China | Okayama Univ, Okayama, Japan<br />
Mini Lecture<br />
An analysis of the worldwide output in Nephrology research<br />
2002-2010<br />
Marc de Broe, Antwerp, Belgium<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 2 11:45 - 13:15<br />
Free Communication Session 6<br />
Paediatric nephrology<br />
Chair: Georges Deschênes, Paris, France<br />
Markus J. Kemper, Hamburg, Germany<br />
FREE COMMUNICATIONS<br />
FO028<br />
IDENTIFICATION OF PROGNOSTIC MARKERS OF POST-<br />
NATAL RENAL FUNCTION IN BILAT<strong>ERA</strong>L OBSTRUCTIVE<br />
NEPHROPATHY BY FOETAL URINE PROTEOME ANALYSIS<br />
Julie Klein | Chrystelle Lacroix | Cécile Caubet | Justyna<br />
Siwy| Françoise Muller | Jean-Loup Bascands | Stéphane Decramer<br />
| Joost Schanstra<br />
Inserm U1048 | CNRS, IPBS (Inst Pharmacologie et Biologie<br />
Structurale)| Mosaiques Diagnostics | Néphrologie Pédiatrique,<br />
Hôp Robert Debré AP-HP| Inst Cardiovascular and Metabolic<br />
Disease<br />
FO029<br />
SWITCH FROM PROTEASOME TO IMMUNOPROTEASOME<br />
IN CHILDREN WITH IDIOPATHIC NEPHROTIC SYNDRO-<br />
ME<br />
Roberta Camilla | Elisa Loiacono | Licia Peruzzi | Rachele<br />
Gallo | Maria Elena Donadio | Luca Vergano | Federica Campolo<br />
| Laura Morando | Alessandro Amore | Rosanna Coppo<br />
Nephrology, Dialysis, Transpl, R.Margherita Hosp, Turin<br />
« FO030<br />
EPIDEMIOLOGY OF THE IDIOPATHIC NEPHROTIC SYN-<br />
DROME IN CHILDREN: ENDEMIC OR EPIDEMIC?<br />
Claire Dossier | Anne-Laure Leclerc | Nathanael Lapidus |<br />
Alexandra Rousseau | Marina Charbit | Helene Sarda | Fouad<br />
Madhi | Fabrice Carrat | Georges Deschenes<br />
Hop Robert Debré | Hop Trousseau | Unité Biostatistiques,<br />
Saint Antoine | URC-Est , Saint Antoine | Hop Necker Enfant<br />
Malade | Hop René Dubos | CH Intercommunal Creteil | Serv<br />
Néphrologie Pédiatique, Hôp Robert Debré, Paris, France<br />
FO031<br />
TH<strong>ERA</strong>PEUTIC DRUG MONITORING OF MYCOPHENOLA-<br />
TE MOFETIL IN CHILDREN WITH STEROID-DEPENDENT<br />
IDIOPATHIC NEPHROTIC SYNDROME<br />
Jerome Harambat | Aymeric Dallocchio | Vincent Guigonis |<br />
Lydia Ichay | Lucie Bessenay | Françoise Broux | Arnaud Garnier<br />
| Denis Morin | Brigitte Llanas | Frank Saint-Marcoux |<br />
Stéphane Decramer<br />
ESPN/<strong>ERA</strong>-<strong>EDTA</strong> Registry, Academic Medical Center, Amsterdam,<br />
Netherlands | Children’s Univ Hosp | Children’s<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
81<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
82<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
Univ Hosp, Limoges, France | Children’s Univ Hosp, Montpelier,<br />
France | Children’s Univ Hosp, Clermond-Ferrand, France<br />
| Children’s Univ Hosp, Rouen, France | Children’s Univ<br />
Hosp, Toulouse, France | Children’s Univ Hosp, Bordeaux,<br />
France | Pharmacology, Univ Hosp, Limoges, France<br />
FO032<br />
POST-TRANSPLANT DISEASE RECURRENCE AND GRAFT<br />
LOSS; STILL A MAJOR PROBLEM IN PEDIATRIC TRAN-<br />
SPLANTATION<br />
Karlijn van Stralen | Enrico Verrina | Mirco Belingheri | Jiri<br />
Dusek | Jan Dudley | Ryszard Grenda | Jacek Rubik | Sarunas<br />
Rudaitis | Christoph Rudin | Franz Schaefer | Kitty Jager<br />
AMC | G. Gaslini | Clinica Pediatrica De Marchi, Milano,<br />
Italy| Charles Univ Prague, Prague, Czech Republic | Bristol<br />
Royal Hosp Children, Bristol, UK | Children’s Memorial Health<br />
Inst, Warsaw, Poland | Hosp Lithuanian Univ Health Sciences<br />
Kaunas Clinics, Kaunas, Lithuania | Univ Children’s Hosp,<br />
Basel, Switzerland | Univ Heidelberg, Heidelberg, Germany |<br />
AMC, Amsterdam, Netherlands<br />
FO033<br />
AN OUTBREAK OF SHIGA-TOXIN PRODUCING E. COLI<br />
O104:H4 HEMOLYTIC UREMIC SYNDROME (STEC-HUS)<br />
IN GERMANY: PRESENTATION AND SHORT TERM OUT-<br />
COME IN CHILDREN. A REPORT OF THE GERMAN PEDIA-<br />
TRIC HUS REGISTRY<br />
Sebastian Loos | Markus J Kemper<br />
Pediatric Nephrology, Hamburg, Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
GRAND AMPHITHEATRE 15:15 - 16:45<br />
Symposium 11<br />
Thrombotic microangiopathies and complement<br />
disorders<br />
Chair: Terry Cook, London, UK<br />
Marina Noris, Bergamo, Italy<br />
EHEC: the German 2011 epidemic<br />
Jan T. Kielstein, Hanover, Germany<br />
Atypical HUS and the complement system<br />
Véronique Fremeaux-Bacchi, Paris, France<br />
The biology of ADAMs in renal diseases<br />
Harry Van Goor, Groningen, Netherlands<br />
C3 glomerulonephritis and CFHR5 nephropathy<br />
Patrick Maxwell, London, UK<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
83<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
84<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 1 15:15 - 16:45<br />
Symposium 12<br />
The prehypertensive kidney<br />
Chair: Kerstin Amann, Erlangen, Germany<br />
Jean-Jacques Boffa, Paris, France<br />
Pathophysiological renal characteristics of prehypertension<br />
Peter W. de Leeuw, Maastricht, Netherlands<br />
Early markers of renal dysfunction in prehypertension<br />
Alexander Rosenkranz, Graz, Austria<br />
Tubulo-interstitial changes in early hypertension and its<br />
relation to natriuresis<br />
Jacek Manitius, Bydgoszcz, Poland<br />
Renal dysfunction and chronic abnormalities in prehypertension<br />
Luis Ruilope, Madrid, Spain<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BLEU 15:15 - 16:45<br />
Symposium 13<br />
Calcium sensing and PTH secretion<br />
Chair: Klaus Olgaard, Copenhagen, Denmark<br />
Justin Silver, Jerusalem, Israel<br />
Physiology and pathophysiology of the calcium sensing<br />
receptor in the kidney<br />
Daniela Riccardi, Cardiff, UK<br />
microRNAs and RNA binding proteins in the regulation<br />
of PTH synthesis<br />
Tally Naveh-Many, Jerusalem, Israel<br />
Calcium sensing receptor: extrarenal effects<br />
Dominique Prié, Paris, France<br />
Modulation of calcium sensing by calcimimetics<br />
J. Mariano Rodriguez, Cordoba, Spain<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
85<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
86<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BORDEAUX 15:15 - 16:45<br />
Symposium 14<br />
Peritoneal dialysis<br />
Chair: Olof Heimbürger, Stockholm, Sweden<br />
Nicholas Topley, Cardiff, UK<br />
The biology of the peritoneum, what’s emerging in the<br />
21st century. Lessons to be learnt by EuTRiPD<br />
Christoph Aufricht, Vienna, Austria<br />
Mechanisms of fibrosis/sclerosis and impact of PD solutions<br />
Vedat Schwenger, Heidelberg, Germany<br />
Peritoneal sclerosis and clinical membrane changes -<br />
when do we need to worry?<br />
Simon Davies, Stoke-on-Trent, UK<br />
Encapsulating Peritoneal Sclerosis: clinical insights and<br />
treatments options<br />
Martin Wilkie, Sheffield, UK<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 2 15:15 - 16:45<br />
Symposium 15<br />
Renal fibrosis<br />
Chair: Christos Chatziantoniou, Paris, France<br />
Katalin Susztak, Bronx, USA<br />
The development of tubulo-interstitial fibrosis<br />
Wilhelm Kriz, Mannheim, Germany<br />
Lipocalin-2 and progression of CKD<br />
Fabiola Terzi, Paris, France<br />
EGF receptor pathway and progression of glomerular<br />
disease<br />
Pierre-Louis Tharaux, Paris, France<br />
Methylation determines fibroblast activation and fibrogenesis<br />
in the kidney<br />
Michael Zeisberg, Göttingen, Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
87<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
88<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE HAVANE 15:15 - 16:45<br />
Free Communication Session 7 + Mini Lecture<br />
Vascular damage and access in CKD<br />
Chair: Giorgina B. Piccoli, Turin, Italy<br />
Dimitrios Tsakiris, Thessaloniki, Greece<br />
FREE COMMUNICATIONS<br />
FO034<br />
KRÜPPEL-LIKE FACTOR 4 CONTRIBUTES TO HIGH PHO-<br />
SPHATE-INDUCED PHENOTYPIC SWITCHING OF VASCU-<br />
LAR SMOOTH MUSCLE CELLS INTO OSTEOGENIC CELLS<br />
Tadashi Yoshida | Maho Yamashita | Matsuhiko Hayashi<br />
Apheresis and Dialysis Center, School Medicine, Keio Univ,<br />
Tokyo Japan<br />
FO035<br />
IN VIVO EFFECTS OF THE PROTEIN-BOUND UREMIC TO-<br />
XINS P-CRESYLSULFATE, P-CRESYLGLUCURONIDE AND<br />
INDOXYLSULFATE ON THE CROSS-TALK BETWEEN LEU-<br />
KOCYTES AND THE VESSEL WALL<br />
Anneleen Pletinck | Griet Glorieux | Eva Schepers | Maria<br />
Van Landschoot | Johan Van de Voorde | Wim Van Biesen |<br />
Raymond Vanholder<br />
Ghent Univ Hosp, Ghent, Belgium<br />
FO036<br />
INDOXYL SULFATE ENHACES NEOINTIMA FORMATION<br />
VIA INDUCTION OF LY6CHIGH INFLAMMATORY MONO-<br />
CYTE<br />
Yoko Yagi | Shunsuke Ito | Sumie Goto | Mizuko Osaka |<br />
Masayuki Yoshida<br />
Biomedical Research Laboratories, Kureha Corp, Tokyo, Japan|<br />
Tokyo Medical and Dental Univ, Tokyo, Japan<br />
Mini Lecture<br />
The vascular access unit: surgeons, nephrologists, nurses<br />
or all of them together?<br />
Carlo Basile, Taranto, Italy<br />
FREE COMMUNICATIONS<br />
FO037<br />
RECENT INTERNATIONAL TRENDS FROM THE DOPPS<br />
IN VASCULAR ACCESS USE IN HEMODIALYSIS PA-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
TIENTS: SUBSTANTIAL RISE IN CATHETER USE IN SOME<br />
COUNTRIES<br />
Ronald Pisoni | Douglas Fuller | Richard Fluck | Joan Fort|<br />
Francesco Locatelli | Lawrence Spergel | David Goodkin |<br />
Friedrich Port | Bruce Robinson<br />
Arbor Research Collaborative for Health, Ann Arbor, USA |<br />
Derby City General Hosp, Derby, UK | Hosp Vall d’Hebron,<br />
Barcelona, Spain | Osp A. Manzoni, Lecco, Italy | Dialysis Management<br />
Medical Group<br />
FO038<br />
AN EVALUATION OF VASCULAR ACCESS AND MORTALI-<br />
TY IN THE IMPACT PROGRAM<br />
Steven Wilson | John Robertson | Grace Chen | Pooja Goel|<br />
Deborah Benner | Mahesh Krishnan | Tracy Mayne | Allen<br />
Nissenson<br />
DaVita, Inc | DaVita, Washington, D.C, US | DaVita, El Segundo,<br />
US<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
89<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
90<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 352AB 15:15 - 16:45<br />
Free Communication Session 8<br />
Clinical epidemiology and CKD 1-5<br />
Chair: Luc Frimat, Nancy, France<br />
Francesca Mallamaci, Reggio Calabria, Italy<br />
FREE COMMUNICATIONS<br />
« FO039<br />
BIRTHWEIGHT PREDICTS GLOMERULAR FILTRATION<br />
RATE<br />
Suad Hannawi | Issa Salmi | Helen Healy | Robert Atkins |<br />
Jonathan Shaw<br />
Al Baraha Hosp, Muscat, Oman | Royal Hosp | Royal Brisbane<br />
Hosp | Baker IDI Heart and Diabetes Inst, Brisbane, Australia<br />
« FO040<br />
SERUM URIC ACID AND RISK OF CHRONIC KIDNEY DISE-<br />
ASE: THE ROTTERDAM STUDY AND META-ANALYSIS<br />
Sanaz Sedaghat | Ewout Hoorn | Frank van Rooij | Albert<br />
Hofman | Oscar H. Franco | Jacqueline Witteman | Abbas Dehghan<br />
Dept Epidemiology, Dept Internal Medicine—Nephrology, Erasmus<br />
Medical Center, Rotterdam, Netherlands<br />
« FO041<br />
RELATIVE ENERGY BALANCE, CHRONIC KIDNEY DISE-<br />
ASE AND RISK OF CARDIOVASCULAR AND ALL-CAUSE<br />
MORTALITY<br />
Samuel Iff | Wong Germaine | Angela C Webster | Jie-Jin<br />
Wang | Paul Mitchell | Jonathan Craig<br />
Centre Kidney Research, Westmead, Australia | Centre Vision<br />
Research, Westmead, Australia<br />
FO042<br />
IS THERE AN ASSOCIATION BETWEEN SHORT TERM<br />
CHANGES IN KIDNEY FUNCTION AND MORTALITY?<br />
Christopher Farmer | Jean Irving | Brenda Hemmelgarn | Josef<br />
Coresh | Paul Stevens<br />
East Kent Univ Hosp NHS Foundation Trust, UK | East Kent<br />
Hosp Univ NHS Foundation Trust, UK | Univ Calgary, Calgary,<br />
Alberta, Canada| Johns Hopkins Bloomberg School Public<br />
Health, Baltimore, USA<br />
« FO043<br />
FGF23 AND ASYMMETRICAL DIMETHYLARGININE (ADMA)<br />
ARE INT<strong>ERA</strong>CTIVE FACTORS IN THE HIGH RISK FOR CKD<br />
PROGRESSION IN STAGE 2-5 CKD PATIENTS<br />
Giovanni Tripepi | Daniela Leonardis | Maurizio Postorino |<br />
Giuseppe Enia | Carmine Zoccali | Francesca Mallamaci | The<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
MAURO Working Group<br />
CNR-IBIM, Reggio Calabria | CNR IBIM and Osp Riuniti, Reggio<br />
Calabria, Italy<br />
« FO044<br />
INTACT FIBROBLAST GROWTH FACTOR 23 LEVELS PRE-<br />
DICT INCIDENT CARDIOVASCULAR EVENT BEFORE BUT<br />
NOT AFTER THE START OF DIALYSIS<br />
Sayoko Yonemoto | Takayuki Hamano | Naohiko Fujii | Yoshitugu<br />
Obi | Isao Matsui | Satoshi Mikami | Chikako Nakano|<br />
Kazunori Inoue | Akihiro Shimomura | Noriyuki Okada|<br />
Yoshiharu Tsubakihara | Hiromi Rakugi | Yoshitaka Isaka |<br />
Masaya Katayama<br />
Hyogo Prefectural Nishinomiya Hosp, Hyogo, Japan | Center<br />
Clinical Epidemiology and Biostatistics, Univ Pennsylvania<br />
Perelman School Medicine, Pennsylvania, USA | Dept Internal<br />
Medicine, Hyogo Prefectural Nishinomiya Hosp, Hyogo,<br />
Japan| Dept Geriatric Medicine and Nephrology, Osaka Univ<br />
Graduate School Medicine, Osaka, Japan | Dept Internal Medicine,<br />
Higashi-Kohri Hosp, Osaka, Japan | Dept Nephrology<br />
and Hypertension, Osaka General Medical Center, Osaka, Japan<br />
| Tokushima Second Clinic, Tokushima, Japan<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
91<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
92<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 342AB 15:15 - 16:45<br />
Free Communication Session 9 + Mini Lectures<br />
AKI clinical studies<br />
Chair: Fatma Ben Moussa, Tunis, Tunisia<br />
Petar Kes, Zagreb, Croatia<br />
Mini Lecture<br />
Epidemiology of AKI in the ICU<br />
Fernando Liano, Madrid, Spain<br />
FREE COMMUNICATIONS<br />
FO045<br />
DOES ACUTE KIDNEY INJURY MANAGED ENTIRELY IN<br />
THE COMMUNITY HAVE SIMILAR MORTALITY OUTCO-<br />
MES TO HOSP ACQUIRED ACUTE KIDNEY INJURY?<br />
Michael Bedford | Helen Hobbs | Jean Irving | Toby Wheeler|<br />
Paul Stevens | Christopher Farmer<br />
East Kent Hosp Univ NHS Foundation Trust<br />
FO046<br />
RENAL HYPOPERFUSION, RATHER THAN TUBULAR DA-<br />
MAGE IS THE MAIN INITIAL EVENT IN AKI DURING EAR-<br />
LY SEPSIS<br />
Jill Vanmassenhove | Wim Van Biesen | Griet Glorieux | Raymond<br />
Vanholder<br />
Ghent Univ Hosp, Nephrology, Gent, Belgium<br />
FO047<br />
ACUTE KIDNEY INJURY IN PATIENTS WITH FALCIPARUM<br />
MALARIA. AN ASSESSMENT OF THE RIFLE CRITERIA<br />
João Brandão | Joao Egidio Romao Jr<br />
Clinica Multiperfil | Hosp Beneficencia Portuguesa, Sao Paulo,<br />
Brazil<br />
Mini Lecture<br />
Disaster nephrology<br />
Mehmet Sukru Sever, Istanbul, Turkey<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
GRAND AMPHITHEATRE 17:00 - 18:30<br />
Symposium 16<br />
Correlating international hemodialysis practice<br />
differences with outcomes: the Dialysis Outcomes<br />
and Practice Patterns Study (DOPPS)<br />
Chair: Friedrich Port, Ann Arbor, USA<br />
Bruce Robinson, Ann Arbor, USA<br />
Benefits of studying differences in practice and outcomes<br />
Bruce Robinson, Ann Arbor, USA<br />
Practices before and after policy changes<br />
Werner Kleophas, Düsseldorf, Germany<br />
Transitions from CKD to dialysis<br />
Christian Combe, Bordeaux, France<br />
Indicators related to Mineral Bone Disease<br />
Francesca Tentori, Ann Arbor, USA<br />
Vascular access: Achieving better outcomes<br />
Richard Fluck, Derby, UK<br />
Panel Discussion<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
93<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
94<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 1 17:00 - 18:30<br />
Symposium 17<br />
Vascular calcification in CKD<br />
Chair: Tilman Drueke, Amiens, France<br />
J. Mariano Rodriguez, Cordoba, Spain<br />
Vascular calcifications – lessons from animal studies<br />
Patrick D’Haese, Antwerp, Belgium<br />
Magnesium and cardiovascular disease in CKD<br />
Fatih Kircelli, Yozgat, Turkey<br />
The mysterious effects of sodium thiosulfate on extraosseous<br />
calcifications<br />
Andreas Pasch, Bern, Switzerland<br />
Vascular calcification in patients with CKD. Outcomes<br />
and therapy<br />
Teresa Adragão, Cascais, Portugal<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE HAVANE 17:00 - 18:30<br />
Symposium 18<br />
Paraneoplastic GN, monoclonal-IgG related<br />
disorders and amyloid<br />
Chair: Fernando Fervenza, Rochester, USA<br />
Dario Roccatello, Turin, Italy<br />
Glomerulonephritis with monoclonal immunoglobulin<br />
deposits: the expanding spectrum<br />
Alexandre Karras, Paris, France<br />
Recent diagnostic and therapeutic advances in ALamyloidosis<br />
Frank Bridoux, Poitiers, France<br />
New strategies for the treatment of amyloidosis<br />
Mark B. Pepys, London, UK<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
95<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
96<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BLEU 17:00 - 18:30<br />
Literature Update 1<br />
Clinical nephrology<br />
Chair: Jacques Bernheim, Kfar-Saba, Israel<br />
Momir Polenakovic, Skopje, F.Y.R. of Macedonia<br />
Dominique Joly, Paris, France<br />
Eberhard Ritz, Heidelberg, Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BORDEAUX 17:00 - 18:30<br />
Literature Update 2<br />
Transplantation<br />
Chair: François Berthoux, Saint-Etienne, France<br />
Rainer Oberbauer, Linz, Austria<br />
Daniel Abramowicz, Brussels, Belgium<br />
Denis Glotz, Paris, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
97<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
98<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 352AB 17:00 - 18:30<br />
Free Communication Session 10<br />
Genetic studies in renal diseases<br />
Chair: Dominique Chauveau, Toulouse, France<br />
Roser Torra, Barcelona, Spain<br />
FREE COMMUNICATIONS<br />
FO048<br />
THE COMPLEXITY OF THE 5’UTR REGION OF CLCN5<br />
GENE: TEN 5’UTR ENDS ARE DIFFERENTIALLY EXPRES-<br />
SED IN THE HUMAN KIDNEY<br />
Enrica Tosetto | Alberto Casarin | Rosalba Cristofaro | Leonardo<br />
Salviati | Franca Anglani<br />
Lab Clinical and Epidemiological Genetics, Dept Pediatrics,<br />
Univ Padua, Padua Italy | Lab Histomorphology and Molecular<br />
Biology Kidney, Div Nephrology, Dept Medicine, Univ<br />
Padua, Italy<br />
FO049<br />
CYSTINURIA: PHENOTYPE AND OUTCOMES IN A LARGE<br />
FRENCH COHORT OF 426 PATIENTS<br />
Caroline Prot Bertoye | Said Lebbah | Michel Daudon | Camille<br />
Couffignal | Caroline Elie | Isabelle Tostivint | Olivier<br />
Traxer | Bertrand Knebelmann | Marie Courbebaisse<br />
Necker Hosp, Paris, France | Tenon Hosp, Paris, France | Pitie-<br />
Salpetriere Hosp, Paris, France | Europeen Georges Pompidou<br />
Hosp, Paris, France<br />
« FO050<br />
HIGHER THROMBIN ACTIVATABLE FIBRINOLYSIS INHI-<br />
BITOR LEVELS ARE ASSOCIATED WITH INFLAMMATION<br />
AND GENETIC MUTATIONS IN ATTACK-FREE FAMILIAL<br />
MEDITERRANEAN FEVER PATIENTS<br />
Nuket Bavbek Ruzgaresen | Mevlut Ceri | Ayse Kargili | Derya<br />
Akdeniz | Ali Akcay | Murat Duranay | Galip Guz<br />
Fatih Univ Medical School, Dept Nephrology, Ankara, Turkey|<br />
Ankara Education and Research Hosp, Dept Nephrology, Ankara,<br />
Turkey | Fatih Univ Medical School Dept Internal Medicine,<br />
Ankara, Turkey | Gazi Univ Medical School Dept Nephrology,<br />
Ankara, Turkey<br />
FO051<br />
CAUSAL ROLE OF URIC ACID IN HYPERTENSION AND<br />
ATHEROSCLEROSIS: NEW EVIDENCE BY A MENDELIAN<br />
RANDOMIZATION APPROACH<br />
Alessandra Testa | Belinda Spoto | Maria Cristina Sanguedolce<br />
| Vincenzo Panuccio | Daniela Leonardis | Rocco Tripepi |<br />
Angela Mafrica | Giovanni Tripepi | Carmine Zoccali | Fran-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
cesca Mallamaci<br />
CNR-IBIM, Reggio Calabria | CNR IBIM and Osp Riuniti, Reggio<br />
Calabria<br />
« FO052<br />
LINKAGE ANALYSIS DETECTS TWO ADDITIONAL RE-<br />
GIONS IN FAMILIAL IGA NEPHROPATHY<br />
Francesco Pesce | Sharon Natasha Cox | Grazia Serino | Fabio<br />
Sallustio | Philippe Froguel | Francesco Paolo Schena | Mario<br />
Falchi<br />
Dept Genomics of Common Disease - School Public Health - Imperial<br />
College London | Dept Emergency and Organ Transpl<br />
(DETO) - Univ Bari-Italy | Nephrology Dialysis and Transpl<br />
Unit<br />
¯ FO053<br />
GENOME-WIDE ASSOCIATION STUDY (GWAS) OF INCI-<br />
DENT CKD AND EGFR CHANGE: THE CKDGEN CONSOR-<br />
TIUM<br />
Carsten Böger on behalf of the CKDGen CKD Progression Writing<br />
Group<br />
Univ Medical Center Regensburg, Germany | CKDGen Consortium<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
99<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
100<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 342AB 17:00 - 18:30<br />
Free Communication Session 11 + Mini Lecture<br />
Hypertension<br />
Chair: Michel Godin, Rouen, France<br />
Gérard M. London, Fleury-Mérogis, France<br />
FREE COMMUNICATION<br />
FO054<br />
MESENCHYMAL STEM CELLS (MSC) PREVENT THE RE-<br />
NOVASCULAR HYPERTENSION, IMPROVE RENAL FUN-<br />
CTION AND REDUCE THE RAS MARKERS IN THE RAT<br />
KIDNEY<br />
Elizabeth Oliveira Sales | Mirian Boim | Edgar Maquigussa|<br />
Patricia Semedo | Luciana Pereira | Niels Camara | Cassia Bergamaschi<br />
| Ruy Campos<br />
Federal Univ São Paulo, São Paulo, Brazil<br />
Mini Lecture<br />
Intrarenal Renin Angiotensin System<br />
Laszlo Rosivall, Budapest, Hungary<br />
FREE COMMUNICATIONS<br />
FO055<br />
ALISKIREN EFFECT IN REVERSING HYPERTENSION-IN-<br />
DUCED CHRONIC KIDNEY DISEASE<br />
Lise Weis | Jean-Claude Dussaule | David Feldman | Christos<br />
Chatziantoniou | Panagiotis Kavvadas<br />
INSERM UMR S702, Paris, France | Novartis Pharamaceuticals<br />
Corp., East Hanover, New Jersey, USA<br />
« FO056<br />
DETERMINANTS OF THE COMMON CAROTID ARTERY<br />
SUBCLINICAL LESIONS IN HYPERTENSIVE SUBJECTS<br />
WITH RENAL FIBROMUSCULAR DYSPLASIA<br />
S Savard | Luca Zanoli | G Bobrie | X Jeunemaitre | M Azizi |<br />
M Frank | PF Plouin | S Laurent | P Boutouyrie<br />
Dept Nephrology, Dept Pharmacology, HEGP, AP-HP, IN-<br />
SERM U970 and Univ Paris-Descartes, Paris, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
FO057<br />
ENDOTHELIAL DYSFUNCTION IN SALT SENSITIVE PEO-<br />
PLE<br />
Fernando Margulis | Veronica Golglid | Ruben Schiavelli<br />
Unidad Nefrologia y Trasplante Renal, Hosp Cosme Argerich,<br />
Buenos Aires, Argentina<br />
FO058<br />
COMPARISON OF BLOOD PRESSURE PATTERNS IN IN-<br />
CIDENT HEMODIALYSIS PATIENTS: EVALUATION OF<br />
DIALYSIS DATA FROM 24 COUNTRIES<br />
Adrian Guinsburg | Inga Bayh | Michael Etter | Gero von Gersdorff<br />
| Aileen Grassmann | Jeroen Kooman | Maggie Lam |<br />
Daniele Marcelli | Cristina Marelli | Laura Scatizzi | Mathias<br />
Schaller | Adam Tashman | Stephan Thijssen | Ted Toffelmire|<br />
Len A Usvyat | Frank M. van der Sande | Yuedong Wang |<br />
Claudia barth | Nathan W Levin | Peter Kotanko<br />
Fresenius Medical Care Latin America | Fresenius Medical<br />
Care Europe | Fresenius Medical Care Asia Pacific | Univ Hosp<br />
Cologne, Cologne, Germany | Maastricht Univ Hosp | Renal<br />
Research Inst, New York, New York, USA | Fresenius Medical<br />
Care Canada | Univ California Santa Barbara | Curatorium<br />
Dialysis and Kidney Transpl (KfH), Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
101<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
102<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 2 17:00 - 18:30<br />
Free Communication Session 12<br />
Anaemia<br />
Chair: Patrick Biggar, Coburg, Germany<br />
Goce Spasovski, Skopje, F.Y.R. of Macedonia<br />
FREE COMMUNICATIONS<br />
FO059<br />
CROSS-SPECIES EVALUATION OF PEGINESATIDE PHAR-<br />
MACOKINETICS, ERYTHROPOIETIC ACTIVITY, AND<br />
ERYTHROPOIETIN RECEPTOR (EPOR) BINDING<br />
Jennifer M. Green | Richard B. Mortensen | K-L Fong | Qing<br />
Fan | Karen Leu | Peter J. Schatz | Kathryn Woodburn<br />
Affymax, Inc., Palo Alto, USA | Affymax, Inc. | Accellient Partners<br />
LLC, USA<br />
FO060<br />
PROTEIN CARBAMYLATION AND ERYTHROPOIETIN RE-<br />
SISTANCE IN END STAGE KIDNEY DISEASE<br />
Sahir Kalim | Hector Tamez | Julia Wenger | Elizabeth Ankers<br />
| Anders Berg | Ananth Karumanchi | Ravi Thadhani<br />
Massachusetts General Hosp, Boston, USA | Beth Israel Deaconess<br />
Medical Center, Boston, USA<br />
FO061<br />
HEMOSIDEROSIS DURING HEMODIALYSIS: AN MRI STU-<br />
DY BASES ON 119 PATIENTS<br />
Rostoker Guy | Griuncelli Mireille | Loridon Christelle | Roy<br />
Myriam | Cohen Yves | Janklewicz Philipppe<br />
Hôp Privé Claude Galien, Quincy sous Senart, France<br />
FO062<br />
HEPCIDIN ISOFORMS AND TH<strong>ERA</strong>PEUTIC EFFECTS OF<br />
RECOMBINANT HUMAN ERYTHROPOIETIN IN PATIENTS<br />
UNDERGOING MAINTENANCE HEMODIALYSIS<br />
Takashi Yokoyama | Yasushi Shimonaka | Yusuke Sasaki |<br />
Yuichi Yoshida | Kenro Yamazaki<br />
Dept Nephrology and Dialysis, Sapporo Higashi-Tokushukai<br />
Hosp, Sapporo, Japan | Product Research Dept, Chugai Pharmaceutical<br />
Co., Led, Kamakura, Japan | Dept Nephrology and<br />
Dialysis, Sapporo Higashinaebo Hosp, Sapporo, Japan<br />
FO063<br />
HEPCIDIN-25 IS ASSOCIATED WITH PROGRESSION TO<br />
END STAGE RENAL DISEASE BUT NOT WITH MORTALITY<br />
IN DIABETIC CHRONIC KIDNEY DISEASE<br />
Martin Wagner | Ahsan Alam | Mark Busbridge | Caroline<br />
Kurtz | Josef Zimmermann | Peter Heuschmann | Christoph<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
Wanner | Damien Ashby | Lothar Schramm<br />
Div Nephrology, Univ Hosp Würzburg, Germany | Div Nephrology,<br />
McGill Univ, Montreal, Canada | Dept Clinical Chemistry,<br />
Imperial College London, UK |Inst Clinical Epidemiology<br />
and Biometry, Univ Würzburg, Germany| Kidney and<br />
Transplant Inst, Imperial College, London, UK<br />
FO064<br />
VITAMIN D AS A NEW REGULATOR OF IRON METABOLI-<br />
SM: VITAMIN D SUPPRESSES HEPCIDIN IN VITRO AND IN<br />
VIVO<br />
Justine Bacchetta | Joshua J Zaritsky | Thomas S Lisse | Jessica<br />
L Sea | Rene F Chun | Elizabeta Nemeth | Thomas Ganz |<br />
Mark Westerman | Isidro B Salusky | Martin Hewison<br />
Centre Reference Maladies Rénales Rares | UCLA, Los Angeles,<br />
USA | Intrinsic LifeSciences, La Jolla, USA<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
103<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
104<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
POSTER SESSION<br />
Poster Area<br />
09:30 - 10:45<br />
Acid-base / Electrolytes FP001-FP013<br />
Cell signalling / Pathophysiology FP014-FP043<br />
Hypertension FP044-FP077<br />
Clinical Nephrology -<br />
Lab methods and other markers FP078-FP147<br />
Clinical Nephrology - Epidemiology I FP148-FP182<br />
Renal anaemia - CKD 1-5 FP183-FP217<br />
Mineral and bone disease - CKD 1-5 FP218-FP254<br />
Diabetes - Experimental FP255-FP282<br />
Diabetes - Clinical FP283-FP318<br />
Electrolyte disorders / Nephrolithiasis FP319-FP330<br />
Primary and secondary glomerulonephritis I FP331-FP377<br />
Extracorporeal dialysis:<br />
techniques and adequacy FP378-FP460<br />
Cardiovascular complications in CKD 5D FP461-FP537<br />
Vascular access FP538-FP585<br />
Epidemiology and outcome research<br />
in CKD 5D FP586-FP663<br />
Nutrition, inflammation and oxidative stress -<br />
CKD 5D FP664-FP687<br />
Transplantation - Clinical I FP688-FP729<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
105<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
106<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
ACID-BASE / ELECTROLYTES<br />
FP001<br />
SEVERE HYPERKALEMIA REQUIRING HOSPITALIZATION; PREDICTORS<br />
OF MORTALITY AND IMPROVEMENT<br />
Jung Nam An | Jung Pyo Lee | Yun Kyu Oh | Chun Soo Lim<br />
Seoul National Univ Hosp | Boramae Medical Center | Seoul National Univ<br />
FP002<br />
PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL TOLVAPTAN<br />
TABLETS IN SUBJECTS WITH VARYING DEGREES OF RENAL FUNCTION<br />
Susan Shoaf | Patricia Bricmont | Suresh Mallikaarjun<br />
Otsuka Pharmaceutical Development & Commercialization, Inc, Rockville, MD,<br />
USA | Otsuka Pharmaceutical Res & Commercialization, inc.<br />
FP003<br />
N-ACETYLCYSTEINE ATTENUATES RENAL AND LUNG ALT<strong>ERA</strong>TIONS IN-<br />
DUCED BY SENESCENCE IN THE RAT<br />
Rildo Aparecido Volpini | Ana Carolina de Braganca | Daniele Canale | Janaina<br />
Garcia Gonçalves | Thais Prevital Bastos Brandão | Lucia Andrade | Antonio<br />
Carlos Seguro | Maria Heloisa Massola Shimizu<br />
Hosp Clínicas Fac Medicina Univ São Paulo, Brasil | Fac Medicina da Univ São<br />
Paulo<br />
FP004<br />
WITH-NO-LYSINE KINASEs (WNKs) IN ALDOSTERONE ESCAPE PHENO-<br />
MENON<br />
Jeonghwan Lee | Kwon Wook Joo | Yun Kyu Oh | Yoon Chul Jung | Jae-Ho<br />
Earm | Jin Suk Han<br />
Internal Medicine, Seoul National Univ Hosp, Seoul, Korea | Internal Medicine,<br />
Seoul National Univ Boramae Hosp, Seoul, Korea | Internal Medicine, Pundang<br />
Jesaeng General Hosp, Sungnam, Korea | Earm Jae-Ho Dialysis Center, Chungju,<br />
Korea | Seoul National Univ College of Medicine, Seoul, Korea<br />
FP005<br />
HYPONATREMIA IN THE HOSP SETTING: INTERIM RESULTS FROM A<br />
PROSPECTIVE, OBSERVATIONAL, MULTI-CENTER, GLOBAL REGISTRY<br />
Esteban Poch | Volker Burst | Arthur Greenberg | Andrew Makin | Sandra<br />
Chase<br />
Hosp Clínic Barcelona | Univsklinik Köln | Duke Univ | Otsuka Pharmaceuticals<br />
Europe Ltd. | Otsuka America Pharmaceutical, Inc.<br />
FP006<br />
HIGH INCIDENCE OF ASYMPTOMATIC HYPONATREMIA IN FEMALE RA-<br />
VERS USING ECSTASY<br />
Boer Walther | R.E. Blom | G.D. Van Dijken | R.J. Hené<br />
Dept Nephrology, Univ Medical Center, Utrecht, Netherlands<br />
FP007<br />
COORDINATED CONTROL OF BASOLAT<strong>ERA</strong>L NA,K-ATPASE AND TIGHT-<br />
JUNCTIONS IN REPSONSE TO APICAL SODIUM ENTRY IN COLLECTING<br />
DUCT CELLS<br />
Wang Yu-Bao | Leroy Valerie | Ernandez Thomas | Maunsbach Arvid | Doucet<br />
Alain | Martin Pierre-Yves | Eric Feraille<br />
Univ Geneva | CHRU Lille | Univ Aarhus | INSERM-Cordelier Res Center-<br />
Paris-France<br />
FP008<br />
IN ACIDOTIC HEMODIALYSIS (HD) PATIENTS, HIGH DIALYSATE BICAR-<br />
BONATE CONCENTRATION CORRECTS PRE-HD ACIDOSIS BUT INDUCES<br />
POST-HD ALKALEMIA, ASSOCIATED WITH ATTENUATED PCO2 INCREA-<br />
SE WITH ITS PARTIAL DECREASE TOWARD END OF HD<br />
David Tovbin | Luna Avnon | Debora Bloch | Moshe Zlotnik | Amir AbdElkadir<br />
| Shimon Storch<br />
Soroka Medical Center, Beer-Sheva, Israel | Medical School for International Health,<br />
Ber-Sheva, Israel | Biomedical Engineering, Ben-Gurion Univ, Beer-Sheva,<br />
Israel | Nephrology, Bnai-Zion Medical Center, Haifa, Israel<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP009<br />
DISRUPTED CHRONOBIOLOGY OF WATER EXCRETION, BUT NOT Na EX-<br />
CRETION, IS ASSOCIATED WITH REDUCED INSULINOSECRETION IN THE<br />
METABOLIC SYNDROME<br />
Leopold Fezeu | Lise Bankir | Boris Hansel | Dominique Guerrot<br />
INSERM Unit 872-E2 | Serv Endocrinologie, Hôp Pitié-Salpetrière, Paris, France|<br />
Nephrology Dept, Rouen Univ Hosp, Rouen, France<br />
FP010<br />
DIFFERENT TRANSPORT MODE OF NPT1 AND NPT4 FOR ORGANIC<br />
ANIONS<br />
Naohiko Anzai | Promsuk Jutabha<br />
Dokkyo Medical Univ School of Medicine, Tochigi, Japan<br />
FP011<br />
ISOLATION AND IDENTIFICATION OF THE STRONGEST MAS-AGONIST<br />
Markus Tölle | Vera Jankowski | Axel Kretschmer | Robson A. S. Santos | Walter<br />
Zidek | Joachim Jankowski | Michael Bader<br />
Charite | Bayer | Univ Minas Gerais, Belo Horizonte, Minas Gerais | Max-Delbrück-Center<br />
Molecular Medicine, Berlin<br />
FP012<br />
IDENTIFICATION OF URINARY EXOSOMAL PROTEINS BY MASS SPECTRO-<br />
METRY<br />
Matthieu Bourderioux | Guerrera Ida Chiara | Nguyen-Khoa Thao | Jeanson<br />
Ludovic | Chhuon Cerina | Planelles Gabrielle | Knebelmann Bertrand | Escudier<br />
Estelle | Escudier Bernard | Edelman Aleksander<br />
INSERM U845 | INSERM | AP-HP | INSERM U933 | Inst Gustave Roussy<br />
FP013<br />
DISTAL CONVOLUTED TUBULE (DCT) SPECIFIC TRANSCRIPTS IDENTI-<br />
FIED USING DCT LARGE SCALE SAMPLING<br />
Nicolas Picard | Johannes Loffing<br />
INSERM UMRS 872, Paris, France | Anatomisches Inst, Zurich, Switzerland<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
107<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
108<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
CELL SIGNALLING / PATHOPHYSIOLOGY<br />
FP014<br />
ROLE OF INDOLE-DERIVED UREMIC SOLUTES ON TISSUE FACTOR PRO-<br />
DUCTION VIA ARYL HYDROCARBON RECEPTOR PATHWAY<br />
Claire Cerini | Bertrand Gondouin | Laetitia Dou | Ariane Duval-Sabatier |<br />
Philippe Brunet | Francoise Dignat- George | Stephane Burtey<br />
INSERM U 1076, Univ Aix Marseille, Marseille, France<br />
FP015<br />
IL-13 HAS AN INHIBITORY EFFECT ON TYPE I COLLAGEN EXPRESSION BY<br />
SUPPRESSION OF SMAD3 ACTIVITIES IN TGF-BETA1-STIMULATED RENAL<br />
TUBULOEPITHELIAL CELLS<br />
Kazuhiro Okano | Tomihito Iwasaki | Hikohiro Jinnai | Asako Hibi | Naoko<br />
Miwa | Naoki Kimata | Kosaku Nitta | Takashi Akiba<br />
Dept Blood Purification and Dept Medicine, Kidney Center, Tokyo Women’s Medical<br />
Univ, Tokyo, Japan<br />
FP016<br />
TELMISARTAN POTENTIATES ANTIANGIOGENIC EFFECTS OF SUNITINIB<br />
IN A XENOGRAFT MODEL OF RENAL CELL CARCINOMA<br />
Thibault Dolley-Hitze | Grégory Verhoest | Florence Jouan | Yannick Arlot-<br />
Bonnemains | Audrey Lavenu | Marc-Antoine Belaud-Rotureau | Nathalie<br />
Rioux-Leclercq | Cécile Vigneau<br />
CNRS UMR6061 / IFR 140, Fac Médecine, Univ Rennes 1 | Dept Pharmacologie<br />
Expérimentale et Clinique, Univ Rennes 1<br />
FP017<br />
ALTERED ANTIGEN HANDLING AND INVOLVEMENT OF THE CX3CR1-<br />
FKN AXIS IN PROMOTING HEMATURIA IN IgA NEPHROPATHY PATIENTS<br />
Sharon Natasha Cox | Fabio Sallustio | Grazia Serino | Antonia Loverre | Francesco<br />
Pesce | Margherita Gigante | Gianluigi Zaza | Patrizia Stifanelli | Nicola<br />
Ancona | Francesco Paolo Schena<br />
Dept Emergency and Organ Transpl, Univ Bari, Bari, Italy | Dept Biomedical<br />
Sciences, Univ Foggia, Foggia, Italy | Nephrology and Dialysis Unit, Dept Medicine,<br />
Univ Verona, Verona, Italy | ISSIA, CNR, Bari, Italy | Nephrology Dialysis<br />
and Transpl Unit, Dept Emergency and Organ Transpl (D.E.T.O.), Univ Bari, Italy<br />
FP018<br />
ARACHIDONIC ACID STIMULATES CA2+ ENTRY INTO MOUSE TAL CELLS<br />
THROUGH AN APICAL TRPM7-LIKE CA2+-PERMEABLE NON-SELECTIVE<br />
CATION CHANNEL<br />
Paulais Marc | Teulon Jacques<br />
UMRS872 - ERL7226<br />
FP019<br />
EXTENDED FUNCTIONAL LIFESPAN OF THE ERYTHROPOIETIN RECEP-<br />
TOR (EPOR) FOLLOWING STIMULATION WITH PEGINESATIDE<br />
Jennifer M. Green | Richard B. Mortensen | Rakesh Verma | Karen Leu | Peter<br />
J. Schatz | Don M. Wojchowski<br />
Affymax, Inc., Palo Alto, USA | Maine Medical Center Res Inst<br />
FP020<br />
SIGNAL TRANSDUCTION PATHWAY AND DIRECT ACTION ON VASCU-<br />
LAR ENDOTHELIAL CELLS BY ERYTHROPOIESIS-STIMULATING AGENT<br />
Chieko Ihoriya | Minoru Satoh | Tamaki Sasaki | Naoki Kashihara<br />
Kawasaki Medical School, Kurashiki, Japan<br />
FP021<br />
SIRT1 OVEREXPRESSION MITIGATES CISPLATIN-INDUCED ACETYLATES<br />
OF NF-KB P65 SUBUNIT AND CYTOTOXICITY<br />
Yu Jin Jung | Ae Sin Lee | Jung Eun Lee | Sik Lee | Sung Kwang Park | Won<br />
Kim | Kyung Pyo Kang<br />
Dept Internal Medicine, Res Inst Clinical Medicine, Chonbuk National Univ Medical<br />
School, Jeonju<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP022<br />
CYSTEINE RESIDUES REGULATE TRANSIENT RECEPTOR POTENTIAL CA-<br />
NONICAL TYPE 6 CHANNEL PROTEIN EXPRESSION<br />
Thilo Florian | Martin Tepel | Liu Ying | Krueger Katharina | Förste Nora |<br />
Wittstock Antje | Scholze Alexandra<br />
Charite Berlin Germany|SDU IMM Odense Denmark|SDU KI Odense Denmark<br />
FP023<br />
RAPAMYCIN PROMOTES PODOCYTE MIGRATION THROUGH THE UPRE-<br />
GULATION OF UROKINASE RECEPTOR<br />
Yung-Tsung Chiu | Ming-Ju Wu<br />
Taichung Veterans General Hosp, Taichung, Taiwan<br />
FP024<br />
MICRORNA-146A DOWNREGULATES TOLL-LIKE RECEPTOR SIGNALING<br />
PATHWAY MEDIATING PUROMYCIN AMINONUCLEOSIDE INDUCED PO-<br />
DOCYTE INJURY<br />
Zhi-Hong Liu | Yaojun Liang | Chun-Xia Zheng | Zhao-Hong Chen | Cai-Hong<br />
Zeng<br />
Res Inst Nephrology, Jinling Hosp, Nanjing Univ School Medicine, Nanjing,<br />
China<br />
FP025<br />
NANOTUBULAR CONNECTIONS BETWEEN HUMAN PERITONEAL MESO-<br />
THELIAL CELLS<br />
Julia Ranzinger | Amin Rustom | Lars Kihm | Danijela Heide | Peter Scheurich|<br />
Martin Zeier | Vedat Schwenger<br />
Nephrology, Univ Heidelberg, Germany | Max-Planck Inst Intelligent Systems,<br />
Stuttgart, Germany | Univ Stuttgart, Stuttgart, Germany<br />
FP026<br />
ROLE OF DNA METHYLATION IN RENAL APOPTOSIS<br />
Jian Liu | Fang Zhong | Lili Xu | Qiao Zhou | Xu Hao | Weiming Wang | Nan<br />
Chen<br />
Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School of Medicine<br />
FP027<br />
1H NMR SPECTROSCOPY ANALYSIS OF METABOLITES IN THE KIDNEYS<br />
PROVIDES NEW INSIGHT INTO PATHOPHYSIOLOGICAL MECHANISMS:<br />
APPLICATIONS FOR TREATMENT WITH CORDYCEPS SINENSIS<br />
Fang Zhong | Xia Liu | Qiao Zhou | Xu Hao | Ying Lu | Shanmai Guo | Weiming<br />
Wang | Donghai Lin | Nan Chen<br />
Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School Medicine<br />
FP028<br />
PHOSPHOPROTEOMIC ANALYSIS OF THE P2X7 SIGNALLING CASCADE<br />
IN MACROPHAGES: A PUTATIVE ROLE IN GLOMERULONEPHRITIS<br />
Annalisa Vilasi | Simona Deplano | Pedro Cutillas | Robert Unwin | Frederick<br />
W.K. Tam<br />
Centre Nephrology, Univ College London Medical School, Royal Free Hosp,<br />
London, UK | Renal Medicine, Imperial College Kidney and Transpl Inst, Hammersmith<br />
Hosp, London, UK | Centre Cell Signalling, Barts Cancer Inst, Bart's<br />
and London School of Medicine, Queen Mary Univ London, London, UK<br />
FP029<br />
TWEAK UP-REGULATES ENDOTHELIN-1 SYSTEM IN HUMAN ENDOTHE-<br />
LIAL CELLS<br />
Diana Medrano-Andres | Vanesa Lopez-Martinez | Patricia Martinez-Miguel |<br />
Jose Luis Cano | Ignacio Arribas | Manuel Rodiguez-Puyol | Susana Lopez-<br />
Ongil<br />
Fund Investigacion Biomedica Hosp Principe de Asturias, Alcala de Henares,<br />
Madrid, Spain | Univ Alcala, Alcala de Henares, Madrid, Spain<br />
« FP030<br />
ENDOTHELIAL DYSFUNCTION PROMOTES THE TRANSITION FROM<br />
COMPENSATORY RENAL HYPERTROPHY TO KIDNEY INJURY AFTER UNI-<br />
LAT<strong>ERA</strong>L NEPHRECTOMY IN MICE<br />
Hiroyuki Kadoya | Hajime Nagasu | Minoru Satoh | Tamaki Sasaki | Naoki<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
109<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
Kashihara<br />
Kawasaki Medical School<br />
110<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP031<br />
CITRATE REDUCES CALCIUM PRECIPITATION FORMATION AND PARTI-<br />
CLE INDUCED INFLAMMATION<br />
Emma Lindeberg | Gunilla Grundström<br />
Gambro Res, Lund, Sweden<br />
FP032<br />
SUPEROXIDE DISMUTASE 1 (SOD1) IN CHRONIC KIDNEY DISEASE<br />
Scholze Alexandra | Krueger Katharina | Maier Alexandra | Martin Tepel<br />
SDU KI Odense Denmark | Charite Berlin Germany<br />
FP033<br />
SIMVASTATIN INHIBITS ANGIOPOIETIN-2 RELEASE AND PRODUCTION –<br />
A NOVEL PLEIOTROPIC EFFECT?<br />
Chandra C Ghosh | Sascha David | Aditit Mukherjee | Steven G John | Christopher<br />
W McIntyre | Hermann Haller | Samir M Parikh<br />
Beth Israel Deaconess Medical Center and Harvard Medical School | Royal Derby<br />
Hosp, Renal Medicine | Nephrology<br />
FP034<br />
INTEGRIN-LINKED KINASE (ILK) MODULATES CELLULAR SENESCENCE<br />
REGULATING THE EXPRESSION OF ANTI-AGING GENES<br />
Nuria Troyano | Maria Del Nogal | Gemma Olmos | Ines Mora | Sergio De<br />
Frutos | Manuel Rodriguez-Puyol | Maria Piedad Ruiz<br />
Physiology Dept, Alcala Univ, Alcala de Henares, Madrid, Spain | Univ Alcala,<br />
Fac Medicina, Alcala de Henares, Madrid, Spain<br />
FP035<br />
DIMERIZATION OF THE CALCIUM-SENSING RECEPTOR AND RESPONSE<br />
TO CINACALCET HCL<br />
Hansjörg Rothe | Warren Shapiro | Markus Ketteler<br />
Klinikum Coburg, Coburg, Germany | Brookdale Univ Hosp & Medical Center<br />
FP036<br />
THE CALCIUM RECEPTOR CASR AND PARATHYROID HORMONE DETER-<br />
MINE THE PARACELLULAR PATHWAY PERMEABILITY TO CALCIUM IN<br />
THE THICK ASCENDING LIMB<br />
Suresh Krishna Ramakrishnan | Alexandre Loupy | Pascal Houillier<br />
Cordeliers Res Centre<br />
FP037<br />
INTRACELLULAR BLOCKADE OF AT1 RECEPTORS DOWNREGULATES<br />
THE (PRO)RENIN RECEPTOR (PRR) GENE EXPRESSION IN MESANGIAL<br />
CELLS<br />
Luciana Guilhermino Pereira | Mirian Boim | Danielle Aragão | Dulce Casarini<br />
Federal Univ São Paulo, São Paulo, Brazil<br />
FP038<br />
THE ROLE OF INTERLEUKIN-10 IN THE FIBROSIS AND INFLAMMATION<br />
OF UNILAT<strong>ERA</strong>L URET<strong>ERA</strong>L OBSTRUCTION IN MICE<br />
Yuanmeng Jin | Nan Chen<br />
Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ, School Medicine<br />
« FP039<br />
ANGIOTENSIN II-INDUCED MITOCHONDRIAL NOX4 IS A MAJOR EN-<br />
DOGENOUS SOURCE OF OXIDATIVE STRESS IN KIDNEY PROXIMAL TU-<br />
BUALR CELLS<br />
Ju-Young Moon | Yang-Gyun Kim | Sang-Ho Lee | Tae-Won Lee | Chun-Gyoo<br />
Ihm | Eun-Young Kim | Hong-Ju Lee | Jeong-Guk Wi | Kyung-Hwan Jeong<br />
Kyung Hee Univ Hosp Gangdong, College Medicine, Kyung Hee Univ | Kyung<br />
Hee Univ<br />
FP040<br />
STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CLEAVAGE-<br />
ACTIVATING PROTEIN (SCAP) MEDIATES THE INFLAMMATORY STRESS<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
IN RENAL PROXIMAL TUBULE CELLS<br />
Xiong Zhong Ruan | Lung-Chih Li | Zac Varghese | Jin-Bor Chen | Chien-Te<br />
Lee | John Moorhead<br />
Centre Nephrology, UCL Medical School, Royal Free Campus | Div Nephrology,<br />
Dept Internal Medicine | Kaohsiung Chang-Gung Memorial Hosp<br />
FP041<br />
THE UREMIC TOXIN INDOLE-3-ACETIC ACID INDUCES ENDOTHELIAL<br />
COX-2 EXPRESSION BY INCREASING OXIDATIVE STRESS<br />
Laetitia Dou | Bertrand Gondouin | Claire Cerini | Stephane Poitevin | Philippe<br />
Brunet | Francoise Dignat-George | Burtey Stephane<br />
INSERM U 1076, Marseille, France<br />
FP042<br />
ROLE OF CAVEOLIN-3 IN ALTERED PI3K/Akt SIGNALING IN SKELETAL<br />
MUSCLE OF PATIENTS WITH CKD<br />
Alice Bonanni | Daniela Verzola | Davide Maggi | Giuliano Brunori | Antonella<br />
Sofia | Irene Mannucci | Sara Maffioli | Barbara Salani | Elena D'Amato| Stefano<br />
Saffioti | Alessandro Laudon | Renzo Cordera | Giacomo Garibotto<br />
Dept Internal Medicine, Nephrology Section, Genoa Univ, Genoa, Italy | Dept<br />
Internal Medicin, Endocrinology Section, Genoa Univ, Genoa, Italy | Nephrology<br />
Section Osp Santa Chiara, Trento, Italy<br />
FP043<br />
POTENTIAL RENOPROTECTIVE EFFECT OF CALCITRIOL IN TUBULOIN-<br />
TERSTITIAL FIBROSIS INDUCED BY A PROTEINURIC NEPHROPATHY MO-<br />
DEL<br />
Edgar Maquigussa | Mirian Boim | Carine Arnoni | Luciana Guilhermino Pereira<br />
Federal Univ São Paulo, São Paulo, Brazil<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
111<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
112<br />
HYPERTENSION<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP044<br />
THE UNIQUE RESPONSE OF RENIN AND ALDOSTERONE ACCORDING TO<br />
THE AMOUNT OF SODIUM INTAKE IN SODIUM SENSITIVITY<br />
Sung Joon Shin | Moo-Yong Rhee | ChiYeon Lim<br />
Dongguk Univ Ilsan Hosp<br />
FP045<br />
DIFFERENTIAL REGULATION BY ANGIOTENSIN II AND TGF-B1 OF NOTCH<br />
SIGNALING IN THE KIDNEY<br />
Carolina Lavoz | Raquel Rodrigues-Díez | Sandra Rayego-Mateos | Alberto<br />
Benito-Martin | Raul Rodrigues-Diez | Matilde Alique | Alberto Ortiz | Sergio<br />
Mezzano | Marta Ruiz-Ortega<br />
Cellular Biology in Renal Diseases Lab. Univ Autónoma Madrid, Spain | Dialysis<br />
Unit, Fund Jiménez Díaz, Madrid, Spain | Nephrology Div, Univ Austral Chile,<br />
Valdivia Chile<br />
FP046<br />
ANGIOTENSIN II (ANGII) INDUCES RAPID, PRONOUNCED INCREASES IN<br />
GLOMERULAR PERMEABILITY IN VIVO INDEPENDENT OF ITS HEMODY-<br />
NAMIC ACTIONS<br />
Josefin Axelsson | Anna Rippe | Kristinn Sverrisson | Bengt Rippe<br />
Lund Univ, Lund, Sweden<br />
FP047<br />
CALCITONIN GENE RELATED PEPTIDE, HEME OXYGENASE-1, ENDOTHE-<br />
LIAL PROGENITOR CELLS AND NITRIC OXIDE-DEPENDENT VASODILA-<br />
TION RELATIONSHIPS IN A HUMAN MODEL OF ANGIOTENSIN II TYPE-1<br />
RECEPTOR ANTAGONISM<br />
Lorenzo Calò | Lucia Dal Maso | Elisa Pagnin | Paola Caielli<br />
Univ Padova, Padova, Italy<br />
FP048<br />
SIRT-1, HEME-OXYGENASE-1 AND NO-MEDIATED VASODILATION IN<br />
A HUMAN MODEL OF BLUNTED ANGIOTENSIN II TYPE 1 RECEPTOR SI-<br />
GNALING. IMPLICATION WITH HYPERTENSION<br />
Lorenzo Calò | Elisa Pagnin | Lucia Dal Maso | Paola Caielli<br />
Univ Padova, Padova, Italy<br />
FP049<br />
CAN RENIN INHIBITOR ALISKIREN KEEP ITS EFFECT ON AN EVERY<br />
OTHER DAY ADMINISTRATION?<br />
George Spanos | Rigas Kalaitzidis | Despina Karasavvidou | Kosmas Pappas |<br />
Olga Balafa | Kostas Siamopoulos<br />
Dept Nephrology, Univ Hosp Ioannina | Div Nephrology, Dept Internal Medicine,<br />
Medical School, Univ Ioannina<br />
FP050<br />
ALISKIREN PREVENTS AND AMELIORATES INSULIN RESISTANCE AND<br />
AORTIC ENDOTHELIAL FUNCTION AND REMODELING IN FRUCTOSE-<br />
FED HYPERTENSIVE RATS<br />
Te-Chao Fang | Tony J.F. Lee<br />
Buddhist Tzu Chi General Hosp, Hualien, Taiwan | Dept Pharmacology, Southern<br />
Illinois Univ School Medicine, Springfield, IL, USA<br />
FP051<br />
A RANDOMIZED PARALLEL GROUP STUDY OF ALISKIREN VERSUS VAL-<br />
SARTAN IN HYPERTENSIVE PATIENTS WITH ALBUMINURIA<br />
George Spanos | Rigas Kalaitzidis | Efthymios Pappas | Eleni Ermeidi | Athina<br />
Tatsioni | Kostas Siamopoulos<br />
Dept Nephrology, Univ Hosp Ioannina | Div Nephrology, Dept Internal Medicine,<br />
Medical School, Univ Ioannina<br />
FP052<br />
URINARY EXCRETION OF KLK9 IS ASSOCIATED TO SUSTAINED HYPER-<br />
TENSION, CARDIAC HYPERTROPHY AND AORTA WALL THICKENING<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Ana Blázquez-Medela | Omar Garcia-Sanchez | Yaremi Quiros | Francisco J.<br />
Lopez-Hernandez | Jose M. Lopez-Novoa | Carlos Martinez-Salgado<br />
Unidad Fisiopatología Renal y Cardiovascular, Inst Reina Sofía Investigación Nefrológica,<br />
Univ Salamanca, Spain | Inst Estudios Ciencias Salud Castilla y León<br />
(IECSCYL), Hosp Univ Salamanca, Spain | Univ Salamanca, Salamanca, Spain, |<br />
Unidad Investigacion, Hosp Univ Salamanca, Spain<br />
« FP053<br />
COMPARATIVE EFFECTIVENESS OF VARIOUS ANTIHYPERTENSIVE<br />
AGENTS IN DIABETIC PATIENTS: A SYSTEMATIC REVIEW AND BAYESIAN<br />
NETWORK META-ANALYSIS<br />
Hon-Yen Wu | Yu-Sen Peng | Kuan-Yu Hung | Tun-Jun Tsai | Yu-Kang Tu |<br />
Kuo-Liong Chien<br />
Internal Medicine, Far Eastern Memorial Hosp, New Taipei City, Taiwan | Internal<br />
Medicine, National Taiwan Univ Hosp, Taipei, Taiwan| Div Biostatistics,<br />
Leeds Inst Genetics, Health & Therapeutics, Univ Leeds, Leeds, UK | Grad Inst<br />
Epidemiology and Preventive Medicine, National Taiwan Univ, Taipei, Taiwan<br />
FP054<br />
ANTIHYPERTENSIVE EFFECT OF CHOLECALCIFEROL DURING WINTER<br />
MONTHS IN PATIENTS WITH HYPERTENSION<br />
Thomas Larsen | Frank H Mose | Annebirthe B Hansen | Erling B Pedersen<br />
Dept Medical Res, Holstebro Hosp | Dept Clinical Biochemistry, Holstebro Hosp<br />
FP055<br />
EFFECT OF PARICALCITOL IN HYPERTENSION AND RENAL DAMAGE IN-<br />
DUCED BY INHIBITION OF NITRIC OXIDE SYNTHASE IN RATS<br />
Yasmir Quiroz | Maria Rivero | Keila Yaguas | Bernardo Rodriguez-Iturbe<br />
Inst Venezolano Investigaciones Científicas, IVIC, Maracaibo, Venezuela | Hosp<br />
Univ Maracaibo<br />
FP056<br />
MARKERS OF ENDOTHELIAL CELL DYSFUNCTION MIGHT PREDICT THE<br />
PROGRESSION TO OVERT PREECLAMPSIA IN WOMEN WITH GESTATIO-<br />
NAL HYPERTENSION<br />
Dimitris Xydakis | Marita Sfakianaki | Christina Petra | Eleftheria Maragaki|<br />
Ergini Antonaki | Eleni Krasoudaki | Konstantinos Kostakis | Konstantinos Stylianou<br />
| Apostolos Papadogiannakis<br />
Internal Medicine, Venizeleio Hosp, Greece | Nephrology Dept, Venizleio Hosp,<br />
Greece<br />
FP057<br />
IS IT A PROMISING MIRACLEOUS TH<strong>ERA</strong>PY? HIGH-TONE EXTERNAL<br />
MUSCLE STIMULATION ELECTROTH<strong>ERA</strong>PHY IN THE TREATMENTS OF<br />
RESISTANT AND IRREVERSIBLE SYMPTOMATIC PERIPHERIC POLYNEU-<br />
ROPATHY WITH DIABETES MELLITUS, CHRONIC KIDNEY DISEASE AND<br />
PRIMARY HYPERTENSIVES<br />
Yahya Sagliker | Nuray Paylar | A Heidland | A Keck | R Erek | P Kolasin | P<br />
S Ozkaynak | H S Sagliker | I Gokcay<br />
Cukurova Univ | Sagliker Hypertension Unit | Nephrology, Würzburg Univ|<br />
Neurology, Private Adana Hosp | Duzen Labs|Nephrology-Hypertension, Cukurova<br />
Univ<br />
FP058<br />
EXCESSIVE MATERNAL SALT INTAKE INCREASES PLASMA MARINOBU-<br />
FAGENIN CONCENTRATION AS WELL AS CAUSES DELAYED HYPERTEN-<br />
SION AND ALBUMINURIA IN MALE OFFSPRING<br />
Eberhard Ritz | Nadezda Koleganova | Marie-Luise Gross-Weissmann | Grzegorz<br />
Piecha<br />
Internal Medicine Div Nephrology, Heidelberg, Germany | Pathology, Heidelberg,<br />
Germany | Dept Nephrology, Endocrinology and Metabolic Diseases, Medical<br />
Univ Silesia, Katowice, Poland<br />
FP059<br />
IMPAIRED EXERCISE-INDUCED PRODUCTION OF ENDOTHELIAL NITRIC<br />
OXIDE IN YOUNG ADULT PATIENTS WITH EARLY AUTOSOMAL DOMI-<br />
NANT POLYCYSTIC KIDNEY DISEASE (ADPKD)<br />
Natalia Reinecke | Thulio Marquez Cunha | Elisa M . S. Higa | Ita Pfeferman<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
113<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
114<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Heilberg | Jose Alberto Neder | José Luiz Nishiura | Waldemar Silva Almeida|<br />
Nestor Schor<br />
UNIFESP, São Paulo, Brazil<br />
FP060<br />
INHIBITION OF URICASE CONCOMITANT TO PHYSIOLOGICAL AMOUNTS<br />
OF GLUCOSE-FRUCTOSE HAS A SYNERGISTIC EFFECT ON INCREASING<br />
SYSTEMIC AND GLOMERULAR PRESSURES IN RATS<br />
Edilia Tapia | Laura G Sanchez-Lozada | Magdalena Cristóbal | Virgilia Soto|<br />
Fernando García-Arroyo | Fabiola Monroy-Sánchez | Magdalena Madero | Richard<br />
Johnson<br />
INC Ignacio Chávez | Univ Colorado<br />
FP061<br />
RENOPROTECTIVE EFFECT OF ROSUVASTATIN IN DAHL SALT-SENSITIVE<br />
HYPERTENSIVE RATS<br />
Sun Moon Kim | Seung Hee Yang | Yon Su Kim<br />
Chungbuk National Univ Hosp, Cheongju, Korea | Kidney Res Inst, Seoul, Korea<br />
| Seoul National Univ<br />
FP062<br />
TUBULAR PROTEINURIA AS AN EARLY SIGN OF RENAL DAMAGE IN PRE-<br />
HYPERTENSION?<br />
Sandra Karanović | Margareta Fištrek | Jelena Kos | Ivan Pećin | Vedran<br />
Premužić | Mirta Abramović | Vesna Matijević | Dubravka Čvorišćec | Ante<br />
Cvitković | Matej Knežević | Milan Bitunjac | Mario Laganović | Bojan Jelaković<br />
School Medicine Univ Zagreb, Dept Nephrology, Hypertension and Dialysis,<br />
UHC Zagreb, Zagreb, Croatia | Outpatient Clinic Bebrina, Bebrina, Croatia |<br />
Outpatient Clinic Slavonski Kobaš, Sl.Kobaš, Croatia | School Medicine Univ<br />
Zagreb, Lab Clinical Diagnosis, UHC Zagreb, Zagreb, Croatia | Inst Public Health<br />
Brodsko-posavska County, Slavonski Brod, Croatia | General Hosp Dr. Josip<br />
Benčević, Slavonski Brod, Croatia<br />
FP063<br />
GLYCAEMIC CONTROL INFLUENCES SHORT-TERM BLOOD PRESSURE<br />
VARIABILITY IN TYPE 2 DIABETIC PATIENTS WITH OVERT DIABETIC NE-<br />
PHROPATHY<br />
Fang Liu | Min Wu | Ping Fu<br />
West China Hosp Sichuan Univ<br />
FP064<br />
EFFECT OF AMILORIDE AND SPIRONOLACTONE ON RENAL TUBULAR<br />
FUNCTION<br />
Solveig Klok Matthesen | Thomas Larsen | Thomas Guldager Lauridsen | Henrik<br />
Vase | Pia Gjørup Holland | Karen Marie Nykjær | Søren Nielsen | Erling<br />
Bjerregaard Pedersen<br />
Depts Medical Res and Medicine | Water and Salt Res Center, Aarhus<br />
FP065<br />
URINARY NGAL EXCRETION IN HYPERTENSIVE DIABETIC RATS IS THE<br />
CONSEQUENCE OF ITS ALTERED TUBULAR HANDLING<br />
Ana Blázquez-Medela | Francisco J. Lopez-Hernandez | Omar Garcia-Sanchez|<br />
Yaremi Quiros | Maria J. Montero | Jose M. Lopez-Novoa | Carlos Martinez-<br />
Salgado<br />
Unidad Fisiopatología Renal y Cardiovascular, Inst Reina Sofía Investigación<br />
Nefrológica, Univ Salamanca, Spain | Univ Salamanca | Inst Estudios Ciencias<br />
Salud Castilla y León (IECSCYL), Unidad Investigacion, Hosp Univ Salamanca,<br />
Spain<br />
FP066<br />
THE EFFECT OF RENAL SYMPATHETIC DENERVATION ON BLOOD PRES-<br />
SURE; DATA OF 6 AND 12 MONTHS FOLLOW UP<br />
Eva Vink | Verloop Willemien | Voskuil Michiel | Spiering Wilko | Vonken<br />
Evert-Jan | PJ Blankestijn<br />
UMC Utrecht, Utrecht, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP067<br />
SERIOUS COMPLICATIONS RELATED TO IMPROPER RENAL SYMPATHE-<br />
TIC DENERVATION: A CASE STUDY<br />
Simona Zerbi | Luciano A Pedrini<br />
AO Bolognini-NephroCare, Seriate, Italy<br />
FP068<br />
RENALASE AND CATECHOLAMINES: CAUSATIVE FACTORS OR INNO-<br />
CENT BYSTANDERS OF HYPERTENSION IN HAEMODIALYSIS AND PERI-<br />
TONEAL DIALYSIS PATIENTS<br />
Edyta Zbroch | Jolanta Malyszko | Jacek Malyszko | Ewa Koc-Zorawska | Michal<br />
Mysliwiec<br />
Dept Nephrology, Medical Univ, Bialystok, Poland<br />
FP069<br />
EFFECTS OF RECOMBINANT RENALASE ON RENAL DOPAMINE ACTIVI-<br />
TY IN THE RENALASE KNOCKOUT MOUSE MODEL<br />
Janete Quelhas-Santos | Paula Serrão | Isabel Soares-Silva | Lieqi Tang | Benedita<br />
Sampaio-Maia | Gary Desir | Manuel Pestana<br />
Nephrology Res and Development Unit, Fac Medicine, Porto, Portugal | Inst<br />
Pharmacology and Therapeutics, Fac Medicine, Univ Porto, Portugal | Dept Medicine,<br />
Yale Univ School Medicine, New Haven, Connecticut, USA | Fac Dental<br />
Medicine, Univ Porto, Portugal<br />
FP070<br />
THE RELATIONSHIP BETWEEN GAMMA-GLUTAMYL TRANSPEPTIDASE<br />
AND PULSE WAVE ANALYSIS IN HYPERTENSIVE PATIENT POPULATION<br />
Rengin Elsurer | Tarik Demir | Gulperi Celik | Melek Yavas | Ozlem Yavas<br />
Dept Internal Medicine, Div Nephrology, Selçuklu Medical Fac, Selçuk Univ,<br />
Selçuklu, Konya | Dept Internal Medicine, Selçuklu Fac Medicine, Selcuk Univ,<br />
Konya, Turkey<br />
FP071<br />
INFORMING PATIENTS ABOUT DIALYSIS - A CALL TO ACTION (RESULTS<br />
OF THE 2011 EUROPEAN KIDNEY PATIENTS FED<strong>ERA</strong>TION SURVEY)<br />
Mark Murphy<br />
Irish Kidney Association<br />
FP072<br />
LUMINAL PROTEOLYTIC ACTIVATION OF THE COLLECTING DUCT EPI-<br />
THELIAL SODIUM CHANNEL (ENAC) AND ITS POTENTIAL ROLE IN RE-<br />
NAL SODIUM REABSORPTION IN VIVO<br />
Gregory Jacquillet | Robert J Unwin | Havovi Chichger | David G Shirley<br />
UCL Centre Nephrology Royal Free<br />
FP073<br />
THE VALUE OF INTRARENAL RESISTIVE INDEX ON RENAL OUTCOMES<br />
IN BENIGN NEPHROANGIOSCLEROSIS<br />
Alexandru Caraba | Munteanu Andreea | Serban Corina | Romosan Ioan<br />
Univ Medicine and Pharmacy Victor Babes Timisoara, Romania<br />
FP074<br />
CLINICAL INERTIA IN THE TREATMENT OF HYPERTENSION IN CHRONIC<br />
KIDNEY DISEASE<br />
Michal Nowicki | Monika Bobik | Agnieszka Pawelec | Joanna Łacisz | Anna<br />
Zapała | Katarzyna Bryc<br />
Medical Univ Łódź<br />
FP075<br />
PRE-PARTUM PROTEINURIA IS A RISK FACTOR FOR SHORT-TERMI HIGH<br />
BLOOD PRESSURE PERSISTENCE AFTER DELIVERY<br />
Ciro Esposito | Maria Lucia Scaramuzzi | Alessandra Manini | Massimo Torreggiani<br />
| Fausta Beneventi | Arsenio Spinillo | Fabrizio Grosjean | Gianluca<br />
Fasoli | Antonio Dal Canton<br />
Unit Nephrology and Hemodialysis, IRCCS Fond Salvatore Maugeri, Univ Pavia,<br />
Pavia, Italy | Unit Nephrology, Dialysis and Transpl, Fond IRCCS Policlinico<br />
San Matteo, Univ Pavia, Pavia, Italy | Unit Gynecology and Obstetrics, Fond<br />
IRCCS Policlinico San Matteo, Univ Pavia, Pavia, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
115<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
116<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP076<br />
NEWLY DIAGNOSED HYPERTENSION IN ADULT PATIENTS WITH EHEC<br />
Chatzykirkou Christos | Schmidt Bernhard M.W. | Nitschke Martin | Kielstein<br />
Jan | Michael Claus | Ramazan Leyla | Beneke Jan | Kunzendorf Ulrich | Haller<br />
Hermann | Jan Menne<br />
Medical School Hannover | Univ Hosp Schleswig-Holstein | Dept Nephrology<br />
& Hypertension, Medical School Hannover, Germany<br />
FP077<br />
ARTERIAL HYPERTENSION FREQUENCY IN URBAN AND RURAL POPU-<br />
LATION OF SCHOOL CHILDREN<br />
Mirjana Pavicevic | Slavica Markovic | Zoran Igrutinovic<br />
Univ Clinic Center Kragujevac, Serbia<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
CLINICAL NEPHROLOGY -<br />
LAB METHODS AND OTHER MARKERS<br />
FP078<br />
IMPLEMENTATION AND FIRST RESULTS OF A GERMAN CHRONIC KID-<br />
NEY DISEASE REGISTRY<br />
Werner Kleophas | B Bieber | BM Robinson | J Duttlinger | D Fliser | G Lonneman<br />
| LC Rump | RL Pisoni | FK Port | H Reichel<br />
Dialysezentrum Karlstrasse | Arbor Res Collaborative for Health, Ann Arbor,<br />
Michigan, USA | Nephrologisches Zentrum Offenburg, Germany | Uniklinik Saarland,<br />
Homburg/Saar, Germany | Gemeinschaftspraxis Eickenhof, Langenhagen,<br />
Germany | Heinrich-Heine-Univ, Düsseldorf, Germany | Nephrologisches<br />
Zentrum Schwennigen, Germany<br />
FP079<br />
CKD PROGRESSION IN ELDERLY<br />
Radulescu Daniela | Alexandru Ciocalteu | Ionel Alexandru Checherita | Ileana<br />
Peride | Daniela Margareta Spataru | Andrei Niculae<br />
Saint John Emergency Hosp, Bucharest, Romania | Carol Davila Medicine Univ,<br />
Bucharest, Romania<br />
FP080<br />
A NEW SIMPLIFIED CKD-EPI EQUATION FOR ELDERLY PEOPLE<br />
Koppe Laetitia | Klich Amna | Dubourd Laurence | Hadj-aissa Aoumeur<br />
HCL, Hôp E. Herriot Lyon France | Hospices Civils Lyon, Serv Biostatistique,<br />
Lyon, France | Univ Claude Bernard Lyon1, Villeurbanne France<br />
FP081<br />
ESTIMATION OF GFR IN THE ELDERLY: WHICH FORMULA SHOULD BE<br />
USED?<br />
Martin Flamant | Jean-Philippe Haymann | Emmanuel Letavernier | Emmanuelle<br />
Vidal-Petiot | Jean-Jacques Boffa | Francois Vrtovsnik<br />
APHP, Paris, France | INSERM UMR_S 702 | Univ Pierre et Marie Curie, Paris,<br />
France | Hôp Bichat, AP-HP<br />
FP082<br />
SUPPLEMENTED VERY LOW PROTEIN DIET (S-VLPD) IN ELDERLY URE-<br />
MIC PATIENTS WITH MULTIPLE COMORBIDITIES<br />
Francesco Bianco | Giuseppina Pessolano | Michele Carraro | Giovanni Oliviero<br />
Panzetta<br />
Azienda Osp Univ Osp Riuniti, Trieste, Italy | Azienda Osp Univ Osp Riuniti,<br />
Verona , Italy<br />
FP083<br />
ASSESSING GFR IN OLDER ADULTS: COMPARISON OF CURRENT EGFR<br />
EQUATIONS WITH MEASURED IOHEXOL-GFR IN A POPULATION BASED<br />
SAMPLE<br />
Natalie Ebert | Jens Gaedeke | Olga Jakob | Martin Kuhlmann | Peter Martus |<br />
Markus van der Giet | Elke Schäffner<br />
Charité Univ Medicine Campus Virchow | Charité Univ Medicine Berlin | Vivantes<br />
Klinikum im Friedrichshain, Berlin<br />
FP084<br />
DIALYSIS IN OCTOGENARIANS: IMPROVED SURVIVAL IN LAST DECADE<br />
Izhar Khan | Yvonne Law<br />
Renal Unit Aberdeen<br />
FP085<br />
COMMUNITY-ACQUIRED HYPONATREMIA IN THE ELDERLY AND VERY<br />
ELDERLY PATIENTS: ASSESSMENT OF CLINICAL FEATURES, OUTCOMES<br />
AND COSTS<br />
Kenan Turgutalp | Onur Ozhan | Ebru Gok Oguz | Ahmet Kiykim<br />
Mersin Univ Dept Internal Medicine Mersin, Turkey | Div Endocrinology and<br />
Metabolism, Dept Internal Medicine, School of Medicine, Mersin Univ, Mersin,<br />
Turkey | Div Nephrology Sanliurfa Hosp, Sanliurfa Turkey | Div Nephrology,<br />
Dept Internal Medicine, School of Medicine, Mersin Univ, Mersin, Turkey<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
117<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
118<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP086<br />
PREDICTION OF GFR IN AGED PATIENTS FROM BODY ELECTRICAL IMPE-<br />
DANCE AND SERUM CREATININE<br />
Carlo Donadio<br />
Dept Internal Medicine, Pisa, Italy<br />
FP087<br />
DOES MEDICAL MANAGEMENT PROGRAM FOR CKD PATIENTS POSTPO-<br />
NE RRT? A 5-YEAR-COHORT<br />
Zinat Nadia Hatmi | Mitra Mahdavi-Mazdeh<br />
Dept Social Medicine, Tehran Univ Medical Sciences<br />
FP088<br />
RENOPROTECTIVE EFFECTS OF SPIRONOLACTONE IN PATIENTS WITH<br />
PROTEINURIC KIDNEY DISEASES<br />
Enrique Morales | Victor Gutierrez-Millet | Jorge Rojas-Rivera | Ana Huerta|<br />
Eduardo Gutierrez | Elena Gutierrez-Solis | Natalia Polanco | Jara Caro | Esther<br />
González | Manuel Praga<br />
Nephrology Dept Hosp 12 de Octubre | Inst Investigación Hosp 12 de Octubre,<br />
Madrid, Spain<br />
FP089<br />
ESTIMATION OF PROTENURIA WITH THE PROTEIN TO CREATININE RA-<br />
TIO SHOULD BE ADJUSTED FOR MUSCLE MASS<br />
María Paz Marco Mayayo | José Manuel Valdivielso | Montserrat Martínez |<br />
Elvira Fernández Giráldez<br />
Hosp Univ Arnau Vilanova | IRB Lleida | Univ Lleida<br />
FP090<br />
VALIDATION OF SERUM CREATININE (SCr) MEASUREMENT WITH THE<br />
POINT-OF-CARE TESTING (POCT) DEVICE i-STAT IN A MEXICAN GOVER-<br />
NMENT SPONSORED-CHRONIC KIDNEY DISEASE (CKD) SCREENING<br />
PROGRAM<br />
Gregorio Obrador | Nadia Olvera | Daniela Ortiz de la Peña | Verónica Gutiérrez<br />
| Antonio Villa<br />
Univ Panamericana School of Medicine, Mexico City, Mexico | Mexican Kidney<br />
Foundation, Mexico City, Mexico | Univ Panamericana School of Nursing & Mexican<br />
Kidney Foundation, Mexico City, Mexico<br />
FP091<br />
THE USE OF ABSOLUTE GLOMERULAR FILTRATION RATE VALUES IM-<br />
PROVES PERFORMANCE OF CKD-EPI FORMULA<br />
Belén Redal-Baigorri<br />
Roskilde Univ Hosp, Roskilde, Denmark<br />
FP092<br />
ARE MDRD AND COCKROFT GAULT DIFFERENT? THE GREEK EXPERIEN-<br />
CE FROM THE PRESTAR STUDY<br />
Konstantinos Sombolos | Dimitris Tsakiris | John Boletis | Dimitrios Vlahakos|<br />
Konstantinos Siamopoulos | Vassilios Vargiemezis | Pavlos Nikolaidis | Christos<br />
Iatrou | Evgenios Dafnis | Christos Argyropoulos | Konstantinos Xynos<br />
Nephrology Clinic, Papanikolaou Hosp, Thessaloniki | Nephrology Clinic, Papageorgiou<br />
Hosp, Thessaloniki | Nephrology Clinic, Laiko Hosp, Athens | Nephrology<br />
Clinic, Attiko Hosp, Athens | Nephrology Clinic, Ioannina Univ Hosp,<br />
Ioannina | Nephrology Clinic, Alexandroupoli Univ Hosp, Alexandroupoli| Nephrology<br />
Clinic, AHEPA Hosp, Thessaloniki | Nephrology Clinic, Nikea Hosp,<br />
Athens | Nephrology Clinic, PE.PA.G.N.I, Crete Univ Hosp, Iraklio Crete| Abbott<br />
Laboratories Hellas<br />
FP093<br />
TRANSCUTANEOUS ASSESSMENT OF GLOMERULAR FILTRATION RATE<br />
IN CONSCIOUS MICE<br />
Daniel Schock-Kusch | Yury Shulhevich | Stefania Geraci | Juergen Hesser |<br />
Dzmitry Stsepankou | Sabine Neudecker | Stefan Koenig| Friederike Hoecklin|<br />
Johannes Pill | Norbert Gretz | Frank Schweda | Andrea Schreiber<br />
Medical Res Center, Medical Fac Mannheim, Univ Heidelberg, Germany |<br />
Experimental Radiation Oncology, Medical Fac Mannheim, Univ Heidelberg,<br />
Mannheim, Germany | Freudenberg Forschungsdienste KG Weinheim, Ger-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
many | Mektec Europe GmbH Weinheim, Germany | Dept Physiology, Univ<br />
Regensburg, Germany<br />
FP094<br />
THE RELATIONSHIP BETWEEN KIDNEY DAMAGE AND STROKE TYPES<br />
Kosuke Kudo | Tsuneo Konta<br />
Yamagata Univ, Yamagata, Japan<br />
FP095<br />
THE EFFECTS OF GLOBULINURIA ON URINARY CYSTATIN C<br />
Seung Ok Choi | Jae Seok Kim | Min Keun Kim | Jae Won Yang | Byoung<br />
Geun Han<br />
Yonsei Univ Wonju College of Medicine, Wonju, Korea<br />
FP096<br />
DETECTION OF DECREASED GLOMERULAR FILTRATION RATE IN INTEN-<br />
SIVE CARE UNITS: INTEREST OF CYSTATIN C<br />
Pierre Delanaye | Etienne Cavalier | Ingrid Masson | Manolie Mehdi | Maillard<br />
Nicolas | Bernard Lambermont | Bernard Dubois | Pierre Damas | Jean-Marie<br />
Krzesinski | Jerome Morel | Alexandre Lautrette | Mariat Christophe<br />
Univ Liège | Serv Nephrologie Dialyse Transpl rénale CHU Saint Etienne, Saint-<br />
Etienne, France | Saint-Etienne | Serv Néphrologie, Dialyse, Transpl Rénale,<br />
Lab Explorations Fonctionnelles Rénales, Hôp Nord, CHU Saint-Etienne | Univ<br />
Clermont Ferrand<br />
FP097<br />
CREATININE AND/OR CYSTATIN C-BASED GFR ESTIMATION IN HIV-<br />
INFECTED PATIENTS<br />
Amandine Gagneux-Brunon | Pierre Delanaye | Fresard Anne | Lucht Frédéric|<br />
Mariat Christophe<br />
Serv Néphrologie, Dialyse, Hypertension et Transpl, CHU Saint-Etienne France|<br />
Univ Liège | Serv Maladies Infectieuses et Tropicales, CHU de Saint-Etienne |<br />
Serv Néphrologie, Dialyse, Transpl Rénale, Lab Explorations Fonctionnelles Rénales,<br />
Hôp Nord, CHU Saint-Etienne,<br />
FP098<br />
IMPACT OF OBESITY ON SIMPLE CYSTATIN C eGFR IN PATIENTS WITH<br />
CHRONIC KIDNEY DISEASE<br />
Sebastjan Bevc | Robert Ekart | Radovan Hojs | Maksimiljan Gorenjak | Ludvik<br />
Puklavec<br />
Dept Nephrology, Dept Dialysis, Clinic for Internal Medicine, Dept Clinical Chemistry,<br />
Dept Nuclear Medicine, Univ Medical Center Maribor, Slovenia<br />
FP099<br />
URINARY PROCOLLAGEN TYPE III AMINOTERMINAL PROPEPTIDE PRE-<br />
DICTS THE DECLINE OF RENAL FUNCTION IN PRE-DIALYSIS CKD PA-<br />
TIENTS<br />
Norihiro Hashimoto | Akira Suzuki | Kensuke Mitsumoto | Morihiro Shimizu|<br />
Kakuya Niihata | Akihiro Kawabata | Yusuke Sakaguchi | Terumasa Hayashi |<br />
Tatsuya Shoji | Noriyuki Okada | Yoshiharu Tsubakihara<br />
Osaka General Medical Center, Osaka, Japan<br />
FP100<br />
FIBROBLAST GROWTH FACTOR 23 AND 25-HYDROXYVITAMIN D PRE-<br />
DICT ANNUALIZED ESTIMATED GFR DECLINE<br />
Takayuki Hamano | Chikako Nakano | Naohiko Fujii | Yoshitugu Obi | Satoshi<br />
Mikami | Kazunori Inoue | Isao Matsui | Noriyuki Okada | Yoshiharu Tsubakihara<br />
| Yoshitaka Isaka | Hiromi Rakugi<br />
Osaka Univ Grad School of Medicine, Suita, Japan | Dept Geriatric Medicine and<br />
Nephrology, Osaka Univ Grad School of Medicine, Osaka, Japan | Dept Internal<br />
Medicine, Hyogo Prefectural Nishinomiya Hosp, Hyogo, Japan | Dept Internal<br />
Medicine, Higashi-Kohri Hosp, Osaka, Japan | Dept Nephrology and Hypertension,<br />
Osaka General Medical Center, Osaka, Japan<br />
FP101<br />
RAPID DETERMINATION OF URINARY 2,8-DIHYDROXYADENINE WITH<br />
LIQUID CHROMATAOGRAPHY - ELECTROSPRAY TANDEM MASS SPEC-<br />
TROMETRY<br />
Vidar Edvardsson | Baldur Sigurðsson | Margret Thorsteinsdottir | Runolfur<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
119<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
120<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Palsson<br />
Landspitali - National Univ Hosp Iceland, Reykjavik, Iceland | Arcticmass, Reykjavik,<br />
Iceland<br />
FP102<br />
TRADITIONAL INDIRECT-MOXIBUSTION THERMAL TH<strong>ERA</strong>PY DECREASE<br />
THE RENAL ARTERIAL RESISTIVE INDEX IN HEALTHY VOLUNTEERS<br />
Jun Matsumoto | Nagisa Miyazaki | Ichijiro Murata | Gakuro Yoshida | Kentaro<br />
Morishita | Hiroaki Ushikoshi | Kazuhiko Nishigaki | Shinji Ogura | Shinya<br />
Minatoguchi<br />
Div Cardiology, Gifu Univ Grad School of Medicine | Dept Cardiology, Respirology<br />
& Nephrology, Gifu Univ Grad School of Medicine, Gifu, Japan | Advanced<br />
Critical Care Centre, Gifu Univ Hosp, Gifu, Japan<br />
FP103<br />
LONG-TERM LITHIUM TREATMENT AND THE RISK OF RENAL FAILURE:<br />
A DECISION ANALYSIS<br />
Ursula Werneke | Michael Ott | Ellinor Salander-Renberg | David Taylor | Bernd<br />
Stegmayr<br />
Dept Clinical Sciences Div Psychiatry, Umeå Univ, Umeå, Sweden | Pharmacy<br />
Dept South London and Maudsley NHS Foundation Trust and Inst Pharmaceutical<br />
Sciences, King’s College, London, UK | Inst Public Health and Clinical Medicine,<br />
Umeå Univ, Umeå, Sweden<br />
FP104<br />
A FRENCH CONNECTION BETWEEN MICROHEMATURIA AND URETHRITIS<br />
Stanislav Surel | Martina Wenzlova<br />
Nephrology Brno, Czech Republic<br />
FP105<br />
RENAL ABNORMALITIES AMONG PATIENTS WITH SICKLE CELL DISEASE<br />
– A COHORT OF 21 PATIENTS IN BRAZIL<br />
Geraldo Silva Junior | Ana Patricia Vieira | Amanda Couto Bem | Marilia Alves<br />
| Alba Torres | Gdayllon Meneses | Alice Martins | Alexandre Liborio |<br />
Elizabeth Daher<br />
School of Medicine, Univ Fortaleza, Fortaleza, Brazil | School of Medicine, Federal<br />
Univ Ceara, Fortaleza, Brazil | Dept Clinical Analysis and Toxicology, Federal<br />
Univ Ceara, Fortaleza, Brazil<br />
FP106<br />
MOLECULAR EVIDENCE OF EXPOSURE TO ARISTOLOCHIC ACID (AA) IN<br />
THE BALKAN ENDEMIC NEPHROPATHY (BEN) REGION MEHEDINTI IN<br />
ROMANIA<br />
Gheorghe Gluhovschi | Mirela Modilca | Liviu Daminescu | Cristina Gluhovschi<br />
| Silvia Velciov | Ligia Petrica | Florica Gadalean | Cristian Balgradean |<br />
Heinz H. Schmeiser<br />
Univ Medicine and Pharmacy Timisoara, Romania | Renamed Dialysis Center,<br />
Drobeta Turnu Severin, Mehedinti, Romania | Emergency Clinical County Hosp<br />
Timisoara, Romania | Victor Babes Univ Medicine and Pharmacy Timisoara, Romania<br />
| German Cancer Res Center (DKFZ), Res Group Genetic Alterations in<br />
Carcinogensis, Heidelberg, Germany<br />
FP107<br />
EFFECT OF HYPEROXALURIA ON THE PROGRESSION OF CHRONIC KID-<br />
NEY DISEASE IN WOMEN WITH RECURRENT UNCOMPLICATED PYELO-<br />
NEPHRITIS<br />
Mykola Kolesnyk | Natalia Stepanova | Liudmyla Surzhko | Natalia Stashevska<br />
State Inst Nephrology National Academy of Medical Sciences, Kyiv, Ukraine<br />
FP108<br />
EFFICACY AND SAFETY OF ORAL FEBUXOSTAT IN SUBJECTS WITH MO-<br />
D<strong>ERA</strong>TE-TO-SEVERE CHRONIC KIDNEY DISEASE (CKD): A PILOT STUDY<br />
Vassilis Filiopoulos | Dimitrios Hadjiyannakos | Dimitrios Arvanitis | Konstantinos<br />
Panagiotopoulos | Dimosthenis Vlassopoulos<br />
Amalia Fleming General Hosp, Athens, Greece | Nephrology Dept, Amalia Fleming<br />
General Hosp, Athens, Greece | Biochemistry Dept, Amalia Fleming General<br />
Hosp, Athens, Greece<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
« FP109<br />
REDUCED Γ-CARBOXYLASE ACTIVITY IN UREMIA- A POSSIBLE MECHA-<br />
NISM OF UREMIC VASCULAR CALCIFICATION<br />
Nadine Kaesler | Thomas Schettgen | Elke Magdeleyns | Vincent Brandenburg|<br />
Cees Vermeer | Jürgen Floege | Thilo Krüger<br />
Medical Clinic II, Nephrology, Univ Clinic RWTH Aachen, Germany | Inst and<br />
Out-patient Clinic Occupational Medicine , Univ Clinic RWTH Aachen, Germany<br />
| VitaK BV, Univ Maastricht, Netherlands | Medical Clinic I, Cardiology,<br />
Univ Clinic RWTH Aachen, Germany| VitaK BV, Univ Maastricht, Netherlands|<br />
Medical Clinic II, Nephrology, Univ Clinic RWTH Aachen, Germany | Medical<br />
Clinic II, Nephrology, Univ Clinic RWTH Aachen, Germany<br />
FP110<br />
PREVALENCE AND CHARACTERISTICS OF NEPHROCALCINOSIS IN A<br />
NEW LARGE OUTPATIENTS UNIT: RARE BUT NOT SO RARE.....<br />
Olga Randone | Martina Ferraresi | Emiliano Aroasio | Agostino Depascale |<br />
Stefania Scognamiglio | Valentina Consiglio | Giorgina Barbara Piccoli<br />
Nephrology, Lab, Radiology, ASOU San Luigi, Univ Torino, Italy<br />
FP111<br />
VALIDATION OF ABRAHAMS FORMULA ESTIMATING EXTRACELLULAR<br />
VOLUME<br />
Belén Redal-Baigorri | Line Vedel Jensen<br />
Roskilde Univ Hosp, Roskilde, Denmark | Copenhagen Univ, Copenhagen, Denmark<br />
FP112<br />
THE EFFECT OF VARIOUS TYPES OF THE RENIN-ANGIOTENSIN-ALDO-<br />
STERON SYSTEM BLOCKADE ON PROTEINURIA IN CHRONIC NON-DIA-<br />
BETIC KIDNEY DISEASE: A DOUBLE-BLIND CROSS-OVER RANDOMISED<br />
CONTROLLED TRIAL<br />
Slawomir Lizakowski | Leszek Tylicki | Przemyslaw Rutkowski | Marcin Renke|<br />
Beata Sulikowska | Rafal Donderski | Rafal Bednarski| Zbigniew Heleniak|<br />
Milena Przybylska | Jacek Manitius | Boleslaw Rutkowski<br />
Dept Nephrology, Transpl and Internal Medicine, Medical Univ Gdansk | Dept<br />
General Nursing, Medical Univ Gdansk | Dept Nephrology, Hypertension and<br />
Internal Medicine, Nicolaus Copernicus Univ Toruń, Collegium Medicum Bydgoszcz,<br />
Poland<br />
FP113<br />
HEREDITARY THROMBOPHILIA AS A CAUSE OF RENAL TMA NOT ASSO-<br />
CIATED WITH ANTIPHOSPHOLIPID SYNDROME<br />
Larisa Bobrova | Natalia Kozlovskaya<br />
I.M. Sechenov First Moscow State Medical Univ<br />
FP114<br />
PROGNOSTIC VALUE OF URINARY CONCENTRATION OF LIVER-TYPE<br />
FATTY ACID-BINDING PROTEIN IN CHRONIC KIDNEY DISEASE<br />
Kyoko Kanayama | Midori Hasegawa | Fumihiko Kitagawa | Jyunichi Ishii |<br />
Yukio Yuzawa<br />
Fujita Health Univ School of Medicine, Toyoake, Japan | Lab Clinical Medicine,<br />
Fujita Health Univ, Toyoake, Japan | Joint Res Lab Clinical Medicine, Fujita Health<br />
Univ School of Medicine, Toyoake, Japan<br />
FP115<br />
FACTORS CONTRIBUTING TO RESPONSE TO ORAL SODIUM BICARBO-<br />
NATE IN PATIENTS WITH CHRONIC KIDNEY DISEASE: CRITICAL LEVEL<br />
IDENTIFIED BY RECEIVER OP<strong>ERA</strong>TOR CHARACTERISTICS CURVE IN<br />
SLOWING CHRONIC KIDNEY DISEASE PROGRESSION<br />
Kentaro Tanaka | Ken Sakai | Shigeko Hara | Yasunori Suzuki | Yoshihide Tanaka<br />
| Atsushi Aikawa<br />
Dept Nephrology, Toho Univ School of Medicine<br />
FP116<br />
PROGRESSION OF CKD IN HIV-INFECTED PATIENTS: A SURVEY AT A SIN-<br />
GLE MAJOR CENTER HOSPITAL IN TOKYO<br />
Fumihiko Hinoshita | Naoto Hamano | Emi Sasaki | Asami Kato | Takashi Katsuki<br />
| Ai Katsuma | Eri Imai | Maki Shibata | Manami Tada | Takuro Shimbo |<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
121<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
122<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Yoshimi Kikuchi | Shinichi Oka<br />
Dept Nephrology, Dept Clinical Res and Informatics, Res Inst, AIDS Clinical<br />
Center, National Center for Global Health and Medicine, Tokyo, Japan<br />
FP117<br />
CLASSIFICATION OF HIV-INFECTED PATIENTS WITH CHRONIC KIDNEY<br />
DISEASE BY A COMBINATION OF ALBUMINURIA AND ESTIMATED GLO-<br />
MERULAR FILTRATION RATE<br />
Takashi Muramatsu | Naoki Yanagisawa | Katsuyuki Fukutake | Yasuyuki Yamamoto<br />
| Atsushi Ajisawa | Ken Tsuchiya | Kosaku Nitta| Minoru Ando<br />
Dept Lab Medicine, Tokyo Medical Univ, Tokyo, Japan | Dept Infectious Diseases<br />
and Nephrology, Tokyo Metropolitan Komagome Hosp, Tokyo, Japan | Dept<br />
IV Internal Medicine, Tokyo Women's Medical Univ, Tokyo, Japan<br />
FP118<br />
THE ROLE OF HYPOXIA INDUCIBLE FACTOR 1Α IN THE PATHOGENESIS<br />
OF TUBULAR EPITHELIAL CELLS APOPTOSIS INDUCED BY ALBUMIN<br />
OVERLOAD<br />
Xianhui Liang | Pei Wang | Zhangsuo Liu | Zhanzheng Zhao<br />
First Affiliated Hosp Zhengzhou Univ<br />
FP119<br />
ASSOCIATION OF BIRTH WEIGHT WITH RISK FACTORS FOR CHRONIC<br />
KIDNEY DISEASE IN RURAL CAUCASIAN AND ABORIGINAL CANADIANS<br />
Valerie Luyckx | Samantha Bowker | Alison Miekle | Ellen Toth<br />
Univ Alberta, Edmonton, Canada<br />
FP120<br />
THE RENAL RESPONSE TO A PROTEIN CHALLENGE IS IMPAIRED IN IN-<br />
DIVIDUALS WITH PROMINENT TUBULO-INTERSTITIAL INVOLVEMENT<br />
Ricardo Heguilen | Ana Malvar | Ricardo Hermes | Lilian Cohen | Graciela<br />
Muguerza | Bruno Lococo | Amelia Bernasconi<br />
Hosp Juan A Fernández<br />
FP121<br />
EFFECTS OF ANTIOXIDANTS IN CHRONIC KIDNEY DISEASE: 12-MONTHLY<br />
SUPERVISION<br />
Olena Loboda | Iryna Dudar | Viktor Krot | Viktoria Alekseeva<br />
Inst Nephrology NAMS of Ukraine, Kyiv, Ukraine | Dept Efferesis Technology,<br />
Inst Nephrology NAMS of Ukraine, Kyiv, Ukraine<br />
FP122<br />
PROTEIN C AND PROTEIN S DEFICIENCIES ARE POTENTIAL RISK FAC-<br />
TORS FOR HEMODAILYSIS PATIENTS<br />
Mayuri Ichinose | Naru Sasagawa | Katstuhide Toyama | Akira Saito | Yuzo<br />
Kayamori | Dongchon Kang<br />
Yokohama Dai-ichi Hosp, Yokohama | Dept Clinical Chemistry and Lab Medicine,<br />
Kyushu Univ<br />
FP123<br />
RELATIVE LYMPHOCYTE COUNT TO PREDICT RENAL PROGRESSION IN<br />
PATIENTS WITH CHRONIC KIDNEY DISEASE<br />
Hyun Woo Kim<br />
Jeju National Univ Hosp<br />
FP124<br />
PREVALENCE AND MORTALITY OF CHRONIC KIDNEY DISEASE IN MYE-<br />
LOMA PATIENTS: AN ASSESSMENT BY RISK CATEGORY SYSTEM COMBI-<br />
NED PROTEINURIA WITH KIDNEY FUNCTION<br />
Kosuke Yoshioka | Minoru Ando | Masaki Hara | Kazuteru Ohashi | Ken Tsuchiya<br />
| Kosaku Nitta<br />
Dept Nephrology and Hematology, Tokyo Metropolitan Komagome Hosp, Tokyo,<br />
Japan | Dept Nephrology, Dept Hematology, Tokyo Metropolitan Komagome<br />
Hosp, Tokyo, Japan | Dept IV Internal Medicine, Tokyo Women's Medical<br />
Univ, Tokyo, Japan<br />
FP125<br />
VALIDITY OF URIC ACID TEST IN DIAGNOSIS OF GOUT NEPHROPATHY<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Adelya Maksudova | Tamila Khalfina<br />
Kazan Medical Univ, Kazan, Russia<br />
FP126<br />
QUANTIFICATION OF P-CRESOL SULPHATE IN HUMAN PLASMA OF URE-<br />
MIC PATIENTS BY MRM<br />
Aurora Cuoghi | Elisa Bellei | Marialuisa Caiazzo | Stefania Bergamini | Giuseppe<br />
Palladino | Emanuela Monari | Aldo Tomasi<br />
Univ Modena and Reggio Emilia, Modena, Italy | Scientifc Affairs, Bellco, Mirandola,<br />
Italy<br />
FP127<br />
INCREASED LEVELS OF INDOLEAMINE 2,3-DIOXYGENASE (IDO) ACTIVI-<br />
TY AND REGULATORY T CELLS IN HENOCH-SCHOENLEIN PURPURA<br />
Elisa Loiacono | Roberta Camilla | Valentina Daprà | Laura Morando | Rachele<br />
Gallo | Licia Peruzzi | Margherita Conrieri | Manuela Bianciotto | Francesca M.<br />
Bosetti | Rosannna Coppo<br />
Nephrology, Dialysis, Transpl, R. Margherita Hosp, Turin | Emergency Pediatric<br />
Dept, R. Margherita Hosp, Turin<br />
FP128<br />
CLINICAL BENEFITS ON SECONDARY HYPERPARATHYROIDISM AND<br />
CHRONIC KIDNEY DISEASE PROGRESSION OF SEVELAMER TREATMENT<br />
ON PRE-DIALYSIS PATIENTS: TWO YEARS FOLLOW - UP<br />
Luca Di Lullo | Fulvio Floccari | Rodolfo Rivera | Antonio Granata | Rossella<br />
Faiola | Cherubino Feliziani | Annalisa Villani | Moreno Malaguti | Alberto<br />
Santoboni<br />
Dept Nephrology and Dialysis - L. Parodi Delfino Hop - Colleferro (Roma)<br />
- Italy| Dept Nephrology and Dialysis S.Paolo Hosp - Civitavecchia (Roma) -<br />
Italy| Dept Nephrology - S. Gerardo Hosp - Monza (Italy) | Dept Nephrology<br />
and Dialysis S.Giovanni di Dio Hosp - Agrigento (Italy) | Post-Grad School Nephrology<br />
Tor Vergata Univ (Roma) - Italy<br />
FP129<br />
CARDIOVASCULAR ROLE OF PARACALCITOL IN NON DIALYSIS CKD PA-<br />
TIENTS<br />
Kollia Kyriaki | John Droulias<br />
Renal Unit, General Hosp Livadia Greece<br />
FP130<br />
AA-AMYLOIDOSIS RISK FACTORS IN PATIENTS WITH DIFFERENT GENE-<br />
TIC VARIANTS OF FAMILIAL MEDITERRANEAN FEVER<br />
Marina Bogdanova | Vilen Vilevich Rameev | Armine Hachaturovna Simonyan|<br />
Lidia Vladimirovna Kozlovskaya<br />
Lomonosov Moscow State Univ, Moscow, Russian Federation | I.M. Sechenov<br />
First Moscow State Medical Univ, Moscow, Russian Federation | Yerevan State<br />
Medical Univ after M. Heratsi, Yerevan, Armenia<br />
FP131<br />
ATHEROSCLEROSIS IN PATIENTS WITH SECONDARY AMYLOIDOSIS DUE<br />
TO FAMILIAL MEDITERRANEAN FEVER<br />
Mehmet Rıza Altıparmak | Sinan Trabulus | Nilgül Akalın | Ayşe Serap Yalın |<br />
Asım Esenkaya | Serkan Feyyaz Yalın | Kamil Serdengeçti<br />
Istanbul Univ Cerrahpasa Medical Fac Dept Internal Medicine, Istanbul, Turkey|<br />
Istanbul Univ Cerrahpasa Medical Fac Dept Radiodiagnostic, Istanbul, Turkey<br />
FP132<br />
DYSFUNCTION OF RENAL SYSTEM COULD MODULATE ACE AND ACE2<br />
PROFILE IN CHRONIC KIDNEY DISEASE PATIENTS<br />
Danielle Arita | Tatiana Cunha | Juliana Perez | Maísa Sakata | Lilian Arita |<br />
Marie Nogueira | Zaira Jara | Nádia Souza | Dulce Casarini<br />
Federal Univ São Paulo, São Paulo, Brazil<br />
FP133<br />
URINARY AMMONIUM EXCRETION, METABOLIC ACIDOSIS AND PRO-<br />
GRESSION TOWARD END-STAGE RENAL DISEASE<br />
Marie Metzger | Marion Vallet | Jean-Philippe Haymann | Martin Flamant |<br />
François Vrtovsnik | Jean-Jacques Boffa | Alexandre Karras| Marc Froissart |<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
123<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
124<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Bénédicte Stengel | Pascal Houillier<br />
Inserm U1018, Villejuif, France | Hôp Tenon, Paris, France | Hôp Bichat, Paris,<br />
France | HEGP, Paris , France<br />
FP134<br />
DECREASE IN CIRCULATING DENDRITIC CELL PRECURSORS - A NEW<br />
BIOMARKER OF CARDIOVASCULAR DISEASE IN CHRONIC KIDNEY DI-<br />
SEASE?<br />
Katharina Paul | Daniel Kretzschmar | Atilla Yilmaz | Barbara Bärthlein | Stephanie<br />
Titze | Hans-Reiner Figulla | Gunter Wolf | Martin Busch<br />
Univ Hosp Jena, Germany | Univ Erlangen-Nürnberg, Germany<br />
FP135<br />
IL-6 LEVEL IN THE SERUM AND URINE AS MARKER OF CRYOGLOBULI-<br />
NAEMIC GLOMERULONEPHRITIS ACTIVITY IN PATIENTS WITH CHRO-<br />
NIC HEPATITIS C<br />
Yulia Korotchaeva | Nadezda Gordovskaya | Lidia Kozlovskaya<br />
I.M. Sechenov First Moscow State Medical Univ<br />
FP136<br />
SEVERITY OF PERIODONTITIS IS ASSOCIATED WITH INCREASED ARTE-<br />
RIAL STIFFNESS IN PROGRESSIVE CHRONIC KIDNEY DISEASE (CKD) PA-<br />
TIENTS<br />
Khai Ping Ng | Praveen Sharma | Stephanie Stringer | Mark Jesky | Mary Dutton<br />
| Charles Ferro | Paul Cockwell<br />
Univ Hosp Birmingham, Birmingham, UK | Birmingham Dental Hosp, Birmingham,<br />
UK | Univ Bimingham, UK | Queen Elizabeth Hosp Birmingham, UK<br />
FP137<br />
THE ASSOCIATION OF CHEMERIN LEVELS WITH CHANGES OF GLOME-<br />
RULAR FILTRATION RATE IN SUBJECTS WITH TYPE 2 DIABETES MELLI-<br />
TUS<br />
Sung Jin Moon | Sang Cheol Lee | Soo Young Yoon | Jung Eun Lee | Seung<br />
Jin Han<br />
Myongji Hosp, Kwandong Univ College of Medicine, Goyang, Korea | Yongin<br />
Severance Hosp | Ajou Univ Hosp, Ajou Univ School of Medicine, Suwon, Korea<br />
FP138<br />
ADAM17 IS AN ACTIVITY MARKER OF GRANULOMATOSIS WITH POL-<br />
YANGIITIS<br />
Bertram Anna | Torsten Kirsch | Lovric Svjetlana | Park Joon-Keun | Becker<br />
Jan| Kegel Johanna | Hermann Haller | Marion Haubitz<br />
Hannover Medical School, Hannover, Germany | Nephrology | Klinikum Fulda,<br />
Germany<br />
FP139<br />
USE OF ACEI OR ANGIOTENSIN BLOCKERS IS ASSOCIATED WITH HI-<br />
GHER EGFR BUT NOT PRIOR RENAL DECLINE IN A HIGH RISK CKD SE-<br />
CONDARY CARE COHORT<br />
Stephanie Stringer | Mark Jesky | Khai Ping Ng | Mary Dutton | Charles Ferro|<br />
Paul Cockwell<br />
Univ Bimingham, UK | Univ Hosp Birmingham, Birmingham, UK | Queen Elizabeth<br />
Hosp Birmingham, UK<br />
FP140<br />
LEFT VENTRICLE HYPERTROPHY AND GLOMERULAR FILTRATION RATE<br />
IN PATIENTS WITH CHRONIC KIDNEY DISEASE<br />
Alexey Smirnov | Ivan Kayukov | Nowel Rafrafi | Olga Degtereva | Vladimir<br />
Dobronravov<br />
St.-Petersburg State Medical Univ n.a. I.P. Pavlov<br />
FP141<br />
ANEMIA CONTROL IN CHRONIC KIDNEY DISEASE PATIENTS WITH<br />
ONCE MONTHLY C.E.R.A. AND IMPACT ON THE PROGRESSION OF THE<br />
RENAL DISEASE<br />
Michael Koch | Heidenreich Stefan<br />
Nephrologisches Zentrum, Mettmann | KfH-Nierenzentrum, Aachen<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP142<br />
IS URINARY ACTIVE TGF-BETA A POTENTIAL DIAGNOSTIC MARKER IN<br />
ENDEMIC NEPHROPATHY?<br />
Živka Dika | Marie-Hélène Antoine | Cécile Husson | Jelena Kos | Maja Mišić|<br />
Mirjana Fuček | Dubravka Čvorišćec | Marie-Françoise Bourgeade | Joëlle L.<br />
Nortier | Bojan Jelaković<br />
School of Medicine Univ Zagreb, UHC Zagreb, Dept Nephrology, Hypertension<br />
and Dialysis, Zagreb, Croatia | Experimental Nephrology Unit, Fac Medicine,<br />
Univ Libre de Bruxelles, Belgium | General Hosp Dr. Josip Benčević, Slavonski<br />
Brod, Croatia | School of Medicine Univ Zagreb, UHC Zagreb, Lab for Clinical<br />
Diagnosis, Zagreb, Croatia | INSERM U785, Centre Hépato-biliaire, Hôp Paul<br />
Brousse, Villejuif, France | Dept Nephrology, Dialysis and Renal Transpl, Erasme<br />
Hosp, Univ Libre de Bruxelles, Brussels, Belgium<br />
FP143<br />
EVALUATION OF THE ABSOLUTE RENAL RISK DIALYSIS / DEATH IN PRI-<br />
MARY IGA NEPHROPATHY: EXPERIENCE OF THE NEPHROLOGY DEPT<br />
THE UNIV HOSP CASABLANCA<br />
El Hafid Nawal | Mtioui Naoufal | Mifdal Nabila | El Mountahi Fadwa | El Khyat<br />
Salma | Bennani Nisrine | Zamd Mohamed | Medkouri Guislaine | Benghanem<br />
Mohamed Gharbi | Ramdani Benyounes<br />
Dept Nephrology Uh Ibn Rochd Casablanca Morocco<br />
FP144<br />
NEW BIOMARKERS FOR EARLY DETECTION ON RENAL INJURY IN HIV<br />
INFECTED PATIENTS<br />
Gianina Gabriela Sotila | Rugina Sorin | Dumitru Irina Magdalena | Cernat Roxana<br />
| Rugina Claudia<br />
Clinical Infectious Diseases Hosp, Centre Excellence Res Hiv Clinic Nephrology,<br />
Ovidius Univ, Constanta, Romania<br />
FP145<br />
NEED FOR EXERCISE AMONG PATIENTS WITH HYPERTENSION AND RE-<br />
NAL DISEASE (NEPHROS TRIAL): RANDOMIZED CONTROLLED TRIAL:<br />
PRELIMINARY RESULTS<br />
Franklin Correa Barcellos | Pedro Hallal Hallal | Maristela Bohlke | Fabricio<br />
Boscolo Del Vechio | Annelise Reges | Ina Santos | Grégore Mielke | Milena<br />
Fortes | Bruno Antunez<br />
PostGrad Program Epidemiology, Federal Univ Pelotas, Brazil | Catholic Univ<br />
Pelotas | Superior School Physical Education | Catholic Univ Pelotas<br />
FP146<br />
RENAL SHAPE AND FUNCTION IN YOUNG ADULT MEN BORN AFTER IN-<br />
TRAUTERINE GROWTH RETARDATION AND PRETERM BIRTH<br />
Mario Laganović | Ivana Vuković Lela | Sandra Karanović | Jadranka Serić|<br />
Vedran Premužić | Jelena Kos | Margareta Fištrek | Živka Dika | Ljiljana Fodor|<br />
Tajana Željković Vrkić | Bojan Jelaković<br />
Dept Nephrology, Arterial Hypertension and Dialysis Univ Hosp Center Zagreb,<br />
Zagreb, Croatia | School of Medicine Univ Zagreb, Zagreb, Croatia | Lab Clinical<br />
Diagnosis Univ Hosp Center Zagreb, Zagreb, Croatia<br />
FP147<br />
VARIATIONS IN THE PREVALENCE OF HIT ANTIBODIES DURING THE PE-<br />
RIOD 2004-<strong>2012</strong>. RELEVANCE TO HEPARIN CONTAMINANTS<br />
Vinod Bansal | Debra Hoppensteadt | Jawed Fareed<br />
Loyola Univ Medical Center<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
125<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
126<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
CLINICAL NEPHROLOGY -<br />
EPIDEMIOLOGY I<br />
FP148<br />
PLASMA RENIN ACTIVITY AND ALDOSTERONE-TO-RENIN RATIO ARE<br />
ASSOCIATED WITH THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE:<br />
THE OHASAMA STUDY<br />
Michihiro Satoh | Shiho Terata | Masahiro Kikuya | Takayoshi Ohkubo | Takanao<br />
Hashimoto | Azusa Hara | Takuo Hirose | Taku Obara | Hirohito Metoki|<br />
Ryusuke Inoue | Kei Asayama | Masaaki Nakayama | Atsuhiro Kanno | Kazuhito<br />
Totsune | Haruhisa Hoshi | Hiroshi Satoh | Hiroshi Sato | Yutaka Imai<br />
Tohoku Univ Grad School Pharmaceutical Sciences, Sendai, Japan | Shiga Univ<br />
Medical Science, Otsu City, Japan | Res Center Cancer Prevention and Screening<br />
National Cancer Center, Tokyo, Japan | College de France, Paris, France | Leuven<br />
Studies Coordinating Centre, Leuven, Belgium | Fukushima Medical Univ,<br />
Fukushima, Japan | Tohoku Fukushi Univ, Sendai, Japan | Ohasama Hosp, Iwate,<br />
Japan | Tohoku Univ Grad School of Medicine and Pharmaceutical Sciences,<br />
Sendai, Japan<br />
FP149<br />
DAILY WATER INTAKE AND RISK OF MORTALITY: LONGITUDINAL CO-<br />
HORT STUDY<br />
Suetonia Palmer | Wong Germaine | Samuel Iff | Jonathan Craig | Paul<br />
Mitchell| Jie Jin Wang | Giovanni Strippoli<br />
Univ Otago Christchurch, New Zealand | Centre Kidney Res, Westmead, Australia<br />
| Univ Sydney, Australia | Cochrane Renal Group, Sydney, Australia<br />
« FP150<br />
META-ANALYSIS: STATIN TH<strong>ERA</strong>PY TO PREVENT DEATH AND MAJOR<br />
CARDIOVASCULAR EVENTS IN PEOPLE WITH CHRONIC KIDNEY DISEASE<br />
Suetonia Palmer | Jonathan Craig | Sankar Navaneethan | Marcello Tonelli |<br />
Fabio Pellegrini | Giovanni Strippoli<br />
Univ Otago Christchurch, New Zealand | Univ Sydney | Cleveland Clinic |<br />
Univ Alberta, Edmonton, Alberta | Consorzio Mario Negri Sud | Cochrane Renal<br />
Group, Sydney, Australia<br />
FP151<br />
SERUM CREATININE IS ASSOCIATED WITH CAROTID INTIMA-MEDIA<br />
THICKNESS IN MALES: RESULTS OF A POPULATION-BASED STUDY (SHIP)<br />
Sylvia Stracke | Friedlinde Ernst | Daniel Robinson | Christian Schwahn | Ulrich<br />
John | Stephan B. Felix | Henry Völzke<br />
Nephrology, Greifswald, Germany | Cardiology, Epidemiology, Univ Medicine<br />
Greifswald, Germany | Ernst-Moritz-Arndt Univ Greifswald<br />
FP152<br />
CAROTID ARTERY REMODELING AND ENDOTHELIAL DYSFUNCTION IN<br />
PREDIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE<br />
Ihor Mysula | Anatoliy Gozhenko | Oleksandr Susla<br />
I.Ya. Horbachevsky Ternopil State Medical Univ, Ternopil, Ukraine | Ukrainian<br />
Scientific-Res Inst Transport Medicine, Odesa, Ukraine | Ternopil Univ Hosp,<br />
Ternopil, Ukraine<br />
FP153<br />
AMBULATORY BLOOD PRESSURE (ABP) AND RESISTANT HYPERTENSION<br />
(RH): TWO INCREMENTAL PREDICTORS OF LONG TERM COMPLICA-<br />
TIONS IN NON-DIALYSIS CKD<br />
Roberto Minutolo | Francis B. Gabbai | Rajiv Agarwal | Vincenzo Bellizzi |<br />
Felice Nappi | Giuseppe Conte | Luca De Nicola<br />
Div Nephrology, Second Univ Naples, Naples, Italy | VA San Diego Healthcare<br />
System and Univ California San Diego, CA, USA | Dept Medicine, Indiana Univ,<br />
and Richard L. Roudebush Veterans Affairs Medical Center, IN, USA | Nephrology<br />
Unit, County Hosp, Salerno | Nephrology Unit, County Hosp, Nola<br />
FP154<br />
ELASTIN DEGRADATION IS ASSOCIATED WITH PROGRESSIVE AORTIC<br />
STIFFENING AND ALL-CAUSE MORTALITY IN PRE-DIALYSIS CKD<br />
Edward Smith | Laurie Tomlinson | Martin Ford | Lawrence McMahon | Cha-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
kravarthi Rajkumar | Stephen Holt<br />
Monash Univ | Dept Clinical Pharmacology, Addenbrooke’s Hosp | Brighton<br />
and Sussex Medical School<br />
FP155<br />
SERUM HOMOCYSTEIN, SERUM CYSTATIN C, AND GLOMERULAR FIL-<br />
TRATION RATE ARE INDEPENDENTLY ASSOCIATED WITH ARTERIAL<br />
STIFFNESS IN CHRONIC KIDNEY DISEASE PATIENTS<br />
Soobong Lee | Ilyoung Kim | Dongwon Lee | Harin Rhee | Sangheon Song |<br />
Eunyoung Seong | Ihmsoo Kwak<br />
Pusan National Univ School Medicine | Pusan National Univ Hosp, Busan,<br />
South Korea<br />
FP156<br />
HEIGHT AS NORMALISATION INDEX OF GLOMERULAR FILTRATION<br />
RATE IN PATIENTS WITH EXTREME BODY SIZES<br />
Belén Redal-Baigorri | Knud Rasmusen | James Goya Heaf<br />
Roskilde Univ Hosp, Roskilde, Denmark | Roskilde Univ Hosp, Roskilde, Denmark<br />
| Herlev Univ Hosp, Herlev, Denmark<br />
FP157<br />
HOW ARE EARLY CKD PATIENTS REFERRED TO NEPHROLOGISTS BY<br />
OTHER SPECIALTIES?<br />
Konstantinos Sombolos | Dimitrios Tsakiris | Boletis John | Dimitrios Vlahakos|<br />
Konstantinos Siamopoulos | Vassilios Vargiemezis | Pavlos Nikolaidis|<br />
Christos Iatrou | Evgenios Dafnis | Christos Argyropoulos | Konstantinos Xynos<br />
Director Nephrology Clinic, Papanikolaou Hosp, Thessaloniki | Director Nephrology<br />
Clinic, Papageorgiou Hosp, Thessaloniki | Director Nephrology Clinic,<br />
Laiko Hosp, Athens | Nephrology Clinic, Attiko Hosp, Athens | Nephrology<br />
Clinic, Ioannina Univ Hosp, Ioannina | Nephrology Clinic, Alexanroupoli<br />
Univ Hosp, Alexandroupoli | Nephrology Clinic, AHEPA Hosp, Thessaloniki|<br />
Nikea Hosp, Athens | Director Nephrology Clinic, PE.PA.G.N.I, Crete Univ<br />
Hosp, Iraklio Crete | Abbott Laboratories Hellas S.A.<br />
FP158<br />
OXIDATIVE STRESS AND KIDNEY EFFECTS IN WORKERS WITH LOW OC-<br />
CUPATIONAL EXPOSURE TO CADMIUM<br />
Hambach Ramona | Droste Jos | François Guido | D'Haese Patrick | Lison Dominique<br />
| Manuel-Y-Keenoy Begona | De Schryver Antoon| van Sprundel Marc<br />
Univ Antwerp, Antwerp, Belgium | Catholic Univ Louvain<br />
FP159<br />
PHYSICAL FUNCTION AT START OF RENAL REPLACEMENT TH<strong>ERA</strong>PY -<br />
INDEPENDENT PREDICTOR OF SURVIVAL<br />
Matthias Hellberg | Eva Maria Wiberg | Peter Höglund | Ole Simonsen | Naomi<br />
Clyne<br />
Dept Nephrology and Transpl Lund, Skane Univ Hosp | Competence Centre<br />
Clinical Res Lund, Skane Univ Hosp<br />
FP160<br />
LOW INTENSITY, HOME-BASED EXERCISE IMPROVES PHYSICAL CAPACI-<br />
TY IN DIALYSIS PATIENTS: THE EXCITE STUDY (EXcercise Introduction To<br />
Enhance performance in dialysis)<br />
Fabio Manfredini | Davide Bolignano | Stefania Rastelli | Antonio Barillà |<br />
Silvio Bertoli | Daniele Ciurlino | Piergiorgio Messa | Fabrizio Fabrizi | Alessandro<br />
Zuccalà | Renato Rapanà | Pasquale Fatuzzo | Francesco Rapisarda |<br />
Graziella Bonanno | Luigi Lombardi | Luciano De Paola | Adamasco Cupisti|<br />
Giorgio Fuiano | Gaetano Lucisano | Giovanni Tripepi | Luigi Catizone | Carmine<br />
Zoccali | Francesca Mallamaci<br />
EXCITE Working Group | CNR IBIM and Osp Riuniti, Reggio Cal.<br />
FP161<br />
ASSOCIATION BETWEEN LIVER ENZYMES AND PROTEINURIA STRATI-<br />
FIED ON DRINKING STATUS: A NATIONWIDE CROSS-SECTIONAL STUDY<br />
Toshihiro Ishigami | Ryohei Yamamoto | Yasuyuki Nagasawa | Yoshitaka Isaka|<br />
Tsuneo Konta | Kunitoshi Iseki | Toshiki Moriyama | Kunihiro Yamagata|<br />
Kazuhiko Tsuruya | Hideaki Yoshida | Shouichi Fujimoto | Koichi Asahi | Tsu-<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
127<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
128<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
yoshi Watanabe<br />
Dept Geriatric Medicine & Nephrology, Osaka Univ Grad School of Medicine |<br />
Steering committee for the 'Research on the positioning of chronic kidney disease<br />
(CKD) in specific health check and guidance in Japan'<br />
FP162<br />
RENAL DYSFUNCTION IN A COHORT OF MARFAN SYNDROME PATIENTS<br />
Enrique Morales | Eduardo Gutiérrez | Alberto Forteza | Raquel Bellot | Violeta<br />
Sánchez | M. Paz Sanz | Arturo Evangelista | Jose Cortina | Manuel Praga<br />
Nephrology Dept Hosp 12 de Octubre, Madrid, Spain | Marfan Center H. 12<br />
Octubre, Madrid, Spain | Marfan Center Vall'de Hebrón. Barcelona, Spain<br />
FP163<br />
DIPYRIDAMOLE IMPROVES PATIENT AND RENAL SURVIVAL IN CHRO-<br />
NIC KIDNEY DISEASE STAGE 3-5 PATIENTS<br />
Chi-Chih Hung | Mei-Li Yang | Shang-Jyh Hwang | Hung-Chen Chen<br />
Kaohsiung Medical Univ Hosp<br />
FP164<br />
SYSTEMATIC REVIEW AND META-ANALYSIS: EFFECTS OF TARGETS FOR<br />
SERUM PHOSPHORUS, PARATHYROID HORMONE AND CALCIUM ON<br />
CLINICAL OUTCOMES IN CHRONIC KIDNEY DISEASE<br />
Valeria Maria Saglimbene | Suetonia Palmer | Jonathan Craig | Fabio Pellegrini|<br />
Mariacristina Vecchio | Marinella Ruospo | Giorgia De Berardis | Giovanni<br />
Strippoli<br />
Consorzio Mario Negri Sud | Univ Otago Christchurch, New Zealand | Univ<br />
Sydney | Diaverum Medical Scientific Office | Cochrane Renal Group, Sydney,<br />
Australia<br />
FP165<br />
EFFECT OF PHOSPHATE BINDER TH<strong>ERA</strong>PY ON MORTALITY IN PRE-<br />
DIALYSIS PATIENTS<br />
Biagio Di Iorio | Antonio Bellasi | Andrea Pota | Luigi Russo | Domenico Russo<br />
Osp Landolfo, Solofra, Avellino, Italia | Osp Sant'Anna, Como | Univ Federico<br />
II, Naples<br />
« FP166<br />
OSTEOPROTEGERIN REPLACES CORONARY ARTERY CALCIFICATION<br />
SCORE AS A PREDICTOR OF INCIDENT CARDIOVASCULAR EVENTS IN<br />
DIABETIC CHRONIC KIDNEY DISEASE<br />
Chikako Nakano | Takayuki Hamano | Naohiko Fujii | Yoshitsugu Obi | Isao<br />
Matsui | Satoshi Mikami | Kazunori Inoue | Akihiro Shimomura | Hiromi Rakugi<br />
| Yoshitaka Isaka<br />
Dept Geriatric Medicine and Nephrology, Osaka Univ Grad School of Medicine,<br />
Osaka, Japan | Center Clinical Epidemiology and Biostatistics, Univ Pennsylvania<br />
Perelman School of Medicine, Pennsylvania, USA | Dept Internal Medicine,<br />
Hyogo Prefectural Nishinomiya Hosp, Hyogo, Japan | Dept Internal Medicine,<br />
Higashi-Kohri Hosp, Osaka, Japan<br />
FP167<br />
HEMATURIA IS A RISK FACTOR FOR END STAGE RENAL DISEASE IN<br />
CHRONIC KIDNEY DISEASE PATIENTS<br />
Chun-Yu Yen | Hsiao-Han Wang | Chi-Chih Hung | Shang-Jyh Hwang |<br />
Hung-Chen Chen<br />
Div Nephrology, Kaohsiung Medical Univ Hosp, Taiwan<br />
FP168<br />
INDICES OF INSULIN RESISTANCE AND RISK OF TOTAL AND CARDIOVA-<br />
SCULAR MORTALITY IN DIALYSIS PATIENTS<br />
Maurizio Postorino | Sebastiano Cutrupi | Patrizia Pizzini | Carmela Marino|<br />
Graziella D'Arrigo | Giovanni Tripepi | Carmine Zoccali | on behalf of the Calabrian<br />
Registry of Dialysis and Transpl Working Group*<br />
CNR-IBIM & Nephrology Unit Reggio Calabria, Italy | CNR-IBIM, Reggio Calabria<br />
| CNR IBIM and Osp Riuniti, Reggio Cal. | Calabrian Registry of Dialysis<br />
and Transpl Working Group<br />
FP169<br />
MONITORING OF INTRA OCULAR PRESSURE CHANGES IN HEMODIALY-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SIS PATIENTS<br />
Hassan Ghasemi | Reza Afshar | Hoda Shabpirai | Ali Davati | Nikan Zerafatjou<br />
| Saeid Abdi | Mani Khorsand Askari<br />
Shahed Univ, Tehran, Iran | Shahid Beheshti Medical Univ, Tehran, Iran<br />
FP170<br />
EVALUATION OF AN INSTRUMENT FOR SCREENING PATIENTS AT RISK<br />
FOR CHRONIC KIDNEY DISEASE: TESTING SCORED (SCREENING FOR OC-<br />
CULT RENAL DISEASE) IN PORTUGUESE POPULATION<br />
Edgar Almeida | Carlota Lavinas | Catarina Teixeira | Mário Raimundo | Cristina<br />
Nogueira | Martina Ferreira | António Sampaio | Inês Henriques | Cecília<br />
Teixeira | António Gomes da Costa | Miguel Leal<br />
Dept Nephrology and Renal Transpl, Hosp Santa Maria, Lisbon, Portugal | Fac<br />
Medicine, Univ Lisbon, Portugal | Diaverum Portugal, Torres Vedras Unit, Portugal<br />
FP171<br />
SUBENDOCARDIAL VIABILITY RATIO AND ALBUMINURIA IN CKD PA-<br />
TIENTS<br />
Robert Ekart | Nina Hojs | Breda Pečovnik Balon | Sebastjan Bevc | Benjamin<br />
Dvoršak | Tina Stropnik Galuf | Radovan Hojs<br />
Univ Clinical Centre Maribor, Clinic Internal Medicine, Dept Dialysis, Maribor,<br />
Slovenia | Univ Clinical Centre Maribor, Clinic for Internal Medicine, Dept Nephrology,<br />
Maribor, Slovenia<br />
FP172<br />
FROM NEWLY DIAGNOSED SYSTEMIC LUPUS ERYTHEMATOSUS TO<br />
DIALYSIS AND THEN ALL-CAUSE MORTALITY: A NATIONWIDE COHORT<br />
STUDY IN TAIWAN<br />
Wei-Hung Lin | Chao-Yu Guo | Wei-Ming Wang | Deng-Chi Yang | Te-Hui<br />
Kuo | Ming-Fei Liu | Ming-Cheng Wang<br />
Tainan | Taipei<br />
FP173<br />
THE SIGNIFICANCE OF HYPERURICEMIA ON NEPHROCALCINOSIS BY<br />
ULTRASONOGRAPHY IN NON-PROTEIURIC CKD OF GEN<strong>ERA</strong>L POPULA-<br />
TION<br />
Shigeko Hara | Kentaro Tanaka | Hiroshi Tsuji | Yukiko Ohmoto | Kazuhisa<br />
Amaka | Yoshifumi Ubara | Kouji Arase<br />
Dept Nephrology, Toho Univ School of Medicine | Health Management Center,<br />
Kidney Center, Toranomon Hosp<br />
FP174<br />
PLATELET TO LYMPHOCYTE RATIO INDEPENDENTLY PREDICTS CAR-<br />
DIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE<br />
Mahmut Ilker Yilmaz | Yalcin Solak | Mutlu Saglam | Halil Yaman | Hilmi<br />
Umut Unal | Mahmut Gok | Hakki Cetinkaya | Zeynep Biyik | Abduzhappar<br />
Gaipov | Kayser Caglar | Halil Zeki Tonbul | Suleyman Turk<br />
Gulhane School of Medicine, Ankara, Turkey | Konya Univ Meram School of<br />
Medicine, Konya, Turkey<br />
FP175<br />
THE ASSOCIATION BETWEEN SERUM POTASSIUM AND CLINICAL OUT-<br />
COMES IN CHRONIC KIDNEY DISEASE STAGE 1-4 PATIENTS<br />
Hsiao-Han Wang | Chun-Yu Yen | Chi-Chih Hung | Shang-Jyh Hwang | Hung-<br />
Chen Chen<br />
Kaohsiung Medical Univ Hosp | Div Nephrology, Kaohsiung Medical Univ<br />
Hosp, Taiwan<br />
FP176<br />
SCREENING FOR CHRONIC KIDNEY DISEASES IN ROMA PEOPLE IN BUL-<br />
GARIA<br />
Stefan Krivoshiev | Anna Koteva | Zdravko Kraev | Georgi Mihaylov | Petar<br />
Shikov<br />
Medical Univ, Sofia, Bulgaria | District Hosp, Pazardjik, Bulgaria<br />
FP177<br />
RDX5791, A NON-SYSTEMIC NHE3 INHIBITOR FOR THE TREATMENT OF<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
129<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
130<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FLUID AND SODIUM OVERLOAD, SHIFTS SODIUM EXCRETION FROM<br />
URINE TO FECES IN HEALTHY SUBJECTS<br />
Rosenbaum David | Jacobs Jeffrey | Spencer Andrew | Raab Michael | Dominique<br />
Charmot<br />
Ardelyx Inc.<br />
FP178<br />
PULMONARY HYPERTENSION IN CHRONIC KIDNEY DISEASE PATIENTS<br />
ON CONSERVATIVE TREATMENT AND ON DIALYSIS. RELATION TO NI-<br />
TRIC OXIDE<br />
Ragai Fouda | Yasser Abdelhamid | Dina Alsayed | Sheren Salah | Dawlat Belal|<br />
Mohammed Salem | Hamdy Ahmed<br />
Fac Medicine, Cairo Univ, Cairo, Egypt | Student Hosp, Cairo Univ, Cairo,<br />
Egypt| Ministry of Health | Dept Biochemistry, National Res Centre, Cairo,<br />
Egypt<br />
FP179<br />
DEPRESSION IN PEOPLE WITH CHRONIC KIDNEY DISEASE: A META-<br />
ANALYIS OF PREVALENCE AND ASSOCIATIONS WITH CLINICAL OUT-<br />
COMES<br />
Mariacristina Vecchio | Suetonia Palmer | Valeria Maria Saglimbene | Marinella<br />
Ruospo | Letizia Gargano | Fabio Pellegrini | Giovanni Strippoli<br />
Consorzio Mario Negri Sud, Italy | Univ Otago Christchurch, New Zealand |<br />
Diaverum Medical Scientific Office | Diaverum | Cochrane Renal Group, Sydney,<br />
Australia<br />
FP180<br />
RENAL BIOPSY REGISTRY FROM CROATIAN UNIV HOSP: A 15 YEARS OF<br />
EXPERIENCE WITH REVIEW OF EPIDEMIOLOGICAL DATA<br />
Miroslav Tisljar | Ivica Horvatic | Borka Bozic | Jasenka Crnjakovic Palmovic |<br />
Jasna Bacalja | Stela Bulimbasic | Danica Galesic Ljubanovic | Kresimir Galesic<br />
Univ Hosp Dubrava, Dept Nephrology, Zagreb, Croatia | Univ Hosp Dubrava,<br />
Dept Pathology, Zagreb, Croatia<br />
FP181<br />
RENAL DYSFUNCTION AS A RISK FACTOR FOR PAINLESS MYOCARDIAL<br />
INFARCTION: RESULTS FROM KOREA ACUTE MYOCARDIAL INFARC-<br />
TION REGISTRY<br />
Joon seok Choi | Chang Seong Kim | Jeong Woo Park | Eun Hui Bae | Seong<br />
Kwon Ma | Soo Wan Kim<br />
Dept Internal Medicine, Chonnam National Univ Medical School, Gwangju, Korea<br />
FP182<br />
SUBOPTIMAL MEDICAL CARE IN ST-ELEVATION MYOCARDIAL INFARC-<br />
TION PATIENTS WITH RENAL DYSFUNCTION<br />
Joon seok Choi | Chang Seong Kim | Jeong Woo Park | Eun Hui Bae | Seong<br />
Kwon Ma | Soo Wan Kim<br />
Dept Internal Medicine, Chonnam National Univ Medical School, Gwangju, Korea<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
RENAL ANAEMIA - CKD 1-5<br />
FP183<br />
CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR (C.E.R.A.) ONCE<br />
MONTHLY MAINTAINS STABLE HEMOGLOBIN VALUES IN HIGH-RISK<br />
PATIENTS WITH CHRONIC KIDNEY DISEASE ON DIALYSIS: AN ANALYSIS<br />
OF 10 INTERNATIONAL TRIALS<br />
Danilo Fliser | Valery Shilo<br />
Dept Internal Medicine IV, Saarland Univ Hosp | Dept Nephrology for Post-<br />
Grad, Moscow Univ Medicine and Dentistry<br />
FP184<br />
RELATIONSHIP BETWEEN CARDIOVASCULAR (CV) EVENTS AND HEMO-<br />
GLOBIN (HB) LEVEL OR HB RATE OF CHANGE IN HEMODIALYSIS (HD)<br />
PATIENTS ON PEGINESATIDE<br />
Adrian Covic | Anatole Besarab | Robert Provenzano | Anne-Marie Duliege |<br />
Minjia Chen | Sandra Tong | Carol Francisco | Hong-Ye Gao | Krishna Polu |<br />
Angel LM de Francisco<br />
Univ Medicine Gr. T. Popa Iasi | Henry Ford Hosp, Detroit, MI, USA | Saint<br />
Claire Specialty Physicians, PC, Detroit, MI, USA | Affymax, Inc., Palo Alto, CA,<br />
USA | Hosp Univ Valdecilla, Santander, Spain<br />
FP185<br />
HIGHER DOSING REQUIREMENTS OF PEGINESATIDE AND EPOETIN FOR<br />
TREATMENT OF ANEMIA IN US VS NON-US HEMODIALYSIS (HD) PA-<br />
TIENTS<br />
Iain Macdougall | Brigitte Schiller | Francesco Locatelli | Andrzej Więcek | Carol<br />
Francisco | Helen Tang | Sandra Tong | Minjia Chen | Anne-Marie Duliege|<br />
Krishna Polu | Martha Mayo | Adrian Covic<br />
King's College Hosp, London, UK | Satellite Healthcare, Inc., San Jose, CA, USA|<br />
Osp A. Manzoni, Lecco, Italy | Dept Nephrology, Endocrinology and Metabolic<br />
Diseases, Medical Univ Silesia | Affymax, Inc., Palo Alto, CA, USA | Univ Medicine<br />
Gr. T. Popa Iasi<br />
FP186<br />
LONG-TERM RESULTS FROM A STUDY OF PEGINESATIDE IN PATIENTS<br />
WITH ANTIBODY-MEDIATED PURE RED CELL APLASIA (AB+PRCA)<br />
Iain Macdougall | Nicole Casadevall | Richard Stead | Maarten Taal | Bernadette<br />
Faller | Alexandre Karras | Minjia Chen | Sandra Tong| Anne-Marie Duliege|<br />
Richard Rowell | Krishna Polu | Kai-Uwe Eckardt<br />
King's College Hosp, London, UK | Hôp Saint Antoine, Paris, France | BioPharma<br />
Consulting Serv, Bellevue, WA, USA | Royal Derby Hosp, Derby, UK | Hôp<br />
Civils, Colmar, France | Néphrologie, HEGP, Paris, France | Univ Erlangen-<br />
Nuremberg, Erlangen, Germany<br />
FP187<br />
CHARACTERISTICS OF PATIENTS WITH CHRONIC KIDNEY DISEASE ON<br />
DIALYSIS WITH A POOR RESPONSE TO CONTINUOUS ERYTHROPOIETIN<br />
RECEPTOR ACTIVATOR (C.E.R.A.) ONCE MONTHLY: AN ANALYSIS OF 10<br />
INTERNATIONAL TRIALS<br />
Francesco Locatelli | Sylvie Dusilova Sulkova<br />
Dept Nephrology, Dialysis and Renal Transpl, Alessandro Manzoni Hosp | Dept<br />
Nephrology, Inst Clinical and Experimental Medicine<br />
FP188<br />
IMPACT OF ON-LINE HAEMODIAFILTRATION ON THE MANAGEMENT<br />
OF ANAEMIA BY C<strong>ERA</strong>: HDFHD STUDY, INTERIM ANALYSIS<br />
Stolz Arnaud | Paris Bruno | Guérard Arnaud | Visanica Dorina | Azoulay<br />
Eric | Mangenot Gérard<br />
Saint André Private Hosp Metz, France<br />
FP189<br />
PROSPECTIVE OBSERVATIONAL MULTICENTER STUDY TO EVALUATE<br />
THE EFFECTIVENESS AND SAFETY OF METHOXY POLYETHYLENE GLY-<br />
COL-EPOETIN BETA (MIRC<strong>ERA</strong>®) IN PATIENTS WITH ANAEMIA SECON-<br />
DARY TO CHRONIC KIDNEY DISEASE. MINERVA STUDY<br />
Aleix Cases | J.M. Portolés | J. Calls | A. Martínez Castelao | D. Sánchez-Gui-<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
131<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
132<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
sande | A. Segarra<br />
Nephrology and Transpl Unit, Hosp Clínic, Barcelona, Spain | Hosp Univ Puerta<br />
de Hierro, Madrid, Spain | Hosp Manacor, Palma de Mallorca, Spain | Hosp<br />
Bellvitge, Barcelona, Spain | Hosp Barbanza, A Coruña, Spain | Hosp Vall d'Hebron,<br />
Barcelona, Spain<br />
FP190<br />
EFFICACY AND SAFETY OF PEGINESATIDE IN JAPANESE CHRONIC KID-<br />
NEY DISEASE PATIENTS NOT ON DIALYSIS<br />
Yoshiharu Tsubakihara | Akira Saito | AF37702/CCT-001 Study Group<br />
Dept Kidney Disease and Hypertension, Osaka General Medical Center, Osaka,<br />
Japan | Yokohama Dai-ichi Hosp, Yokohama, Japan<br />
FP191<br />
EFFICACY AND SAFETY OF PEGINESATIDE IN JAPANESE CHRONIC KID-<br />
NEY DISEASE PATIENTS ON HEMODIALYSIS<br />
Akira Saito | Yoshiharu Tsubakihara | AF37702/CCT-101 Study Group<br />
Yokohama Dai-ichi Hosp, Yokohama, Japan | Dept Kidney Disease and Hypertension,<br />
Osaka General Medical Center, Osaka, Japan<br />
FP192<br />
MANAGEMENT OF RENAL ANAEMIA IN PATIENTS WITH CHRONIC<br />
KIDNEY DISEASE STAGES 3, 4 AND 5 NOT ON DIALYSIS TREATED WITH<br />
C.E.R.A. IN CATALONIAN NEPHROLOGY UNITS (THE MICENAS II STUDY)<br />
A. Martínez-Castelao | A. Cases | J. Fort | J. Bonal | X. Fulladosa | J.M. Galcerán|<br />
V. Torregrosa | E. Coll<br />
Nephrology Unit, Hosp Bellvitge, Barcelona, Spain | Nephrology and Transpl<br />
Unit, Hosp Clínic, Barcelona, Spain | Nephrology Unit, Hosp Vall d'Hebron, Barcelona,<br />
Spain | Nephrology Unit, Hosp Germans Trias i Pujol, Badalona, Spain |<br />
Nephrology Unit, Fund Althaia, Manresa, Spain | Nephrology Unit, Fund Puigvert,<br />
Barcelona, Spain<br />
FP193<br />
SWITCH TO LOW DOSE C.E.R.A. MAINTAINS HEMOGLOBIN (Hb) LEVELS<br />
IN NON DIALYSIS CHRONIC KIDNEY DISEASE (CKD): A MULTICENTRIC<br />
PROSPECTIVE STUDY IN ITALY<br />
Roberto Minutolo | Mario Cozzolino | Biagio Di Iorio | Pasquale Polito | Domenico<br />
Santoro | Flavia Manenti | Felice Nappi | Sandro Feriozzi | Giuseppe<br />
Conte | Luca De Nicola<br />
Div Nephrology, Second Univ Naples, Naples, Italy | DMCO, Univ Milan, Renal<br />
Div, San Paolo Hosp, Milan, Italy | County Hosp Solofra| County Hosp Tivoli|<br />
Univ Messina | San Salvatore Hosp, Pesaro | County Hosp Nola | Belcolle<br />
Hosp Viterbo<br />
FP194<br />
DOSE RELATIONSHIP BETWEEN PEGINESATIDE AND EPOETIN FOR PA-<br />
TIENTS ON DIALYSIS<br />
Ashraf Mikhail | Robert Provenzano | Brigitte Schiller | Anatole Besarab | Carol<br />
Francisco | Hong-Ye Gao | Richard Daley | Sandra Tong | Martha Mayo | Alex<br />
Yang | Krishna Polu | Iain Macdougall<br />
Renal Unit, Morriston Hosp, Swansea, UK | Saint Claire Specialty Physicians,<br />
PC, Detroit, MI, USA | Satellite Healthcare, Inc., San Jose, CA, USA | Henry Ford<br />
Hosp, Detroit, MI, USA | Affymax, Inc., Palo Alto, CA, USA | King's College<br />
Hosp, London, UK<br />
FP195<br />
RELATIONSHIP BETWEEN CARDIOVASCULAR (CV) EVENTS, MORTALITY<br />
AND DOSES OF PEGINESATIDE VS EPOETIN IN HEMODIALYSIS (HD) PA-<br />
TIENTS<br />
Andrzej Więcek | Brigitte Schiller | Bernard Canaud | Francesco Locatelli | Alex<br />
Yang | Minjia Chen | Krishna Polu | Carol Francisco | Hong-Ye Gao | Sandra<br />
Tong | Anne-Marie Duliege | Robert Provenzano<br />
Dept Nephrology, Endocrinology and Metabolic Diseases, Medical Univ Silesia|<br />
Satellite Healthcare, Inc., San Jose, CA, USA | Univ Montpellier, Hôp Lapeyronie,<br />
Dept Nephrology, Montpellier, France | Osp A. Manzoni, Lecco, Italy | Affymax,<br />
Inc., Palo Alto, CA, USA | Saint Claire Specialty Physicians, PC, Detroit,<br />
MI, USA<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP196<br />
IRON UTILIZATION IN US HEMODIALYSIS (HD) PATIENTS TREATED<br />
WITH PEGINESATIDE VS EPOETIN FOR ANEMIA OF CHRONIC KIDNEY<br />
DISEASE (CKD)<br />
Francesco Locatelli | Robert Provenzano | Anatole Besarab | Thomas Rath |<br />
Alex Yang | Martha Mayo | Carol Francisco | Iain Macdougall<br />
Osp A. Manzoni, Lecco, Italy | Saint Claire Specialty Physicians, PC, Detroit, MI,<br />
USA | Henry Ford Hosp, Detroit, MI, USA | Westpfalz-Klinikum Kaiserslautern<br />
Medizinische Klinik III Abteilung für Nephrologie und Transpl, Kaiserslautern,<br />
Germany | Affymax, Inc., Palo Alto, CA, USA | King's College Hosp, London,<br />
UK<br />
FP197<br />
EFFECT OF METHOXY POLYETHYLENE GLYCOL – EPOETIN BETA ON<br />
POLYMORPHONUCLEAR (PMN) CELLS APOPTOSIS IN PREDIALYSIS PA-<br />
TIENTS WITH CHRONIC KIDNEY DISEASE (CKD)<br />
Piotr Bartnicki | Zbigniew Baj | Ewa Majewska | Jacek Rysz<br />
Dept Nephrology Hypertension and Family Medicine | Medical Univ | WAM<br />
Univ Hosp<br />
FP198<br />
FUNCTIONAL IRON DEFICIENCY IS A FACTOR LIMITING THE USE OF<br />
HIGH DOSES OF INTRAVENOUS IRON IN PREDIALYSIS<br />
Patrick Fievet | Maryam Assem | François Brazier | Xiaoli Xu | Oumeria Nadia<br />
Soltani | Renato Demontis<br />
Serv Néphrologie Hémodialyse, CH Laennec, CREIL<br />
FP199<br />
IS HEPCIDIN-25 A CLINICALLY RELEVANT PARAMETER FOR THE IRON<br />
STATUS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS?<br />
Liliana Barsan | Simona Stancu | Ana Stanciu | Cristina Capusa | Ligia Petrescu|<br />
Adrian Zugravu | Gabriel Mircescu<br />
Dr Carol Davila Teaching Hosp Nephrology, Bucharest, Romania | Nephrology<br />
Dept, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania<br />
FP200<br />
IRON METABOLISM IN HEMODIALYSIS PATIENTS - STILL A MYSTERY?<br />
Jolanta Malyszko Malyszko | Nomy Levin-Iaina | Jacek Malyszko | Irena<br />
Głowińska | Ewa Koc-Zorawska | Itzachk Slotki | Michal Mysliwiec<br />
Dept Nephrology and Transpl, Medical Univ, Bialystok Poland | Shaare Zedek<br />
Medical Center, Jerusalem, Israel<br />
FP201<br />
ACUTE RENAL AND VASCULAR EFFECTS OF INTRAVENOUS IRON<br />
Gabriel Mircescu | Cristina Capusa | Simona Stancu | Liliana Barsan | Doina<br />
Grabowski | Violeta Blaga | Daniela Dumitru<br />
Nephrology Dept, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania<br />
| Dr Carol Davila Teaching Hosp Nephrology, Bucharest, Romania<br />
FP202<br />
SYSTEMIC INFLAMMATION AS A FACTOR OF ANEMIA DEVELOPMENT<br />
IN PATIENTS WITH EARLY STAGES OF DIABETIC NEPHROPATHY<br />
Ivan Pchelin | Alexander Shishkin<br />
St.Petersburg Univ, St. Petersburg, Russia<br />
FP203<br />
EVALUATION OF RELATIONSHIP BETWEEN HEMOGLOBIN VARIABILITY<br />
AND OXIDATIVE STRESS AND INFLAMMATION IN CHRONIC RENAL FAI-<br />
LURE<br />
Tulay Kus | Celalettin Usalan | Ozlem Tiryaki<br />
Gaziantep Univ School of Medicine, Dept Internal Medicine | Gaziantep Univ<br />
School of Medicine, Dept Nephrology, Turkey<br />
FP204<br />
NUMBER OF RED BLOOD CELLS AS A RESPONSE OF INNATE ERYTHRO-<br />
POIETIN IS AN IMPORTANT RISK FACTOR<br />
Ho Jun Chin | Dong-Wan Chae | Suhnggwon Kim<br />
Seoul National Univ Bundang Hosp Seongnam Korea | SNUBH | SNUH<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
133<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
134<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP205<br />
A PHARMACODYNAMIC VIEW ON THE TREAT TRIAL – THE DARBEPOE-<br />
TIN THRESHOLD AND CEILING CONCENTRATIONS<br />
Hartmann Bertram | Frieder Keller<br />
Nephrology, Center for Internal Medicine, Univ Hosp, Ulm, Germany<br />
FP206<br />
MINIMISATION OF ESA TH<strong>ERA</strong>PY POST-TREAT STUDY: ONE-YEAR EXPE-<br />
RIENCE<br />
Adam Rumjon | Cheryl Wood | Paul Wilson | Shammim Khakoo | Mee Onn<br />
Chai | Iain C. Macdougall<br />
King's College Hosp NHS Foundation Trust, London, UK | Renal Unit, King's<br />
College Hosp<br />
FP207<br />
USE OF PENTOXIFYLLINE IN HEMODIALYSIS PATIENTS WITH ERYTHRO-<br />
POIESIS-STIMULATING AGENT (ESA) RESISTANCE: A CASE-CONTROL<br />
STUDY<br />
Garcia-Fernandez Nuria | Ferrer Maria Asuncion | Mora-Gutierrez Jose Maria|<br />
Calderon Carmen | Martin-Moreno Paloma Leticia | Lavilla Francisco Javier<br />
Clinica Univ Navarra, Pamplona, Spain<br />
FP208<br />
HEMOGLOBIN AND QUALITY OF LIFE IN PATIENTS ON PRE-DIALYSIS<br />
CARE<br />
de Goeij Moniek | Meuleman Yvette | Grootendorst Diana | Dekker Friedo |<br />
Halbesma Nynke<br />
Leiden Univ Medical Center, Dept Clinical Epidemiology, Leiden, Netherlands|<br />
Leiden Univ Medical Center, Dept Medical Psychology, Leiden, Netherlands |<br />
Kennemer Gasthuis, Linnaeus Inst, Haarlem, Netherlands<br />
FP209<br />
PHARMACOKINETICS OF ERYTHROPOIETIN IN BALKAN ENDEMIC NE-<br />
PHROPATHY PATIENTS<br />
Visnja Lezaic | Branislava Miljkovic | Nenad Petkovic | Ivko Maric | Katarina<br />
Vučićević | Sanja Simic Ogrizovic | Ljubica Djukanovic<br />
Medical Fac, Belgrade, Serbia | Fac Pharmacy, Univ Belgrade, Serbia | FMC<br />
Center Šamac, BH | Special Hosp for Endemic Nephropathy, Lazarevac, Serbia<br />
FP210<br />
PREVALENCE OF ANAEMIA AND ITS MANAGEMENT IN PATIENTS WITH<br />
CHRONIC KIDNEY DISEASE STAGES 3, 4 AND 5 NOT ON DIALYSIS AT NE-<br />
PHROLOGY UNITS IN CATALONIA (THE MICENAS I STUDY)<br />
Aleix Cases | A. Martínez-Castelao | A. Fort | J. Bonal | X. Fulladosa | J.M.<br />
Galcerán | V. Torregrosa | E. Coll<br />
Nephrology and Transpl Unit, Hosp Clínic, Barcelona, Spain | Nephrology Unit,<br />
Hosp Bellvitge, Barcelona, Spain | Nephrology Unit, Hosp Vall d'Hebron, Barcelona,<br />
Spain | Nephrology Unit, Hosp Germans Trias i Pujol, Badalona, Spain |<br />
Nephrology Unit, Fund Althaia, Manresa, Spain | Nephrology Unit, Fund Puigvert,<br />
Barcelona, Spain<br />
FP211<br />
THE ASSOCIATION OF KIDNEY TRANSPL STATUS WITH ESA DOSE REQUI-<br />
REMENT: INTERIM ANALYSIS OF THE EXTEND STUDY<br />
S Di Giulio | J Galle | I Kiss | H Herlitz | G Wirnsberger | K Claes | M Suranyi|<br />
A Guerin | C Winearls | J Addison | M D’Souza | M Froissart<br />
Osp San Camillo Forlanini, Rome, Italy | Klinikum Luedenscheid, Luedenscheid,<br />
Germany | Fov. Onk. Szent Imre Korhaz, Budapest, Hungary | Dept<br />
Molecular and Clinical Medicine/Nephrology, Inst Medicine, Sahlgrenska Academy<br />
Univ Gothenburg, Göteborg, Sweden | Dept Internal Medicine, Medical<br />
Univ Graz, Graz, Austria | UZ Gasthuisberg, Leuven, Belgium | Renal Unit,<br />
Liverpool Hosp, Sydney, Australia | Clinique Mont Loius, Paris, France | Oxford<br />
Kidney Unit, Churchill Hosp, Oxford, UK | Amgen Limited, Cambridge,<br />
UK | Contract statistician on behalf of Amgen Limited, Cambridge, UK | Amgen<br />
(Europe) GmbH, Zug<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
« FP212<br />
EARLY RECOMBINANT HUMAN ERYTHROPOIETIN TREATMENT PRO-<br />
MOTES CARDIORENAL CYTOPROTECTION IN A RAT MODEL OF CHRO-<br />
NIC RENAL FAILURE<br />
Patrícia Garrido | Margarida Teixeira | Elísio Costa | Paulo Rodrigues-Santos|<br />
Belmiro Parada | Luís Belo | Rui Alves | Frederico Teixeira | Alice Santos-<br />
Silva| Flávio Reis<br />
Pharmacology & Experimental Therapeutics, IBILI, Medicine Fac, Coimbra Univ,<br />
Coimbra| Inst Health Sciences of Univ Catholic, Porto | Group of Immunology<br />
and Oncology, CNC, Coimbra | Inst Molecular and Cellular Biology, Porto Univ,<br />
Porto | Serv Nephrology, HUC, Coimbra<br />
FP213<br />
TRENDS IN CKD ANAEMIA MANAGEMENT: THE IMPACT OF A CHAN-<br />
GING ENVIRONMENT (AN INTERIM ANALYSIS OF THE EXTEND STUDY)<br />
C Winearls | S Di Giulio | J Galle | I Kiss | H Herlitz | G Wirnsberger | K Claes|<br />
M Suranyi | A Guerin | J Addison | M D’Souza | B Fouqueray<br />
Oxford Kidney Unit, Churchill Hosp, Oxford, UK | Osp San Camillo Forlanini,<br />
Rome, Italy | Klinikum Luedenscheid, Luedenscheid, Germany | Fov. Onk.<br />
Szent Imre Korhaz, Budapest, Hungary | Dept Molecular and Clinical Medicine/<br />
Nephrology, Inst Medicine, Sahlgrenska Academy Univ Gothenburg, Göteborg,<br />
Sweden | Dept Internal Medicine, Medical Univ Graz, Graz, Austria | UZ Gasthuisberg,<br />
Leuven, Belgium | Renal Unit, Liverpool Hosp, Sydney, Australia|<br />
Clinique Mont Louis, Paris, France | Amgen Limited, Cambridge, UK | Contract<br />
statistician on behalf of Amgen Limited, Cambridge, UK | Amgen (Europe)<br />
GmbH, Zug, Switzerland<br />
FP214<br />
CARDIORENAL SYNDROME TYPE 4 (CRS 4) ASSOCIATED WITH ANAEMIA<br />
LONG TERM SURVIVAL ANALYSIS<br />
Matteo Floris | Maura Conti | Riccardo Cao | Gianfranco Pili | Patrizia Melis|<br />
Valeria Matta | Efisio Murgia | Alice Atzeni | Valentina Binda | Andrea Angioi|<br />
Marcella Peri | Antonello Pani<br />
Nephrology, Brotzu Hosp, Cagliari | Pediatry, Univ Cagliari<br />
FP215<br />
EVALUATION OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE<br />
INHIBITOR FG-4592 FOR HEMOGLOBIN CORRECTION AND MAINTENAN-<br />
CE IN NONDIALYSIS CHRONIC KIDNEY DISEASE PATIENTS FOR 16 AND<br />
24 WEEKS<br />
Anatole Besarab | Diogo Belo | Susan Diamond | Edouard Martin | Chao Sun|<br />
Tyson Lee | Khalil Saikali | Marietta Franco | Robert Leong | Thomas Neff |<br />
Kin-Hung Peony Yu<br />
Henry Ford Hosp, Detroit, USA | California Inst Renal Res, Chula Vista, USA|<br />
San Antonio Kidney Disease Center, San Antonio, USA | South Florida Res Inst,<br />
Lauderdale Lakes, USA | Apex Res, Riverside, USA | FibroGen, Inc., San Francisco,<br />
USA<br />
FP216<br />
RECHALLENGE WITH INTRAVENOUS RECOMBINANT HUMAN<br />
ERYTHROPOIETIN (r-HuEpo) CAN SUCCESSFULLY TREAT ANTI-RECOM-<br />
BINANT ERYTHROPOIETIN ASSOCIATED PRCA<br />
Khajohn Tiranathanagul | Pisut Katavetin | Talerngsak Kanjanabuch | Yingyos<br />
Avihingsanon | Kriang Tungsanga | Somchai Eiam-Ong<br />
Chulalongkorn Univ, Bangkok, Thailand<br />
FP217<br />
A PROSPECTIVE, IMMUNOGENICITY SURVEILLANCE REGISTRY (PRIMS)<br />
TO ESTIMATE THE INCIDENCE OF ERYTHROPOIETIN ANTIBODY-ME-<br />
DIATED PURE RED CELL APLASIA AMONG SUBJECTS WITH CHRONIC<br />
RENAL FAILURE AND SUBCUTANEOUS EXPOSURE TO RECOMBINANT<br />
ERYTHROPOIETIN PRODUCTS<br />
Iain C. Macdougall | Nicole Casadevall | Paul Percheson | Anna Potamianou |<br />
Arnaud Foucher | Daniel Fife | Els Vercammen | PRIMS Study Group<br />
Renal Unit, King's College Hosp | Sce d'Immunologie et Hématologie Biologiques,<br />
Hôp Saint Antoine, Paris, France | Janssen, Pharmaceutical Companies of<br />
Johnson & Johnson<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
135<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
136<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
MIN<strong>ERA</strong>L AND BONE DISEASE - CKD 1-5<br />
FP218<br />
CLINICAL AND DEMOGRAPHIC PREDICTORS FOR VITAMIN D DEFICIEN-<br />
CY IN MULTI-ETHNIC ASIAN PATIENTS WITH CHRONIC KIDNEY DISEASE<br />
Zhong Yi Loh | Chun Wei Yap | Vathsala Anantharaman | Priscilla How<br />
National Univ Singapore, Singapore | National Univ Health System, Singapore<br />
FP219<br />
22-OXACALCITRIOL PREVENTS PROGRESSION OF ENDOTHELIAL DY-<br />
SFUNCTION THROUGH ANTI-OXIDATIVE EFFECTS IN RATS WITH TYPE<br />
2 DIABETES<br />
Michinori Hirata | Ken Aizawa | Kenji Yogo | Yoshihito Tashiro | Satoshi Takeda<br />
| Koichi Endo | Masafumi Fukagawa | Ken-ich Serizawa<br />
Chugai Pharmaceutical Co., Ltd. | Div Nephrology, Endocrinology and Metabolism,<br />
Tokai Univ School of Medicine, Isehara, Japan<br />
FP220<br />
EFFECT OF VITAMIN D ON VASCULAR LESIONS AND OXIDATIVE STRESS<br />
AT EARLY STAGE OF DIABETIC NEPHROPATHY<br />
Hideki Fujii | Keiji Kono | Kentaro Nakai | Shunsuke Goto | Michinori Hirata|<br />
Masami Shinohara | Riko Kitazawa | Sohei Kitazawa | Masafumi Fukagawa |<br />
Shinichi Nishi<br />
Div Nephrology and Kidney Center, Kobe Univ Grad School of Medicine, Kobe,<br />
Japan | Fuji Gotemba Res Labs, Chugi pharmaceutical Co., Ltd, Shizuoka, Japan|<br />
CLEA Japan, Inc., Tokyo, Japan | Div Molecular Pathology, Dept Biomedical<br />
Informatics, Kobe Univ Grad School of Medicine, Kobe, Japan | Div Molecular<br />
Pathology, Ehime Univ Grad School of Medicine, Japan | Div Nephrology,<br />
Endocrinology and Metabolism, Tokai Univ School of Medicine, Isehara, Japan<br />
FP221<br />
VITAMIN D RECEPTOR ACTIVATORS PRESERVE VASCULAR CALCIFI-<br />
CATION BY REDUCING OSTEOPROTEGERIN LEVELS IN HEMODIALYSIS<br />
PATIENTS<br />
Aysegul Oruc | Serhat Korkmaz | Oznur Bal | Arzu Yilmaztepe Oral | Alparslan<br />
Ersoy | Mustafa Gullulu<br />
Uludag Univ, Nephrology Dept, Bursa, Turkey | Uludag University, Biochemistry<br />
Dept, Bursa, Turkey<br />
FP222<br />
IMPROVED iPTH LOWERING OF PARICALCITOL VS. CINACALCET IN<br />
SUBJECTS ON HEMODIALYSIS: ANALYSIS OF THE IMPACT STUDY<br />
Markus Ketteler | Kevin Martin | Michael Amdahl | Mario Cozzolino | David<br />
Goldsmith | Amit Sharma | Samina Khan<br />
Klinikum Coburg, Coburg Germany | Dept Internal Medicine, Div Nephrology,<br />
Saint Louis Univ, St. Louis, USA | Abbott Laboratories, Abbott Park, USA|<br />
DMCO, Univ Milan, Renal Div, San Paolo Hosp, Milan, Italy | Guy’s Hosp, London,<br />
UK | Boise Kidney and Hypertension Inst, Boise, USA | Abbott Laboratories,<br />
Abbott Park, USA<br />
FP223<br />
EFFECTS OF THE SELECTIVE VITAMIN D RECEPTOR (VDR) AGONIST,<br />
PARICALCITOL, COMPARED TO CINACALCET ON CALCIUM, PHOSPHO-<br />
ROUS AND iPTH: RESULTS FROM THE IMPACT SHPT STUDY<br />
Markus Ketteler | Kevin Martin | Michael Amdahl | Mario Cozzolino | David<br />
Goldsmith | Amit Sharma | Samina Khan<br />
Klinikum Coburg, Coburg Germany | Dept Internal Medicine, Div Nephrology,<br />
Saint Louis Univ, St. Louis, USA | Abbott Laboratories, Abbott Park, USA|<br />
DMCO, Univ Milan, Renal Div, San Paolo Hosp, Milan, Italy | Guy’s Hosp, London,<br />
UK | Boise Kidney and Hypertension Inst, Boise, USA | Abbott Laboratories,<br />
Abbott Park, USA<br />
FP224<br />
VITAMIN D IS LINKED WITH ANTI-INFLAMMATORY CYTOKINES IN PA-<br />
TIENTS WITH NON-DIALYSIS DEPENDENT CKD<br />
Nihil Chitalia | Behdad Afzali | Francis Edozie | Padmini Manghat | Anthony<br />
Wierzbicki | Geeta Hampson | David Goldsmith<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
King's Health Partners (AHSC) | MRC Centre for Transpl, Kings college London|<br />
Guy's and St Thomas' NHS Foundation Hosp<br />
FP225<br />
CALCITRIOL DIRECTLY INFLUENCES FETUIN-A SYNTHESIS THROUGH<br />
ITS ACTION ON HEPATOCYTE VDR<br />
Mattia Corradini | Francesco Iannuzzella | Lucio Manenti | Alessia Ciarrocchi |<br />
Laura Albertazzi | Danio Somenzi | Sonia Pasquali<br />
Nephrology and Dialysis Unit Arcisp Santa Maria Nuova, Reggio Emilia , Italy|<br />
Dept Clinical Medicine Nephrology and Health Sciences, Univ Parma Medical<br />
School, Parma, Italy | Molecular Biology Lab, Arcisp Santa Maria Nuova, Reggio<br />
Emilia, Italy | Chemical and Clinical Lab, Arcisp Santa Maria Nuova, Reggio<br />
Emilia, Italy<br />
FP226<br />
BODY FAT IS A PREDICTOR OF HYPOVITAMINOSIS D IN RENAL TRANSPL<br />
PATIENTS<br />
Alessandra Calábria Baxmann | Viviane Barcellos Menon | Leila Froeder | José<br />
Osmar Medina-Pestana | Aluizio Barbosa Carvalho | Ita Pfeferman Heilberg<br />
Univ Federal de São Paulo<br />
FP227<br />
IS A 25 VITAMIN D DEFICIENCY A RISK FACTOR FOR ANEMIA IN CHRO-<br />
NIC KIDNEY DISEASE PATIENTS?<br />
Laura Solá | Nancy De Souza | Jaquelin Flores | Norberto Perico<br />
Preventive Medicine, Univ Republic, Montevideo, Uruguay | Hosp Maciel |<br />
Mario Negri Inst<br />
FP228<br />
THE EFFECT OF CHOLECALCIFEROL SUPPLEMENTATION IN CHRONIC<br />
KIDNEY DISEASE<br />
Claudia Yuste | Maria Soledad Garcia De Vinuesa | Jose Luno | Maria Angeles<br />
Goicoechea | Daniel Barraca | Nayara Panizo | Borja Quiroga<br />
Hosp Gregorio Marañón, Madrid, Spain<br />
FP229<br />
THE EFFECT OF ORAL VITAMIN D SUPPLEMENTATION IN CKD PATIENTS<br />
Sun Moon Kim | Soon Kil Kwon | Hye-Young Kim<br />
Chungbuk National Univ Hosp, Cheongju, Korea<br />
FP230<br />
FIVE YEARS FOLLOW UP OF 25 OH VITAMIN D REMPLACEMENT THE-<br />
RAPY IN 165 CANADIAN DIALYSIS PATIENTS WITH CHOLECALCIFEROL<br />
10000 UNITS ONCE A WEEK<br />
Serge Cournoyer | Robert Bell | Djamal Berbiche | Lorraine Ménard<br />
Serv Néphrologie Charles LeMoyne Hosp, Greenfield Park Canada | Dept<br />
Pharmacie, Maisonneuve-Rosemont Hosp Montréal Canada | Div Statistics, Fac<br />
Medecine Univ Sherbrooke Greenfield Park Canada | Charles Lemoyne Hosp<br />
Greenfield Park Canada<br />
FP231<br />
UREMIA SUPPRESSES IMMUNE SIGNAL-INDUCED CYP27B1 EXPRESSION<br />
IN HUMAN MONOCYTES, WHILE INCREASING BACKGROUND EXPRES-<br />
SION<br />
Liesbeth Viaene | Pieter Evenepoel | Björn Meijers | Lut Overbergh | Chantal<br />
Mathieu<br />
KULeuven, Nephrology, Leuven| KULeuven, Clinical and Experimental Endocrinology<br />
FP232<br />
1,25D/25D RATIO TO ASSESS THE OV<strong>ERA</strong>LL BALANCE OF VITAMIN D<br />
HYDROXYLASES (OH-ase)<br />
Marzia Pasquali | Silverio Rotondi | Carmina Conte | Giuliana Pirrò | Sandro<br />
Mazzaferro | Aurora Frasheri | Martino Marangella | Lida Tartaglione<br />
Dept Cardiovascular, Respiratory, Nephrologic and Geriatric Sciences, Sapienza<br />
Univ Rome | Nephrology and Dialysis Unit, ASO Ordine Mauriziano, Turin<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
137<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
138<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP233<br />
IMPACT OF 1,25-DIHYDROXYVITAMIN D ON RENAL FUNCTION IN<br />
CHRONIC KIDNEY DISEASE PATIENTS<br />
Joon-Sung Park | Tai Yeon Koo | Gheun-Ho Kim | Chong Myung Kang |<br />
Chang-Hwa Lee<br />
Depts Internal Medicine, Hanyang Univ College Medicine, Seoul | Hanyang<br />
Univ College Medicine, Seoul, Korea<br />
FP234<br />
PLASMA EXCHANGE INDUCES VITAMIN D DEFICIENCY<br />
Thomas F Hiemstra | Alina Casian | Paul Boraks | David Jayne | Inez Schoenmakers<br />
Univ Cambridge | Lupus and Vasculitis Clinic | Apheresis Unit | Addenbrookes<br />
Hosp, UK | MRC Human Nutrition Res<br />
FP235<br />
VITAMIN D DEFICIENCY IN FABRY DISEASE<br />
Benjamin Schmiedeke | Markus Niemann | Daniel Schmiedeke | Irina Davydenko<br />
| Andrea Emmert | Stefan Pilz | Barbara Obermayer-Pietsch | Frank<br />
Weidemann | Frank Breunig | Christoph Wanner | Christiane Drechsler<br />
Univ Würzburg, Germany | Univ Graz, Austria<br />
FP236<br />
TREATMENT OF EXPERIMENTAL RENAL OSTEODYSTROPHY WITH RISE-<br />
DRONATE<br />
Kazuhiro Shiizaki | Chiharu Ito | Akira Onishi | Eiko Nakazawa | Manabu<br />
Ogura | Eiji Kusano<br />
Univ Texas Southwestern Medical Center, Dallas, USA | Jichi Medical Univ<br />
School of Medicine, Shimotsuke, Japan<br />
FP237<br />
ORAL NITROGEN-CONTAINING BISPHOSPHONATES USE IN TREAT-<br />
MENT OF MIN<strong>ERA</strong>L AND BONE DISORDERS (MBD) OF PATIENTS WITH<br />
CHRONIC KIDNEY DISEASE (CKD) STAGES 3 AND 4<br />
Valentin Ermolenko | Natalia Mikhaylova | Karen Vartanjan | Dmitry Levchuk|<br />
Eleonora Dobrina<br />
Russian Medical Academy of PostGrad Education, Moscow, Russia<br />
FP238<br />
IS ALKALINE PHOSPHATASE A USEFUL TOOL FOR CHRONIC KIDNEY DI-<br />
SEASE - MIN<strong>ERA</strong>L AND BONE DISORDER ASSESSMENT IN NON-DIALYSIS<br />
PATIENTS?<br />
Cristina Capusa | Simona Stancu | Daniela Maria | Iulia Vladu | Liliana Barsan|<br />
Liliana Garneata | Eugen Mota | Gabriel Mircescu<br />
Nephrology Dept, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania<br />
| Nephrology Dept, Emergency County Hosp, Craiova, Romania | Dr Carol<br />
Davila Teaching Hosp Nephrology, Bucharest, Romania<br />
FP239<br />
ARE MIN<strong>ERA</strong>L METABOLISM ABNORMALITIES PREDICTORS OF VASCU-<br />
LAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE?<br />
Cristina Capusa | Simona Stancu | Liliana Barsan | Andrea Ilyes | Nicoleta<br />
Dorobantu | Ligia Petrescu | Gabriel Mircescu<br />
Nephrology Dept, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania<br />
| Dr Carol Davila Teaching Hosp Nephrology, Bucharest, Romania<br />
FP240<br />
INCREASED SERUM PHOSPHATE CONCENTRATIONS IN PATIENTS WITH<br />
CHRONIC KIDNEY DISEASE TREATED WITH DIURETICS<br />
Rocio Martínez-Gallardo | Flavio Ferreira | Guadalupe García-Pino | Enrique<br />
Luna | Francisco Caravaca<br />
Hosp Infanta Cristina, Badajoz, Spain<br />
FP241<br />
COMPLIANCE WITH KDOQI AND KDIGO GUIDELINES FOR SERUM PHO-<br />
SPHORUS AND SERUM CALCIUM IN RELATION TO DISEASE PROGRES-<br />
SION IN PRE-DIALYSIS PATIENTS<br />
Dinanda J. de Jager | Diana C Grootendorst | Iris Postmus | Moniek C.M. de<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Goeij | Els W. Boeschoten | Yvo W.J. Sijpkens | Friedo W. Dekker | Nynke<br />
Halbesma<br />
Dept Clinical Epidemiology, Leiden Univ Medical Center, Leiden, Netherlands |<br />
Hans Mak Inst, Naarden, Netherlands | Dept Nephrology, Leiden Univ Medical<br />
Center, Leiden, Netherlands<br />
FP242<br />
PA21: AN EFFECTIVE AND WELL TOL<strong>ERA</strong>TED IRON-BASED PHOSPHATE<br />
BINDER FOR HEAMODIALYSIS PATIENTS, INCLUDING THOSE WITH DIA-<br />
BETES<br />
Rudolf P. Wüthrich | Adrian Covic | Sylvain Gaillard | Viatcheslav Rakov<br />
Div Nephrology | Univ Medicine Gr. T. Popa Iasi | Vifor Pharma Ltd<br />
FP243<br />
MAGNESIUM PREVENTS PHOSPHATE-INDUCED CALCIFICATION IN PRI-<br />
MARY HUMAN AORTIC VASCULAR SMOOTH MUSCLE CELLS (HAVSMC)<br />
Loïc Louvet | Janine Büchel | Sonja Steppan | Jutta Passlick-Deetjen | Ziad A.<br />
Massy<br />
INSERM U 1088, Amiens, France | Fresenius Medical Care Deutschland GmbH,<br />
Bad Homburg, Germany | Dept Nephrology, Univ Dusseldorf, Dusseldorf, Germany<br />
FP244<br />
METABOLIC BONE DISEASE, ATHEROSCLEROSIS AND FIBROBLAST<br />
GROWTH FACTOR-23 IN PERITONEAL DIALYSIS PATIENTS<br />
Nilgül Akalın | Mehmet Rıza Altıparmak | Sinan Trabulus | Ayşe Serap Yalın|<br />
Nurhan Seyahi | Rezzan Ataman | Kamil Serdengeçti<br />
Istanbul Univ Cerrahpasa Medical Fac Dept Internal Medicine, Istanbul, Turkey<br />
FP245<br />
EXPRESSION OF FGF23/KLOTHO SYSTEM IN HUMAN VASCULAR TISSUE<br />
Javier Donate-Correa | Rafael Martínez-Sanz | Mercedes Muros-de-Fuentes |<br />
Javier García | P García | Violeta Cazaña | Carmen Mora-Fernández | Juan<br />
Francisco Navarro-González<br />
Res Unit, Univ Hosp Nuestra Señora de Candelaria, Santa Cruz de Tenerife,<br />
Spain | Hosp Univ Canarias, Canary Islands, Spain | Hosp Univ Nuestra Señora<br />
de Candelaria, Canary Islands, Spain<br />
FP246<br />
SERUM FGF-23 IS LINKED WITH INCREASED INFLAMMATORY CYTOKI-<br />
NES IN CKD STAGE 3-5. IS THIS THE EXPLANATION FOR ITS ADVERSE CV<br />
EFFECTS?<br />
Nihil Chitalia | Behdad Afzali | Francis Edozie | Padmini Manghat | Anthony<br />
Wierzbicki | Geeta Hampson | David Goldsmith<br />
King's Health Partners (AHSC) | MRC Centre Transpl, Kings College London|<br />
Guy's and St Thomas' NHS Foundation Hosp<br />
FP247<br />
PTH: WHAT ARE WE MEASURING? CLINICAL IMPLICATIONS OF A THIRD<br />
GEN<strong>ERA</strong>TION ASSAY FOR THE DETERMINATION OF PTH LEVELS<br />
Silvia Berutti | Diega Marranca | Giorgio Soragna | Laura Erroi | Marco Migliardi<br />
| Martino Marangella<br />
Osp Mauriziano, Turin, Italy<br />
FP248<br />
TOTAL SERUM CALCIUM CORRECTION FORMULAS IN HYPOALBUMINE-<br />
MIA: WHICH WORKS BETTER?<br />
Mattia Corradini | Francesco Iannuzzella | Lucia Belloni | Danio Somenzi |<br />
Maria Parmeggiani | Sonia Pasquali<br />
Nephrology and Dialysis Unit, Arcisp Santa Maria Nuova, Reggio Emilia, Italy |<br />
Lab Autoimmunity, Allergology and Biotechnology, Arcisp Santa Maria Nuova,<br />
Reggio Emilia, Italy<br />
FP249<br />
PREVALENCE AND PROGRESSION OF AORTIC VASCULAR CALCIFICA-<br />
TIONS IN CHRONIC KIDNEY DESEASE STAGE II, III AND IV<br />
Corrado Camerini | Mauro Pezzotta | Roberta Zani | Ezio Movilli | Giovanni<br />
Cancarini<br />
Univ Brescia<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
139<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
140<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP250<br />
HYPERCALCEMIA A RISK FACTOR FOR RENAL TRANSPL DYSFUNCTION<br />
siddiq Anwar | Rishi Pruthi | Shivkumar Kenchayikoppad<br />
Dept Renal Medicine Kent and Canterbury Hosp | Guys and St Thomas NHS<br />
Trust, London<br />
FP251<br />
AUTONOMOUS HYPERPARARHYROIDISM IN CKD STAGES 3-4 TREATED<br />
WITH CINACALCET<br />
Joselyn Reyes | Iara DaSilva | Monica Furlano | Francesca Calero | Rosario<br />
Montañés | Nadia Ayasreh | Maitane Del Pozo | M Estorch | Ferran Rousaud |<br />
Jose A. Ballarin | Jordi Bover<br />
Fundacio Puigvert<br />
FP252<br />
BONE DISEASE IN NEWLY DIAGNOSED LUPUS NEPHRITIS PATIENTS<br />
Aline Resende | Cristiane Bitencourt Dias | Luciene Dos Reis | Vanda Jorgetti|<br />
Viktoria Woronik<br />
São Paulo Univ, São Paulo, Brazil | Hosp das Clínicas, Univ São Paulo<br />
FP253<br />
PRO-INFLAMMATORY CYTOKINES AND BONE FRACTURES IN CKD PA-<br />
TIENTS. A PROSPECTIVE SINGLE CENTRE STUDY<br />
Vincenzo Panuccio | Giuseppe Enia | Rocco Tripepi | Sebastiano Cutrupi | Patrizia<br />
Pizzini | Roberta Aliotta | Carmine Zoccali<br />
CNR IBIM Reggio Calabria Italy<br />
FP254<br />
STRIKING AND PROMISING MIS-SENSE MUTATIONS ON THE GNAS1<br />
GENE EXONS’ 1,4,10 AND 4 IN SAGLIKER SYNDROME (SS). A UNIQUE<br />
CATASTROPHIC ENTITY. CYTOGENETIC STUDIES FOR CHROMOSOMAL<br />
ABNORMALITIES, CASR GENES AND GNAS 1 MUTATIONS. INTERNATIO-<br />
NAL EVALUATION OF UNRECOGNIZABLY UGLYFYING HUMAN FACES<br />
IN LATE AND SEVERE SH IN CKD<br />
I Yildiz | Yahya Sagliker | O Demirhan | E Tunç | N Inandiklioglu | D Tasdemir<br />
| V Acharya | L Zhang | O Golea | A Sabry | D Ookalkar | C Capusa |<br />
D Radulescu | L Garneata | G Mircescu | H Ben Maiz | C Hsu Chen | J Prado<br />
Rome | M Benzegoutta | N Paylar | K Eyupoglu | E Karatepe | M Esenturk|<br />
O Yavascan | A Grzegorzevska | V Shilo | M M-Mazdeh | R C Francesco | Z<br />
Gouda | S M Adam | I Emir | F Ocal | E Usta | N Kıralp | C Sagliker | P S Ozkaynak<br />
| H.S Sagliker | M Bassuoni | H.S El-Wakil | H Akar | Y Yenicerioglu|<br />
E Kose | O Sekin<br />
Div Nephrology, Baskent Univ | Cukurova Univ | NKF, Mumbai | China-Japan<br />
Hosp | Timisoara Hosp | Mansoura Univ | Nagpur Dialysis Center | Bucharest<br />
Univ | Charles Nichole Hosp | Taichung Hosp | DF Nacional Siglo XX1 Hosp|<br />
Mila Hosp | Sagliker Hypertension Unit | Duzce State Hosp | Corum Dialysis<br />
Center | Malatya Hosp | Tepecik Hosp | Poznan Univ | Moscow Dialysis<br />
Center | Tehran Univ Medical Sciences | Damanhur Kidney Center | Fresenius<br />
Centers | Emir Dialysis | Bingol Dialysis | Alexandria Univ | Adnan Menderes<br />
Univ | Ata Dialysis Center<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
DIABETES - EXPERIMENTAL<br />
FP255<br />
METFORMIN DECREASES OBESITY-INDUCED RENAL INJURY VIA ACTI-<br />
VATION OF AMP-ACTIVATED PROTEIN KINASE<br />
Kyung Pyo Kang | Jung Eun Lee | Ae Sin Lee | Yu Jin Jung | Sik Lee | Sung<br />
Kwang Park | Won Kim<br />
Chonbuk National Univ Medical School, Jeonju, Korea<br />
FP256<br />
IMPACT OF FRUCTOSE ON PANCREATIC ISLET INSULIN SECRETION IN<br />
EXPERIMENTAL MODEL OF CHRONIC KIDNEY DISEASE<br />
Marta Pokrywczynska | Arkadiusz Jundzill | Sandra Krzyzanowska | Mariusz<br />
Flisinski | Andrzej Brymora | Magdalena Bodnar | Aleksander Deptula | Andrzej<br />
Marszalek | Jacek Manitius | Tomasz Drewa | Tomasz Kloskowski<br />
Dept Tissue Engineering, Nicolaus Copernicus Univ, Bydgoszcz, Poland | Chair<br />
and Dept Nephrology and Hypertension, Nicolaus Copernicus Univ, Bydgoszcz,<br />
Poland | Dept Clinical Pathomorphology, Nicolaus Copernicus Univ, Bydgoszcz,<br />
Poland | Chair and Dept Microbiology, Nicolaus Copernicus Univ, Bydgoszcz,<br />
Poland<br />
FP257<br />
TREATMENT WITH PYRIDOXAMINE (PYR), PENTOSAN POLYSULFATE<br />
(PPS) AND ENALAPRIL (EN) REDUCES KIDNEY ALT<strong>ERA</strong>TIONS IN A MOU-<br />
SE MODEL OF PROGRESSIVE DIABETIC NEPHROPATHY (DN)<br />
Fabrizio Grosjean | Vittoria Esposito | Massimo Torreggiani | Ciro Esposito |<br />
Feng Zheng | Helen Vlassara | Gary Striker<br />
Fond Salvatore Maugeri | Unit Nephrology and Hemodialysis, IRCCS Fond Salvatore<br />
Maugeri, Univ Pavia, Pavia, Italy | Unit Nephrology and Hemodialysis,<br />
IRCCS Fond Salvatore Maugeri, Univ Pavia, Pavia, Italy | Dept Geriatrics, Div<br />
Experimental Diabetes and Aging, MSSM, NY<br />
FP258<br />
INSULIN RESISTANCE MEDIATED PATHOLOGICAL CHANGES IN THE<br />
KIDNEY OF STREPTOZOTOCIN- INDUCED CHRONIC DIABETIC RATS<br />
Shiju Michael | Pragasam Viswanathan | Rajesh Ganesh<br />
VIT Univ, Vellore and India | JIPMER, Puducherry and India<br />
« FP259<br />
INVOLVEMENT OF IFN-Γ IN THE PATHOGENESIS OF TYPE2 DIABETIC NE-<br />
PHROPATHY<br />
Miho Kimachi | Saori Nishio | Daigo Nakazawa | Yasunobu Ishikawa | Takayuki<br />
Toyoyama | Akiko Satou | Tasuku Nakagaki | Sekiya Shibasaki | Tatuya<br />
Atumi<br />
Internal Medicine II, Hokkaido Univ Grad School Medicine, Sapporo, Hokkaido,<br />
Japan<br />
FP260<br />
DIABETIC NEPHROPATHY IN THE ZDSD RAT<br />
Vincent Gattone | Richard Peterson | Karen Zimmerman<br />
Indiana Univ School Medicine | Preclinomics Inc., Indianapolis, IN, USA<br />
FP261<br />
NEPHROPATHY EVOLUTION IS PREVENTED BY THE DIPEPTIDYL PEPTI-<br />
DASE-4 INHIBITOR, SITAGLIPTIN, IN A RAT MODEL OF TYPE 2 DIABETES<br />
Cristina Mega | Edite Teixeira de Lemos | Helena Vala | Rosa Fernandes | Jorge<br />
Oliveira | Frederico Teixeira | Flávio Reis<br />
Lab Pharmacology & Experimental Therapeutics, IBILI, Medicine Fac, Coimbra<br />
Univ, Coimbra, Portugal | ESAV, Polytechnic Inst Viseu, Viseu, Portugal<br />
FP262<br />
THE ROLE OF IFN GAMMA ASSOCIATED WITH OXIDATIVE STRESS RE-<br />
DUCTION IN PREVENTING DIABETIC NEPHROPATHY IN RODENTS WITH<br />
TYPE II DIABETES AND OBESITY<br />
Andrei Niculae | Ionel-Alexandru Checherita | Alexandru Ciocalteu<br />
St. John Emergency Clinical Hosp, Carol Davila Univ Medicine and Pharmacy,<br />
Bucharest, Romania | Carol Davila Univ Medicine and Pharmacy, Bucharest,<br />
Romania<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
141<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
142<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP263<br />
PHYSIOLOGICAL LEVELS OF ENDOSTATIN SUPPRESS RENAL INJURY IN<br />
DIABETIC NEPHROPATHY<br />
Yuki Hamano | Yuki Udagawa | Yoshihiko Ueda | Osamu Yokosuka | Makoto<br />
Ogawa<br />
Dept Clinical Education and Res, Grad School of Pharmaceutical Sciences, Chiba<br />
Univ, Chiba, Japan | Dept Pathology, Dokkyo Medical Univ Koshigaya Hosp,<br />
Koshigaya, Japan | Dept Medicine and Clinical Oncology, Grad School of Medicine,<br />
Chiba Univ, Chiba, Japan | Dept Nephrology, Chiba Univ Hosp, Chiba,<br />
Japan<br />
« FP264<br />
PRESERVATION OF ENDOTHELIAL GTP CYCLOHYDROLASE I ACTIVITY<br />
AND IMPROVEMENT OF RENAL NITRIC OXIDE AVAILABILITY PREVENT<br />
THE DEVELOPMENT OF DIABETIC NEPHROPATHY<br />
Minoru Satoh | Kengo Kidokoro | Hajime Nagasu | Yuko Nishi | Chieko Ihoriya<br />
| Hiroyuki Kadoya | Toyotaka Yada | Keith M Channon | Tamaki Sasaki|<br />
Naoki Kashihara<br />
Kawasaki Medical School | Univ Oxford, John Radcliffe Hosp<br />
FP265<br />
ENHANCED DOWN REGULATION OF AT1B RECEPTORS ON AFFERENT<br />
AND EFFERENT ARTERIOLES IN STZ-INDUCED DIABETIC RAT KIDNEY<br />
Jens Randel Nyengaard | Zsolt Razga<br />
Stereology and Electron Microscopy Lab, Univ Aarhus, Denmark<br />
FP266<br />
NEPHROPATHY IS ACCEL<strong>ERA</strong>TED IN DIABETIC MICE WITH RENOVA-<br />
SCULAR HYPERTENSION<br />
Stella Hartono | Bruce Knudsen | Joseph Grande<br />
Mayo Clinic, Rochester MN, USA<br />
FP267<br />
AGGRAVATION OF DIABETIC NEPHROPATHY IN OLETF RATS WITH THY-<br />
1 NEPHROTIS<br />
Maho Watanabe | Kenji Ito | Yasuhiro Abe | Satoru Ogahara | Hitoshi Nakashima<br />
| Toshinobu Sato | Takao Saito<br />
Fukuoka Univ, Fukuoka, Japan | Sendai Shakai Hoken Hosp, Sendai, Japan<br />
FP268<br />
MITOCHONDRIAL INSTABILITY OF PODOCYTE AGGRAVATES DIABETIC<br />
NEPHROPATHY IN STREPTOZOTOCIN INDUCED DIABETIC MICE<br />
Young Tai Shin | Dae Eun Choi | Ki-Ryang Na | Yoon Kyung Chang | Seong<br />
Suk Kim | Kang Wook Lee<br />
Renal Div, Chungnam National Univ Hosp, Daejeon, South Korea | Dept Internal<br />
Medicine, Daejeon Saint Mary Hosp, Daejeon, South Korea | Internal Medicine,<br />
Sun Hosp, Daejeon, South Korea | Renal Div, Dept Internal medicine,<br />
Chungnam National Univ Hosp. Daejeon, South Korea<br />
FP269<br />
NOVEL TH<strong>ERA</strong>PEUTICS IN DIABETIC NEPHROPATHY: SIALIC ACID PRE-<br />
CURSORS REDUCE PROTEINURIA IN EXPERIMENTAL DIABETIC NEPHRO-<br />
PATHY<br />
Camille Mace | Sumant Chugh | Lionel Clement<br />
Univ Alabama Birmingham, Alabama, USA<br />
FP270<br />
ROLES OF INSULIN RECEPTOR SUBSTRATES (IRS) IN RENAL FUNCTION<br />
AND RENAL HEMODYNAMICS<br />
Maoka Tomochika | Hashimoto Seiji | Mochizuki Toshio | Kawata Tetsuya |<br />
Koike Takao<br />
NTT East Japan Sapporo Hosp | Hokkaido Univ Grad School Medicine, Internal<br />
Medicine II<br />
FP271<br />
CCR2 INHIBITION IN DIABETIC BKS db/db MICE RESULTS IN A RAPID<br />
AND ROBUST IMPROVEMENT OF RENAL INFLAMMATION AND RENAL<br />
FUNCTION<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Juan C. Jaen | Timothy J. Sullivan | Zhenhua Miao | Niky Zhao | Rob Berahovich<br />
| Antoni Krasinski | Jay P. Powers | Linda Ertl | Thomas J. Schall<br />
ChemoCentryx Inc., Mountain View (CA), USA<br />
FP272<br />
PHOSPHODIEST<strong>ERA</strong>SE INHIBITOR IMPROVES RENAL TUBULOINTERSTI-<br />
TIAL HYPOXIA OF DIABETIC RAT KIDNEY<br />
Sang Youb Han | Hui-Kyoung Sun | Kum Hyun Han | Han-Seong Kim | Seon-<br />
Ho Ahn<br />
Dept Medicine, Inju Univ Ilsan-Paik Hosp | Dept Medicine, Wonkwang Univ<br />
FP273<br />
SCAI CONTROLS TGF-β1 INDUCED α-SMOOTH MUSCLE ACTIN EXPRES-<br />
SION DURING EPITHELIAL-MESENCHYMAL TRANSITION AND IS DOWN-<br />
REGULATED IN DIABETIC NEPHROPATHY<br />
Gabor Kokeny | Akos Gasparics | Lilla Fang | Laszlo Rosivall | Attila Sebe<br />
Semmelweis Univ, Budapest, Hungary<br />
FP274<br />
ALDOSTERONE ANTAGONISTS IN MONOTH<strong>ERA</strong>PY ARE PROTECTIVE<br />
AGAINST STZ-INDUCED DIABETIC NEPHROPATHY<br />
Nora F Banki | Andrea Fekete | Laszlo Wagner | Agota Ver | Peter Degrell |<br />
Agnes Prokai | Reusz George | Attila Szabo | Chris Baylis| Adam Vannay |<br />
Tivadar Tulassay<br />
Semmelweis Univ First Dept Pediatrics, Hungary | Dept Transpl and Surgery,<br />
Semmelweis Univ, Budapest, Hungary | Semmelweis Univ, Dept Medical Chemistry,<br />
Molecular Biology and Pathobiochemistry, Budapest, Hungary | Second<br />
Dept Medicine and Nephrological Center, Pécs, Hungary | Dept Physiology<br />
and Functional Genomics and Medicine, Univ Florida | Res Lab Pediatrics and<br />
Nephrology, Hungarian Academy of Sciences and Semmelweis Univ, Budapest,<br />
Hungary<br />
FP275<br />
ANGIOTENSIN 1 CONVERTING ENZYME AND RENAL VASCULAR REAC-<br />
TIVITY. STUDY IN NORMAL AND DIABETIC MOUSE<br />
Catherine Chollet | Annette Hus-Citharel | Nathalie Caron | Nadine Bouby<br />
INSERM U872, Paris, France | INSERM U1050, CIRB, Collège de France, Paris,<br />
France | FUNDP, Namur, Belgium<br />
FP276<br />
RELATIONSHIP BETWEEN DIABETIC NEPHROPATHY AND CARDIAC<br />
FUNCTION: ROLE OF PREVIOUS EXERCISE TRAINING<br />
Kleiton Silva | Rodolfo Rampaso | Rafael Luiz | Kátia De Angelis | Cristiano<br />
Teixeira Mostarda | Nayda Abreu | Maria Claudia Irigoyen| Nestor Schor<br />
Federal Univ São Paulo | Nove de Julho Univ | São Paulo Univ - Hypertension<br />
Unit<br />
FP277<br />
ROLE OF HIGH-INTENSITY AEROBIC EXERCISE (HIAE) ON THE CARDIO-<br />
VASCULAR AND RENAL FUNCTIONS IN DIABETIC RATS BY STZ<br />
Rodolfo Rampaso | Rafael Luiz | Kleiton Silva | Jairo Montemor | Elisa M. S.<br />
Higa | Nestor Schor<br />
Federal Univ São Paulo<br />
FP278<br />
ENDOTHELIAL CELL INT<strong>ERA</strong>CTED WITH PODOCYTE AND MESANGIAL<br />
CELLS VIA NAD(P)H OXIDASE<br />
Hajime Nagasu | Minoru Satoh | Kengo Kidokoro | Naoki Kashihara<br />
Kawasaki Medical School<br />
FP279<br />
LANTHANUM SUPPRESSES AGES-INDUCED OSTEOBLASTIC DIFFEREN-<br />
TIATION VIA INHIBITION OF RAGE-NF-KAPPAB SIGNALING IN RAT VA-<br />
SCULAR SMOOTH MUSCLE CELLS<br />
Yosuke Nakayama | Kei Fukami | Nana Obara | Ryotaro Ando | Yusuke Kaida|<br />
Seiji Ueda | Sho-ichi Yamagishi | Seiya Okuda<br />
Div Nephrology, Dept Medicine, Kurume Univ, School Medicine | Dept Pathophysiology<br />
and Therapeutics Diabetic Vascular Complications, Kurume Univ<br />
School of Medicine<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
143<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
144<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP280<br />
HEPARANASE INDUCED BY ADVANCED GLYATION END PRODUCTS ME-<br />
DIATES MACROPHAGE MIGRATION INVOLVING RAGE AND PI3K/AKT<br />
PATHWAY<br />
Qiaojing Qin | Zhaoxia Wang | Jianying Niu | Wangjie Xu | Zhongdong Qiao|<br />
Weiwei Qi | Yong Gu<br />
Dept Nephrology, Shanghai Fifth People’s Hosp, Fudan Univ, Shanghai, China|<br />
School Life Science and Biotechnology, Shanghai Jiaotong Univ, Shanghai,<br />
China| Dept Nephrology, Shanghai Fifth People’s Hosp/Huashan Hosp, Fudan<br />
Univ, Shanghai, China<br />
FP281<br />
GENE EXPRESSION ANALYSIS OF THE TH<strong>ERA</strong>PEUTIC EFFECTS OF VITA-<br />
MIN D ON DIABETIC-LIKE CONDITIONS IN VASCULAR SMOOTH MUSCLE<br />
CELLS<br />
Tali Zitman-Gal | Eliezer Golan | Janice Green | Metsada Pasmanik-Chor | Varda<br />
Oron-Karni | Jacques Bernheim | Sydney Benchetrit<br />
Renal Physiology Lab, Dept Nephrology and Hypertension, Meir Medical Center<br />
| Dept Nephrology and Hypertension, Meir Medical Center | Bioinformatics<br />
Unit, G. S. Wise Fac Life Sciences, Tel Aviv Univ<br />
FP282<br />
HIGH GLUCOSE MEDIATES ENDOTHELIAL-TO-CHRONDROCYTE TRAN-<br />
SITION IN HUMAN AORTIC ENDOTHELIAL CELL<br />
Ri-Ning Tang | Min Wu | Min Gao | Hong Liu | Xiao-Liang Zhang | Bi Cheng<br />
Liu<br />
Inst Nephrology, ZhongDa Hosp, Medical School, Southeast Univ, Nanjing, China<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
DIABETES - CLINICAL<br />
FP283<br />
MEAN PLATELET VOLUME AND RELATED FACTORS IN PATIENTS AT<br />
DIFFERENT STAGES OF DIABETIC NEPHROPATHY<br />
Kenan Turgutalp | Onur Ozhan | Esen Akbay | Naci Tiftik | Turkay Ozcan |<br />
Sercan Yılmaz | Ahmet Kiykim<br />
Div Endocrinology and Metabolism, Div Hematology, Dept Cardiology, Div<br />
Nephrology, Dept Internal Medicine, School Medicine, Mersin Univ, Mersin,<br />
Turkey<br />
FP284<br />
COMPARATIVE EFFICACY OF VARIOUS RENIN-ANGIOTENSIN SYSTEM<br />
BLOCKERS AND OTHER ANTIHYPERTENSIVE DRUGS IN DIABETIC NE-<br />
PHROPATHY: A SYSTEMATIC REVIEW AND BAYESIAN NETWORK META-<br />
ANALYSIS<br />
Hon-Yen Wu | Yu-Sen Peng | Jenq-Wen Huang | Kwan-Dun Wu | Yu-Kang<br />
Tu | Kuo-Liong Chien<br />
Internal Medicine, Far Eastern Memorial Hosp, New Taipei City, Taiwan | Div<br />
Biostatistics, Leeds Inst Genetics, Health & Therapeutics, Univ Leeds, Leeds,<br />
UK| Grad Inst Epidemiology and Preventive Medicine, National Taiwan Univ,<br />
Taipei, Taiwan<br />
FP285<br />
PLASMA ADIPONECTIN IS RELATED TO PROGRESSION OF KIDNEY DISE-<br />
ASE IN TYPE 2 DIABETES PATIENTS<br />
Ina Maria Kacso | Diana Moldovan | Alina Lenghel | Crina Claudia Rusu |<br />
Mirela Gherman Caprioara<br />
Univ Medicine and Pharmacy Iuliu Hatieganu Cluj, Cluj Napoca, Romania<br />
FP286<br />
ADIPONECTIN: ASSOCIATION WITH NON-TRADITIONAL RISK FACTORS<br />
AND CARDIOVASCULAR MORTALITY IN TYPE 2 DIABETICS WITH MILD<br />
TO MOD<strong>ERA</strong>TE KIDNEY DISEASE<br />
Ana Paula Silva | André Fragoso | Ana Pinho | Cláudia Silva | Nélio Santos |<br />
Nelson Tavares | Marilia Faísca | Ana Camacho | Fernanda Mesquita | Pedro<br />
Leao<br />
Nephrology Dept, Hosp Faro, Faro, Portugal | Serv Patologia clinica- Hosp<br />
Faro| Gnóstica Lab | Serv Cardiologia- Hosp Faro E.P.E | Inst Superior Ciências<br />
da Saúde Egas Moniz<br />
FP287<br />
ADIPOKINES, OXIDATIVE STRESS, INFLAMMATION, MIN<strong>ERA</strong>L METABO-<br />
LISM, AND INSULIN RESISTANCE: NEW PREDICTORS OF CAROTID ARTE-<br />
RY INTIMA-MEDIA THICKNESS<br />
Ana Paula Silva | Cláudia Silva | Nélio Santos | Fatima Rato | André Fragoso |<br />
Ana Pinho | Marilia Faísca | Fernanda Mesquita | Pedro Leao<br />
Serv Nefrologia Hosp Faro E.P.E | Serv Patologia clinica- Hosp Faro | Gnóstica<br />
Lab | Inst Superior Ciências da Saúde Egas Moniz<br />
FP288<br />
DIABETIC NEPHROPATHY AND CARDIOVASCULAR RISK: POTENTIAL<br />
ROLE OF ADIPOKINES, OXIDATIVE STRESS, INFLAMMATION AND MINE-<br />
RAL METABOLISM<br />
Ana Paula Silva | Cláudia Silva | Nélio Santos | Fatima Rato | André Fragoso |<br />
Ana Pinho | Marilia Faísca | Fernanda Mesquita | Pedro Leao<br />
Serv Nefrologia Hosp Faro E.P.E | Serv Patologia Clinica, Hosp Faro E.P.E |<br />
Gnóstica Lab | Inst Superior Ciências da Saúde Egas Moniz<br />
FP289<br />
ROLE OF HUMAN BETA DEFENSINS IN PATIENTS WITH CHRONIC KID-<br />
NEY DISEASE<br />
Dong-Jin Oh | Hye-Ryoun Kim | Su-Hyun Kim<br />
Chung-Ang Univ Hosp, Seoul, Korea<br />
FP290<br />
TLR4 GENE EXPRESSION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
145<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
146<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
AND NEPHROPATHY<br />
Kamal Okasha | Mohammad Sweilam | Hala Nagy | Marwa Hassan Rizk<br />
Tanta Univ Hosp, Dept Internal Medicine, Div Nephrology, Fac Medicine, Tanta,<br />
Egypt | Clinical pathology-Fac Medicine-Tanta Univ, Tanta, Egypt | Clinical<br />
pathology-Fac Medicine-Tanta Univ,Tanta, Egypt<br />
FP291<br />
BASELINE DEMOGRAPHIC, CLINICAL AND LAB PARAMETERS RELATED<br />
WITH 24 HOUR URINARY SODIUM EXCRETION IN NEWLY DIAGNOSED<br />
PATIENTS WITH TYPE 2 DIABETES<br />
Alper Kirkpantur | Baris Afsar<br />
FP292<br />
CLINICAL IMPLICATIONS OF PATHOLOGIC DIAGNOSIS AND CLASSIFI-<br />
CATION FOR DIABETIC NEPHROPATHY<br />
Dong-Wan Chae | Ho Jun Chin | Suhnggwon Kim<br />
SNUBH | Seoul National Univ Bundang Hosp Seongnam Korea | SNUH<br />
FP293<br />
ADDITION OF SILYMARIN TO RENNIN-ANGIOTENSIN SYSTEM INHIBI-<br />
TORS ATTENUATES PROTEINURIA IN TYPE 2 DIABETIC PATIENTS WITH<br />
OVERT NEPHROPATHY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-<br />
CONTROLLED TRIAL<br />
Mohammad Kazem Fallahzadeh Abarghouei | Banafshe Dormanesh | Jamshid<br />
Roozbeh | Eskandar Kamali-Sarvestani | Ghazal Vessal | Maryam Pakfetrat |<br />
Mohammad Mahdi Sagheb<br />
Health Policy Res Center, Shiraz Univ Medical Sciences, Shiraz, Iran | AJA Univ<br />
Medical Sciences, Tehran, Iran | Shiraz Nephro-Urology Res Center, Shiraz Univ<br />
Medical Sciences, Shiraz, Iran | Autoimmune Diseases Res Center, Shiraz Univ<br />
Medical Sciences, Shiraz, Iran | Dept Clinical Pharmacy, Shiraz Univ Medical<br />
Sciences, Shiraz, Iran<br />
FP294<br />
PREDICTION OF THE PROGNOSIS IN TYPE 2 DIABETIC NEPHROPATHY BY<br />
RENAL PATHOLOGICAL FINDINGS<br />
Toshiyuki Imasawa | Motonobu Nishimura | Takehiko Kawaguchi | Ryoichi<br />
Ishibashi | Hiroshi Kitamura<br />
Chiba-East National Hosp<br />
FP295<br />
GLYCATED ALBUMIN IS TOXIC FOR THE PROXIMAL TUBULE BUT SPARES<br />
THE GLOMERULAR ENDOTHELIUM IN NORMOALBUMINURIC PATIENTS<br />
WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL STUDY<br />
Adrian Vlad | Ligia Petrica | Maxim Petrica | Dragos Catalin Jianu | Gheorghe<br />
Gluhovschi | Calina Ianculescu | Mioara Negru | Victor Dumitrascu | Florica<br />
Gadalean | Alina Zamfir | Cristina Popescu | Sorin Giju | Cristina Gluhovschi|<br />
Silvia Velciov | Oana Milas | Cristian Balgradean | Sorin Ursoniu<br />
Victor Babes Univ Medicine and Pharmacy Timisoara, Romania | Inst Chemistry<br />
Timisoara, Romania | V. Goldis Univ, Dept Molecular Chemistry | Univ Medicine<br />
and Pharmacy Timisoara Romania<br />
FP296<br />
THE RELATIONSHIP BETWEEN DAYTIME, NIGHTTIME AND TOTAL HE-<br />
ART RATE WITH ALBUMIN AND PROTEIN EXCRETION IN NEWLY DIA-<br />
GNOSED TYPE 2 DIABETIC PATIENTS<br />
Baris Afsar<br />
Konya Numune State Hosp<br />
FP297<br />
IS VITAMIN D A RISK FACTOR OR A BIOMARKER OF RENAL DISEASE IN<br />
TYPE 2 DIABETICS?<br />
Ana Paula Silva | Ana Pinho | André Fragoso | Cláudia Silva | Nélio Santos |<br />
Marilia Faísca | Fernanda Mesquita | Pedro Leao<br />
Serv Nefrologia Hosp Faro E.P.E | Serv Patologia clinica- Hosp Faro | Gnóstica<br />
Laboratório | Inst Superior Ciências Saúde Egas Moniz<br />
FP298<br />
NEUTROPHIL GELATINASE-ASSOCIATED LIPOKALIN AND CATHEPSIN<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
AS AN EARLY PREDICTORS OF KIDNEY DYSFUNCTION IN CHILDREN<br />
WITH DIABETES<br />
Jolanta Soltysiak | Jacek Zachwieja | Piotr Fichna | Katarzyna Lipkowska |<br />
Bogda Skowronska | Witold Stankiewicz | Maria Stachowiak-Lewandowska |<br />
Agnieszka Kluska-Jozwiak<br />
Dept Pediatric Cardiology and Nephrology, Poznan Univ Medical Science, Poznan,<br />
Poland | Dept Pediatric Diabetes and Obesity, Poznan Univ Medical Science,<br />
Poznan, Poland<br />
FP299<br />
PREVALENCE AND CLINICAL CHARACTERISTIC OF PATIENTS WITH CLI-<br />
NICALLY DEFINED MANIFEST DIABETIC NEPHROPATHY IN A GEN<strong>ERA</strong>L<br />
TYPE 2 DIABETES POPULATION<br />
Hanri Afghahi<br />
Dept Renal Medicin, Skövde, Sweden<br />
FP300<br />
PREVALENCE AND OUTCOMES OF NON-DIABETIC KIDNEY DISEASE IN<br />
TYPE 2 DIABETES MELLITUS PATIENTS<br />
Narayan Prasad | Dharmender Bhadauria | Anurag Gupta | Raj Kumar Sharma|<br />
Amit Gupta | Anupama Kaul | Manoj Jain<br />
Sanjay Gandhi PostGrad Inst Medical Sciences,Lucknow, India<br />
FP301<br />
POSSIBILITIES OF INFLUENCE ON OXIDATIVE STRESS MARKERS AT DIA-<br />
BETIC NEPHROPATHY<br />
Olena Loboda | Iryna Dudar | Lesya Korol | Iryna Shifris<br />
Inst Nephrology NAMS of Ukraine, Kyiv, Ukraine | Dept Efferesis Technology,<br />
Inst Nephrology NAMS of Ukraine, Kyiv, Ukraine<br />
FP302<br />
CLINICAL PREDICTORS FOR RENAL BIOPSY IN PATIENTS WITH CONCO-<br />
MITANT DIABETES MELLITUS AND RENAL DISEASE<br />
Kenji Ito | Yasuhiro Abe | Satoru Ogahara | Tetsuhiko Yasuno | Maho Watanabe<br />
| Yoshie Sasatomi | Satoshi Hisano | Hitoshi Nakashima | Takao Saito<br />
Fukuoka Univ School of Medicine, Fukuoka, Japan<br />
FP303<br />
C-PEPTIDE AND MARKERS OF KIDNEY DAMAGE CORRELATIONS IN PA-<br />
TIENTS WITH DIABETES MELLITUS TYPE 1<br />
Assem Nogaibayeva | Saltanat Tuganbekova | Zhannat Taubaldiyeva | Bolat<br />
Bekishev | Rakhat Trimova<br />
National Scientific Medical Centre<br />
FP304<br />
SERUM MONOCYTE CHEMOATTRACTANT PROTEIN-1 AND CD16+ MO-<br />
NOCYTES IN TYPE 2 DIABETIC PATIENTS WITH NEPHROPATHY<br />
Ivan Topchii | Polina Semenovykh | Valentina Galchiskaya | Natalia Efimova|<br />
Tatyana Scherban<br />
Inst Therapy named after L.T. Malaya of NAMS of Ukraine<br />
FP305<br />
THE PATHOLOGIC CLASSIFICATION OF DIABETIC NEPHROPATHY IS<br />
CORRELATED WITH THE CLINICAL CHARACTERISTICS OF DIABETES<br />
MELLITUS<br />
Fumihiko Yasuda | Akira Shimizu | Akiko Mii | Megumi Fukui<br />
Nippon Medical School, Tokyo, Japan | Internal Medicine (Div Neurology, Nephrology,<br />
and Reumatology)<br />
FP306<br />
RELATIONSHIP BETWEEN CHRONIC KIDNEY DISEASE AND ANEMIA IN<br />
PATIENTS WITH TYPE 2 DIABETES<br />
M. Postorino | E. Alessi | E. Dal Moro | S. Postorino | G. Mannino | A. Giandalia<br />
| D. Mannino<br />
Diabetology and Endocrinology Unit Reggio Calabria<br />
FP307<br />
HYPERGLYCEMIA STIMULATES UBIQUITIN-CONJUGATING ENZYME E2<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
147<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
148<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
VARIANT 1 (UBE2V1) MEDIATED LYSINE 63 UBIQUITINATION IN DIABE-<br />
TIC NEPHROPATHY (DN)<br />
Paola Pontrelli | Francesca Conserva | Matteo Accetturo | Massimo Papale |<br />
Anna Maria Di Palma | Giorgia Cordisco | G Grandaliano | Loreto Gesualdo<br />
DETO, Univ Bari, Italy | Dept Emergency and Organ Transpl, Univ Bari, Italy |<br />
Policlinic Hosp Bari, Nephrology, Dyalisis and Transpl Unit, Italy | Nephrology,<br />
Dialysis and Transpl Unit, Dept Biomedical Sciences, Univ Foggia<br />
FP308<br />
REMNANT LIPOPROTEIN AND STEROL ABSORPTION IN DIABETIC PA-<br />
TIENTS WITH CHRONIC KIDNEY DISEASE<br />
Eiji Kimoto | Tetsuo Shoji | Mika Sonoda | Hideaki Shima | Shoko Tsuchikura<br />
| Katsuhito Mori | Masanori Emoto | Eiji Ishimura | Yoshiki Nishizawa |<br />
Masaaki Inaba<br />
Dept Metabolism, Endocrinology and Molecular Medicine, Dept Nephrology,<br />
Osaka City Univ Grad School Medicine, Osaka, Japan<br />
FP309<br />
DYNAMIC COLOR DOPPLER SONOGRAPHIC CORTICAL PERFUSION ME-<br />
ASUREMENT DETECTS DIABETIC NEPHROPATHY BEFORE THE OCCU-<br />
RENCE OF MICROALBUMINURIA<br />
Christian Vogel | Thomas Scholbach | Nils Bergner<br />
Hosp Children and Adolescents, Chemnitz, Germany<br />
FP310<br />
PODOCYTOURIA AS AN EARLIER MARKER OF DIABETIC NEPHROPATHY<br />
Eirini Lioudaki | Konstantinos Stylianou | Eleutheria Maragkaki | Stavros Stratakis<br />
| Maria Panteri | Christianna Choulaki | Eleutheria Vardaki | Emmanuel<br />
Ganotakis | Eugene Daphnis<br />
Lab Experimental Nephrology and Dept Internal Medicine, Fac Medicine, Univ<br />
Crete, Heraklion, Greece | Lab Experimental Nephrology and Dept Nephrology,<br />
Fac Medicine, Univ Crete, Heraklion, Greece | Dept Nephrology, Univ Crete,<br />
Greece | Dept Internal Medicine, Univ Crete, Greece | Lab Rheumatology, Clinical<br />
Immunology and Allergy, Univ Crete, Greece<br />
FP311<br />
ASSOCIATION OF TRADITIONAL RISK FACTORS WITH RENAL FUNCTIO-<br />
NAL VARIATIONS IN TYPE 2 DIABETIC SUBJECTS WITHOUT NEPHROPA-<br />
THY – OBSERVATIONS FROM BNDC TRIAL IN BIRDEM, BANGLADESH<br />
MM Iqbal | Z Ahmed | MA Mansur | S Iqbal | S Choudhury | N Nahar | S Ali|<br />
T Ahmed | AKMS Alam | Z Rahman | MN Islam | AK Azad Khan<br />
NIKDU | BIRDEM | UHL<br />
FP312<br />
SIGNIFICANT INCREASE IN THE RENAL RESISTIVE INDEX IN PATIENTS<br />
WITH TYPE 2 DIABETIC NEPHROPATHY WITH OVERT PROTEINURIA<br />
Ayu Ogawa | Hitoshi Sugiyama | Masashi Kitagawa | Hiroshi Morinaga |<br />
Tatsuyuki Inoue | Keiichi Takiue | Yoko Kikumoto | Haruhito Adam Uchida<br />
| Shinji Kitamura | Yohei Maeshima | Yoshinori Tsuchiyama | Hirofumi<br />
Makino<br />
Okayama Univ Grad School of Medicine, Dentistry and Pharmaceutical Sciences,<br />
Okayama, Japan | Kyoto Univ, Kyoto, Japan | Kochi Health Sciences Center,<br />
Kochi, Japan<br />
FP313<br />
INVESTIGATION ON THE VALIDITY OF FASTING BLOOD SUGAR AND<br />
GLUCOSE TOL<strong>ERA</strong>NCE TEST IN THE FIFTH DAY AFTER KIDNEY TRANSPL<br />
FOR ANTICIPATING DIABETES MELLITUS<br />
Fatemeh Nazemian | Mostafa Jafari | Narges o Sadat Zahed | Reza Javidi Dasht<br />
Bayaz<br />
Mahhad Univ Nedical Sciences. Mashhad, Iran | Shahid Beheshti Univ Medical<br />
Sciences | Tehran Univ Medical Sciences<br />
FP314<br />
CLINICAL SIGNIFICANCE OF INCREASED URINARY β2-MICROGLOBULIN<br />
IN DIABETIC NEPHROPATHY (DN)<br />
Massimo Papale | Salvatore Di Paolo | Grazia Vocino | Annamaria Di Palma|<br />
Cataneo Federica | Maria Teresa Rocchetti | Giuseppe Grandaliano | Loreto<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Gesualdo<br />
D.E.T.O. Univ Bari, Italy | Nephrology and Dialysis Unit, Hosp Dimiccoli , ASL<br />
BAT, Barletta, Italy | InterDept Res Center Bioagromed, Univ Foggia, Italy |<br />
Nephrology, Dialysis and Transpl Unit, Dept Emergency and Transpl, A. Moro<br />
Univ, Bari | Nephrology, Dialysis and Transpl Unit, Dept Biomedical Sciences,<br />
Univ Foggia<br />
FP315<br />
PATTERN OF DIABETIC RETINOPATHY PATIENTS ON CHRONIC DIALYSIS<br />
Candra Wibowo Prajitno<br />
Nephrology and Hypertension Div Internal Medicine Dept Trisakti Univ Jakarta<br />
FP316<br />
SECOND HARMONIC MICROSCOPY TO QUANTIFY RENAL INTERSTITIAL<br />
FIBROSIS IN ADULT PATIENTS WITH DIABETIC NEPHROPATHY<br />
Gener Ismail | Alexe Ditoiu | Stefan Stanciu | Vlad Herlea | Otilia Motoi<br />
Fundeni Clinical Inst, Dept Nephrology, Bucharest, Romania | Center Microscopy-Microanalysis<br />
and Information Processing, Univ Politehnica Bucharest,<br />
Bucharest, Romania | Dept Pathology, Fundeni Hosp, Bucharest, Romania |<br />
Dept Internal Medicine, Fundeni Clinical Inst, Bucharest, Romania<br />
FP317<br />
DOSE DEPENDENT REDUCTION OF CYTOTOXIC ADVANCED GLYCA-<br />
TION ENDPRODUCTS BY SEVELAMER CARBONATE<br />
Gary Striker | Jaime Uribarri | Helen Vlassara<br />
Mount Sinai School of Medicine<br />
FP318<br />
RELATIONSHIP VITAMIN D LEVELS AND MICROALBUMINURIA IN TYPE<br />
2 DIABETIC PATIENTS<br />
Bulent Gul | Ozen Oz Gul | Abdulmecit Yildiz | Ayca Eroglu | Nermin Keni |<br />
Canan Ersoy | Alparslan Ersoy | Sazi İmamoglu | Mustafa Yurtkuran<br />
Uludag Univ Medical School Dept Nephrology, Bursa, Turkey | Cekirge State<br />
Hosp, Bursa, Turkey | Uludag Univ Medical School Dept Internal Medicine |<br />
Uludag Univ Medical School Dept Endocrinology<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
149<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
150<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
ELECTROLYTE DISORDERS / NEPHROLITHIASIS<br />
FP319<br />
MANAGEMENT OF HYPERNATREMIA IN EMERGENCY DEPT<br />
Baralla Camille | Buffat Christophe | Berland Yvon | Vacher-Coponat Henri |<br />
Michelet Pierre | Torro Dominique | Stanislas Bataille<br />
Univ Aix-Marseille, AP-HM, Marseille, France | Hôp Conception<br />
FP320<br />
THIAZIDE INDUCED SEVERE HYPONATREMIA AND OSMOTIC DEMYELI-<br />
NATION SYNDROME - A CASE STUDY AND LIT<strong>ERA</strong>TURE REVIEW<br />
Satish Chondolu | Tyler An | Shaza Khan | Supratik* Rayamajhi<br />
Michigan State Univ, East Lansing, USA<br />
FP321<br />
CICLETANINE-INDUCED HYPONATREMIA AND HYPOKALEMIA IN PA-<br />
TIENTS WITH KIDNEY TRANSPLANTATION<br />
Gheun-Ho Kim | Young Wook Roh | Chang Hwa Lee | Chong Myung Kang<br />
Hanyang Univ College of Medicine, Seoul, Korea<br />
FP322<br />
HYPOPHOSPHATEMIA: A SIGNIFICANT PROBLEM IN HOSPITALIZED PA-<br />
TIENTS<br />
Ravi Bansal | Kailash Nath Singh | Sanjiv Saxena | KK Malhotra<br />
Pushpawati Singhania Res Inst, New Delhi, India<br />
FP323<br />
THE ASSOCIATION BETWEEN HYPOMAGNESEMIA AND PROTON PUMP<br />
INHIBITOR USE IN CHRONIC KIDNEY DISEASE<br />
Steven Van Laecke | Evi Nagler | Wim Van Biesen | Michel Jadoul | Raymond<br />
Vanholder<br />
Renal Div Ghent Univ Hosp, Ghent, Belgium | Ghent Univ Hosp | Cliniques<br />
Univ Saint-Luc, Univ Catholique Louvain, Brussels, Belgium<br />
FP324<br />
WHAT YOU WOULD NOT EXPECT FROM A RENINOMA: METASTASIS<br />
AND SYNDROME OF INAPPROPRIATE SECRETION OF ANTIDIURETIC<br />
HORMONE (SIADH)<br />
David Cucchiari | Claudio Angelini | Marco Mirani | Paola Arosio | Giorgio<br />
Graziani | Salvatore Badalamenti<br />
Ist Clin Humanitas IRCCS - Rozzano, Milano - Italy<br />
FP325<br />
CT SCAN EVALUATION OF PAPILLARY DENSITY IN HYPERCALCIURIC<br />
AND NON-HYPERCALCIURIC STONE FORMERS<br />
Daniela Girfoglio | Darren Allen | Alex Kirkham | Nikhil Johri | David C. Wheeler<br />
| Simon Choong | Shabbir Moochhala | Robert Unwin<br />
Centre Nephrology, Royal Free Campus UCL Medical School, London UK | Royal<br />
Free Hampstead NHS Trust, London, Uk | Univ College Hosp, London UK<br />
FP326<br />
ABNORMAL ARTERIAL STIFFNESS AND BONE DENSITY IN CALCIUM RE-<br />
NAL STONE FORMERS PATIENTS<br />
Antonia Fabris | Antonio Lupo | Francesco Fantin | Pietro Manuel Ferraro |<br />
Chiara Caletti | Gabrielle Comellato | Michele Messa | Giovanni Gambaro<br />
Nephrology Univ Verona | Section Nephrology, Dept Medicine | Section Geriatic<br />
Depts Medicine | Neprhology Catholic Univ Rome | Catholic Univ Rome<br />
FP327<br />
PREVALENCE OF HYPOKALAEMIA IN OUTPATIENTS<br />
Hiroshi Tanaka | Narihito Tatsumoto | Shoji Tsuneyoshi | Yasunori Daijo<br />
Hiroshima Red Cross Hosp and Atomic-bomb Survivors Hosp, Hiroshima, Japan<br />
FP328<br />
MAGNESIUM LEVELS IN PATIENTS WITH ADPKD TREATED WITH ANTI<br />
EGF-R, NIMOTUZUMAB<br />
Raymed A. Bacallao Méndez | Tania Crombet | José M. Dávalos | Betsy Llere-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
na| Christian Leyva | Reynaldo Manalich<br />
Inst Nefrología | Centro Inmunología Molecular<br />
FP329<br />
RETROGRADE INTRA RENAL SURGERY FOR RENAL STONES<br />
Paolo Beltrami | Lorenzo Ruggera | Alessandro Iannetti | Massimo Iafrate |<br />
Andrea Guttilla | Fabio Zattoni | Marcello Arancio | Filiberto Zattoni<br />
Urology Clinic, Univ Padova, Padova, Italy | Dept Urology, S. Maria degli Angeli<br />
Hosp, Pordenone, Italy<br />
FP330<br />
THE ENDOUROLOGICAL TREATMENT OF RENAL MATRIX STONES<br />
Paolo Beltrami | Lorenzo Ruggera | Andrea Guttilla | Alessandro Iannetti |<br />
Fabio Zattoni | Francesca Gigli | Filiberto Zattoni<br />
Urology Clinic, Univ Padova, Padova, Italy | Dept Urology, S. Maria degli Angeli<br />
Hosp, Pordenone, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
151<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
152<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
PRIMARY AND SECONDARY<br />
GLOMERULONEPHRITIS I<br />
FP331<br />
TRADITIONAL THERMAL TH<strong>ERA</strong>PY WITH INDIRECT-MOXIBUSTION RE-<br />
DUCES RESISTIVE INDEX OF RENAL SEGMENTAL ARTERY IN CKD PA-<br />
TIENTS. A RANDOMIZED CROSS-OVER CONTROLLED TRIAL<br />
Nagisa Miyazaki | Jun Matsumoto<br />
Dept Cardiology, Respirology & Nephrology, Gifu Univ Grad School Medicine,<br />
Gifu, Japan | Div Cardiology, Gifu Univ Grad School Medicine<br />
FP332<br />
METHOTREXATE PLUS PREDNISONE IN PATIENTS WITH RELAPSING<br />
IDIOPATHIC RETROPERITONEAL FIBROSIS<br />
Federico Alberici | Alessandra Palmisano | Federica Maritati | Elena Oliva |<br />
Carlo Buzio | Augusto Vaglio<br />
Nephrology Unit, Univ Parma, Italy<br />
FP333<br />
OUTCOME IN BIOPSY-PROVEN LUPUS NEPHRITIS<br />
Geir Mjoen | Gudrun E Norby | Bjorn Egil Vikse | Einar Svarstad | Bjoerneklett<br />
Rune | Aasaroed Knut<br />
Oslo Univ Hosp, RiksHosp | Haukeland Univ Hosp | St Olavs Hosp<br />
FP334<br />
HEPARANASE AS A NOVEL MARKER OF LUPUS NEPHRITIS ACTIVITY<br />
Maciej Szymczak | Jakub Kuźniar | Wacław Kopeć | Zofia Marchewka | Marian<br />
Klinger<br />
Dept Nephrology and Transpl Medicine, Wrocław, Poland | Dept Toxicology,<br />
Wroclaw Medical Univ<br />
FP335<br />
ANTIPHOSPHOLIPID SYNDROME-ASSOCIATED NEPHROPATHY IN PA-<br />
TIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: PREVALENCE, CLINI-<br />
CAL MANIFESTATIONS AND RENAL FUNCTIONAL OUTCOME<br />
Pilar Arrizabalaga | Ricardo Silvariño | Francesc Sant | Gerard Espinosa | Manel<br />
Solé | Ricard Cervera<br />
Hosp Clínic | Autoimmune Diseases. Hosp Clínic | Pathology. Fund Althaia<br />
FP336<br />
CLINICOPATHOLOGICAL PROFILE OF PATIENTS WITH BIOPSY PROVEN<br />
LUPUS NEPHRITIS AT A TERTIARY CARE HOSP<br />
Dilip Gude | Sashidhar Chennamsetty<br />
Medwin Hosp, Nampally, Hyderabad<br />
FP337<br />
HIGH-DOSE IMMUNOSUPPRESSIVE TH<strong>ERA</strong>PY WITH AUTOLOGOUS HE-<br />
MATOPOIETIC STEM CELL TRANSPL FOR SEVERE REFRACTORY SYSTE-<br />
MIC LUPUS ERYTHEMATOSUS WITH LUPUS NEPHRITIS: REMOTE OUT-<br />
COMES<br />
Alexander Demin | Vladimir Kozlov | Igor Lisukov | Olga Kotova | Aleksey<br />
Sizikov | Vera Sergeevicheva | Larissa Demina<br />
Novosibirak State Medical Univ | Clinical Immunology Inst Russian Medical<br />
Sciences Academy, Novosibirsk, Russian Federation | Internal Medicine and<br />
SLE Centre, Novosibirsk State Medical Univ, Novosibirsk, Russian Federation |<br />
Nephrology and Dialysis City Centre, Novosibirsk, Russian Federation<br />
FP338<br />
MACROPHAGE INHIBITORY FACTOR (MIF) AND EUTHYROID SICK SYN-<br />
DROME IN ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS<br />
Ola Börjesson | Mårten Wendt | Aune Avik | Abdul R Qureshi | Johan Bratt |<br />
Edmund J Miller | Iva Gunnarsson | Annette Bruchfeld<br />
Unit Rheumatology, Dept Medicine, Karolinska Univ Hosp, Karolinska Inst,<br />
Stockholm, Sweden | Baxter Novum, CLINTEC, Karolinska Inst, Stockholm,<br />
Sweden | Feinstein Inst Medical Res, Manhasset, New York, USA | Dept Renal<br />
Medicine, Karolinska Univ Hosp, CLINTEC, Karolinska Inst, Stockholm, Sweden<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP339<br />
CLINICAL FEATURES, TREATMENT DIVERSITY AND OUTCOME OF MPO-<br />
ANCA-ASSOCIATED VASCULITIS – EXPERIENCE FROM THE DEPTS RHEU-<br />
MATOLOGY AND NEPHROLOGY OF A SINGLE JAPANESE CENTER<br />
Kazuhiro Sugiyama | Midori Hasegawa | Koichiro Yamamoto | Hiroki Hayashi|<br />
Shigehisa Koide | Kazutaka Murakami | Makoto Tomita | Shunji Yoshida<br />
| Yukio Yuzawa<br />
Fujita Health Univ Scool of Medicine, Dept Nephrology | Fujita Health Univ<br />
Scool Medicine, Dept Rheumatology<br />
FP340<br />
THE DEMOGRAPHY OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS<br />
RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY<br />
GROUP TRIALS<br />
Steven Yew | David Jayne | Kerstin Westman | Peter Hoglund | Oliver Flossman<br />
| Alfred Mahr | Raashid Luqmani | Jo Robson<br />
Addenbrookes Hosp, UK | Malmo Univ Hosp, Malmo Sweden | Univ Lund,<br />
Skane Univ Hosp, Sweden | Reading Hosp, Reading, UK | Hosp Cochin, Paris,<br />
France | Nufflield Hosp, Oxford, UK<br />
FP341<br />
NON RAPIDLY-PROGRESSIVE GLOMERULONEPHRITIS: A FREQUENT<br />
CLINICAL PRESENTATION OF ANCA-ASSOCIATED VASCULITIS WITH<br />
RENAL INVOLVEMENT<br />
Eric Thervet | Charlène Levi | Elsa Guiard | Mélanie Roland | Dominique Nochy<br />
| Cristina Daniliuc | Loïc Guillevin | Luc Mouthon | Christian Jacquot |<br />
Alexandre Karras<br />
Néphrologie, HEGP, Paris, France | Renal Pathology, HEGP, Paris, France |<br />
Médecine Interne, Cochin, Paris, France<br />
FP342<br />
CIRCULATING ANTIBODIES SPECIFIC FOR �-ENOLASE AND PHOSPHOLI-<br />
PASE A2 RECEPTOR IN JAPANESE PATIENTS WITH PRIMARY OR SECON-<br />
DARY MEMBRANOUS NEPHROPATHY<br />
Yukihiro Kimura | Hiroyuki Morita | Hanna Debiec | Harutaka Yamada | Naoto<br />
Miura | Shogo Banno | Pierre Ronco | Hirokazu Imai<br />
Div Nephrology and Rheumatology, Dept Internal Medicine, Aichi Medical Univ<br />
School Medicine | Univ Pierre et Marie Curie, Paris 6, Assist Publique–Hôp Paris<br />
(AP-HP), Tenon Hosp | Kawana Hosp<br />
FP343<br />
PRESERVATION OF RENAL FUNCTION BY GLUCOCORTICOIDS ALONE<br />
OR WITH CYCLOSPORINE IN KOREAN PATIENTS WITH IDIOPATHIC<br />
MEMBRANOUS NEPHROPATHY<br />
Dong Ho Shin | Hyang Mo Koo | Seung Hyeok Han | Kyu Hun Choi | Tae-<br />
Hyun Yoo | Shin-Wook Kang<br />
Dept Internal Medicine, College Medicine, Yonsei Univ, Seoul, Korea<br />
FP344<br />
MEMBRANOUS NEPHROPATHY AND MALIGNANCIES<br />
Claudia Fofi | Luca Scabbia | Francescaromana Festuccia | Antonella Stoppacciaro<br />
| Paolo Mene’<br />
U.O. Nefrologia, Azienda Osp S. Andrea, Univ Roma Sapienza, Rome, Italy|<br />
U.O. Istologia ed Anatomia Patologica, Azienda Osp S. Andrea, Univ Roma Sapienza,<br />
Rome, Italy<br />
FP345<br />
THE MECHANISM OF THE DEVELOPMENT OF SEGMENTAL GLOMERU-<br />
LAR SCLEROSIS IN IDIOPATHIC MEMBRANOUS NEPHROPATHY<br />
Akira Shimizu | Akiko Mii | Tomohiro Kaneko | Yukinari Masuda | Yasuhiko<br />
Iino | Yasuo Katayama | Yuh Fukuda<br />
Pathology, Internal Medicine (Div Neurology, Nephrology, and Reumatology),<br />
Nippon Medical School, Tokyo, Japan<br />
FP346<br />
ANTIGEN NON-SPECIFIC ACTIVATION OF CD8 T CELLS TRIGGERS AU-<br />
TOIMMUNE RESPONSE IN IDIOPATHIC MEMBRANOUS NEPHROPATHY<br />
Aki Kuroki | Kei Matsumoto | Tadao Akizawa<br />
Div Nephrology, Dept Medicine, Showa Univ, Tokyo, Japan<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
153<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
154<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP347<br />
EFFICACY AND SAFETY OF TRIPLE TH<strong>ERA</strong>PY WITH MMF, CYCLOSPORI-<br />
NE AND PREDNISOLONE VERSUS CYCLOSPORINE AND PREDNISOLONE<br />
IN ADULT PATIENTS WITH IDIOPATHIC MEMBRANOUS NEPHROPATHY<br />
AND PERSISTENT HEAVY PROTEINURIA<br />
Roxana Jurubita | Gener Ismail | Raluca Bobeica | Elena Rusu | Diana Zilisteanu<br />
| Andreea Andronesi | Otilia Motoi | Valerian Ditoiu | Ionel Copaci |<br />
Mihai Voiculescu<br />
Fundeni Clinical Inst, Dept Nephrology, Bucharest, Romania<br />
FP348<br />
LOW AND HIGH MOLECULAR WEIGHT URINARY PROTEINS AS PREDIC-<br />
TORS OF RESPONSE TO RITUXIMAB IN PATIENTS WITH MEMBRANOUS<br />
NEPHROPATHY: A PROSPECTIVE STUDY<br />
Maria V. Irazabal | Alfonso Eirin | John C. Lieske | Laurence H. Beck | John J.<br />
Dillon | Patrick H. Nachman | Sanjeev Sethi | Stephen B. Erickson | Daniel C.<br />
Cattran | Fernando C. Fervenza<br />
Mayo Clinic | Boston Univ | Univ North Carolina | Toronto General Hosp<br />
FP349<br />
MEASUREMENT OF ANTI-PLA2R ANTIBODIES IN A CZECH COHORT OF<br />
PATIENTS WITH MEMBRANOUS NEPHROPATHY<br />
Barbora Svobodova | Zdenka Hruskova | Ivana Janatkova | Eva Jancova | Vladimir<br />
Tesar<br />
Dept Nephrology, General Univ Hosp, Prague, Czech Republic | Inst Clinical<br />
Biochemistry and Lab Diagnostics , General Univ Hosp, Prague, Czech Republic<br />
FP350<br />
EFFECT OF TREATMENT ON URINARY KIDNEY INJURY MOLECULE-1 IN<br />
IGA NEPHROPATHY<br />
Mi Seon Seo | Eun Bin Lee | Jin Young You | Yu Kyung Hyun | Sung Ae<br />
Woo| Moo Young Park | Soo Jung Choi | Jin Seok Jeon | Hyunjin Noh | Jin<br />
Gook Kim | Dong Cheol Han | Seung Duk Hwang | Tae Youn Choi | So young<br />
Jin | Soon Hyo Kwo<br />
Dept Internal Medicine, Dept Lab Medicine, Dept Pathology, Soon Chun Hyang<br />
Univ Hosp, Korea<br />
FP351<br />
REGULATORY T CELLS (TREG) AND TRYPTOPHAN/KYNURENINE PATH-<br />
WAY IN IgA NEPHROPATHY<br />
Elisa Loiacono | Davide Defedele | M. Paola Puccinelli | Roberta Camilla |<br />
Rachele Gallo | Licia Peruzzi | Cristiana Rollino | Giulietta Beltrame | Michela<br />
Ferro | Luca Vergano | Federica Campolo | Alessandro Amore | Rosanna<br />
Coppo<br />
Nephrology, Dialysis, Transpl, R.Margherita Hosp, Turin | Diagnostic Servs,<br />
Diagnostic Dept, R.Margherita Hosp, Turin | Nephrology and Dialysis, G.Bosco<br />
Hosp, Turin<br />
FP352<br />
STANDARDIZED MORTALITY RATE IN IGA NEPHROPATHY PATIENTS<br />
Thomas Knoop | Bjørn Egil Vikse | Einar Svarstad | Leif Bostad | Torbjørn<br />
Leivestad | Rune Bjørneklett<br />
Medical Dept, Haukeland Univ Hosp, Bergen, Norway | Dept Pathology, Haukeland<br />
Univ Hosp, Bergen, Norway | Medical Dept, Oslo Univ Hosp, RiksHosp,<br />
Oslo, Norway<br />
« FP353<br />
ACE INSERTION(I)/DELETION(D) POLYMORPHISM PREDICTED RENO-<br />
PROTECTIVE EFFECTIVENESS OF RENIN-ANGIOTENSIN SYSTEM (RAS)<br />
BLOCKADE IN PATIENTS WITH IGA NEPHROPATHY<br />
Junya Teranishi | Ryohei Yamamoto | Yasuyuki Nagasawa | Tatsuya Shoji |<br />
Hirotsugu Iwatani | Noriyuki Okada | Toshiki Moriyama | Atsushi Yamauchi |<br />
Yoshiharu Tsubakihara | Enyu Imai | Hiromi Rakugi | Yoshitaka Isaka<br />
Dept Geriatric Medicine & Nephrology, Osaka Univ Grad School of Medicine,<br />
Suita, Japan | Dept Kidney Disease and Hypertension, Osaka General Medical<br />
Center, Osaka, Japan | Clinical Lab Medicine, Osaka General Medical Center,<br />
Osaka, Japan | Osaka Univ Healthcare Center, Toyonaka, Japan | Dept Nephrology,<br />
Osaka Rosai Hosp, Sakai, Japan | Nagoya Univ, Nagoya, Japan<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP354<br />
HYPOCOMPLEMENTEMIA AND MESANGIAL C3 DEPOSITION PREDICT<br />
RENAL OUTCOME IN PATIENTS WITH IGA NEPHROPATHY<br />
Hyang Mo Koo | Fa Mee Doh | Seung Jun Kim | Shin-Wook Kang | Kyu Hun<br />
Choi | Dae Suk Han | Seung Hyeok Han<br />
College of Medicine, Yonsei Univ, Seoul, Korea<br />
FP355<br />
GALACTOSE-DEFICIENT IGA1 AND IGA-IGG IMMUNE COMPLEX AS NO-<br />
VEL NONINVASIVE BIOMARKERS FOR DISEASE ACTIVITY OF IGA NE-<br />
PHROPATHY (IGAN)<br />
Yusuke Suzuki | Keiichi Matsuzaki | Hitoshi Suzuki | Keiko Okazaki | Hiroyuki<br />
Yanagawa | Masayuki Maiguma | Masahiro Muto | Toshinobu Sato |<br />
Satoshi Horikoshi | Jan Novak | Osamu Hotta | Yasuhiko Tomino<br />
Div Nephrology, Dept Internal Medicine, Juntendo Univ Fac Medicine | Dept<br />
Nephrology, Sendai Shakaihoken Hosp, Sendai, Miyagi, Japan | Univ Alabama<br />
Birmingham, Birmingham, AL<br />
FP356<br />
LONG-TERM OUTCOME OF BIOPSY-PROVEN IgA NEPHROPATHY PRE-<br />
SENTING WITH NORMAL RENAL FUNCTION AND MINIMAL OR NEGA-<br />
TIVE PROTEINURIA<br />
Eduardo Gutierrez | Isabel Zamora | José Ballarín | Yolanda Arce | Sara Jiménez<br />
| Carlos Quereda | Teresa Olea | Jorge Martínez-Ara | Alfons Segarra|<br />
Carmen Bernis | Asunción García | Marian Goicoechea | Soledad García de Vinuesa|<br />
Jorge Rojas | Manuel Praga<br />
Hosp Univ 12 de Octubre, Madrid, Spain | Hosp Univ La Fe, Valencia, Spain |<br />
Fund Puigvert, Barcelona, Spain | Hosp Univ Ramón y Cajal, Madrid, Spain |<br />
Hosp Univ La Paz, Madrid, Spain | Hosp Univ Vall d´Hebrón, Barcelona, Spain|<br />
Hosp Univ La Princesa, Madrid, Spain | Hosp Univ Gregorio Marañón, Madrid,<br />
Spain | por Grupo Estudio Enfermedades Glomerulares Sociedad Española Nefrología<br />
(GLOSEN).<br />
FP357<br />
LONG-TERM EFFECTS OF STEROIDS AND MYCOPHENOLATE MOFETIL IN<br />
NEPHROTIC IGA NEPHROPATHY PATIENTS WITH SCLEROTIC AND EN-<br />
DOCAPILLARY PROLIF<strong>ERA</strong>TIVE CHANGES<br />
Vesna Ristovska | Gordana Petrushevska | Ladislava Grcevska<br />
Dept Nephrology, Skopje | Inst Pathology Skopje<br />
FP358<br />
VALIDATION OF FRENCH MODEL TO PREDICT ESRD AND DEATH IN IGA<br />
NEPHROPATHY PATIENTS<br />
Thomas Knoop | Bjørn Egil Vikse | Einar Svarstad | Leif Bostad | Torbjørn<br />
Leivestad | Rune Bjørneklett<br />
Medical Dept, Haukeland Univ Hosp, Bergen, Norway | Medical Dept, Oslo<br />
Univ Hosp, RiksHosp, Oslo, Norway<br />
FP359<br />
POLYMERIC IGA1 FOR THE SELECTIVE ANALYSIS OF O-GLYCOSYLATION<br />
IN PATIENTS WITH IGA NEPHROPATHY<br />
Kenji Satake | Yoshio Shimizu | Nozomi Mugitani | Hitoshi Suzuki | Yusuke<br />
Suzuki | Satoshi Horikoshi | Shinichiro Honda | Kazuko Shibuya | Akira Shibuya<br />
| Yasuhiko Tomino<br />
Juntendo Univ, Tokyo, Japan | Univ Tsukuba, Tsukuba, Japan<br />
FP360<br />
DECREASE OF PERLECAN LG3 PEPTIDE AND FREE K-LIGHT CHAINS<br />
URINE EXCRETION IN IgA NEPHROPATHY: NEW INSIGHTS FOR A NON-<br />
INVASIVE DIAGNOSIS OF IgAN?<br />
Massimo Papale | Maria Teresa Rocchetti | Salvatore Di Paolo | Ida Valentina<br />
Suriano | Annamaria D'Apollo | Grazia Vocino | Eustacchio Montemurno |<br />
Leonarda Varraso | Giuseppe Grandaliano | Loreto Gesualdo<br />
Proteomics Core Facility, Res Center BioAgroMed Univ Foggia, Italy | 2Div Nephrology<br />
and Dialysis, Hosp Dimiccoli, Barletta, Italy | Res Center Bioagromed<br />
Univ Foggia, Italy | Res Center Bioagromed Univ Foggia, Italy | Nephrology<br />
Dialysis and Transpl Unit, DETO, Univ Bari, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
155<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
156<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP361<br />
IgA NEPHROPATHY - CLINICAL AND HISTOLOGICAL PROGNOSTIC FAC-<br />
TORS<br />
Ana Huerta | Andrew S. Bomback | Pietro A. Canetta | Jai Radhakrishnan | Leal<br />
Herlitz | Barry Stokes | Vivette D´Agati | Glen Markowitz | Gerald B. Appel<br />
Hosp 12 de Octubre, Madrid, Spain | Columbia Univ College Physicians and<br />
Surgeons, New York, U.S.<br />
FP362<br />
TREATMENT OF PRIMARY AMYLOIDOSIS<br />
Vesna Ristovska | Ladislava Grcevska<br />
Dept Nephrology, Skopje<br />
FP363<br />
ACUTE POSTINFECTIOUS GLOMERULONEPHRITIS IN ADULTS<br />
Hamouda Mouna | Ben Dhia Nasr | Imen Mrabet | Letaif Ahmed | Aloui Sabra|<br />
Frih Mohamed Ammeur | Elmay Mezri | Skhiri Habib<br />
Dept of Nephrology, Fattouma Bourguiba Hosp, Monastir, Tunisia<br />
FP364<br />
CHRONIC AUTOIMMUNE THYROIDITIS AND GLOMERULONEPHRITIS: A<br />
TRULY RARE ASSOCIATION?<br />
Maurizio Innocenti | Antonio Pasquariello | Giovanna Pasquariello | Paola<br />
Mattei | Anna Bottai | Giordano Fumagalli | Laura Bozzoli | Sara Samoni |<br />
Adamasco Cupisti<br />
Medical Area, U.O. Nefrologia 2 SSN, AOUP, Pisa, Tuscany, Italy | Medical<br />
Area, U.O. Nefrologia 1 Univ, AOUP, Pisa, Tuscany, Italy<br />
FP365<br />
KIDNEY BIOPSIES IN HIV PATIENTS: A FIFTEEN-YEAR SINGLE CENTER<br />
EXPERIENCE IN BRAZIL<br />
Bruno Caldin | James Hung | Liliany Repizo | Denise M. Malheiros | Rui Barros|<br />
Viktoria Woronik<br />
Univ São Paulo | Hosp Clínicas, Univ São Paulo | Dept Pathology, Univ São<br />
Paulo<br />
FP366<br />
PREGNANCY IN PATIENTS WITH CRYOGLOBULINEMIC VASCULITIS TRE-<br />
ATED WITH PLASMAPHERESIS AND MYCOPHENOLATE MOFETIL (MMF).<br />
A CASE REPORT<br />
Carlo Giammarresi | Luisa Bono | Angelo Ferrantelli | Calogera Tortorici | Gioacchino<br />
Licavoli | Ugo Rotolo<br />
ARNAS Civico U.O: Nefrologia e Dialisi, Palermo, Italy<br />
FP367<br />
THE INDUCTION TH<strong>ERA</strong>PY WITH BORTEZOMIB AND DEXAMETHASO-<br />
NE FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPL CAN IMPRO-<br />
VE BOTH THE HEMATOLOGICAL AND ORGAN RESPONSE RATE IN AL<br />
AMYLOIDOSIS<br />
Xianghua Huang | Qingwen Wang | Mingjun Shi | Wencui Chen | Zhihong Liu<br />
Res Inst Nephrology, Jinling Hosp, Nanjing Univ School of Medicine, Nanjing,<br />
China<br />
FP368<br />
INTERLEUKIN-1-RECEPTOR ANTAGONIST CANAKINUMAB MAY AME-<br />
LIORATE RENAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DI-<br />
SEASE AND SECONDARY AMYLOIDOSIS (AA) IN THE MUCKLE-WELLS<br />
SYNDROME<br />
Roberto Scarpioni | Luca Cantarini | Antonio Lazzaro | Marco Ricardi | Vittorio<br />
Albertazzi | Luigi Melfa | Claudia Concesi | Daniele Vallisa | Luigi Cavanna<br />
Nephrology and Dialysis Unit, Dept Speciality, Guglielmo da Saliceto Hosp<br />
AUSL Piacenza, Italy | Rheumatology Unit, Dept Clinical Medicine and Immunologic<br />
Sciences, Univ Siena, Italy | Haematology Unit, Dept Oncohematology,<br />
Guglielmo da Saliceto Hosp AUSL Piacenza, Italy | Dept Oncohematology, Guglielmo<br />
da Saliceto Hosp AUSL Piacenza, Italy<br />
FP369<br />
SERUM AND URINE NGAL LEVELS IN PATIENTS WITH CIRRHOSIS AND<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
HEPATO-RENAL SYNDROME<br />
Gökhan Güngör | Hüseyin Ataseven | Ali Demir | Yalcin Solak | Murat Biyik|<br />
Bahadır Öztürk | İlker Polat | Aysel Kıyıcı | Özlem Özer Çakır | Hakkı Polat<br />
Konya Univ Meram School of Medicine, Konya, Turkey | Selcuk Univ Selcuklu<br />
School of Medicine, Konya, Turkey<br />
FP370<br />
HIGH PREVALENCE OF OCCULT HCV INFECTION IN PATIENTS WITH PRI-<br />
MARY AND SECONDARY GLOMERULAR NEPHROPATHIES<br />
Jorge Martinez-Ara | Inmaculada Castillo | Vicente Carreño | Ana Aguilar |<br />
Rosario Madero | Eduardo Hernandez | Carmen Bernis | Javier Bartolomé |<br />
Francisco Gea | Rafael Selgas<br />
Hosp Univ La Paz, Madrid, Spain | Fund Estudio Hepatitis Virales, Madrid,<br />
Spain | Serv Nefrología, Serv Bioestadística, Hosp Univ La Paz, Madrid, Spain|<br />
Serv Nefrología, Hosp Univ 12 de Octubre, Madrid | Serv Nefrología, Hosp la<br />
Princesa, Madrid, Spain | Serv Gastroenterología, Hosp Univ La Paz, Madrid<br />
FP371<br />
RENAL TUBULAR FUNCTION AND ITS RELATIONSHIP TO ADIPONECTIN<br />
AND OXIDATIVE STRESS IN OBESE SUBJECTS WITH AND WITHOUT EVI-<br />
DENCE OF NEPHROPATHY<br />
Hayam Abdel Meguid El Aggan | Hisham Salah El Banawy | Eman Wagdy<br />
Fac Medicine, Alexandria, Egypt | Medical Res Inst, Alexandria, Egypt<br />
FP372<br />
EXTRAVASCULAR EFFECTS OF PLASMINOGEN ACTIVATOR INHIBITOR<br />
TYPE 1 (PAI-1) IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS<br />
(CGN): IMPORTANT MECHANISM OF THE RENAL TUBULOINTERSTITIO-<br />
NAL FIBROSIS (TIF) AND POTENTIAL TARGET FOR ITS TREATMENT<br />
Natalia Tchebotareva | Olga Li | Irina Bobkova | Lidiya Kozlovskaya | Vladimir<br />
Varshavskiy | Ekaterina Golicina<br />
I.M. Sechenov First Moscow State Medical Univ, Russia | First Moscow State<br />
Medical Univ, Nephrology Dept, Russia<br />
FP373<br />
THE EFFICACY AND SAFETY OF ABELMOSCHUS MOSCHATUS (A TRADI-<br />
TIONAL CHINESE MEDICINE) FOR CHRONIC KIDNEY DISEASE: A META-<br />
ANALYSIS OF RANDOMIZED CONTROLLED TRIALS AND OBSERVATIO-<br />
NAL TRIALS<br />
Yizhi Chen | Zhixiang Gong | Xiangmei Chen | Li Tang | Jianhui Zhou |<br />
Xueying Cao | Ribao Wei<br />
PLA General Hosp (301 Hosp), Beijing, China | Chinese PLA 532 Hosp, Anhui,<br />
China<br />
FP374<br />
URINARY ANGIOTENSINOGEN ORIGINATES FROM KIDNEY AND RE-<br />
FLECTS KIDNEY INJURY REGARDLESS OF THE EXTENT OF PROTEINURIA<br />
Eun Hee Koo | Ji Hyeon Park | Hyun Kyung Kim | Min Su Kim | Hye Ryoun<br />
Jang | Jung Eun Lee | Wooseong Huh | Dae Joong Kim | Ha Young Oh |<br />
Yoon-Goo Kim<br />
Samsung Medical Center, Seoul, Korea<br />
« FP375<br />
ASSESSMENT OF PODOCYTE DYSFUNCTION AND URINARY PODOCYTE<br />
LOSS IN CHRONIC GLOMERULONEPHRITIS (CGN): SIGNIFICANCE FOR<br />
ESTIMATION OF CLOMERULAR DAMAGE AND GLOMERULOSCLEROSIS<br />
RISK<br />
Natalia Tchebotareva | Irina Bobkova | Lidiya Kozlovskaya | Olga Li | Olga<br />
Eskova | Mikhail Shvetsov | Ekaterina Golytsina | Vladimir Varshavskiy | Olga<br />
Popova<br />
I.M. Sechenov First Moscow State Medical Univ, Russia<br />
FP376<br />
OSTEOPONTIN AND SOLUBLE UROKINASE-LIKE PLASMINOGEN ACTI-<br />
VATOR RECEPTOR PLASMA LEVELS ARE ASSOCIATED WITH PROTEI-<br />
NURIA IN IMMUNOLOGICAL DISORDERS: A NEW RATIONALE FOR ACE-<br />
INHIBITORS?<br />
Marco Quaglia | Sara Monti | Roberta Fenoglio | Alberto Menegotto | Andrea<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
157<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
158<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Airoldi | Cristina Izzo | Maria Antonietta Rizzo | Umberto Dianzani | Piero<br />
Stratta<br />
Amedeo Avogadro Univ; Maggiore della Carità Hosp, Novara<br />
FP377<br />
A PILOT TRIAL OF SIROLIMUS PLUS PREDNISONE FOR THE TREATMENT<br />
OF ERDHEIM-CHESTER DISEASE<br />
Augusto Vaglio | Federico Alberici | Davide Gianfreda | Carlo Buzio<br />
Nephrology Unit, Univ Hosp Parma, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
EXTRACORPOREAL DIALYSIS:<br />
TECHNIQUES AND ADEQUACY<br />
FP378<br />
DIRECT CALCULATION OF Kt/V AS TOTAL BLOOD CLEARANCE OF UREA<br />
OVER TOTAL BODY WATER VOLUME<br />
Carlo Donadio | Angeliki Kanaki<br />
Dept Internal Medicine, Pisa, Italy | Dept Internal Medicine, Nephrology, Univ<br />
Pisa, Italy<br />
FP379<br />
SPKT/V MEASUREMENT THROUGH ULTRAVIOLET ABSORPTIOMETRY<br />
Adoración Martín-Gómez | Sergio Garcia | MEugenia Palacios-Gómez<br />
Agencia Sanitaria Hosp Poniente<br />
FP380<br />
SPECTROPHOTOMETRIC AND SPECTROFLUORIMETRIC ANALYSIS OF<br />
SPENT DIALYSATE SHOULD ALLOW MONITORING OF DIALYSIS ADE-<br />
QUACY EVEN IF UREA CONCENTRATIONS CANNOT BE DETERMINED BY<br />
THESE METHODS<br />
Carlo Donadio | Dario Calia | Elisa Colombini | Fabio Di Francesco | Silvia<br />
Ghimenti | Angeliki Kanaki | Massimo Onor | Danika Tognotti | Roger Fuoco<br />
Dept Internal Medicine, Pisa, Italy | Dept Chemistry & Industrial Chemistry,<br />
Univ Pisa, Pisa | Dept Internal Medicine – Nephrology, Univ Pisa, Pisa | IC-<br />
COM, CNR, Pis<br />
FP381<br />
RELATIONSHIP OF KT/VM AND PROTEIN CATABOLIC RATE WITH<br />
HYPERPHOSPHATEMIA IN PATIENTS UNDER CHRONIC HEMODIALYSIS<br />
Edwin Marka-Castro | Manuel Ignacio Torres Zamora | Juan Giron-Mino |<br />
Maria Angelica Jaime-Solis | Luis Mauro Arteaga | Hector Romero | Edwin<br />
Marka-Castro<br />
Hosp Dalinde | Hosp San Rafael<br />
FP382<br />
NOVEL COMPOSITE DIALYSIS ADEQUACY INDEX: COMPARISON WITH<br />
UREA STANDARD KT/V (STDKT/V)<br />
Alp Akonur | Markku Asola | Bruce Culleton<br />
Baxter Healthcare Corporation<br />
FP383<br />
KT/V IS A POOR PREDICTOR OF CONCENTRATION OF A BROAD RANGE<br />
OF UREMIC TOXINS<br />
Sunny Eloot | Griet Glorieux | Neirynck Nathalie | Raymond Vanholder<br />
Hemodialysis 1P8, Ghent Univ Hosp | Ghent Univ Hosp, Ghent, Belgium | Nephrology<br />
- Gent - Belgium<br />
FP384<br />
MORBIDITY OF METABOLIC SYNDROME IN HAEMODIALYSIS PATIENTS<br />
Ana Pérez de José | Ursula Verdalles Guzman | Soraya Abad Esttebanez | Almudena<br />
Vega Martinez | Daniel Barraca | Claudia Yuste | Laura Bucalo | Abraham<br />
Rincon | Juan Manuel López-Gómez<br />
Spain, Madrid, Hosp Gregorio Marañón<br />
FP385<br />
EFFECTS ON NUTRITIONAL MARKERS OF HAEMODIAFILTRATION WITH<br />
REGEN<strong>ERA</strong>TION OF ULTRAFILTRATE (HFR) VERSUS HIGH FLUX DIALY-<br />
SIS: A CROSS-OVER RANDOMIZED TRIAL MULTICENTRE TRIAL<br />
Pierre Bataille | Pierkarski Celine | Azar Raymond | Glowacki Francois | Lemonies<br />
Hervé | Dracon Michel | Renaux Jean Louis<br />
Hôp Docteur Duchenne | Bellco | Hôp Dunkerque | CHRU Lille | Hôp Roubaix<br />
FP386<br />
PREDICTION OF INTRADIALYTIC MORBID EVENTS BY CHANGES IN THE<br />
SLOPE OF RELATIVE BLOOD VOLUME IN HEMODIALYSIS PATIENTS<br />
Fansan Zhu | Peter Kotanko | Stephan Thijssen | Nathan W Levin<br />
Renal Res Inst, New York USA<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
159<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
160<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP387<br />
THE ELEVATED FILLING PRESSURES OF THE LEFT VENTRICLE DETERMI-<br />
NE THE DYSFUNCTION OF CORONARY MICROCIRCULATION IN HEMO-<br />
DIALYSIS PATIENTS<br />
Nickos Papamichail | Maria Bougiakli | Chara Gouva | Sophie Antoniou | Sophie<br />
Gianitsi | Afroditi Vlachopanou | Spiridon Chachalos | Katherina Naka |<br />
Despina Kaarsavvidou | Kostantinos Katopodis | lampros Michalis<br />
Cardiology Dept General Hosp Artas | Cardiology Dept, Michaelidion Center |<br />
Nephrology Dept, Artas General Hosp<br />
FP388<br />
INFLUENCE OF INTRADIALYSIS HEART RATE AT INITIATION OF HAE-<br />
MODIALYSIS ON LONG-TERM OUTCOME<br />
Koichi Sasaki | Keiko Yasuda | Masaya Yamato<br />
Rinku General Medical Center, Izumisano, Japan<br />
FP389<br />
METHOD FOR CLUSTERING HEMODIALYSIS (HD) PATIENTS BASED ON<br />
THE ESTIMATED WATER REFILLING INDEX (WRI)<br />
Alessandro Surace | Paolo Rovatti | Denis Steckiph | Roberta Bandini | Stefano<br />
Severi | Alberto Dellacasa Bellingegni | Antonio Santoro<br />
Gambro Dasco S.p.A., Medolla, Italy | Gambro Hospal S.p.A., Bologna, Italy|<br />
Univ Bologna, Cesena, Italy | DEIS Bologna Univ, Cesena, Italy | Malpighi<br />
Hosp, Bologna, Italy<br />
FP390<br />
COMBINING BLOOD VOLUME MONITORITING AND BIOELECTRICAL IM-<br />
PEDANCE FOR HYPOTENSION PREVENTION AND ADJUSTMENT OF DRY<br />
WEIGHT<br />
Marta Arias | Alexis Sentis | Nuria Perez | Nestor Fontsere | Manel Vera | Nestor<br />
Rodriguez | Carola Arcal | Nancy Ortega | Fernando Uriza | Aleix Cases|<br />
Francisco Maduell<br />
Hosp Clinic Barcelona<br />
FP391<br />
COMPARISON OF ULTRAFILTRATION VOLUME AND CHANGES IN IN-<br />
TRADIALYTIC EXTRACELLULAR FLUID VOLUME ESTIMATED BY MULTI-<br />
FREQUENCY AND SINGLE FREQUENCY BIOIMPEDANCE TECHNIQUES IN<br />
HEMODIALYSIS PATIENTS<br />
Samer R. Abbas | Fansan Zhu | Peter Kotanko | Nathan W Levin<br />
Renal Res Inst, NY, USA<br />
FP392<br />
LONG INTERDIALYTIC INTERVAL IS ASSOCIATED WITH GREATER CEN-<br />
TRAL AORTIC PRESSURE AUGMENTATION THAN A REGULAR 2-DAY IN-<br />
TERDIALYTIC INTERVAL ON MAINTENANCE HEMODIALYSIS PATIENTS<br />
Panagiotis Georgianos | Pantelis Sarafidis | Pavlos Nikolaidis | Anastasios Lasaridis<br />
Section Nephrology and Hypertension, 1st Dept Medicine, AHEPA Univ Hosp,<br />
Thessaloniki, Greece | Academic Dept Renal Medicine, King’s College Hosp<br />
FP393<br />
A MODEL TO CALCULATE CARDIAC OUTPUT IN HAEMODIALYSIS PA-<br />
TIENTS BY THERMODILUTION<br />
Alayoud Ahmed | Hassani Kaoutar | Benyahya Mohammed | Oualim Zouhir<br />
Serv Nephrology, Hemodialysis and Kidney Transpl, Military Hosp Instruction,<br />
Mohammed V. Rabat, Morocco<br />
FP394<br />
IN INCIDENT HEMODIALYSIS PATIENTS A HIGHER ULTRAFILTRATION<br />
RATE AND CHANGES IN ULTRAFILTRATION RATE ARE ASSOCIATED<br />
WITH POORER OUTCOMES<br />
Paul Balter | Nancy Ginsberg | Patrice Taylor | Terry Sullivan | Len A Usvyat |<br />
Nathan W Levin | Peter Kotanko | Paul Zabetakis<br />
Renal Res Inst, New York, USA<br />
FP395<br />
GUIDED FLUID STATUS OPTIMIZATION IN HYPERHYDRATED CHRONIC<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
HD PATIENTS<br />
Ulrich Moissl | Manuela Ferrario | Francesco Garzotto | Peter Wabel | Dinna<br />
Cruz | Ciro Tetta | Maria Gabriella Signorini | Sergio Cerutti | Alessandra Brendolan<br />
| Claudio Ronco<br />
Fresenius Medical Care D GmbH | Politecnico Milano | Nephrology Dept, St.<br />
Bortolo Hosp, Vicenza. Italy<br />
FP396<br />
MULTIPASS HAEMODIALYSIS: A NOVEL DIALYSIS MODALTIY<br />
James Heaf | Mette Axelsen | Robert Smith Pedersen<br />
Univ Copenhagen, Herlev Hosp, Copenhagen, Denmark | Aarhus Univ, Aarhus,<br />
Denmark | Flexdiaysis ApS, Copenhagen, Denmark<br />
FP397<br />
PLASMA REFILLING DURING DIALYSIS<br />
Alayoud Ahmed | Hamzi Amine | Zouhir Oualim<br />
Serv Nephrology, Hemodialysis and Kidney Transpl, Military Hosp Instruction,<br />
Mohammed V. Rabat, Morocco<br />
FP398<br />
PRE AND POST DIALYSIS ECHOCARDIOGRAPHY PERFORMED BY A NE-<br />
PHROLOGIST. AN USEFUL TOOL FOR HEMODYNAMIC EVALUATION OF<br />
CHRONIC HEMODIALYSIS PATIENTS<br />
Adriano Luiz Ammirati | Nadia Karina Guimarães de Souza | Thais Nemoto<br />
Matsui | Marcelo Luiz Vieira | Wercules Antonio Alves de Oliveira | Cláudio<br />
Henrique Fischer | Fabiana Dias Carneiro | Ilson Jorge IIzuka | Marisa Aparecida<br />
de Souza | Ana Claudia Mallet | Maria Claudia Cruz Andreoli | Bento<br />
Fortunato Cardoso dos Santos<br />
Hosp Israelita Albert Einstein, São Paulo, Brazil<br />
FP399<br />
HEMODYNAMIC STABILITY DURING SORBENT-BASED DIALYSIS WITH<br />
THE 2008 SORBENT HEMODIALYSIS SYSTEM<br />
Laura Rosales | Yanna Dou | Mary Carter | Stephan Thijssen | Peter Kotanko<br />
Renal Res Inst; Beth Israel Medical Cener, New York, USA | Sustainable Kidney<br />
Care Foundation, New York, USA | Renal Res Inst, New York, USA<br />
FP400<br />
FREE LIGHT CHAIN CLEARANCE ON IMMUNE AND INFLAMMATORY<br />
RESPONSE IN CKD PATIENTS (FIREFLIES STUDY)<br />
Angelo Testa | Laura Sottini | Bruno Giacon | Elisabetta Prati | Carmelo Loschiavo<br />
| Mario Brognoli | Cosimo Marseglia | Adalberto Tommasi | Luisa<br />
Sereni | Giuseppe Palladino | Sergio Bove<br />
E.C.H.O. Nantes France | U.O. Nefrologia e Dialisi P.O. Montichiari | U.O. Nefrologia<br />
e Dialisi, Bolzano | Dialysis Center, Osp Desenzano | Nephrology and<br />
Dialysis Legnago (VR) Italy | U.O. Nefrologia e Dialisi, Manerbio | U.O. Nefrologia<br />
e Dialisi, Mantova | U.O. Nefrologia e Dialisi, Vimercate | Scientific Affairs<br />
Dept Bellco Mirandola<br />
FP401<br />
CALCIUM AND CITRATE MASS-BALANCES IN REGIONAL CITRATE ANTI-<br />
COAGULATION DIALYSIS FOR ACUTE KIDNEY INJURY<br />
Gianmario Bosticardo | Enrico Schillaci | Paolo Detoma | Roberto Bergia<br />
Nephrology Unit ASLBI, Biella, Italy | Lab Unit ASLBI - Biella<br />
FP402<br />
HEPARIN REDUCTION AND CLINICAL EFFICACY USING CITRATE-BASED<br />
DIALYSATE<br />
Jong Won Park | Sung Jin Moon | Hoon Young Choi | Sung Kyu Ha | Hyeong-<br />
Cheon Park<br />
Gangnam Severance Hosp, YUMC, Seoul, Korea | Myongji Hosp, Kwandong<br />
Univ College Medicine, Gyeonggido, Korea<br />
FP403<br />
SIMPLIFIED REGIONAL CITRATE ANTICOAGULATION USING A CAL-<br />
CIUM-CONTAINING REPLACEMENT SOLUTION FOR CONTINUOUS VE-<br />
NOVENOUS HEMOFILTRATION<br />
Yujie Liao | Ling Zhang | Ping Fu<br />
West China Hosp Sichuan Univ, Chengdu, China<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
161<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
162<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP404<br />
ETRF PERFORMANCE SUSTAINABILITY IN THE PREPARATION OF UL-<br />
TRAPURE DIALYSIS FLUID AND ON-LINE HDF IN THE CENTRAL DIALY-<br />
SIS FLUID DELIVERY SYSTEM<br />
Hiroyuki Igarashi | Norio Suzuki | Shiho Esashi | Ikuto Masakane<br />
Yabuki-shima Clinic<br />
FP405<br />
COMPARISON OF ON-LINE HDF MODES AUTOMATED TMP CONTROL VS.<br />
VOLUME CONTROL ON ACHIEVED CONVECTIVE VOLUME AND MIDDLE<br />
MOLECULE CLEARANCE<br />
Vincenzo Panichi | Giacomo De Ferrari | Stefano Saffiotti | Antonio Sidoti |<br />
Marina Biagioli | Stefano Bianchi | Patrizio Imperiali | Claudio Gabrielli | Paolo<br />
Conti | Pietro Patrone | Giuseppe Rombolà | Valeria Falqui | Carlo Mura | Andrea<br />
Icardi | Alberto Rosati | Francesco Santori | Antonio Mannarino | Andrea<br />
Bertucci | Denis Steckiph<br />
Versilia's Hosp | Nephrology and Dialysis, Univ Genova | Dialysis and Nephrology<br />
Unit, Alta Val d’Elsa Hosp | Dialysis and Nephrology Unit, San Donato<br />
Hosp | Dialysis and Nephrology Unit, della Misericordia Hosp | Dialysis and<br />
Nephrology Unit, Osp Civile Hosp | Dialysis and Nephrology Unit, S. Andrea<br />
Hosp | Dialysis and Nephrology Unit, S.Maria della Gruccia Hosp | Dialysis<br />
and Nephrology Unit, La Colletta Hosp | Dialysis and Nephrology Unit, Campo<br />
di Marte | Dialysis and Nephrology Unit, Osp Riuniti Val di Chiana Hosp |<br />
Dialysis and Nephrology Unit, San Giovanni di Dio Hosp | Gambro Hospal SpA<br />
FP406<br />
SAFETY AND EFFICACY OF ON-LINE HEMODIAFILTRATION; SEQUEN-<br />
TIAL INCREMENT METHOD OF REPLACEMENT FLUID<br />
Jimin Jeong | Ok Ki Kim | Nam Ho Kim<br />
Chonnam National Univ Hosp<br />
FP407<br />
THE EFFECT OF ONLINE HEMODIAFILTRATION ON SYSTEMIC INFLAM-<br />
MATION IN A RANDOMIZED CONTROLLED TRIAL: RESULTS FROM THE<br />
CONVECTIVE TRANSPORT STUDY (CONTRAST)<br />
ML Bots | Claire den Hoedt | Muriel PC Grooteman | Neelke C. van der Weerd|<br />
Albert H.A. Mazairac | Renée Lévesque | Pieter M. ter Wee | Menso J. Nubé | PJ<br />
Blankestijn | Marinus A van den Dorpel<br />
Univ Medical Center Utrecht | VU Medical Center, Amsterdam | St. Luc Hosp,<br />
Montréal, Canada | Maasstad Hosp, Rotterdam<br />
FP408<br />
DIALYSATE CONSUMPTION AND DIALYSIS DOSE IN ON-LINE HEMODIA-<br />
FILTRATION WITH AUTOMATED COUPLING DIALYSATE/BLOOD FLOW<br />
FUNCTION (AUTOFLOW FUNCTION)<br />
Yongki Park | Jimin Jeon<br />
Dongrae BongSaeng Hosp<br />
FP409<br />
EFFECT OF A SINGLE HEMODIALYSIS SESSION BY HFR AND LOW-FLUX<br />
BICARBONATE DIALYSIS ON SERUM HEPCIDIN-25 LEVELS: A RANDOMI-<br />
ZED CROSS-OVER STUDY<br />
Nicola Tessitore | Valeria Bedogna | Domenico Girelli | Luca Corazza<br />
Nephrology and Dialysis dpt., Borgo Roma Univ Hosp, Verona, Italy | Internal<br />
Medicine B dpt., Borgo Roma Univ Hosp, Verona, Italy | Bellco srl<br />
FP410<br />
INSTRUCTION FOR USE OF DIALYZERS IN POST DILUTION ON LINE HE-<br />
MODIAFILTRATION<br />
Potier Jacky | Queffeulou Guillaume | Bouet Julien<br />
CHPC Cherbourg France<br />
FP411<br />
THE RESULTS OF MULTICENTER STUDY COMPARING EFFECTS OF DIF-<br />
FERENT RENAL REPLACEMENT TH<strong>ERA</strong>PY MODALITIES (ONLINE HEMO-<br />
DIAFILTRATION VS. LOW-FLUX HEMODIALYSIS)<br />
Wojciech Marcinkowski | Maciej Drozdz | Andrzej Milkowski | Teresa<br />
Rydzynska | Tomasz Prystacki | Ryszard August | Ewa Benedyk-Lorens |<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Katarzyna Bladek | Jan Cina | Grazyna Janiszewska | Andrzej Kaczmarek |<br />
Teresa Lewinska | Malgorzata Mendel | Mariusz Paszkot | Ewa Trafidlo | Malgorzata<br />
Trzciniecka-Kloczkowska<br />
Fresenius Nephrocare Polska, Poland<br />
FP412<br />
ON-LINE MONITORING OF URIC ACID CONCENTRATION IN SPENT<br />
DIALYSATE DURING HEMODIALYSIS ACCOMPANIED BY GRADD PHYSI-<br />
CAL EXERCISES WITH THE BISPECTRAL OPTICAL SENSOR<br />
Aleksandr Vasilevsky | Georgy Konoplev | Oksana Lopatenko | Artemy Komashnya<br />
| Konstantin Visnevsky | Roman Gerasimchuk | Indrek Neivelt |<br />
Aleksandr Frorip<br />
St. Petersburg Electrotechnical Univ, St. Petersburg, Russia | St. Petersburg Pavlov<br />
State Medical Univ, St. Petersburg, Russia | Mariinsky Hosp, St. Petersburg,<br />
Russia | LDIAMON AS, Tallinn, Estonia<br />
FP413<br />
LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN HAEMODIALYSIS<br />
PATIENTS AND ITS RELATION TO THEIR PROGNOSIS AND OTHER RISK<br />
FACTORS OF CARDIOVASCULAR DISEASES<br />
Michal Vostrý | Jaroslav Racek | Daniel Rajdl | Jaromír Eiselt | Lada Malánová<br />
Fac Hosp, Pilsen, Czech Republic | Dialysis Centre B. Braun Avitum, Pilsen,<br />
Czech Republic<br />
FP414<br />
EPIDEMIOLOGY PROFILE AND SURVIVAL OF RENAL REPLACEMENT<br />
TH<strong>ERA</strong>PY PATIENTS<br />
Ülle Pechter | Anne Selart | Mai Ots-Rosenberg<br />
Tartu Univ<br />
FP415<br />
PLATELET ACTIVATION DURING HEMODIALYSIS AND HEMODIAFIL-<br />
TRATION WITH E-BEAM STERILIZED POLYETHERSULFONE DIALYZERS<br />
Detlef H. Krieter | Sebastian Seidel | Karin Merget | Horst-Dieter Lemke | Christoph<br />
Wanner<br />
Univ Würzburg, Dept Medicine, Div Nephrology, Würzburg, Germany | EXcor-<br />
Lab GmbH, Obernburg, Germany<br />
FP416<br />
BISPHENOL A IN CHRONIC KIDNEY DIESEASE<br />
Detlef H. Krieter | Bernard Canaud | Horst-Dieter Lemke | Annie Rodriguez|<br />
Andreas Morgenroth | Kai von Appen | Gerd-Peter Dragoun | Christoph Wanner<br />
Univ Würzburg, Dept Medicine, Div Nephrology, Würzburg, Germany | Univ<br />
Montpellier, Hôp Lapeyronie, Dept Nephrology, Montpellier, France | Membrana<br />
GmbH, R & D, Wuppertal, Germany | Dialysis Center, Elsenfeld, Germany|<br />
Hamburger Dialyse Lohbrügge, Hamburg, Germany | KfH Center, Aschaffenburg,<br />
Germany<br />
FP417<br />
NEPHROLOGISTS’ PERSPECTIVES ON DIALYSIS TREATMENT: RESULTS OF<br />
AN INTERNATIONAL SURVEY<br />
Richard Fluck | Denis Fouque | Robert Lockridge<br />
Royal Derby Hosp, Derby, UK | Hôp Edouard Herriot, Lyon, France | Univ<br />
Virginia Health System, Charlottesville, Virginia, USA<br />
FP418<br />
A CONFORMATIONAL CHANGE OF AN INTERMEDIATE ß2-MICROGLO-<br />
BULIN ASSOCIATED WITH HAEMODIALYSIS<br />
Yoshihiro Motomiya | Yoshinori Uji | Tadashi Hiramatsu | Yukio Ando<br />
Suiyukai Clinic | Toyama Univ Hosp | Grad School Medical Sciences, Kumamoto<br />
Univ<br />
FP419<br />
THE SYNERGY EFFECT ON INFLAMMATORY CYTOKINES OF ADSORBENT<br />
COLUMN FOR Β2-MICROGLOBULIN AND AN69 MEMBRANE<br />
Minoru Furuta | Takahiro Kuragano | Aritohi Kida | Mana Yahiro | Yoshinaga<br />
Otaki | Yukiko Hasuike | Hiroshi Nonoguchi | Takeshi Nakanishi<br />
Hyogo College Medicine<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
163<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
164<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP420<br />
WHAT ARE THE LOWEST DOSES OF LOW MOLECULAR WEIGHT HEPA-<br />
RIN IN DIFFERENT SUBGROUPS OF HD PATIENTS?<br />
Milenka Sain | Vedran Kovacic | Dragan Ljutic | Josipa Radic | Ivo Jelicic<br />
Dept Nephrology and Dialysis, Univ Split School Medicine, Split, Croatia | Univ<br />
Hosp Split<br />
FP421<br />
FACTORS ASSOCIATED WITH MORTALITY IN PATIENTS UNDERWENT<br />
EMERGENCY HEMODIALYSIS<br />
Serkan Feyyaz Yalın | Sinan Trabulus | Ayşe Serap Yalın | Mehmet Rıza<br />
Altıparmak | Kamil Serdengeçti<br />
Istanbul Univ Cerrahpaşa Medical Fac Dept Internal Medicine Nephrology Unit,<br />
Istanbul, Turkey<br />
FP422<br />
DIFFERENTIAL EFFECTS OF POLYSULFONE MEMBRANE DIALYZER ON<br />
BIO-INCOMPATIBILITY AND HMGB-1-SRAGE SYSTEM IN HEMODIALYSIS<br />
PATIENTS<br />
Aki Ohtsuka | Kei Fukami | Kazuhiro Ishikawa | Ryotaro Ando | Yusuke Kaida|<br />
Takeki Adachi | Kenzo Sugi | Seiya Okuda<br />
Sugi Cardiovascular Medicine Hosp | Div Nephrology, Dept Medicine, Kurume<br />
Univ School Medicine<br />
FP423<br />
THE FIRST EXPERIENCE OF HEMODIALYSIS WITH SUCCINATE-CONTAI-<br />
NING DIALYSIS FLUID: A CROSS-OVER STUDY<br />
Oxana Borisovna Nesterova | Elena Dmitrievna Suglobova | Roman Vladimirovitch<br />
Golubev | Alexandr Nicolaevitch Vasiliev | Valentina Alexandrovna<br />
Lazeba | Alexej Vladimirivitch Smirnov<br />
St Petersburg Pavlov State Medical Univ | NPO Nephron, St Petersburg, Russia<br />
FP424<br />
A SUPER HIGH-FLUX DIALYZER (PS: APS-EA) ELIMINATES 40% OF IN-<br />
JECTED RECOMBINANT HUMAN (rh) ERITHROPOIETIN (EPO) DURING<br />
4-HOUR HEMODIALYSIS (HD)<br />
Kazuko Arita | Emi Kihara | Katsutoshi Maeda | Hiroaki Oda | Shigehiro Doi|<br />
Takao Masaki<br />
Oda Medical Clinic, Hiroshima, Japan | Hiroshima Univ Hosp | Dept Nephrology,<br />
Hiroshima Univ Hosp, Hiroshima, Japan<br />
FP425<br />
DIFFERENCES IN BIOCOMPATIBILITY EXERTED ON ENDOTHELIAL FUN-<br />
CTION BY DIFFERENT TYPES OF POLYSULFONE HEMODIALYSIS MEM-<br />
BRANE<br />
Sumi Hidaka | Kunihiro Ishioka | Machiko Oka | Hidekazu Moriya | Takayasu<br />
Ohtake | Shosaku Nomura | Shuzo Kobayashi<br />
Dept Nephrology, Immunology, and Vascular Medicine Shonan Kamakura General<br />
Hosp, Kamakura, Japan | First Dept Internal Medicine, Kansai Medical<br />
Univ, Moriguchi, Japan<br />
FP426<br />
INCREASED REMOVAL OF SMALL AND MIDDLE MOLECULES BY USE OF<br />
MEMBRANES WITH LARGER SURFACE AND HIGHER ULTRAFILTRATION<br />
COEFFICIENT<br />
Stephan Wagner | Andreas Gmerek | Juergen Wagner | Volker Wizemann<br />
Georg-Haas Dialysezentrum, Gießen, Germany | B. Braun Avitum AG, Melsungen,<br />
Germany<br />
FP427<br />
IMPACT OF LOW-CALCIUM DIALYSATE ON THE LENGTH OF QT INTER-<br />
VAL DURING HEMODIALYSIS SESSION<br />
Natasha Eftimovska-Otovic | Katerina Spaseska-Gjurovska | Sudanka Bogdanovska<br />
| Elena Babalj-Banskolieva | Maja Milovanceva | Risto Grozdanovski<br />
Dialysis Center Diamed, Skopje, Macedonia<br />
FP428<br />
PROTECTIV EFFECTS OF A NEW ISOFORM OF HUMAN RECOMBINANT<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
MNSOD ON HAEMODIALYSIS-INDUCED REACTIVE OXYGEN SPECIES<br />
AND PRO-INFLAMMATORY CYTOKINES<br />
Antonio Pisani | Eleonora Riccio | Aldo Mancini<br />
Chair Nephrology Univ Naples | Molecular Biology & Viral Oncogenesis Dept<br />
National Cancer<br />
FP429<br />
KLOTHO AS A PROGNOSTIC MARKER IN PATIENTS ON MAINTENANCE<br />
HEMODIALYSIS<br />
Patrice Ambühl | Starke Astrid | Pavik Ivana | Hersberger Martin | Kistler Thomas<br />
| Räz Hans-Rudolf | Aerne Daniel | Kiss Denes | Miozzari Marco | Rudolf<br />
P. Wüthrich | Serra Andreas<br />
Renal Div, Stadtspital Waid Zurich, Switzerland | Renal Div, Univ Hosp, Zurich,<br />
Switzerland | Clinical Chemistry, Children's Univ Hosp, Zurich, Switzerland |<br />
Renal Div, Kantonsspital, Winterthur, Switzerland | Renal Div, Kantonsspital,<br />
Baden, Switzerland | Renal Div, Spital Lachen, Switzerland | Renal Div, Kantonsspital,<br />
Liestal, Switzerland | Renal Div, Kantonsspital, Schaffhausen, Switzerland<br />
| Div Nephrology | Renal Div, Univ Hosp, Zurich<br />
FP430<br />
PREDICTORS OF HAEMOGLOBIN LEVELS AND RESISTANCE TO<br />
ERYTHROPOIESIS-STIMULATING AGENTS IN PATIENTS TREATED WITH<br />
LOW FLUX HEMODIALYSIS, HEMOFILTRATION AND HEMODIAFILTRA-<br />
TION: RESULTS OF A MULTICENTRE, RANDOMIZED AND CONTROLLED<br />
TRIAL<br />
Simeone Andrulli | Paolo Altieri | Giovanna Sau | Piergiorgio Bolasco | Luciano<br />
Alberto Pedrini | Carlo Basile | Salvatore David | Mariano Feriani | Pier<br />
Eugenio Nebiolo | Rocco Ferrara | Domenica Casu | Francesco Logias | Renzo<br />
Tarchini | Francesco Cadinu | Mario Passaghe | Gianfranco Fundoni | Giuseppe<br />
Villa | Biagio Raffaele Di Iorio | Carmine Zoccali | Francesco Locatelli<br />
A. Manzoni Hosp, Lecco, Italy | Azienda Osp G. Brotzu, Cagliari, Italy| Dip<br />
Territoriale ASL 8, Cagliari, Italy | Osp Bolognini, Seriate, Italy | Osp F. Miulli,<br />
Acquaviva delle Fonti, Italy | Osp Maggiore, Parma, Italy | Osp dell'Angelo,<br />
Mestre, Italy | Osp Regionale Aosta, Italy | Osp SS. Trinità ASL 8, Cagliari, Italy|<br />
Osp Civile, Alghero, Italy | Osp San Camillo, Sorgono, Italy | Azienda Osp Carlo<br />
Poma, Mantova, Italy | Osp S. Francesco, Nuoro, Italy | ASL 2 Olbia - P.O. P.<br />
Dettori, Tempio Pausania, Italy | Osp S. Giovanni di Dio, Olbia, Italy | Fond<br />
Maugeri IRCCS, Pavia, Italy | Osp Agostino Landolfi, Solofra, Italy | Azienda<br />
Osp Bianchi Melacrino Morelli Reggio Calabria, Italy | Azienda Osp Provincia<br />
Lecco, Osp Alessandro Manzoni Lecco, Italy<br />
FP431<br />
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) HETE-<br />
RODIMERS REDUCE SERUM LDL-CHOLESTEROL (LDL-C) LEVELS IN<br />
MAINTENANCE HEMODIALYSIS (HD) PATIENTS ASSOCIATED WITH<br />
DYSLIPIDEMIA CHARACTERIZED BY INCREASED TRIGLYCERIDE-RICH<br />
LIPOPROTEINS<br />
Emi Kihara | Kazuko Arita | Misuzu Hamamoto | Katsutoshi Maeda | Hiroaki<br />
Oda | Shigehiro Doi | Takao Masaki<br />
Oda Medical Clinic, Hiroshima, Japan | Dept Nephrology, Hiroshima Univ Hosp<br />
FP432<br />
THE EFFECT OF LOWERING DIALYSATE SODIUM CONCENTRATION ON<br />
THE INTERDIALYTIC WEIGHT GAIN AND BLOOD PRESSURE IN ANURIC<br />
HEMODIALYSIS PATIENTS<br />
Dong-Young Lee | Beom Kim | Kyoung Hyoub Moon<br />
Seoul Veteran Hosp, Seoul, Korea<br />
FP433<br />
EFFECT OF ELEVATING CALCIUM CONCENTRATION OF DIALYSATE TO<br />
TREAT INTRA-DIALYTIC HYPOTENSION: A CROSS-OVER SELF-CONTROL<br />
TRIAL<br />
Zi Li | Ping Fu<br />
West China Hosp, Sichuan Univ<br />
FP434<br />
HEPARIN REDUCTION AND IMPROVED BIOCOMPATIBILITY USING CI-<br />
TRATE ENRICHED DIALYSATE IN HIGH FLUX DIALYSIS<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
165<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
166<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Peter Ahrenholz | Roland E. Winkler | Grit Waitz | Hartmut Wolf<br />
BioArtProducts GmbH, Rostock, Germany | Praxisverbund Dialyse und Apherese,<br />
Rostock, Germany | Biomedical Consulting, Hohen Neuendorf, Germany<br />
FP435<br />
IMPROVED ACID-BASE STATUS BY A NOVEL SAFE CITRATE CONTAI-<br />
NING ACETATE-FREE HEMODIALYSIS FLUID<br />
Gunilla Grundström | Maria Alquist | Madeleine Holmquist | Anders Christensson<br />
| Peter Björk | Mohamed AbdGawad | Lars Ekholm | Mårten Segelmark<br />
Gambro Res, Lund, Sweden | Gambro Medical Safety Office, Lund, Sweden |<br />
Skåne Univ Hosp, Malmoe, Sweden | Skåne Univ Hosp, Malmoe, Sweden | Skåne<br />
Univ Hosp, Lund, Sweden | Ljungby Hosp, Ljungby, Sweden | Dept Medicine<br />
and Health, Linköping Univ, Sweden<br />
FP436<br />
A NOVEL METHOD FOR NONINVASIVE BLOOD POTASSIUM ASSESSE-<br />
MENT DURING HEMODIALYSIS<br />
Cristiana Corsi | Johan De Bie | Emanuele Mambelli | David Mortara | Antonio<br />
Santoro | Stefano Severi<br />
Univ Bologna, Cesena, Italy | Mortara Instrument Inc, Milwaukee, USA | Malpighi<br />
Hosp, Bologna, Italy<br />
FP437<br />
POLYMYXIN B HEMOPERFUSION FOR THE TREATMENT OF SEVERE SEP-<br />
TIC SHOCK<br />
David Arroyo | Nayara Panizo | Borja Quiroga | Javier Reque | Rosa Melero|<br />
Marisa Rodriguez-Ferrero | Patrocinio Rodriguez-Benitez | Fernando Anaya |<br />
Jose Luno<br />
Hosp General Univ Gregorio Maranon, Madrid, Spain<br />
FP438<br />
MICROBIOLOGICAL QUALITY CONTROL OF DIALYSIS FLUIDS FOR ON-<br />
LINE HEMODIAFILTRATION: 4 YEARS EXPERIENCE IN A PUBLIC HOSP<br />
DIALYSIS UNIT<br />
Alain Ragon | Anthony James | Philippe Brunet<br />
Lab Pôle Uro-Néphrologie | Serv Hémodialyse - Pôle Uro-Néphrologie<br />
FP439<br />
ERYTHROCYTE MEMBRANE PROTEIN COMPOSITION AND BAND 3 PRO-<br />
FILE IN CHRONIC KIDNEY DISEASE PATIENTS UNDER ON-LINE HEMO-<br />
DIAFILTRATION<br />
Sandra Ribeiro | M. Sameiro Faria | S. Rocha | S. Rodrigues | C. Catarino | F.<br />
Reis | H. Nascimento | J. Fernandes | V. Miranda | A. Quintanilha | L. Belo |<br />
E. Costa | A. Santos-Silva<br />
Fac Farmácia, Univ Porto; Inst Biologia Molecular e Celular (IBMC) | FMC, Dinefro<br />
– Diálises e Nefrologia, SA; Inst Ciências Biomédicas Abel Salazar, Univ<br />
Porto | Inst Farmacologia e Terapêutica Experimental, IBILI, Fac Medicina, Univ<br />
Coimbra | Fac Farmácia, Univ Porto; Inst Farmacologia e Terapêutica Experimental,<br />
IBILI, Fac Medicina, Univ Coimbra | FMC, Dinefro – Diálises e Nefrologia,<br />
SA | Inst Biologia Molecular e Celular (IBMC), Univ Porto; Inst Ciências<br />
Biomédicas Abel Salazar| Inst Biologia Molecular e Celular (IBMC), Univ Porto;<br />
Inst Ciências Saúde Univ Católica Portuguesa<br />
FP440<br />
IMPACT OF PARACETAMOL ON OPTICAL ON-LINE DIALYSIS MONITO-<br />
RING AND ON URICEMIA<br />
Jürgen Arund | Risto Tanner | Ivo Fridolin | Merike Luman<br />
Inst Biomedical Engineering Technomedicum Tallinn Univ Technology | Tallinn<br />
Univ Technology | North-Estonian Medical Centre, Tallinn, Estonia<br />
FP441<br />
PROSPECTIVE LONGITUDINAL EVALUATION OF IN-CENTER CONVER-<br />
SION FROM CONVENTIONAL TO INTENSIFIED NOCTURNAL HEMO-<br />
DIALYSIS<br />
Christian Clajus | Jan T Kielstein | Hermann Haller | Sascha David<br />
Medical School Hannover, Nephrology<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP442<br />
SODIUM SETPOINT AND SODIUM GRADIENT IN BICARBONATE HAEMO-<br />
DIALYSIS<br />
Carlo Basile | Pasquale Libutti | Piero Lisi | Luigi Vernaglione | Francesco Casucci<br />
| Nicola Losurdo | Annalisa Teutonico | Carlo Lomonte<br />
Miulli General Hosp Acquaviva delle Fonti Italy | Giannuzzi Hosp Manduria<br />
Italy<br />
FP443<br />
MUDPIT ANALYSIS AS A PROTEOMIC TOOL FOR NOVEL POTENTIAL<br />
UREMIC TOXIN IDENTIFICATION IN HAEMODIALYSIS FILTRATES<br />
Christoph Krisp | Andreas Gmerek | Juergen Wagner | Dirk A. Wolters | Luciano<br />
A. Pedrini<br />
Analytical Chemistry, Ruhr Univ Bochum, Bochum, Germany | B. Braun Avitum<br />
AG, Melsungen, Germany | Nephrology and Dialysis Unit, Bolognini Hosp,<br />
Seriate, Italy<br />
FP444<br />
BLOOD CONTACT CHARACTERISTICS OF SYNTHETIC DIALYSIS MEM-<br />
BRANE<br />
Makoto Matsuyama | Kaede Ishida | Kazuhiro Matsuyama | Takeshi Nakata|<br />
Junichi Kadota<br />
Oita Univ, Fac Medicine, Dept Internal Medicine, Yufu-city, Oita-Pref, Japan<br />
FP445<br />
STEPS STUDY: SUPERHIGHFLUX TH<strong>ERA</strong>PIES FOR HEMODIALYSIS. A PRO-<br />
TEOMIC APPROACH<br />
Marialuisa Caiazzo | Emanuela Monari | Aurora Cuoghi | Elisa Bellei | Stefania<br />
Bergamini | Giuseppe Palladino | Aldo Tomasi<br />
Univ Modena and Reggio Emilia, Modena, Italy | Scientifc Affairs, Bellco, Mirandola,<br />
Italy<br />
FP446<br />
IMPROVEMENT OF THE REMOVAL OF MEDIUM-SIZED MOLECULES IN<br />
PRE-DILUTIONAL HEMODIAFILTRATION BY THE USE OF A VERY HIGH<br />
PERMEABILITY DIALYZER: STUDY ON 16 PATIENTS<br />
Thierry Baranger | Piotr Seniuta | Frank Berge | Valerie Drouillat | Carlos Frangie<br />
| Emmanuelle Rosier<br />
PBNA<br />
FP447<br />
PULMONARY HYPERTENSION IN PATIENTS UNDERGOING HEMO-<br />
DIALYSIS<br />
Walter Labonia | Adrián Lescano | Débora Rubio<br />
Diaverum Paternal, Buenos Aires, Argentina | Hosp Santojanni, Buenos Aires,<br />
Argentina<br />
FP448<br />
GENDER DIFFERENCES IN HRQOL IN PATIENTS RESUMING DIALYSIS AF-<br />
TER GRAFT LOSS<br />
Nanna von der Lippe | Jakob Anker Jørgensen | Tone Brit Østhus | Bård Waldum<br />
| Ingrid Os<br />
Oslo Univ Hosp Ullevål<br />
FP449<br />
QUALITIES OF FATIGUE IN CHRONIC HEMODIALYSIS PATIENTS<br />
Maurizio Bossola | Enrico Di Stasio | Manuela Antocicco | Luigi Tazza<br />
Catholic Univ<br />
FP450<br />
HEAT-SHOCK PROTEIN 27 KINETICS IN END STAGE RENAL DISEASE PA-<br />
TIENTS<br />
Ioannis Griveas | Andreas Karameris | Ploumis Pasadakis<br />
401 Army Hosp Athens | 417 Veterans Army Hosp Athens | Thrace Univ Medical<br />
School<br />
FP451<br />
INCREASED LEVELS OF INTERLEUKIN-22 IN END STAGE RENAL DISEASE<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
167<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
168<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
AND PATIENTS AND ROLE OF DIALYSIS<br />
Vincenzo Savica | Domenico Santoro | Salvatore Saitta | Valeria Tigano | Guido<br />
Bellinghieri | Sebastiano Gangemi<br />
Unit Nephrology and Dialysis, Univ Messina | Unit Allergy and Clinical Immunology,<br />
Univ Messina<br />
FP452<br />
COMPARISSON BETWEEN HEMODIALYSIS AND PERITONEAL DIALYSIS<br />
IN ELDERLY PATIENTS<br />
Radulescu Daniela | Ionel Alexandru Checherita | Alexandru Ciocalteu | Ileana<br />
Adela Vacaroiu | Andrei Niculae<br />
Saint John Emergency Hosp, Bucharest, Romania | Carol Davila Medicine Univ,<br />
Bucharest, Romania<br />
FP453<br />
BODY COMPOSITION MONITORING TO ADJUST DRY WEIGHT IN ON-LI-<br />
NE HEMODIAFILTRATION PATIENTS<br />
Katarzyna Błądek | Ewa Stefaniak| Irena Pietrzak | Dariusz Krupa<br />
FNC Poznań Poland | Fresenius Nephrocare<br />
FP454<br />
CLINICAL VALIDATION OF A MATHEMATICAL MODEL OF CONVEC-<br />
TION IN MID-DILUTION HEMODIAFLTRATION<br />
Laurie Garred | Antonio Santoro | Elena Mancini | Luca Corrazza | Mauro Atti<br />
Lakehead Univ | Malpighi Hosp, Bologna, Italy | Bellco S.r.l., Mirandola, Italy<br />
FP455<br />
SOCIODEMOGRAPHIC, CLINICAL AND LAB PARAMETERS RELATED<br />
WITH PRESENCE OF REGULAR TOOTH BRUSHING IN HEMODIALYSIS<br />
PATIENTS<br />
Baris Afsar<br />
Konya Numune State Hosp<br />
FP456<br />
CRYSTALLIZATION OF ELECTROLYTES OF THE REPLACEMENT MEDIUM<br />
AT THE PERIPHERY OF RED BLOOD CELLS IN TH<strong>ERA</strong>PEUTIC PLASMA<br />
EXCHANGE: AN INVESTIGATION WITH SCANNING-ELECTRON AND<br />
ATOMIC-FORCE MICROSCOPES<br />
Dimosthenis Stamopoulos | Nerantzoula Mpakirtzi | Basiliki Gogola | Manos<br />
Zeibekis | Dora Stivarou | Maria Panagiotou | Eirini Grapsa<br />
Inst Materials Science, National Center Scientific Res Demokritos, Athens, Greece|<br />
Dept Nephrology, National Hosp Athens G. Gennimatas | Dept Experimental<br />
Pathology and Oncology, Univ Florence | Dept Nephrology, General Hosp<br />
Athens Alexandras, Athens, Greece<br />
FP457<br />
EFFECTS OF A REDUCED INNER DIAMETER OF HOLLOW FIBERS IN<br />
DIALYZERS IN ON-LINE HEMODIAFILTRATION<br />
Olynka Vega Vega | Daniel Barraca Nuñez | Soraya Abad Esttebanez | Laura<br />
Bucalo | Claudia Yuste | Juan Manuel López-Gómez<br />
National Inst Nutrition. Mexico, Mexico | Hosp General Univ Gregorio Marañón<br />
FP458<br />
MEGESTROL ACETATE AS A TREATMENT FOR UREMIC ANOREXIA:<br />
ANALYSIS OF BODY COMPOSITION BY BIOELECTRICAL IMPEDANCE<br />
Milagros Fernández-Lucas | Antonio Gomis | José Luis Teruel | Sandra Elías|<br />
Carlos Quereda<br />
Hosp Ramón y Cajal, Madrid, Spain<br />
FP459<br />
HAEMODIALYSIS: DIALYSIS TO LIVE RATHER THAN LIVING TO DIALYSE.<br />
UK EXPERIENCE WITH THE NX STAGE SYSTEM ONE<br />
Laura Hignell | Sheila Humphrey | Nicola Pacy<br />
Wessex Renal and Transpl Serv<br />
FP460<br />
EXTRACORPOREAL BLOOD CIRCULATION TH<strong>ERA</strong>PIES: A COMPARATIVE<br />
STUDY ON RED BLOOD CELLS OF HAEMODIALYSIS PATIENTS, TH<strong>ERA</strong>-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
PEUTIC PLASMA EXCHANGE PATIENTS AND HEALTHY DONORS WITH<br />
ADVANCED MICROSCOPES<br />
Dimosthenis Stamopoulos | Nerantzoula Mpakirtzi | Nikolaos Afentakis | Eirini<br />
Grapsa<br />
Inst Materials Science, National Center Scientific Res Demokritos, Athens, Greece|<br />
Dept Nephrology, National Hosp Athens G. Gennimatas | Dept Nephrology,<br />
General Hosp Athens G. Gennimatas, Athens, Greece | Dept Nephrology,<br />
General Hosp Athens Aretaieion, Athens, Greece<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
169<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
170<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
CARDIOVASCULAR COMPLICATIONS<br />
IN CKD 5D<br />
FP461<br />
CHRONIC PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED WITH<br />
AN INCREASED RISK OF VASCULAR CALCIFICATIONS IN CHRONIC KID-<br />
NEY DISEASE<br />
Maria Fusaro | Marianna Noale | Giovanni Tripepi | Angela D'Angelo | Davide<br />
Miozzo | Maurizio Gallieni | PPI-VC (Protein Pump Inhibitors – Vascular<br />
Calcification) Study Group<br />
Consiglio Nazionale delle Ricerche (CNR) - Inst Neuroscience, Aging Section,<br />
Padua, Italy | Clinical Epidemiology and Physiopathology of Renal Diseases and<br />
Hypertension, CNR - Ist Biometeorologia, Reggio Calabria, Italy | Nephrology<br />
Unit, Univ Padua, Italy<br />
FP462<br />
INFLAMMATION AND SERUM FETUIN-A LEVELS ARE ASSOCIATED WITH<br />
CARDIOVASCULAR CALCIFICATIONS IN CHRONIC HEMODIALYSIS PA-<br />
TIENTS<br />
Mzia Tsamelesvili | Chrysostomos Dimitriadis | Aikaterini Papagianni | Christos<br />
Raidis | Georgios Efstratiadis | Dimitrios Memmos<br />
Dept Nephrology, Hippokration General Hosp, Thessaloniki, Greece<br />
FP463<br />
ASSOCIATIONS BETWEEN OSTEOPONTIN, INTERLEUKIN-6 AND HOMO-<br />
CYSTEIN LEVELS AND MALNUTRITION, CALCIFICATION AND CAROTID<br />
INTIMA-MEDIA THICKNESS IN DIALYSIS PATIENTS<br />
Ruya Mutluay | Ceyla Konca Degertekin | Ülver Derici | Serpil Müge Değer|<br />
Ferda Akkıyal | Serap Gültekin | Sevim Gönen | Gülten Taçoy | Turgay<br />
Arınsoy | Şükrü Sindel<br />
Gazi Univ Fac Medicine, Dept Nephrology, Ankara, Turkey | Gazi Univ Fac Medicine,<br />
Dept Endocrinology, Ankara, Turkey | Gazi Univ Fac Medicine, Dept<br />
Radiology, Ankara, Turkey | Gazi Univ Fac Medicine, Dept Cardiology, Ankara,<br />
Turkey<br />
FP464<br />
VALVULAR CALCIFICATION PREDICTS ATRIAL FIBRILLATION ON<br />
CHRONIC DIALYSIS PATIENTS<br />
Carmen Sánchez-Perales | Eduardo Vázquez | Enoc Merino | Pilar Pérez del<br />
Barrio | Francisco José Borrego | M. José Borrego | Antonio Liébana<br />
Serv Cardiología, C.H Jaén | Serv Nefrología, C.H. Jaén<br />
FP465<br />
CALCIUM SCORING (CASC) AS A LONG TERM PREDICTOR OF CARDIO-<br />
VASCULAR MORTALITY IN A POPULATION OF DIALYSIS PATIENTS<br />
Marcin Krzanowski | Katarzyna Janda | Paulina Dumnicka | Andrzej Kraśniak|<br />
Władysław Sułowicz<br />
Chair and Dept Nephrology Clinic, Jagiellonian Univ Collegium Medicum, Cracow<br />
| Dept Medical Diagnostics, Jagiellonian Univ Collegium Medicum, Cracow<br />
FP466<br />
RADIAL ARTERY MICRO-CALCIFICATION IS ASSOCIATED WITH CORO-<br />
NARY ARTERY CALCIUM SCORE IN HEMODIALYSIS PATIENTS<br />
Young-Ok Kim | Sun-Ae Yoon | Yu-Seon Yun | Ho-Cheol Song | Byung-Soo<br />
Kim | Myeong A Cheong<br />
Uijeongbu St. Mary's Hosp, Catholic Univ Korea | Bucheon St. Mary's Hosp,<br />
Catholic Univ Korea | St. Paul's Hosp, Catholic Univ Korea | Korean Cancer<br />
Center Hosp<br />
FP467<br />
A NANOPARTICLE-BASED SERUM TEST MEASURING OV<strong>ERA</strong>LL CALCIFI-<br />
CATION INHIBITION<br />
Andreas Pasch | Stefan Farese | Jürgen Floege | Willi Jahnen-Dechent<br />
Univ Hosp Bern, Bern, Switzerland | RWTH Univ Aachen, Aachen, Germany<br />
FP468<br />
LANTHANUM CARBONATE DELAYS THE PROGRESSION OF CORONARY<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
ARTERY CALCIFICATION COMPARED WITH CALCIUM-BASED PHOSPHA-<br />
TE BINDER IN PATIENTS ON HEMODIALYSIS<br />
Takayasu Ohtake | Rei Furuya | Masao Iwagami | Daimu Tsutsumi | Yasuhiro<br />
Mochida | Kunihiro Ishioka | Machiko Oka | Kyoko Maesato | Hidekazu Moriya<br />
| Sumi Hidaka | Shuzo Kobayashi<br />
Shonan Kamakura General Hosp<br />
FP469<br />
DETERMINANTS OF VALVULAR CALCIFICATIONS IN PREVALENT HE-<br />
MODIALYSIS PATIENTS<br />
Anabela Guedes | Ana Pinho | André Fragoso | Andreia Cruz | Patrícia Mendes<br />
| Elsa Morgado | Isilda Bexiga | Ana Paula Silva | Pedro Neves<br />
Nephrocare, Faro, Portugal<br />
FP470<br />
THE DIFFERENCES IN THE RISK FACTORS FOR PROGRESSIVE CALCIFICA-<br />
TION OF CORONARY ARTERY, AORTIC VALVE AND MITRAL ANNULUS<br />
Nobuyuki Oyake | Keiko Suzuki | Saki Itoh | Shozo Yano<br />
Otsuka Clinic | Shimane Univ Fac Medicine<br />
FP471<br />
THE RELATIONSHIP BETWEEN BONE MIN<strong>ERA</strong>L DENSITOMETRY AND<br />
VASCULAR CALCIFICATION IN PATIENTS WITH END-STAGE RENAL DI-<br />
SEASE<br />
Kultigin Turkmen | Hatice Kayikcioglu | Orhan Ozbek | Mustafa Saglam |<br />
Aysun Toker | Halil Zeki Tonbul<br />
Konya Univ, Meram School Medicine, Konya, Turkey | Konya Univ, Dept Biochemistry,<br />
Konya, Turkey<br />
FP472<br />
THE RELATIONSHIP BETWEEN CARDIAC VALVЕ CALCIFICATION PRE-<br />
SENCE AND QT INTERVAL (ECG) PROLONGATION IN HEMODIALYSIS<br />
PATIENTS<br />
Saso Gelev | Lada Trajceska | Elizabeta Srbinovska | Svetlana Pavleska | Vili<br />
Amitov | Gjulsen Selim | Pavlina Dzekova | Aleksandar Sikole<br />
Univ Clinic Nephrology, Skopje, FYR Macedonia | Univ Clinic Cardiology,<br />
Skopje, FYR Macedonia<br />
FP473<br />
DO CORONARY CALCIFICATIONS PREDICT CARDIOVASCULAR EVENTS<br />
AND MORTALITY IN ADVANCED CKD PATIENTS?<br />
Hanane Bouarich | Susana Lopez | Concepcion Alvarez | Ignacio Arribas | Patricia<br />
De Sequera | Diego Rodriguez<br />
Hosp Univ Principe Asturias, Madrid, Spain | Hosp Infanta Leonor, Madrid,<br />
Spain<br />
FP474<br />
WARFARIN USE IS ASSOCIATED WITH HIGHER PREVALENCE VERTE-<br />
BRAL FRACTURES, VASCULAR CALCIFICATIONS AND INCREASED MOR-<br />
TALITY IN CHRONIC KIDNEY DISEASE<br />
Maria Fusaro | Marianna Noale | Giovanni Tripepi | Angela D'Angelo | Davide<br />
Miozzo | Maurizio Gallieni | PPI-VC (Protein Pump Inhibitors – Vascular<br />
Calcification) Study Group<br />
Consiglio Nazionale delle Ricerche (CNR) - Inst Neuroscience, Aging Section,<br />
Padua, Italy | Clinical Epidemiology and Physiopathology of Renal Diseases and<br />
Hypertension, CNR - Ist Biometeorologia, Reggio Calabria, Italy | Nephrology<br />
Unit, Univ Padua, Italy<br />
FP475<br />
SILENT MYOCARDIAL ISCHEMIA IN HEMODIALYSIS PATIENTS WITH CO-<br />
RONARY ARTERY DISEASE<br />
Shinji Tanaka | Takafumi Kanemitsu | Mai Sugahara | Masafumi Kobayashi |<br />
Lisa Uchida | Yu Ishimoto | Nagaaki Kotera | Shuzou Tanimoto | Kengo Tanabe<br />
| Kazuhiro Hara | Tokuichiro Sugimoto | Naobumi Mise<br />
Dept Nephrology, Dept Cardiology, Mitsui Memorial Hosp, Tokyo, Japan<br />
« FP476<br />
TRENDS IN THE INCIDENCE OF ATRIAL FIBRILLATION IN OLDER PA-<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
171<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
172<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
TIENTS INITIATING DIALYSIS IN THE USA<br />
Benjamin Goldstein | Mintu Turakhia | Cristina Arce | Wolfgang Winkelmayer<br />
Stanford Univ, Palo Alto, USA | Veterans Affairs Palo Alto Health Care System,<br />
Palo Alto, USA<br />
FP477<br />
RIGHT VENTRICULAR FUNCTION IN CKD STAGE 5 PATIENTS WITH END-<br />
STAGE RENAL DISEASE STARTING DIALYSIS TH<strong>ERA</strong>PY. A TISSUE DOP-<br />
PLER IMAGING STUDY<br />
Bahaa El-Din Zayed | Kareem Said<br />
Nephrology Dept Kasr Al-Aini School Medicine, Cairo Univ Egypt | Cardiolgy<br />
Dept Kasr Alaini, Cairo Univ<br />
FP478<br />
PREDICTION OF CARDIOVASCULAR EVENTS IN HEMODIALYSIS PA-<br />
TIENTS BY AMINOTERMINAL PROPEPTIDE OF TYPE III PROCOLLAGEN<br />
CIRCULATING LEVELS<br />
Masato Nishimura | Yu Okamoto | Toshiko Tokoro | Masashi Nishida | Tetsuya<br />
Hashimoto | Noriyuki Iwamoto | Hakuo Takahashi | Toshihiko Ono<br />
Toujinkai Hosp, Kyoto, Japan. | Kansai Medical Univ, Osaka, Japan<br />
FP479<br />
ORAL NICORANDIL TO REDUCE SUDDEN CARDIAC DEATH OF HEMO-<br />
DIALYSIS PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY<br />
Masato Nishimura | Yu Okamoto | Toshiko Tokoro | Nodoka Sato | Masashi<br />
Nishida | Tetsuya Hashimoto | Noriyuki Iwamoto | Hakuo Takahashi | Toshihiko<br />
Ono<br />
Toujinkai Hosp, Kyoto, Japan | Kansai Medical Univ<br />
FP480<br />
LOWER MAGNESIUM LEVELS PREDICT PULSE PRESSURE IN PREVALENT<br />
HEMODIALYSIS PATIENTS<br />
Anabela Guedes | Andreia Cruz | Elsa Morgado | Ana Pinho | André Fragoso |<br />
Patrícia Mendes | Isilda Bexiga | Ana Paula Silva | Pedro Neves<br />
Nephrocare, Faro, Portugal<br />
FP481<br />
SERUM MAGNESIUM CONCENTRATION RELATES TO INTRADIALYTIC<br />
HYPOTENSIVE EVENTS IN CHRONIC HEMODIALYSIS PATIENTS<br />
Jochen Raimann | Len A Usvyat | Jeffrey Sands | Nathan W Levin | Peter Kotanko<br />
Renal Res Inst, New York, USA | Fresenius Medical Care NA<br />
FP482<br />
EEFFICACY OF DIGIT NUMBER OF NT-proBNP FOR SCREENING OF CAR-<br />
DIOVASCULAR DISEASE IN NEW HEMODIALYSIS PATIENTS<br />
Masaki Iwasaki | Nobuhiko Joki | Yuri Tanaka | Nobutaka Ikeda | Toshihide<br />
Hayashi | Shun Kubo | Taka-aki Imamura | Yasunori Takahashi | Koichi Hirahata<br />
| Yoshihiko Imamura | Hiroki Hase<br />
Toho Univ Ohashi Medical Center | Nissan Tamagawa Hosp | Hirahata Clinic<br />
FP483<br />
PLASMA LEVELS OF ADMA AND SDMA REMAIN STABLE IN INCIDENT<br />
PD PATIENTS DESPITE A DECLINING RESIDUAL RENAL FUNCTION: A<br />
PROSPECTIVE STUDY<br />
Kathleen Claes | Björn Meijers | Bert Bammens | Dirk Kuypers | Maarten Naesens<br />
| Yves Vanrenterghem | Pieter Evenepoel<br />
Univ Hosp Gasthuisberg, Leuven | KULeuven, Nephrology | Univ Hosp, Leuven,<br />
Belgium<br />
FP484<br />
DYSLIPIDEMIA, CHOLESTEROL ESTERIFICATION AND HIGH DENSITY LI-<br />
POPROTEINS IN DIALYSIS PATIENTS<br />
Giuliano Boscutti | Laura Calabresi | Manuela Bosco | Sara Simonelli | Emanuela<br />
Boer | Cecilia Vitali | Massimiliano Martone | Piero Luigi Mattei | Guido<br />
Franceschini<br />
ASS2 Isontina, Gorizia Italy | Center E. Grossi Paoletti Univ Milan<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
« FP485<br />
WHAT IS THE EFFECT OF A/V FISTULA FLOW ON RIGHT VENTRICULAR<br />
PERFORMANCE INDEX IN PATIENTS WITH ESRD; A THREE MONTH FOL-<br />
LOW UP TISSUE DOPPLER ECHOCARDIOGRAPHIC STUDY?<br />
Essam Baligh | Bahaa El-Din Zayed | Karim Said<br />
Cardiology Dept, Kasr Al-Aini School of Medicine, Cairo Univ, Egypt | Nephrology<br />
Dept Kasr Al-Aini School of Medicine, Cairo Univ, Egypt<br />
FP486<br />
PLASMA ADIPONECTIN LEVELS FOR PREDICTION OF CARDIOVASCU-<br />
LAR RISK AMONG HEMODIALYSIS PATIENTS<br />
Eid El-Shafey | Amal Ezaat<br />
Internal Medicine Dept, Fac Medicine, Tanta Univ | Clinical Pathology Dept, Fac<br />
Medicine, Tanta Univ<br />
FP487<br />
DNA METHYLATION PROFILING REVEALS DYSREGULATION OF ATHE-<br />
ROSCLEROSIS-RELATED GENES IN DIALYSIS PATIENTS<br />
Adam Zawada | Kyrill Rogacev | Björn Hummel | Oliver Grün | Annika Friedrich<br />
| Björn Rotter | Peter Winter | Jürgen Geisel | Danilo Fliser | Gunnar<br />
Henrik Heine<br />
Dept Internal Medicine IV, Saarland Univ Medical Center, Homburg, Germany |<br />
Clinical Chemistry and Lab Medicine/Central Lab, Saarland Univ Medical Center,<br />
Homburg, Germany | GenXPro GmbH, Frankfurt, Germany<br />
FP488<br />
HYPER-BETA 2 MICROGLOBULINEMIA SEEMS TO BE A RISK FACTOR FOR<br />
VENTRICULAR ABNORMAL RELAXATION WITH NORMAL SYSTOLIC<br />
FUNCTION OF THE HEART IN HEMODIALYSIS PATIENTS<br />
Jun-ichi Makino | Kuni-shiro Makino | Takahito Ito<br />
Makino clinic | National Hosp Organization Osaka National Hosp<br />
FP489<br />
ITALIAN SURVEY ON HEMORRHAGIC AND THROMBOEMOLIC RISK AND<br />
ORAL ANTICOAGULANT TH<strong>ERA</strong>PY IN A LARGE POPULATION OF HEMO-<br />
DALYSIS PATIENTS WITH ATRIAL FIBRILLATION<br />
Simonetta Genovesi | Paolo Fabbrini | Emanuela Rossi | Daniela Pogliani | Andrea<br />
Stella | Giuseppe Bonforte | Giuseppe Remuzzi | Silvio Bertoli | Claudio<br />
Pozzi | Maurizio Gallieni | Sonia Pasquali | Leonardo Cagnoli | Ferruccio Conte<br />
| Antonio Santoro<br />
Italian Study Group Atrial Fibrillation in Hemodialysis | Clinica Nefrologica,<br />
AO San Gerardo, Monza Italy<br />
FP490<br />
POLYMORPHISMS OF ANGIOTESIN CONVERTING ENZYME AND MATRIX<br />
METALLOPROTEINASE 3 GENES IN HAEMODIALYSIS PATIENTS – ASSO-<br />
CIATION WITH CARDIOVASCULAR MORBIDITY AND MORTALITY<br />
Ivana Buzadzic | Jelena Tosic | Nada Dimkovic | Zivka Djuric | Jovan Popovic|<br />
Ivana Pejin Grubisa | Nada Barjaktarevic<br />
Zvezdara Univ Hosp, Dept Human Genetics and Prenatal Diagnostic | Zvezdara<br />
Univ Hosp, Nefrology Dept, Belgrade, Serbia<br />
FP491<br />
“DE NOVO” CARDIOVASCULAR DISEASES ONSET DURING CHRONIC<br />
DIALYSIS: AN EPIDEMIOLOGYC STUDY<br />
Anteo Di Napoli | Domenico Di Lallo | Maria Flora Salvatori | Francesco Franco|<br />
Serena Chicca | Gabriella Guasticchi<br />
Agency Public Health Lazio Region, Rome, Italy<br />
FP492<br />
STRICT VOLUME CONTROL GUIDED BY BIOIMPEDANCE ANALYSIS AND<br />
THE EFFECT ON ARTERIAL STIFFNESS IN HEMODIALYSIS PATIENTS - A<br />
RANDOMIZED TRIAL<br />
Mihai Onofriescu | Simona Hogas | Voroneanu Luminita | Apetrii Mugurel |<br />
Veisa Gabriel | Florea Laura | Mititiuc Irina | Covic Adrian<br />
Parhon Hosp, Univ Medicine and Farmacy Gr.T.Popa, Iasi, Romania | Univ Medicine<br />
and Pharmacy Gr.T.Popa Iasi, Romania<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
173<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
174<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP493<br />
CHANGES IN LEFT VENTRICULAR STRUCTURE AFTER PARICALCITOL<br />
TH<strong>ERA</strong>PY IN CHRONIC HEMODIALYSIS PATIENTS<br />
Elvira Bosch | Eduardo Baamonde | Carlos Culebras | German Perez | Bilal<br />
El Hayek | Jose Ignacio Ramirez | Ana Ramirez | Cesar Garcia | Mar Lago |<br />
Agustín Toledo | Maria Dolores Checa<br />
Centro Hemodiálisis Avericum, Las Palmas de Gran Canaria, Spain | Dept Cardiology,<br />
Las Palmas, Spain | Dept Nephrology, Hosp Univ Insular Gran Canaria<br />
FP494<br />
CILOSTAZOL INCREASES HDL2 CHOLESTEROL LEVELS IN CHRONIC HE-<br />
MODIALYSIS PATIENTS<br />
Takayasu Taira | Tsutomu Hirano | Kyoko Nohtomi | Toru Hyodo | Tetsuo<br />
Chiba | Akira Saito<br />
Yokohama Daichi Hosp | Dept Diabetes, Metabolism, and Endocrinology, Showa<br />
Univ School of Medicine | Dept Urology, Kitasato Univ School of Medicine,<br />
Sagamihara, Japan | Dept Nephrology, Yokohama Daiichi Hosp, Yokohama,<br />
Japan<br />
FP495<br />
RELATIONSHIP BETWEEN ERYTHROPOIETIN RESISTANCE INDEX AND<br />
LEFT VENTRICULAR MASS AND FUNCTION AND CARDIOVASCULAR<br />
EVENTS IN PATIENTS ON CHRONIC HEMODIALYSIS<br />
Yong Kyun Kim | Ho-Cheol Song | Euy Jin Choi | Chul Woo Yang | Yong-Soo<br />
Kim<br />
Dept Internal Medicine, Bucheon Saint Mary’s Hosp | Bucheon St. Mary's Hosp,<br />
Catholic Univ Korea | Dept Internal Medicine, Seoul Saint Mary’s Hosp, Catholic<br />
Univ Korea<br />
FP496<br />
THE REDOX STATE OF SERUM ALBUMIN AND MORTALITY IN HEMO-<br />
DIALYSIS PATIENTS<br />
Paik Seong Lim | Wu Ming Ying | Jeng Ya-Chung<br />
Providence Univ, Taiwan | Tungs Taichung Metroharbours Hosp<br />
FP497<br />
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM BLOCHADE AND LEFT<br />
VENTRICULAR HYPERTROPHY IN MAINTENANCE HEMODIALYSIS PA-<br />
TIENTS<br />
Inna Zaripova | Ivan Kayukov | Ashot Essaian | Aysa Nimgirova<br />
St.Petersburg State Medical Univ named after I.P.Pavlov, St.Petersburg, Russian<br />
Federation<br />
FP498<br />
EXERCISE IN END STAGE RENAL FAILURE: PATIENT PERCEIVED BAR-<br />
RIERS AND MOTIVATORS<br />
Hannah Young | Maurice Dungey | Emma L Watson | Richard Baines | James<br />
O Burton | Alice C Smith<br />
John Walls Renal Unit, Leicester General Hosp, Leicester | School of Sport, Exercise<br />
and Health Science, Loughborough Univ | Dept Infection, Immunity and<br />
Inflammation, Univ Leicester, UK<br />
FP499<br />
THE BEST CUT-OFF VALUE FOR DIAGNOSING OF ACUTE CORONARY<br />
SYNDROME AT EMERGENCY ROOM IN PATIENTS WITH END STAGE KID-<br />
NEY DISEASE<br />
Nobuhiko Joki | Masaki Iwasaki | Yuri Tanaka | Shun Kubo | Toshihide Hayashi<br />
| Nobutaka Ikeda | Kenji Yamazaki | Hiroki Hase<br />
Toho Univ Ohashi Medical Center | National Center Global Health And Medicine<br />
FP500<br />
REACTIVE OXYGEN METABOLITES (ROMS) ARE ASSOCIATED WITH<br />
CARDIOVASCULAR DISEASE AND NEW CARDIOVASCULAR EVENTS IN<br />
CHRONIC HEMODIALYSIS PATIENTS<br />
Maurizio Bossola | Luigi Colacicco | Donata Scribano | Carlo Vulpio | Luigi<br />
Tazza<br />
Catholic Univ, Rome, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP501<br />
EFFECT OF LOW DOSE ASPIRIN ON PREVENTION OF FOOT ULCERS IN<br />
HEMODIALYSIS PATIENTS WITH DIABETES: A RETROSPECTIVE COHORT<br />
STUDY<br />
Tadashi Okada | Noriyuki Okada | Iwao Michibata | Takafumi Yura<br />
Hakuyu Chiyoda Clinic | Hakuyu Chiyoda Clinic | Hakuyu Clinic<br />
FP502<br />
POOR PATIENT SURVIVAL AFTER EARLY DIALYSIS INITIATION MAY BE<br />
EXPLAINED BY ADVANCED AGE<br />
Nuria Montero | MªJosé Soler | MºJosé Pascual | Clara Barrios | Eva Márquez|<br />
Eva Rodríguez | Mª Antonia Orfila | Higini Cao | Emma Arcos | Jordi Comas|<br />
Julio Pascual<br />
Hosp Mar, Barcelona Spain | Registre Malalts Renals Catalunya, Barcelona Spain<br />
FP503<br />
ANALYSIS OF QT PROLONGATION IN ESRD PATIENTS DURING HEMO-<br />
DIALYSIS TREATMENT<br />
Manuela Ferrario | Tommaso Sironi | Simone Monacizzo | Flavio Basso | Francesco<br />
Garzotto | Dinna N. Cruz | Ulrich Moissl | Ciro Tetta | Maria G. Signorini|<br />
Sergio Cerutti | Claudio Ronco<br />
Politecnico Milano | San Bortolo Hosp, Vicenza | Fresenius Medical Care, R&D,<br />
Bad Homburg<br />
FP504<br />
BETA 2-MICROGLOBULIN IS A PREDICTOR OF LEFT VENTRICULAR MASS<br />
INDEX IN HEMODIALYSIS PATIENTS<br />
Irina Mostovaya | Muriel Grooteman | Marinus van den Dorpel | Lars Penne |<br />
Neelke van der Weerd | Albert Mazairac | Claire den Hoedt | Renee Levesque |<br />
Menso Nube | Piet ter Wee | Michiel Bots | Peter Blankestijn<br />
Univ Medical Centre Utrecht, Utrecht, Netherlands | VU Univ Medical Center,<br />
Amsterdam, Netherlands | Maasstad Hosp, Rotterdam, Netherlands | Centre<br />
Hosp Univ Montréal, St-Luc Hosp, Montreal, Canada<br />
FP505<br />
THE ACTIVATION OF MTOR PATHWAY INDUCED BY INFLAMMATION<br />
ACCEL<strong>ERA</strong>TES THE PROGRESSION OF ATHEROSCLEROSIS IN HEMO-<br />
DIALYSIS PATIENTS<br />
Jing Liu | Kun Ling Ma | Xiaoliang Zhang | Bi Cheng Liu<br />
Inst Nephrology, Southeast Univ, Nanjing China | Zhong Da Hosp, School of<br />
Medicine, Southeast Univ, Nanjing, China<br />
FP506<br />
CLINICAL RES OF RELATIONSHIP BETWEEN CAROTID INTIMA-MEDIA<br />
THICKNESS AND CARDIOVASCULAR RISK FACTORS IN HEMODIALYSIS<br />
PATIENTS<br />
Iulia-Daniela Vladu | Roxana Mustafa | Daniela Cana-Ruiu | Cristina Vaduva |<br />
Corina Grauntanu | Eugen Mota<br />
Nephrology Dept, Emergency County Hosp, Craiova, Romania | Cardiology<br />
Dept, Emergency County Hosp, Craiova, Romania<br />
FP507<br />
PRO-INFLAMMATORY AND PRO-COAGULANT CHARACTERISTICS OF<br />
PLATELET DERIVED MICROVESICLES IN HAEMODIALYSIS PATIENTS<br />
Ruchir Singh | Nima Abbasian | Cordula Stover | Nigel Brunskill | James Burton<br />
Univ Leicester, Dept Infection, Immunity, and Inflammation, Leicester, UK<br />
« FP508<br />
HYPERPHOSPHATAEMIA AND MICROVESICLE FORMATION: A NOVEL<br />
MECHANISM FOR CARDIOVASCULAR RISK IN CHRONIC KIDNEY DISEASE<br />
Nima Abbasian | Karl Herbert | Alan Bevington | Nigel Brunskill | James Burton<br />
Dept Infection, Immunity, and Inflammation, Univ Leicester, Leicester, UK |<br />
Dept Cardiovascular Sciences, Univ Leicester, Leicester, UK<br />
FP509<br />
PARATHYROID HORMONE INDUCES ENDOTHELIAL-TO-MESENCHY-<br />
MAL TRANSITION IN HUMAN AORTIC ENDOTHELIAL CELLS<br />
Min Wu | Ri-Ning Tang | Min Gao | Hong Liu | Long Chen | Lin-Li Lv | Bi-<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
175<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
176<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Cheng Liu<br />
Inst Nephrology, Zhong Da Hosp, Southeast Univ, NanJing, China<br />
FP510<br />
ALFACALCIDOL AND PARICALCITOL HAVE SIMILAR EFFECTS ON LEFT<br />
VENTRICULAR HYPERTROPHY<br />
Maria Nikodimopoulou | Spyridon Liakos | Stergios Kapoulas | Charalampos<br />
Karvounis<br />
Renal Unit AHEPA, Aristotelian Univ Thessalonik, Greece | Aristotelian Univ<br />
Thessaloniki<br />
FP511<br />
THE RELATIONSHIP BETWEEN TNF-RELATED APOPTOSIS INDUCING LI-<br />
GAND CONCENTRATION AND INFLAMMATORY MARKERS<br />
Danuta Fedak | Marek Kuzniewski | Dumnicka Paulina | Beata Kusnierz-Cabala<br />
| Maria Kapusta | Bogdan Solnica | Wladyslaw Sulowicz<br />
Dept Clinical Biochemistry, Jagiellonian Univ Collegium Medicum, Krakow, Poland<br />
| Dept Medical Diagnostics Fac Pharmacy, UJCM, Krakow, Poland | Dept<br />
Nephrology, Jagiellonian Univ Collegium Medicum, Krakow, Poland<br />
FP512<br />
BENEFITS OF AN ENDURANCE TRAINING PROGRAM IN PATIENTS ON<br />
HEMODIALYSIS: A CASE-CONTROL STUDY<br />
Anna Junqué | Esteve Simo Vicent | Lidia Moreno | Miquel Fulquet | Veronica<br />
Duarte | Anna Saurina | Monica Pou | Javier Macías | Marisa Lavado | Manel<br />
Ramírez de Arellano<br />
Hosp Terrassa, Consorci Sanitari Terrassa, Barcelona<br />
FP513<br />
SEASONAL AND WEEKLY VARIABILITY OF HOME BLOOD PRESSURE<br />
EVALUATED WITH TELEMEDECINE SYSTEM USING CELLULAR PHONE<br />
IN HEMODIALYSIS PATIENTS<br />
Munekazu Ryuzaki | Hidetomo Nakamoto | Shyunsuke Kinoshita | Emi Kobayashi<br />
| Chie Takimoto | Takashi Shishido<br />
Dept Internal Medecine, Kawasaki Municipal Ida Hosp, Kanagawa, Japan | Dept<br />
Internal Medecine, Saitama Medical School, Morohongo, Japan<br />
FP514<br />
PULMONARY CONGESTION AND PHYSICAL FUNCTIONING IN CKD-5 HD<br />
PATIENTS<br />
Giuseppe Enia | C. Torino | R. Tripepi | V. Panuccio | M. Postorino | A. Clementi<br />
| M. Garozzo | G. Bonanno | R. Boito | G. Natale | T. Cicchetti | A.<br />
Chippari | D. Logozzo | G. Alati | S. Cassani | A. Sellaro | Carmine Zoccali<br />
CNR IBIM Reggio Calabria Italy | Lung Comets Cohort (LCC) working group<br />
FP515<br />
INCIDENCE AND MORTALITY RISK FACTORS ASSOCIATED WITH NON-<br />
OCCLUSIVE MESENTERIC ISCHAEMIA IN PATIENTS UNDERGOING HE-<br />
MODIALYSIS<br />
Borja Quiroga | Eduardo Verde | Soraya Abad | Almudena Vega | Marian Goicoechea<br />
| Javier Reque | Juan Manuel López-Gómez | José Luño<br />
Hosp Gregorio Marañón<br />
FP516<br />
COGNITIVE DYSFUNCTION AND WHITE MATTER LESIONS IN MAINTE-<br />
NANCE HAEMODIALYSIS PATIENTS<br />
Carmen Cabre Menendez | Veronica Moles | Joan Pere Vives | Diasol Villa |<br />
Jaume Viñas | Teresa Compte | Mercedes Arruche | Carlos Diaz | Jordi Soler |<br />
Josep Aguilera | Alberto Martinez Vea<br />
Joan XXIII Univ Hosp, Tarragona, Spain | Dept Diagnostic Imaging, Joan XXIII<br />
Univ Hosp, Tarragona, Spain | Dept Neurology, Joan XXIII Univ Hosp, Tarragona,<br />
Spain | Nephrology Unit Tortosa, Spain | Dialysis Center Reus Medical,<br />
Reus, Spain | Dialysis Center Llevant, Tarragona, Spain | Dept Nephrology,<br />
Joan XXIII Univ Hosp, Tarragona, Spain<br />
FP517<br />
UREMIC FOOT: THE EMERGENT ROLE OF VITAMIN K-ANTAGONISTS<br />
Andreana De Mauri | Paola David | Maria Maddalena Conte | Doriana Chiari-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
notti | Carlo Edoardo Ruva | Martino De Leo<br />
Nephrology Dept, Univ Hosp Maggiore della Carità<br />
FP518<br />
VITAMIN E-COATED POLYSULFONE MEMBRANE IMPROVED RED BLOOD<br />
CELL ANTIOXIDANT STATUS: A PROSPECTIVE MULTICENTER STUDY<br />
Anne-Sophie Bargnoux | Marion Morena | Isabelle Jaussent | Lotfi Chalabi |<br />
Pierre Bories | Jean-Jacques Dion | Patrick Henri | Martine Delage | Anne-Marie<br />
Dupuy | Stéphanie Badiou | Bernard Canaud | Jean-Paul Cristol<br />
Lab Biochimie, CHRU Montpellier | INSERM, U1061 | AIDER | Serv Néphrologie,<br />
CHU, Toulouse | Serv Néphrologie, CH Manchester | Serv Néphrologie,<br />
CHU Caen | Serv Néphrologie-Hémodialyse et Soins Intensifs, CHRU Montpellier<br />
FP519<br />
P WAVE DURATION, ATRIAL DIMENSION AND ATRIAL FIBRILLATION IN<br />
HEMODIALYSIS PATIENTS<br />
Paolo Fabbrini | Elisabetta Sironi | Federico Pieruzzi | Eleonora Galbiati | Maria<br />
Rosa Viganò | Andrea Stella | Simonetta Genovesi<br />
Clinica Nefrologica, AO San Gerardo, Monza Italy<br />
FP520<br />
ROLE OF PRE-TRANSPL ECHOCARDIOGRAPHY IN PREDICTING OUTCO-<br />
ME IN PATIENTS WAITING FOR KIDNEY TRANSPL<br />
Sheela Anpalakhan | Sofia Rocha | Nihil Chitalia | Rajan Sharma | Juan Carlos<br />
Kaski | John Chambers | David Goldsmith | Debasish Banerjee<br />
St George's, Univ London | St Georges Healthcare NHS Trust | Guys Hosp NHS<br />
Foundation Trust<br />
FP521<br />
CHANGES IN RELAXIN’S SERUM LEVELS DURING ACETATE-FREE BIOFIL-<br />
TRATION: WHAT MEANINGS?<br />
Valeria Cernaro | Antonio Lacquaniti | Rosaria Lupica | Silvia Lucisano | Maria<br />
Rosaria Fazio | Valentina Donato | Michele Buemi<br />
Polyclinic Messina, Dept Internal Medicine, Div Nephrology<br />
FP522<br />
RISK OF SUDDEN CARDIAC DEATH IN HEMODIALYSIS PATIENTS<br />
Isabelle Segalen | Ulrich Vinsonneau | Tugdual Tanquerel | Gilles Quiniou |<br />
Yannick Le Meur<br />
Nephrology, CHRU Brest, France | Dept Cardiology, Clermont Tonnerre Hosp,<br />
Brest, France | Dept Cardiology, Pasteur Clinic, Brest, France<br />
FP523<br />
AUTONOMIC NERVOUS DYSFUNCTION AND INFLAMMATION IN HAE-<br />
MODIALYSIS PATIENTS<br />
Eric Seibert | Matthias Girndt | Kristina Zohles | Christof Ulrich | Alexander<br />
Kluttig | Sebastian Nuding | CA Swenne | JA Kors | Karl Werdan | Roman<br />
Fiedler<br />
Dept Internal Medicine II | Inst Medical Epidemiology | Dept Internal Medicine<br />
III | Dept Cardiology, Leiden Univ Medical Center | Dept Medical Informatics,<br />
Erasmus Univ Medical Center Rotterdam | Martin-Luther-Univ Halle-Wittenberg<br />
FP524<br />
HEPCIDIN-25 IS RELATED TO CARDIOVASCULAR EVENTS IN CHRONIC<br />
HEMODIALYSIS PATIENTS<br />
Neelke C. van der Weerd | Muriel PC Grooteman | ML Bots | Marinus A van<br />
den Dorpel | Claire den Hoedt | Menso J. Nubé | JFM Wetzels | Dorine W.<br />
Swinkels | PJ Blankestijn | Pieter M. ter Wee<br />
VU Medical Center, Amsterdam | Univ Medical Center Utrecht | Maasstad<br />
Hosp, Rotterdam| Radboud Univ Nijmegen Medical Center | Dept Lab Medicine,<br />
Lab Genetic, Endocrine and Metabolic Diseases, Radboud Univ Medical<br />
Center, Nijmegen<br />
FP525<br />
INCIDENCE OF CARDIOVASCULAR DISEASE (CVD) IN CHRONIC KIDNEY<br />
DISEASE SUBJECTS (PRE-DIALYSIS): THE ROLE OF PLASMA HIGH SENSITI-<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
177<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
178<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
VITY C-REACTIVE PROTEIN (HS-CRP), HOMOCYSTEINE (HCY), CAROTID<br />
INTIMA MEDIA THICKNESS (CIMT) AND LEFT VENTRICULAR HYPER-<br />
TROPHY (LVH)<br />
Ashwini Khandekar | Jitendra Khandge<br />
Bhabha Atomic Res Centre Hosp, Anushaktinagar, Mumbai<br />
FP526<br />
NONINVASIVE DETECTION OF CORONARY ARTERY STENOSIS WITH<br />
MULTIDETECTOR ROW COMPUTED TOMOGRAPHY IN CHRONIC KID-<br />
NEY DISEASE PATIENTS AT THE INITIATION OF RENAL REPLACEMENT<br />
TH<strong>ERA</strong>PY<br />
Jung Eun Lee | Sung Jin Moon | Kyu Hun Choi | Ho Yung Lee | Beom Seok Kim<br />
Yongin Severance Hosp | Myongji Hosp, Kwandong Univ College of Medicine,<br />
Goyang, Korea | Dept Nephrology, Inst Kidney Disease, Yonsei Univ College<br />
Medicine, Seoul, Korea | Severance Hosp, Seoul, Korea<br />
FP527<br />
IMPAIRMENT IN ENDOTHELIAL PROGENITOR CELLS MOBILIZATION AS<br />
A COMPONENT OF MALNUTRITION INFLAMMATION COMPLEX SYN-<br />
DROME: WHICH ROLE FOR DIALYSIS MODALITIES?<br />
Marion Morena | Edouard Tuaillon | Isabelle Jaussent | Annie Rodriguez | Leila<br />
Chenine | Jean-Pierre Vendrell | Jean-Paul Cristol | Bernard Canaud<br />
IRFD, CHRU, Montpellier, France | CHRU, Lab Virologie, Montpellier, France |<br />
INSERM U1061, Montpellier, France | CHRU, Serv Néphrologie, Hémodialyse<br />
et Soins Intensifs, Montpellier, France | Univ Montpellier, Hôp Lapeyronie, Dept<br />
Nephrology, Montpellier, France<br />
FP528<br />
CARDIOPROTECTIVE DRUGS PROLONG HEART FAILURE SURVIVAL IN<br />
LONG-TERM HEMODIALYSIS PATIENTS<br />
Yuh-Mou Sue | Chao-Hsiun Tang | Yen-Chen Chen<br />
Wan-Fang Hosp, Taipei City, Taiwan | School of Health Care Administration,<br />
Taipei Medical Univ, Taipei, Taiwan<br />
FP529<br />
ACUTE MYOCARDIAL INFARCTION IN INCIDENT DIALYSIS PATIENTS<br />
Carmen Sánchez-Perales | Eduardo Vázquez | Pilar Segura | M. José García<br />
Cortés | Jose Manuel Gil | M. Mar Biechy | Antonio Liébana<br />
Serv Cardiología, C.H. Jaén | Serv Nefrología, C.H. Jaén<br />
FP530<br />
SAFETY AND EFFICACY OF BETA BLOCKERS IN HAEMODIALYSIS<br />
Dimitrios Poulikakos | Apeksha Shah | Mattias Persson | Debasish Banerjee<br />
St George's Hosp NHS Trust, London, UK | St Georges Healthcare NHS Trust,<br />
London UK<br />
FP531<br />
VARIABILITY IN ESA DOSING AND NOT IN HAEMOGLOBIN LEVELS IS A<br />
STRONG PREDICTOR OF DEATH RISK IN HAEMODIALYSIS PATIENTS<br />
Pietro Dattolo | Marco Amidone | Stefano Michelassi | Luigi Moriconi | Giancarlo<br />
Betti | Paolo Conti | Alberto Rosati | Antonio Mannarino | Vincenzo Panichi<br />
| Francesco Pizzarelli<br />
S M Annunziata Hosp, Florence, Italy | ASL 11 | ASL 1 | ASL 9 | ASL 4 | ASL<br />
10 | ASL 12<br />
FP532<br />
AGE AND GENDER PREDICT OPG LEVEL AND OPG/SRANKL RATIO IN<br />
MAINTENANCE HEMODIALYSED PATIENTS<br />
Katarzyna Klejna | Beata Naumnik | Ewa Koc-Zorawska | Michal Mysliwiec<br />
Dept Nephrology and Transpl with Dialysis Unit, Medical Univ, Bialystok, Poland<br />
| Medical Univ Bialystok, Bialystok, Poland<br />
FP533<br />
EVALUATION OF LUNG WATER BY ULTRASOUND AND ITS RELATION<br />
WITH CARDIAC PARAMETERS AND BIOIMPEDANCE-DERIVED BODY<br />
WATER IN HAEMODIALYSIS PATIENTS<br />
Siriopol Dimitrie | Hogas Simona | Oleniuc Mihaela | Apetrii Mugurel | Onode<br />
Gabriela | Sascau Radu | Prisada Octavian | Covic Adrian<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Parhon Hosp, Univ Medicine and Farmacy Gr.T. Popa, Iasi, Romania | Cardiology<br />
Center, Univ Medicine and Farmacy Gr.T. Popa, Iasi, Romania<br />
FP534<br />
THE EVALUATION OF ARTERIAL STIFFNESS AND VOLUME STATUS IN<br />
CHRONIC KIDNEY DISEASE PATIENTS<br />
Hakan Akdam | Harun Akar | Yavuz Yenicerioglu | Özgül Küçük | İmran Kurt<br />
Ömürlü<br />
Div Nephrology, Adnan Menderes Univ Medical School, Aydın, Turkey<br />
FP535<br />
CIRCULATING SCLEROSTIN AND DICKKOPF-1 (DKK1) IN PRE-DIALYSIS<br />
CHRONIC KIDNEY DISEASE (CKD): RELATIONSHIP WITH BONE DENSITY<br />
AND ARTERIAL STIFFNESS<br />
David Goldsmith | S Thambiah | R Roplekar | P Manghat | P Manghat | I<br />
Fogelman | W Fraser | G Hampson<br />
King's Health Partners<br />
FP536<br />
ABI TO EVALUATE PERIPH<strong>ERA</strong>L ARTERIAL DAMAGE IN HEMODIALYSIS<br />
PATIENTS<br />
Erjola Likaj | Gentian Caco | Saimir Seferi | Merita Rroji | Myftar Barbullushi|<br />
Nestor Thereska<br />
UHC Mother Theresa, Tirana, Albania<br />
FP537<br />
A RANDOMIZED TRIAL OF BIOIMPEDANCE VS. CLINICAL METHODS FOR<br />
EVALUATING “DRY WEIGHT” IN HEMODIALYSIS AND THE EFFECT ON<br />
HYDRATION STATUS, BLOOD PRESSURE AND MORTALITY<br />
Mihai Onofriescu | Simona Hogas | Voroneanu Luminita | Apetrii Mugurel|<br />
Ardeleanu Serban | Volovat Carmen | Stoicescu Cristian | Lungu Silvia |<br />
Adrian Covic<br />
Univ Medicine and Pharmacy Gr.T. Popa Iasi, Romania | Parhon Hosp, Univ<br />
Medicine and Farmacy Gr.T. Popa, Iasi, Romania | Dr C.I. Parhon Hosp, Iasi,<br />
Romania<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
179<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
180<br />
VASCULAR ACCESS<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP538<br />
ESTABLISHMENT AND MAINTENANCE OF VASCULAR AND PERITONE-<br />
AL ACCESSES IN INCIDENT DIALYSIS PATIENTS: A COST-EFFECTIVENESS<br />
ANALYSIS<br />
Luis Coentrao | Carlos Ribeiro | Carla Santos-Araujo | Ricardo Neto | Manuel<br />
Pestana<br />
Nephrology Res and Development Unit, Fac Medicine, Univ Porto, Sao Jao Hosp<br />
Centre, Porto, Portugal | Financial Management Unit, São João Hosp Centre,<br />
Porto, Portugal<br />
FP539<br />
THREE YEARS PROSPECTIVE SINGLE CENTER OBSERVATION OF NATU-<br />
RAL HISTORY OF TRANSHEPATIC PERMCATHETER IN HEMODIALYSIS<br />
PATIENTS<br />
Ebadur Rahman | Habibur Rahman | Dildar Ahmed | Dujanah Mousa | Mohamed<br />
El Bishlawi<br />
Riyadh Military Hosp | KKUH | RMH<br />
FP540<br />
HISTOLOGICAL FINDINGS OF CLINICALLY DIAGNOSED EXIT-SITE IN-<br />
FECTIONS OF TUNNELED CUFFED CATHETERS<br />
Hiroshi Shibahara | Nami Shibahara | Susumu Takahashi<br />
Sagamihara Kyodo Hosp, Kanagawa, Japan | Nihon Univ Grad School, Tokyo,<br />
Japan<br />
FP541<br />
TRISODIUM CITRATE 46.7% VERSUS HEPARIN CATHETER LOCKS FOR<br />
TUNNELED CENTRAL VENOUS CATHETERS: A SINGLE-CENTER STUDY<br />
Emmanuel Dupuis | Xavier Duval | Quentin Dornic | C Bonnal | Jean-Christophe<br />
Lucet | Olivier Cerceau | Christine Randoux | Cellou Balde | Frederic<br />
Besson | France Mentre | Francois Vrtovsnik<br />
Nephrology, CHU Bichat Paris France | Hop Bichat, AP-HP | Inserm UMR-S738<br />
FP542<br />
THE CHOICE BETWEEN TUNNELED OR NOT CENTRAL VEIN HEMO-<br />
DIALYSIS CATHETERS FOR SHORT PERIODS OF TIME<br />
George Koutroubas | Pavlos Malindretos | George Zagotsis | Panagiota Makri|<br />
Christos Syrganis<br />
General Hosp Volos Achillopoulion, Volos, Greece | Nephrology Dept, General<br />
Hosp Volos Achillopoulion, Volos, Greece<br />
FP543<br />
HAEMOCATCH®: A NEW DEVICE FOR THE MANAGEMENT OF CVC (CEN-<br />
TRAL VENOUS CATHETERS) FOR HEMODIALYSIS<br />
Emanuele Mambelli | Elena Mancini | Cinzia Elia | Vincenza Guadagno | Maria<br />
Grazia Facchini | Annalisa Zucchelli | Michele Grazia | Laura Patregnani |<br />
Antonio Santoro<br />
Nefrologia, Dialisi Ipertensione, Policlinico S.Orsola-Malpighi, Bologna, Italy<br />
FP544<br />
CATHETER-RELATED INFECTIONS IN CHRONIC HEMODIALYSIS – A CLI-<br />
NICAL AND ECONOMIC PERSPECTIVE<br />
Gabriel Stefan | Simona Stancu | Cristina Capusa | Oana Ramaiana Ailioaiei |<br />
Gabriel Mircescu<br />
Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania | Nephrology<br />
Dept, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania | Dr Carol<br />
Davila Teaching Hosp Nephrology, Bucharest, Romania<br />
FP545<br />
LINE STRIPPING: AN UNDERUSED, SAFE AND EFFECTIVE OPTION FOR<br />
BLOCKED TUNNELLED HAEMODIALYSIS CATHETERS<br />
Siddiq Anwar | Callum Little | Richard Kingston | Previn Diwakar | Robert<br />
Kaikini<br />
Dept Renal Medicine Kent and Canterbury Hosp | Dept Interventional Radiology,<br />
Kent and Canterbury Hosp<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP546<br />
INFECTIONS RELATED TO CENTRAL VEIN DIALYSIS CATHETERS - 11 YE-<br />
ARS EXPERIENCE<br />
Christos Syrganis | George Koutroubas | George Zagotsis | Pavlos Malindretos|<br />
Panagiota Makri | Evdokia Nikolaou | George Loukas<br />
General Hosp Volos Achillopoulion, Volos, Greece<br />
FP547<br />
THE LECEL OF C REACTIVE PROTIEN IN CHRONIC HEMODIALYSIS PA-<br />
TIENTS WITH NON INFECTED HEMODIALYSIS ACTHETER COMPARED<br />
TO AVF IN A LARGE SAUDI HEMODIALYSIS CENTER<br />
Alaa Sabry | Khalid AlSaran | Sherrine Al Sherbeiny | Mohamed Abdulkader1<br />
Mansoura Urology and Nephrology Center | Prince Salman Center For Kidney<br />
Diseases<br />
FP548<br />
BACTERIAL COLONIZATION OF TUNNELED CUFFED CATHETER IN PA-<br />
TIENTS WITH HEMODIALYSIS<br />
Ihmsoo Kwak | Sangheon Song | Eunyoung Seong | Soobong Lee | Dongwon<br />
Lee | Ilyoung Kim | Harin Rhee<br />
Pusan National Univ Hosp | Pusan National Univ School of Medicine | Pusan<br />
National Univ Yangsan Hosp<br />
FP549<br />
PREDICTORS OF STEAL SYNDROME IN HEMODIALYSIS PATIENTS<br />
Fernanda Silva | José Queirós | Jorge Malheiro | António Cabrita | Ana Rocha<br />
Centro Hosp Porto, Portugal<br />
FP550<br />
SOUND INTENSITY ANALYSIS OF ARTERIOVENOUS FISTULA (AVF) IN<br />
HEMODIALYSIS PATIENTS<br />
Panagiotis Bamidis | Christos Liaskos | Ioannis Chryssogonidis | Christos<br />
Frantzidis | Andreas Papagiannis | Dionisis Vrochides | Anastasios Lasaridis |<br />
Pavlos Nikolaidis | Pavlos Malindretos<br />
Lab Medical Informatics, Aristotle Univ Thessaloniki | Radiology Dept, Aristotle<br />
Univ, Thessaloniki, Greece | Organ Transpl Unit, Aristotle Univ, Thessaloniki,<br />
Greece | Nephrology Dept, 1st Medical Dept, AHEPA Univ Hosp | Nephrology<br />
Dept, Acillopoulion General Hosp, Volos, Greece<br />
FP551<br />
BUTTONHOLE VERSUS SHARPNEEDLE CANNULATION: SERVLIVERY<br />
AND CLINICAL OUTCOMES<br />
Sradha Kotwal | Christopher Muir | Carmel Hawley | Paul Snelling | Martin<br />
Gallagher | Meg Jardine<br />
George Inst Global Health | Univ Sydney, Sydney, Australia | Princess Alexandria<br />
Hosp, Brisbane, Australia | Statewide Renal Servs, Sydney, Australia<br />
FP552<br />
BUTTONHOLE NEEDLING OF HEMODIALYSIS ARTERIOVENOUS FISTU-<br />
LAE RESULTS IN LESS PAIN AND STRESS COMPARING TO THE ROPE-<br />
LADDER PUNCTURE TECHNIQUE<br />
Kazuhiko Shibata | Yoshiyuki Toya | Satoshi Umemura | Tamio Iwamoto |<br />
Syuji Ono | Eri Ikeda | Atsushi Kitazawa | Tadashi Kuji | Naoaki Koguchi | Hidehisa<br />
Satta | Masahiro Nishihara | Seiichi Kawata | Tomoko Kaneda | Yukiko<br />
Yamada | Tomoyuki Murakami | Mai Yanagi | Gen Yasuda<br />
Yokohama Minami Clinic | Yokohama City Univ, Yokohama, Japan | Saiseikai<br />
Yokohamashi Nanbu Hosp | Yokodai Central Clinic, Yokohama, Japan | Toshin<br />
Clinic | Yokohama City Univ Medical Center<br />
FP553<br />
PER HEMODIALYSIS VASCULAR ACCESS BLOOD FLOW MEASURMENT<br />
BY DOPPLER ULTRASOUND: TECHNIC DESCRIPTION AND VALIDATION<br />
Sacquépée Mathieu | Doussy Yves | Tivollier Jean-Michel | Quirin Nicolas |<br />
Cantin Jean-François<br />
ATIR NC, Noumea, New Caledonia | CHT, BPJ9, Nouméa, New Calédonia<br />
FP554<br />
PROGNOSTIC VALUE OF B2 GLYCOPROTEIN I ANTIBODIES IN<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
181<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
182<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Mohamed Ibrahim | Mona Abdel Salam | Ahmed Awadalla | Walid Bichari |<br />
Shaimaa Zaki<br />
Ain Shams Univ, Cairo, Egypt | Benha Univ, Cairo, Egypt<br />
FP555<br />
INCIDENCE AND ETIOLOGY OF VASCULAR ACCESS (VA) THROMBOSIS<br />
IN PREVALENT PATIENTS UNDER VA SURVEILLANCE FOR STENOSIS BY<br />
BLOOD FLOW RATE (QA) MEASUREMENTS<br />
Ramon Roca-Tey | Rosa Samon | Omar Ibrik | Amparo Roda | Juan Carlos<br />
González-Oliva | Román Martínez-Cercós | Jordi Viladoms<br />
Dept Nephrology, Hosp Mollet, Mollet del Vallès, Barcelona, Spain<br />
FP556<br />
FAR INFRARED TH<strong>ERA</strong>PY IMPROVES ENDOTHELIAL FUNCTION AND<br />
ACCESS FLOW OF NEWLY-CREATED AV FISTULA IN PATIENTS WITH<br />
STAGE 5 CHRONIC KIDNEY DISEASE<br />
Chih-Ching Lin | Wu-Chang Yang<br />
School Medicine, National Yang-Ming Univ, Taipei, Taiwan | Div Nephrology,<br />
Taipei Veterans General Hosp, Taipei, Taiwan<br />
FP557<br />
THE IMPACT OF VASCULAR MICRO-CALCIFICATION OF RADIAL ARTERY<br />
ON CARDIOVASCULAR MORTALITY IN HEMODIALYSIS PATIENTS<br />
Young-Ok Kim | Sun-Ae Yoon | Yu-Seon Yun | Ho-Cheol Song | Byung-Soo<br />
Kim | Myeong-A Cheong<br />
Uijeongbu St. Mary's Hosp, Catholic Univ Korea | Bucheon St. Mary's Hosp,<br />
Catholic Univ Korea | St. Paul's Hosp, Catholic Univ Korea | Korea Cancer Center<br />
Hosp<br />
FP558<br />
STUDY ON PREDICTION OF ARTERIOVENOUS FISTULA PATENCY DURA-<br />
TION AFTER PTA PROCEDURE<br />
Tomonari Ogawa | Tota Kiba | Shinpei Okazaki | Minoru Hatano | Mizuki<br />
Iwanaga | Chie Noiri | Akihiko Matsuda | Hajime Hasegawa | Tetsuya Mitarai<br />
Dept Nephrology and Blood Purification, Saitama Medical Center, Saitama Medical<br />
Univ<br />
FP559<br />
EPIDEMIOLOGY OF HEMODIALYSIS VASCULAR ACCESS IN AN ITALIAN<br />
REGION: PREVALENCE, INCIDENCE, DETERMINANTS, SURVIVAL<br />
Anteo Di Napoli | Domenico Di Lallo | Luigi Tazza | Carmine De Cicco | Maria<br />
Flora Salvatori | Serena Chicca | Gabriella Guasticchi<br />
Agency Public Health Lazio Region, Rome, Italy | Catholic Univ | Ars Medica<br />
Dialysis Unit, Rome, Italy<br />
FP560<br />
IS THERE AN ASSOCIATION BETWEEN ARTERIOVENOUS FISTULA<br />
THROMBOSIS AND PRESENCE OF THE CARDIAC VALVE CALCIFICATION<br />
IN NON-DIABETIC HEMODIALYSIS PATIENTS<br />
Saso Gelev | Lada Trajceska | Elizabeta Srbinovska | Svetlana Pavleska | Angel<br />
Oncevski | Petar Dejanov | Vesna Gerasomovska | Gjulsen Selim | Aleksandar<br />
Sikole<br />
Univ Clinic Nephrology, Skopje, FYR Macedonia | Univ Clinic Cardiology,<br />
Skopje, FYR Macedonia<br />
FP561<br />
CATHAWAY FISTULA VASCULAR ACCESS PROGRAM ACHIEVES IMPRO-<br />
VED OUTCOMES AND SETS A NEW STANDARD OF TREATMENT FOR<br />
END-STAGE RENAL DISEASE<br />
Steven Wilson | Tracy Mayne | Mahesh Krishnan | Janet Holland | Abbe Volz|<br />
Lori Good | Allen Nissenson<br />
DaVita, Inc, Denver, USA<br />
FP562<br />
CREATION OF UPPER EXTREMITY VASCULAR ACCESS IN DIALYSIS PA-<br />
TIENTS WITH SUPERIOR VENA CAVA STENOSIS<br />
Aristeidis Stavroulopoulos | Vasiliki Aresti | Georgios Maragkakis | Stelios<br />
Kyriakides<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Neprology Dept, Radiology Dept, Surgery Dept, IASIO Hosp, General Clinic Kallithea,<br />
Athens, Greece<br />
FP563<br />
CHANGES IN ACCESS BLOOD FLOW RATE AND BLOOD PRESSURE DU-<br />
RING HEMODIALYSIS<br />
Csaba Rikker | Edina Juhász | László Tornóci | Szilveszter Tóvárosi | Judit Greguschik<br />
| Otília Mag | László Rosivall<br />
FMC Dialysis Center, Péterfy Hosp, Budapest, Hungary | Inst Pathophysiology,<br />
Hungarian Academy of Sciences, Semmelweis Univ, Res Group for Pediatrics<br />
and Nephrology, Budapest, Hungary | FMC Hungary, Budapest, Hungary<br />
FP564<br />
CREATION OF ARTERIOVENOUS FISTULAE IN DIALYSIS NESTORS ABOVE<br />
85 YEARS OLD<br />
Tomasz Golebiowski | Ewa Watorek | Mariusz Kusztal | Krzysztof Letachowicz|<br />
Waldemar Letachowicz | Katarzyna Madziarska | Hanna Augustyniak Bartosik<br />
| Magdalena Krajewska | Wacław Weyde | Marian Klinger<br />
Dept Nephrology and Transpl Medicine Wroclaw Medical Univ Poland<br />
FP565<br />
PAINFUL SHOULDER IN HEMODIALYSIS: THE ROLE OF VASCULAR AC-<br />
CESS<br />
Alessandro Capitanini | Sara Lange | Adamasco Cupisti<br />
Dept Nephrology, Civil Hosp Pescia | Rehabilitation Medicine Unit, Pescia<br />
Hosp, Pescia - Italy | Div Nephrology, Dept Internal Medicine, Univ Pisa<br />
FP566<br />
INCIDENCE OF AV FISTULA CLOSURE DUE TO HIGH OUTPUT CARDIAC<br />
FAILURE IN KIDNEY TRANSPLED PATIENTS<br />
Tabea Schier | Georg Göbel | Claudia Bösmüller | Ingrid Gruber | Martin Tiefenthaler<br />
Medical Univ Innsbruck, Dept Internal Medicine IV (Nephrology and Hypertension)<br />
| Dept Medical Statistics and Computer Science, Medical Univ Innsbruck|<br />
Dept Visceral, Transpl and Thoracic Surgery, Medical Univ Innsbruck | Dept<br />
Vascular Surgery, Medical Univ Innsbruck<br />
FP567<br />
DOES FAR INFRARED TH<strong>ERA</strong>PY AID AV FISTULA MATURATION AND<br />
MAINTENANCE?<br />
Timothy Shipley | Jennifer Adam | Deborah Sweeney | Sean Fenwick | Hatem<br />
Mansy | Saeed Ahmed | Iain Moore<br />
City Hosp Sunderland<br />
FP568<br />
RANDOMIZED TRIAL COMPARING NEW CHITOSAN-BASED BANDAGE<br />
WITH KALTOSTAT HEMOSTATIC DRESSING TO CONTROL BLEEDING<br />
FROM HEMODIALYSIS PUNCTURE SITE<br />
Tamio Iwamoto | Kazuhiko Shibata | Gen Yasuda | Tomoko Kaneda | Tomoyuki<br />
Murakami | Tadashi Kuji | Naoaki Koguchi | Hidehisa Satta | Masahiro Nishihara<br />
| Seiichi Kawata | Mai Yanagi | Yukiko Yamada | Syuji Ono | Eri<br />
Ikeda| Atsushi Kitazawa | Yoshiyuki Toya | Satoshi Umemura<br />
Saiseikai Yokohamashi Nanbu Hosp | Yokohama City Univ Medical Center |<br />
Yokodai Central Clinic, Yokohama, Japan | Toshin Clinic | Yokohama Minami<br />
Clinic | Yokohama City Univ, Yokohama, Japan<br />
FP569<br />
POST-PUNCTURE BLEEDING TIME OF ARTERIO-VENOUS FISTULAE IS<br />
SHORTENED BY THE USE OF ‘IRIS’ BANDAGE<br />
Philippe Vigeral | Salima Saksi | Martin Flamant | Henri Boulanger<br />
Serv Nephro-dialyse Clinique Lambert | Clinique Estree Stains | CHU Bichat<br />
FP570<br />
CLINICAL SIGNIFICANCE OF EARLY POST-OP<strong>ERA</strong>TIVE VENOGRAPHY<br />
OF VASCULAR ACCESS BEFORE FIRST NEEDLING IN HEMODIALYSIS PA-<br />
TIENTS<br />
Young-Ok Kim | Sun-Ae Yoon | Yu-Seon Yun | Ho-Cheol Song | Byung-Soo<br />
Kim | Won-Do Park | Myeong A Cheong<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
183<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
184<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Uijeongbu St. Mary's Hosp, Catholic Univ Korea | Bucheon St. Mary's Hosp, Catholic<br />
Univ Korea | St. Paul's Hosp, Catholic Univ Korea | Sanggye Paik Hosp,<br />
Inje Univ | Korea Cancer Center Hosp<br />
FP571<br />
OPTIFLOWTM DEVICE – A NOVEL TECHNOLOGY FOR CREATION OF AR-<br />
TERIOVENOUS FISTULAE FOR HAEMODIALYSIS: EARLY CLINICAL EXPE-<br />
RIENCE, SAFETY AND EFFICACY<br />
Milind Nikam | Afshin Tavakoli | Eric Chemla | Jackie Evans | Hazel Malete |<br />
Lajos Matyas | Istvan Mogan | Miltos Lazarides | Adrian Ebner<br />
Manchester Royal Infirmary, Manchester, UK | Central Manchester Foundation<br />
Trust, Manchester, UK | St Georges Healthcare NHS trust, London, UK | B.A.Z.<br />
Megyei KH., Miskolc, Hungary | Szent Imre, Budapest, Hungary | Demokritos<br />
Univ, Alexandroupolis, Greece | French Hosp, Paraguay<br />
FP572<br />
ANATOMICAL FACTOR FOR THE LEFT BRACHIOCEPHALIC VEIN STENO-<br />
SIS IN HEMODIALYSIS PATIENTS<br />
Yaxue Shi | Jiwei Zhang | Jiejun Cheng<br />
Dept Vascular Surgery, Dept Radiology, RenJi Hosp, Shanghai, China<br />
FP573<br />
COMPARISON OF HEMODIALYSIS BLOOD ACCESS FLOW RATES USING 3<br />
ON-LINE TECHNIQUES AND ULTRASOUND DILUTION<br />
Le Roy Frank | Hanoy Mélanie | Bertrand Dominique | Godin Michel<br />
Rouen Universitary Hosp, Rouen, France<br />
FP574<br />
THE IMPORTANCE OF LOW-PRESSURE DILATION TO CONTROL LINING<br />
MEMBRANE DAMAGE IN VAIVT<br />
Kiyoshi Ikeda | Toru Yasuda | Hideki Yotueda<br />
Ikeda Vascular Access, Dialysis, and Internal Medicine Clinic| Fukuoka Red<br />
Cross Hosp<br />
FP575<br />
VASCULAR ACCESS IN HOME HAEMODIALYSIS: TRENDS AND OUTCO-<br />
MES<br />
Milind Nikam | Leonard Ebah | Anuradha Jayanti | Jackie Evans | Durga Kanigicherla<br />
| Angela Summers | Grace Manley | Gillian Dutton | Nicholas Chalmers<br />
| Sandip Mitra<br />
Manchester Royal Infirmary, Manchester, UK | Central Manchester Found Trust,<br />
Manchester, UK<br />
FP576<br />
INFLUENCE OF CKD ETIOLOGY AND HbA1C ON ACHIEVING A MATURE<br />
AVF<br />
Ionel-Alexandru Checherita | Andrei Niculae | Daniela Radulescu | Cristiana<br />
David | Flavia Liliana Turcu | Alexandru Ciocalteu<br />
Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania | Saint John<br />
Emergency Hosp, Bucharest, Romania<br />
FP577<br />
ARTERIOVENOUS FISTULA FOR HEMODIALYSIS IN ELDERLY PATIENTS<br />
Vanja Persic | Jadranka Buturovic-Ponikvar | Rafael Ponikvar<br />
Univ Medical Center, Ljubljana, Slovenia<br />
FP578<br />
PLASMA BNP LEVELS AND AVF FLOW IN HEMODIALYSIS (HD) PATIENTS<br />
Malik Touam | Victorio Menoyo | Tilman Drüeke | Mohamed Rifaat | Carmina<br />
Muresan | Mehdi Abtahi | Zineb Koochakipour | Dominique Joly<br />
AURA, Paris | ECHO, Vannes | Inserm ERI 12, Amiens | Hôp Necker<br />
FP579<br />
RETROSPECTIVE SURVEY OF VASCULAR ACCESS PROVISION FOR PA-<br />
TIENTS STARTING ON HAEMODIALYSIS AT BIRMINGHAM HEARTLANDS<br />
HOSP IN 2007 AND 2009/2010<br />
Jyoti Baharani | Sara Rizvi | Khai Ping Ng<br />
Birmingham Heartlands Hosp | Univ Hosp Birmingham, Birmingham, UK<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP580<br />
ENDOVASCULAR RECANALIZATION OF AN ACUTE DISTAL AVF THROM-<br />
BOSIS WITH EKOS® SYSTEM<br />
Laura Buzzi | Elena Alberghini | Francesca Ferrario | Ivano Baragetti | Gaia<br />
Santagostino | Silvia Furiani | Enzo Corghi | Cristina Sarcina | Veronica Terraneo<br />
| Francesco Rastelli | Giuseppe Bacchini | Claudio Pozzi<br />
Bassini Hosp, Cinisello Balsamo, Milan, Italy | A. Manzoni Hosp, Lecco, Italy<br />
FP581<br />
VALIDATION OF A NEW FISTULA (AVF) MONITORING SYSTEM BY TIME<br />
PATTERN DATA ANALYSIS<br />
Massimo Adorati Menegato | Rossella Mortellaro | Antonina Locicero | Alessandra<br />
Romano | Pier Paolo Manzini | Denis Steckiph<br />
San Antonio's Hosp | Gambro Hospal Spa, Italy<br />
FP582<br />
EXPERIENCE WITH THE MILLER BANDING PROCEDURE FOR HEMO-<br />
DIALYSIS PATIENTS WITH HIGH FLOW ACCESS OR STEAL SYNDROME<br />
Sadanori Shintaku | Hideki Kawanishi| Misaki Moriishi | Masataka Bansyodani<br />
| Syunpei Nakamura | Masafumi Saito | Shinichiro Tsuchiya<br />
Tsuchiya General Hosp, Hiroshima, Japan<br />
FP583<br />
ALTERNATIVE VASCULAR ACCESS FOR HEMODIALYSIS – A DEPT'S EX-<br />
PERIENCE<br />
Francisca Barros | Raquel Vaz | Berta Carvalho | Ricardo Neto | Patrícia Martins<br />
| Manuel Pestana<br />
Nephrology Dept, Hosp São João, Porto, Portugal<br />
FP584<br />
VASCULAR ACCESS: HAVE THE ALBANIAN NEPHROLOGISTS "DONE<br />
THE HOMEWORKS" LEFT BY THE INTERNATIONAL GUIDELINES<br />
Erjola Likaj | Saimir Seferi | Merita Rroji | Alma Idrizi | Ahmet Duraku | Myftar<br />
Barbullushi | Nestor Thereska<br />
UHC Mother Theresa, Tirana, Albania<br />
FP585<br />
FLOW VOLUME AND RESISTANCE INDEX PREDICT EARLY ACCESS FAI-<br />
LURE IN ARTERIOVENOUS FAILURE<br />
Sadanori Shintaku | Hideki Kawanishi| Misaki Moriishi | Masataka Bansyodani<br />
| Syunpei Nakamura | Masafumi Saito | Shinichiro Tsuchiya<br />
Tsuchiya General Hosp, Hiroshima, Japan<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
185<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
186<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
EPIDEMIOLOGY AND OUTCOME RESEARCH<br />
IN CKD 5D<br />
FP586<br />
BUNDLED PAYMENT FOR RENAL DIALYSIS IN A PORTUGUESE SETTING:<br />
ECONOMIC IMPLICATIONS<br />
Luis Coentrao | Carlos Ribeiro | Carla Santos-Araujo | Ricardo Neto | Manuel<br />
Pestana<br />
Nephrology Res and Development Unit, Fac Medicine, Univ Porto, Sao Jao Hosp<br />
Centre, Porto, Portugal | Financial Management Unit, São João Hosp Centre,<br />
Porto, Portugal<br />
FP587<br />
TRENDS BEFORE AND AFTER THE INTRODUCTION OF A REIMBURSE-<br />
MENT FLAT RATE AND A QUALITY MONITORING PROGRAM: EXPERIEN-<br />
CE FROM THE DOPPS IN GERMANY<br />
Werner Kleophas | Angelo Karaboyas | Yun Li | Juergen Bommer | Ronald<br />
Pisoni | Bruce Robinson | Friedrich Port<br />
Gemeinschaftspraxis Karlstrasse, Dusseldorf, Germany | Arbor Res Collaborative<br />
for Health, Ann Arbor, USA | Dialysezentrum Heidelberg, Germany<br />
FP588<br />
IS SLEEP AND LIFE QUALITY OF CAREGIVERS AFFECTED AS MUCH AS<br />
THAT OF HEMODIALYSIS PATIENTS?<br />
Gülperi Çelik | Bilge Burcak Annagur | Mümtaz Yılmaz | Tarık Demir | Fatih<br />
Kara<br />
Dept Internal Medicine, Div Nephrology, Selçuklu Fac Medicine, Selcuk Univ,<br />
Konya, Turkey | Dept Psychiatry, Selçuklu Fac Medicine, Selcuk Univ, Konya,<br />
Turkey | Dept Internal Medicine, Div Nephrology, Kütahya State Hosp, Kütahya,<br />
Turkey | Dept Public Health, Selçuklu Fac Medicine, Selcuk Univ, Konya,<br />
Turkey<br />
FP589<br />
SLEEP QUALITY, DAYTIME ACTIVITY AND RESTLESS LEGS SYNDROME IN<br />
PATIENTS UNDERGOING HEMODIALYSIS AND HEMODIAFILTRATION: A<br />
SINGLE CENTRE EXPERIENCE<br />
Konstantina Trigka | Periklis Dousdampanis | Nikolaos Vaitsis | Stamatina<br />
Aggelakou-Vaitsi<br />
Kyanous Stayros Patron<br />
FP590<br />
HEALTH RELATED QUALITY OF LIFE, SLEEP QUALITY AND DEPRESSION<br />
IN ELDERLY HEMODIALYSIS PATIENTS<br />
Kultigin Turkmen | Ibrahim Guney | Faruk Turgut | Lutfullah Altintepe | Halil<br />
Zeki Tonbul | Emaad Abdel-Rahman<br />
Konya Univ, Meram School of Medicine, Konya, Turkey | Meram Training and<br />
Reseach Hosp | Iskenderun Training and Res Hosp, Iskenderun, Turkey | Univ<br />
Virginia, Health System, Div Nephrology, Virginia, USA<br />
FP591<br />
ASSESSING QUALITY OF LIFE IN DIALYSIS PATIENTS: A ROLE FOR COM-<br />
PNENTS OF FRAILTY<br />
Paola Sclauzero | Giovanni Galli | Giulia Barbati | Michele Carraro | Giovanni<br />
Oliviero Panzetta<br />
Nephrology and Dialisis Unit AOUTS, Trieste - Italy | Cardiology Unit AOUTS,<br />
Trieste - Italy<br />
FP592<br />
PREDICTING MORTALITY IN DIABETIC INCIDENT DIALYSIS PATIENTS<br />
Merel van Diepen | Marielle Schroijen | Olaf Dekkers | Friedo Dekker<br />
Leiden Univ Medical Center, Leiden, Netherlands<br />
FP593<br />
DOES THE DAILY SODIUM INTAKE INFLUENCE MORTALITY IN DIALYSIS<br />
PATIENTS?<br />
Aleksandar Sikole | Galina Severova- Andreevska | Lada Trajceska | Saso Gelev|<br />
Vili Amitov | Svetlana Pavleska- Kuzmanovska<br />
Univ Clinic of Nefrology<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
« FP594<br />
HIGHER DIALYSATE SODIUM IS ASSOCIATED WITH BETTER HEMO-<br />
DIALYSIS PATIENT-REPORTED OUTCOMES: RESULTS FROM THE DOPPS<br />
Angelo Karaboyas | Hugh Rayner | Yun Li | Raymond Vanholder | Ronald<br />
Pisoni | Bruce Robinson | Friedrich Port | Manfred Hecking<br />
Arbor Res Collaborative for Health, Ann Arbor, USA | Birmingham Heartlands<br />
Hosp, UK | Ghent Univ Hosp, Belgium | Medical Univ Vienna, Austria<br />
FP595<br />
LONGITUDINAL EVALUATION OF SYMPTOM BURDEN IN HEMODIALY-<br />
SIS PATIENTS<br />
Beverly Jung | Marianna Leung | Fong Huynh | Tinnie Chung | Stan Marchuk |<br />
Mercedeh Kiaii | Lee Er | Ronald Werb | Clifford Chan-Yan | Monica Beaulieu<br />
St. Paul's Hosp, Vancouver, Canada | BC Renal Agency<br />
FP596<br />
SUBJECTIVE GLOBAL ASSESSMENT, NUTRITIONAL STATUS AND HE-<br />
ALTH RELATED QUALITY OF LIFE IN HEMODIALYSIS PATIENT<br />
Pavlos Malindretos | P Makri | G Zagkotsis | G Koutroumbas | G Loukas |<br />
E Nikolaou | M Pavlou | E Gourgoulianni | M Paparizou | M Markou | E<br />
Syrgani| Ch Syrganis<br />
Nephrology Dept, Acillopoulion General Hosp, Volos, Greece | Biochemistry<br />
Dept, Achillopoulion General Hosp, Volos, Greece | Statistician, Volos, Greece |<br />
1st Dept Internal Medicine, Achillopoulion General Hosp<br />
FP597<br />
DIFFERENCES IN SELF-REPORTED PHYSICAL AND MENTAL WELL-BEING<br />
BETWEEN DIABETIC AND NON-DIABETIC US HEMODIALYSIS PATIENTS<br />
Jochen Raimann | Len A Usvyat | Viraj Bhalani | Nathan W Levin | Peter Kotanko<br />
Renal Res Inst, New York, USA<br />
FP598<br />
ESTIMATED HEPATIC AND ADIPOSE TISSUE STEAROYL-COA DESATU-<br />
RASE-1 ACTIVITIES ARE ASSOCIATED WITH INFLAMMATION AND ALL-<br />
CAUSE MORTALITY IN DIALYSIS PATIENTS<br />
Xiaoyan Huang | Peter Stenvinkel | Abdul Rashid Qureshi | Ulf Riserus | Tommy<br />
Cederholm | Peter Barany | Olof Heimburger | Bengt Lindholm | Juan Jesus<br />
Carrero<br />
Karolinska Inst | Uppsala Univ | Div Renal Medicine and Baxter Novum, Dept<br />
Clinical Science, Intervention and Technology, Karolinska Inst, Stockholm, Sweden<br />
| Renal Medicine and Baxter Novum, Karolinska Inst<br />
FP599<br />
MORTALITY COMPARISON OF DIALYSIS MODALITY IN INCIDENT PA-<br />
TIENTS WITH END STAGE RENAL DISEASE: A PROPENSITY SCORE AP-<br />
PROACH<br />
Jae Hyun Chang | Ji Yoon Sung | Ji Yong Jung | Hyun Hee Lee | Wookyung<br />
Chung | Sejoong Kim<br />
Dept Internal Medicine, Gachon Univ School Medicine, Incheon, Korea | Dept<br />
Internal Medicine, Seoul National Univ Bundang Hosp, Seongnam, Korea<br />
FP600<br />
EFFECT OF TIMING OF DIALYSIS INITIATION ON MORTALITY IN ESRD<br />
PATIENTS<br />
Jin Suk Han | Sejoong Kim | Jae Hyun Chang | Ji Yong Jung | Wookyung<br />
Chung | Ki Young Na<br />
Seoul National Univ College Medicine, Seoul, Korea | Gachon Univ Gil Hosp,<br />
Incheon, Korea | Seoul National Univ Bundang Hosp, Seongnam, Korea<br />
FP601<br />
RELATIONSHIP BETWEEN VARIABILITY OF PRE DIALYSIS SERUM SO-<br />
DIUM AND MORTALITY RISK IN INCIDENT HEMODIALYSIS PATIENTS<br />
Jochen Raimann | Len A Usvyat | Peter Kotanko | Nathan W Levin<br />
Renal Res Inst, New York, USA<br />
FP602<br />
CHARLSON COMORBIDITY INDEX INDEPENDENTLY PREDICTS VASCU-<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
187<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
188<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
LAR CALCIFICATION IN HEMODIALYSIS PATIENTS<br />
André Fragoso | Ana Pinho | Anabela Malho | Ana Paula Silva | Elsa Morgado|<br />
Pedro Leão Neves<br />
Nephrology Dept, Hosp Faro, Faro, Portugal<br />
FP603<br />
THE TRANSITION OF PREVALENCE OF CORONARY ARTERY DISEASE AT<br />
THE INITIATION OF DIALYSIS OVER THE LAST TWO DECADES<br />
Nobuhiko Joki | Yuri Tanaka | Masaki Iwasaki | Shun Kubo | Toshihide Hayashi<br />
| Yasunori Takahashi | Koichi Hirahata | Yoshihiko Imamura | Hiroki<br />
Hase<br />
Toho Univ Ohashi Medical Center | Nissan Tamagawa Hosp | Hirahata Clinic<br />
FP604<br />
FACTORS AFFECTING THE NUMBER OF PATIENTS TREATED WITH EI-<br />
THER PERITONEAL OR HOME HAEMODIALYSIS IN THE UK<br />
Clare Castledine | Julie Gilg | Chris Rogers | Yoav Ben-Shlomo | Fergus Caskey<br />
UK Renal Registry, Bristol, UK | Univ Bristol | School Social and Community<br />
Medicine, Bristol Univ, UK | NHS North Bristol, Bristol, UK<br />
FP605<br />
LOW RESISTIN LEVELS IS ASSOCIATED WITH POOR HOSPITALIZATION-<br />
FREE SURVIVAL IN HEMODIALYSIS PATIENTS<br />
Ki Young Na | Sejoong Kim | Wookyung Chung | Ji Yong Jung | Jae Hyun<br />
Chang | Hyun Hee Lee<br />
SNUBH | Gachon Univ Gil Hosp, Incheon, Korea<br />
FP606<br />
OCULAR CHANGES IN PATIENTS OF CHRONIC KIDNEY DISEASE AND<br />
RENAL ALLOGRAFT RECIPIENTS<br />
Jasvinder Singh Sandhu | G S Bajwa | Shyna Kansal | Jashan Sandhu<br />
Dayanand Medical College, Ludhiana, India<br />
FP607<br />
TECHNIQUE FAILURE IN HOME HAEMODIALYSIS- A PROSPECTIVE SIN-<br />
GLE CENTRE EXPERIENCE<br />
Anuradha Jayanti | Milind Nikam | Leonard Ebah | Angela Summers | Sandip<br />
Mitra<br />
Manchester Royal Infirmary, Manchester, UK<br />
FP608<br />
AN AFFORDABLE MODEL FOR SOLAR-ASSISTED HOME HAEMODIALYSIS<br />
John Agar | Anthony Perkins | Rosemary Simmonds | Alwie Tjipto<br />
Geelong Hosp, Barwon Health<br />
FP609<br />
PREVALENCE OF NEPHROGENIC SYSTEMIC FIBROSIS (NSF) IN DIALYSIS<br />
PATIENTS: FINAL RESULTS OF THE PRO-FINEST STUDY<br />
Sabine Amet | Vincent Launay-Vacher | Maurice Laville | Aurore Tricotel | Camille<br />
Frances | Benedicte Stengel | Jean-Yves Gauvrit | Nicolas Grenier | Genevieve<br />
Reinhardt | Olivier Clement | Nicolas Janus | Laurence Rouillon | Gabriel<br />
Choukroun | Gilbert Deray<br />
Serv ICAR, Nephrology Dept, Pitie-Salpetriere Hosp, Paris, France | Nephrology<br />
Dept, Edouard Herriot Hosp, Lyon, France | Drug Monitoring, Afssaps, Saint-Denis,<br />
France | Dermatology Dept, Tenon Hosp, Paris, France | Inserm U1018, Paul<br />
Brousse Hosp, Villejuif, France | Radiology Dept, Pontchaillou Hosp, Rennes,<br />
France | Radiology Dept, Pellegrin Hosp, Bordeaux, France | Radiology Dept,<br />
Haguenau Hosp, Haguenau, France | Radiology Dept, G. Pompidou Hosp, Paris,<br />
France | Nephrology Dept, South Hosp, Amiens, France | Nephrology Dept,<br />
Pitie-Salpetriere Hosp, Paris, France<br />
FP610<br />
CAN A REDUCED RENAL RESPONSE TO A PROTEIN CHALLENGE IN PRE-<br />
GNANT WOMEN SUFFERING FROM CHRONIC RENAL DISEASE PRECLU-<br />
DE THE INITIATION OF RENAL IMPAIRMENT?<br />
Amelia Bernasconi | Rosa Waisman | Ana Patricia Montoya | Amador Andrés<br />
Liste | Ricardo Hermes | Graciela Muguerza | Ricardo Heguilen<br />
Hosp J.A. Fernandez<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP611<br />
CROSS SECTIONAL EPIDEMIOLOGICAL STUDY IN HEMODIALYSIS PA-<br />
TIENTS<br />
Elena Laura Iliescu<br />
Fundeni Clinical Inst, Bucharest, Romania<br />
FP612<br />
EVALUATION OF CHRONIC PAIN IN CKD PATIENTS<br />
Valentina Martina | Maria Antonietta Rizzo | Paolo Magenta | Lorenzo Lubatt|<br />
Giuseppe Rombolà | Maurizio Gallieni<br />
Nephrology and Dialysis Unit, San Carlo Borromeo Hosp, Milano, Italy | Pain<br />
Therapy Unit, San Carlo Borromeo Hosp, Milano, Italy | Nephrology and Dialysis<br />
Unit, Osp Sant'Andrea, La Spezia, Italy<br />
FP613<br />
SOCIOPROFESSIONAL OUTCOME AT ADULT AGE OF CHILDREN AFTER<br />
KIDNEY TRANSPL<br />
Chantal Loirat | Hélène Mellerio | Marylène Labèguerie | Béatrice Andriss |<br />
Emilie Savoye | Mathilde Lassale | Christian Jacquelinet | Corinne Alberti<br />
Pediatric Nephrology, Hôp Robert Debré, Paris, France | Inserm, CIC-EC, CIE 5,<br />
Hôp Robert Debré, Paris, France | Agence Biomédecine, Saint Denis La Plaine,<br />
France<br />
FP614<br />
END OF LIFE DECISION-MAKING: WITHDRAWING FROM DIALYSIS – A 10<br />
YEAR RETROSPECTIVE SINGLE CENTRE EXPERIENCE FROM THE UK<br />
Yogita Aggarwal | Jyoti Baharani<br />
Birmingham Heartlands Hosp<br />
FP615<br />
DRUG COMPLIANCE IN HEMODIALYSIS PATIENTS- CORRELATION WITH<br />
DEPRESSION AND PARACLINICAL FINDINGS<br />
Shiva Tabrizian | Shahrzad Ossareh | Marjan Zebarjadi<br />
Hasheminejad Clinical Res Development Center, Tehran Univ Medical Sciences<br />
FP616<br />
UNDERSTANDING A NEW <strong>ERA</strong> FOR DEPRESSION AND ANXIETY IN HE-<br />
MODIALYSIS PATIENTS<br />
Pedro Azevedo | Francisco Travassos | Inês Frade | Manuela Almeida | José<br />
Queirós | Fernanda Silva | António Cabrita | Rosária Rodrigues<br />
Centro Hosp Porto | Mirandela Hemodialysis Center<br />
FP617<br />
CLUSTERING COUNTRIES BY RENAL SERV CHARACTERISTICS: RESULTS<br />
FROM THE EVEREST STUDY<br />
Cécile Couchoud | Jager Kitty | Stengel Bénédicte | Caskey Fergus<br />
Agence Biomédecine | AMC, Amsterdam, Netherlands | Inserm/Univ Paris<br />
Sud, Villejuif, France | Southmead Hosp, Bristol, UK<br />
FP618<br />
A NEW APPROACH FOR MEASURING GENDER DISPARITY IN ACCES TO<br />
RENAL TRANSPL<br />
Couchoud Cécile | Bayat Sahar | Villar Emmanuel | Jacquelinet Christian |<br />
Ecochard René<br />
Agence Biomédecine, France | School Public Health, Rennes, France | Hospices<br />
Civils Lyon, France<br />
FP619<br />
INTEGRATION OF CHRONIC KIDNEY DISEASE SCREENING IN NATIONAL<br />
PRIMARY HEALTH CARE NETWORK , PILOT STUDY, IRAN<br />
Hamid Barahimi | Mitra Mahdavi-Mazdeh | Mohsen Nafar<br />
Ministry Health, Transpl and Specific Disease Office | Iranian Tissue Bank & Res<br />
Center, TUMS | Labbafinejad Hosp; Tehran; Iran<br />
FP620<br />
THIRST AND ORAL SYMPTOMS IN PEOPLE ON HEMODIALYSIS: A MULTI-<br />
NATIONAL PROSPECTIVE COHORT STUDY<br />
Massimo Petruzzi | Michele De Benedittis | Michela Sciancalepore | Letizia Gar-<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
189<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
190<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
gano | Patrizia Natale | Maria Cristina Vecchio | Valeria Saglimbene | Fabio<br />
Pellegrini | Giorgio Gentile | Paul Stroumza | Luc Frantzen | Miguel Leal | Marietta<br />
Torok | Anna Bednarek | Jan Dulawa | Eduardo Celia | Ruben Gelfman|<br />
Jorgen Hegbrant | Charlotta Wollheim | Suetonia Palmer | David W Johnson |<br />
Pauline J Ford | Jonathan C Craig | Giovanni FM Strippoli | Marinella Ruospo<br />
Univ Bari, School Dentistry and Surgery, Italy | Diaverum Italy | Consorzio Mario<br />
Negri Sud, Italy | Univ Perugia, Italy | Diaverum France | Diaverum Portugal|<br />
Diaverum Hungary | Diaverum Poland | Diaverum Argentina | Diaverum<br />
Medical Scientific Office, Sweden | Univ Otago Christchurch, New Zealand|<br />
Univ Queensland, Princess Alexandra Hosp, Australia | Univ Queensland, School<br />
Dentistry, Australia | School Public Health, Univ Sydney, Australia<br />
FP621<br />
GEN<strong>ERA</strong>LIZED ANXIETY DISORDER (GAD) IN PREVALENT PATIENTS ON<br />
HEMODIALYSIS<br />
Bilal El Hayek | Eduardo Baamonde | Elvira Bosch | Jose I Ramirez | German<br />
Perez | Ana Ramirez | Agustin Toledo | Maria M Lago | Cesar Garcia-Canton|<br />
M Dolores Checa<br />
Avericum Hemodialysis Center, Las Palmas, Spain | Centro Hemodiálisis Avericum<br />
| Serv Nefrología<br />
FP622<br />
A SIMPLIFIED FORMULA TO CALCULATE THE CREATININE INDEX IN<br />
HEMODIALYSIS PATIENTS: STRONG ASSOCIATION WITH PATIENT CHA-<br />
RACTERISTICS AND MORTALITY IN THE DOPPS<br />
Bernard Canaud | Brett Lantz | Ronald Pisoni | Alexandre Granger-Vallée |<br />
Paungpaga Lertdumrongluk | Nicolas Molinari | Jean Ethier | Michel Jadoul |<br />
Brenda Gillespie | Friedrich Port<br />
Lapeyronie Univ Hosp, Montpellier, France | Arbor Res Collaborative for Health,<br />
Ann Arbor, USA | Montpellier Regional Univ Hosp, Montpellier, France |<br />
Srinakharinwirot Univ, Pakkret, Nonthaburi, Thailand | INSERM, Montpellier,<br />
France | Centre Hosp Univ Montréal, Montreal, Quebec, Canada | Cliniques<br />
Univ St-Luc, Brussels, Belgium | Univ Michigan, Ann Arbor, USA<br />
FP623<br />
PILL BURDEN AND ITS ASSOCIATION WITH MEDICATION POSSESSION<br />
RATIO AMONG HEMODIALYSIS PATIENTS WITH HYPERPHOSPHATEMIA<br />
Christopher Bond | Steven Wang | Thomas Alfieri | Peter Braunhofer | Britt<br />
Newsome<br />
DaVita Inc, Denver, CO, USA | Vifor Pharma, Glattbrugg, Switzerland, EU |<br />
Denver Nephrology, Denver, CO, USA<br />
FP624<br />
DIALYSIS TREATMENT TIME, DIALYSIS FREQUENCY, AND DELIVERED<br />
SINGLE POOL KT/V AMONG HEMODIALYSIS PATIENTS IN THE CHINA<br />
DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS)<br />
M Wang | M Guidinger | B Bieber | M Wang | L Zuo | RL Pisoni | X Yu | X<br />
Yang | J Qian | N Chen | J Albert | Y Yan | S Ramirez<br />
Peking Univ First Hosp, Beijing, China | Univ Michigan, Ann Arbor, Michigan,<br />
USA | Arbor Res Collaborative for Health, Ann Arbor, Michigan, USA| First<br />
Affiliated Hosp Sun Yat-Sen Univ, Guangzhou, China | Dept Medicine, Renji<br />
Hosp | Shanghai Ruijin Hosp, Shanghai, China<br />
FP625<br />
PREGNANCY: INTENSIFIED HEMODIALYSIS YES OR NO?<br />
Amelia Bernasconi | Rosa Waisman | Marina Beresan | Alicia Lapidus | Marcela<br />
Canteli | Ricardo Heguilen<br />
Hosp J.A. Fernandez<br />
FP626<br />
CLINICIAN BELIEFS AND ATTITUDES ABOUT HOME HAEMODIALYSIS:<br />
QUALITATIVE INTERVIEW STUDY<br />
Allison Tong | Suetonia Palmer | Braden Manns | Jonathan Craig | Marinella<br />
Ruospo | Letizia Gargano | Giovanni Strippoli<br />
Univ Sydney | Univ Otago Christchurch, New Zealand | Univ Calgary, Calgary,<br />
Alberta | Diaverum Medical Scientific Office | Diaverum | Cochrane Renal<br />
Group, Sydney, Australia<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP627<br />
AEROBIC EXERCISE IMPROVES SIGNS OF RESTLESS LEG SYNDROME IN<br />
END STAGE RENAL DISEASE PATIENTS SUFFERING CHRONIC HEMO-<br />
DIALYSIS<br />
Mojgan Mortazavi | Babak Vahdatpour | Shahrzad Shahidi | Aida Ghasempour|<br />
Diana Taheri | Shahaboddin Dolatkhah | Afsoon Emami Naieni | Maryam<br />
Ghassami<br />
Isfahan, Iran<br />
FP628<br />
A STAFF SURVEY ON END OF LIFE CARE IN ADVANCED KIDNEY DISEASE<br />
Muhammad Khan | Khaled Abdulnabi | Pearl Pai<br />
Royal Liverpool and Broadgreen Hosp NHS Trust<br />
FP629<br />
PREVALENCE OF ORAL LESIONS IN HEMODIALYSIS PATIENTS: A PRO-<br />
SPECTIVE MULTINATIONAL COHORT STUDY<br />
Marinella Ruospo | Massimo Petruzzi | Michele De Benedittis | Michela Sciancalepore<br />
| Letizia Gargano | Mariacristina Vecchio | Valeria Saglimbene | Patrizia<br />
Natale | Fabio Pellegrini | Giorgio Gentile | Paul Stroumza | Luc Frantzen|<br />
Miguel Leal | Marietta Torok | Anna Bednarek | Jan Dulawa | Eduardo Celia|<br />
Ruben Gelfman | Jorgen Hegbrant | Charlotta Wollheim | Suetonia Palmer |<br />
David W Johnson | Pauline J Ford | Jonathan C Craig | Giovanni FM Strippoli<br />
Diaverum Medical Scientific Office, Sweden | Univ Bari, School Dentistry and<br />
Surgery, Italy | Diaverum Italy | Consorzio Mario Negri Sud, Italy | Univ Perugia,<br />
Italy | Diaverum France | Diaverum Portugal | Diaverum Hungary |<br />
Diaverum Poland | Diaverum Argentina | Diaverum Medical Scientific Office,<br />
Sweden | Univ Otago Christchurch, New Zealand | Univ Queensland, Princess<br />
Alexandra Hosp, Australia | Univ Queensland, School Dentistry, Australia |<br />
School Public Health, Univ Sydney, Australia<br />
FP630<br />
PREVALENCE OF CHRONIC KIDNEY DISEASE (CKD) AND IDENTIFICA-<br />
TION OF ASSOCIATED RISK FACTORS IN A RURAL AREA BY MASS SCRE-<br />
ENING<br />
Md. Abdul Muqueet | Mahmud Javed Hasan | M. Abul Kashem | Pradip Kumar<br />
Dutta<br />
Nephrology Dept MMC | Nephrology Dept CBMCB | Nephrology Dept CMC<br />
FP631<br />
PERITONEAL DIALYSIS VS. IN-CENTER HEMODIALYSIS: A SYSTEMATIC<br />
REVIEW OF THE ECONOMIC LIT<strong>ERA</strong>TURE<br />
Frank Xiaoqing Liu | Les Noe | Tiffany Quock | Nancy Neil | Gary Inglese<br />
Baxter Healthcare Corporation, McGaw Park, USA | ICON/Oxford Outcomes,<br />
Eugene, USA | ICON/Oxford Outcomes, San Francisco, USA | Decision Res,<br />
Eugene, USA<br />
FP632<br />
PRACTICE PATTERNS FOR VASCULAR ACCESS AND ANEMIA MANAGE-<br />
MENT: FINDINGS FROM THE CHINA DIALYSIS OUTCOMES AND PRACTI-<br />
CE PATTERNS STUDY (DOPPS) POPULATION<br />
J Qian | M Guidinger | B Bieber | N Chen | Y Yan | RL Pisoni | M Wang | L<br />
Zuo | X Yu | X Yang | M Wang | J Albert | S Ramirez<br />
Shanghai Society Internal Medicine, Shanghai, China | Univ Michigan, Ann Arbor,<br />
Michigan, USA | Arbor Res Collaborative for Health, Ann Arbor, Michigan,<br />
USA | Shanghai Ruijin Hosp, Shanghai, China | Renji Hosp, Shanghai, China |<br />
Peking Univ First Hosp, Beijing, China | First Affiliated Hosp Sun Yat-Sen Univ,<br />
Guangzhou, China<br />
FP633<br />
EFFECTIVENESS OF COGNITIVE- EXISTENTIAL GROUP TH<strong>ERA</strong>PY ON IN-<br />
CREASING HOPE IN WOMEN UNDER MAINTENANCE HEMODIALYSIS<br />
Shahrzad Ossareh | Maryam Motamed Najjar | Bahman Bahmani | Abdolah<br />
Shafiabadi<br />
Dept Medicine, Nephrology Section, Hasheminejad Clinical Res Development<br />
Center, Tehran Univ Medical Sciences, Tehran, Iran | Univ Social Welfare and<br />
Rehabilitation Sciences, Tehran, Iran | Allameh Tabatabayi Univ, Tehran, Iran<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
191<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
192<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP634<br />
BIOCHEMICAL VARIABLES AND SURVIVAL IN PATIENTS WITH TYPE 1<br />
DIABETES ON RENAL REPLACEMENT TH<strong>ERA</strong>PY<br />
Jaakko Helve | Mikko Haapio | Per-Henrik Groop | Carola Grönhagen-Riska|<br />
Patrik Finne<br />
Helsinki Univ Hosp, Dept Medicine, Helsinki, Finland | Helsinki Univ Central<br />
Hosp, Div Nephrology, Helsinki, Finland | Finnish Registry for Kidney Diseases,<br />
Helsinki, Finland<br />
FP635<br />
PREDIALYTIC MEDICATION AND SURVIVAL IN PATIENTS WITH TYPE 1<br />
DIABETES ON RENAL REPLACEMENT TH<strong>ERA</strong>PY<br />
Jaakko Helve | Mikko Haapio | Reijo Sund | Per-Henrik Groop | Carola Grönhagen-Riska<br />
| Patrik Finne<br />
Helsinki Univ Hosp, Dept Medicine, Helsinki, Finland | Helsinki Univ Central<br />
Hosp, Div Nephrology, Helsinki, Finland | National Inst Health and Welfare<br />
(THL), Serv Systems Res, Helsinki, Finland | Finnish Registry Kidney Diseases,<br />
Helsinki, Finland<br />
FP636<br />
PSYCHOLOGICAL AND EXERCISE INTERVENTION IN DIALYSIS STUDY<br />
Michael Cai | Sanjeev Baweja | Amy Clements | Annette Kent | Rachel Reilly |<br />
Nicholas Taylor | Stephen Holt | Lawrence McMahon<br />
Eastern Health, Melbourne, Australia | Northern Hosp | Monash Univ | Eastern<br />
Health<br />
FP637<br />
HIGHER INTERDIALYTIC WEIGHT GAIN BUT ALSO ITS DECLINES ARE<br />
ASSOCIATED WITH POORER OUTCOMES IN INCIDENT HEMODIALYSIS<br />
PATIENTS<br />
Len A Usvyat | Mary Carter | Frank M. van der Sande | Jeroen Kooman | Jochen<br />
Raimann | Nathan W Levin | Peter Kotanko<br />
Renal Res Inst, New York, USA | Sustainable Kidney Care Foundation, New<br />
York, USA | Maastricht Univ Hosp<br />
FP638<br />
INCREASES IN NEUTROPHIL-TO-LYMPHOCYTE RATIO ARE ASSOCIATED<br />
WITH POORER OUTCOMES IN INCIDENT HEMODIALYSIS PATIENTS<br />
Len A Usvyat | Rakesh Malhotra | Georges Ouellet | E. Lars Penne | Jochen<br />
Raimann | Stephan Thijssen | Nathan W Levin | Peter Kotanko<br />
Renal Res Inst, New York, USA | Renal Res Inst, Beth Israel Medical Center |<br />
Hosp Maisonneuve-Rosemont | VU Medical Center<br />
FP639<br />
PREDICTORS OF HEMODIALYSIS PATIENT OUTCOMES IN THE FIRST<br />
YEAR: RESULTS FROM AN INTERNATIONAL STUDY<br />
Michael Etter | Adam Tashman | Adrian Guinsburg | Aileen Grassmann | claudia<br />
barth | Cristina Marelli | Daniele Marcelli | Frank M. van der Sande | Gero<br />
von Gersdorff | Inga Bayh | Jeroen Kooman | Laura Scatizzi | Maggie Lam |<br />
Mathias Schaller | Stephan Thijssen | Ted Toffelmire | Yuedong Wang | Penny<br />
Sheppard | Len A Usvyat | Nathan W Levin | Peter Kotanko<br />
Fresenius Medical Care Asia Pacific | Renal Res Inst, New York, New York, USA|<br />
Fresenius Medical Care Latin America | Fresenius Medical Care Europe | Curatorium<br />
Dialysis and Kidney Transpl (KfH) | Maastricht Univ Hosp | Univ Hosp<br />
Cologne, Cologne, Germany | Fresenius Medical Care Canada | Univ California<br />
Santa Barbara<br />
FP640<br />
INEQUALITIES IN TRANSPL WAITING LIST ACTIVATION FOR PATIENTS<br />
ON DIALYSIS IN THE MIGLIORDIALISI STUDY SAMPLE<br />
Luca Neri | Victor A. Andreucci | Lisa A. Rocca-Rey | Silvio V. Bertoli | Diego<br />
Brancaccio<br />
Dept Occupational and Environmental Health, Univ Milan | Fond Italiana Rene,<br />
onlus | Multimedica Hosp, Castellanza (VA)<br />
FP641<br />
THE IMPACT OF A HOME NOCTURNAL HAEMODIALYSIS PROGRAM ON<br />
THE GROWTH OF FACILITY HAEMODIALYSIS: A RETROSPECTIVE RE-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
VIEW (JANUARY 2000 – DECEMBER 2011)<br />
Alwie Tjipto | Rosemary Simmonds | John Agar<br />
Geelong Hosp, Barwon Health<br />
FP642<br />
ESSENTIAL POLYUNSATURATED FATTY ACIDS, INFLAMMATION AND<br />
MORTALITY IN DIALYSIS PATIENTS<br />
Xiaoyan Huang | Peter Stenvinkel | Abdul Rashid Qureshi | Ulf Riserus | Tommy<br />
Cederholm | Peter Barany | Olof Heimburger | Bengt Lindholm | Juan Jesus<br />
Carrero<br />
Karolinska Inst | Uppsala Univ | Div Renal Medicine and Baxter Novum, Dept<br />
Clinical Science, Intervention and Technology, Karolinska Inst, Stockholm, Sweden<br />
| Renal Medicine and Baxter Novum, Karolinska Inst<br />
FP643<br />
SEXUAL DYSFUNCTION IN WOMEN WITH END-STAGE KIDNEY DISEA-<br />
SE REQUIRING HEMODIALYSIS: A MULTINATIONAL CROSS-SECTIONAL<br />
STUDY<br />
Mariacristina Vecchio | Suetonia Palmer | Giorgia De Berardis | Jonathan Craig|<br />
Giuseppe Lucisano | David Johnson | Fabio Pellegrini | Antonio Nicolucci |<br />
Michela Sciancalepore | Valeria Saglimbene | Letizia Gargano | Carmen Bonifati<br />
| Marinella Ruospo | Sankar D Navaneethan | Vincenzo Montinaro| Paul<br />
Stroumza | Marianna Zsom | Marietta Torok | Eduardo Celia | Ruben Gelfman|<br />
Anna Bednarek-Skublewska | Jan Dulawa | Giusi Graziano | Giorgio Gentile|<br />
Juan Nin Ferrari | Antonio Santoro | Annalisa Zucchelli | Giorgio Triolo | Stefano<br />
Maffei | Jörgen Hegbrant | Charlotta Wollheim | Salvatore De Cosmo |<br />
Valeria M Manfreda | Giovanni FM Strippoli<br />
Consorzio Mario Negri Sud, Italy | Dept Medicine, Univ Otago, Christchurch,<br />
New Zealand | Dept Clinical Pharmacology and Epidemiology, Mario Negri Sud<br />
Consortium | School Public Health, Univ Sydney, Australia | Dept Nephrology,<br />
Univ Queensland Princess Alexandra Hosp, Brisbane, Australia | Diaverum Medical-Scientific<br />
Office, Sweden | Dept Nephrology and Hypertension, Cleveland<br />
Clinic, Cleveland, OH, USA | Dept Emergency and Organ Transpl, Univ Bari,<br />
Italy | Univ Perugia, Italy | Dept Nephrology, Dialysis, Hypertension, Policlinico<br />
S. Orsola-Malpighi, Bologna, Italy | SCDO Nefrology and Dialysis, Azienda Osp<br />
CTO/CRF/M. Adelaide, Torino | Unit Endocrinology, Scientific Inst Casa Sollievo<br />
della Sofferenza, San Giovanni Rotondo, Italy | Osp A Perrino, Brindisi, Italy<br />
FP644<br />
EVOLUTION OF THE MANAGEMENT OF CHRONIC KIDNEY DISEASE IN<br />
FRANCE BETWEEN 1998 AND 2009: THE ORACLE STUDY<br />
Nicolas Janus | Vincent Launay-Vacher | Laurent Juillard | Adrien Rousset |<br />
François Butel | Sandrine Girardot-Seguin | Gilbert Deray | Thierry Hannedouche<br />
| Myriam Isnard | Yvon Berland | Philippe Vanhille | Jean-Paul Ortiz|<br />
Gérard Janin | Nicoud | Malik Touam | Elfie Bruce | Laurence Rouillon | Maurice<br />
Laville<br />
Serv ICAR, Nephrology Dept, Pitie-Salpetriere Hosp, Paris, France | Nephrology<br />
Dept, Edouard Herriot Hosp, Lyon, France | Roche Pharma, Boulogne-Billancourt,<br />
France | Nephrology Dept, Pitie-Salpetriere Hosp, Paris, France | Nephrology<br />
Dept, Hop Univ Strasbourg, Strasbourg, France | Nephrology Dept, AURA<br />
Auvergne, Chamalieres, France | Nephrology Dept, Conception Hosp, Marseille,<br />
France | Nephrology Dept, Valenciennes Hosp, Valenciennes, France| Nephrology<br />
Dept, Saint-Roch Private Hosp, Cabestany, France | Nephrology Dept, Chanaux<br />
Hosp, Mâcon, France | Nephrology Dept, Pays du Mont-Blanc Hosp, Chamonix,<br />
France | Nephrology, AURA Paris, Paris, France<br />
FP645<br />
THE COURSE OF RENAL DISEASE IN DIABETIC PATIENTS IN FRANCE THE<br />
ORACLE STUDY<br />
Nicolas Janus | Laurent Juillard | Adrien Rousset | François Butel | Sandrine<br />
Girardot-Seguin | Gilbert Deray | Thierry Hannedouche | Myriam Isnard| Yvon<br />
Berland | Philippe Vanhille | Jean-Paul Ortiz | Gérard Janin | Philippe Nicoud |<br />
Malik Touam | Bruce | Laurence Rouillon | Maurice Laville<br />
Pitié-Salpêtrière Hosp, Paris, France | Nephrology Dept, Edouard Herriot Hosp,<br />
Lyon, France | Roche Pharma, Boulogne-Billancourt, France | Serv ICAR, Nephrology<br />
Dept, Pitie-Salpetriere Hosp, Paris, France | Nephrology Dept, Hôp<br />
Univ Strasbourg, Strasbourg, France | Nephrology Dept, AURA-Auvergne,<br />
Chamalières, France | Nephrology Dept, Conception Hosp, Marseille, France |<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
193<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
194<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Nephrology Dept, Valenciennes Hosp, Valenciennes, France | Nephrology Dept,<br />
Saint-Roch Pivate Hosp, Cabestany, France | Nephrology Dept, Chanaux Hosp,<br />
Macon, France | Nephrology Dept, Pays du Mont-Blanc Hosp, Chamonix, France|<br />
Nephrology Dept, AURA-Paris, Paris, France<br />
FP646<br />
THE COURSE OF CHRONIC KIDNEY DISEASE IN FRANCE RESULTS OF THE<br />
ORACLE STUDY<br />
Nicolas Janus | Vincent Launay-Vacher | Laurent Juillard | Adrien Rousset |<br />
François Butel | Sandrine Girardot-Seguin | Gilbert Deray | Thierry Hannedouche<br />
| Myriam Isnard | Yvon Berland | Philippe Vanhille | Jean-Paul Ortiz<br />
| Gérard Janin | Philippe Nicoud | Malik Touam | Elfie Bruce | Laurence<br />
Rouillon| Maurice Laville<br />
Serv ICAR, Nephrology Dept, Pitie-Salpetriere Hosp, Paris, France | Nephrology<br />
Dept, Edouard Herriot Hosp, Lyon, France | Roche Pharma, Boulogne-Billancourt,<br />
France | Nephrology Dept, Hôp Univ Strasbourg, Strasbourg, France|<br />
Nephrology Dept, AURA-Auvergne, Chamalières, France | Nephrology Dept,<br />
Conception Hosp, Marseille, France | Nephrology Dept, Valenciennes Hosp,<br />
Valenciennes, France | Nephrology Dept, Saint-Roch Private Hosp, Cabestany|<br />
Nephrology Dept, Chanaux Hosp, Mâcon, France | Nephrology Dept, Pays du<br />
Mont-Blanc Hosp, Chamonix, France | Nephrology Dept, AURA-Paris, Paris,<br />
France<br />
FP647<br />
DIALYSIS MODALITY AND SOCIO-ECONOMIC STATUS IN AUSTRALIA<br />
Blair Grace | Philip Clayton | Alan Cass | Stephen McDonald<br />
ANZDATA Registry, Adelaide, Australia | Australia and New Zealand Dialysis<br />
and Transpl Registry | George Inst Global Health<br />
FP648<br />
WHEN 'NO' DOESNT MEAN NO. PATIENTS WHO OPT FOR CONSERVA-<br />
TIVE MANAGEMENT AND THEN CHANGE THEIR MIND REGARDING<br />
DIALYSIS TREATMENT- EXPERIENCE OF A SINGLE UK CENTRE<br />
Jyoti Baharani<br />
Birmingham Heartlands Hosp<br />
FP649<br />
DIALYSIS SPECIALISTS ACHIEVED HIGHER GUIDELINE ADHERENCE<br />
RATE COMPARED WITH NON-SPECIALISTS<br />
Yoshiyuki Furumatsu | Tetsuya Kitamura | Naohiko Fujii | Satoshi Ogata |<br />
Hidetomo Nakamoto | Kunitoshi Iseki | Yoshiharu Tsubakihara<br />
Fujiidera Keijinkai Clinic | Hyogo Prefectural Nishinomiya Hosp | Hiroshima<br />
International Univ | Saitama Medical School | Univ Hosp Ryukyus | Depts<br />
Kidney Disease and Hypertension, Osaka General Medical Center, Osaka, Japan<br />
FP650<br />
OUTCOMES OF DEMENTIA AMONG DIALYSIS PATIENTS: A NATIONWIDE<br />
POPULATION-BASED STUDY IN TAIWAN<br />
Chih-Chiang Chien | Jhi-Joung Wang | Jyh-Chang Hwang | Hsien-Yi Wang |<br />
Wei-Chih Kan<br />
Depts Nephrology, Chi-Mei Medical Center<br />
FP651<br />
DOES HIGH SENSITIVITY TROPONIN T MODIFY LONG TERM RISK STRATI-<br />
FICATION IN DIALYSIS PATIENTS?<br />
Nils Kuster | Laure Patrier | Anne-Sophie Bargnoux | Marion Morena | Anne-<br />
Marie Dupuy | Stéphanie Badiou | Bernard Canaud | Jean-Paul Cristol<br />
Lab Biochimie, CHRU Montpellier | Serv Néphrologie-Hémodialyse et Soins<br />
Intensifs, CHRU Montpellier<br />
FP652<br />
PERCEPTIVE OBSTACLES TO PERITONEAL DIALYSIS IMPLEMENTATION:<br />
AN OPINION POLL AMONG THE FRENCH-SPEAKING BELGIAN NEPHRO-<br />
LOGISTS<br />
Jean-Marc Desmet | Vasco Fernandes | Frédéric Collart | Nathalie Spinogatti |<br />
Jean-Michel Pochet | Max Dratwa | Eric Goffin | Joëlle Nortier<br />
Vésale Hosp, Montigny-le-Tilleul | Curry Cabral Hosp | Brugmann Hosp, Brussels<br />
| Centre Hosp Charleroi, Charleroi | Clinique St Elisabeth, Namur | Cliniques<br />
Univ St Luc, Brussels | Erasme Hosp, Brussels, Belgium<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP653<br />
NEPHROLOGY REFERRAL AND DIALYSIS INITIATION – STILL ROOM FOR<br />
IMPROVEMENT<br />
Diana Silvia Zilisteanu | Mihai Voiculescu | Elena Rusu | Camelia Achim |<br />
Raluca Bobeica | Sonia Balanica | Teodora Atasie<br />
Fundeni Center Internal Medicine and Nephrology, Carol Davila Univ Medicine<br />
and Pharmacy, Bucharest, Romania<br />
FP654<br />
IMPACT OF A NEW DIALYSIS UNIT DEVELOPMENT ON PATIENTS REFER-<br />
RING TO HOSPITAL HEMODIALYSIS IN FRANCE<br />
Sens Florence | Schott Anne-Marie | Labeeuw Michel | Colin Cyrille | Villar<br />
Emmanuel<br />
Hospices Civils Lyon, Centre Hosp Lyon-Sud, Dept Nephrology and Renal Transpl,<br />
Pierre Benite, France | Hospices Civils Lyon, Pole IMER, EAM 4128, Lyon,<br />
France<br />
FP655<br />
RENAL REPLACEMENT T<strong>ERA</strong>PY IN ALBANIA<br />
Ariana Strakosha | Nevi Pasko | Sulejman Kodra | Nestor Thereska<br />
Univ Hosp Center Mother Tereza | Univ Hosp Center Mother Tereza Dept Clinical<br />
Biology<br />
FP656<br />
CROSS SECTIONAL OBSERVATIONAL STUDY OF SYMPTOM BURDEN AND<br />
HEALTH-RELATED QUALITY OF LIFE IN PREVALENT HAEMODIALYSIS<br />
PATIENTS IN IRELAND<br />
Aoife Lowney | Eanna Lowney | Rosie Grant | Marie Murphy | Liam Casserly|<br />
Tony O' Brien | William D Plant<br />
Cork Univ Hosp | Kerry General Hosp | Marymount Univ Hospice | Midwestern<br />
Regional Hosp<br />
FP657<br />
RELATIONSHIP BETWEEN INFLAMMATION AND COGNITIVE PSYCHO-<br />
MOTOR FUNCTION IN DIALYSIS PATIENTS<br />
Josipa Radic | Dragan Ljutic | Vedran Kovacic | Mislav Radic | Katarina Dodig-<br />
Curkovic | Milenka Sain | Ivo Jelicic<br />
Univ Hosp Split, Split, Croatia | Univ Hosp Osijek, Osijek, Croatia<br />
FP658<br />
BONE TURNOVER MARKERS ASSOCIATE MORE STRONGLY WITH CAR-<br />
DIOVASCULAR MORTALITY THAN ALL-CAUSE DEATH IN MAINTENAN-<br />
CE HEMODIALYSIS PATIENTS<br />
Naohiko Fujii | Takayuki Hamano | Chikako Nakano | Sayoko Yonemoto |<br />
Ayako Okuno | Masaya Katayama | Yoshitaka Isaka<br />
Hyogo Prefectural Nishinomiya Hosp | Center Clinical Epidemiology and Biostatistics,<br />
Univ Pennsylvania Perelman School Medicine, Pennsylvania, USA |<br />
Dept Geriatric Medicine and Nephrology, Osaka Univ Grad School Medicine,<br />
Osaka, Japan | Rokushima Second Clinic, Hyogo, Japan<br />
FP659<br />
OUTCOME PREDICTION OF DIFFERENT DIALYSIS MODALITIES IN ITALY:<br />
APPLICATION OF A MULTISTATE MODEL<br />
Maurizio Nordio | Aurelio Limido | Maurizio Postorino | Michele Nichelatti<br />
P. Cosma Hosp, Camposampiero, Italy | Nephrology and Dialysis Unit, Azienda<br />
Osp Fatebenefratelli e Oftalmico | CNR-IBIM | Serv Biostatistics, Niguarda Ca’<br />
Granda Hosp – Milan, Italy<br />
FP660<br />
STUDY OF VIRAL LOAD DYNAMICS IN CKD 5D PATIENTS WITH HEPA-<br />
TITIS C VIRUS<br />
Miroslava Khil | Irina Dudar | Vladimir Khil | Irina Shifris<br />
Inst Epidemiology and Infectious Diseases AMS of Ukraine, Kyiv, Ukraine |<br />
Inst Nephrology AMS of Ukraine, Kyiv, Ukraine | Main Military Hosp Ukraine,<br />
Kyiv, Ukraine<br />
FP661<br />
EVALUATION OF AN ISOLATION PROGRAM OF HEPATITIS C VIRUS IN-<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
195<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
196<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FECTED HEMODIALYSIS PATIENTS IN SOME HEMODIALYSIS CENTERS IN<br />
EGYPT<br />
Mohamed Momtaz | Amin Roshdy Soliman | Mona I El lawindi<br />
Cairo Univ, Cairo, Egypt<br />
FP662<br />
DECREASING PREVALENCE OF HEPATITIS C VIRUS INFECTION IN HE-<br />
MODIALYSIS PATIENTS: FOLLOWING KDIGO GUIDALINES<br />
Pavlina Dzekova-Vidimliski | Svetlana Pavleska-Kuzmanovska | Lada Trajceska<br />
| Igor Nikolov | Gjulsen Selim | Saso Gelev | Vili Amitov | Aleksandar<br />
Sikole<br />
Univ Clinic Nephrology, Skopje, FYR Macedonia<br />
FP663<br />
DECREASED SERUM ADRENAL ANDROGEN DEHYDROEPIANDROSTERO-<br />
NE SULFATE AS AN INDEPENDENT PREDICTOR OF MORTALITY IN HE-<br />
MODIALYSIS PATIENTS<br />
Tetsuo Shoji | Ryusuke Kakiya | Tomoshige Hayashi | Naoko Tatsumi-Shimomura<br />
| Yoshihiro Tsujimoto | Tsutomu Tabata | Hideaki Shima | Katsuhito<br />
Mori | Shinya Fukumoto | Hideki Tahara | Hidenori Koyama | Masanori Emoto<br />
| Eiji Ishimura | Yoshiki Nishizawa |<br />
Osaka City Univ Grad School Medicine, Osaka, Japan | Inoue Hosp<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
NUTRITION, INFLAMMATION AND OXIDATIVE<br />
STRESS - CKD 5D<br />
FP664<br />
INCREASES IN SERUM CREATININE LEVELS ARE ASSOCIATED WITH IM-<br />
PROVED PATIENT OUTCOMES IN CHRONIC HEMODIALYSIS PATIENTS<br />
WITH NO RESIDUAL RENAL FUNCTION<br />
Len A Usvyat | Jochen Raimann | Stephan Thijssen | Frank M. van der Sande |<br />
Jeroen Kooman | Nathan W Levin | Peter Kotanko<br />
Renal Res Inst, New York, USA | Maastricht Univ Hosp<br />
FP665<br />
A RISE IN MARKERS OF INFLAMMATION PRECEEDS THE END OF LIFE IN<br />
DIALYSIS PATIENTS: A GLOBAL PERSPECTIVE<br />
Gero von Gersdorff | Mathias Schaller | Inga Bayh | Michael Etter | Aileen<br />
Grassmann | Adrian Guinsburg | Jeroen Kooman | Maggie Lam | Daniele Marcelli<br />
| Cristina Marelli | Laura Scatizzi | Adam Tashman | Stephan Thijssen|<br />
Ted Toffelmire | Len Usvyat | Frank van der Sande | Yuedong Wang | Nathan<br />
W. Levin | Claudia Barth | Peter Kotanko<br />
Univ Hosp Cologne, Cologne, Germany | Fresenius Medical Care, Bad Homburg,<br />
Germany | Fresenius Medical Care, Hong Kong | Fresenius Medical Care,<br />
Argentina | Univ Maastricht, Netherlands | Univ California, Santa Barbara,<br />
USA| Renal Res Inst, New York, USA | Fresenius Medical Care, Canada | KfH<br />
Curatorium for Dialysis and Kidney Transpl, Germany<br />
FP666<br />
SPECIFIC OXIDATIVE DNA DAMAGE IN MAINTENANCE HAEMODIALY-<br />
SIS PATIENTS<br />
TA Moffitt | F Hariton | M Devlin | PJ Garrett | MP Hannon-Fletcher<br />
Western Renal Serv, Derry/Londonderry, Northern Ireland | Univ Ulster, Coleraine,<br />
Northern Ireland<br />
FP667<br />
SELENIUM SUPPLEMENTATION IMPROVES NUTRITIONAL STATUS IN<br />
HEMODIALYSIS PATIENTS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-<br />
CONTROLLED TRIAL<br />
Maryam Ekramzadeh | Zahra Sohrabi | Moosa Salehi | Mohammad Kazem<br />
Fallahzadeh | Maryam Ayatollahi | Bita Geramizadeh | Jafar Hassanzadeh |<br />
Mohammad Mahdi Sagheb<br />
Shiraz Univ Medical Sciences, Shiraz, Iran<br />
FP668<br />
LOW SERUM OBESTATIN PREDICTS MORTALITY IN PREVALENT HEMO-<br />
DIALYSIS PATIENTS<br />
Ilia Beberashvili | Inna Sinuani | Ada Azar | Hadas Kadoshi | Gregory Shapiro|<br />
Leonid Feldman | Zhan Averbukh | Joshua Weissgarten<br />
Nephrology Dept, Assaf Harofeh Medical Center, Zerifin, Israel | Nutrition<br />
Dept, Assaf Harofeh Medical Center, Zerifin, Israel<br />
FP669<br />
N-TERMINAL PROBRAIN NATRIURETIC PEPTIDE - MARKER OF<br />
OVERHYDRATION, MALNUTRITION, INFLAMMATION OR ADIPONEC-<br />
TIN IN HEMODIALYSIS PATIENTS?<br />
Yasuhiro Abe | Maho Watanabe | Kenji Ito | Yoshie Sasatomi | Satoru Ogahara|<br />
Hitoshi Nakashima | Takao Saito<br />
Div Nephrology and Rheumatology, Dept Internal Medicine, Fukuoka Univ,<br />
Fukuoka, Japan<br />
FP670<br />
KEY PARAMETERS DISCRIMINATING DIABETIC FROM NON-DIABETIC<br />
HEMODIALYSIS PATIENTS<br />
Sabine Witt | Hans Jürgen Guth | Horst Skarabis | Rudolf Kunze | Joerg Vienken<br />
Biometc GmbH | Praxis für Nieren- und Hochdruckkrankheiten | Statistical<br />
Consultant | Biomed Office Berlin Campus MDC | Fresenius Medical Care, Bad<br />
Homburg, Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
197<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
198<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP671<br />
LOSS OF PLANT POLYPHENOLS AND THEIR METABOLITES PRESENT IN<br />
BLOOD, DURING SINGLE HAEMODIALYSIS SESSION IN PATIENTS WITH<br />
END-STAGE CHRONIC KIDNEY DISEASE<br />
Piotr Nowak | Radoslaw Wilk | Beata Mamelka | Anna Prymont-Przyminska|<br />
Anna Zwolinska | Agata Sarniak | Anna Wlodarczyk | Jacek Rysz | Dariusz<br />
Nowak<br />
Dept Nephrology, Hypertension and Family Medicine, Medical Univ Lodz,<br />
Lodz, Poland | Dept Lab Diagnostics and Clinical Biochemistry, Medical Univ<br />
Lodz, Lodz, Poland| Dept Clinical Physiology, Medical Univ Lodz, Lodz, Poland|<br />
WAM Univ Hosp<br />
FP672<br />
NUTRITION IN RELATION TO ADVANCED GLYCATION END PRODUCTS<br />
IN DIALYSIS PATIENTS<br />
Lada Trajceska | Pavlina Dzekova-Vidimliski | Saso Gelev | Stefan Arsov |<br />
Aleksandar Sikole<br />
Univ Clinic Nephrology-Skopje, Macedonia<br />
FP673<br />
ROLE OF DIALYSIS MODALITY AND MEMBRANES ON SELENIUM STATUS<br />
IN CHRONIC HEMODIALYSIS<br />
Makrouhi Sonikian | Artemisia Dona | Iakovos Skarakis | Polyxeni Metaxaki|<br />
Christos Chiotis | Ioannis Papoutsis | Aphroditi Karaitianou | Chara Spiliopoulou<br />
A. Fleming General Hosp | Forensic Medicine and Toxicology, Medical School,<br />
Kapodistriakon Univ, Athens, Greece | Chemistry School, Kapodistriakon Univ,<br />
Athens, Greece | 101 Renal Unit, Medical Center, Athens, Greece | Biochemistry<br />
Dept, A. Fleming General Hosp, Athens, Greece<br />
FP674<br />
DECLINE IN ALBUMIN LEVELS IN HEMODIALYSIS PATIENTS IS ASSOCIA-<br />
TED WITH POOR OUTCOMES: A GLOBAL PERSPECTIVE<br />
Daniele Marcelli | Adam Tashman | Adrian Guinsburg | Aileen Grassmann|<br />
Claudia Barth | Cristina Marelli | Frank M. van der Sande | Gero von Gersdorff|<br />
Inga Bayh | Jeroen Kooman | Laura Scatizzi | Maggie Lam | Mathias<br />
Schaller | Michael Etter | Stephan Thijssen | Ted Toffelmire | Yuedong Wang |<br />
Len A Usvyat | Peter Kotanko | Nathan W Levin<br />
Fresenius Medical Care Europe | Renal Res Inst, New York, New York, USA |<br />
Fresenius Medical Care Latin America | Curatorium Dialysis and Kidney Transpl<br />
(KfH) | Maastricht Univ Hosp | Univ Hosp Cologne, Cologne, Germany |<br />
Fresenius Medical Care Asia Pacific | Fresenius Medical Care Canada | Univ<br />
California Santa Barbara<br />
FP675<br />
PIOGLITAZONE IMPROVES INSULIN SENSITIVITY, REDUCES VISC<strong>ERA</strong>L<br />
FAT AND INFLAMMATION, AND STIMULATES LIPOLYSIS IN NON DIABE-<br />
TIC DIALYZED PATIENTS<br />
Daniel Teta | Luc Tappy | Nicolas Theumann | Georges Halabi | Thierry Gauthier<br />
| Claudine Mathieu | Sylvie Tremblay | Pauline Coti | Michel Burnier |<br />
Anne Zanchi<br />
Serv Nephrology, Univ Hosp (CHUV), Lausanne, Switzerland | Dept Physiology,<br />
Univ Lausanne, Switzerland | Dept Radiology, Univ Hosp (CHUV), Lausanne,<br />
Switzerland | Dept Endocrinology and Metabolism, Univ Hosp (CHUV),<br />
Lausanne, Switzerland<br />
FP676<br />
IS OXIDATIVE STRESS RELATED TO WHITE MATTER LESIONS IN CHRO-<br />
NIC HAEMODIALYSIS PATIENTS?<br />
Alberto Martinez Vea | Carmen Cabre | Diasol Villa | Monica Muñoz | Joan<br />
Pere Vives | Mercedes Arruche | Jordi Soler | Maria Teresa Compte | Josep<br />
Aguilera | Marta Romeu | Montse Giralt<br />
Hosp Univ Tarragona Joan XXIII, Tarragona, Spain | Pharmacology Unit, Dept<br />
Basic Sciences, Univ Rovira i Virgili, Tarragona, Spain | Reus Medical, Reus, Tarragona,<br />
Spain | Hosp Jesus, Tortosa, Tarragona, Spain | Centre Dialisi, Hosp<br />
Llevant, Tarragona, Spain<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP677<br />
SPANISH MULTICENTRIC STUDY ABOUT NUTRITION-INFLAMATION<br />
WITH MID DILUTION (ENIMID STUDY): PRELIMINARY RESULTS<br />
Guillermina Barril | S Anaya | C Vozmediano | AO Celayeta | R Novillo |<br />
V Bernal | I Beiret | E Huarte | J Martin | H Santana | G Torres | F Sousa |<br />
R Sanchez | A Lopez-Montes | F Tornero | J Uson | M Pousa | M Giorgi | B<br />
Rdez Cubillo<br />
Hosp U. Princesa | H. Ciudad Real | Hosp Donostia, San Sebastian | H. San<br />
Pedro Alcantara, Caceres | H. San Millan, Logroño | Hosp Sonsoles, Avila | H.<br />
Virgen del Camino, Zamora | H. General Yague, Burgos | H. Rio Carrión, Palencia<br />
| Hosp Segovia | C.H.U. Albacete | Hosp Sureste, Arganda del Rey | Hosp<br />
Virgen de la Luz, Cuenca | Hosp Costa, Burela, Lugo | Hosp Clinico, Madrid<br />
FP678<br />
RELATIONSHIP OF NEUTROPHIL-TO-LYMPHOCYTE RATIO AND SERUM<br />
ALBUMIN LEVELS WITH C-REACTIVE PROTEIN IN HEMODIALYSIS PA-<br />
TIENTS: RESULTS FROM AN INTERNATIONAL STUDY<br />
Rakesh Malhotra | Len Usvyat | Samer R. Abbas | Stephan Thjissen | Mary<br />
Carter | Micahel Etter | Adam Tashman | Adrian Guinsburg | Aileen Grassmann|<br />
Claudia Barth | Cristina Marelli | Frank Van der Sande | Gero von<br />
Gersdorff| Inga Bayh | Jeroen Kooman | Laura Scatizzi | Maggie Lam | Mathias<br />
Schaller| Ted Toffelmire | Yuedong Wang | Daniele Marcelli | Nathan<br />
Levin | Peter Kotanko<br />
Renal Res Inst, Beth Israel Medical Center, New York, NY, USA | FMC Asia<br />
Pacific, Hong Kong, Hong Kong | FMC Latin America, Buenos Aires, Argentina|<br />
KfH Dialysis Centre Koeln-Lindenthal, Bad Homburg, Germany | Maastricht<br />
Univ Medical Center, Maastricht, Netherlands | Univ Cologne Medical Center,<br />
Cologne, Germany | FMC North America, Waltham, MA | Univ California-Santa<br />
Barbara, Santa Barbara, USA | FMC Europe, Bad Homburg, Germany<br />
FP679<br />
EFFECT OF LOW- AND HIGH-FLUX MEMBRANE HEMODIALYSIS ON THE<br />
VITAMIN A TRANSPORT COMPLEX IN PLASMA OF PATIENTS WITH END-<br />
STAGE RENAL FAILURE<br />
Raila Jens | Martin Tepel | Espe Katharina | Henze Andrea | Frey Simone |<br />
Schweigert Florian<br />
Inst Nutritional Science Potsdam Germany<br />
FP680<br />
ORAL HEALTH IN HAEMODIALYSIS PATIENTS AND IN NORMAL<br />
SUBJECTS – IS THERE A DIFFERENCE?<br />
Oana Slusanschi | Liliana Garneata | Ruxandra Moraru | Elena Preoteasa | Carmen<br />
Barbulescu | Caterina Santimbrean | Christian Klein | Diana Dragomir |<br />
Gabriel Mircescu<br />
Fac Dental Medicine, Dept Preventive Dentistry, Carol Davila Univ Medicine<br />
and Pharmacy, Bucharest, Romania | Carol Davila Univ Medicine, Dept Nephrology<br />
and Internal Medicine, Bucharest, Romania | Queen Mary Univ London,<br />
Barts& London School Medicine and Dentistry, Inst Dentistry | Fac Dental<br />
Medicine, Dept Mobile Prosthetics, Carol Davila Univ Medicine and Pharmacy,<br />
Bucharest, Romania | Dr Carol Davila Fresenius NephroCare Dialysis Center,<br />
Bucharest, Romania | Dr Carol Davila Teaching Hosp Nephrology, Bucharest,<br />
Romania | Fac Medicine, Dept Nephrology and Internal Medicine, Carol Davila<br />
Univ Medicine and Pharmacy, Bucharest, Romania<br />
FP681<br />
GASTROINTESTINAL-MEDIATED GLUCOSE DISPOSAL, INCRETIN EFFECT<br />
AND GLUCAGON RESPONSES IN PATIENTS WITH END-STAGE RENAL<br />
DISEASE<br />
Thomas Idorn | Filip Knop | Jens Juul Holst | Mads Hornum | Bo Feldt-Rasmussen<br />
Dept Nephrology, Copenhagen Univ Hosp, RigsHosp, Copenhagen, Denmark|<br />
Gentofte Hosp, Hellerup, Denmark | Dept Biomedical Sciences, Panum Inst,<br />
Univ Copenhagen<br />
FP682<br />
VASCULAR CALCIFICATION ON PLAIN RADIOGRAPHS IS ASSOCIATED<br />
WITH CAROTID INTIMA MEDIA THICKNESS, MALNUTRITION AND CAR-<br />
DIOVASCULAR EVENTS IN DIALYSIS PATIENTS<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
199<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
200<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Young Ki Son | Won Suk An | Seong Eun Kim | Ki Hyun Kim<br />
Dong-A Univ, Busan<br />
FP683<br />
ORAL HEALTH, INFLAMMATION AND MALNUTRITION IN HAEMO-<br />
DIALYSIS PATIENTS – IS THERE A LINK?<br />
Liliana Garneata | Oana Slusanschi | Elena Preoteasa | Carmen Barbulescu |<br />
Caterina Santimbrean | Christian Klein | Gabriel Mircescu<br />
Carol Davila Univ Medicine, Dept Nephrology and Internal Medicine, Bucharest,<br />
Romania | Fac Dental Medicine, Dept Preventive Dentistry, Carol Davila Univ<br />
Medicine and Pharmacy, Bucharest, Romania | Fac Dental Medicine, Dept Mobile<br />
Prosthetics, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania|<br />
Dr Carol Davila Fresenius NephroCare Dialysis Center, Bucharest, Romania<br />
FP684<br />
EFFECT OF HEMODIAFILTRATION WITH ENDOGENOUS REINFUSION<br />
(HFR) ON CHRONIC INFLAMMATION AND UNDER-NUTRITION IN MAIN-<br />
TENANCE HEMODIALYSIS (HD) PATIENTS: AN ITALIAN MULTICENTER<br />
OBSERVATIONAL STUDY<br />
Silvio Borrelli | Roberto Minutolo | Luca De Nicola | Giuseppe Conte | Walter<br />
De Simone | Bruno Zito | Pasquale Guastaferro | Filippo Nigro | Antonio<br />
Bassi| Luigi Leone | Olga Credendino | Raffaele Genualdo | Maria Capuano |<br />
Giuseppe Iulianiello | Maria Rita Auricchio<br />
Second Univ Naples, Naples, Italy | G.Moscati Hosp Avellino Italy | G. Criscuoli<br />
Hosp, S. Angelo dei Lombardi (AV) Italy | County Hosp, Nocera Inferiore (SA)<br />
Italy | A. Cardarelli Hosp, Naples Italy | Trinità dei Pellegrini Hosp, Naples<br />
Italy | Melorio Hosp, S. Felice a Cancello (CE) Italy | Osp Riuniti Area Stabiese<br />
Hosp, Castellammare di Stabia (NA) Italy<br />
FP685<br />
LONG TERM CLINICAL AND NUTRITIONAL INFLUENCE OF ORAL NU-<br />
TRITIONAL SUPPLEMENTATION IN MAINTENANCE HEMODIALYSIS<br />
PATIENTS<br />
Siren Sezer | Zeynep Bal | Emre Tutal | Mehtap Erkmen Uyar | F. Nurhan<br />
Ozdemir Acar<br />
Dept Nephrology, Baskent Univ, Ankara, Turkey<br />
FP686<br />
PON1 ACTIVITY IN HEMODIALYSIS PATIENTS: GENETIC AND NON-GE-<br />
NETIC FACTORS<br />
Sandra Ribeiro | M. Sameiro Faria | F. Melo | J. Sereno | I. Freitas | M. Mendonça<br />
| H. Nascimento | J. Fernandes | P. Rocha-Pereira | V. Miranda | D.<br />
Mendonça | A. Quintanilha | L. Belo | E. Costa | F. Reis | A. Santos-Silva<br />
Fac Farmácia, Univ Porto; Inst Biologia Molecular e Celular (IBMC)| FMC, Dinefro<br />
– Diálises e Nefrologia, SA; Inst Ciências Biomédicas Abel Salazar (ICBAS),<br />
Univ Porto | Lab Farmacologia e Terapêutica Experimental, IBILI, Fac Medicina,<br />
Univ Coimbra | Unidade Investigação, Hosp Central Funchal; Lab Genética Humana,<br />
Campus Univ Penteada, Madeira | Centro Investigação Ciências Saúde,<br />
Univ Beira Interior, Covilhã | Inst Biologia Molecular e Celular (IBMC), Univ do<br />
Porto; Inst Ciências Saúde Univ Católica Portuguesa, Porto<br />
FP687<br />
SCALING BODY COMPOSITION TO HEIGHT AND WEIGHT: DIFFERENCES<br />
BETWEEN BODY MASS INDEX (BMI) AND BODY SURFACE AREA (BSA) IN<br />
HEMODIALYSIS (HD) PATIENTS<br />
Rodolfo Valtuille | Maria Elisa Casos | Elmer Andres Fernandez<br />
FMC Burzaco | Univ Catolica Cordoba<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
TRANSPLANTATION - CLINICAL I<br />
FP688<br />
A RANDOMIZED OPEN-LABEL CLINICAL TRIAL EXAMINING THE EF-<br />
FECT OF DENOSUMAB ON THE PREVENTION OF 1ST-YEAR BONE MINE-<br />
RAL DENSITY LOSS AFTER RENAL TRANSPLANTATION (POSTOP study;<br />
NCT01377467)<br />
Marco Bonani | Jens Brockmann | Clemens David Cohen | Thomas Fehr | Antonio<br />
Nocito | Marc Schiesser | Andreas L. Serra | Markus Blum | Marian Struker|<br />
Diana F. Frey | Rudolf P. Wüthrich<br />
Div Visceral and Transpl Surgery, Univ Hosp Zurich, Switzerland | Div Nephrology,<br />
Univ Hosp Zurich, Switzerland | Dept Rheumatology, Univ Hosp Zurich,<br />
Switzerland<br />
FP689<br />
ASSOCIATIONS BETWEEN MMP-2 GENE POLYMORPHISMS AND POST-<br />
TRANSPLANTATIONAL DIABETES MELLITUS IN KOREAN RENAL ALLO-<br />
GRAFT RECIPIENTS<br />
Yang Wook Kim | Seok Ju Park | Tae Hee Kim | Yeong-Hoon Kim | Sun Woo<br />
Kang<br />
Inje Univ, Busan, Korea<br />
FP690<br />
PRIMARY RENAL DISEASE AND SURVIVAL AFTER TRANSPLANT FAILU-<br />
RE – IS THERE A RELATIONSHIP? AN ANALYSIS OF UK RENAL REGISTRY<br />
DATA<br />
Lynsey Webb | Anna Casula | Charlie Tomson | Yoav Ben-Shlomo<br />
UK Renal Registry, Bristol, UK | Southmead Hosp, Bristol, UK | School Social<br />
and Community Medicine, Bristol Univ, UK<br />
FP691<br />
THE CLINICAL CHARACTERISTICS OF PATIENTS STARTING DIALYSIS AF-<br />
TER RENAL TRANSPLANT FAILURE IN THE UK 2000-2008: A UK RENAL<br />
REGISTRY ANALYSIS<br />
Lynsey Webb | Anna Casula | Yoav Ben-Shlomo | Charlie Tomson<br />
UK Renal Registry, Bristol, UK | School Social and Community Medicine, Bristol<br />
Univ, UK | Southmead Hosp, Bristol, UK<br />
FP692<br />
POST-TRANSPLANT GLOMERULONEPHRITIS IN LIVE-DONOR RENAL<br />
TRANSPLANT RECIPIENTS: CLINICAL COURSE AND RISK FACTORS<br />
Hany Mansour | Ahmed Akl | Ehab Wafa | Mohamed El Shahawy<br />
Hamed Al Essa OTC, Kuwait | Urology and Nephrology Center, Mansoura,<br />
Egypt | Benha Fac Medicine, Benha, Egypt<br />
FP693<br />
PRE-TRANSPLANT HEPATITIS B SURFACE ANTIBODY (HBsAb) IS ASSO-<br />
CIATED WITH PREVALENT AND INCIDENT HLA ANTIBODIES, HUMO-<br />
RAL REJECTION AND GRAFT LOSS<br />
Ramiro Palma | Suda Swaminathan | Ashley Bruce Irish<br />
San Cecilio Clinical Hosp, Granada, Spain| Royal Perth Hosp, Perth, Australia<br />
FP694<br />
THE NEPHRON UNDERDOSING AS A RISK FACTOR FOR AN IMPAIRED<br />
EARLY FUNCTION AND AN INCREASED GRAFT LOSS IN THE LONG-<br />
TERM FOLLOW-UP PERIOD<br />
Aureliusz Kolonko | Jerzy Chudek | Andrzej Więcek<br />
Dept Patophisiology, Dept Nephrology, Endocrinology and Metabolic Diseases,<br />
Medical Univ Silesia, Katowice, Poland<br />
FP695<br />
RECIPIENT’S SMOKING HABITS AND DEATH-CENSORED RENAL ALLO-<br />
GRAFT SURVIVAL<br />
Yves Vanrenterghem | Dirk Kuypers | De Vusser Katrien | Pieter Evenepoel |<br />
Kathleen Claes | Bert Bammens | Björn Meijers | Maarten Naesens<br />
Univ Hosp, Leuven, Belgium | Univ Hosp Gasthuisberg, Leuven | KULeuven,<br />
Nephrology<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
201<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
202<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FP696<br />
LONG-TERM GRAFT FUNCTION AND SURVIVAL IN KIDNEY TRAN-<br />
SPLANT RECIPIENTS DEPEND ON THE CONTINUITY OF DOPPLER SPEC-<br />
TRUM MEASURED IN THE EARLY PERIOD AFTER TRANSPLANTATION<br />
Aureliusz Kolonko | Jerzy Chudek | Andrzej Więcek<br />
Dept Patophisiology, Dept Nephrology, Endocrinology and Metabolic Diseases,<br />
Medical Univ Silesia, Katowice, Poland<br />
FP697<br />
RISK FACTORS FOR DEATH WITH A FUNCTIONING GRAFT IN RENAL<br />
TRANSPLANT PATIENTS FROM HONG KONG RENAL REGISTRY DATA<br />
Stanley Lo | Ching-kit Chan | David Yong | Ping-nam Wong | Tze-hoi Kwan|<br />
Yuk-lun Cheng | Ka-shun Fung | Bo-ying Choy | Ka-foon Chau | Chi-bong<br />
Leung | James Ebben | Jiannong Liu | Shu-cheng Chen | Allan Collins | Yiu-<br />
Wing Ho<br />
Dept Medicine, Pamela Youde Nethersole Eastern Hosp | UCH, Hong Kong |<br />
CMC, Hong Kong | KWH, Hong Kong | TMH, Hong Kong | AHNH, Hong<br />
Kong | PMH, Hong Kong | QMH, Hong Kong | QEH, Hong Kong | PWH,<br />
Hong Kong | USRDS, USA<br />
FP698<br />
NON-HEART-BEATING DONATION AFTER 20-MINUTE NO-TOUCH PE-<br />
RIOD RESULTS WITH FASTER RECOVERY USING MACHINE-PERFUSED<br />
KIDNEY GRAFTS<br />
Massimo Abelli | Elena Ticozzelli | Benedetta Maiga | Antonjacopo Ferrario di<br />
Torvajana | Alessandro Patané | Paolo Albrizio | Marilena Gregorini | Carmelo<br />
Libetta | Teresa Rampino | Paolo Albrizio | Paolo Geraci | Antonio Dal Canton<br />
Fond IRCCS Policlinico San Matteo | Univ Pavia<br />
FP699<br />
DUAL KIDNEY TRANSPLANTATION WITHOUT PREIMPLANTATION<br />
BIOPSY: A SINGLE CENTER EXPERIENCE<br />
Marie-Therese Rotter | Johannes Jacobi | Katharina Pressmar | Kerstin Amann|<br />
Kai-Uwe Eckardt | Alexander Weidemann<br />
Medical Clinic 4 - Nephrology and Hypertension, Erlangen, Germany | Inst Nephropathology,<br />
Erlangen, Germany<br />
FP700<br />
MEASUREMENT OF INTERFERON-GAMMA INDUCED PROTEIN 10 IN SE-<br />
RUM: A RISK ASSESSMENT APPROACH FOR BKV-ASSOCIATED NEPHRO-<br />
PATHY<br />
Karin Müller | Maik Stein | Claudia Diezemann | Anett Sefrin | Nina Babel |<br />
Petra Reinke | Thomas Schachtner<br />
Charité Univ Medicine Berlin, Campus Virchow Clinic, Berlin, Germany<br />
FP701<br />
POLYOMAVIRUS BK DETECTION AND SIGNIFICANCE IN RENAL TRAN-<br />
SPLANT PATIENTS WITH LUPUS NEPHRITIS AS UNDERLYING DISEASE<br />
Cristina Costa | Giovanni Antonio Touscoz | Francesca Sidoti | Franca Sinesi|<br />
Samantha Mantovani | Salvatore Simeone | Cinzia Balloco | Elsa Piasentin<br />
Alessio | Maria Messina | Giuseppe Segoloni | Rossana Cavallo<br />
Univ Hosp San Giovanni Battista, Turin, Italy<br />
FP702<br />
FUNCTIONAL ASSESSMENT OF RENAL ALLOGRAFT BY DIFFUSION<br />
WEIGHTED MR IMAGING<br />
R.K Sharma | R.K. Gupta | Amit Gupta | Narayan Prasad | Dharmendra Bhadhuria<br />
|K.J. Suresh<br />
Sanjay Gandhi Post Grad Inst Medical Sciences<br />
FP703<br />
CHOLECALCIFEROL OPTIMAL TREATMENT DURING THE FIRST YEAR<br />
AFTER RENAL TRANSPLANTATION DETERMINED BY A POPULATION<br />
PHARMACOKINETIC MODEL<br />
Sihem Benaboud | Dominqiue Prié | Eric Thervet | Saik Urien | Christophe<br />
Legendre | Jean-Claude Souberbielle | Déborah Hirt | Gérard Friedlander |<br />
Jean-Marc Tréluyer | Marie Courbebaisse<br />
Univ Paris Desacrtes Sorbonne Paris Cité EA3620 | Serv Explorations Fonction-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
nelles, Hôp Necker Enfants Malades, AP-HP, Univ Paris Descartes, Paris, France|<br />
Serv Transpl Rénale, Hôp Necker Enfants Malades, Univ Paris Descartes, Paris,<br />
France| Univ Paris Descartes Sorbonne Paris Cité, EA3620, Unité Recherche<br />
Clinque Hôp Tarnier; Paris, France<br />
FP704<br />
PREVALENCE AND FACTORS ASSOCIATED WITH EARLY-ONSET ANA-<br />
EMIA AFTER KIDNEY TRANSPLANTATION IN SPAIN: A MULTICENTER,<br />
OBSERVATIONAL AND RETROSPECTIVE STUDY<br />
Manuel Arias | Josep Campistol | Julio Pascual | Josep Mª Grinyó | Domingo<br />
Hernández | José Mª Morales | Luis Miguel Pallardó | Daniel Serón<br />
Hosp Univ Marqués Valdecilla, Santander, Spain | Hosp Clínic i Provincial, Barcelona,<br />
Spain | Hosp Mar, Barcelona, Spain | Ciutat Sanitaria i Univ de Bellvitge,<br />
L´Hosp de Llobregat (Barcelona), Spain | Hosp Regional Univ Carlos Haya, Málaga,<br />
Spain | Hosp 12 de Octubre, Madrid, Spain | Hosp Univ Dr. Peset, Valencia,<br />
Spain | Hosp General Vall d'Hebron, Barcelona, Spain<br />
FP705<br />
IMPACT OF DONOR ACUTE RENAL FAILURE ON KIDNEY FUNCTION ONE<br />
YEAR AFTER CADAVERIC RENAL TRANSPLANTATION<br />
Lynne Senécal | Raymond Dandavino | Anne Boucher | Suzon Colette | Michel<br />
Vallée | Jean-Philippe Lafrance<br />
Hôp Maisonneuve-Rosemont<br />
FP706<br />
THE EXPRESSION OF NITROTYROSINE IS ASSOCIATED WITH INTERSTI-<br />
TIAL FIBROSIS/TUBULAR ATROPHY (IF/TA) IN CHRONIC ALLOGRAFT<br />
NEPHROPATHY: A QUANTITATIVE STUDY BY IMMUNOHISTOCHEMIST-<br />
RY (IHC) ANALYSIS<br />
Yu Tung-Min | Wu Min-Ju | Chen Cheng-Hsu | Cheng Chi-Hung | Shu Kuo-<br />
Hsiung | Wen Mei-Chin<br />
Taichung Veterans General Hosp<br />
FP707<br />
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY FOR TRANSPLANT<br />
RENAL ARTERY STENOSIS USING SINGLE OR MULTIPLE PROCEDURES:<br />
CLINICAL OUTCOMES FROM ONE CENTRE<br />
Shamindra Direkze | Maryam Khorsavi | Sam Stuart | Antony Goode | Gareth<br />
Jones<br />
Royal Free Hosp, London, UK<br />
FP708<br />
NO EFFECT OF BILAT<strong>ERA</strong>L NEPHRECTOMY PRIOR TO KIDNEY TRAN-<br />
SPLANT ON THE RESISTIVE INDICES MEASURED IN THE KIDNEY GRAFT<br />
Jerzy Chudek | Aureliusz Kolonko | Andrzej Więcek<br />
Dept Patophisiology, Dept Nephrology, Endocrinology and Metabolic Diseases,<br />
Medical Univ Silesia, Katowice, Poland<br />
FP709<br />
FOLATE SUPPLEMENTATION DOES NOT REDUCE INCREASE OF CARO-<br />
TID INTIMA-MEDIA THICKNESS IN RENAL TRANSPLANT RECIPIENTS<br />
Carlo Massimetti | Ilaria Napoletano | Gea Imperato | Maria Teresa Muratore |<br />
Sara Fazio | Gloria Pessina | Franco Brescia | Sandro Feriozzi<br />
Nefrologia-Dialisi, Osp Belcolle | Lab Analisi, Osp Belcolle | Lab Diagnostica<br />
Molecolare delle Emopatie, Osp Belcolle | Radiologia, Osp Belcolle<br />
FP710<br />
SERUM URIC ACID IS AN INDEPENDENT PREDICTOR OF NEW-ONSET<br />
DIABETES AFTER TRANSPLANTATION (NODAT) IN LIVING-DONOR KID-<br />
NEY TRANSPLANTATION<br />
Kentaro Tanaka | Ken Sakai | Aki Futaki | Youji Hyoudo | Masaki Muramatsu|<br />
Takeshi Kawamura | Seiichiro Shishido | Shigeko Hara | Akifumi Kushiyama|<br />
Atsushi Aikawa<br />
Dept Nephrology, Toho Univ School Medicine | Div Diabetes and Metabolism,<br />
Inst Adult Diseases, Asahi Life Foundation<br />
FP711<br />
PREVALENCE OF THE CORONARY HEART DISEASE RISK FACTORS AND<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
203<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
204<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
10-YEAR RISK OF CARDIOVASCULAR MORTALITY BASED ON THE HE-<br />
ARTSCORE IN PEOPLE QUALIFIED FOR KIDNEY DONATION<br />
Krzysztof Jankowski | Jolanta Gozdowska | Dorota Lewandowska | Artur<br />
Kwiatkowski | Magdalena Durlik | Piotr Pruszczyk<br />
Dept Internal Medicine and Cardiology, Medical Univ Warsaw, Poland | Dept<br />
Transpl Medicine and Nephrology, Medical Univ Warsaw | Dept General and<br />
Transpl Surgery, Medical Univ Warsaw<br />
FP712<br />
THE IMPACT OF ONCE-DAILY DOSING ON ADHERENCE TO IMMUNO-<br />
SUPPRESSIVE MEDICATION IN KIDNEY TRANSPLANT RECIPIENTS<br />
Yoshitsugu Obi | Naotsugu Ichimaru | Taigo Kato | Masayoshi Okumi | Junya<br />
Kaimori | Koji Yazawa | Norio Nonomura | Yoshitaka Isaka | Shiro Takahara<br />
Dept Geriatric Medicine & Nephrology, Osaka Univ Grad School Medicine, Osaka,<br />
Japan | Deparment of Urology, Osaka Central Hosp, Osaka, Japan | Dept<br />
Specific Organ Regulation (Urology), Osaka Univ Grad School Medicine, Osaka,<br />
Japan | Dept Advanced Technology Transpl, Osaka Univ Grad School Medicine,<br />
Osaka, Japan<br />
FP713<br />
A CASE OF MALIGNANT VZV VASCULOPATHY IN A RENAL TRAN-<br />
SPLANT RECIPIENT<br />
Meftah Aimele | Ridel Christophe | d'Ythurbide Géraldine | Rondeau Eric |<br />
Hertig Alexandre<br />
APHP, Hôp Tenon | APHP, Paris, France | Inserm U702<br />
« FP714<br />
PERFORMANCE, LIMITATIONS AND UTILITY OF CYSTATIN C AS AN EN-<br />
DOGENOUS GFR MARKER IN RENAL TRANSPLANTATION<br />
Ingrid Masson | Maillard Nicolas | Tack Ivan | Jaafar Acil | Thibaudin Lise |<br />
Hadj-Aissa Aoumeur | Dubourg Laurence | Delanaye Pierre | Cavalier Etienne|<br />
Rostaing Lionel | Kamar Nassim | Morelon Emmanuel | Alamartine Eric|<br />
Mariat Christophe<br />
Serv Nephrologie Dialyse Transpl Rénale CHU Saint Etienne, Saint-Etienne,<br />
France | Serv Explorations Fonctionnelles Physiologiques CHU Toulouse Rangeuil,<br />
Toulouse, France | Serv Dialyse CHU Sart-Tilman, Liège, Belgique | Serv<br />
Biochimie CHU Sart Tilman, Liège, Belgique | Serv Nephrologie Dialyse Transpl<br />
d'Organes CHU Toulouse Rangueil, Toulouse, France | Serv Nephrologie Dialyse<br />
Transpl Rénale CHU Edouard Herriot, Lyon, France<br />
« FP715<br />
SURVIVAL AFTER RENAL TRANSPLANT FAILURE: A UK RENAL REGISTRY<br />
ANALYSIS<br />
Lynsey Webb | Anna Casula | Charlie Tomson | Yoav Ben-Shlomo<br />
UK Renal Registry, Bristol, UK | Southmead Hosp, Bristol, UK | School Social<br />
and Community Medicine, Bristol Univ, UK<br />
FP716<br />
STRUCTURAL AND MECHANICAL PROPERTIES OF LARGE ARTERIES AF-<br />
TER KIDNEY TRANSPLANTATION: MAJOR IMPACT OF DONOR SOURCE<br />
Karras Alexandre | Boutouyrie Pierre | Haymann Jean-Philippe | Prie Dominique<br />
| Legendre Christophe | Girschovitz Alexei | Delahousse Michel<br />
Hôp Européen Georges Pompidou, Paris | Hôp Tenon, Paris | Hôp Necker, Paris<br />
| Hop Foch<br />
FP717<br />
OUTCOME OF DESENSITIZATION PROTOCOL FOR SENSITIZED RENAL<br />
TRANSPLANT PATIENTS<br />
Pankaj Shah | Vivek Balkrishna Kute | Aruna Vanikar | Manoj Gumber | Pranjal<br />
Modi | Hargovind Trivedi<br />
IKDRC-ITS, Ahmedabad, India<br />
« FP718<br />
URINARY TRACT INFECTIONS DURING FIRST YEAR AFTER RENAL TRAN-<br />
SPLANTATION<br />
Justyna Gołębiewska | Alicja Dębska-Ślizień | Boleslaw Rutkowski<br />
Dept Nephrology, Transpl and Internal Medicine, Medical Univ Gdańsk<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
FP719<br />
ARE THE OXIDOREDUCTASES (ENDOTHELIAL NO SYNTHASE, CATA-<br />
LASE, GLUTATHIONE PEROXIDASE, SUPEROXIDE DISMUTASES) GENES<br />
POLYMORPHISMS IMPLICATED IN THE EARLY PHASE AFTER KIDNEY<br />
TRANSPLANTATION?<br />
Leszek Domanski | Grazyna Dutkiewicz | Karolina Kloda | Andrzej Pawlik |<br />
Andrzej Ciechanowicz | Agnieszka Binczak-Kuleta | Jacek Rozanski | Marek<br />
Myslak | Krzysztof Safranow | Kazimierz Ciechanowski<br />
Dept Nephrology, Transpl and Internal Medicine, PMU | Dept Therapeutic Drug<br />
Monitoring, PMU | Dept Lab Diagnostics and Molecular Medicine, PMU | Dept<br />
Biochemistry, Pomeranian Medical Univ<br />
FP720<br />
PHARMACOLOGICAL EVALUATION OF A REDUCED DOSING STRATEGY<br />
OF MYCOPHENOLATE MOFETIL IN TACROLIMUS-TREATED RENAL<br />
TRANSPLANT PATIENTS<br />
Chabroux Seffert Aline | Thierry Basset | Xavier Delavenne | Eric Alamartine|<br />
Christophe Mariat<br />
CHU Saint Etienne France<br />
FP721<br />
LACK OF ASSOCIATION OF THE CTLA4, ICAM1 AND VCAM1 GENES PO-<br />
LYMORPHISMS WITH CHRONIC ALLOGRAFT NEPHROPATHY DEVELOP-<br />
MENT<br />
Karolina Kloda | Leszek Domanski | Andrzej Pawlik | Katarzyna Bobrek-Lesiakowska<br />
| Magda Wisniewska | Maciej Romanowski | Krzysztof Safranow| Mateusz<br />
Kurzawski | Jacek Rozanski | Marek Myslak | Kazimierz Ciechanowski<br />
Dept Nephrology, Transpl and Internal Medicine, PMU | Dept Therapeutic Drug<br />
Monitoring, PMU | Dept General and Transpl Surgery, PMU | Dept Biochemistry<br />
and Medical Chemistry, PMU | Dept Pharmacology, PMU<br />
FP722<br />
SERUM PHOSPHATE IS AN INDEPENDENT RISK FACTOR FOR LATE<br />
GRAFT FAILURE AFTER KIDNEY TRANSPLANTATION<br />
Martin De Borst | Leandro Baia | Gerjan Navis | Stephan Bakker<br />
Dept Nephrology, Univ Medical Center Groningen<br />
FP723<br />
A NEWLY IDENTIFIED MUTATION IN THE COMPLEMENT FACTOR I GENE<br />
NOT ASSOCIATED WITH POST-TRANSPLANT RECURRENCE OF aHUS<br />
Andrea Ranghino | Giuliana Tognarelli | Elisa Basso | Maria Messina | Ana<br />
Maria Manzione | Germana Daidola | Giuseppe Paolo Segoloni<br />
Dept Internal Medicine, Nephrology, Dialysis and Transpl Unit, Univ Torino,<br />
Italy | Nephrology, Dialysis and Transpl Unit, San Giovanni Battista Hosp, Torino,<br />
Italy<br />
FP724<br />
OUTCOME OF RENAL TRANSPLANTATION IN PATIENTS WITH LONG-<br />
TERM (MORE THAN 10 YEARS) DIALYSIS TH<strong>ERA</strong>PY<br />
Takaaki Kimura | Takashi Yagisawa | Nobuo Ishikawa | Yasunaru Sakuma |<br />
Takehito Hujiwara | Akinori Nukui | Masahiro Yashi<br />
Jichi Medical Univ | Jichi Medical Univ Hosp<br />
FP725<br />
MALIGNANCY INCIDENCE AFTER RENAL TRANSPLANTATION: A 20-<br />
YEAR SINGLE-CENTER EXPERIENCE<br />
Ji Hyun Kim | Sung-Soo Kim | Duck Jong Han | Su-Kil Park<br />
Asan Medical Center<br />
FP726<br />
EQUITY IN ORGAN DONATION AND TRANSPLANTATION: FACT OR FAL-<br />
LACY?<br />
Gurch Randhawa<br />
Univ Bedfordshire, Luton, England<br />
FP727<br />
TRANSPLANTATION WITH KIDNEY PAIRED DONATION TO INCREASE<br />
THE DONOR POOL: A SINGLE-CENTER EXPERIENCE<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
205<br />
FRIDAY, MAY 25
FRIDAY, MAY 25<br />
206<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Manoj Gumber | Vivek Balkrishna Kute | Pankaj Shah | Himanshu Patel | Aruna<br />
Vanikar | Pranjal Modi | Hargovind Trivedi<br />
IKDRC-ITS, Ahmedabad, India<br />
FP728<br />
POSTTRANSPLANT LYMPHOPROLIF<strong>ERA</strong>TIVE DISORDERS IN PAEDIA-<br />
TRIC RECIPIENTS OF KIDNEY ALLOGRAFT<br />
Saeed Taheri<br />
Dr. Taheri Medical Res Group, Tehran, Iran<br />
FP729<br />
EFFECT AND TOL<strong>ERA</strong>BILITY OF AGALSIDASE ALFA WERE ASSESSED<br />
IN PATIENTS WITH FABRY DISEASE WHO WERE TREATMENT-NAÏVE<br />
(NAÏVE) OR PREVIOUSLY TREATED WITH AGALSIDASE BETA (SWITCH<br />
PATIENTS)<br />
Ozlem Goker-Alpan | Khan Nedd | Suma Shankar | Howard Lein | Bruce Barshop<br />
| Ellen Boyd | Myrl Holida | Richard Hillman | Jennifer Ibrahim | Rebecca<br />
Mardach | Neil Wienreb | Barbara Rever | Richard Forte | Alpana Desai |<br />
Anna Wijatyk | Peter Chang | Rick Martin<br />
Lysosomal Disorders Res & Treatment Unit, Springfield, VA | Infusion Associates,<br />
Grand Rapids, MI | Emory Univ, Atlanta, GA | AKDHC, Tucson, AZ|<br />
UCSD, San Diego, CA | Fullerton Genetics Center, Asheville, NC | U Iowa Health<br />
Care, Iowa City, IA | U Missouri, Columbia, MO | St Joseph’s Children’s<br />
Hosp, Paterson, NJ | Kaiser Permanente, Los Angeles, CA | Univ Res Foundation<br />
for Lysosomal Storage Disorders, Coral Springs, FL | Central Coast Nephrology,<br />
Salinas, CA | North Shore Univ Hosp, Manhasset, NY | Stuart Oncology<br />
Associates, Stuart, FL | Shire HGT, Lexington, MA<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
DAY AT A GLANCE<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
page<br />
08:00 - 09:30 Symposia<br />
Salt and volume management<br />
in dialysis patients 208<br />
Highlights of the 2011 ESOT congress 209<br />
Pathophysiology of AKI 210<br />
Markers of renal progression 211<br />
Tubular function 212<br />
Free Communications + Mini Lectures<br />
EU and glomerular diseases 213<br />
Diabetes basic research 215<br />
Bone and mineral diseases - 1 217<br />
09:30 - 10:45 Poster session 249<br />
10:45 - 11:30 Plenary Lecture R. Johnson<br />
Fructose, metabolic syndrome<br />
and kidney disease 219<br />
11:45 - 13:15 Symposia<br />
Atherosclerotic and cardiac disease in CKD 220<br />
Ciliopathies and PKD 221<br />
Renal sympathetic denervation,<br />
baroreflex stimulation 222<br />
Minimal change diseases/FSGS 223<br />
Free Communications + Mini Lectures<br />
Transplantation basic 224<br />
Peritoneal dialysis 226<br />
Renal fibrosis 228<br />
13:15 - 15:15 Industry Symposia 373<br />
15:15 - 16:45 Symposia<br />
Progression of CKD and associated<br />
cardiovascular complications 230<br />
Membranous nephropathy 231<br />
Elderly patient with CKD or on dialysis 232<br />
Genetic diseases of the glomerular barrier 233<br />
Outcomes after transplantation 234<br />
Free Communications + Mini Lectures<br />
Genetic diseases 235<br />
Dialysis techniques and adequacy 237<br />
Mineral homeostasis and nephrolithiasis 239<br />
17:00 - 18:30 Symposia<br />
Management issues in patients with CKD 240<br />
Vasculitis and lupus 241<br />
Glomerular permeability and permeability-<br />
inducing factors 242<br />
Tolerance and predictors of tx outcome 243<br />
Literature Update<br />
CKD and dialysis 244<br />
Free Communications + Mini Lectures<br />
Bone and mineral diseases - 2 245<br />
Diabetes clinical studies 247<br />
207<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
208<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
GRAND AMPHITHEATRE 08:00 - 09:30<br />
Symposium 19<br />
Salt and volume management in dialysis patients<br />
Chair: Michel Jadoul, Brussels, Belgium<br />
Eberhard Ritz, Heidelberg, Germany<br />
Improving survival in dialysis patients: salt and volume<br />
management is more important than higher uremic toxin<br />
removal<br />
Adrian Covic, Iasi, Romania<br />
Improving survival in dialysis patients: higher uremic<br />
toxin removal is more important than salt and volume<br />
management!<br />
Raymond Vanholder, Ghent, Belgium<br />
Bioimpedance measurements in the assessment of volume<br />
status<br />
Martin K. Kuhlmann, Berlin, Germany<br />
Lung ultrasound to assess volume status in dialysis patients<br />
Carmine Zoccali, Reggio Calabria, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 1 08:00 - 09:30<br />
Symposium 20<br />
Highlights of the 2011 ESOT congress<br />
(in cooperation with European Society for Organ Transplantation)<br />
Chair: Alan G. Jardine, Glasgow, UK<br />
Marian Klinger, Wroclaw, Poland<br />
Basic and translational science highlights from ESOT<br />
2011<br />
Martin J. Hoogduijn, Rotterdam, Netherlands<br />
Clinical highlights from ESOT 2011<br />
Keith Rigg, Nottingham, UK<br />
Changes to clinical practice suggested by ESOT 2011<br />
Josep M. Campistol, Barcelona, Spain<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
209<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
210<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BLEU 08:00 - 09:30<br />
Symposium 21<br />
New advances in the pathophysology of AKI<br />
Chair: Andreas Kribben, Essen, Germany<br />
Claudio Ronco, Vicenza, Italy<br />
Protection of mitochondria: new target to prevent nephrotoxicity<br />
Dmitry B. Zorov, Moscow, Russia<br />
NGAL: more than a marker of AKI<br />
Jonathan Barasch, New York, USA<br />
The role of complement in the pathogenesis of ischemiareperfusion<br />
damage<br />
Giuseppe Grandaliano, Foggia, Italy<br />
FREE COMMUNICATIONS<br />
SAO001<br />
NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN<br />
PREDICTS THE NEED FOR RENAL REPLACEMENT THE-<br />
RAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY<br />
INJURY<br />
Dinna Cruz | Hilde R de Geus | Claudio Ronco | A B Johan<br />
Groeneveld<br />
San Bortolo Hosp Vicenza | Erasmus Univ Medical Center, Rotterdam,<br />
Netherlands<br />
SAO002<br />
RENAL DENDRITIC CELLS RELEASE INTERLEUKIN-22<br />
WHICH PROMOTES REGEN<strong>ERA</strong>TION OF TUBULAR EPI-<br />
THELIAL CELLS AFTER ACUTE KIDNEY INJURY<br />
Onkar P. Kulkarni | Jan H. Hagemann | Shrikant R. Mulay |<br />
Dana Thomasova | Mi Ryu | Hans-Joachim Anders<br />
Nephrological Center, Medical Policlinic, Univ Munich, Germany<br />
| Medizinische Poliklinik Innenstadt der LMU, Munich,<br />
Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BORDEAUX 08:00 - 09:30<br />
Symposium 22<br />
Markers of renal progression - New approaches<br />
and studies<br />
Chair: Matthias Kretzler, Ann Arbor, USA<br />
Carmine Zoccali, Reggio Calabria, Italy<br />
Systems biology: building a useful model from multiple<br />
markers and profiles<br />
Gert Mayer, Innsbruck, Austria<br />
Genome-wide association studies in CKD<br />
Murielle Bochud, Epalinges, Switzerland<br />
The French CKD-REIN cohort study<br />
Bénédicte Stengel, Villejuif, France<br />
The BIND-NL cohort: a strategic initiative in CKD<br />
Gerjan Navis, Groningen, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
211<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
212<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE HAVANE 08:00 - 09:30<br />
Symposium 23<br />
Advances in understanding tubular function<br />
Chair: Heini Murer, Zurich, Switzerland<br />
Pierre Verroust, Paris, France<br />
Molecular pathophysiology of renal magnesium handling<br />
Joost G.J. Hoenderop, Nijmegen, Netherlands<br />
Cubilin and tubular function<br />
Erik Ilsø Christensen, Aarhus, Denmark<br />
Renal TRPathies<br />
Thomas Gudermann, Munich, Germany<br />
Role of parvalbumin in the distal tubule<br />
Olivier Devuyst, Zurich, Switzerland<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 352AB 08:00 - 09:30<br />
Free Communication Session 13 + Mini Lecture<br />
The EU and glomerular diseases<br />
Chair: Manuel Praga, Madrid, Spain<br />
Rolf A.K. Stahl, Hamburg, Germany<br />
Mini Lecture<br />
Presentation of EU-funded consortia in nephrology<br />
Carsten Wagner, Zurich, Switzerland<br />
FREE COMMUNICATIONS<br />
SAO003<br />
NOVEL CONCEPTS IN NEPHROTIC SYNDROME: ANGIO-<br />
POIETIN-LIKE 4 INDUCED HYPERTRIGLYCERIDEMIA RE-<br />
SULTS FROM A MULTISYSTEM EFFORT TO REDUCE PRO-<br />
TEINURIA<br />
Camille Mace | Sumant Chugh | Lionel Clement<br />
Univ Alabama Birmingham, Birmingham, Alabama, USA<br />
« SAO004<br />
mTORC1 CONTRIBUTES TO THE PATHOGENESIS OF FSGS<br />
Stefan Zschiedrich | Markus Gödel | Björn Hartleben | Kristina<br />
Eulenbruch | Stefan Munder | Nadja Herbach | Maria-Pia<br />
Rastaldi | Clemens D. Cohen | Michael N. Hall | Markus A.<br />
Rüegg | Gerd Walz | Tobias B. Huber<br />
Renal Div, Univ Hosp Freiburg, Germany | Inst Veterinary Pathology,<br />
Ludwig-Maximilians-Univ, Munich, Germany | Renal<br />
Research Lab, Milan, Italy | Renal Div and Inst Physiology,<br />
Univ Hosp and Univ Zürich, Switzerland | Biozentrum, Univ<br />
Basel, Switzerland<br />
SAO005<br />
PLA2R ANTIGEN IN GLOMERULAR DEPOSITS IS A SEN-<br />
SITIVE DIAGNOSTIC MARKER FOR MEMBRANOUS NE-<br />
PHROPATHY<br />
Svobodova Barbora | Honsova Eva | Ronco Pierre | Tesar Vladimir<br />
| Debiec Hanna<br />
Dept Nephrology, First Fac Medicine and General Univ Hosp,<br />
Prague, Czech Republic | INSERM U702, Dept Nephrology Tenon<br />
Hosp, Paris, France<br />
SAO006<br />
MONOCLONAL IGG3 KAPPA ANTIBODIES TO THE PHO-<br />
SPHOLIPASE A2 RECEPTOR AND RECURRENT MEMBRA-<br />
NOUS NEPHROPATHY<br />
Debiec Hanna | Hanoy Mélanie | Francois Arnaud | Guerrot<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
213<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
214<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
Dominique | Ferlicot Sophie | Johanet Catherine | Aucouturier<br />
Pierre | Godin Michel | Ronco Pierre<br />
Inserm U702 | Dept Nephrology Univ Hosp | Dept Pathology<br />
Univ Hosp | Kremlin-Bicêtre Hosp | Dept Immunology Saint-<br />
Antoine Hosp, Paris, France<br />
SAO007<br />
RENAL INTERSTITIAL CELLULAR INFILTRATION IS PRE-<br />
DICTIVE OF POOR RENAL PROGNOSIS IN HIV-INFECTED<br />
PATIENTS<br />
Florence Aulagnon | Laure Champion | Francine Walker |<br />
Jerome Verine | Laurent Arnaud | Denis Glotz | François Vrtovsnik<br />
| Eric Daugas<br />
Nephrology Dpt Bichat Hosp AP-HP, Paris, France | Pathology<br />
Dpt Bichat Hosp AP-HP, Paris, France | Pathology Dpt Saint-<br />
Louis Hosp AP-HP, Paris, France | Internal Medicine Dpt Pitie<br />
Salpetriere APHP, Paris, France | Nephrology Dpt Saint-Louis<br />
Hosp AP-HP, Paris, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 342AB 08:00 - 09:30<br />
Free Communication Session 14<br />
Diabetes basic research<br />
Chair: Peter Mertens, Magdeburg, Germany<br />
Fabiola Terzi, Paris, France<br />
FREE COMMUNICATIONS<br />
SAO008<br />
5/6 NEPHRECTOMIZED MICE EXHIBITED EARLY FAT<br />
MASS LOSS ASSOCIATED WITH ECTOPIC LIPID REDEPO-<br />
SITION AND INSULIN RESISTANCE: PUTATIVE ROLE OF<br />
LIPOTOXICITY<br />
Koppe Laetitia | Pelletier Caroline | Vella Roxane | Fouque<br />
Denis | Guebre-Egziahbher Fitsum | Soulage Christophe<br />
HCL, Hôp E. Herriot Lyon France | Univ Lyon, CarMeN, IN-<br />
SERM U1060, INSA Lyon, Univ Lyon-1, Villeurbanne, France<br />
SAO009<br />
INVOLVEMENT OF INFLAMMATION-RELATED MICROR-<br />
NAS: MIR-155 AND MIR-146-A IN DIABETIC NEPHROPA-<br />
THY: IMPLICATION IN INFLAMMATION-MEDIATED EN-<br />
DOTHELIAL INJURY<br />
Fang Liu | Youqun Huang | Ping Fu<br />
West China Hosp Sichuan Univ, Chengdu, China<br />
SAO010<br />
PROTECTIVE ROLE OF MAFB IN DIABETIC NEPHROPA-<br />
THY<br />
Naoki Morito | Keigyou Yoh | Akiko Fujita | Satoru Takahashi<br />
| Kunihiro Yamagata<br />
Dept Nephrology, Div Clinical Medicine, Fac Medicine, Univ<br />
Tsukuba, Tsukuba, Ibaraki, Japan | Dept Anatomy and Embryology,<br />
Life System Medical Sciences, Univ Tsukuba, Tsukuba,<br />
Ibaraki, Japan<br />
« SAO011<br />
THE SOLUBLE GUANYLATE CYCLASE ACTIVATOR CI-<br />
NACIGUAT ATTENUATES NEPHROPATHY IN DIABETIC<br />
RATS<br />
Lilla Fang | Tamas Radovits | Bela Merkely | Miklos Mozes<br />
M.| Laszlo Rosivall | Gabor Kokeny<br />
Semmelweis Univ, Budapest, Hungary<br />
SAO012<br />
INSULIN TREATMENT RESTORES HYPERFILTRATION<br />
AND AMELIORATES ARTERIAL HYPERTENSION IN NOD/<br />
ShiLtJ DIABETIC MICE<br />
Marta Riera | Eva Marquez | Javier Gimeno | Heleia Roca |<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
215<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
216<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
Sergi Clotet | Nuria Juanpere | Josep Lloreta | Julio Pascual |<br />
MªJose Soler<br />
Kidney Disease Research Group, Nephrology Dept, Hosp del<br />
Mar-IMIM Barcelona, Spain | Pathology Dept, Hosp del Mar<br />
Barcelona, Spain<br />
SAO013<br />
THE BENEFITS OF ASOCIATING IFN GAMMA WITH MI-<br />
N<strong>ERA</strong>LCORTICOIDS RECEPTOR BLOCKERS IN DELAYING<br />
DIABETIC NEPHROPATHY IN RODENTS WITH TYPE II<br />
DIABETES AND OBESITY<br />
Ionel-Alexandru Checherita | Andrei Niculae | Alexandru<br />
Ciocalteu<br />
Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania<br />
| St. John Emergency Clinical Hosp, Bucharest, Romania<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 2 08:00 - 09:30<br />
Free Communication Session 15<br />
Bone and mineral diseases - 1<br />
Chair: Jorge B. Cannata-Andía, Oviedo, Spain<br />
Patrick D’Haese, Antwerp, Belgium<br />
FREE COMMUNICATIONS<br />
SAO014<br />
KAI-4169, A NOVEL PEPTIDE AGONIST OF THE CALCIUM<br />
SENSING RECEPTOR, ATTENUATES PTH AND SOFT TIS-<br />
SUE CALCIFICATION AND RESTORES PARATHYROID<br />
GLAND VDR LEVELS IN UREMIC RATS<br />
Sarah Walter | Jin Dong | Shawn Alexander | Tom Hunter |<br />
Kevin Yin | Derek Maclean | Jim Tomlinson | Felix Karim |<br />
Randy Johnson<br />
KAI Pharmaceuticals Inc., South San Francisco, US<br />
« SAO015<br />
EFFECTS OF PHOSPHATE ON VASCULATURE CAN BE<br />
CORRECTED WITH A PHOSPHODIEST<strong>ERA</strong>SE 5 INHIBITOR<br />
Kathryn Stevens | Rajan Patel | Marc Clancy | Delyth Graham|<br />
Christian Delles | Alan Jardine<br />
Univ Glasgow, Glasgow, UK<br />
SAO016<br />
SCLEROSTIN AND DKK-1 LEVELS IN PRE-DIALYISIS CKD<br />
PATIENTS<br />
Geert Behets | Liesbeth Viaene | Björn Meijers | Patrick D’Haese<br />
| Pieter Evenepoel<br />
Univ Antwerp, Antwerp, Belgium | KULeuven, Nephrology,<br />
Leuven | Univ Hosp, Leuven, Belgium<br />
SAO017<br />
ELEVATED FGF-23 LEVELS IN CKD PATIENTS ON LOOP<br />
DIURETIC TREATMENT<br />
Sarah Seiler | Esther Herath | Franziska Flügge | Anja<br />
Weihrauch | Danilo Fliser | Gunnar Henrik Heine<br />
Dept Internal Medicine IV, Saarland Univ Hosp, Homburg,<br />
Germany<br />
SAO018<br />
THE GERMAN CALCIPHYLAXIS REGISTRY<br />
Vincent Brandenburg | Thilo Krüger | Rabea Wagstaff | Jürgen<br />
Floege | Paula Specht | Markus Ketteler<br />
Univ Hosp Aachen | Nephrology, Univ Hosp Aachen | CTC-A,<br />
Univ Hosp Aachen | RWTH Aachen Univ | Cardiology, Univ<br />
Hosp Aachen | Klinikum Coburg, Coburg Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
217<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
218<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
SAO019<br />
EPC NUMBER AND FUNCTION IS IMPROVED BY VDRA<br />
TREATMENT IN HEMODIALYSIS PATIENTS<br />
Maria Laura Angelini | Giuseppe Cianciolo | Gaetano La<br />
Manna | Maria Laura Cappuccilli | Elena Della Bella | Iolanda<br />
Rum | Diletta Conte | Vania Cuna | Ada Dormi | Paola Todeschini<br />
| Gabriele Donati | Roberta Costa | Gian Paolo Bagnara|<br />
Sergio Stefoni<br />
Inst Nephrology, Dialysis and Renal Transpl, Dept Medicine<br />
and Public Health, Dept Histology, Embryology and Applied<br />
Biology, Univ Bologna, Bologna, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
GRAND AMPHITHEATRE 10:45 - 11:30<br />
Plenary Lecture 2<br />
Chair: Jürgen Floege, Aachen, Germany<br />
Vladimir Tesar, Prague, Czech Republic<br />
Fructose, metabolic syndrome and kidney disease<br />
Richard Johnson, Denver, USA<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
219<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
220<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
GRAND AMPHITHEATRE 11:45 - 13:15<br />
Symposium 24<br />
Atherosclerotic and cardiac disease in CKD<br />
Chair: Adrian Covic, Iasi, Romania<br />
Peter Stenvinkel, Stockholm, Sweden<br />
Features of cardiovascular disease in CKD<br />
Ziad A. Massy, Amiens, France<br />
Vascular hemodynamic changes in CKD<br />
Gérard M. London, Fleury-Mérogis, France<br />
Cardiovascular complications in CKD: role of oxidative<br />
stress<br />
Kostas Siamopoulos, Ioannina, Greece<br />
Reducing the risk of stroke in dialysis patients<br />
Christiane Drechsler, Würzburg, Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 1 11:45 - 13:15<br />
Symposium 25<br />
Ciliopathies and polycystic kidney disease (basic<br />
and translational)<br />
Chair: Nine Knoers, Utrecht, Netherlands<br />
Gerd Walz, Freiburg, Germany<br />
HNF1beta, cystic kidneys and morphogenesis<br />
Marco Pontoglio, Paris, France<br />
Regulation of mTOR signalling by cilia and flow<br />
Wolfgang Kuehn, Freiburg, Germany<br />
Ciliopathies / BBS<br />
Nicholas Katsanis, Durham, USA<br />
Are animal models suitable for testing therapies applicable<br />
to humans?<br />
Dorien Peters, Leiden, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
221<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
222<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BLEU 11:45 - 13:15<br />
Symposium 26<br />
Novel invasive strategies in antihypertensive treatment<br />
- Renal sympathetic denervation, baroreflex<br />
stimulation<br />
Chair: Michel Azizi, Paris, France<br />
Peter J. Blankestijn, Utrecht, Netherlands<br />
Renal denervation as antihypertensive treatment - How<br />
does it work?<br />
Gerald F. DiBona, Iowa City, USA<br />
Sympathetic denervation as antihypertensive treatment<br />
- critical appraisal of first results<br />
Johannes Mann, Munich, Germany<br />
Resistant hypertension – baroreflex stimulation as a new<br />
tool<br />
Jan Menne, Hanover, Germany<br />
FREE COMMUNICATIONS<br />
SAO020<br />
OVERVIEW OF PATIENTS SCREENEND FOR RENAL<br />
SYMPATHETIC DENERVATION AT THE UMC UTRECHT<br />
Eva Vink | Verloop Willemien | Voskuil Michiel | Spiering<br />
Wilko | Vonken Evert-Jan | PJ Blankestijn<br />
UMC Utrecht, Utrecht, Netherlands<br />
SAO021<br />
CHRONIC BILAT<strong>ERA</strong>L RENAL DENERVATION ATTENUA-<br />
TES FIBROTIC MARKER EXPRESSION AND ALBUMINURIA<br />
IN EXPERIMENTAL DIABETIC NEPHROPATHY<br />
Yimin Yao | Joanne Harrison | Gerard Davis | Ivan Sammut<br />
Univ Otago School of Medical Sciences, Dunedin, New Zealand<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BORDEAUX 11:45 - 13:15<br />
Symposium 27<br />
Minimal Change Disease / FSGS<br />
Chair: Alain Meyrier, Paris, France<br />
Jack F.M. Wetzels, Nijmegen, Netherlands<br />
Minimal change nephropathy: the search for molecular<br />
mediators<br />
Sumant Singh Chugh, Birmingham, USA<br />
FSGS: the search for permeability factors<br />
Jochen Reiser, Miami, USA<br />
When to start a genetic study in a patient with FSGS?<br />
Roser Torra, Barcelona, Spain<br />
Which treatment for steroid dependent nephrotic syndrome<br />
in children?<br />
Patrick Niaudet, Paris, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
223<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
224<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE HAVANE 11:45 - 13:15<br />
Free Communication Session 16<br />
Transplantation basic<br />
Chair: Josep M. Campistol, Barcelona, Spain<br />
Olivier Thaunat, Lyon, France<br />
FREE COMMUNICATIONS<br />
SAO022<br />
MICROVESICLES DERIVED FROM ENDOTHELIAL PRO-<br />
GENITOR CELLS PROTECT FROM ANTIBODY- AND COM-<br />
PLEMENT-MEDIATED ENDOTHELIAL INJURY THROUGH<br />
TRANSFER OF SPECIFIC mRNAs AND microRNAs: POTEN-<br />
TIAL ROLE IN GRAFT ACCOMODATION<br />
Vincenzo Cantaluppi | Michela De Lena | Federico Figliolini |<br />
Silvia Beltramo | Davide Medica | Giuliana Tognarelli | Luigi<br />
Biancone | Ciro Tetta | Giuseppe Paolo Segoloni | Giovanni<br />
Camussi<br />
Univ Turin, Italy | Fresenius Medical Care, Bad Homburg, Germany<br />
« SAO023<br />
THROMBIN MODULATE T CELLS RESPONSE INDUCED BY<br />
DENDRITIC CELLS (DC) IN KIDNEY TRANSPLANT RECI-<br />
PIENTS WITH DELAYED GRAFT FUNCTION (DGF)<br />
Paola Pontrelli | Marica Cariello | Raffaella Verrienti | Tiziana<br />
Tataranni | Margherita Gigante | Antonia Loverre | Giovanni<br />
Stallone | Francesco Paolo Schena | Elena Ranieri | Loreto Gesualdo<br />
| G Grandaliano<br />
DETO, Univ Bari, Italy | Dept Nephrology | Dept Biomedical<br />
Sciences, Univ Foggia, Foggia, Italy<br />
SAO024<br />
PROFILING AND FUNCTIONAL CHARACTERIZATION OF<br />
POST-TRANSPLANT CIRCULATING ANTIBODIES IN KID-<br />
NEY TRANSPLANTATION USING DONOR ENDOTHELIAL<br />
CELLS<br />
Stephanie Coupel | Emmanuel Canet | Nathalie Gerard | Beatrice<br />
Charreau<br />
Inserm U643-ITERT-CHU Hotel-Dieu, Nantes, France<br />
« SAO025<br />
A SPECIFIC B-CELL SUBSET AND FUNCTIONAL PROFILE<br />
IN THE CHRONIC HUMORAL REJECTION!<br />
Isabelle Segalen | Nouel Alexandre | Anne Grall | Pers Jacques-Olivier<br />
| Sophie Hillion | Yannick Le Meur<br />
Transplant unit, CHRU Brest, FRANCE | Immunology, Unity<br />
2216, Brest, France | Transplant unit, CHRU Cavale Blanche<br />
Brest, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
SAO026<br />
THE PHENOTYPE OF TUBULAR EPITHELIAL CELLS IS PRE-<br />
DICTIVE OF LONG TERM GRAFT FUNCTION<br />
Hertig Alexandre | Anglicheau Dany | Delahousse Michel|<br />
Glotz Denis | Legendre Christophe | Ouali Nacéra | Brochériou<br />
Isabelle | Rondeau Eric | Dubois Xu Yi Chun<br />
Inserm U702 | APHP, Hôp Necker | Hop Foch | APHP, Hop<br />
Saint Louis | APHP, Hôp Tenon, Paris, France<br />
SAO027<br />
THREE-YEAR OUTCOME OF ISOLATED GLOMERULITIS<br />
ON 3-MONTH PROTOCOL BIOPSIES OF DONOR HLA AN-<br />
TIBODY NEGATIVE PATIENTS<br />
David Buob | Philippe Grimbert | François Glowacki |<br />
Myriam Labalette | Françoise Dufossé | Dominique Nochy |<br />
Marie-Christine Copin | Emmanuel Boleslawski | Christian<br />
Noël | Marc Hazzan<br />
Serv Anatomie Pathologique, Centre Biologie Pathologie,<br />
CHRU Lille | Serv Néphrologie et Transpl Rénale, Hôp Henri<br />
Mondor, APHP et Univ Paris XII, Créteil, France | Serv Néphrologie,<br />
Hôp Huriez, CHU Lille, France | Serv Immunologie,<br />
Centre Biologie-Pathologie, CHU de Lille, Lille, France | Lab<br />
Anatomie Pathologique, Hôp Européen Georges Pompidou,<br />
APHP, Paris, France | Inst Pathologie, Centre Biologie-Pathologie,<br />
CHU Lille, Lille, France | Serv Chirurgie Digestive et Transpl,<br />
Hôp Huriez, CHU Lille, Lille, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
225<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
226<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 352AB 11:45 - 13:15<br />
Free Communication Session 17<br />
Peritoneal dialysis<br />
Chair: Nada Dimkovic, Belgrade, Serbia<br />
Cengiz Utas, Kayseri, Turkey<br />
FREE COMMUNICATIONS<br />
t SAO028<br />
NFAT5 CONTRIBUTES TO OSMOLALITY-INDUCED MCP-1<br />
EXPRESSION IN MESOTHELIAL CELLS<br />
Franz-Xaver Beck | Christoph Küper | Wolfgang Neuhofer<br />
Univ Munich, Munich, Germany<br />
t SAO029<br />
INTERLEUKIN L-17A: A NOVEL PLAYER IN PERITONEAL<br />
INJURY BY DIALYSIS<br />
Raquel Rodrigues-Díez | Luiz Guilherme Stark Aroeira | Jose<br />
A. Jimenez | Raul Rodrigues-Diez | Sandra Rayego-Mateos |<br />
Auxiliadora Bajo Rubio | Alberto Ortiz | Jesus Egido | Manuel<br />
Lopez-Cabrera | Rafael Selgas | Marta Ruiz-Ortega<br />
Cellular Biology Renal Diseases Lab Univ Autónoma Madrid,<br />
Spain | IDIPAZ, Madrid, Spain | Hosp Univ Puerta de Hierro,<br />
Madrid, Spain | Dialysis Unit, Fund Jiménez Díaz, Madrid,<br />
Spain | IIS-FJD, Madrid, Spain | Unidad Biología Molecular,<br />
Hosp Univ de la Princesa, Madrid, Spain<br />
« SAO030<br />
REFUTING A TABOO: OVERHYDRATION PREVALENCE<br />
DOES NOT INCREASE IN PERITONEAL DIALYSIS PA-<br />
TIENTS - A PROSPECTIVE LONGITUDINAL STUDY<br />
Aguiar Pedro Ventura | Santos Olivia | Laetitia Teixeira | Vidinha<br />
Joana | Ferrer Francisco | Carvalho Maria João | Cabrita<br />
António | Anabela Soares Rodrigues<br />
Centro Hosp Porto - Hosp Santo António, Porto, Portugal |<br />
PDMA, ICBAS-UP, Porto, Portugal | Hosp São Teotónio, Viseu,<br />
Portugal | Centro Hosp Coimbra, Coimbra, Portugal<br />
« SAO031<br />
PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS IN AU-<br />
STRIA: EPIDEMIOLOGY, RISK FACTORS, AND THE ROLE<br />
OF ORAL ACTIVE VITAMIN D<br />
Andreas Vychytil | Julia Kerschbaum | Karl Lhotta | Friedrich<br />
Prischl | Martin Wiesholzer | Gertrude Kopriva-Altfahrt | Veronika<br />
Machold-Fabrizii | Christoph Schwarz | Peter Balcke |<br />
Rainer Oberbauer | Reinhard Kramar | Paul König | Michael<br />
Rudnicki<br />
Medical Univ Vienna, Dept Nephrology and Dialysis | Academic<br />
Teaching Hosp Feldkirch | Dept Medicine III, Clinical<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
Div Nephrology and Dialysis, Krankenhaus der Barmherzigen<br />
Schwestern vom Hl. Kreuz, Wels | First Dept Medicine, Div<br />
Nephrology and Dialysis A.ö. Krankenhaus St. Pölten | Dept<br />
Medicine VI, Div Nephrology and Dialysis, Wilhelminenspital,<br />
Vienna|Dept Nephrology, Krankenhaus der Elisabethinen,<br />
Linz | Austrian Dialysis and Transplant Registry, Linz,<br />
Austria| Dept Internal Medicine IV, Nephrology and Hypertension,<br />
Medical Univ Innsbruck | Medical Univ, Innsbruck,<br />
Austria<br />
« SAO032<br />
A DUTCH GUIDELINE FOR THE MANAGEMENT OF EN-<br />
CAPSULATING PERITONEAL SCLEROSIS<br />
Meelad Habib | Michiel Betjes | Mario Korte<br />
Erasmus MC, Univ Medical Center, Rotterdam, Netherlands |<br />
Albert Schweizer Hosp, Dordrecht, Netherlands<br />
« SAO033<br />
ENCAPSULATING PERITONEAL SCLEROSIS IN PEDIATRIC<br />
PERITONEAL DIALYSIS PATIENTS: THE EXPERIENCE OF<br />
THE ITALIAN REGISTRY OF PEDIATRIC CHRONIC DIALYSIS<br />
Enrico Vidal | Alberto Edefonti | Roberto Chimenz | Bruno<br />
Gianoglio | Giovanna Leozappa | Silvio Maringhini | Francesca<br />
Mencarelli | Carmine Pecoraro | Flora Puteo | Sara Testa |<br />
Rossella Cannavò | Enrico Verrina<br />
Dept Pediatrics, Univ Padova, Italy | Pediatric Nephrology and<br />
Dialysis Unit, Clinica Pediatrica De Marchi, Milano, Italy | Dept<br />
Pediatrics, Nephrology Unit, Univ School Medicine, Messina,<br />
Italy | Nephrology, Dialysis and Transpl Unit, Regina Margherita<br />
Children’s Hosp, Torino, Italy | Nephrology and Urology<br />
Dept, Bambino Gesù Children’s Hosp, Roma, Italy | Pediatric<br />
Nephrology Unit, Children’s Hosp G. Di Cristina, Palermo,<br />
Italy | Nephrology and Dialysis Unit, Dept Pediatrics, Azienda<br />
Osp Univ Sant’Orsola-Malpighi, Bologna, Italy | Nephrology<br />
and Dialysis Unit, Santobono Children’s Hosp, Napoli, Italy |<br />
Nephrology Div, Giovanni XXIII Children’s Hosp, Bari, Italy |<br />
Nephrology and Dialysis Div, Giannina Gaslini Inst, Genova,<br />
Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
227<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
228<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 2 11:45 - 13:15<br />
Free Communication Session 18 + Mini Lecture<br />
Renal fibrosis<br />
Chair: Jonathan Fox, Glasgow, UK<br />
Hans-Peter Marti, Solothurn, Switzerland<br />
FREE COMMUNICATIONS<br />
SAO034<br />
FIBROCYTE DEVELOPMENT: ROLE OF CCR2+GR-1+ MO-<br />
NOCYTES<br />
Barbara Reich | Fabian Hermann | Yvonne Talke | Manuel<br />
Rodriguez Gomez | Kathrin Schmidbauer | Nicole Göbel | Isabel<br />
Ketelsen | Matthias Mack<br />
Univ Hosp Regensburg, Dept Internal Medicine II, Regensburg,<br />
Germany<br />
SAO035<br />
A SUBSET OF METZINCINS AND RELATED GENES CON-<br />
STITUTES A MARKER OF SOLID ORGAN FIBROSIS ACROSS<br />
SPECIES<br />
Aikaterini Anagnostopoulou | Rob Walker | Aaron Jeffs | Andreas<br />
Scherer | Jennifer Bedford | John Leader | Ged Davis |<br />
Hans-Peter Marti<br />
Inst Anatomy, Univ Bern, Bern, Switzerland | Dept Medicine,<br />
Univ Otago, Dunedin, New Zealand | Pathology, Univ Otago,<br />
Dunedin, New Zealand | Australian Genome Research Facility<br />
Ltd., Walter and Eliza Hall Inst, Parkville, Australia | Dept Medicine,<br />
Bürgerspital, Solothurn, Switzerland<br />
SAO036<br />
PERIOSTIN NULL MICE ARE PROTECTED AGAINST THE<br />
DEVELOPMENT OF URET<strong>ERA</strong>L OBSTRUCTION- INDUCED<br />
RENAL DISEASE<br />
Mouna Mael-ainin | Simon J Conway | Jean-Claude Dussaule|<br />
Christos Chatziantoniou<br />
INSERM UMR S 702, Paris, France|Indiana Univ School Medicine,<br />
Indianapolis, USA<br />
SAO037<br />
SILENCING DISCOIDIN DOMAIN RECEPTOR 1: A NOVEL<br />
APPROACH TO REVERSE THE PROGRESSION OF GLOME-<br />
RULONEPHRITIS<br />
Carlo Alfieri | Monique Kerroch | Aude Dorison | Laurent<br />
Mesnard | Jean-Claude Dussaule | Christos Chatziantoniou<br />
Inserm UMR 702, Paris, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
SAO038<br />
CORRELATION STUDY OF RENAL EXPRESSION OF COL-<br />
LAGEN IV Α-CHAINS IN FEMALE X-LINKED ALPORT SYN-<br />
DROME PATIENT<br />
Yu Yuan-Ting | Xiaodan Yao | Huang Gao-Yuan | Chen Xin|<br />
Xu Shu-Tian | Wang Qing-Wen | Chen Hui-Ping | Hu Wei-<br />
Xin | Tang Zhen | Liu Zhi-Hong<br />
Research Inst Nephrology, Jinling Hosp, Nanjing Univ School<br />
Medicine, Nanjing, China<br />
Mini Lecture<br />
Balkan nephropathy - new insights<br />
Bojan Jelakovic, Zagreb, Croatia<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
229<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
230<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
GRAND AMPHITHEATRE 15:15 - 16:45<br />
Symposium 28<br />
Progression of CKD and associated cardiovascular<br />
complications<br />
Chair: Ariela Benigni, Bergamo, Italy<br />
Andrzej Wiecek, Katowice, Poland<br />
Endothelin antagonists and renal progression<br />
David J. Webb, Edinburgh, UK<br />
Effects of endothelin antagonists in CKD<br />
René R. Wenzel, Zell am See, Austria<br />
The role of renalase in cardiovascular risk/pathology<br />
in CKD<br />
Manuel Pestana, Porto, Portugal<br />
Vascular effects of aldosterone: role in CKD?<br />
Ernesto L. Schiffrin, Montréal, Canada<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 1 15:15 - 16:45<br />
Symposium 29<br />
Membranous nephropathy<br />
Chair: Paul Brenchley, Manchester, UK<br />
Richard Glassock, Los Angeles, USA<br />
Recent advances in the pathogenesis of membranous nephropathy<br />
Hanna Debiec, Paris, France<br />
PLA2-Receptor antibodies and their role in the monitoring<br />
of treatment of membranous nephropathy<br />
Rolf A.K. Stahl, Hamburg, Germany<br />
Spontaneous remission of nephrotic syndrome in membranous<br />
nephropathy<br />
Manuel Praga, Madrid, Spain<br />
KDIGO Guidelines: Treatment of membranous nephropathy<br />
Jack F.M. Wetzels, Nijmegen, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
231<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
232<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BLEU 15:15 - 16:45<br />
Symposium 30<br />
The elderly patient with CKD or on dialysis<br />
Chair: Denis Fouque, Lyon, France<br />
Francesco Locatelli, Lecco, Italy<br />
Haemodialysis in the elderly<br />
Antonio Santoro, Bologna, Italy<br />
Treatment of frail CKD patients: maximum conservative<br />
management vs timely initiation of dialysis<br />
Pedro Ponce, Cascais, Portugal<br />
Protein-energy wasting in elderly dialysis patients<br />
Peter Barany, Stockholm, Sweden<br />
Kidney transplantation in the elderly<br />
Maria Alicja Dębska-Slizien, Gdansk, Poland<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BORDEAUX 15:15 - 16:45<br />
Symposium 31<br />
Genetic diseases of the glomerular barrier<br />
Chair: Tobias Huber, Freiburg, Germany<br />
Marie Claire Gubler, Paris, France<br />
The cytoskeleton and FSGS<br />
Marina Noris, Bergamo, Italy<br />
A new protein mutated in glomerular disease and neuropathy<br />
Corinne Antignac, Paris, France<br />
COL4A1 related disorders in mice and men<br />
Emmanuelle Plaisier, Paris, France<br />
Molecular genetics of familial hematuric diseases<br />
Constantinos Deltas, Nicosia, Cyprus<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
233<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
234<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 2 15:15 - 16:45<br />
Symposium 32<br />
Outcomes after transplantation<br />
Chair: Josep M. Grinyó, Barcelona, Spain<br />
Claudio Ponticelli, Milan, Italy<br />
Kidney preservation and outcome after transplantation<br />
Sarah A. Hosgood, Leicester, UK<br />
Impact of CKD in the outcome after non-renal transplants<br />
Gültekin Süleymanlar, Antalya, Turkey<br />
Renal transplantation with expanded criteria donors<br />
(the ERBP guideline)<br />
Uwe Heemann, Munich, Germany<br />
Scandiatransplant 2011<br />
Søren Schwarz Sørensen, Copenhagen, Denmark<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE HAVANE 15:15 - 16:45<br />
Free Communication Session 19 + Mini Lecture<br />
Genetic diseases<br />
Chair: Laurence Heidet, Paris, France<br />
Dorien Peters, Leiden, Netherlands<br />
FREE COMMUNICATIONS<br />
SAO039<br />
CHARACTERIZATION OF MOLECULAR PARTNERS OF<br />
THE PKD SUSCEPTIBILITY GENE SAMCYSTIN (ANKS6)<br />
Delestré Laure | Rude Estelle | Bakey Zeineb | Lelongt Brigitte|<br />
Bihoreau Marie-Thérèse | Gauguier Dominique<br />
INSERM UMRS872, Centre Recherche Cordeliers, Paris, France|<br />
INSERM UMRS702, Hôp Tenon, Paris, France | Centre National<br />
Génotypage, Evry, France<br />
SAO040<br />
HYPERTENSION REQUIRES RENAL CYST FORMATION<br />
AND IS ASSOCIATED WITH INCREASED INTRARENAL<br />
EXPRESSION OF RENIN-ANGIOTENSIN SYSTEM COMPO-<br />
NENTS IN Pkd1-DEFICIENT MICE<br />
Jonathan M. Fonseca | Ana P. Bastos | Andressa G. Amaral|<br />
Mauri F. Sousa | Leandro E. Souza | Denise M. Malheiros |<br />
Klaus Piontek | Maria C. Irigoyen | Terry J. Watnick | Luiz F.<br />
Onuchic<br />
Div Nephrology and Molecular Medicine, Univ São Paulo, São<br />
Paulo, Brazil | Dept Medicine, Federal Univ Goiás | Heart Inst,<br />
Univ São Paulo | Dept Pathology, Univ São Paulo | Dept Oncology,<br />
Johns Hopkins Univ | Div Nephrology, Johns Hopkins<br />
Univ, Baltimore, USA<br />
SAO041<br />
RAPAMYCIN FOR TREATMENT OF TYPE I AUTOSOMAL<br />
DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) STU-<br />
DY: A RANDOMIZED, CONTROLLED STUDY<br />
G Stallone | B Infante | F Bruno | C Bristogiannis | G Grandaliano<br />
| L Macarini | D Mezzopane | E Montemurno | Schirinzi<br />
A | M Sabatini | A Pisani | T Tataranni | FP Schena | L<br />
Gesualdo<br />
Nephrology, Dialysis and Transpl Unit, Dept Biomedical Sciences,<br />
Univ Foggia |Dept Surgical Sciences, Diagnostic Imaging<br />
Unit, Univ Foggia |Dept Systematic Pathology, Nephrology<br />
Unit, Federico II Univ, Naples | Dept Emergency and Organ<br />
Transpl, Nephrology, Dialysis and Transpl Unit, A. Moro Univ,<br />
Bari, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
235<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
236<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
« SAO042<br />
PKD1 MUTATION INFLUENCES RENAL OUTCOME IN AU-<br />
TOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE:<br />
RESULTS FROM THE GENKYST REGISTRY<br />
Emilie Cornec Le Gall | Audrezet Marie-Pierre | Treguer Laetitia<br />
| Hourmant Maryvonne | Morin Marie-Pascale | Wehbe<br />
Bassem | Charasse Christophe | Perrichot Regine | Renaudineau<br />
Eric | Jousset Phillipe | Ferec Claude | Le Meur Yannick<br />
CHRU BREST | Molecular Genetic, CHRU Brest, France | Nephrology,<br />
CHRU Brest, France | Nephrology, CHU Rennes,<br />
France | Nephrology, CHU Nantes, France | Nephrology, CH<br />
Quimper, France | Nephrology, CH Saint-Brieuc, France | Nephrology,<br />
CH Vannes, France | Nephrology, CH Saint-Malo,<br />
France | Nephrology, CH Pontivy, France | Molecular Genetic,<br />
CHRU Brest, France | Nephrology, CHRU Brest, France<br />
SAO043<br />
DEVELOPMENT AND VALIDATION OF A PREDICTION SCO-<br />
RE FOR GENETIC TESTING IN HNF1B-RELATED DISEASE<br />
Stanislas Faguer | Nicolas Chassaing | Flavio Bandin | Cathie<br />
Prouheze | Patrick Calvas | Stéphane Decramer | Dominique<br />
Chauveau<br />
Serv Néphrologie et Immunologie clinique, CHU Rangueil,<br />
Toulouse | Serv Génétique Médicale, CHU Purpan, Toulouse,<br />
France | Serv Néphrologie - Médecine Interne - Transpl, Hôp<br />
des Enfants, Toulouse, France | Serv Génétique Médicale, CHU<br />
Purpan, Toulouse, France<br />
Mini Lecture<br />
The Medullary Sponge Kidney: a still misunderstood nephropathy<br />
Giovanni Gambaro, Rome, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 352AB 15:15 - 16:45<br />
Free Communication Session 20 + Mini Lecture<br />
Dialysis techniques and adequacy<br />
Chair: Farid Haddoum, Algiers, Algeria<br />
Martin Kuhlmann, Berlin, Germany<br />
FREE COMMUNICATIONS<br />
« SAO044<br />
A LOOK BEYOND BLOOD IN THE UREMIC SYNDROME:<br />
COMPARATIVE ANALYSIS OF INTERSTITIAL FLUID AND<br />
PLASMA IN KIDNEY DISEASE<br />
Leonard Ebah | Eystein Oveland | Ian Read | Angela Summers|<br />
Milind Nikam | Andrew Sayce | Christopher Chaloner|<br />
Warwick Dunn | Helge Wiig | Paul Brenchley | Sandip Mitra<br />
Manchester Royal Infirmary, Manchester, UK | Univ Bergen|<br />
Univ Manchester, UK<br />
SAO045<br />
VARIATION IN FLUID STATUS IN HAEMODIALYSIS PA-<br />
TIENTS: INFLUENCE OF DAILY FLUID GAINS AND BMI ON<br />
PRESCRIBED TARGET WEIGHT<br />
Elizabeth Lindley | David Keane | Boyce Charlie | Hardy Jill |<br />
Jones Linda | Oldroyd Jayne | Garthwaite Elizabeth<br />
Leeds Teaching Hosp NHS Trust, UK<br />
SAO046<br />
EFFECT OF BODY COMPOSITION ON CARDIOVASCULAR<br />
MORBIDITY AND MORTALITY IN HAEMODIALYSIS PA-<br />
TIENTS<br />
Ana Pérez de José | Soraya Abad Esttebanez | Úrsula Verdalles<br />
Guzmán | Almudena Vega Martinez | Laura Bucalo Mana |<br />
Abraham Rincón Bello | Daniel Barraca | Claudia Yuste Lozano<br />
| Juan Manuel López-Gómez<br />
Hosp Gregorio Marañón, Madrid, Spain<br />
Mini Lecture<br />
What have we learnt from the CONTRAST study (on<br />
convective removal in dialysis)<br />
Peter J. Blankestijn, Utrecht, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
237<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
238<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
FREE COMMUNICATIONS<br />
SAO047<br />
THE OXYGEN SATURATION ITALIAN STUDY GROUP: FI-<br />
NAL RESULTS<br />
Elena Mancini | Piergiorgio Bolasco | Stefano Severi | Luca<br />
Corazza | Antonio Santoro<br />
Nephrology, Dialysis and Hypertension dpt, S. Orsola-Malpighi<br />
Hosp, Bologna, Italy | Territorial Nephrology and Dialysis dpt.,<br />
Civil Hosp, Cagliari, Italy | Fac Bioengineering, DEIS dpt, Alma<br />
Mater Studiorum Univ Bologna, Bologna, Italy |Bellco srl, Mirandola,<br />
Italy on behalf of all the SOGLIA study investigators<br />
SAO048<br />
DETERMINANTS OF PHOSPHORUS KINETIC PARAME-<br />
TERS DURING HAEMODIALYSIS: RESULTS FROM THE<br />
HEMO STUDY<br />
Baris Agar | Ken Leypoldt | Alp Akonur | Audrey Hutchcraft|<br />
Bruce Culleton<br />
Baxter Healthcare Corporation, McGaw Park, USA<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 342AB 15:15 - 16:45<br />
Free Communication Session 21 + Mini Lecture<br />
Mineral homeostasis and nephrolithiasis<br />
Chair: Joost G.J. Hoenderop, Nijmegen, Netherlands<br />
Dominique Prié, Paris, France<br />
FREE COMMUNICATIONS<br />
SAO049<br />
IS TRPC3 A NOVEL MEDIATOR IN CALCIUM HOMEOSTA-<br />
SIS?<br />
Emmanuel Letavernier | Anita Rodenas | Dominique Guerrot|<br />
Jean-Philippe Haymann<br />
Univ Pierre et Marie Curie, Paris, France | AP-HP<br />
SAO050<br />
CALCIUM SENSING RECEPTOR GENE MUTATIONS AND<br />
POLYMORPHISMS ARE FOUND IN MORE THAN 50% OF<br />
PATIENTS WITH HYPOCALCIURIC HYPERCALCEMIA: A<br />
SINGLE-CENTER STUDY<br />
Marco Quaglia | Guido Merlotti | Roberta Fenoglio | Alberto<br />
Menegotto | Cristina Izzo | Andrea Airoldi | Vito Guarnieri|<br />
Piero Stratta<br />
Amedeo Avogadro Univ, Novara, Italy |Maggiore della Carità<br />
Hosp, Novara, Italy| Casa Sollievo Sofferenza Hosp, San Giovanni<br />
Rotondo (FG), Italy<br />
SAO051<br />
RENAL HISTOPATHOLOGICAL FINDINGS IN PATIENTS<br />
WITH 2,8-DIHYDROXYADENINURIA<br />
Vidar Edvardsson | Sverrir Harðarson | Runolfur Palsson<br />
Landspitali - National Univ Hosp Iceland, Reykjavik, Iceland<br />
¯ t SAO052<br />
GLUT9-MEDIATED RENAL URIC ACID HANDLING<br />
Bernard Thorens | Auberson Muriel | Bonny Olivier<br />
Dept Physiology and Center Integrative Genomics, Lausanne,<br />
Switzerland<br />
« SAO053<br />
ENTERIC HYPEROXALURIA PREDISPOSING TO NEPHRO-<br />
LITHIASIS IS A COMPLICATION OF BARIATRIC SURGERY<br />
Leila Froeder | Alessandra Calábria Baxmann | Ita Pfeferman<br />
Heilberg<br />
Univ Federal São Paulo, São Paulo, Brazil<br />
Mini Lecture<br />
Genetic animal models for primary hyperoxaluria<br />
Eduardo Salido, La Laguna, Spain<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
239<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
240<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
GRAND AMPHITHEATRE 17:00 - 18:30<br />
Symposium 33<br />
Management issues in patients with CKD<br />
Chair: Pieter Evenepoel, Leuven, Belgium<br />
Kostas Siamopoulos, Ioannina, Greece<br />
New uraemic toxins<br />
Griet Glorieux, Ghent, Belgium<br />
Obesity and renoprotection<br />
Francesca Mallamaci, Reggio Calabria, Italy<br />
Contrast-induced AKI in CKD patients: how much contrast<br />
agent is “safe”?<br />
Patrick Murray, Dublin, Ireland<br />
Are all iron preparations equal?<br />
Walter H. Hörl, Vienna, Austria<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 1 17:00 - 18:30<br />
Symposium 34<br />
Vasculitis and lupus<br />
Chair: Ricard Cervera, Barcelona, Spain<br />
Wladimir M. Szpirt, Copenhagen, Denmark<br />
Unravelling ANCA vasculitis mechanisms using animal<br />
models<br />
Ralph Kettritz, Berlin, Germany<br />
Lupus nephritis: the role of extracellular matrix and chemokines<br />
Liliana Schaefer, Frankfurt am Main, Germany<br />
Recent advances in the treatment of ANCA-positive vasculitis<br />
Wladimir M. Szpirt, Copenhagen, Denmark<br />
Recent advances in the treatment of lupus nephritis<br />
Vladimir Tesar, Prague, Czech Republic<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
241<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
242<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BORDEAUX 17:00 - 18:30<br />
Symposium 35<br />
Glomerular permeability and permeability-inducing<br />
factors<br />
Chair: Erik Ilsø Christensen, Aarhus, Denmark<br />
Jochen Reiser, Miami, USA<br />
Electrical effects across the glomerular filtration barrier<br />
Marcus J. Moeller, Aachen, Germany<br />
Podocytes, the filtration barrier and glomerular permeability<br />
Tobias Huber, Freiburg, Germany<br />
c-mip and idiopathic nephrotic syndrome<br />
Dil Sahali, Créteil, France<br />
The role of the glomerular endothelial barrier<br />
Börje Haraldsson, Gothenburg, Sweden<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 2 17:00 - 18:30<br />
Symposium 36<br />
Tolerance and predictors of transplant outcome<br />
Chair: Ulrich Kunzendorf, Kiel, Germany<br />
Manuel Pascual, Lausanne, Switzerland<br />
Biomarkers of transplantation tolerance<br />
Maria Hernandez-Fuentes, London, UK<br />
New clinical and biological correlates of kidney operational<br />
tolerance in humans<br />
Jean-Paul Soulillou, Nantes, France<br />
Can genotypes predict renal graft outcomes?<br />
Lidia Ghisdal, Brussels, Belgium<br />
Clinical and histological predictors of long-term kidney<br />
graft survival<br />
Eric Rondeau, Paris, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
243<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
244<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BLEU 17:00 - 18:30<br />
Literature Update 3<br />
CKD & Dialysis<br />
Chair: Walter Hörl, Vienna, Austria<br />
Ercan Ok, Izmir, Turkey<br />
Tilman Drueke, Amiens, France<br />
Carmine Zoccali, Reggio Calabria, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE HAVANE 17:00 - 18:30<br />
Free Communication Session 22<br />
Bone and mineral diseases - 2<br />
Chair: Teresa Adragão, Cascais, Portugal<br />
David Goldsmith, London, UK<br />
FREE COMMUNICATIONS<br />
SAO054<br />
KAI-4169, A NOVEL CALCIUM SENSING RECEPTOR AGO-<br />
NIST, DECREASES SERUM IPTH, FGF-23 AND IMPROVES<br />
SERUM BONE MARKERS IN A PHASE 2 STUDY IN HEMO-<br />
DIALYSIS SUBJECTS WITH CHRONIC KIDNEY DISEASE-<br />
MIN<strong>ERA</strong>L AND BONE DISORDER<br />
Geoffrey Block | Gregory Bell| Karen Pickthorn | Saling<br />
Huang | Kevin Martin<br />
Denver Nephrology, Denver, US | KAI Pharmaceuticals, Inc.,<br />
South San Francisco, US | Div Nephrology, Saint Louis Univ<br />
School Medicine, St Louis, USA<br />
¯ SAO055<br />
PARATHYROID HORMONE (PTH) LEVELS ROSE OVER<br />
TIME IN HEMODIALYSIS (HD) PATIENTS: RESULTS FROM<br />
THE DIALYSIS OUTCOMES AND PRACTICE PATTERNS<br />
STUDY (DOPPS)<br />
F Tentori | B Bieber | H Morgenstern | SH Jacobson | V Andreucci<br />
| M Fukagawa | DA Mendelssohn | RL Pisoni | BM<br />
Robinson<br />
Arbor Research Collaborative for Health, Ann Arbor, Michigan,<br />
USA | Univ Michigan, Ann Arbor, Michigan, USA | Danderyd<br />
Hosp, Stockholm, Sweden | Italian Kidney Foundation, Italy |<br />
Tokai Univ School Medicine, Kanagawa, Japan | Humber River<br />
Regional Hosp, Toronto, Canada<br />
« SAO056<br />
EFFECTIVENESS OF A MG-BASED PHOSPHATE BINDER<br />
ON THE DEVELOPMENT OF VASCULAR CALCIFICATIONS<br />
IN UREMIC RATS<br />
Tineke De Schutter | Ellen Neven | Geert Behets | Mirjam Peter<br />
| Sonja Steppan | Jutta Passlick-Deetjen | Patrick D’Haese<br />
Univ Antwerpen, Antwerpen, Belgium | Fresenius Medical<br />
Care Deutschland GmbH | Fresenius Medical Care, Bad Homburg,<br />
Germany | Univ Dusseldorf, Dusseldorf, Germany<br />
SAO057<br />
A MULTI-CENTRE, OPEN-LABEL, FLEXIBLE DOSE, LONG-<br />
TERM SAFETY STUDY OF COLESTILAN IN CHRONIC KID-<br />
NEY DISEASE STAGE V SUBJECTS ON DIALYSIS WITH<br />
HYPERPHOSPHATAEMIA<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
245<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
246<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
Fred Senatore | Allan Manning | Shigekazu Nakajima | Yoshiteru<br />
Ushirogawa | Kikumi Tsuda | Hiroaki Egawa<br />
Mitsubishi Tanabe Pharma Development America Inc, Warren,<br />
NJ, USA | Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan<br />
| Mitsubishi Pharma Europe, London, UK<br />
SAO058<br />
RELATIONSHIP BETWEEN FIBROBLAST GROWTH FAC-<br />
TOR 23 AND WEEKLY SERUM PHOSPHATE SERIAL MEA-<br />
SUREMENTS IN A PROSPECTIVE COHORT OF PATIENTS<br />
UNDERGOING CHRONIC INTERMITTENT HEMODIALYSIS<br />
TREATMENT<br />
Gaetano Lucisano | Sarah Seiler | Philipp Ege | Fiita Romero<br />
de Vorsmann | Matthias Klingele | Anne-Kathrin Lerner-Gräber<br />
| Danilo Fliser | Gunnar Henrik Heine<br />
Dept Internal Medicine IV - Nephrology and Hypertension, Saarland<br />
Univ Hosp, Homburg, Germany | Universitätsklinikum<br />
des Saarlandes, Homburg, Germany<br />
« SAO059<br />
SEVELAMER ATTENUATES CV MORTALITY IN INCIDENT<br />
HEMODIALYSIS PATIENTS: OPEN LABEL, RANDOMIZED<br />
CLINICAL TRIAL OF EFFICACY AND SAFETY (INDEPEN-<br />
DENT STUDY)<br />
Donald Molony | Antonio Bellasi | Vincenzo Bellizzi | Domenico<br />
Russo | Biagio Di Iorio<br />
2. Div Renal Dis & Hypertension, Dept Medicine, Univ Texas<br />
Houston Medical School, Houston, Texas, USA | UOC Nefrologia,<br />
AO Ruggi d’Aragona, Salerno, Italy | Univ Federico II<br />
Napoli | Osp Landolfi, Solofra, Avellino, Italia<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 352AB 17:00 - 18:30<br />
Free Communication Session 23<br />
Diabetes clinical studies<br />
Chair: Zhihong Liu, Nanjing, China<br />
Carl Erik Mogensen, Aarhus, Denmark<br />
FREE COMMUNICATIONS<br />
SAO060<br />
SYSTEMIC TRANSCRIPTOME ANALYSIS FOR EXTRAC-<br />
TION OF SPECIFIC GENE CLUSTERS IN DIABETIC NE-<br />
PHROPATHY-REDUCED EXPRESSION OF INSULIN REGU-<br />
LATED AMINOPEPTIDASE ANGIOTENSIN IV RECEPTOR<br />
(AT4/IRAP) IN DIABETIC RENAL TISSUE<br />
Tadashi Konoshita | Mai Ichikawa | Tomoko Kimura | Satsuki<br />
Sato | Miki Fujii | Yasukazu Makino | Shigeyuki Wakahara|<br />
Isamu Miyamori<br />
Fukui Univ, Eiheiji, Fukui, Japan<br />
SAO061<br />
ALBUMINURIA AND RENAL FUNCTION AS RISK FAC-<br />
TORS FOR CARDIOVASCULAR EVENTS AND MORTALITY<br />
Maria Svensson | Jan Cederholm | Björn Eliasson | Bjorn Zethelius<br />
| Soffia Gudbjörnsdottir<br />
Dept Nephrology, Sahlgrenska Univ Hosp, Gothenburg, Sweden<br />
| Dept Public Health and Caring Sciences, Family Medicine<br />
and Clinical Epidemiology, Uppsala Univ, Uppsala | Dept Medicine,<br />
Sahlgrenska Academy Univ Gothenburg, Gothenburg,<br />
Sweden | Dept Public Health and Caring Sciences/Geriatrics,<br />
Uppsala Univ, Uppsala, Sweden<br />
¯ t SAO062<br />
10-YEAR CARDIOVASCULAR RISK IN TYPE 2 DIABETES IS<br />
PREDICTED BY MEASURABLE URINARY ALBUMIN EVEN<br />
IN THE NORMOALBUMINURIC RANGE<br />
Esteban Porrini | Piero Ruggenenti | Nicola Motterlini | Annalisa<br />
Perna | Aneliya Parvanova Ilieva | Ilian Petrov Iliev|<br />
Alessandro Roberto Dodesini | Antonio Bossi | Giuseppe Sampietro<br />
| Enrica Capitoni | Flavio Gaspari | Nadia Rubis | Giulia<br />
Gherardi | Bogdan Ene-Iordache | Giuseppe Remuzzi<br />
Hosp Univ Canarias, Tenerife, Spain | Clinical Research Center<br />
for Rare Diseases Aldo & Cele Daccò, Mario Negri Inst Pharmacological<br />
Research | Units Diabetology Azienda Osp Riuniti<br />
Bergamo | Unit Diabetology, Treviglio Hosp | Epidemiological<br />
Observatory, Azienda Sanitaria Locale Provincia Bergamo | Research<br />
Foundation, Azienda Osp Riuniti Bergamo, Italy<br />
SAO063<br />
EFFECT OF GLYCEMIC CONTROL ON GLOMERULAR HE-<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
247<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
248<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
MODYNAMIC MEASURED BY INULIN AND PARA-AMI-<br />
NOHYPURIC ACID CLEARANCE IN HUMAN—POOR GLY-<br />
CEMIC CONTROL INDUCES INCREASED RESISTANCE OF<br />
EFFERENT ARTERIOLE<br />
Akihiro Tsuda | Eiji Ishimura | Yoshiteru Ohno | Mitsuru<br />
Ichii| Shinya Nakatani | Katsuhito Mori | Masaaki Inaba<br />
Osaka City Univ Graduate School of Medicine, Osaka, Japan<br />
SAO064<br />
TREATMENT OF DIABETIC NEPHROPATHY WITH TRIPTE-<br />
RYGIUM WILFORDII HOOK F: A PROSPECTIVE RANDOMI-<br />
ZED CONTROLLED CLINICAL TRIAL<br />
Yongchun Ge | Honglang Xie | Shijun Li | Bo Jin | Jinhua<br />
Hou| Haitao Zhang | Mingjun Shi | Zhihong Liu<br />
Reasch Inst Nephrology, Jinling Hosp, Nanjing Univ School<br />
Medicine, Nanjing China<br />
SAO065<br />
DIABETES MELLITUS (DM) REDUCES SURVIVAL IN PA-<br />
TIENTS WITH RENAL CELL CARCINOMA (RCC): ROLE OF<br />
OGG1 AND TUBERIN<br />
Simona Simone | Marica Cariello | Antonio Vavallo | Antonia<br />
Loverre | Elena Ranieri | Michele Battaglia | Pasquale Ditonno|<br />
Loreto Gesualdo | G Grandaliano | Giovanni Pertosa<br />
Nephrology, Dialysis and Transpl Unit, DETO, Univ Bari,<br />
Italy| Urology Unit, DETO, Univ Bari, Italy | Univ Bari, Bari,<br />
Italy | Dialysis and Transpl Unit, Dept Biomedical Sciences,<br />
Univ Foggia, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
POSTER SESSION<br />
Poster Area<br />
09:30 - 10:45<br />
Renal development / Cystic diseases SAP001-SAP011<br />
Genetic diseases SAP012-SAP045<br />
Hormones SAP046-SAP051<br />
AKI - Experimental SAP052-SAP100<br />
AKI - Clinical SAP101-SAP181bis<br />
Clinical Nephrology - Epidemiology II SAP182-SAP246<br />
Clinical studies in CKD 1-5 SAP247-SAP260<br />
Nutrition, inflammation<br />
and oxidative stress - CKD 1-5 SAP261-SAP285<br />
Primary and secondary<br />
glomerulonephritis II SAP286-SAP329<br />
Experimental pathology SAP330-SAP407<br />
Renal histopathology SAP408-SAP427<br />
Peritoneal dialysis SAP428-SAP509<br />
Renal anaemia - CKD 5D SAP510-SAP537<br />
Mineral and bone disease - CKD 5D SAP538-SAP595<br />
Pathophysiology CKD 5D SAP596-SAP613<br />
Transplantation - Basic SAP614-SAP642<br />
Transplantation - Clinical II SAP643-SAP680<br />
Paediatric nephrology SAP681-SAP724<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
249<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
250<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
RENAL DEVELOPMENT / CYSTIC DISEASES<br />
SAP001<br />
MAS RECEPTOR INHIBITS URETERIC BUD (UB) BRANCHING MORPHOGE-<br />
NESIS VIA DOWNREGULATION OF THE GDNF/RET/WNT11 PATHWAY<br />
Ihor Yosypiv | Renfang Song | Graeme Preston<br />
Tulane Univ School Medicine<br />
SAP002<br />
DELETIONS OF SIX1 AND UPK3A MAY CONTRIBUTE TO A RENAL PHE-<br />
NOTYPE IN SYNDROMAL PATIENTS<br />
Albertien M. van Eerde | Ellen van Binsbergen | Yvette Konijnenberg | Merel<br />
C. Maiburg | Klaske Lichtenbelt | Peter G.J. Nikkels | Jasper vd Smagt | Kirsten<br />
Y. Renkema | Jacques C. Giltay | Tom P.V.M. de Jong | Marc R. Lilien | Nine<br />
V.A.M. Knoers<br />
UMC Utrecht, Dept Medical Genetics, Netherlands | UMC Utrecht, Paediatric<br />
Renal Center, Netherlands | UMC Utrecht, Dept Pathology, Netherlands<br />
SAP003<br />
POLYCYSTIC KIDNEY DISEASE IN TRANSGENIC MICE EXPRESSING A MU-<br />
TANT KI-RAS GENE<br />
Charlotte Gueydan | Germano Serena | Grouls Stephan | Robert Koesters<br />
Inserm U702, Paris, France | Dept Nephrology, Univ Heidelberg, Heidelberg,<br />
Germany | Univ Pierre et Marie Curie, Paris, France<br />
SAP004<br />
CHARACTERISATION OF A NEW MOUSE MODEL OF POLYCYSTIC KID-<br />
NEY DISEASE INDUCED BY ENU MUTAGENESIS OF ANKS6<br />
Bakey Zeineb | Delestré Laure | Arnould Catherine | Bihoreau Marie-Thérèse |<br />
Dominique Gauguier | Brigitte Lelongt<br />
INSERM UMR_S702 | INSERM UMRS872, Centre Recherche Cordeliers, Paris,<br />
France | Centre National Génotypage<br />
SAP005<br />
DIAGNOSIS OF CYST INFECTION BY 18F-FDG LABELED WBC PET/CT<br />
SCAN IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KID-<br />
NEY DISEASE: A PROSPECTIVE STUDY<br />
Seung Hwan Moon | Hayne Cho Park | Ho-Young Lee | Jin Ho Hwang | Jong<br />
Cheol Jeong | Jae-Yoon Park | Seong Woo Lee | Young-Hwan Hwang | Keon<br />
Wook Kang | Curie Ahn<br />
Dept Nuclear Medicine, Seoul National Univ College Medicine, Seoul, Korea |<br />
Dept Internal Medicine, Seoul National Univ College Medicine, Seoul, Korea |<br />
Dept Internal Medicine, Eulji General Hosp, Seoul, Korea<br />
SAP006<br />
RAPAMYCIN INHIBITS COMPENSATORY HYPERTROPHY ASSOCIATED<br />
ENLARGEMENT IN RODENT NEPHRONOPHTHISIS<br />
Vincent Gattone | Alexander Carr | Robin Crosler-Roberts<br />
Indiana Univ School of Medicine, Indianapolis, IN, USA<br />
SAP007<br />
A NOVEL PPAR GAMMA AGONIST DJ5 RETARDS CYST GROWTH AND<br />
PRESERVES KIDNEY FUNCTION IN A RAT POLYCYSTIC KIDNEY DISEASE<br />
MODEL<br />
Xueqi Wang | Yang Liu | Jianhua Shen | Rudolf Wuthrich | Andreas Serra |<br />
Changlin Mei<br />
Univ Hosp Zurich, Zurich, Switzerland | Inst Physiology, Univ Zürich, Div<br />
Nephrology, Univ Hosp Zürich, Zurich, Switzerland | Shanghai Inst Materia<br />
Medica, Chinese Academy of Sciences, Shanghai, China| Kidney Inst PLA,<br />
Dept Nephrology, Shanghai Changzheng Hosp, Second Military Medical Univ,<br />
Shanghai, China<br />
SAP008<br />
DO SYMPTOMATIC RENAL CYSTS EVEN REALLY NEED TH<strong>ERA</strong>PEUTIC<br />
INTERVENTION?<br />
Liliana Tuta | Florin Botea<br />
Ovidius Univ, Fac Medicine, Constanta, Romania<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP009<br />
HNF1-β PATIENTS COHORT: PRELIMINARY ANALYSIS OF THE FIRSTS 121<br />
PATIENTS<br />
Vincent Guigonis | Nicolas Rodier | Claire Bahans | Stephane Decramer |<br />
Aurelia Bertholet-Thomas | Laurence Heidet | Philippe Eckart | Marie-Pierre<br />
Lavocat | Isabelle Vrillon | Sylvie Cloarec | Annie Lahoche | Lucie Bessenay |<br />
Ferielle Louillet | Gwenaelle Roussey | Caroline Rousset-Rivière | Olivier Dunand<br />
| Véronique Baudouin | François Nobili | Christine Pietrement | Loïc De<br />
Parscau | Vincent Gajdos | Denis Morin<br />
CHU Limoges, Limoges, France | CHU Toulouse, France | CHU Lyon, France |<br />
Hop Necker, Paris, France | CHU Caen, France | CHU Saint Etienne, France |<br />
CHU Nancy, France | CHU Tours, France | CHU Lille, France | CHU Clermont-<br />
Ferrand, France | CHU Rouen, France | CHU Nantes, France | CHU Marseille,<br />
France | CHU La Réunion, France | Hop Robert Debré, Paris, France | CHU<br />
Besançon, France | CHU Reims, France | CHU Brest, France | Hôp Béclère, Clamart,<br />
France | CHU Montpelier, France<br />
SAP010<br />
HNF1-β DELETION AND NEUROLOGICAL DISORDERS: A NON FORTUI-<br />
TUS ASSOCATION<br />
Fanny Laffargue | Brigitte Llanas | Véronique Baudouin | Annie Lahoche |<br />
Jean-Bernard Palcoux | Denis Morin | Loïc De Parscau | Claire Bahans | Marie-<br />
Ange Delrue | Emilie Dizier | Elisabeth Taupiac | Nicolas Rodier | Cecile Laroche<br />
| Bertrand Lacombe | Sylvie Bourthoumieu | Vincent Guigonis<br />
CHU Limoges, France | CHU, Bordeaux, France | Hop Robert Debré, Paris,<br />
France | CHU Lille, France | CHU Clermont-Ferrand, France | CHU Montpelier,<br />
France | CHU Brest, France<br />
SAP011<br />
PREMATURE DELIVERY TRIGGERS TERMINATION OF NEPHROGENE-<br />
SIS PROGRAM WHICH LEADS TO REDUCED NEPHRON NUMBER AND<br />
HYPERTENSION<br />
Ashraf El-Meanawy | Victoriya Rufanova | Cary Stelloh<br />
Medical College Wisconsin and Milwaukee VA Medical Center, Milwaukee,<br />
Wisconsin, USA<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
251<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
252<br />
GENETIC DISEASES<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP012<br />
MUTATIONAL ANALYSIS OF THE URATE TRANSPORTER 1 GENE IN JAPA-<br />
NESE PATIENTS WITH RENAL HYPOURICEMIA<br />
Tetsuya Inazu | Tetsuya Kawahara | Hitoshi Endou | Naohiko Anzai<br />
Ritsumeikan Univ, Kusatsu, Japan | Niigata Rosai Hosp | Kyorin Univ School<br />
Medicine, Tokyo, Japan<br />
SAP013<br />
NEPHROLITHIASIS CAUSED BY HEREDITARY RENAL HYPOURICEMIA<br />
Ivan Sebesta | Blanka Stiburkova | Kimiyoshi Ichida | Makoto Hosoyamada<br />
Inst Clinical Biochemistry and Lab Diagnostics, First Fac Medicine, Charles Univ,<br />
Prague, Czech Republic | Inst Inherited Metabolic Disorders | Dept Pathophysiology,<br />
Tokyo Univ Pharmacy and Life Sciences, Tokyo, Japan | Div Pharmacotherapeutics,<br />
Fac Pharmacy, Keio Univ, Tokyo, Japan<br />
SAP014<br />
SLC2A9 POLYMORPHISM, THE MAJOR GENETIC DETERMINANT OF SE-<br />
RUM URIC ACID LEVEL, PREDICTS PROGRESSION TO KIDNEY FAILURE<br />
IN CKD PATIENTS<br />
Alessandra Testa | Daniela Leonardis | Filippo Catalano | Anna Pisano | Angela<br />
Mafrica | Belinda Spoto | Maria Cristina Sanguedolce | Rosa Maria Parlongo|<br />
Giovanni Tripepi | Maurizio Postorino | Giuseppe Enia | Carmine Zoccali |<br />
Francesca Mallamaci | MAURO Working Group*<br />
CNR-IBIM, Reggio Calabria | MAURO Working Group<br />
SAP015<br />
SEVERE MANIFESTATION OF BARTTER SYNDROME TYPE IV CAUSED BY<br />
A NOVEL INSERTION MUTATION IN THE BSND GENE<br />
Augusto Luque de Pablos | Victor Garcia-Nieto | Jesús C. López-Menchero |<br />
Elena Ramos-Trujillo | Hilaria González-Acosta | Felix Claverie-Martin<br />
Hosp General Gregorio Marañón, Madrid, Spain | Hosp N. S. de Candelaria,<br />
Santa Cruz de Tenerife, Spain | Hosp General Ciudad Real, Ciudad Real, Spain<br />
SAP016<br />
THE CLINICAL RELEVANCE OF FAMILIAL MICROSCOPIC HEMATURIA.<br />
PATHOPHYSIOLOGY AND NATURAL PROGRESSION. THE GREAT DIA-<br />
GNOSTIC SIGNIFICANCE OF MOLECULAR GENETICS<br />
Maria Arsali | Panayiota Demosthenous | Louiza Papazachariou | Yiannis<br />
Athanasiou | Konstantinos Voskarides | Constantinos Deltas | Alkis Pierides<br />
Dept Nephrology, Nicosia General Hosp, Nicosia, Cyprus | Molecular Medicine<br />
Res Center and Lab Molecular and Medical Genetics, Univ Cyprus, Nicosia,<br />
Cyprus | Hippokrateon Hosp, Nicosia, Cyprus<br />
SAP017<br />
SIGNIFICANT ASSOCIATION BETWEEN TOLL-LIKE RECEPTORS GENE PO-<br />
LYMORPHISM AND POST-TRANSPLAL DIABETES MELLITUS<br />
Sulra Lee | Kyung Hwan Jeong | ChunGyoo Ihm | Tae Won Lee | Sang Ho Lee|<br />
Ju Young Moon | Jeong Gook Wi | Hong Joo Lee | Eun Young Kim<br />
Kyung Hee Univ Medical Center<br />
SAP018<br />
PLASMA LEVELS OF THE EPIGENETIC REGULATION FACTOR S-ADENO-<br />
SYLHOMOCYSTEINE ARE ASSOCIATED WITH SUBCLINICAL ATHERO-<br />
SCLEROSIS AND EGFR AMONG APPARENTLY HEALTHY SUBJECTS<br />
Kyrill Rogacev | Annika Friedrich | Björn Hummel | Judith Berg | Adam Zawada<br />
| Danilo Fliser | Jürgen Geisel | Gunnar Henrik Heine<br />
Dept Internal Medicine IV, Saarland Univ Medical Center, Homburg, Germany |<br />
Clinical Chemistry and Lab Medicine/Central Lab, Saarland Univ Medical Center,<br />
Homburg, Germany<br />
SAP019<br />
STUDY OF TRANSCRIPTOME OF NODULAR AND DIFFUSE PARATHYROID<br />
GLANDS IN DIALYSIS AND KIDNEY TRANSPL PATIENTS<br />
Irena Brabcova | Sylvie Dusilova-Sulkova | Zdenek Krejcik | Viktor Stranecky |<br />
Kvetoslav Lipar | Tomas Marada | Jitka Stepankova | Ondrej Viklicky<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Inst Clinical and Experimental Medicine, Prague | Inst Hematology and Blood<br />
Transfusion, Prague | Center Applied Genomics, Prague<br />
SAP020<br />
STRONG ASSOCIATION OF MATRIX METALLOPROTEINASE-9 GENE PO-<br />
LYMORPHISM WITH CARDIOVASCULAR DISEASE IN END-STAGE RENAL<br />
DISEASE PATIENTS<br />
Monika Buraczynska | Pawel Zukowski | Wojciech Zaluska | Agata Kuczmaszewska<br />
| Andrzej Ksiazek<br />
Medical Univ, Lublin, Poland<br />
SAP021<br />
PREDICTORS OF URINARY GLOBOTRIAOSYLC<strong>ERA</strong>MIDE (GB3) EXCRE-<br />
TION IN PATIENTS WITH CHRONIC KIDNEY DISEASE<br />
Martina Gaggl | Stefanie Weidner | Marlene Hofer | Julia Kleinert | Günter<br />
Fauler | Manfred Wallner | Peter Kotanko | Gere Sunder-Plassmann | Eduard<br />
Paschke<br />
Medical Univ Vienna, Dept Medicine III, Div Nephrology & Dialysis, Vienna,<br />
Austria | Medical Univ Graz, Clinical Inst Medical and Chemical Lab Diagnostics,<br />
Graz, Austria | Dept Internal Medicine IV, Section Nephrology, Klinikum<br />
Wels-Grieskirchen, Wels, Austria | Renal Res Inst, New York USA | Medical<br />
Univ Graz, Dept Pediatrics, Graz, Austria<br />
SAP022<br />
FABRY DISEASE 9 YEAR FOLLOW UP<br />
Ricardo Heguilén | Lautaro Albarracin | Juan Politei | Amador Andrés Liste |<br />
Amelia Bernasconi<br />
Hosp J.A.Fernandez<br />
SAP023<br />
PREVALENCE OF FABRY DISEASE IN DIALYSIS PATIENTS IN JAPAN<br />
Eiji Kusano<br />
Jichi Medical Univ<br />
SAP024<br />
EFFECTS OF SWITCH TH<strong>ERA</strong>PY WITH AGALSIDASE-ALFA IN PATIENTS<br />
WITH ANDERSON-FABRY DISEASE (AFD) PREVIOUSLY TREATED WITH<br />
AGALSIDASE-BETA: A PROSPECTIVE CARDIAC MAGNETIC RESONANCE<br />
IMAGING STUDY<br />
Roberta Russo | Antonio Pisani | Giancarlo Messalli | Massimo Imbriaco<br />
Chair Nephrology Federico II Naples | Chair Radiology FedericoII Naples<br />
SAP025<br />
WHETHER NPHS1 GENE POLYMORPHISM c.349G>A CONTRIBUTES TO EF-<br />
FICASY OF IMMUNOSUPPRESSIVE TREATMENT OF STEROID-RESISTANT<br />
NEPHROTIC SYNDROME IN CHILDREN?<br />
Larisa Prikhodina | Oxana Ryzhkova | Vladimir Polyakov<br />
Res Inst Pediatrics & Children Surgery | Res Center for Medical Genetics, Moscow;<br />
Russia<br />
« SAP026<br />
THE JaK/STAT SIGNALING PATHWAY MODIFICATIONS BY GLUCOCOR-<br />
TICOSTEROIDS IN THE LEUKOCYTES OF CHILDREN WITH NEPHROTIC<br />
SYNDROME<br />
Katarzyna Lipkowska | Danuta Ostalska-Nowicka | Magdalena Smiech |<br />
Małgorzata Jaroniec | Katarzyna Zaorska | Witold Szaflarski | Michal Nowicki|<br />
Jacek Zachwieja<br />
Dept Pediatric Cardiology and Nephrology, Poznan Univ Medical Science, Poznan,<br />
Poland<br />
SAP027<br />
A COMMONLY CARRIED ALLELE OF THE FAT-MASS AND OBESITY-RELA-<br />
TED GENE (FTO) IS A PREDICTOR OF ALL-CAUSE MORTALITY IN KIDNEY<br />
FAILURE<br />
Belinda Spoto | Alessandra Testa | Maria Cristina Sanguedolce | Graziella<br />
D'Arrigo | Rosa Maria Parlongo | Anna Pisano | Giovanni Tripepi | Carmine<br />
Zoccali| Francesca Mallamaci<br />
CNR-IBIM, Reggio Calabria | CNR IBIM and Osp Riuniti, Reggio Calabria<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
253<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
254<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP028<br />
UROMODULIN GENOTYPES PREDICT AGE AT ONSET OF GOUT AND<br />
ESRD IN PATIENTS WITH AN UROMODULIN-ASSOCIATED KIDNEY DISE-<br />
ASE: RESULTS FROM AN INTERNATIONAL DATA REVIEW<br />
Jonathan Moskowitz | Sian Piret | Adam Tashman | Erin Velez | Karl Lhotta |<br />
Rajesh Thakker | Peter Kotanko<br />
Renal Res Inst, New York, New York, USA | Academic Endocrine Unit, Oxford<br />
Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Churchill Hosp,<br />
Univ Oxford, Headington, Oxford, UK | Academic Teaching Hosp Feldkirch<br />
SAP029<br />
THE NATURAL HISTORY OF RENAL ANGIOMYOLIPOMATA (AMLS) IN<br />
TUBEROUS SCLEROSIS COMPLEX (TSC)<br />
Jane Cox | John Kingswood | Jana Mbundi | Ginny Attard | Uday Patel |<br />
Anand Saggar | Frances Elmslie | Tim Doyle<br />
Brighton & Sussex Univ Hosp Trust | South West Thames Regional Genetics<br />
Serv | Radiology, St Georges Hosp<br />
SAP030<br />
EFFECT OF EVEROLIMUS TH<strong>ERA</strong>PY ON RENAL ANGIOMYOLIPOMA RE-<br />
SPONSE IN PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX BEING TRE-<br />
ATED FOR SUBEPENDYMAL GIANT CELL ASTROCYTOMA: EXPLORATO-<br />
RY RESULTS FROM EXIST-1<br />
Anna Jansen | Sergiusz Jozwiak | Elena Belousova | Michael Frost | Rachel<br />
Kuperman | Martina Bebin | Bruce Korf | Robert Flamini | Michael Kohrman |<br />
Steven Sparagana | Joyce Wu | James Ford | Gaurav Shah | David Franz<br />
Pediatric Neurology Dept, UZ Brussel Campus Jette, Brussels, Belgium | Dept<br />
Child Neurology, Children's Memorial Health Inst Warsaw, Poland | Moscow<br />
Res Inst Pediatrics & Pediatric Surgery, Moscow, Russia | Minnesota Epilepsy<br />
Group, St. Paul, MN, USA | Dept Neurology, Children's Hosp and Res Center<br />
Oakland, Oakland, CA | Dept Neurology, Univ Alabama School of Medicine,<br />
Birmingham, AL, USA | Dept Genetics, Univ Alabama at Birmingham, Birmingham,<br />
AL, USA | Children’s Healthcare of Atlanta, Atlanta, GA, USA | Univ Chicago<br />
and Comer Children’s Hosp, Chicago, IL, USA | Texas Scottish Rite Hosp<br />
for Children, Dallas, TX, USA | Div Pediatric Neurology, Mattel Children’s Hosp<br />
at UCLA, Los Angeles, CA, USA | Novartis Pharmaceuticals Corporation, Florham<br />
Park, NJ, USA | Dept Pediatrics and Neurology, Cincinnati Children's Hosp<br />
Medical Center, Cincinnati, OH, USA<br />
SAP031<br />
PHARMACOKINETICS/PHARMACODYNAMICS OF EVEROLIMUS IN PA-<br />
TIENTS WITH RENAL ANGIOMYOLIPOMA ASSOCIATED WITH TUBEROUS<br />
SCLEROSIS COMPLEX OR SPORADIC LYMPHANGIOLEIOMYOMATOSIS<br />
Bernard Zonnenberg | Wing Cheung | Shweta Urva | Jixian Wang | Michael<br />
Frost | Chris Kingswood | Klemens Budde<br />
Univ Medical Center Utrect, Utrecht, Netherlands | Novartis Pharmaceuticals<br />
Corporation, East Hanover, NJ, USA | Minnesota Epilepsy Group, St. Paul, MN,<br />
USA | Royal Sussex County Hosp, Brighton, UK | Charite-Univsmedizin Berlin,<br />
Berlin, Germany<br />
SAP032<br />
COLLAPSING GLOMERULOPATHY ASSOCIATED LUPUS IN A BLACK FE-<br />
MALE WITH HOMOZYGOUS APOL1 MUTATION<br />
Tomek Kofman | Celine Narjoz | Quentin Raimbourg | Melanie Roland | Marie-Anne<br />
Loriot | Alexandre Karras | Gary, S. Hill | Christian Jacquot | Dominique<br />
Nochy | Eric Thervet<br />
APHP, Paris, France | Univ Paris Descartes, INSERM UMR-S 775, Paris, France|<br />
Assist Publ Hôp Paris, Hôp Européen Georges Pompidou, Serv Néphrologie,<br />
Paris | Néphrologie, HEGP, Paris, France | Assistance Publique Hôpitaux de<br />
Paris, Hôp Européen Georges Pompidou, Serv Anatomopathologie, Paris, France<br />
SAP033<br />
GENETIC FACTOR IN THE DEVELOPMENT OF PRIMARY CHRONIC GLO-<br />
MERULONEPHRITIS<br />
Paweł Jagodziński | Magdalena Mostowska | Andrzej Oko<br />
Dept Biochemistry and Molecular Biology, Poznań Univ Medical Sciences | Dept<br />
Nephrology, Transpl and Internal Medicine, Poznan Univ Medical Sciences, Poznan,<br />
Poland<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP034<br />
IDENTIFICATION AND CHARACTERIZATION OF A RARE GENE VARIANT<br />
IN CONGENITAL INTERSTITIAL LUNG FIBROSIS AND NEPHROTIC SYN-<br />
DROME<br />
Nayia Nicolaou | SH Kevelam | MR Lilien | MJ Oosterveld | Roel Goldschmeding<br />
| Albertien van Eerde | R Pfundt | Arnoud Sonnenberg | P ter Hal | Nine<br />
Knoers | Kirsten Renkema<br />
Univ Medical Centre Utrecht, Netherlands | Dept Medical Genetics UMC<br />
Utrecht, Netherlands | Dept Pediatric Nephrology, UMC Utrecht | Dept Pathology,<br />
UMC Utrecht, Netherlands | Dept Human Genetics, Radboud Univ Nijmegen<br />
Medical Centre | Div Cell Biology, Netherlands Cancer Inst, Amsterdam<br />
SAP035<br />
RENAL CONSEQUENCES OF MEGALIN DEFICIENCY IN HUMANS<br />
Tina Storm | Rikke Nielsen | Erik Christensen | Carina Frykholm | Lisbeth Tranebjaerg<br />
| Henrik Birn | Pierre Verroust | Tryggve Neveus | Birgitta Sundelin |<br />
Jens Michael Hertz | Gerd Holmström | Katharina Ericson<br />
Inst Biomedicine, Aarhus Univ, Aarhus, Denmark | Dept Biomedicine, Aarhus<br />
Univ, Aarhus, Denmark | Dept Immunology, Genetics and Pathology, Uppsala<br />
Univ, Uppsala, Sweden | Dept Audiology, Bispebjerg Hosp and Wilhelm<br />
Johannsen Centre Functional Genomics, Inst Cellular and Molecular Medicine,<br />
Univ Copenhagen, Panum Inst, Copenhagen, Denmark | Dept Women's and<br />
Children's Health, Uppsala Univ, Uppsala, Sweden | Pathology Unit, Karolinska<br />
Univ Hosp, Karolinska Inst, Stockholm, Sweden | Dept Clinical Genetics, Odense<br />
Univ Hosp, Odense, Denmark | Dept Neuroscience, Uppsala Univ, Uppsala,<br />
Sweden<br />
SAP036<br />
PREGNANCY IN ALPORT SYNDROME: TWO CASE REPORTS WITH DIFFE-<br />
RENT EVOLUTION<br />
Alberta Fabris | Daniela Cremasco | Alessandra Zambon | Eva Muraro | Marianna<br />
Alessi | Angela D'Angelo | Franca Anglani | Dorella Del Prete<br />
Obstetric Unit, Univ Padua | Div Nephrology Dept Medicine Univ Padova<br />
SAP037<br />
PROMOTER POLYMORPHISM OF THE IL-6 (C-174G) GENE AND THE ESTI-<br />
MATION OF METABOLIC SYNDROME OCCURRENCE AMONG A COHORT<br />
OF PATIENTS WITH HYPERTENSION<br />
Andrei Alkmim Teixeira | Beata Marie Quinto | Cassio Jose Rodrigues | Artur<br />
Beltrame Ribeiro | Marcelo Batista<br />
UNIFESP - EPM / Sao Paulo / Brasil | Univ Federal São Paulo, São Paulo, Brazil<br />
SAP038<br />
NPHS2 p.V290M MUTATION IN ADULT-ONSET STEROID-RESISTANT NE-<br />
PHROTIC SYNDROME – SHOULD IT BE SCREENED FOR?<br />
Andrea Kerti | Rózsa Csohány | Attila Szabó | Ottó Árkossy | Péter Sallai |<br />
Vincent Moriniére | Virginia Vega-Warner | Orsolya Lakatos | Tamás Szabó |<br />
George Reusz | Kálmán Tory<br />
First Dept Pediatrics, Semmelweis Univ, Budapest, Hungary | Szent János Hosp,<br />
Budapest, Hungary | INSERM U983, Hôp Necker, Paris, France | Dept Pediatrics<br />
and Human Genetics, Univ Michigan, Ann Arbor, Michigan, USA | Univ Pécs,<br />
Hungary | Univ Debrecen, Hungary<br />
SAP039<br />
ATYPICAL DENT’S DISEASE PHENOTYPES: THE POSSIBLE ROLE OF DIGE-<br />
NIC INHERITANCE<br />
Maria Addis | Enrica Tosetto | Franca Anglani | Cristina Meloni | Monica<br />
Ceol| Rosalba Cristofaro | Maria Antonietta Melis | Paolo Vercelloni | Angela<br />
D'Angelo | Giuseppina Marra<br />
Dept Biomedical and Biotecnology Sciences, Univ Cagliari, Italy | Div Nephrology,<br />
Dept Medicine, Univ Padova, Italy | Nefrology Unit, IRCCS Ca’ Grande<br />
Univ Milano, Italy<br />
SAP040<br />
GITELMAN SYNDROME DUE TO TWO NOVEL MUTATIONS IN SLC12A3<br />
GENE<br />
Sonia Kaniuka | Mato Nagel | Wojciech Wołyniec | Łukasz Obołończyk | Renata<br />
Świątkowska-Stodulska | Krzysztof Sworczak | Boleslaw Rutkowski<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
255<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
256<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Dept Endocrinology and Internal Medicine, Medical Univ Gdansk, Poland |<br />
Center Nephrology and Metabolic Disorders, Weisswasser, Germany | Dept Nephrology,<br />
Transpl and Internal Medicine, Gdansk, Poland<br />
SAP041<br />
SIX NOVEL SLC12A3 MUTATIONS IN CHINESE PATIENTS WITH GITEL-<br />
MAN SYNDROME<br />
Chen Chen | Lanping Jiang | Limeng Chen<br />
PUMCH<br />
SAP042<br />
STRAIN DEPENDENT PROGRESSION OF MYOCARDIAL FIBROSIS IN MOU-<br />
SE MODEL OF TGF-ß INDUCED RENAL FIBROSIS<br />
Lilla Fang | Miklos Mozes M. | Martina Boosi | Laszlo Rosivall | Gabor Kokeny<br />
Semmelweis Univ, Budapest, Hungary<br />
SAP043<br />
ANTIFIBROTIC, NEPHROPROTECTIVE EFFECTS OF PARICALCITOL VS.<br />
CALCITRIOL ON TOP OF ACE-INHIBITOR TH<strong>ERA</strong>PY IN THE COL4A3-<br />
KNOCKOUT MOUSE-MODEL FOR PROGRESSIVE RENAL FIBROSIS<br />
Rubel Diana | Oliver Gross | Temme Johanna | Girgert Rainer | Ciner Ayse |<br />
Hiller Henrik | Müller Gerhard-Anton<br />
Univ Medicine Goettingen, Goettingen, Germany<br />
SAP044<br />
KCNJ11 E23K MISSENSE MUTATION INFLUENCE DIABETIC NEPHROPA-<br />
THY AND HYPERGLYCEMIA CONTROL IN TYPE 2 DIABETES PATIENTS<br />
Mtiraoui Nabil | Ezzidi Intissar<br />
Hematology Lab Fac Pharmacy Monastir Tunisia<br />
SAP045<br />
HDR SYNDROME: UNDER-RECOGNISED, YET GENETICALLY IDENTIFIA-<br />
BLE<br />
Hendrica Belge | Julie Bloch | Karin Dahan | Yves Pirson | Philippe Vanhille |<br />
Nathalie Demoulin<br />
Serv Néphrologie, Cliniques Univ St Luc, Bruxelles | Serv Néphrologie, Centre<br />
Hosp Valenciennes | Serv Génétique, Cliniques Univ St Luc, Bruxelles<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
HORMONES<br />
SAP046<br />
RENAL AND INTESTINAL GUANYLIN PEPTIDES SYSTEM IN A MOUSE<br />
MODEL OF DIET-INDUCED OBESITY<br />
Liliana Simões-Silva | Mónica Moreira-Rodrigues | Janete Quelhas-Santos |<br />
Cátia Fernandes-Cerqueira | Manuel Pestana | Isabel Soares-Silva | Benedita<br />
Sampaio-Maia<br />
Unit Res and Development Nephrology, Fac Medicine, Univ Porto | Inst Pharmacology<br />
and Therapeutics, Fac Medicine, Univ Porto, Porto, Portugal<br />
SAP047<br />
INFLUENCE OF SMOKING ON PLASMA VASOPRESSIN AND URINE CON-<br />
CENTRATION IN A FRENCH MIDDLE-AGED POPULATION (THE D.E.S.I.R.<br />
COHORT)<br />
Lise Bankir | Fezeu Leopold | Bouby Nadine | Ronan Roussel | Beverley Balkau|<br />
Marre Michel | Bichet Daniel<br />
INSERM U872-E2, Centre Recherche Cordeliers, Paris, France | INSERM U1018,<br />
Centre Recherche Epidémiologie et Santé Publique, Villejuif, France | Univ Paris–Diderot;<br />
AP-HP, Hôp Bichat, Diabétologie, Paris, France | Dépt Néphrologie,<br />
Univ Montréal, Hôp Sacré-Coeur, Montréal, Canada<br />
SAP048<br />
SEX HORMONE LEVELS AND CORONARY CALCIFICATION IN POSTME-<br />
NOPAUSAL WOMEN WITH CHRONIC KIDNEY DISEASE STAGE 3-5<br />
Ilona Kurnatowska | Piotr Grzelak | Magdalena Kaczmarska | Anna Masajtis-<br />
Zagajewska | Ludomir Stefańczyk | Michał Nowicki<br />
Dept Nephrology, Hypertension and Kidney Transpl Łódź, Poland | Dept Radiology<br />
and Diagnostic Imaging, Medical Univ Łódź, Poland<br />
SAP049<br />
THE CONCENTRATION OF TESTOSTERONE MORE THAN AGE INFLUEN-<br />
CES THE CONVERSION OF THYROID HORMONES IN PATIENTS WITH CRF<br />
Stanislaw Niemczyk | Longin Niemczyk | Katarzyna Szamotulska | Zbigniew<br />
Bartoszewicz | Ivanna Dubchak | Urszula Syta | Joanna Matuszkiewicz-<br />
Rowińska<br />
Dept Nephrology, Military Inst Medicine, Warsaw, Poland | Dept Nephrology<br />
and Internal Diseases, Medical Univ Warsaw, Warsaw, Poland | National Res<br />
Inst Mother and Child, Warsaw, Poland | Dept Internal Diseases and Endocrynology,<br />
Medical Univ Warsaw, Warsaw, Poland<br />
SAP050<br />
DETERMINING THE ENZYMATIC ACTIVITIES OF IODOTHYRONINE 5’ DE-<br />
IODINASES IN RENAL MEDULLA AND CORTEX<br />
Stanislaw Niemczyk | Marta Dudek | Zbigniew Bartoszewicz | Katarzyna<br />
Szamotulska | Dorota Brodowska | Łukasz Woźniacki | Longin Niemczyk |<br />
Małgorzata Gomółka | Urszula Syta | Aleksandra Rymarz<br />
Dept Nephrology, Military Inst Medicine, Warsaw, Poland | Medical Univ, Warsaw,<br />
Poland | Mother and Child Inst, Warsaw, Poland<br />
SAP051<br />
A NEW MARKER IN NEPHROLOGY: THE APELIN<br />
Antonio Lacquaniti | Valentina Donato | Maria Rosaria Fazio | Silvia Lucisano|<br />
Valeria Cernaro | Rosaria Lupica | Michele Buemi<br />
Univ Messina, Messina, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
257<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
258<br />
AKI - EXPERIMENTAL<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP052<br />
IS THERE ANY WAY TO PROTECT FROM TACROLIMUS-INDUCED RENAL<br />
AND PANCREAS INJURY?<br />
Kubra Kaynar | Safak Ersoz | Rezzan Aliyazioglu | Aysegul Uzun | Sukru Ulusoy<br />
| Sait Al | Gulsum Ozkan | Muammer Cansız<br />
Dept Nephrology, Dept Pathology, School Medicine, Karadeniz Technical Univ |<br />
Dept Basic Science, School Pharmacy, Karadeniz Technical Univ | Dept Biochemistry;<br />
Dept Surgery Res Center<br />
« SAP053<br />
IS VASCULAR SMOOTH MUSCLE CELLS MIN<strong>ERA</strong>LOCORTICOID RECEP-<br />
TOR INVOLVED IN CYCLOSPORINE A NEPHROTOXICITY?<br />
Jean-Philippe Bertocchio | Jenny Lançon | Soumaya El Moghrabi | Guillaume<br />
Galmiche | Jean-Paul Duong Van Huyen | Philippe Rieu | Frédéric Jaisser<br />
INSERM UMRS872 Team 1, Paris, France | Hôp Européen Georges Pompidou,<br />
Paris, France | CHU Hôp Maison Blanche, Reims, France<br />
SAP054<br />
RESV<strong>ERA</strong>TROL INHIBITS THE INTRACELLULAR CALCIUM INCREASE<br />
AND RAS/ENDOTHELIN SYSTEMS ACTIVATION INDUCED BY SOLUBLE<br />
URIC ACID IN MESANGIAL CELLS<br />
Guilherme Albertoni | Sheila Andrade | Jose Augusto Barreto | Fernanda Borges<br />
| Nestor Schor<br />
Federal Univ São Paulo (UNIFESP)<br />
SAP055<br />
HEME OXYGENASE-1 ENHANCES RENAL TUBULAR CELLS REGEN<strong>ERA</strong>-<br />
TION IN ISCHEMIA-REPERFUSION INJURY THROUGH ACTIVATION OF<br />
ERK1/2 IN MICE<br />
Wen-Yu Ho | Shin-Hung Chen | Ching-Jiunn Tseng<br />
Div General Internal Medicine, Dept Internal Medicine, Kaohsiung Medical Univ<br />
Hosp, Kaohsiung, Taiwan | Dept Medical Education and Res, Kaohsiung Veterans<br />
General Hosp, Kaohsiung, Taiwan<br />
SAP056<br />
PRODUCTION OF REACTIVE OXYGEN SPECIES IN MITOCHONDRIA OF<br />
PROXIMAL TUBULES SECONDARY TO HYPOXIA/REOXYGENATION<br />
Anja Bienholz | Thorsten Feldkamp | Joel M Weinberg<br />
Div Nephrology, Dept Internal Medicine, Univ Hosp Essen, Essen, Germany |<br />
Div Nephrology, Dept Internal Medicine, Univ Michigan, Ann Arbor, USA<br />
SAP057<br />
CONDITIONED MEDIUM FROM MESENCHYMAL STEM CELLS (MSCs)<br />
PROTECTS HUMAN PROXIMAL TUBULAR CELLS (HK2) FROM GENTAMI-<br />
CIN (GENTA) AND LPS TOXICITIES<br />
Jéssica Suller Garcia | Marcelo Naves | Fernanda Borges | Nestor Schor<br />
Federal Univ São Paulo (UNIFESP), São Paulo, Brazil<br />
SAP058<br />
GENTAMICIN (G) NEPHROTOXICITY: PREVENTION AND REPAIR BY<br />
BONE MARROW-DERIVED MESENQUIMAL STEM CELLS (BMSCS) TRAN-<br />
SPL (TX)<br />
Fernanda Borges | Luciana Aparecida Reis | Manuel de Jesus Simões | Nestor<br />
Schor<br />
Federal Univ São Paulo (UNIFESP) | Morphology Dept<br />
SAP059<br />
EVALUATION OF REPARATIVE POTENTIAL OF CELL TH<strong>ERA</strong>PY WITH ME-<br />
SENCHYMAL STEM CELLS (MSCS) IN THE RENAL DAMAGE INDUCED BY<br />
IONIZING RADIATION (IR) IN AN ANIMAL MODEL<br />
Waldemar S Almeida | Vitória Moreau Longo | Helena Regina Comodo Segreto|<br />
Nestor Schor<br />
Escola Paulista Medicina/UNIFESP | Radioterapy Dept | Federal Univ São Paulo<br />
(UNIFESP)<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP060<br />
THE EFFECT OF BONE MARROW MESENCHYMAL STEM CELLS IN RATS<br />
WITH SEPSIS INDUCED ACUTE KIDNEY INJURY<br />
Ahmed Ghoneim | Ahmed Elkholy | Tarek Medhat Abbas | Mona El Hadeedy|<br />
Fatma Elhusseini | Basem Elessawey | Eman Eltanaihy| Ahmed Lotfy | Sara<br />
Eldesoky | Hussein Sheashaa | Mohamed Sobh<br />
Mansoura Experimental Res Center Nephrology Dept, Urology & Nephology<br />
Center, Mansoura Univ, Mansoura, Egypt | Nephrology Dept, Urology & Nephology<br />
Center Univ Mansoura, Mansoura, Egypt | Microbiology Dept, Mansoura<br />
Univ, Mansoura, Egypt | Pathology Dept, Mansoura Univ, Mansour, Egypt<br />
SAP061<br />
MESENCHYMAL STEM CELLS EFFECTIVELY TREAT ACUTE KIDNEY INJU-<br />
RY (AKI) WHEN ADMINISTERED 24 OR 48 HOURS AFTER INJURY IN THE<br />
RAT ISCHEMIA-REPERFUSION AKI MODEL<br />
Dena M. Minning | David Warnock | Ali S. Mohamed | John B. Wirthlin | Subba<br />
R. Chintalacharuvu | Laura Boone | Robert M. Brenner<br />
AlloCure, Inc., Burlington, MA, USA | Univ Alabama Birmingham, Birmingham,<br />
AL USA | Covance Laboratories, Inc., Greenfield, IN, USA<br />
SAP062<br />
THE EFFECT OF CONDITIONED MEDIUM (CM) OF MESENQUIMAL STEM<br />
CELLS DERIVED FROM BONE MARROW (BMSC) IN ACUTE KIDNEY INJU-<br />
RY (AKI) INDUCED BY GENTAMICIN (G) IN RATS<br />
Fernanda Borges | Luciana Aparecida Reis | Manuel de Jesus Simões | Nestor<br />
Schor<br />
Federal Univ São Paulo (UNIFESP) | Morphology Dept<br />
SAP063<br />
EFFECT OF THE APPLIANCE OF BONE MARROW MESENCHYMAL STEM<br />
CELLS (MSC) IN RATS WITH ACUTE KIDNEY INJURY (AKI) DUE TO SEPSIS<br />
Joelma Santina Christo | Clévia dos Santos Passos | Luciana Aparecida Reis |<br />
Douglas Rene de Alencar | Jéssica Suller Garcia | Nestor Schor<br />
Univ Federal São Paulo<br />
SAP064<br />
NATURAL TRIGGERING OF p21 PROTEIN UPREGULATION IS INHIBITED<br />
IN VITAMIN D-DEPLETED RATS WITH ISCHEMIC ACUTE KIDNEY INJURY<br />
Ana Carolina de Braganca | Daniele Canale | Janaina Garcia Gonçalves | Thais<br />
Prevital Bastos Brandão | Maria Heloisa Massola Shimizu | Rildo Aparecido<br />
Volpini | Antonio Carlos Seguro | Lucia Andrade<br />
Hosp Clínicas Fac Medicina Univ São Paulo | Fac Medicina Univ São Paulo |<br />
HCFMUSP<br />
SAP065<br />
TENOFOVIR-INDUCED NEPHROTOXICITY IN VITAMIN D-DEFICIENT<br />
RATS: THE ROLE OF OXIDATIVE STRESS<br />
Daniele Canale | Ana Carolina de Braganca | Janaina Garcia Gonçalves | Thais<br />
Prevital Bastos Brandão | Maria Heloisa Massola Shimizu | Rildo Aparecido<br />
Volpini | Lucia Andrade | Antonio Carlos Seguro<br />
Fac Medicina Univ São Paulo | Hosp Clínicas Fac Medicina Univ São Paulo |<br />
HCFMUSP<br />
SAP066<br />
PARICALCITOL SUPPRESSES THE RENAL INFLAMMATION DURING<br />
ISCHEMIA/REPERFUSION-INDUCED ACUTE KIDNEY INJURY<br />
Jae-Won Lee | Hyung Kyu Kim | Won Yong Cho | Sang-Kyung Jo | Eunjung<br />
Cho<br />
Korea Univ Anam Hosp, Seoul, Korea<br />
SAP067<br />
EXPERIMENTAL SEPSIS DIFFERENTIALLY REGULATES RENAL Ca2+<br />
TRANSPORT PROTEINS IN MICE<br />
Klaus Höcherl | Christoph Schmidt<br />
Univ Regensburg | Martin-Luther-Univ Halle-Wittenberg<br />
« SAP068<br />
CALCIUM-OXALATE CRYSTALS INDUCE RENAL INFLAMMATION AND<br />
ACUTE KIDNEY INJURY BY ACTIVATING NLRP3 INFLAMMASOME-ME-<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
259<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
260<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
DIATED INTERLEUKIN-1Β SECRETION IN RENAL DENDRITIC CELLS<br />
Shrikant R. Mulay | Onkar P. Kulkarni | Khader Valli Rupanagudi | Adriana<br />
Migliorini | Helen Liapis | Hans-Joachim Anders<br />
Nephrological Center, Medical Policlinic, Univ Munich, Germany | Dept Pathology,<br />
Washington Univ, School Medicine, St Louis, MO, USA<br />
SAP069<br />
MECHANISMS OF DELETERIOUS EFFECTS OF MYOGLOBIN UNDER RHAB-<br />
DOMYOLISIS<br />
Irina Pevzner | Anastasia Chupyrkina | Egor Plotnikov | Dmitry Zorov<br />
Mitoengineering Res Inst, Lomonosov Moscow State Univ, Moscow, Russia |<br />
A.N.Belosersky Inst Physico-Chemical Biology, Moscow State Univ, Moscow,<br />
Russia<br />
SAP070<br />
ROLE OF RENAL ENDOGLIN DURING RENAL ISCHEMIA-REPERFUSION<br />
INJURY<br />
Jose-Miguel Lopez-Novoa | Fernando Perez-Barriocanal | Miguel Arevalo |<br />
Neil Docherty<br />
Univ, Salamanca, Spain | Conway Inst Biomolecular and Biomedical Sciences,<br />
Univ College, Dublin, Ireland<br />
SAP071<br />
COMPLEMENT (C) ACTIVATION IN RENAL ISCHEMIA/REPERFUSION<br />
(I/R) INJURY IS MEDIATED BY PENTRAXIN 3 (PTX3): A SPECIES-SPECIFIC<br />
DIFFERENCE<br />
Giuseppe Castellano | Chiara Divella | Antonia Loverre | Alessandra Stasi |<br />
Claudia Curci | Michele Rossini | Pasquale Ditonno | Michele Battaglia | Mohamed<br />
R. Daha | Cees Van Kooten | Loreto Gesualdo | Francesco Paolo Schena|<br />
Giuseppe Grandaliano<br />
Dept Emergency and Organ Transpl, Univ Bari, Bari, Italy, | Urology and Transpl<br />
Unit, Univ Bari, Bari, Italy | Dept Nephrology, Univ Medical Center, Leiden,<br />
Netherlands | Nephrology Unit, Dept Biomedical Sciences, Univ Foggia, Italy<br />
SAP072<br />
NOVEL XANTHINE OXIDOREDUCTASE INHIBITOR, FEBUXOSTAT, ATTE-<br />
NUATES RENAL ISCHEMIA-REPERFUSION INJURY IN RATS<br />
Hidetoshi Tsuda | Noritaka Kawada | Hirotsugu Iwatani | Toshiki Moriyama|<br />
Shiro Takahara | Hiromi Rakugi | Yoshitaka Isaka<br />
Osaka Univ<br />
« SAP073<br />
HYPOXIC RESPONSE IN MACROPHAGES IN RENAL ISCHEMIA REPERFU-<br />
SION INJURY<br />
Gunnar Schley | Joanna Kalucka | Bernd Klanke | Jonathan Jantsch | Susanne<br />
Olbrich | Jasmin Baumgärtl | Kerstin Amann | Kai-Uwe Eckardt | Alexander<br />
Weidemann<br />
Medical Clinic 4 - Nephrology and Hypertension, Univ Erlangen-Nuremberg,<br />
Erlangen, Germany | Inst Microbiology, Univ Erlangen-Nuremberg, Erlangen,<br />
Germany | Inst Nephropathology, Univ Erlangen-Nuremberg, Erlangen, Germany<br />
SAP074<br />
CORRECTION OF ENDOTHELIAL DISFUNCTION AFTER RENAL ISCHE-<br />
MIA-REPERFUSION INJURY IN RATS<br />
Anna Dolgolikova | Valery Pilotovich | G Ivanchik | I. Shved<br />
Belarusian Medical Academy of Post-Grad Education Minsk, Belarus<br />
SAP075<br />
DEHYDROEPIANDROSTERONE (DHEA) AND CASTRATION IMPROVES<br />
KIDNEY FUNCTION FOLLOWING ISCHEMIA/REPERFUSION (IR) INJURY:<br />
ROLE OF SIGMA-1 RECEPTOR (SIGMA-1R) – AKT - NA/K ATPASE (NKA)<br />
PATHWAY<br />
Nora F Banki | Zsuzsanna Antal | Adam Hosszu | Sandor Koszegi | Adam<br />
Vannay | Laszlo Wagner | Agnes Prokai | Vera Muller | Attila J Szabo | Andrea<br />
Fekete<br />
Semmelweis Univ 1st Dept Pediatrics, Hungary | Dept Pulmonology, Semmelweis<br />
Univ<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP076<br />
TLR-4: “TROJAN HORSE” IN AKI INDUCED ENCEPHALOPATHY<br />
Sally Farrag | Sarah Abulasrar | Mohamed Salama | Maha Amin | Azza Ali |<br />
Hussein Sheashaa | Mohamed Sobh<br />
Mansoura Medical Experimental Res Center<br />
SAP077<br />
INHIBITION OF eIF5A HYPUSINATION: A NEW PHARMACOLOGICAL<br />
TARGET APPLIED TO THE PROTECTION OF THE ISCHEMIC INDUCED RE-<br />
NAL DYSFUNCTION<br />
Isabelle Rubera | Christophe Duranton | Marc Cougnon | Nicolas Melis | Michel<br />
Tauc<br />
LP2M CNRS FRE 3472<br />
SAP078<br />
PROTECTION OF MITOCHONDRIA: NEW TARGET TO PREVENT NEPHRO-<br />
TOXICITY<br />
Egor Plotnikov | Dmitry Zorov | Anastasia Chupyrkina | Stanislovas Jankauskas<br />
| Maria Morosanova | Irina Pevzner | Natalia Pulkina | Ljubava Zorova<br />
Belozersky Inst, Lomonosov Moscow State Univ, Moscow, Russia<br />
SAP079<br />
ERK PHOSPHORYLATION PLAYS A KEY ROLE IN HYPOTHERMIC RENAL<br />
PROTECTION<br />
Young Tai Shin | Seong Suk Kim | Yoon Kyung Chang | Dae Eun Choi | Ki-<br />
Ryang Na | Kang Wook Lee<br />
Renal Div, Chungnam National Univ Hosp, Daejeon, Korea | Internal Medicine,<br />
Sun Hosp, Daejeon| Internal Medicine, Daejeon Saint Mary Hosp, Daejeon,<br />
Korea | Renal Div, Dept Internal Medicine, Chungnam National Univ Hosp,<br />
Daejeon, Korea<br />
SAP080<br />
EXPRESSION OF CALCINEURIN AND REGULATOR OF CALCINEURIN 1<br />
(RCAN1) IN THE RAT KIDNEY FOLLOWING LIPOPOLYSACCHARIDE AD-<br />
MINISTRATION<br />
Jae-Youn Choi | Dong-Chan Jin | Jung-Ho Cha<br />
Dept Anatomy, Dept Internal Medicine, College of Medicine, Catholic Univ Korea,<br />
Seoul, Korea<br />
SAP081<br />
EVIDENCE FOR THE INVOLVEMENT OF OAT1/3 IN RENAL OUTCOME AF-<br />
TER ISCHEMIC ACUTE KIDNEY INJURY<br />
Reinhard Schneider | Boris Betz | Marcus Meusel | Christopher Held | Christoph<br />
Wanner | Michael Gekle | Christoph Sauvant<br />
Univklinikum Würzburg | Julius-Bernstein-Inst Physiologie | Univklinikum<br />
Halle<br />
SAP082<br />
RECOMBINANT HUMAN MANGANESE SUPEROXIDE DISMUTASE PRO-<br />
TECTS AGAINST POSTISCHEMIC RENAL INJURY<br />
Antonio Pisani | Aldo Mancini | Roberta Rossano<br />
Chair of Nephrology FedericoII Naples | Molecular Biology & Viral Oncogenesis<br />
Dept National Cancer<br />
SAP083<br />
ENDOTHELIAL CELL-DERIVED ENDOTHELIN-1 KNOCK-OUT PRESERVES<br />
CORTEX ARCHITECTURE AFTER ISCHEMIC-REPERFUSION EPISODE IN<br />
MICE<br />
Nur Arfian | Keiko Yagi | Kazuhiko Nakayama | Hirowati Ali | Dyah S. Mayasari<br />
| Eko Purnomo | Noriaki Emoto<br />
Cardiovascular Div Internal Dept, Grad School of Medicine Kobe Univ | Clinical<br />
Pharmacy Dept, Kobe Pharmaceutical Univ<br />
SAP084<br />
PREVENTION OF HYPERGLYCEMIA-INDUCED AKI DEVELOPMENT<br />
Shai Efrati | Sylvia Berman | Ramzia Abu Hamad | Joshua Weissgarten<br />
Assaf Harofeh Medical Center<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
261<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
262<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP085<br />
EXTRACELLULAR HISTONES AGGRAVATE ACUTE KIDNEY INJURY BY<br />
CAUSING MICROVASCULAR DAMAGE AND TOLL-LIKE RECEPTOR-2/4<br />
ACTIVATION<br />
Christina Rebecca Scherbaum | Ramanjaneyulu Allam | Julia Lichtnekert |<br />
Murthy Narayana Darisipudi | Holger Hägele | Shrikant R Mulay | Khader<br />
Valli Rupanagudi | Bernd Hohenstein | Christian Hugo | Liliana Schaefer |<br />
Hans-Joachim Anders<br />
Dept Nephrology, Medizinische Poliklinik, Klinikum Univ München, Campus<br />
Innenstadt, München, Germany | Div Nephrology, Univ Dresden, Dresden,<br />
Germany | Inst Allgemeine Pharmakologie und Toxikologie, Klinikum Goethe-<br />
Univ, Frankfurt am Main, Germany<br />
SAP086<br />
A RABBIT MODEL OF UREMIA-INDUCED CARDIOMYOPATHY<br />
Cristiana Corsi | Emiliana Ferramosca | Eleonora Grandi | Luciano Pisoni |<br />
Ilaria Rivolta | Boris Dalpozzo | Eriselda Hoxha | Stefano Severi | Antonio<br />
Santoro<br />
DEIS, Univ Bologna, Italy | Veterinary Medicine, Univ Bologna, Italy | Experimental<br />
Medicine, Bicocca Univ Milano, Italy | Nephrology, Dialysis and Hypertension,<br />
S.Orsola-Malpighi Univ Hosp, Bologna, Italy<br />
SAP087<br />
GENETIC BACKGROUND INFLUENCES VEGFR PATHWAYS AND GLOME-<br />
RULAR THROMBOTIC LESIONS IN NEPHROTOXIC NEPHRITIS<br />
Mesnard Laurent | Rafat Cedric | Cathelin Dominique | Vandermeersch Sophie|<br />
Dominique Nochy | Garcon Loic | Callard Patrice | Jouanneau Chantal |<br />
Verpont Marie-Christine | Hertig Alexandre | Rondeau Eric<br />
INSERM U702, Paris, France | APHP, Paris, France | Assist Publ Hôp Paris, Hôp<br />
Européen Georges Pompidou, Serv Anatomopathologie, Paris, France<br />
SAP088<br />
PERFLUOROCARBON PROTECTS KIDNEY TUBULAR EPITHELIAL CELLS<br />
BY SEPTIC PLASMA-INDUCED APOPTOSIS AND PROMOTES CD133+ RE-<br />
NAL PROGENITOR CELL DIFFERENTIATION<br />
Vincenzo Cantaluppi | Davide Medica | Alessandro Domenico Quercia | Federico<br />
Figliolini | Sergio Dellepiane | Olga Randone | Giuseppe Paolo Segoloni |<br />
Giovanni Camussi<br />
Univ Turin, Turin, Italy<br />
SAP089<br />
A NOVEL MITOCHONDRIA TARGET ANTIOXIDANT AMELIORATES CI-<br />
SPLATIN NEPHROTOXICITY<br />
Young Tai Shin | Dae Eun Choi | Ki-Ryang Na | Yoon Kyung Chang | Seong<br />
Suk Kim | Bong-Hyun Ahn | Soon Ha Kim | Kang Wook Lee<br />
Renal Div, Dept Internal Medicine, Chungnam National Univ Hosp, Daejeon,<br />
Korea | Internal Medicine, Daejeon Saint Mary Hosp, Catholic Univ, Korea | LG<br />
Life Sciences Ltd., R&D Park, Daejeon, Korea<br />
SAP090<br />
PHYSICAL EXERCISE MINIMIZES CISPLATIN-INDUCED ACUTE RENAL IN-<br />
JURY WITH DOWN-MODULATION OF TNF<br />
Mariana Yasue Saito Miyagi | Niels Camara | Marilia Cerqueira Leite Seelaender<br />
| Lucas Maceratesi Enjiu | Patrícia Estler Rocha Guilherme | Marcus Pisciottano<br />
| Meire Hiyane | Caroline Yuri Hayashida | Vinícius de Andrade Oliveira|<br />
Niels Olsen Saraiva Camara | Mariane Tami Amano<br />
Inst Biomedical Sciences USP, São Paulo, Brazil<br />
SAP091<br />
IDENTIFICATION OF EXOSOMAL BIOMARKERS OF CISPLATIN CYTOTO-<br />
XICITY IN RENAL TUBULAR CELLS: POTENTIAL DIAGNOSTIC APPLICA-<br />
TIONS IN ACUTE KIDNEY INJURY<br />
Sandra M. Sancho-Martinez | Fernando Sanchez-Juanes | Laura Vicente | Jose<br />
Manuel Gonzalez-Buitrago | Ana Isabel Morales | Jose M. Lopez-Novoa | Francisco<br />
J. Lopez-Hernandez<br />
Univ Salamanca | Hosp Univ Salamanca | Unidad Toxicología and Unidad<br />
Fisiopatología Renal y Cardiovascular, Univ Salamanca, Spain | Inst Estudios<br />
Ciencias Salud Castilla y León (IECSCYL)<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP092<br />
USING A HEAT INJURY ENDOTHELIAL CELL MODEL TO STUDY THE RE-<br />
LATIONSHIP AMONG AMILORID, PLASMINOGEN, UROKINASE, UROKI-<br />
NASE RECEPTOR, AND ALPHA-ENOLASE<br />
Jin-Shuen Chen | Li-Chien Chang | Chun-Chi Chen<br />
Tri-Serv General Hosp, National Defense Medical Center, Taipei, Taiwan | School<br />
Pharmacy, National Defense Medical Center, Taipei, Taiwan<br />
SAP093<br />
THE ANTI-INFLAMMATORY EFFECTS OF STATIN IN 5/6 NEPHRECTOMI-<br />
ZED RAT<br />
Moo Young Park | Soo Jung Choi | Jin Gook Kim | Seung Duk Hwang<br />
Dept Internal Medicine, Soon Chun Hyang Univ Hosp, Korea<br />
SAP094<br />
TRANSFERRIN, A POTENTIAL TOOL FOR THE DIAGNOSIS OF THE ACUTE<br />
PREDISPOSITION TO CISPLATIN-INDUCED ACUTE KIDNEY INJURY<br />
Laura Vicente-Vicente | Laura Ferreira | Marta Prieto | Omar García-Sánchez |<br />
María A. Sevilla | Francisco J. López-Hernández | Jose Miguel López-Novoa |<br />
Ana Isabel Morales<br />
Unidad Toxicología and Unidad Fisiología Renal y Cardiovascular, Univ Salamanca,<br />
Spain | Unidad Investigación, Hosp Univ Salamanca, Spain<br />
SAP095<br />
CHRONIC PREDISPOSITION TO ACQUIRE ACUTE KIDNEY INJURE CAN BE<br />
DETECTED BY URINARY TRANSFERRIN IN RATS<br />
Laura Vicente-Vicente | Laura Ferreira | Jose Manuel González-Buitrago | Francisco<br />
J. López-Novoa | Jose Miguel López-Novoa | Ana Isabel Morales<br />
Unidad Toxicología and Unidad Fisiopatología Renal y Cardiovascular, Univ Salamanca,<br />
Spain | Unidad Investigación, Hosp Univ Salamanca, Salamanca, Spain<br />
SAP096<br />
SEPSIS-RELATED DOWNREGULATION OF MEDULLARY SOLUTE AND<br />
WATER TRANSPORTERS IS MEDIATED BY NO-INDUCED INACTIVATION<br />
OF TONEBP/NFAT5<br />
Küper Christoph | Fraek Maria-Luisa | Beck Franz-Xaver | Wolfgang Neuhofer<br />
Dept Physiology, Dept Nephrology, Univ Munich, Munich, Germany<br />
SAP097<br />
TIME COURSE mRNA EXPRESSION OF DNA METHYLTRANSF<strong>ERA</strong>SE 1, 3a,<br />
3b and 3L DURING DEVELOPMENT OF RENAL FIBROSIS<br />
Benjamin Vervaet | Nathalie Le Clef | Anja Verhulst | Patrick D'Haese<br />
Univ Antwerpen, Antwerpen, Belgium<br />
SAP098<br />
CCAAT/ENHANCER-BINDING PROTEIN DELTA (CEBPD) AS A NOVEL RE-<br />
GULATOR OF HYPOXIA-INDUCIBLE FACTOR-1 (HIF-1) IN KIDNEY DISEASE<br />
Tetsuhiro Tanaka | Junna Yamaguchi | Nobuaki Eto | Ichiro Kojima | Toshiro<br />
Fujita | Masaomi Nangaku<br />
Univ Tokyo, Tokyo, Japan | Div Nephrol & Endocrinol, Univ Tokyo Sch Med<br />
SAP099<br />
EFFECT OF METFORMIN GIVEN BEFORE OR DURING RENAL ISCHEMIA<br />
ON ACUTE KIDNEY INJURY IN RATS<br />
Antoni Wystrychowski | Grzegorz Wystrychowski | Ewa Obuchowicz |<br />
Władysław Grzeszczak | Andrzej Więcek<br />
Dept Nephrology, Endocrinology and Metabolic Diseases, Medical Univ Silesia,<br />
Katowice, Poland | Dept Internal Medicine, Diabetology and Nephrology, Medical<br />
Univ Silesia, Zabrze, Poland | Dept Pharmacology, Medical Univ Silesia,<br />
Katowice, Poland<br />
« SAP100<br />
EFFECT OF ERYTHROPOIETIN ON SHORT TERM I/R REPERFUSION INJU-<br />
RY IN RATS<br />
Ciro Esposito | Massimo Torreggiani | Francesca Castoldi | Clara Migotto |<br />
Nicoletta Serpieri | Fabrizio Grosjean | Alessandra Manini | Enrico Pertile |<br />
Antonio Dal Canton<br />
Unit Nephrology and Hemodialysis, IRCCS Fond Salvatore Maugeri, Univ Pavia,<br />
Pavia, Italy | Unit Nephrology, Dialysis and Transpl, Fond IRCCS Policlinico<br />
San Matteo, Univ Pavia, Pavia, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
263<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
264<br />
AKI - CLINICAL<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP101<br />
IS THE CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING OR<br />
MAGNETIC FIELD SAFE FOR THE PATIENTS WITH HIGH-RISK FOR ACUTE<br />
KIDNEY INJURY?<br />
Ebru Gok Oguz | Refik Olmaz | Kenan Turgutalp | Necati Muşlu | Mehmet Ali<br />
Sungur | Ahmet Kiykim<br />
Div Nephrology Sanliurfa Hosp, Sanliurfa Turkey | Dept Internal Medicine, Div<br />
Nephrology, Shool Medicine, Mersin Univ, Mersin | Dept Biochemistry, Shool<br />
Medicine, Mersin Univ, Mersin, Turkey | Dept Bioistatistic, Shool Medicine,<br />
Mersin Univ, Mersin, Turkey<br />
SAP102<br />
NEURAL NETWORKS FOR THE DIAGNOSIS OF ACUTE KIDNEY INJURY<br />
Wim Van Biesen | Jill Vanmassenhove | Griet Glorieux | Raymond Vanholder<br />
Ghent Univ Hosp, Nephrology, Gent, Belgium | Ghent Univ Hosp, Ghent, Belgium<br />
SAP103<br />
ASSOCIATION OF ACE D ALLELE WITH ACUTE KIDNEY INJURY IN NON-<br />
CHINESE PATIENTS AFTER CARDIAC SURGERY IN A MULTI-ETHNIC<br />
SOUTH ASIAN POPULATION<br />
Sophia Chew<br />
Singapore General Hosp, Singapore<br />
SAP104<br />
PREOP<strong>ERA</strong>TIVE SERUM URIC ACID IS THE MOST PREDICTIVE MARKER<br />
FOR THE INCIDENCE OF ACUTE KIDNEY INJURY FOLLOWING CARDIAC<br />
SURGERY<br />
Katharina Förster | Tim Kaufeld | Jan Kielstein | Tobias Schilling | Axel Haverich<br />
| Hermann Haller | Bernhard Schmidt<br />
Hannover Medical School, Hannover, Germany | Dept Nephrology & Hypertension,<br />
Medical School of Hannover, Germany<br />
SAP105<br />
DEVELOPMENT AND VALIDATION OF A SEVERE A ACUTE KIDNEY INJU-<br />
RY RISK INDEX FOR CHINESE ELDERLY PATIENTS WITH CARDIAC SUR-<br />
GERY<br />
Penghua Hu | Xinling Liang | Yuanhan Chen | Ruizhao Li | Fen Jiang | Zhilian<br />
Li | Wei Shi<br />
Div Nephrology, Guangdong General Hosp, Guangdong Academy of Medical<br />
Sciences Guangzhou, Guangdong, China<br />
SAP106<br />
LONG TERM RENAL OUTCOMES IN PATIENTS WITH ACUTE KIDNEY IN-<br />
JURY REQUIRING RENAL REPLACEMENT TH<strong>ERA</strong>PY AFTER CORONARY<br />
ARTERY BYPASS GRAFT SURGERY<br />
Cynthia C.W. Lim | Cynthia M.L. Chia | Ann Kheng Tan | Chieh Suai Tan<br />
Singapore General Hosp, Dept Renal Medicine | Singapore General Hosp, Dept<br />
Cardiothoracic Surgery<br />
SAP107<br />
EARLY POSTOP<strong>ERA</strong>TIVE ANGIOTENSIN COVERTING ENZYME INHIBI-<br />
TORS/ANGIOTENSIN RECEPTOR INHIBITORS OR DIURETICS USE IS AS-<br />
SOCIATED WITH A LOWER INCIDENCE OF ACUTE KIDNEY INJURY AFTER<br />
CARDIAC SURGERY IN ELDERLY PATIENTS<br />
Penghua Hu | Xinling Liang | Yuanhan Chen | Ruizhao Li | Fen Jiang | Zhilian<br />
Li | Wei Shi<br />
Div Nephrology, Guangdong General Hosp, Guangdong Academy of Medical<br />
Sciences Guangzhou, Guangdong, China<br />
SAP108<br />
ASSOCIATION BETWEEN THE LOWEST HEMATOCRIT DURING CARDIO-<br />
PULMONARY BYPASS AND ACUTE KIDNEY INJURY<br />
Roderica Ng | Sudhakar Subramani | Sophia Chew<br />
NUS, Singapore | SGH, Singapore<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP109<br />
ANAEMIA PREVIOUS CARDIAC SURGERY PREDICTS ACUTE KIDNEY IN-<br />
JURY<br />
Ana Pérez de José | Carmen Bernis Carro | Rosario Madero Jarabo | Juan Bustamante<br />
| Jose Antonio Sánchez Tomero<br />
Spain, Madrid, Hosp Gregorio Marañón | Hosp la Princesa, Madrid, Spain |<br />
Hosp la Paz, Madrid, Spain<br />
SAP110<br />
RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BLOCKADE EXACERBA-<br />
TES CONTRAST-INDUCED NEPHROPATHY IN PATIENTS UNDERGOING<br />
CORONARY ANGIOGRAPHY: PROPENSITY-MATCHED COMPARISON<br />
Wookyung Chung | Han Ro | Jae Hyun Chang | Hyun Hee Lee | Ji Yong Jung<br />
Gachon Univ Medicine and Science<br />
SAP111<br />
URINARY NGAL AT ADMISSION DOES NOT PROVIDE ADDITIONAL IN-<br />
FORMATION THAN SERUM CREATININE, URINE OUTPUT AND FIRST 24H<br />
FLUID BALANCE, FOR PREDICTION OF AKI IN SEPTIC PATIENTS AT ICU<br />
Jill Vanmassenhove | Wim Van Biesen | Griet Glorieux | Raymond Vanholder<br />
Ghent Univ Hosp, Ghent, Belgium | Ghent Univ Hosp, Nephrology, Gent, Belgium<br />
SAP112<br />
RENAL RECOVERY OF ACUTE KIDNEY INJURY (AKI) AFTER CARDIAC<br />
SURGERY<br />
Loredana Fazzari | Anna Giuliani | Jacopo Scrivano | Laura Pettorini | Umberto<br />
Benedetto | Remo Luciani | Antonino Roscitano | Antonello Napoletano |<br />
Daniela Coclite | Emanuela Cordova | Giorgio Punzo | Riccardo Sinatra | Paolo<br />
Menè | Nicola Pirozzi<br />
Dept Clinical and Molecular Medicine, Univ Rome Sapienza, UOC Nephrology<br />
and Dialysis, AO Sant’Andrea, Italy | Dept Cardiac Surgery, Univ Rome Sapienza,<br />
AO Sant’ Andrea, Italy | UOC Nefrologia, AO G.Rummo, Benevento, Italy |<br />
Ist Superiore Sanità, Rome, Italy<br />
SAP113<br />
URINARY NGAL (NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN)<br />
FOR EARLY DETECTION OF ACUTE KIDNEY INJURY (AKI) IN GERIATRIC<br />
PATIENTS WITH URINARY TRACT INFECTION (UTI) TREATED BY COLISTIN<br />
Linda Shavit | Rackhel Manilov | Nurit Algur | Yonit Wiener-Well | Itzchak<br />
Slotki<br />
Shaare Zedek Medical Center, Jerusalem, Israel<br />
SAP114<br />
THE COMBINATION OF URINE NGAL AND SERUM CREATININE IS A<br />
GOOD PREDICTOR FOR DIALYSIS REQUIREMENT IN ICU POPULATION<br />
Chrysoula Pipili | Charikleia S. Vrettou | Kyparissia Avrami | Foteini Economidou<br />
| Kostas Glynos | Sophia Ioannidou | Vasiliki Markaki | Evaggelia Douka|<br />
Serafeim Nanas<br />
Dept Nephrology, Aretaieion Univ Hosp, Athens, Greece | First Critical Care<br />
Dept National and Kapodistrian Univ Athens,Greece | Dept Biochemistry, Evangelismos<br />
Hosp, Athens, Greece<br />
SAP115<br />
ACUTE KIDNEY INJURY AFTER CARDIAC SURGERY: ROLE OF CYSTATIN<br />
C AND NGAL<br />
Antonio De Pascalis | Piero Cofano | Stefania Proia | AnnaRita Valletta | Ottavia<br />
Vitale | Franco Russo | Erasmo Buongiorno<br />
Nephrology, Dialysis, Transpl Unit, V. Fazzi Hosp, Lecce, Italy | Central Lab, V.<br />
Fazzi Hosp, Lecce, Italy<br />
SAP116<br />
PLASMA NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL)<br />
AS AN EARLY PREDICTIVE MARKER OF CONTRAST-INDUCED NEPHRO-<br />
PATHY IN HOSPITALIZED LOW-RISK PATIENTS UNDERGOING COMPU-<br />
TED TOMOGRAPHY (CT)<br />
Vassilis Filiopoulos | Dimitra Biblaki | Dimitrios Lazarou | Dimitios Chrysis |<br />
Mavra Fatourou | Sofia Lafoyianni | Dimosthenis Vlassopoulos<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
265<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
266<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Nephrology Dept, 1st Dept Internal Medicine, 2nd Dept Internal Medicine,<br />
Amalia Fleming General Hosp, Athens, Greece | Amalia Fleming General Hosp,<br />
Athens, Greece<br />
SAP117<br />
EVALUATION OF NOVEL BIOMARKERS IN PATIENTS WITH ACUTE KID-<br />
NEY INJURY<br />
Oskar Zakiyanov | Vítězslav Kříha | Jan Vachek | Jana Švarcová | Tomáš<br />
Zima| Vladimír Tesař | Marta Kalousová<br />
Dept Nephrology, First Fac Medicine, Charles Univ Prague and General Univ<br />
Hosp Prague, Prague, Czech Republic | Dept Physics, Fac Electrical Engineering,<br />
Czech Technical Univ in Prague, Prague | Inst Medical Biochemistry and Lab Diagnostics,<br />
First Fac Medicine, Charles Univ Prague and General Univ Hosp Prague<br />
SAP118<br />
NOVEL BIOMARKERS FOR PREDICTION OF RENAL REPLACEMENT THE-<br />
RAPY IN ACUTE KIDNEY INJURY: A SYSTEMATIC REVIEW<br />
Manish Kaushik | Claudio Ronco | Dinna Cruz<br />
San Bortolo Hosp, Vicenza, Italy<br />
SAP119<br />
EXPRESSION OF NESTIN IDENTIFIED BY PROTEOMICS: AS A URINARY<br />
BIOMARKER OF ACUTE KIDNEY INJURY<br />
Lu Zhang | Wen Zhang | Nan Chen<br />
Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School of Medicine<br />
SAP120<br />
COMPARISON OF SERUM URIC ACID AND BIOMARKERS TO PREDICT<br />
ACUTE KIDNEY INJURY<br />
A Ahsan Ejaz | Ganesh Kambhampati | Noel Ejaz | Bhagwan Dass | Vijay Lapsia<br />
| Amir A. Arif | Abdo Asmar | Michiko Shimada | Mourad Alsabbagh |<br />
Ravi Aiyer | Richard Johnson<br />
Univ Florida | College Univ Chicago | Mount Sinai School of Medicine | Univ<br />
Central Florida | Hirosaki Univ | Univ Colorado Health Sciences Center<br />
SAP121<br />
ACUTE KIDNEY INJURY BIOMARKERS FOR PATIENTS IN A CORONARY<br />
CARE UNIT: A PROSPECTIVE COHORT STUDY<br />
Tien-Hsing Chen | Chih-Hsiang Chang | Ming-Yang Chang | Ya-Chung Tian|<br />
Cheng-Chieh Hung | Ji-Tseng Fang | Chih-Wei Yang | Yung-Chang Chen<br />
Second Sect Cardiology | Dept Nephrology | Div Critical Care Nephrology,<br />
Chang Gung Memorial Hosp<br />
SAP122<br />
RETROSPECTIVE 10-YEAR ANALYSIS OF SEPSIS-ASSOCIATED ACUTE<br />
KIDNEY INJURY: INCIDENCE, IMPACT ON OUTCOME, IDENTIFICATION<br />
OF PLASMA MICROVESICLES AS POTENTIAL MEDIATORS AND BIOMAR-<br />
KERS OF DISEASE<br />
Vincenzo Cantaluppi | Alessandro Domenico Quercia | Federico Figliolini |<br />
Sylvia Giacalone | Alfonso Pacitti | Massimo Gai | Cesare Guarena | Gianluca<br />
Leonardi | Luigi Biancone | Giovanni Camussi | Giuseppe Paolo Segoloni<br />
Univ Turin, Turin, Italy | Nephrology and Dialysis, Cuneo, Italy<br />
SAP123<br />
THE ROLE OF PLASMA BIOMARKERS IN THE CHARACTERIZATION OF<br />
ICU PATIENTS WITH SEPSIS AND WITH AKI<br />
Massimo de Cal | Paolo Lentini | Anna Clementi | Grazia M Virzì | Elisa Scalzotto<br />
| Claudio Ronco<br />
Div Nephrology, Univ Padua, Padua, Italy | San Bassiano Hosp | San Bortolo<br />
Hosp | Dept Nephrology, Dialysis and Transpl, St Bortolo Hosp, IRRIV-International<br />
Renal Resarch Inst Vicenza, Vicenza, Italy<br />
SAP124<br />
CONTRAST MEDIA, NEPHROTOXICITY AND NEUTROPHIL-GELATINASE<br />
ASSOCIATED LIPOCALIN: BETWEEN DOUBTS AND CERTAINTIES<br />
Antonio Lacquaniti | Valentina Donato | Maria Rosaria Fazio | Silvia Lucisano|<br />
Valeria Cernaro | Rosaria Lupica | Michele Buemi<br />
Univ Messina, Messina, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP125<br />
COMMUNITY ACQUIRED ACUTE KIDNEY INJURY IN THE ELDERLY AND<br />
VERY ELDERLY PATIENTS: A SINGLE CENTER EXPERIENCE<br />
Kenan Turgutalp | Ilter Helvacı | Ekrem Anık | Ahmet Kiykim<br />
Mersin Univ Dept Internal Medicine Mersin, Turkey | Dept Biostatistic School<br />
Medicine, Mersin Univ | Dept Internal Medicine, Div Nephrology, School Medicine,<br />
Mersin Univ, Mersin, Turkey<br />
SAP126<br />
CLINICAL PRESENTATION, COURSE AND OUTCOME OF ACUTE KIDNEY<br />
INJURY DUE TO VITAMIN D INTOXICATION<br />
Muzafar Wani | Imtiaz Wani | Mohd Ashraf Bhat | Khurshid Banday | Mohd<br />
Saleem Najar | Abdul Rashid Reshi | Nazir Ahmed Palla<br />
SKIMS, Soura, Srinagar, India<br />
SAP127<br />
RENAL ARTERY STENOSIS: THE COMPARISON OF THE DOPPLER USG,<br />
CONTRAST-ENHANCED MAGNETIC RESONANCE ANGIOGRAPHY AND<br />
SELECTIVE RENAL ARTERIOGRAPHY<br />
Kenan Turgutalp | Ahmet Kiykim | Ilter Helvacı<br />
Mersin Univ Dept Internal Medicine Mersin, Turkey | Div Nephrology, Dept<br />
Internal Medicine, School Medicine, Mersin Univ, Mersin, Turkey | Dept Biostatistic<br />
School Medicine, Mersin Univ<br />
SAP128<br />
THYROID FUNCTION TESTS IN ACUTE KIDNEY INJURY<br />
Pedro Iglesias | Teresa Olea | Cristina Vega-Cabrera | Manuel Heras |<br />
M.Auxiliadora Bajo | Gloria del Peso | M.J. Arias | Rafael Selgas | Juan Jose Diez<br />
Hosp Ramón y Cajal | Hosp Univ La Paz | Hosp General Segovia<br />
SAP129<br />
THE KIDNEY-LUNG CROSSTALK AND MORTALITY IN A COHORT OF PA-<br />
TIENTS WITH SEVERE LEPTOSPIROSIS (WEIL SYNDROME) IN BRAZIL<br />
Elizabeth Daher | Pedro Lucas Costa | Eduardo N.S. Pereira | Renata D.P. Santos<br />
| Krasnalhia Livia Abreu | Geraldo Silva Junior | Eanes D.B. Pereira<br />
School Medicine, Federal Univ Ceara, Fortaleza, Brazil | School Medicine, Univ<br />
Fortaleza, Fortaleza, Brazil<br />
SAP130<br />
REDUCED SYSTEMIC OXYGEN DELIVERY AND LOW BLOOD PRESSURE<br />
ON DAY OF EARLY AKI INCREASE THE RISK OF PROGRESSION TO SEVERE<br />
AKI IN CRITICALLY ILL PATIENTS<br />
Mário Raimundo | Siobhan Crichton | Yadullah Syed | Jonny Martin | Craig<br />
Whiteley | David Bennett | Marlies Ostermann<br />
Hosp Santa Maria, Lisbon, Portugal | King’s College London, London, UK |<br />
Guy’s & St Thomas Hosp, Dept Critical Care, London, UK<br />
SAP131<br />
ACUTE KIDNEY INJURY ACCORDING TO RIFLE CLASSIFICATION IN THE<br />
INTENSIVE CARE UNIT: OCURRENCE, RISK FACTORS, OUTCOME AND<br />
PREDICTIVE FACTORS<br />
Albana Gjyzari | Nestor Thereska | Alketa Koroshi | Myftar Barbullushi | Sulejman<br />
Kodra | Alma Idrizi | Arjana Strakosha | Elizana Petrela<br />
Nephrology, Epidemiology, Univ Hosp Center Nënë Tereza<br />
SAP132<br />
REDUCED BLOOD PRESSURE AND FLUID ACCUMULATION IN CRITICAL-<br />
LY ILL PATIENTS WITH EARLY AKI ARE ASSOCIATED WITH INCREASED<br />
MORTALITY<br />
Mário Raimundo | Siobhan Crichton | Yadullah Syed | Jonny Martin | Joanna<br />
Lemmich Smith | David Bennett | Marlies Ostermann<br />
Hosp Santa Maria, Lisbon, Portugal | King’s College London, London, UK |<br />
Guy’s & St Thomas Hosp, Dept Critical Care, London, UK<br />
SAP133<br />
ACUTE KIDNEY INJURY IN PATENTS HOSPITALIZED WITH ACUTE DE-<br />
COMPENSATED HEART FAILURE DEPENDING ON HYDRATION STATUS<br />
Anna Klimenko | Evgeny Tuykhmenev | Svetlana Villevalde | Zhanna Kobalava<br />
Peoples’ Friendship Univ Russia, Moscow, Russia<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
267<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
268<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP134<br />
ACUTE KIDNEY INJURY IN PATIENTS WITH NON-ST-ELEVATION ACUTE<br />
CORONARY SYNDROME<br />
Svetlana Avdoshina | Svetlana Villevalde | Evgeny Tyukhmenev | Marina Efremovtseva<br />
| Zhanna Kobalava<br />
Peoples' Frendship Univ Russia, Moscow<br />
SAP135<br />
DISTANT EFFECTS OF AKI ON LUNG INJURIES BY SOLUBLE MEDIATORS<br />
IN BRONCHO-ALVEOLAR LAVAGE FLUID IN PATIENTS WITH ACUTE<br />
LUNG INJURY / ACUTE RESPIRATORY DISTRESS SYNDROME<br />
Hiroki Hayashi | Sachiyo Suzuki | Kensuke Kataoka | Yasuhiro Kondoh | Hiroyuki<br />
Taniguchi | Daisuke Sugiyama | Kunihiro Nishimura | Waichi Sato |<br />
Shoichi Maruyama | Seiichi Matsuo | Yukio Yuzawa<br />
Nephrology, Fujita Health Univ School Medicine, Toyoake, Aichi, Japan | Nephrology,<br />
Nagoya Univ Grad School Medicine, Nagoya, Aichi, Japan | Respiratory<br />
and Allergic Medicine, Tosei General Hosp, Seto, Aichi, Japan | Clinical Pathology<br />
and Immunology, Kobe Univ Grad School Medicine, Kobe, Hyogo, Japan<br />
SAP136<br />
COMPARED ANALYSIS OF THE MORTALITY IN PATIENTS WITH ACUTE<br />
RENAL FAILURE VS MULTI-ORGAN FAILURE IN FRENCH ICU<br />
d'Ythurbide Géraldine | Fartoukh Muriel | Hertig Alexandre | Rondeau Eric<br />
APHP, Hôp Tenon | Inserm U702<br />
SAP137<br />
HEMOPERFUSION PLUS CONTINUOUS VENO-VENOUS HEMOFILTRA-<br />
TION ON PATIENTS WITH MULTIPLE ORGAN DYSFUNCTION SYNDROME<br />
Ping Fu | Ling Zhang<br />
West China Hosp Sichuan Univ, Chengdu, China<br />
SAP138<br />
A NEW CITRATE ANTICOAGULATION PROTOCOL IN EXTRACORPOREAL<br />
TREATMENT FOR SEPTIC SHOCK PATIENTS WITH COUPLED PLASMA FIL-<br />
TRATION ADSORPTION (CPFA)<br />
Marco Pozzato | Fiorenza Ferrari | Pasqualina Cecere | Paola Mesiano | Antonella<br />
Vallero | Sergio Livigni | Francesco Quarello<br />
ASLTO2, Nephrology and Dialysis Dept, San Giovanni Bosco Hosp, Turin, Italy|<br />
ASLTO2, ICU Dept, San Giovanni Bosco Hosp, Turin, Italy<br />
SAP139<br />
IMPACT OF INTENSIVE DAILY HAEODIALYSIS ON RENAL RECOVERY OF<br />
CAST NEPHROPATHIES: A RETROSPECTIVE STUDY<br />
Laurent Hudier | Olivier Decaux | Atman Haddj-Elmrabet | Lise Mandart |<br />
Marie Lino-Daniel | Franck Bridoux | Eric Renaudineau | Théophile Sawadogo|<br />
Patrick Le Pogamp | Cécile Vigneau<br />
Médecine Interne, CHU Rennes | Néphrologie, CHU RENNES | Néphrologie,<br />
Centre Hosp Bretagne Atlantique, Vannes | Néphrologie, CHU Nantes | Néphrologie,<br />
CHU Poitiers | Néphrologie, Centre Hosp Broussais, Saint-Malo |<br />
Néphrologie, Centre Hosp Bretagne Sud, Lorient<br />
SAP140<br />
URINE OUTPUT AS A FACTOR IN INITIATING CONTINUOUS RENAL RE-<br />
PLACEMENT TH<strong>ERA</strong>PY FOR ACUTE KIDNEY INJURY<br />
Doh Famee | Hyang Mo Koo | Hyung Jung Oh | Seung Hyeok Han | Kyu Hun<br />
Choi | Shin-Wook Kang<br />
Dept Internal Medicine, College of Medicine, Yonsei Univ, Seoul, Korea<br />
SAP141<br />
ECONOMIC IMPACT OF TWO MODALITIES OF CVVHDF ON NURSES<br />
WORKING LOAD<br />
Manolie Mehdi | Maillard Nicolas | Christophe Mariat<br />
CHU Saint Etienne, France<br />
SAP142<br />
OUTCOME AND PROGNOSTIC FACTORS OF MALARIA-ASSOCIATED<br />
ACUTE KIDNEY INJURY<br />
Pankaj Shah | Vivek Balkrishna Kute | Aruna Vanikar | Manoj Gumber | Hi-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
manshu Patel | Hargovind Trivedi<br />
IKDRC-ITS, Ahmedabad, India<br />
SAP143<br />
MICROCIRCULATION CORRELATES WITH RIFLE SCORE ON ADMISSION<br />
AND PRIOR TO CRRT INITIATION<br />
Chrysoula Pipili | Christos Manetos | Charikleia S. Vrettou | Stefania Poulaki|<br />
Elli-Sophia Tripodaki | Adroula Papastylianou | Christina Routsi | Serafeim<br />
Nanas<br />
Dept Nephrology, Aretaieion Univ Hosp, Athens, Greece | First Critical Care<br />
Dept National and Kapodistrian Univ Athens, Greece<br />
SAP144<br />
DOES ACUTE KIDNEY INJURY LEADS TO OR WORSEN CHRONIC KIDNEY<br />
DISEASE? RISK FACTORS FOR CHRONIC KIDNEY DISEASE AFTER ACUTE<br />
KIDNEY INJURY<br />
Kensuke Uchida | Kunihiro Yamagata | Chie Saitou | Masashi Okada<br />
Mito-Saiseikai General Hosp, Mito city, Japan | Tsukuba Univ Hosp, Tsukuba<br />
city, Japan<br />
SAP145<br />
THE THROMBOTIC MICROANGIOPATHIES IN THE <strong>ERA</strong> OF HIV - AN AFRI-<br />
CAN PERSPECTIVE<br />
Gaji Chita | Malcolm Davies | Yusuf Veriawa | Saraladevi Naicker<br />
Univ Witwatersrand, Johannesburg, South Africa<br />
SAP146<br />
SURROGATE PREDICTORS OF SNAKEBITE MEDIATED ACUTE KIDNEY IN-<br />
JURY AND CARBONYL STRESS – A PROSPECTIVE STUDY<br />
Pinaki Mukhopadhyay | Debarati Mukherjee | Raghwendra Mishra | Monoj Kar<br />
NRS Medical College & Hosp, Kolkata, India<br />
SAP147<br />
ACUTE TUBULOINTERSTITIAL NEPHRITIS CAUSED BY ABACAVIR AND<br />
LAMIVUDINE (KIVEXA ®)<br />
Daniel Zickler | Hans Wesselmann | Ralf Schindler<br />
Charité Nephrology and Intensive Care | Dept Infectious Diseases and Pulmonary<br />
Medicine, Charité-Univ Berlin | Charité-Virchow Klinik<br />
SAP148<br />
PATHOGENIC MECHANISMS INFLUENCING THE RECOVERY OF RENAL<br />
FUNCTION AFTER MACROHEMATURIA-INDUCED ACUTE KIDNEY INJU-<br />
RY (AKI) IN IGA NEPHROPATHY<br />
Eduardo Gutierrez | Jesús Egido | Alfonso Rubio-Navarro | Irene Buendía |<br />
Luis Miguel Blanco-Colío | Oscar Toldos | Félix Manzarbeitia | Alberto De Lorenzo<br />
| Rosa Sánchez | Manuel Praga | Juan Antonio Moreno<br />
Hosp Univ 12 de Octubre, Madrid, Spain | IIS-Fund Jiménez Díaz, Autonoma<br />
Univ, FRIAT; Madrid, Spain | Complejo Hosp Segovia, Segovia, Spain<br />
SAP149<br />
HIGHER INFUSION RATE OF MANNITOL INCREASES THE RISK OF ACUTE<br />
KIDNEY INJURY IN PATIENTS WITH INTRACRANIAL HEMORRHAGE<br />
Min Young Kim | Na Ree Kang | Hye Ryoun Jang | Jung Eun Lee | Wooseong<br />
Huh | Yoon-Goo Kim | Dae Joong Kim | Seung-Chyul Hong | Jong-Soo Kim|<br />
Ha Young Oh<br />
Seoul Medical Center, Seoul, Korea | Samsung Medical Center, Seoul, Korea<br />
SAP150<br />
GADOLINIUM-CONTRAST NEPHROTOXICITY IN MAGNETIC RESONAN-<br />
CE IMAGING<br />
Tomoko Okamoto | Kouju Kamata | Shokichi Naito | Hiromi Tazaki | Shinichi<br />
Kan<br />
Kitasato Univ, Sagamihara, Japan<br />
SAP151<br />
EARLY INITIATION OF CONTINUOUS RENAL REPLACEMENT TH<strong>ERA</strong>PY<br />
IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY IS ASSOCIA-<br />
TED WITH A BETTER RENAL RECOVERY - A PROSPECTIVE OBSERVATIO-<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
269<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
270<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
NAL TRIAL<br />
Lerner-Gräber Anne-Kathrin | Timo Speer | Link Andreas | Groesdonk Heinrich<br />
| Volk Thomas | Aaron Poppleton | Fliser Danilo | Klingele Matthias<br />
Saarland Univ Hosp, Dept Internal Medicine 4, Homburg/Saar, Germany | Saarland<br />
Univ Hosp, Dept Internal Medicine 3, Homburg/Saar, Germany | Saarland<br />
Univ Hosp, Dept Cardiothoracic Surgery, Homburg/Saar, Germany | Saarland<br />
Univ Hosp, Dept Anesthesiology, Homburg/Saar, German<br />
SAP152<br />
IN-HOSP MORTALITY AND LONG-TERM OUTCOMES OF NON-DIALYSIS<br />
REQUIRING ACUTE KIDNEY INJURY IN CRITICALLY-ILL PATIENTS<br />
Chun-Fu Lai | Vin-Cent Wu | Chih-Chung Shiao | Tao-Min Huang | Kwan-<br />
Dun Wu<br />
National Taiwan Univ Hosp, Taipei, Taiwan | Saint Mary’s Hosp, Luodong, Taiwan<br />
| National Taiwan Univ Hosp Yun-Lin Branch, Douliou, Taiwan<br />
SAP153<br />
ACUTE KIDNEY INJURY (AKI): AN ACCEPTABLE RISK OF TREATMENT<br />
WITH ACE INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS?<br />
Michael Bedford | Christopher Farmer | Jean Irving | Paul Stevens<br />
East Kent Hosp Univ NHS Found Trust<br />
SAP154<br />
CHANGES IN THE INCIDENCE OF ACUTE KIDNEY INJURY REQUIRING<br />
DIALYSIS (AKI-D): A FIVE YEARS SINGLE-CENTER REGISTER<br />
Francesco Patera | Francesca Mattozzi | Sara Battistoni | Riccardo Maria Fagugli<br />
Nephrology - Azienda Osp Perugia, Perugia, Italy<br />
SAP155<br />
THE URINARY CYSTATIN C LEVEL AS A PROGNOSTIC BIOMARKER OF<br />
MORTALITY IN PATIENTS WITH ACUTE KIDNEY INJURY<br />
Moo Young Park | Soo Jung Choi | Jin Gook Kim | Seung Duk Hwang<br />
Dept Internal Medicine, Soon Chun Hyang Univ Hosp, Korea<br />
SAP156<br />
CLINDAMYCIN RELATED ACUTE KIDNEY INJURY IN 22 CASES<br />
Honglang Xie | Huiping Chen | Shutian Xu | Qunpeng He | Jin Liu | Weixin<br />
Hu | Zhihong Liu<br />
Res Inst Nephrology, Jinling Hosp, Nanjing, China<br />
SAP157<br />
CYSTATIN C PREDICT MORTALITY BUT NOT AKI OCCURRENCE AMONG<br />
ELDERLY CRITICALLY ILL PATIENTS<br />
Maria Dalboni | Rosangela Blaya | Beata Marie Quinto | Roberto Narciso | Moacir<br />
Oliveira | Julio Monte | Marcelino Durão | Miguel Cendoroglo | Marcelo<br />
Batista<br />
Univ Federal São Paulo/UNIFESP, São Paulo, Brazil | Hosp Israelita Albert Einstein<br />
SAP158<br />
RENAL EXPRESSION OF MONOCYTE CHEMOTACTIC PROTEIN-1 IN PA-<br />
TIENTS WITH SCHISTOSOMIASIS MANSONI IN AN AREA OF LOW ENDE-<br />
MICITY IN NORTHEAST BRAZIL<br />
Ana Lucia Hanemann | Alexandre Liborio | Elizabeth Daher | Alice Martins |<br />
Maria Christiany C. Pinheiro | Geraldo Silva Junior | Gdayllon Meneses | Ramon<br />
de Paula Pessoa | Mariana Sousa | Fernando Schemelzer M. Bezerra<br />
Dept Pathology and Legal Medicine, Federal Univ Ceara, Fortaleza, Brazil |<br />
School Medicine, Univ Fortaleza, Fortaleza, Brazil | School Medicine, Federal<br />
Univ Ceara, Fortaleza, Brazil | Dept Clinical Analysis and Toxicology, Federal<br />
Univ Ceara, Fortaleza, Brazil | Dept Physiology and Pharmacology, Federal<br />
Univ Ceara, Fortaleza, Brazil<br />
SAP159<br />
SNAKEBITES-INDUCED ACUTE KIDNEY INJURY IN NORTHEAST BRAZIL<br />
Polianna L.M.M. Albuquerque | Juliana B. Lima | Caroline B. Lima | Maria do<br />
Socorro B. Veras | Geraldo Silva Junior | Elizabeth Daher<br />
School of Medicine, Federal Univ Ceara, Fortaleza, Brazil | Hosp Geral Waldemar<br />
Alcântara, Fortaleza, Brazil | Center Toxicological Assistance, Inst Dr. José<br />
Frota, Fortaleza, Brazil | School of Medicine, Univ Fortaleza, Fortaleza, Brazil<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP160<br />
AKIN (ACUTE KIDNEY INJURY NETWORK) SCORE DID NOT PREDICT SUR-<br />
VIVAL AFTER ORTHOTOPIC LIVER TRANSPL (OLT)<br />
Thais Nemoto Matsui | Claudia Totoli | Maria Claudia Cruz Andreoli | Maria<br />
Paula Vilela Coelho | Nadia Karina Guimaraes de Souza | Adriano Luiz Ammirati<br />
| Fellype de Carvalho Barreto | Ben-Hur Ferraz Neto | Bento Fortunato<br />
Cardoso dos Santos<br />
Albert Einstein Jewish Hosp, Sao Paulo, Brazil | Federal Univ Sao Paulo<br />
SAP161<br />
SNAKE BITES, OBSTETRIC COMPLICATIONS AND INDIGENOUS MEDICI-<br />
NES ACCOUNT FOR HALF THE CASES OF BIOPSIED ACUTE KIDNEY INJU-<br />
RY IN SOUTHERN INDIA<br />
Anila Abraham | Georgi Abraham | Milly Mathew<br />
Madras Medical Mission, Chennai, India<br />
SAP162<br />
ACUTE KIDNEY INJURY AFTER AUTOLOGOUS BONE MARROW TRANSPL<br />
IN PACIENTS USING LOWER DOSAGE OF DIMETHYL SULFOXIDE<br />
Pastora M.A. Duarte | Fernando B. Duarte | Emanuelle M. Barros | Farnando<br />
Q.S. Castro | Geraldo Silva Junior | Elizabeth Daher<br />
School Medicine, Federal Univ Ceara, Fortaleza, Brazil | School Medicine, Univ<br />
Fortaleza, Fortaleza, Brazil<br />
SAP163<br />
PREDICTIVE FACTORS FOR AKI DEVELOPMENT IN OLDER PATIENTS<br />
Henrique Palomba | Isac Castro | Sirlei Regina Sousa | Andressa Nascimento<br />
Jesus | Thiago Romano | Emannuel Burdmann | Luis Yu<br />
State Univ São Paulo | Hosp Sancta Maggiore<br />
SAP164<br />
OUTCOME OF HOSP-ACQUIRED ACUTE KIDNEY INJURY ACCORDING TO<br />
AKIN CRITERIA: LONG-TERM FOLLOW UP<br />
Soon Hyo Kwon | Jin Young You | Yu Kyung Hyun | Sung Ae Woo | Jin Seok<br />
Jeon | Hyun Jin Noh | Dong Cheol Han<br />
Dept Internal Medicine, Soon Chun Hyang Univ Hosp, Seoul, Korea<br />
SAP165<br />
THE VALIDITY OF THE URINE OUTPUT AND SERUM CREATININE AS CRI-<br />
TERIA OF RIFLE CLASSIFICATION IN OUTCOME OF AKI<br />
Liljana Tozija | Zvezdana Petronievic | Gjulsen Selim | Igor Nikolov | Olivera<br />
Stojceva-Taneva | Koco Cakalaroski<br />
Univ Clinic Nephrology, Univ Sts. Cyril and Methodius Skopje, R. Macedonia<br />
SAP166<br />
CIRCULATING ANGIOPOIETIN-2 AS A MARKER OF A COMPLICATED<br />
COURSE OF E.COLI 0104:H4 INDUCED HEMOLYTIC UREMIC SYNDROME<br />
IN ADULT PATIENTS<br />
Alexander Lukasz | Jan Beneke | Bernhard Schmidt | Jan Kielstein | Hermann<br />
Haller | Jan Menne | Mario Schiffer<br />
Dept Nephrology & Hypertension, Hannover Medical School<br />
SAP167<br />
FIBRATE-INDUCED ACUTE KIDNEY INJURY: A COMMON AND OCCASIO-<br />
NALLY IRREVERSIBLE COMPLICATION<br />
Natalia Polanco | Eduardo Hernandez | Eduardo Gutierrez | Victor Gutierrez<br />
Millet | Esther Gonzalez Monte | Enrique Morales | Manuel Praga<br />
12 de Octubre Univ Hosp<br />
SAP168<br />
A PROSPECTIVE OBSERVATIONAL BIOELECTRICAL IMPEDANCE STUDY:<br />
PROGNOSIS IN ACUTE KIDNEY INJURY<br />
Lavilla Francisco Javier | Garcia-Fernandez Nuria | Mora-Gutierrez Jose Maria|<br />
Maira Bes Rastrollo<br />
Clinica Univ Navarra, Pamplona, Spain<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
271<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
272<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP169<br />
METFORMIN-ASSOCIATED LACTIC ACIDOSIS (MALA): A SINGLE CENTRE<br />
EXPERIENCE ON 14 PATIENTS<br />
Andrea Angioi | Maura Conti | Riccardo Cao | Alice Atzeni | Gianfranco Pili|<br />
Valeria Matta | Efisio Murgia | Patrizia Melis | Valentina Binda | Antonello Pani<br />
Div Nephrology and Dialysis, Azienda Osp G.Brotzu, Cagliari, Italy<br />
SAP170<br />
PHARMACOKINETICS OF MEROPENEM WITH 3-HOUR INFUSION REGI-<br />
MEN IN CRITICALLY ILL PATIENTS ON CONTINUOUS RENAL REPLACE-<br />
MENT TH<strong>ERA</strong>PY<br />
Fernando Thomé | Fabiane Leusin | Elvino Barros | Cássia Morsch | Antônio<br />
Balbinotto | Carmen Pilla<br />
Hosp Clínicas Porto Alegre, Brazil<br />
SAP171<br />
ACUTE MYOGLOBINURIC RENAL FAILURE IN THE INTENSIVE CARE PA-<br />
TIENTS<br />
Vladimir Premru | Jadranka Buturović-Ponikvar | Rafael Ponikvar | Andreja<br />
Marn-Pernat | Bojan Knap | Janko Kovač | Jakob Gubenšek | Boštjan Kersnič |<br />
Ljuba Krnjak | Marija Prezelj<br />
Univ Medical Center Ljubljana, Slovenia<br />
SAP172<br />
CLINICAL SIGNIFICANCE OF HIGH URINARY ALPHA-1-MICROGLOBULI-<br />
NE - PROMISING MARKER OF ACUTE KIDNEY INJURY?<br />
Jana Granatova | Martin Havrda | Zdenka Hruskova | Karolina Kratka | Ondrej<br />
Remes | Magdalena Mokrejsova | Milada Bolkova | Vera Lanska | Ivan<br />
Rychlik<br />
Thomayer Hosp, Prague, Dept Biochemistry | Charles Univ, 3rd Medical Fac,<br />
Prague, Czech Republic | Charles Univ, 1st Medical Fac, Prague, Czech Republic|<br />
Inst Clinical and Experimental Medicine, Prague, Czech Republic<br />
SAP173<br />
DOES THE CAUSE OF ‘PRE-RENAL’ AKI IN A GEN<strong>ERA</strong>L HOSPITAL SET-<br />
TING MAKE A DIFFERENCE TO OUTCOMES?<br />
Mark D. Uniacke | Robert J. Lewis | Scott Harris | Paul Roderick<br />
Wessex Renal and Transpl Serv, Portsmouth, UK | Univ Southampton, Southampton,<br />
UK<br />
SAP174<br />
IMPROVEMENT IN OUTCOMES OVER TIME ARE BIASED BY ACUTE KID-<br />
NEY INJURY PATIENTS WHO DO NOT BENEFIT FROM RENAL REPLACE-<br />
MENT TH<strong>ERA</strong>PY<br />
Fernando Thomé | Antônio Balbinotto | Elvino Barros | Cássia Morsch<br />
Hosp Clínicas Porto Alegre, Brazil<br />
SAP175<br />
MAIN PAPER SHIGA-TOXIN INDUCED HUS<br />
Nitschke Martin | Kunzendorf Ulrich | Beneke Jan | Bramstedt Jörn | Brunkhorst<br />
Reinhard | Kielstein Jan | Haller Hermann | Meyer Tobias F. | Ramazan<br />
Leyla | Schmidt Bernhard M.W. | Schoecklmann Harald | Steinhoff Jürgen |<br />
Kuehbacher Tanja | Jan Menne | Schiffer Mario<br />
Univ Hosp Schleswig-Holstein | Medical School Hannover | Bremerhaven Hosp<br />
Reinkenheide | Hosp Hannover Oststadt | Asklepios Hosp Hamburg Barmbek|<br />
Dept Nephrology & Hypertension, Medical School Hannover, Germany<br />
SAP176<br />
SYMPTOMS IN SHIGA-TOXIN INDUCED HUS PATIENTS<br />
Beneke Jan | Emden Sang Hi | Ramazan Leyla | Michael Claus | Vetter Frank|<br />
Sartison Aleksej | Samiri Sengül | Kielstein Jan | Bramstedt Jörn | Brunkhorst<br />
Reinhard | Meyer Tobias F. | Schmidt Bernhard M.W. | Schiffer Mario |<br />
Nitschke Martin | Kunzendorf Ulrich | Stingele Robert | Weissenborn Karin |<br />
Kuehbacher Tanja | Haller Hermann | Jan Menne<br />
Medical School Hannover | Hosp Reinkenheide | Hosp Hannover Oststadt |<br />
Asklepios Hosp Hamburg Barmbek | Univ Hosp Schleswig-Holstein | Dept Nephrology<br />
& Hypertension, Medical School Hannover, Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP177<br />
WOMEN ARE PRONE TO DEVELOP A MORE SEVERE COURSE OF SHIGA-<br />
TOXIN MEDIATED HUS<br />
Ramazan Leyla | Kielstein Jan | Beneke Jan | Brunkhorst Reinhard | Gueler<br />
Feikah | Haller Hermann | Kuehbacher Tanja | Kunzendorf Ulrich | Menne Tobias<br />
F. | Michael Claus | Nitschke Martin | Schiffer Mario | Schmidt Bernhard<br />
M.W.| Schoecklmann Harald | Steinhoff Jürgen | Jan Menne<br />
Medical School Hannover | Hosp Hannover Oststadt | Univ Hosp Schleswig-<br />
Holstein | Freeman Hosp | Dept Nephrology & Hypertension, Medical School<br />
Hannover, Germany<br />
SAP178<br />
PREDICTIVE PARAMETERS FOR PATIENTS WITH SHIGA-TOXIN INDUCED<br />
HUS<br />
Michael Claus | Kielstein Jan | Beneke Jan | Brunkhorst Reinhard | Gueler Feikah<br />
| Haller Hermann | Kunzendorf Ulrich | Menne Tobias F. | Meyer Tobias<br />
N.| Nitschke Martin | Ramazan Leyla | Schmidt Bernhard M.W. | Schoecklmann<br />
Harald | Steinhoff Jürgen | Kuehbacher Tanja | Schiffer Mario | Jan Menne<br />
Medical School Hannover | Hosp Hannover Oststadt | Universital Hosp Schleswig-Holstein<br />
| Freeman Hosp | Asklepios Hosp Hamburg Barmbek | Dept<br />
Nephrology & Hypertension, Medical School Hannover, Germany<br />
¯ SAP179<br />
BEST SUPPORTIVE CARE AND TH<strong>ERA</strong>PEUTIC PLASMA EXCHANGE<br />
Jan Kielstein | Gernot Beutel | Susanne Fleig | Jürgen Steinhoff | Tobias Meyer<br />
| Carsten Hafer | Joern Bramstedt | Veit Busch | Martin Vischedyk | Uwe<br />
Kuhlmann | Wolfgang Ries | Steffen Mitzner | Stefan Mees | Sylvia Stracke|<br />
Jens Nürnberger | Peter Gerke | Monika Wiesner | Bernd Sucke | Miriam Abu-<br />
Tair | Andreas Kribben | Norbert Klause | Ralf Schindler | Frank Merkel |<br />
Sabine Schnatter | Eiske Dorresteijn | Ola Samuelsson | Reinhard Brunkhorst |<br />
German STEC-HUS Registry<br />
Medical School Hannover | Univ Hosp Lübeck | Asklepios Klinik Hamburg |<br />
Klinikum Bremerhaven | Univ Hosp Münster | St. Vinzenz Krankenhaus Paderborn|<br />
Klinikum Bremen Mitte | Diakonissenkrankenhaus Flensburg | Center<br />
Extracorporeal Organ Support Univ Rostock | Walddoerfer Dialyse | Nephrology<br />
| Helios Klinikum Schwerin | Nierenzentrum am Sana Klinikum | Klinikum<br />
Oldenburg | Klinikum Darmstadt | Evangelisches Krankenhaus Gilead | Dept<br />
Nephrology, Univ Hosp Essen, Univ Duisburg-Essen, Essen, Germany | Nephrologisches<br />
Zentrum Rendsburg-Eckernfoerde | Charité-Virchow Klinik | Klinikum<br />
Merheim| Klinikum Ernst v. Bergmann | Erasmus Medical Center, Rotterdam,<br />
Netherlands | Dept Kidney Diseases, Sahlgrenska Univ Hosp, Gothenburg, Sweden<br />
| President German Society of Nephrology | German STEC-HUS Registry<br />
SAP180<br />
CAMPYLOBACTER INFECTION PRESENTING WITH BLOODY DIARRHEA:<br />
SONOGRAPHIC DIFFERENTIATION FROM EHEC/STEC INFECTION DU-<br />
RING A LARGE OUTBREAK IN GERMANY<br />
Ansgar Reising | Carsten Hafer | Jan Kielstein | Bernhard Schmidt | Franz-<br />
Christoph Bange | Marcus Hiss<br />
Dept Nephrology and Hypertension, Medical School Hannover, Germany | Medical<br />
School Hannover | Dept Microbiology, Medical School Hannover<br />
SAP181<br />
MARKED AND PROLONGED DECREASE IN THE NO PRODUCTION CAPA-<br />
CITY IN PATIENTS WITH STEC-HUS INDICATED BY A LOW L-ARGININE/<br />
ADMA RATIO<br />
Frank Vetter | Jan Beneke | Stefanie M Bode-Böger | Jens Martens-Lobenhoffer|<br />
Mario Schiffer | Bernhard M. W. Schmidt | Herrmann Haller | Jan Menne | Jan<br />
T Kielstein<br />
Dept Nephrology and Hypertension Medical School Hannover, Hannover, Germany<br />
| Inst Clinical Pharmacology, Otto-von-Guericke Univ, Magdeburg, Germany<br />
SAP181bis<br />
OUTCOMES OF ACUTE KIDNEY INJURY PATIENTS WITH AND WITHOUT<br />
CANCER<br />
Ho Sik Shin | Yeon Soon Jung | Hark Rim<br />
Kosin Univ College Medicine, Busan, Korea<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
273<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
274<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
CLINICAL NEPHROLOGY -<br />
EPIDEMIOLOGY II<br />
SAP182<br />
THE BIRMINGHAM VASCULITIS ACTIVITY SCORE (BVAS) PREDICTS ALL<br />
CAUSE MORTALITY IN PATIENTS WITH ANCA ASSOCIATED VASCULITIS<br />
Haris Agnes | Polner Kalman | Aranyi Jozsef | Braunitzer Henrik | Istvan Mucsi<br />
Nephrology Dept, St. Margit Hosp, Budapest, Hungary | McGill Univ Health<br />
Centre, Montreal, Quebec, Canada<br />
SAP183<br />
CLINICAL CHARACTERISTICS OF PRIMARY ANTIPHOSPHOLIPID ANTI-<br />
BODY SYNDROME (APS) WITH CHRONIC KIDNEY DISEASE (CKD)<br />
Kouju Kamata | Takashi Sano | Shokichi Naito | Tomoko Okamoto | Chikako<br />
Okina | Mariko Kamata | Junya Murano | Kei Kobayashi | Mamiko Uchida |<br />
Togo Aoyama | Yasuo Takeuchi | Yasushi Nagaba | Hisato Sakamoto<br />
Kitasato Univ School Medicine | Kitasato Univ, Sagamihara, Japan | Kitasato<br />
Univ Hosp, Kanagawa, Japan<br />
« SAP184<br />
LUNG CONGESTION BY ULTRASOUND PREDICTS DEATH AND CARDIO-<br />
VASCULAR COMPLICATIONS IN HEMODIALYSIS (HD) PATIENTS: A MUL-<br />
TICENTRE COHORT STUDY<br />
Claudia Torino | Vincenzo Panuccio | Anna Clementi | Maurizio Garozzo |<br />
Graziella Bonanno | Rosalia Boito | Giuseppe Natale | Teresa Cicchetti | Antonio<br />
Chippari | Domenico Logozzo | Giovanni Alati | Simonetta Cassani |<br />
Arcangelo Sellaro | Graziella D’Arrigo | Giovanni Tripepi | Aliotta Roberta |<br />
Maurizio Postorino | Francesca Mallamaci | Carmine Zoccali<br />
CNR-IBIM, Reggio Calabria | Lung Comets Cohort (LCC) Working Group |<br />
CNR IBIM and Osp Riuniti, Reggio Calabria<br />
SAP185<br />
CARDIOVASCULAR EVENTS AND INCEPTION OF DIALYSIS IN DIABETIC<br />
AND NON-DIABETIC CKD PATIENTS WITH CORONARY ARTERY CALCIFI-<br />
CATION. FOLLOW-UP STUDY<br />
Elisa Buonanno | Stefania Brancaccio | Vanessa Fimiani | Paola Napolitano |<br />
Rosanna Spadola | Luigi Morrone | Biagio Di Iorio | Domenico Russo<br />
Univ Naples Federico II, Naples, Italy | Osp Rummo, Benevento, Italy | Osp<br />
Landolfi, Solofra, Avellino, Italy<br />
SAP186<br />
EARLY DETECTION OF ATHEROMATOUS DISEASE AT ALL STAGES OF<br />
CHRONIC KIDNEY DISEASE IMPROVES WITH SIMULTANEOUS FEMORAL<br />
AND CAROTID ULTRASOUND<br />
Angels Betriu | Montserrat Martinez-Alonso | Teresa Vidal | Jose Valdivielso|<br />
Elvira Fernandez<br />
IRBLleida, Lleida, Spain | Hosp Arnau Vilanova, Lleida, Spain<br />
SAP187<br />
A PROSPECTIVE STUDY IN VERY ELDERLY (>80 YEARS) PATIENTS WITH<br />
CKD STAGE 4-5 NEWLY REFERRED FOR NEPHROLOGY CARE<br />
Faller Bernadette | Beuscart Jean-Baptiste | Luc Frimat<br />
Serv Néphrologie, Hôp Pasteur | Serv Néphrologie, CHU Lille | Nephrology<br />
Dept, Nancy Univ<br />
SAP188<br />
CKD AND CVD RISK FACTORS IN THE POORLY-RESOURCED NORTHERN<br />
KWAZULU-NATAL, SOUTH AFRICA<br />
N.D. Madale | G.P. Thusi | N. Sibisi | B.G. Mazubuki | A.G.H. Assounga<br />
Univ Kwazulu-Natal, Durban, South Africa<br />
SAP189<br />
DIURETICS TREATMENT AND RELATED SERUM SODIUM IMBALANCE<br />
ARE ASSOCIATED WITH WORSE CLINICAL OUTCOME IN CHRONIC KID-<br />
NEY DISEASE PATIENTS<br />
Ni-Chin Tsai | Hsiao-Han Wang | Yun-Chen Chen | Chi-Chih Hung | Shang-<br />
Jyh Hwang | Hung-Chen Chen<br />
Kaohsiung Medical Univ Hosp<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP190<br />
HEART RATE VARIABILITY IN CKD PATIENTS<br />
Patricia Branco | Teresa Adragao | Rita Birne | Ana Rita Martins | Ricardo Vizinho<br />
| Augusta Gaspar | Maria José Grilo | Jose Diogo Barata | Daniel Bonhorst<br />
| Pedro Adragão<br />
Hosp Santa Cruz, Lisbon, Portugal | Inst Português Ritmo Cardíaco, Oeiras,<br />
Portugal<br />
SAP191<br />
THE E/E' RATIO CAN PREDICT MORTALITY AND CARDIOVASCULAR<br />
EVENTS IN CKD PATIENTS WITH DIASTOLIC DYSFUNCTION<br />
Jae Seok Kim | Min Keun Kim | Seung Ok Choi | Byoung Geun Han<br />
Yonsei Univ Wonju College of Medicine, Wonju, Korea<br />
SAP192<br />
ESTIMATED GLOMERULAR FILTRATION RATE DOES NOT ASSOCIATE<br />
WITH THE CONCENTRATION OF LOW MOLECULAR WEIGHT PROTEINS<br />
IN CHRONIC KIDNEY DISEASE<br />
Neirynck Nathalie | Eloot Sunny | Griet Glorieux | Barreto Daniela | Barreto<br />
Fellype | Liabeuf Sophie | Lemke Horst D | Massy Ziad | Vanholder Raymond<br />
Ghent Univ Hosp, Gent, Belgium | INSERM ERI-12 (EA4292), Amiens, France |<br />
EXcorLab GmbH, Obernburg, Germany | Amiens Univ Hosp, Amiens, France<br />
SAP193<br />
IMPORTANCE OF BLOOD PRESSURE CONTROL IN THE HIGH RISK PO-<br />
PULATION OF CHRONIC KIDNEY DISEASE: FROM THE RESULTS OF THE<br />
KIDNEY EARLY EVALUATION PROGRAM IN JAPAN<br />
Mitsuru Yanai | Kazuyoshi Okada | Kazuhisa Takeuchi | Kosaku Nitta | Susumu<br />
Takahashi<br />
Div General Medicine, Dept Internal Medicine, Nihon Univ School Medicine |<br />
International Kidney Evaluation Association Japan, Tokyo, Japan<br />
SAP194<br />
MOD<strong>ERA</strong>TE AND SEVERE CORONARY CALCIFICATIONS IN NON DIALY-<br />
SIS CHRONIC KIDNEY DISEASE PATIENTS. WHICH BIOMARKERS? FIBRO-<br />
BLAST GROWTH FACTOR-23 AND/OR OSTEOPROTEGERIN?<br />
Marion Morena | Isabelle Jaussent | Aurore Halkovich | Anne-Marie Dupuy |<br />
Anne-Sophie Bargnoux | Leila Chenine | Hélène Leray-Moragues | Kada Klouche<br />
| Hélène Vernhet | Bernard Canaud | Jean-Paul Cristol<br />
IRFD, CHRU, Montpellier, France | INSERM U1061, Montpellier, France |<br />
CHRU, Montpellier, France | Lab Biochimie, CHRU Montpellier | CHRU, Serv<br />
Néphrologie, Hémodialyse et Soins Intensifs, Montpellier, France | CHRU, Serv<br />
Réanimation Métabolique, Montpellier, France | CHRU, Serv Radiologie, Montpellier,<br />
France | Univ Montpellier, Hôp Lapeyronie, Dept Nephrology, Montpellier,<br />
France<br />
SAP195<br />
THE LOW GLOMERULAR FILTRATION RATE IN PATIENTS WITH CHRO-<br />
NIC HEART FAILURE IS ASSOCIATED WITH HIGH INCIDENCE OF ARTE-<br />
RIAL HYPOTENSION<br />
Alexander Shutov | Valery Serov | Julia Kuznetsova | Maxim Menzorov | Diana<br />
Serova<br />
Ulyanovsk State Univ, Ulyanovsk, Russian Federation<br />
SAP196<br />
VASCULAR CALCIFICATION, ARTERIAL STIFFNESS AND HYPERHYDRA-<br />
TION: PREVALENCE, DETERMINANTS AND CORRELATIONS IN NON-<br />
DIALYSED CKD PATIENTS<br />
Ligia Petrescu | Adrian Zugravu | Cristina Capusa | Simona Stancu | Simona<br />
Cinca | Cristina Anghel | Delia Timofte | Lacramioara Medrihan | Dorin Ionescu<br />
| Gabriel Mircescu<br />
Nephrology, Carol Davila Univ Medicine and Pharmacy, Bucharest, Romania|<br />
Dr Carol Davila Teaching Hosp Nephrology, Bucharest, Romania | Dialmed<br />
Dialysis Centers S.R.L., Bucharest, Romania | Univ Emergency Hosp, Bucharest,<br />
Romania<br />
SAP197<br />
SEVERITY OF CORONARY ARTERY DISEASE AND SUBSEQUENT RENAL<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
275<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
276<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
FUNCTION DECLINE IN NON-DIABETIC PATIENTS<br />
Ta-Wei Hsu | Ko-Lin Kuo | Szu-Chun Hung | Der-Cherng Tarng<br />
National Yang-Ming Univ Hosp, Yilan, Taiwan | Div Nephrology, Buddhist<br />
Tzu Chi Hosp Taipei Branch | Div Nephrology, Dept Medicine, Taipei Veterans<br />
General Hosp, and Inst Physiology and Clinical Medicine, National Yang-Ming<br />
Univ, Taipei, Taiwan<br />
SAP198<br />
DECREASED RENAL FUNCTION IS INDEPENDENTLY ASSOCIATED WITH<br />
THE SEVERITY OF CORONARY ARTERY DISEASE IN PATIENTS WITH<br />
CHRONIC KIDNEY DISEASE<br />
Soobong Lee | Ilyoung Kim | Dongwon Lee | Harin Rhee | Sangheon Song |<br />
Eunyoung Seong | Ihmsoo Kwak<br />
Pusan National Univ School Medicine, Busan, Korea<br />
SAP199<br />
RENAL DYSFUNCTION AND RISK OF FIRST HOSPITALIZATION FOR HE-<br />
ART FAILURE FOLLOWING CORONARY ARTERY BYPASS GRAFTING<br />
Martin Holzmann | Carl Gardell | Anders Jeppsson | Ulrik Sartipy<br />
Karolinska Inst | Göteborgs Univ<br />
SAP200<br />
MALNUTRITION, INFLAMMATION, AND ATHEROSCLEROSIS SYNDRO-<br />
ME COMPONENTS PREDICTS POOR CARDIOVASCULAR OUTCOMES IN<br />
PATIENTS WITH STAGE 3-5 CHRONIC KIDNEY DISEASE<br />
Yalcin Solak | Mahmut Ilker Yilmaz | Kayser Caglar | Mutlu Saglam | Halil<br />
Yaman | Alper Sonmez | Hilmi Umut Unal | Mahmut Gok | Abduzhappar Gaipov<br />
| Mehmet Kayrak | Tayfun Eyileten | Suleyman Turk | Abdulgaffar Vural<br />
Konya Univ Meram School Medicine, Konya, Turkey | Gulhane School Medicine,<br />
Ankara, Turkey<br />
SAP201<br />
ECHOCARDIOGRAPHY, RIGHT VENTRICULAR FUNCTION AND CHRO-<br />
NIC KIDNEY DISEASE<br />
Luca Di Lullo | Fulvio Floccari | Rodolfo Rivera | Antonio Granata | Alessandro<br />
D'Amelio | Franco Logias | Giovanni Otranto | Moreno Malaguti | Alberto<br />
Santoboni | Fulvio Fiorini<br />
Dept Nephrology and Dialysis, L. Parodi Delfino Hosp, Colleferro (Roma), Italy|<br />
Dept Nephrology and Dialysis, S. Paolo Hosp, Civitavecchia (Roma), Italy | Dept<br />
Nephrology S. Gerardo Hosp, Monza, Italy | Dept Nephrology and Dialysis, S.<br />
Giovanni di Dio Hosp, Agrigento, Italy | Dept Nephrology, Dialysis and Transpl<br />
Vito Fazzi Hosp, Lecce, Italy | Dept Nephrology and Dialysis Sorgono Hosp,<br />
Sorgono (Nuoro), Italy |Dept Nephrology and Dialysis S. Maria della Misericordia<br />
Hosp, Rovigo, Italy<br />
SAP202<br />
HIGH INCIDENCE OF END-STAGE RENAL DISEASE IN THE TURKISH-<br />
CYPRIOT POPULATION OF NORTHERN CYPRUS: A POPULATION BASED<br />
STUDY<br />
Thomas Connor | Deren Oygar | Dorothea Nitsch | Danniel Gale | Retha Steenkamp<br />
| Guy H. Neild | Patrick Maxwell<br />
Univ College London | Nicosia State Hosp | London School Hygiene and Tropical<br />
Medicine | UK Renal Registry<br />
SAP203<br />
ESTIMATION OF KIDNEY FUNCTION IN CANCER PATIENTS WITH RISK<br />
FACTORS OF CHRONIC KIDNEY DISEASE<br />
Ida Louise Høgsbro | Belén Redal-Baigorri<br />
Roskilde Univ Hosp, Roskilde, Denmark<br />
SAP204<br />
EXISTENCE OF AN INTERNATIONAL NETWORK OF WORKING GROUPS<br />
ON OUTCOMES MEASURES IS ASSOCIATED WITH BETTER REPORTING<br />
AND GREATER HOMOGENEITY IN OUTCOME MEASUREMENT IN RAN-<br />
DOMISED TRIALS: RHEUMATOLOGY VERSUS NEPHROLOGY<br />
Benedicte Sautenet | Jean Michel Halimi | Agnes Caille | Philippe Goupille |<br />
Bruno Giraudeau<br />
Hop Bretonneau, Tours, France | CHU Bretonneau, Tours, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP205<br />
RED CELL DISTRIBUTION WIDTH INDEPENDENTLY PREDICTS CARDIO-<br />
VASCULAR EVENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE<br />
Yalcin Solak | Mahmut Ilker Yilmaz | Kayser Caglar | Mutlu Saglam | Halil<br />
Yaman | Hilmi Umut Unal | Mahmut Gok | Yusuf Oguz | Abduzhappar Gaipov<br />
| Mujdat Yenicesu | Hakki Cetinkaya | Tayfun Eyileten | Suleyman Turk|<br />
Abdulgaffar Vural<br />
Konya Univ Meram School Medicine, Konya, Turkey | Gülhane School Medicine,<br />
Ankara, Turkey<br />
SAP206<br />
SIMILARITY AND DIFFERENCE IN CLINICAL OUTCOMES BETWEEN PA-<br />
TIENTS WITH DIABETIC NEPHROPATHY AND CHRONIC GLOMERULO-<br />
NEPHROPATHY IN A PROPENSITY SCORE MATCHED COHORT OF CHRO-<br />
NIC KIDNEY DISEASE<br />
Yun-Chen Chen | Hsiao-Han Wang | Ni-Chin Tsai | Chi-Chih Hung | Shang-<br />
Jyh Hwang | Hung-Chen Chen<br />
Kaohsiung Medical Univ Hosp<br />
SAP207<br />
OUTCOMES IN HEPATOCELLULAR CARCINOMA AND RENAL FUNCTION<br />
Yu Ishimoto | Takamasa Ohki | Mai Sugahara | Takafumi Kanemitsu | Masafumi<br />
Kobayashi | Lisa Uchida | Nagaaki Kotera | Shinji Tanaka | Tokuichiro<br />
Sugimoto | Naobumi Mise<br />
Mitsui Memorial Hosp, Tokyo, Japan<br />
SAP208<br />
TRADITIONAL THERMAL TH<strong>ERA</strong>PY WITH INDIRECT-MOXIBUSTION RE-<br />
DUCES THE RESISTIVE INDEX OF RENAL SEGMENTAL ARTERIES IN PA-<br />
TIENTS WITH CHRONIC KIDNEY DISEASE<br />
Nagisa Miyazaki | Jun Matsumoto | Ichijiro Murata | Gakuro Yoshida | Kentaro<br />
Morishita | Hiroaki ushikoshi | Kazuhiko Nishigaki | Shinji Ogura | Shinya<br />
Minatoguchi<br />
Dept Cardiology, Respirology & Nephrology, Gifu Univ Grad School Medicine,<br />
Gifu, Japan | Advanced Critical Care Centre, Gifu Univ Hosp, Gifu, Japan<br />
SAP209<br />
PATIENT-CENTERED, COLLABORATIVE, COMMUNITY RENAL CLINIC<br />
Rebecca Harvey | Azhar Ala | Debasish Banerjee<br />
St Georges, Univ London | Lambeth Primary Healthcare Trust | St Georges Healthcare<br />
NHS Trust, London UK<br />
SAP210<br />
CLINICAL DECISION SUPPORT IN PRIMARY CARE LEADS TO REDUCED<br />
LATE REFERRAL FOR RENAL REPLACEMENT TH<strong>ERA</strong>PY<br />
Christopher Farmer | Jean Irving | Helen Hobbs | Toby Wheeler | Bernhard<br />
Klebe | Paul Stevens<br />
East Kent Univ Hosp NHS Found Trust<br />
SAP211<br />
EARLY NEPHROLOGY REFERRAL AND LATE INITIATION OF DIALYSIS<br />
PREDICTS SURVIVAL IN HEMODALYSIS PATIENTS: 5 YEAR FOLLOW-UP<br />
ANALYSIS<br />
Gjulsen Selim | Olivera Stojceva-Taneva | Liljana Tozija | Nikola Stojcev | Saso<br />
Gelev | Pavlina Dzekova-Vidimliski | Svetlana Pavleska | Aleksandar Sikole<br />
Univ Clinic Nephrology, Univ Sts. Cyril and Methodius Skopje, R. Macedonia<br />
SAP212<br />
INCREASE IN RENAL REPLACEMENT TH<strong>ERA</strong>PY INCIDENCE HAS COME<br />
TO AN END IN SWEDEN<br />
Abdul Rashid Qureshi | Marie Evans | Maria Stendahl | Karl Göran Prütz |<br />
Carl Gustaf Elinder<br />
Karolinska Inst | Div Renal Medicine, CLINTEC Karolinska Inst, Stockholm,<br />
Sweden| Dept Internal Medicine, Ryhov Hosp, Jönköping, Sweden | Dept Internal<br />
Medicine, Helsingborg Hosp, Helsingborg, Sweden<br />
SAP213<br />
LEFT VENTRICULAR GEOMETRIC PATTERNS IN THE PROGRESSION OF<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
277<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
278<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
CHRONIC KIDNEY DISEASE<br />
Keiichi Tamagaki | Hiroshi Kado | Mayumi Nakata | Takashi Kitani | Noriyoshi<br />
Ota | Ryo Ishida | Eiko Matsuoka | Yayoi Shiotsu | Mami Ishida | Yasukiyo<br />
Mori<br />
Kyoto, Japan<br />
SAP214<br />
IMPACT OF THE MANAGEMENT OF CKD PATIENTS IN A CARE NETWORK<br />
ON EARLY CARDIOVASCULAR MORBIDITY AND PREMATURE MORTALI-<br />
TY IN INCIDENT DIALYSIS PATIENTS<br />
Maurice Christelle | Nicolas Rognant | Decullier Evelyne | Fave Sophie | Juillard<br />
Laurent | Laville Maurice<br />
Hospices Civils Lyon, Lyon, France | Réseau TIRCEL, Lyon, France | Hôp Edouard<br />
Herriot, Lyon, France<br />
SAP215<br />
CHILDHOOD BODY MASS INDEX TRAJECTORY AND CHRONIC KIDNEY<br />
DISEASE AT AGE 60-4 YEARS<br />
Richard Silverwood | Mary Pierce | Diana Kuh | Caroline Savage | Charles<br />
Ferro | Dorothea Nitsch<br />
London School Hygiene and Tropical Medicine, London, UK | MRC Unit Lifelong<br />
Health and Ageing, Univ College London, London | Univ Birmingham,<br />
Birmingham | Queen Elizabeth Hosp, Birmingham<br />
SAP216<br />
COURSE OF UREMIC SYMPTOMS AND QUALITY OF LIFE DURING PRE-<br />
DIALYSIS CARE<br />
de Goeij Moniek | Halbesma Nynke | Ocak Gurbey | Rotmans Joris | Dekker<br />
Friedo<br />
Leiden Univ Medical Center, Dept Clinical Epidemiology, Leiden, Netherlands |<br />
Leiden Univ Medical Center, Dept Nephrology, Leiden, Netherlands<br />
SAP217<br />
SOCIO-ECONOMIC STATUS AND INCIDENCE OF RENAL REPLACEMENT<br />
TH<strong>ERA</strong>PY IN AUSTRALIA<br />
Philip Clayton | Blair Grace | Alan Cass | Stephen McDonald<br />
Australia and New Zealand Dialysis and Transpl Registry | George Inst Global<br />
Health<br />
SAP218<br />
SERUM PHOSPHATE QUALIFIES AS AN ATHEROSCLEROTIC RISK FAC-<br />
TOR PARTICULARLY IN THE SETTING OF YOUNGER CKD PATIENTS<br />
Victor Lorenzo | Marisa Martin Conde | Angels Betriu | Adriana Dusso | Jose<br />
M Valdivielso | Elvira Fernandez<br />
Hosp Univ La Laguna, Tenerife | IRBLleida, Lleida, Spain | Nefrologia Experimental<br />
IRB Lleida | Hosp Arnau Vilanova, Lleida<br />
SAP219<br />
SHPT PARAMETERS AND TH<strong>ERA</strong>PEUTIC COSTS IN PATIENTS NEW TO<br />
HAEMODIALYSIS: A SUB POPULATION ANALYSIS OF THE FARO2 STUDY<br />
Daniela Paola Roggeri | Giuseppe Cannella | Mario Cozzolino | Sandro Mazzaferro<br />
| PierGiorgio Messa | Diego Brancaccio<br />
Health Economist, Bergamo, Italy | Nefrologia, Osp S Martino, Genova, Italy |<br />
DMCO, UO Nefrologia e Dialisi AO San Paolo, Univ Milano, Italy | Sapienza,<br />
Univ Roma, Italy | Nefrologia, Osp Policlinico, Milano, Italy | UO Emodialisi<br />
Simone Martini, Milano, Italy<br />
SAP220<br />
THE PULMONARY FUNCTION AND PHYSICAL CAPACITY BEHIND THE<br />
KIDNEY: AN EVALUATION OF PATIENTS WITH PRE-DIALYTIC CHRONIC<br />
KIDNEY DISEASE<br />
Ruiter de Souza Faria | Natalia Fernandes | Julio Lovisi | Murilo Moura Marta |<br />
Maycon Reboredo | Bruno do Vale Pinheiro | Marcus Bastos<br />
Interdisciplinary Program Studies, Res, and Treatment in Nephrology, Federal<br />
Univ Juiz de Fora, Juiz de Fora – MG, Brazil<br />
SAP221<br />
PRECAPILLARY PULMONARY HYPERTENSION IN PATIENTS WITH<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
CHRONIC KIDNEY DISEASE ON DIALYSIS AND WITHOUT DIALYSIS: RE-<br />
SULTS OF THE PEPPER-STUDY<br />
Felix Hundt | Stefan Pabst | Christoph Hammerstingl | Thomas Gerhardt |<br />
Dirk Skowasch | Rainer Woitas<br />
Univ Hosp Bonn, Clinic Internal Medicine I, Bonn | Univ Hosp Bonn, Clinic for<br />
Internal Medicine II, Bonn | Praxis für Nieren und Hochdruckkrankheiten, Bonn,<br />
Germany<br />
SAP222<br />
ASSOCIATIONS OF HANDGRIP STRENGTH WITH MORTALITY RISK AND<br />
HEALTH-RELATED QUALITY OF LIFE IN MAINTENANCE HAEMODIALY-<br />
SIS PATIENTS: A 6-YEAR COHORT STUDY<br />
Antonio Alberto Lopes | Luciana Ferreira Silva | Cácia Mendes Matos | Márcia<br />
Silva Martins | Fernanda Albuquerque Silva | Gildete Barreto Lopes<br />
Fac Medicina Bahia, Univ Federal Bahia, Salvador, Brazil | Univ Estado Bahia,<br />
Salvador, Brazil | Inst Nefrologia e Diálise, Salvador, Brazil | Clinica Rim e Hipertensão,<br />
Salvador, Brazil | Clínica NEPHRON, Salvador, Brazil | Federal Univ<br />
Bahia, Salvador, Brazil<br />
SAP223<br />
EFFECT MODIFICATION BY ARGININE OF ADMA-RELATED LONG-TERM<br />
CLINICAL OUTCOMES IN AN ELDERLY GEN<strong>ERA</strong>L POPULATION<br />
Francesco Pizzarelli | Pietro Dattolo | Giovanni Tripepi | Stefano Michelassi |<br />
Cristina Rossi | Stefania Bandinelli | Maren Mieth | Renke Mass | Luigi Ferrucci|<br />
Carmine Zoccali<br />
S M Annunziata Hosp, Florence, Italy | CNR-IBIM and Nephrology-Transpl<br />
Unit, Osp Riuniti, Reggio Calabria, Italy | Geriatric Unit and InCHIANTI Study,<br />
Florence, Italy | Clinical Pharmacology, Univ Erlangen-Nuremberg, Nuremberg,<br />
Germany | National Inst Aging, Baltimore, USA<br />
SAP224<br />
MULTIPLE GESTATION IN CKD PATIENTS: AN EXPLOSIVE MIX<br />
Silvia Parisi | Silvana Arduino | Rossella Attini | Federica Fassio | Marilisa Biolcati<br />
| Arianna Pagano | Carlotta Bossotti | Martina Ferraresi | Piero Gaglioti|<br />
Tullia Todros | Giorgina Barbara Piccoli<br />
Materno-Foetal Unit, Dept Obstetrics, ASOU OIRM S Anna, Univ Torino, Italy |<br />
SS Nefrologia Dept Clinical and Biological Sciences, ASOU San Luigi Gonzaga,<br />
Univ Torino, Italy<br />
SAP225<br />
DISCORDANCES IN THE CLASSIFICATION OF RENAL IMPAIRMENT IN<br />
SUMMARIES OF PRODUCT CHARACTERISTICS<br />
Teresa M. Salgado | Blanca Arguello | Shalom I. Benrimoj | Fernando Fernandez-Llimos<br />
Res Inst Medicines and Pharmaceutical Sciences (iMed.UL), Fac Pharmacy, Univ<br />
Lisbon, Lisbon, Portugal | Grad School Pharmacy, Univ Technology Sydney,<br />
Sydney, Australia | Res Inst Medicines and Pharmaceutical Sciences (iMed.UL),<br />
Dept Social Pharmacy, Fac Pharmacy, Univ Lisbon, Portugal<br />
SAP226<br />
COMPARING METHODS OF ESTIMATING RENAL FUNCTION IN AN IN-<br />
DIAN POPULATION: ASSOCIATION WITH DXA MEASURED MUSCLE MASS<br />
Pippa Bailey | Charlie Tomson | Yoav Ben-Shlomo<br />
Southmead Hosp, Bristol, UK | School Social and Community Medicine, Bristol<br />
Univ, UK<br />
SAP227<br />
THE CLASSIFICATION TREE METHODOLOGY: A NEW WAY TO ESTIMATE<br />
THE RISK AND THE PREDICTORS OF PROGRESSION OF CHRONIC KID-<br />
NEY DISEASE<br />
Antonio Santoro | Paola Rucci | Marcora Mandreoli | Francesco Caruso | Mattia<br />
Corradini | Marta Flachi | Dino Gibertoni | Angelo Rigotti | Giorgia Russo|<br />
Mariapia Fantini<br />
Malpighi Hosp, Bologna, Italy | Dept Medicine and Public Health, Univ Bologna|<br />
Unità Operativa Nefrologia, Dialisi e Ipertensione, Azienda S.Orsola - Malpighi,<br />
Bologna, Italy | Osp Ramazzini, Carpi- Italy | Nephrology and Dialysis<br />
Unit Arcisp Santa Maria Nuova, Reggio Emilia , Italy | Dept Nephrology and<br />
Dialysis, Osp Bufalini; Cesena | Osp Infermi, Rimini-Italy | Arcisp S. Anna, Ferrara<br />
-Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
279<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
280<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP228<br />
SCREENING FOR DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE<br />
(CKD) AMONG HIGH RISK CENTRAL GOVERNMENT EMPLOYEES IN DEL-<br />
HI, INDIA: A WHO SPONSORED PILOT STUDY<br />
Himansu Sekhar Mahapatra | Shamsunder Choudhury | Gurdeep Buxi | Neera<br />
Sharma | Yadunanda Gupta | Venkentsan Sekhar<br />
PGIMER, Dr. RML Hosp New Delhi, India | ICFAI Business School, Gurgaon,<br />
Hariyana, India<br />
SAP229<br />
DEVELOPMENT OF A QUESTIONNAIRE TO CLASSIFY POPULATION IN TO<br />
HIGH RISK (HR) AND NO RISK (NR) GROUPS FOR CHRONIC KIDNEY DI-<br />
SEASE (CKD) SCREENING AMONG CENTRAL GOVERNMENT EMPLOYEES<br />
IN DELHI, INDIA<br />
Himansu Sekhar Mahapatra | Shamsunder Choudhury | Gurdeep Buxi | Neera<br />
Sharma | Yadunanda Gupta | Venkentsan Sekhar<br />
PGIMER, Dr. RML Hosp New Delhi, India | ICFAI Business School, Gurgaon,<br />
Hariyana, India<br />
SAP230<br />
RISK CATEGORY SYSTEM COMBINED GLOMERULAR FUNCTION WITH<br />
ALBUMINURIA HAS BETTER ABILITY TO PREDICT ADVERSE OUTCOMES<br />
IN HIV-INFECTED MEN<br />
Naoki Yanagisawa | Minoru Ando | Atsushi Ajisawa | Ken Tsuchiya | Kosaku<br />
Nitta<br />
Dept Infectious Diseases and Nephrology, Tokyo Metropolitan Komagome<br />
Hosp, Tokyo, Japan | Dept IV Internal Medicine, Tokyo Women's Medical Univ,<br />
Tokyo, Japan<br />
SAP231<br />
PSYCHOLOGICAL ASPECTS OF THE QUALITY OF LIFE (QoL)IN DIALYSED<br />
PATIENTS. PART II: CORRELATION BETWEEN THE QoL AND THE PERSO-<br />
NALITY TYPE OF DIALYSED PERSONS<br />
Ostrowski Janusz | Majkowicz Mikołaj | Manitius Jacek | Rutkowski Bolesław<br />
Dept Nephrology, Wloclawek, Poland | Dept Psychiatric Diseases and Neurotic<br />
Disorders, Medical Univ, Gdańsk, Poland | Dept Nephrology and Internal Medicine,<br />
Medical Univ, Bydgoszcz, Poland | Dept Nephrology, Transpl and Internal<br />
Medicine, Medical Univ, Gdańsk, Poland<br />
« SAP232<br />
GEOGRAPHIC DISTRIBUTION OF SERVS MAY BE A BARRIER TO HOME<br />
DIALYSIS IN THE USA<br />
Suma Prakash | Rick Coffin | Jesse Schold | Douglas Einstadter | Susan Stark |<br />
Darlene Rodgers | Matthew Howard | Ashwini Sehgal<br />
Case Western Reserve Univ, Cleveland Ohio, USA | Renal Netowrk, Indianapolis,<br />
USA | Cleveland Clinic Foundation | MetroHealth Medical Center | The<br />
Intermountain ESRD Network<br />
SAP233<br />
IDENTIFICATION OF CHRONIC KIDNEY DISEASE IN PRIMARY CARE AND<br />
THE INFLUENCE OF COMPUTERISED CLINICAL DECISION SUPPORT<br />
Paul Stevens | Jean Irving | Toby Wheeler | Bernhard Klebe | Christopher Farmer<br />
East Kent Univ Hosp NHS Found Trust<br />
SAP234<br />
SYSTEMATIC REVIEW: HOME VERSUS IN-CENTER HEMODIALYSIS FOR<br />
PEOPLE WITH END-STAGE KIDNEY DISEASE<br />
Suetonia Palmer | Allison Tong | Braden Manns | Jonathan Craig | Marinella<br />
Ruospo | Letizia Gargano | Giovanni Strippoli<br />
Univ Otago Christchurch, New Zealand | Univ Sydney | Univ Calgary, Calgary,<br />
Alberta | Diaverum Medical Scientific Office | Cochrane Renal Group, Sydney,<br />
Australia<br />
SAP235<br />
ORAL DISEASE IN PEOPLE WITH CHRONIC KIDNEY DISEASE: META-<br />
ANALYSIS OF PREVALENCE AND ASSOCIATION WITH CLINICAL OUT-<br />
COMES<br />
Marinella Ruospo | Suetonia Palmer | Mariacristina Vecchio | Letizia Gargano|<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Massimo Petruzzi | M De Benedictis | Fabio Pellegrini | Giovanni Strippoli<br />
Diaverum Medical Scientific Office | Univ Otago Christchurch, New Zealand|<br />
Consorzio Mario Negri Sud, Italy | Univ Bari, Italy | Cochrane Renal Group,<br />
Sydney, Australia<br />
SAP236<br />
PREVALENCE OF AND FACTORS ASSOCIATED WITH CHRONIC KIDNEY<br />
DISEASE IN JAPANESE SUBJECTS, WHO HAVE NO KNOWN CHRONIC DI-<br />
SEASE, UNDERGOING AN ANNUAL HEALTH CHECKUP<br />
Yoshiteru Ohno | Eiji Ishimura | Toshihide Naganuma | Kyoko Kondo | Wakaba<br />
Fukushima | Kayo Mui | Masaaki Inaba | Yoshio Hirota<br />
Osaka City Univ Grad School Medicine<br />
SAP237<br />
AGE-RELATED CHANGES IN KIDNEY FUNCTION, ITS INFLUENCING<br />
FACTORS, AND ASSOCIATION WITH ASYMPTOMATIC CAROTID ATHE-<br />
ROSCLEROSIS IN HEALTHY INDIVIDUALS. A 5-YEAR FOLLOW-UP STUDY<br />
Xuefeng Sun | Shimin Jiang | Hongxia Gu | Yunshuang Chen | Chunsheng Xi|<br />
Xi Qiao | Xiangmei Chen<br />
Dept Nephrology, Chinese PLA General Hosp, State Key Lab Kidney Disease,<br />
Beijing, China<br />
SAP238<br />
DETECTING RISK FACTORS FOR KIDNEY DISEASE IN THE GEN<strong>ERA</strong>L PO-<br />
PULATION – EXPERIENCE OF NEPHROLOGY CAMPAIGNS IN A LARGE<br />
URBAN CENTER IN BRAZIL<br />
Elizabeth Daher | Geraldo Silva Junior | Camilla N. Jacinto | Rodrigo S. Pimentel<br />
| Graziela B.R. Aguiar | Caroline B. Lima | Renata C. Borges | Livia P.C.<br />
Mota | João Victor L. Melo | Saulo A. Melo | Vanessa T. Canamary | Marilia<br />
Alves | Sônia M.H.A. Araújo<br />
School Medicine, Federal Univ Ceara, Fortaleza, Brazil | School Medicine, Univ<br />
Fortaleza, Fortaleza, Brazil<br />
SAP239<br />
WHY ELDER CHRONIC KIDNEY DISEASE PATIENTS HAVE LESS DIALYSIS<br />
THAN DEATH, BESIDES THE EFFECT OF COMPETING RISK OF DEATH?<br />
Yun-Chen Chen | Yen Kai Huang | Ni-Chin Tsai | Hsiao-Han Wang | Chi-Chih<br />
Hung | Shang-Jyh Hwang | Hung-Chen Chen<br />
Kaohsiung Medical Univ Hosp, Kaohsiung City, Taiwan<br />
SAP240<br />
CD14++CD16+ MONOCYTES ARE PREDICTORS OF CARDIOVASCULAR<br />
OUTCOME<br />
Kyrill Rogacev | Bodo Cremers | Adam Zawada | Sarah Seiler | Nadine Binder|<br />
Philipp Ege | Gunnar Große-Dunker | Isabel Heisel | Florian Hornof |<br />
Jana Jeken | Niko Rebling | Christof Ulrich | Bruno Scheller | Michael Böhm |<br />
Danilo Fliser | Gunnar Henrik Heine<br />
Dept Internal Medicine IV, Dept Internal Medicine III, Saarland Univ Medical<br />
Center | Inst Medical Biometry and Medical Informatics, Univ Medical Center,<br />
Freiburg<br />
SAP241<br />
INTERNATIONAL VARIATION IN INFLUENZA VACCINATION PRACTI-<br />
CES AND COV<strong>ERA</strong>GE RATES AMONG HEMODIALYSIS PATIENTS: AN OP-<br />
PORTUNITY TO IMPROVE CARE<br />
BM Robinson | Mia Wang | Brian Bieber | Richard Fluck | Peter G. Kerr | Björn<br />
Wikström | Mahesh Krishnan | Allen Nissenson | Ronald L. Pisoni<br />
Arbor Res Collaborative for Health, Ann Arbor, Michigan, USA | Derby City General<br />
Hosp, UK | Monash Univ, Australia | Akademiska Hosp,Uppsala, Sweden<br />
| DaVita, Washington, USA | DaVita, El Segundo, USA<br />
SAP242<br />
BELIEFS ABOUT MEDICINES IN DIALYSIS PATIENTS DIFFER FROM THE<br />
GEN<strong>ERA</strong>L POPULATION<br />
Solveig Mykleset | Tone Brit Østhus | Bård Waldum | Ingrid Os<br />
Oslo Univ Hosp Ullevål, Oslo<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
281<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
282<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP243<br />
IMPROVEMENT IN KIDNEY FUNCTION AFTER CARDIAC RESYNCHRONI-<br />
ZATION TH<strong>ERA</strong>PY<br />
Jesmar Buttigieg | Andrew Cassar | Joseph Farrugia Agius<br />
Mater Dei Hosp Nephrology Dept Malta | Mater Dei Hosp Cardiology Dept<br />
Malta<br />
SAP244<br />
IDENTIFICATION OF PATIENTS WITH GLOMERULAR HYPERFILTRATION<br />
Belén Redal-Baigorri<br />
Roskilde Univ Hosp, Roskilde, Denmark<br />
SAP245<br />
PRESENCE OF PROTEINURIA HAS A SIGNIFICANT IMPACT ON SHORT-<br />
TERM MORTALITY OF PATIENTS WITH NON-HODGKIN LYMPHOMA<br />
Masaki Hara | Minoru Ando | Ken Tsuchiya | Kosaku Nitta<br />
Tokyo Metropolitan Komagome Hosp, Tokyo, Japan | Tokyo Women's Medical<br />
Univ, Tokyo, Japan<br />
SAP246<br />
A PILOT STUDY OF ANTI-BETA1-ADRENERGIC RECEPTOR ANTIBODIES<br />
IN CKD PATIENTS<br />
Masaya Yamato | Keiko Yasuda | Koichi Sasaki<br />
Rinku General Medical Center<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
CLINICAL STUDIES IN CKD 1-5<br />
SAP247<br />
PLASMA ADIPONECTIN CONCENTRATION AND ESTIMATED GLOMERU-<br />
LAR FILTRATION RATE (eGFR) IN ELDERLY SUBJECTS. THE POLISH POPU-<br />
LATION STUDY - POLSENIOR<br />
Magdalena Szotowska | Jerzy Chudek | Andrzej Więcek | Marcin Adamczak<br />
Nephrology, Endocrinology and Metabolic Clinic, Medical Univ Silesia | Dept<br />
Patophisiology, Dept Nephrology, Endocrinology and Metabolic Diseases, Medical<br />
Univ Silesia, Katowice, Poland<br />
SAP248<br />
TIME OF RECOVERY AFTER HEMODIALYSIS IS RELATED TO THE NUMBER<br />
OF FATIGUE QUALITIES<br />
Maurizio Bossola | Enrico Di Stasio | Manuela Antocicco | Patrizia Silvestri |<br />
Luigi Tazza<br />
Catholic Univ<br />
SAP249<br />
LATENT TUBERCULOSIS INFECTION IN END STAGE RENAL DISEASE PA-<br />
TIENTS ON DIALYSIS IN POPULATION WITH MOD<strong>ERA</strong>TE PREVALENCE<br />
RATE OF TUBERCULOSIS<br />
Anna Steć | Maria Kozioł-Montewka | Andrzej Książek<br />
Nephrology Dept, Medical Univ Lublin, Poland | Dept Medical Microbiology,<br />
Medical Univ Lublin, Poland<br />
SAP250<br />
OBSERVATIONAL DATA TO STUDY SODIUM BICARBONATE IN CKD: THE<br />
FEASIBILITY OF MARGINAL STRUCTURAL MODELLING<br />
Kate Birnie | Fergus Caskey | Aisha Iqbal Geeson<br />
Bristol Univ, Bristol, UK | NHS North Bristol Trust, Bristol, UK<br />
SAP251<br />
CLINICAL DOSE SELECTION OF THE C5A RECEPTOR ANTAGONIST<br />
CCX168 FOR THE PHASE 2 ANCA-ASSOCIATED RENAL VASCULITIS CLI-<br />
NICAL TRIAL (THE CLEAR TRIAL)<br />
Daniel Dairaghi | Daniel Johnson | Manmohan Leleti | Shichang Miao | Hong<br />
Xiao | J. Charles Jennette | Jay P. Powers | Lisa Seitz | Yu Wang | Juan C. Jaen|<br />
Thomas J. Schall | Pirow Bekker<br />
ChemoCentryx, Mountain View, CA, USA | Univ North Carolina, Chapel Hill,<br />
NC, USA<br />
SAP252<br />
SEQUENTIAL CLINICAL AND PATHOLOGICAL EVALUATION OF IGG4-<br />
RELATED RENAL DISEASE PATIENTS<br />
Haruna Arai | Hiroki Hayashi | Kazuhiro Sugiyama | Kouichirou Yamamoto|<br />
Shigehisa Koide | Kazutaka Murakami | Makoto Tomita | Midori Hasegawa |<br />
Yukio Yuzawa<br />
Dept Nephrology, Fujita Health Univ School of Medicine, Aichi<br />
SAP253<br />
COGNITIVE DYSFUNCTION IN CKD AND HYPERTENSIVE PATIENTS WI-<br />
THOUT CLINICAL DEMENTIA. PREVALENCE AND ASSOCIATED FAC-<br />
TORS<br />
Despina Karasavvidou | Rigas Kalaitzidis | George Spanos | Kosmas Pappas |<br />
Athina Tatsioni | Kostas Siamopoulos<br />
Dept Nephrology, Univ Hosp Ioannina<br />
SAP254<br />
SIGNIFICANCE OF MAST CELL RENAL INFILTRATION IN PATIENTS WITH<br />
ANTI-GLOMERULAR BASEMENT MEMBRANE NEPHRITIS<br />
Yi-Yan Zhang | Zheng Tang | Dong-Mei Chen | Ming-Chao Zhang | Zhi-Hong<br />
Liu<br />
Res Inst Nephrology, Jinling Hosp, Nanjing Univ School of Medicine<br />
SAP255<br />
THE CLINICAL SIGNIFICANCE OF MORPHOGENETIC PROTEIN-FGF-23<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
283<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
284<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
AND KLOTHO SERUM DETERMINING IN CKD PATIENTS<br />
Yuriy Milovanov | Ludmila Milovanova | Lidia Kozlovskaya<br />
I.M. Sechenov First Moscow State Medical Univ, Ministry Health and Social Development<br />
Russia<br />
SAP256<br />
EXPOSURE-RESPONSE ANALYSES OF BARDOXOLONE METHYL SAFETY<br />
AND EFFICACY AND CLINICAL TRIAL SIMULATIONS TO INFORM PHASE<br />
III DOSE SELECTION<br />
Cheri Klein | Peter Noertersheuser | Sven Mensing | Nathan Teuscher | Colin<br />
Meyer | Emily Dumas | Walid Awni<br />
Abbott Laboratories | Abbott GmBH & Co | Reata Pharmaceuticals<br />
SAP257<br />
VITAMIN D3 SUPPLEMENTATION DOES NOT AFFECT SERUM LIPIDS IN<br />
NON-DIABETIC PATIENTS WITH MOD<strong>ERA</strong>TE IMPAIRMENT OF RENAL<br />
FUNCTION<br />
Hamid Dezfoolian | Ola Samuelsson | Maria Svensson<br />
Dept Nephrology, Sahlgrenska Academy, Gothenburg Univ, Gothenburg, Sweden<br />
| Dept Kidney Diseases, Sahlgrenska Univ Hosp, Gothenburg, Sweden |<br />
Dept Nephrology, Sahlgrenska Univ Hosp, Gothenburg, Sweden<br />
SAP258<br />
PITAVASTATIN AMELIORATES RENAL FUNCTION IN PATIENTS WITH<br />
CKD (P-STAR-CKD)<br />
Yoshinari Yasuda | Sawako Kato | Naotake Tsuboi | Waichi Sato | Shoichi Maruyama<br />
| Enyu Imai | Yukio Yuzawa | Seiichi Matsuo<br />
Nagoya Univ Grad School Medicine, Nagoya, Japan | Fujita Health Univ, Toyoake,<br />
Japan<br />
SAP259<br />
PREVALENCE AND DETERMINANTS OF HYPERKALEMIA IN PRE-DIALY-<br />
SIS PATIENTS FOLLOWED IN A LOW-CLEARANCE CLINIC ENVIRON-<br />
MENT<br />
Pantelis Sarafidis | Rochelle Blacklock | Eleri Wood | Adam Rumjon | Shanique<br />
immonds | Jessica Fletcher-Rogers | Rob Elias | Beatriz Tucker | Dawn Baynes|<br />
Claire Sharpe | Katie Vinen<br />
Academic Dept Renal Medicine, King’s College Hosp<br />
SAP260<br />
BARDOXOLONE METHYL IMPROVES MARKERS OF RENAL FUNCTION IN<br />
PATIENTS WITH STAGE 4 CKD AND TYPE 2 DIABETES<br />
Sudarshan Hebbar | Angie Goldsberry, MS | Melanie Chin | Colin Meyer |<br />
Paul Audhya<br />
Reata Pharmaceuticals, Irving TX, USA<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
NUTRITION, INFLAMMATION<br />
AND OXIDATIVE STRESS - CKD 1-5<br />
SAP261<br />
OXIDATIVE STRESS AND SYSTEMIC INFLAMMATION AS IMPORTANT<br />
COMPONENTS OF CARDIAC VALVE CALCIFICATION IN PREDIALYSIS<br />
PATIENTS<br />
Oleksandr Susla<br />
Ternopil Univ Hosp, Ternopil, Ukraine<br />
SAP262<br />
GERIATRIC NUTRITIONAL RISK INDEX MAY BE A SIGNIFICANT PREDIC-<br />
TOR OF MORTALITY IN KOREAN HEMODIALYSIS PATIENTS: A SINGLE<br />
CENTER STUDY<br />
Ho Sik Shin | Yeon Soon Jung | Hark Rim<br />
Kosin Univ College Medicine<br />
SAP263<br />
CARBAMYLATED LOW DENSITY LIPOPROTEIN (LDL) INDUCES ENDO-<br />
THELIAL DYSFUNCTION<br />
Timo Speer | Frederick O. Owala | Marjan Razawi | Eric Holy | Bahlmann Ferdinand<br />
| Fliser Danilo | Thomas F. Lüscher | Felix C. Tanner<br />
Univ Hosp Zurich, Cardiovascular Center, Zurich, Switzerland | Saarland Univ<br />
Hosp, Dept Internal Medicine IV, Homburg/Saar, Germany<br />
SAP264<br />
THE ROLE OF LEPTIN IN NUTRITIONAL STATUS AND SURVIVAL IN<br />
CHRONIC KIDNEY DISEASE (CKD) PATIENTS<br />
Anastasia Markaki | Ioannis Petrakis | Vasiliki Mavroeidi | Kostas Perakis |<br />
George A Fragkiadakis | Maria Venyhaki | Michael Tzanakakis | Eleftheria Vardaki<br />
| Kyriaki Maraki | Theodoros Doskas | Eugene Daphnis<br />
Dept Nutrition and Dietetics, Technological Educational Inst Crete, Crete, Greece<br />
| Dept Nephrology, Univ Hosp Heraklion, Heraklion, Crete, Greece | Dept<br />
Clinical Chemistry, School Medicine, Univ Crete, Greece | Dept Nephrology,<br />
General Hosp Chios, Chios, Greece<br />
SAP265<br />
CENTRAL ADIPOSITY AND INFLAMMATION IN CHRONIC KIDNEY DISE-<br />
ASE PATIENTS<br />
Rachel Bregman | Barbara Vale | Carla Lemos | Laura Kawakami | Maria Ines<br />
Silva<br />
State Univ Rio de Janeiro<br />
SAP266<br />
ESTIMATION OF TOTAL ADIPOSE TISSUE IN HEMODIALYSIS PATIENTS<br />
USING BIOIMPEDANCE TECHNIQUES<br />
Fansan Zhu | George Kaysen | Peter Kotanko | Samer R. Abbas | Yanna Dou |<br />
Steven Heymsfield | Nathan W Levin<br />
Renal Res Inst, New York USA | Univ California Davis, Davis CA USA | Renal<br />
Res Inst; Beth Israel Medical Cener, New York, USA | St. Lukes Hosp, New York,<br />
USA<br />
SAP267<br />
PERI-AORTIC FAT TISSUE AND MALNUTRITION-INFLAMMATION-ATHE-<br />
ROSCLEROSIS/CALCIFICATION SYNDROME IN END-STAGE RENAL DISE-<br />
ASE PATIENTS<br />
Kultigin Turkmen | Hatice Kayikcioglu | Ibrahim Guney | Lutfullah Altintepe|<br />
Orhan Ozbek | Halil Zeki Tonbul<br />
Konya Univ, Meram School Medicine, Konya, Turkey | Konya Univ, Konya, Turkey<br />
| Meram Training and Reseach Hosp<br />
SAP268<br />
HIGH DENSITY LIPOPROTEIN VARIABILITY AND LOW TRIGLYCERIDE LE-<br />
VELS PREDICT MORTALITY IN INCIDENT HEMODIALYSIS PATIENTS BY<br />
VIRTUE OF THEIR ASSOCIATION WITH INFLAMMATION<br />
George A Kaysen | Len A Usvyat | Stephan Thijssen | Nathan W Levin | Peter<br />
Kotanko<br />
Dept Medicine Div Nephrology UC Davis | Renal Res Inst, New York, USA<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
285<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
286<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP269<br />
SERUM FETUIN-A IS ASSOCIATED WITH THE COMPONENTS OF MIAC<br />
(MALNUTRITION, INFLAMMATION, ATHEROSCLEROSIS, CALCIFICA-<br />
TION) SYNDROME IN DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE<br />
Ruya Mutluay | Ceyla Konca Degertekin | Ülver Derici | Mahmut Ilker Yılmaz|<br />
Ferda Akkıyal | Serap Gültekin | Sevim Gönen | Serpil Müge Değer | Turgay<br />
Arınsoy | Şükrü Sindel<br />
Gazi Univ Fac Medicine, Dept Nephrology, Ankara, Turkey | Gazi Univ Fac Medicine,<br />
Dept Endocrinology, Ankara, Turkey | Dept Radiology, Gazi Univ Fac<br />
Medicine, Ankara, Turkey<br />
SAP270<br />
ACTIVATION OF NUCLEAR FACTOR-K B IN THE AORTA OF PATIENTS<br />
IS ASSOCIATED WITH THE SEVERITY OF ATHEROSCLEROSIS BUT NOT<br />
WITH CHRONIC KIDNEY DISEASE<br />
Miguel Hueso | Joan Torras | Marta Carrera | August Vidal | Estanis Navarro |<br />
Israel Rivas | Ines Rama | Nuria Bolaños | Cristian Varela | Alberto Martinez-<br />
Castelao | Josep M. Grinyo<br />
Hosp Bellvitge-IDIBELL | Lab Oncologia Molecular-IDIBELL<br />
SAP271<br />
THE EFFECT OF N-3 POLYUNSATURATED FATTY ACIDS ON ADIPONEC-<br />
TIN LEVELS IN PATIENTS WITH END STAGE RENAL DISEASE<br />
Frederik Harving | My Svensson | Erik Berg Schmidt | Kaj Anker Jørgensen |<br />
Jeppe Hagstrup Christensen<br />
Dept Nephrology Aalborg Hosp, Aalborg, Denmark | Dept Cardiology, Center<br />
Cardiovascular Res, Aalborg Hosp, Aalborg, Denmark | Dept Renal Medicine C,<br />
Skejby Hosp, Aarhus Univ Hosp, Aarhus, Denmark<br />
SAP272<br />
PROCALCITONIN IS NOT SUPERIOR TO C-REACTIVE PROTEIN AS A MAR-<br />
KER OF INFECTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE<br />
Ji Hyeon Park | Eun Hee Koo | Hyun Kyung Kim | Min Su Kim | A Jin Cho |<br />
Jung Eun Lee | Hye Ryoun Jang | Wooseong Huh | Dae Joong Kim | Yoon-Goo<br />
Kim | Ha Young Oh<br />
Samsung Medical Center, Seoul, Korea<br />
SAP273<br />
EFFECT OF ORAL FRUCTOSE LOAD ON SERUM URIC ACID, LIPIDS AND<br />
BLOOD PRESSURE IN RENAL TRANSPL RECIPIENTS AND NON-TRAN-<br />
SPLED CHRONIC KIDNEY DISEASE PATIENTS<br />
Anna Zawiasa | Dariusz Nowak | Michał Nowicki<br />
Dept Nephrology, Hypertension and Kidney Transpl, Medical Univ Łódź |<br />
Chair Clinical and Experimental Physiology, Medical Univ Łódź, Poland<br />
SAP274<br />
DO CYTOKINES AT CURRENTLY OBSERVED CONCENTRATIONS IN<br />
CHRONIC KIDNEY DISEASE INDUCE LEUKOCYTE ACTIVITY?<br />
Neirynck Nathalie | Glorieux Griet | Schepers Eva | Vanholder Raymond<br />
Ghent Univ Hosp, Gent, Belgium<br />
SAP275<br />
USE OF ALLOPURINOL IS ASSOCIATED WITH REDUCED ARTERIAL STIFF-<br />
NESS IN PROGRESSIVE CHRONIC KIDNEY DISEASE (CKD)<br />
Khai Ping Ng | Stephanie Stringer | Mark Jesky | Mary Dutton | Charles Ferro|<br />
Paul Cockwell<br />
Univ Hosp Birmingham, Birmingham, UK | Univ Bimingham, UK | Queen Elizabeth<br />
Hosp Birmingham, UK<br />
SAP276<br />
INSULIN GROWTH FACTOR-1 (IGF-1) AS A PREDICTOR OF NUTRITIONAL<br />
STATUS AND MORTALITY IN CHRONIC KIDNEY DISEASE (CKD) STAGE<br />
5 PATIENTS<br />
Ting Jia | Thiane Gama Axelsson | Bengt Lindholm | Olof Heimburger | Peter<br />
Barany | Peter Stenvinkel | Abdul Rashid Qureshi<br />
Div Renal Medicine and Baxter Novum, Dept Clinical Science, Intervention and<br />
Technology, Karolinska Inst, Stockholm,Sweden | Baxter Novum and Renal Medicine,<br />
Karolinska Inst | Karolinska Inst<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP277<br />
INFLUENCE OF INTRA-INDIVIDUAL INTERLEUKIN-6 VARIATIONS ON<br />
THE CARDIOVASCULAR PROGNOSIS OF PATIENTS WITH CHRONIC RE-<br />
NAL DISEASE (NOT ON DIALYSIS)<br />
Borja Quiroga | Marian Goicoechea | Soledad García de Vinuesa | Úrsula Verdalles<br />
| Javier Reque | Nayara Panizo | David Arroyo | Alba Santos | Nicolás<br />
Macías | José Luño<br />
Hosp Gregorio Marañón<br />
SAP278<br />
OXIDIZED HIGH-DENSITY LIPOPROTEIN AND ITS SUBFRACTION ARE IN-<br />
CREASED ACCORDING TO CKD STAGE SEVERITY<br />
Hirokazu Honda | Tsutomu Hirano | Masashi Ueda | Shiho Kojima | Shinichi<br />
Mashiba | Yasuyuki Hayase | Tetsuo Michihata | Tadao Akizawa<br />
Div Nephrology, Diabetes, Metabolism, and Endocrinology, Dept Medicine, Showa<br />
Univ School Medicine, Tokyo, Japan | Ikagaku Co. Ltd., Kyoto, Japan | Ebara<br />
Clinic, Tokyo, Japan<br />
SAP279<br />
INCREASED ARTERIAL STIFFNESS IN NEPHROTIC SYNDROME PATIENTS<br />
Ozkan Gungor | Meltem Sezis Demirci | Fatih Kircelli | Erhan Tatar | Ender<br />
Hur | Sait Sen | Huseyin Toz | Ali Basci | Ercan Ok<br />
Ege Univ School of Medicine, Div Nephrology | Ege Univ School Medicine, Div<br />
Pathology<br />
SAP280<br />
PBMC MICRO RNA-155 IS UP-REGULATED IN CHRONIC HEMODIALYSIS<br />
PATIENTS<br />
Vincenzo Sepe | Paolo Albrizio | Massimiliano Gnecchi | Elisabetta Cervio |<br />
Pasquale Esposito | Teresa Rampino | Carmelo Libetta | Antonio Dal Canton<br />
Fond IRCCS Policlinico San Matteo, Pavia, Italy | Univ Pavia<br />
SAP281<br />
OXIDIZED-LDL AND LIPOPROTEIN (A) LEVELS IN CHRONIC KIDNEY DI-<br />
SEASE PATIENTS UNDER HEMODIALYSIS: INFLUENCE OF ADIPONECTIN<br />
AND OF A POLYMORPHISM IN THE APOLIPOPROTEIN (A) GENE<br />
M. Sameiro Faria | Sandra Ribeiro | G. Silva | H. Nascimento | P. Rocha-Pereira|<br />
V. Miranda | E. Vieira | R. Santos | D. Mendonça | A. Quintanilha | E.<br />
Costa| L. Belo | A. Santos-Silva<br />
FMC, Dinefro – Diálises e Nefrologia, SA; Inst Ciências Biomédicas Abel Salazar,<br />
Univ Porto | Fac Farmácia, Univ Porto; Inst Biologia Molecular e Celular<br />
(IBMC)| Inst Biologia Molecular e Celular (IBMC), Univ Porto; Centro Investigação<br />
Ciências Saúde, Univ Beira Interior, Covilhã | Unidade Genética Molecular,<br />
Centro Genética Médica Dr. Jacinto Magalhães (INSARJ) | Inst Ciências<br />
Biomédicas Abel Salazar, Univ Porto; Inst Saúde Pública da Univ Porto (ISPUP)<br />
SAP282<br />
EFFECT OF DARK CHOCOLATE INTAKE ON RENAL TISSUE OXYGENA-<br />
TION AS MEASURED BY BOLD-MRI<br />
Menno Pruijm | Lucie Hofmann | Elise Heuvelin | Valentina Forni | Andrew<br />
Coristine | Matthias Stuber | Bruno Vogt | Michel Burnier<br />
Univ Lausanne, Lausanne | Univ Hosp Lausanne, Lausanne<br />
SAP283<br />
AN ORIGINAL MODEL FOR DIAGNOSIS AND FOLLOW-UP OF MALNUTRI-<br />
TION IN CHRONIC KIDNEY DISEASE PATIENTS<br />
Maria Grazia Chiappini | Thomas Ammann | Lina Muzzi | Alessandra Grosso<br />
Nefrology and Dialysis Unit, FBF Hosp | Nephrology and Dialysis Unit AfaR<br />
CRCCS FBF Hosp, Rome, Italy<br />
SAP284<br />
TREATMENT OF CHRONIC HCV WITH PEGYLATED IFN ALPHA 2-A IN HE-<br />
MODIALYSIS PATIENTS; SINGLE SAUDI CENTER EXPERIENCE<br />
Alaa Sabry<br />
Mansoura Urology and Nephrology Center<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
287<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
288<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP285<br />
INCREASED LEVELS OF SERUM AMYLOID A IN END STAGE RENAL DISE-<br />
ASE PATIENTS IS ASSOCIATED WITH THE PRESENCE OF A UNIQUE BIO-<br />
MARKER IDENTIFIED BY PROTEIN CHIP ARRAY ANALYSIS<br />
Vinod Bansal | Debra Hoppensteadt | Walter Jeske | Jawed Fareed<br />
Loyola Univ Medical Center<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
PRIMARY AND SECONDARY<br />
GLOMERULONEPHRITIS II<br />
SAP286<br />
PERUVIAN AMAZONIC RACE AS A FACTOR OF WORSE PROGNOSIS ON<br />
RENAL FUNCTION IN PROLIF<strong>ERA</strong>TIVE LUPUS NEPHRITIS<br />
Renzo P. Valdivia Vega | Jessica Perez Carlos<br />
Hosp Nacional Edgardo Rebagliati Martins, Lima, Peru | EsSalud<br />
SAP287<br />
FUNCTIONAL MR IMAGING OF KIDNEYS IN PATIENTS WITH LUPUS NE-<br />
PHRITIS: INITIAL STUDY<br />
Xiao Li | Xueqin Xu | Wen Zhang | Hong Ren | Nan Chen<br />
Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School Medicine | Ruijin<br />
Hosp, Shanghai Jiaotong Univ<br />
SAP288<br />
ORAL MIZORIBINE PULSE TH<strong>ERA</strong>PY FOR NEPHROTIC SYNDROME AND<br />
LUPUS NEPHRITIS<br />
Noriaki Yorioka | Toshiki Doi | Shuma Hirashio | Michiko Arita | Akira Hirabayashi<br />
Hiroshima Kidney Organization, Hiroshima | East Clinic, Hiroshima | Hiroshima<br />
Univ Hosp, Hiroshima | Hiroshima Bay Clinic, Hiroshima<br />
SAP289<br />
ANTIPHOSPHOLIPID SYNDROM, ANTIPHOSHPHOLIPID ANTIBODIES<br />
AND RENAL INVOLVEMENT - CLINICOPATHOLOGIC FEATURES, TREAT-<br />
MENT AND OUTCOME<br />
Eduard Tilkiyan | Emilia Chonova | Yovko Ronchev | Emil Kumchev<br />
MHAT Kaspela Plovdiv Bulgaria Nephrology Ward<br />
SAP290<br />
COMPARISON OF TWO DIFFERENT TH<strong>ERA</strong>PEUTIC REGIMENS FOR THE<br />
TREATMENT OF PURE MEMBRANOUS LUPUS NEPHRITIS<br />
Panagiotis Giamalis | Michalis Spartalis | Maria Stangou | Ioannis Tsouchnikas|<br />
Dimitrios Moysiades | Despina Dimopoulou | Alexandros Garyfalos |<br />
George Efstratiadis | Dimitrios Memmos<br />
Nephrology Clinic, Hippokration General Hosp, Thessaloniki, Greece | 4th Clinic<br />
Internal Medicine, Hippokration General Hosp, Thessaloniki, Greece<br />
SAP291<br />
MEMBRANOUS GLOMERULONEPHRITIS AND ANTI-PHOSPHOLIPASE A2-<br />
RECEPTOR ANTIBODY TESTING: USEFUL TOOL IN IN ROUTINE CLINICAL<br />
PRACTICE<br />
Ulf Schönermarck | Peter Eichhorn | Thomas Sitter | Thorsten Wendler | Volker<br />
Vielhauer | Stephan Lederer | Kai Fechner | Michael Fischereder<br />
Nephrology Div, Medical Clinic IV, Inst Clinical Chemistry, Univ Hosp Munich,<br />
Ludwig-Maximilians Univ, Munich, Germany | KfH Nierenzentrum Laim, Munich,<br />
Germany | Inst Experimental Immunology, Euroimmun AG, Luebeck,<br />
Germany<br />
SAP292<br />
INFLUENCE OF A FUNCTIONAL POLYMORPHISM OF VASCULAR ENDO-<br />
THELIAL GROWTH FACTOR (VEGF) GENE ON MEMBRANOUS NEPHRO-<br />
PATHY<br />
Christos Bantis | Peter Heering | Nicoletta-Maria Kouri | Maria Stangou | Christina<br />
Schwandt | Nicola Kuhr | Katrin Ivens | Lars-Christian Rump<br />
Dept Nephrology, Papanikolaou General Hosp, Thessaloniki, Greece | Dept Nephrology,<br />
Heinrich-Heine Univ Düsseldorf, Germany<br />
SAP293<br />
LONG TERM (MORE THAN 20 YEARS) CLINICAL OUTCOME OF 114 IMN<br />
PATIENTS: A SINGLE CENTRE EXPERIENCE<br />
Valeria Matta | Patrizia Melis | Maura Conti | Riccardo Cao | Valentina Binda|<br />
Paolo Altieri | Anna Maria Asunis | Walter Catani | Matteo Floris | Andrea<br />
Angioi | Mauro Congia | Francesco Cucca | Luigi Minerba | Marcella Peri |<br />
Antonello Pani<br />
Nephrology, Pathology, Brotzu Hosp, Cagliari | Univ Cagliari | Univ Sassari<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
289<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
290<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP294<br />
TREATMENT OF MEMBRANOUS NEPHROPATHY WITH ADRENOCORTI-<br />
COTROPIC HORMONE (ACTH) GEL: CORRELATION OF ANTI-PLA2R AND<br />
DISEASE ACTIVITY<br />
Laurence H. Beck | Fernando C. Fervenza | Andrew S. Bomback | Rivka Ayalon|<br />
Maria V. Irazabal | Alfonso Eirin | Daniel C. Cattran | Gerald B. Appel |<br />
David J. Salant<br />
Boston Univ | Mayo Clinic | Columbia Univ | Toronto General Hosp<br />
SAP295<br />
UNEXPECTED EFFECT OF ANTI-TNF TH<strong>ERA</strong>PY IN MEMBRANOUS GLO-<br />
MERULONEPHRITIS<br />
Domenico Santoro | Adele Postorino | Giuseppe Costantino | Guido Bellinghieri<br />
| Vincenzo Savica<br />
Unit Nephrology and Dialysis, Univ Messina<br />
SAP296<br />
ANCA-ASSOCIATED VASCULITIS IN THE ELDERLY – A PRELIMINARY RE-<br />
PORT<br />
Maria Weiner | Suh Mein Goh | Aladdin Mohammad | Per Eriksson | Kerstin<br />
Westman | Daina Selga | Alan Salama | Mårten Segelmark<br />
Linköping Univ, Linköping, Sweden | Royal Free Hosp | Lund Univ | Dept<br />
Rheumatology, County Council Östergötland, Linköping, Sweden | Lund Univ,<br />
Malmö, Sweden | Lund Univ, Lund, Sweden<br />
SAP297<br />
MARKERS OF T CELL ACTIVATION INCREASE AFTER RITUXIMAB ADMI-<br />
NISTRATION IN ANCA-ASSOCIATED VASCULITIS<br />
Zdenka Chocova | Zdenka Hruskova | Helena Mareckova | Barbora Svobodova|<br />
Eva Jancova | Vladimira Bednarova | Romana Rysava | Vladimir Tesar<br />
Dept Nephrology, Inst Immunology and Microbiology, First Fac Medicine and<br />
General Teaching Hosp, Charles Univ, Prague, Czech Republic<br />
SAP298<br />
CLINICAL FEATURES AND OUTCOMES OF cANCA vs. pANCA-ASSOCIA-<br />
TED RENAL VASCULITIS<br />
Zdenka Hruskova | Eva Jancova | Vladimir Hanzal | Kamil Zamboch | Monika<br />
Grussmannova | Jan Svojanovsky | Jan Klaboch | Michaela Kubisova | Jakub<br />
Sevcik | Renata Olsanska | Marta Sobotkova | Radim Becvar | Petr Nemec |<br />
Michal Kodeda | Dalibor Jilek | Zdenka Chocova | Vladimir Tesar<br />
Dept Nephrology, General Univ Hosp and First Fac Medicine, Charles Univ,<br />
Prague, Czech Republic | Dept Nephrology, Inst Clinical and Experimental<br />
Medicine, Prague, Czech Republic | Third Dept Medicine, Teaching Hosp and<br />
Fac Medicine, Olomouc, Czech Republic | First Dept Internal Medicine, Third<br />
Fac Medicine, Charles Univ, Prague, Czech Republic | Second Dept Medicine,<br />
St Ann’s Hosp, Brno, Czech Republic | First Dept Medicine, Teaching Hosp and<br />
Fac Medicine, Plzen, Czech Republic | Dept Gerontology and Metabolism, Univ<br />
Hosp and Fac Medicine, Hradec Kralove | Third Dept Medicine, Brno-Bohunice<br />
Teaching Hosp, Brno, Czech Republic | Dept Medicine, Teaching Hosp and Fac<br />
Medicine, Ostrava, Czech Republic | Dept Immunology, Univ Hosp Motol, Prague,<br />
Czech Republic | Inst Rheumatology and First Fac Medicine, Charles Univ<br />
Prague, Prague, Czech Republic | Second Dept Medicine, Teaching Hosp and<br />
Fac Medicine, Hradec Kralove, Czech Republic | Dept Clinical Immunology and<br />
Allergology, Health Inst, Usti n. Labem, Czech Republic<br />
SAP299<br />
FACTORS PREDICTING INFECTIVE COMPLICATIONS OF CYCLOPHOSP-<br />
HAMIDE TH<strong>ERA</strong>PY IN ANCA ASSOCIATED VASCULITIS<br />
Memuna Hussain | Ajay Dhaygude<br />
Royal Preston Hosp | Royal Preston Hosp<br />
SAP300<br />
PAUCI-IMMUNE RENAL VASCULITIS: COMPARISON BETWEEN TWO<br />
GROUPS OF ELDERLY AND VERY ELDERLY PATIENTS<br />
Claire Cartery | Antoine Huart | Emmanuelle Plaisier | Vanina Bongard |<br />
François Montastruc | Pierre Ronco | Jacques Pourrat | Dominique Chauveau<br />
Tenon Hosp, Paris France | Rangueil Hosp, Toulouse France | Purpan Hosp,<br />
Toulouse France<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP301<br />
ANCA-NEGATIVE PAUCI-IMMUNE CRESCENTIC GLOMERULONEPHRI-<br />
TIS: CLINICAL CHARACTERISTICS AND OUTCOMES<br />
Narayan Prasad | Desraj Gurjar | Dharmender Bhadauria | Raj Kumar Sharma|<br />
Amit Gupta | Anupama Kaul | Manoj Jain<br />
Sanjay Gandhi PostGrad Inst Medical Sciences,Lucknow, India<br />
SAP302<br />
PREVENTION OF TREATMENT RELATED MORBIDITY IN ANCA- ASSOCIA-<br />
TED VASCULITIS: THE PATIENT'S PERSPECTIVE<br />
Michael Venning | Nina Brown | Ian Bruce<br />
Manchester Royal Infirmary, Manchester, UK | Univ Manchester, Manchester, UK<br />
SAP303<br />
INCREASED INCIDENCE OF VENOUS THROMBOEMBOLISM IN ANCA AS-<br />
SOCIATED VASCULITIS<br />
Sehrash Noor | Ajay Dhaygude<br />
Royal Preston Hosp<br />
SAP304<br />
ORAL C5A RECEPTOR ANTAGONIST CCX168 IN A PHASE 2 CLINICAL<br />
TRIAL IN ANCA-ASSOCIATED RENAL VASCULITIS<br />
Pirow Bekker | Antonia Potarca | Daniel Dairaghi | Shichang Miao | Jay P.<br />
Powers | Juan C. Jaen | Thomas J. Schall<br />
ChemoCentryx, Inc. | ChemoCentryx Inc, Mountain View (CA), USA<br />
SAP305<br />
TH-CYTOKINES IN THE URINE OF PATIENTS WITH PRIMARY GLOMERU-<br />
LONEPHRITIS IN REMISSION AND THEIR POTENTIAL ROLE AS MARKERS<br />
OF DISEASE ACTIVITY<br />
Dimitra Kalavrizioti | Miltiadis Gerolymos | Dimitrios Komninakis | Maria<br />
Rodi | Athanasia Mouzaki | Pantelitsa Kalliakmani | Dimitrios Goumenos<br />
Univ Hosp, Patras, Greece | Div Hematology, Dept Internal Medicine, Fac Medicine,<br />
Patras, Greece<br />
SAP306<br />
CLINICAL CHARACTERISTICS AND TREATMENT OF HEPATITIS B ASSO-<br />
CIATED IgA NEPHROPATHY<br />
Bum Soon Choi | Cheol Whee Park | Yong-Soo Kim | Chul Woo Yang | In O Sun<br />
Catholic Univ Korea, Seoul, Korea | Dept Internal Medicine, Seoul Saint Mary’s<br />
Hosp, Catholic Univ Korea<br />
SAP307<br />
MYCOPHENOLIC ACID REVERSE IgA1 ABERRANT GLYCOSYLATION<br />
THROUGH UP-REGULATING COSMC EXPRESSION IN IgA NEPHROPATHY<br />
Wei Qin | Linshen Xie | Chunyu Tan<br />
Div Nephrology, Div Rheumatology and Immunology, West China Hosp, Sichuan<br />
Univ<br />
SAP308<br />
DOWN-REGULATED PERIPH<strong>ERA</strong>L LYMPHOCYTE MICORRNA-155 IS RE-<br />
LATED TO IGA NEPHROPATHY<br />
Wei Qin | Wei Mian | Ping Fu | Chunyu Tan<br />
Div Nephrology, West China Hosp, Sichuan Univ | West China Hosp Sichuan<br />
Univ, Chengdu, China | Div Rheumatology and Immunology, West China Hosp,<br />
Sichuan Univ<br />
SAP309<br />
URINARY C-REACTIVE PROTEIN CONCENTRATION IN PATIENTS WITH<br />
PRIMARY GLOMERULONEPHRITIS AND EFFECT ON IT OF QUERCETIN<br />
Vitaliy Kaminskyy<br />
Ivano-Frankivsk National Medical Univ, Ivano-Frankivsk, Ukraine<br />
SAP310<br />
INFLUENCE OF G-1082A POLYMORPHISM OF INTERLEUKIN-10 GENE ON<br />
FOCAL SEGMENTAL GLOMERULONEPHRITIS: A CLINICOPATHOLOGIC<br />
STUDY<br />
Christos Bantis | Peter Heering | Nicoletta-Maria Kouri | Nicola Kuhr | Christi-<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
291<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
292<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
na Schwandt | Katrin Ivens | Lars-Christian Rump<br />
Dept Nephrology, Papanikolaou General Hosp, Thessaloniki, Greece | Dept Nephrology,<br />
Heinrich-Heine Univ Düsseldorf, Germany<br />
SAP311<br />
UNIQUE METABOLIC PROFILE OF HUMAN FOCAL SEGMENTAL GLOME-<br />
RULOSCLEROSIS<br />
Xu Hao | Hong Ren | Weiming Wang | Nan Chen<br />
Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School of Medicine<br />
SAP312<br />
SUBCLINICAL CARDIOVASCULAR DISEASE IN CHILDREN WITH IDIOPA-<br />
THIC STEROID RESISTANT NEPHROTIC SYNDROME<br />
Candan Cengiz | Canpolat Nur | Yildiz Nurdan | Gokalp Selman | Turhan<br />
Pınar | Tasdemir Mehmet | Sever Lale | Salim Caliskan<br />
Medeniyet Univ | Cerrahpasa Medical Fac | Marmara Medical Fac<br />
SAP313<br />
METHYLPREDNISOLONE PULSE TH<strong>ERA</strong>PY ACCEL<strong>ERA</strong>TED COMPLETE<br />
REMISSION OF PROTEINURIA IN ADULT-ONSET MINIMAL CHANGE NE-<br />
PHROTIC SYNDROME PATIENTS<br />
Maki Shinzawa | Ryohei Yamamoto | Yasuyuki Nagasawa | Susumu Oseto |<br />
Daisuke Mori | Kakuya Niihata | Megumu Fukunaga | Atsushi Yamauchi |<br />
Yoshiharu Tsubakihara | Hiromi Rakugi | Yoshitaka Isaka<br />
Dept Geriatric Medicine & Nephrology, Osaka Univ Grad School of Medicine,<br />
Suita, Japan | Dept Internal Medicine, Toyonaka Municipal Hosp, Toyonaka, Japan<br />
| Dept Nephrology, Osaka Rosai Hosp, Sakai, Japan | Dept Kidney Disease<br />
and Hypertension, Osaka General Medical Center, Osaka, Japan<br />
SAP314<br />
ROLE OF SERUM LEVEL OF SOLUBLE UROKINASE RECEPTOR IN VARIOUS<br />
BIOPSY-PROVEN KIDNEY DISEASES<br />
Jin-Shuen Chen | Yuh-Feng Lin | Wei-Ya Lin | Kuo-Hsiung Shu | Han-Hsiang<br />
Chen | Chih-Jen Wu | Chwei-Shiun Yang | Tzu-Ling Tseng<br />
Tri-Serv General Hosp, National Defense Medical Center, Taipei, Taiwan |<br />
Shuang Ho Hosp, Taipei Medical Univ, Taipei, Taiwan | Biomedical Engineering<br />
Res Labs, Industrial Technology Res Inst, Hsinchu, Taiwan | Taichung Veterans<br />
General Hosp, Taipei, Taiwan | Mackay Memorial Hosp, Taipei, Taiwan | Cathay<br />
General Hosp, Taipei, Taiwan<br />
SAP315<br />
INCIDENCE OF PRIMARY GLOMERULONEPHRITIS IN A LARGE NORTH-<br />
EASTERN ITALIAN AREA: A 13-YEAR RENAL BIOPSY STUDY<br />
Gianluigi Zaza | Patrizia Bernich | Antonio Lupo<br />
Renal and Dialysis Unit Hosp, Univ Verona, Italy<br />
« SAP316<br />
DECREASING INCIDENCE IN RENAL AMYLOIDOSIS. DATA FROM LARGE<br />
REGISTRY OF KIDNEY BIOPSIES<br />
Nayara Panizo | Francisco Rivera | Juan Manuela Lopez Gomez | Spanish Registry<br />
of Glomerulonephrities REGN<br />
Hosp General Univ Gregorio Marañón, Madrid, Spain | Hosp General Univ Ciudad<br />
Real, Ciudad Real, Spain | SEN<br />
SAP317<br />
ASSOCIATION BETWEEN AUTOIMMUNE THYROIDITIS AND IDIOPATHIC<br />
RETROPERITONEAL FIBROSIS: A CASE-CONTROL STUDY<br />
Graziano Ceresini | Maria Letizia Urban | Domenico Corradi | Elisa Usberti |<br />
Alessandra Palmisano | Carlo Buzio | Augusto Vaglio<br />
Geriatrics and Endocrinology, Nephrology Unit, Pathology, Univ Parma, Italy<br />
SAP318<br />
RENAL BIOPSY DURING PREGANCY: RETROSPECTIVE STUDY ABOUT 9<br />
CASES<br />
Houmaid Zineb |Benyounes Ramdani<br />
Univ Hosp Centre, Casablanca, Morocco<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP319<br />
CONSEQUENCES OF GLOMEROPATHY-PREGNANCY INT<strong>ERA</strong>CTION<br />
Luiz Paulo José Marques | Lilimar da Silveira Rioja | Regina Rocco | Ana Cassia<br />
Falcão Nery | Benedita Calheiros Novaes<br />
Federal Univ Rio de Janeiro State<br />
SAP320<br />
NON-PROTEINURIC LCDD NEPHROPATHY: A RETROSPECTIVE STUDY OF<br />
14 PATIENTS<br />
Frank Bridoux | Antoine Sicard | Delphine Labatut | Guy Touchard | Clémetine<br />
Sarkozy | Philippe Vanhille | Patrice Callard | Marie Essig | François Provot|<br />
Alain Nony | Pierre Ronco | Alexandre Karras<br />
Néphrologie, CHU, Poitiers, France | Néphrologie, Valenciennes, France | Renal<br />
Pathology, CHU, Poitiers, France | Hématologie, Hôp A. Mignot, Versailles,<br />
France | Néphrologie, Valenciennes, France | Renal Pathology, Hôp Tenon, Paris,<br />
France | Néphrologie, CHU, Limoges, France | Néphrologie, CHU, Lille,<br />
France | Néphrologie, CH, Bourges, France | Néphrologie, Hôp Tenon, Paris,<br />
France | Néphrologie, HEGP, Paris, France<br />
SAP321<br />
IMPACT OF BORTEZOMIB IN THE SURVIVAL OF PATIENTS WITH REFRAC-<br />
TORY OR RELAPSED MULTIPLE MYELOMA WITH RENAL FAILURE. EXPE-<br />
RIENCE OF A SINGLE CENTRE<br />
Carreño Parrilla Agustin | Hernandez Ruiz M Belen | Calle Primo Carmen |<br />
Olazo Eliana | Pereira Elisa | Piccone Luis | Martinez-Calero Alberto | Nieto<br />
Javier | Ferreras Isabel<br />
Hosp General Univ Ciudad Real<br />
SAP322<br />
CLINICAL PRESENTATION AND OUTCOME OF PATIENTS AFFECTED BY<br />
SYSTEMIC AMYLOIDOSIS WITH PREDOMINANT RENAL INVOLVEMENT:<br />
A 10 YEAR, SINGLE CENTRE EXPERIENCE<br />
Riccardo Cao | Maura Conti | Alice Atzeni | Antioco Fois | Doloretta Piras |<br />
Stefania Maxia | Andrea Angioi | Valentina Binda | Patrizia Melis | Giovanna<br />
Sau | Gianfranco Pili | Matteo Floris | Anna Maria Asunis | Maurizio Porcu |<br />
Daniele Derudas | Emanuele Angelucci | Antonio Ledda | Giorgio La Nasa |<br />
Antonello Pani<br />
Nephrology, Pathology, Cardiology, Brotzu Hosp, Cagliari | Haematology, Businco<br />
Hosp, Cagliari | Haematology, Binaghi Hosp, Cagliari<br />
SAP323<br />
CLINICO-PATHOLGIC FINDINGS IN IRANIAN ELDERLY KIDNEY PA-<br />
TIENTS - A CASE SERIES STUDY<br />
Shahrzad Ossareh | Mojgan Asgari | Shokoufeh Savaj | Yousef Ataipour | Ezatollah<br />
Abdi | Tahereh Malakoutian<br />
Dept Medicine, Nephrology Section, Hasheminejad Clinical Res Development<br />
Center, Tehran Univ Medical Sciences, Tehran, Iran | Dept Medicine, Nephrology<br />
Unit, Firoozgar Hosp, Tehran Univ Medical Sciences, Tehran, Iran<br />
SAP324<br />
EVOLUTIVE PROFILE OF ACUTE POST INFECTIOUS GLOMERULONEPHRI-<br />
TIS WITH EXTRACAPILLARY PROLIF<strong>ERA</strong>TION: EXPERIENCE IN 14 CASES<br />
Rifai Rajaa | Fatima Zahra Berkchi | Laila Haffane | Zoubair Squalli | Lamiae<br />
Rouass | Zaitouna Al Hamany | Fatima Ezzaitouni | Loubna Benamar | Rabia<br />
Bayahya | Naima Ouzeddoun<br />
Serv Néphrologie Dialyse Transpl Rénale CHU Ibn Sina Rabat Morocco | Serv<br />
Antomie Pathologique Hop Enfants Rabat Morocco<br />
SAP325<br />
PILOT OBSERVATION OF LIPID PROFILE CHANGES IN LIPOPROTEIN<br />
CAST NEPHROPATHY TREATED WITH FENOFIBRATE OR STATIN<br />
Huang Gao-Yuan | Xiaodan Yao | Chen Xin | Cheng Zhen | Guo Yong-Chun|<br />
Wang Qing-Wen | Chen Hui-Ping | Ji Da-Xi | Gong De-Hua | Hu Wei-Xin |<br />
Liu Zhi-Hong<br />
Res Inst Nephrology, Jinling Hosp, Nanjing Univ School Medicine, Nanjing,<br />
China<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
293<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
294<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP326<br />
CLINICAL AND EVOLUTIVE PROFILE OF THE ACUTE POST INFECTIOUS<br />
GLOMERULONEPHRITIS: EXPERIENCE IN 30 CASES<br />
Rifai Rajaa | Fatima Zahra Berkchi | Laila Haffane | Zoubair Squalli | Lamiae<br />
Rouass | Zaitouna Al Hamany | Fatima Ezzaitouni | Loubna Benamar | Rabia<br />
Bayahya | Naima Ouzeddoun<br />
Serv Néphrologie Dialyse Transpl Rénale CHU Ibn Sina Rabat Morocco | Serv<br />
Antomie Pathologique Hop Enfants Rabat Morocco<br />
SAP327<br />
IS THERE ANY LINK BETWEEN THE DETECTION OF ANTI-C1Q ANTIBO-<br />
DIES IN THE SERUM AND CLINICAL MANIFESTATION OF GLOMERULAR<br />
INJURY IN PRIMARY AND SECONDARY GLOMERULONEPHRITIDES<br />
Katarzyna Smykal-Jankowiak | Zofia Niemir | Magdalena Polcyn-Adamczak |<br />
Beata Szramka-Pawlak | Ryszard Zaba<br />
Dept Nephrology, Dept Dermatology, Univ Medical Sciences, Poznan, Poland<br />
SAP328<br />
CLINICAL ANALYSIS OF THE PATIENTS WITH PRIMARY DISTAL RENAL<br />
TUBULAR ACIDOSIS<br />
Chunli Zhang | Hong Ren | Yuhua Ma | Weiming Wang | Wen Zhang | Pingyan<br />
Shen | Nan Chen<br />
Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School Medicine<br />
SAP329<br />
CHARACTERISTICS OF CLINICAL MANIFESTATIONS IN CHINESE FABRY<br />
PATIENTS<br />
Yan Ouyang | Xiaoxia Pan | Zhaohui Wang | Xiaobei Feng | Pingyan Shen |<br />
Hong Ren | Liyan Ni | Wen Zhang | Nan Chen<br />
Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School Medicine<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
EXPERIMENTAL PATHOLOGY<br />
SAP330<br />
THE TUBULAR EXPRESSION OF MESENCHYMAL MARKERS INCLUDES<br />
EXTRACELLULAR MATRIX PROTEINS<br />
Dubois Xu Yi Chun | Hertig Alexandre | Baugey Edith | Ouali Nacéra | Peltier<br />
Julie | Jouanneau Chantal | Rondeau Eric<br />
APHP, Hôp Tenon | Inserm U702<br />
SAP331<br />
1,25-DIHYDROXYVITAMIN D3 SUPPRESSES HIGH GLUCOSE ACTIVATED<br />
MACROPHAGE DROVED TUBULAR EPITHELIAL TO MESENCHYMAL<br />
TRANSITION IN PROXIMAL TUBULAR EPITHELIAL CELLS<br />
Xiaoliang Zhang | Yansheng Jin<br />
Zhong Da Hosp, School Medicine, Southeast Univ, Nanjing, China<br />
SAP332<br />
RENAL TUBULAR FLUID SHEAR STRESS FACILITATES MONOCYTE ACTI-<br />
VATION TOWARDS INFLAMMATORY MACROPHAGES<br />
Mathieu Miravete | Romain Dissard | Julie Klein | Julien Gonzalez | Cécile<br />
Caubet | Christiane Pecher | Bernard Pipy | Jean-Loup Bascands | Muriel Mercier-Bonin<br />
| Joost Schanstra | Bénédicte Buffin-Meyer<br />
Inserm U1048 | UMR-MD3 EA2405 | INSA, UPS, INPT, LISBP<br />
SAP333<br />
CD154 INDUCES MATRIX METALLOPROTEASE-9 SECRETION IN HUMAN<br />
PODOCYTES<br />
Rigothier Claire | Daculsi Richard | Lepreux Sébastien | Saleem Moin | Bourget<br />
Chantal | Combe Christian | Ripoche Jean<br />
INSERM U1026, Univ Bordeaux 2, Bordeaux, France | Serv Anatomie Pathologique,<br />
CHU Bordeaux, France | Children's Renal Unit and Academic Renal Unit,<br />
Univ Bristol, Bristol, UK<br />
SAP334<br />
BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MEDIATES THE ANTI-<br />
PROTEINURIC EFFECT OF FLUOXETIN THROUGH PRESERVATION OF PO-<br />
DOCYTE INTEGRITY<br />
Massimiliano Migliori | Vincenzo Cantaluppi | Claudio Mannari | Davide Medica<br />
| Luca Giovannini | Vincenzo Panichi<br />
Nephrology and Dialysis Unit, Versilia Hosp | Nephrology, Dialysis, Renal<br />
Transpl Unit and Centre Experimental Medical Res (CeRMS), Univ Turin | Dept<br />
Neuroscience, Univ Pisa<br />
SAP335<br />
IMPAIRMENT OF PODOCYTE FUNCTION BY DIPHTERIA TOXIN - A NEW<br />
REVERSIBLE PROTEINURIA MODEL IN MICE<br />
Andreas Goldwich | Steinkasserer Alexander | Gessner André | Kerstin Amann<br />
Univ Hosp | Univ Hosp Erlangen | Univ Regensburg | Nephropathology<br />
SAP336<br />
IFN-alpha AND IFN-beta SPECIFICALLY AFFECT RENAL PROGENITORS<br />
AND PODOCYTES IN-VITRO AND IN-VIVO<br />
Adriana Migliorini | Costanza Sagrinati | Maria Lucia Angelotti | Shrikant R.<br />
Mulay | Elisa Ronconi | Anna Peired | Paola Romagnani | Hans-Joachim Anders<br />
Nephrological Center, Medical Policlinic, Univ Munich, Germany | Excellence<br />
Center Res, Transfer and High Education Denothe, Univ Florence, Italy | Univ<br />
Florence<br />
SAP337<br />
ANGIOPOIETINS MODULATES ENDOTHELIAL ADAPTATION, GLOMERU-<br />
LAR AND PODOCYTE HYPERTROPHY AFTER UNINEPHRECTOMY<br />
Wen Chih Chiang | Chun Fu Lai | Wei-Hao Peng | Ching Fang Wu | Fan-Chi<br />
Chang | Yi-Ting Chen | Shuei-Liong Lin | Yung Ming Chen | Kwan Dun Wu |<br />
Kuo-Shyan Lu | Tun Jun Tsai<br />
National Taiwan Univ Hosp, Taipei, Taiwan | College Medicine, National Taiwan<br />
Univ, Taipei, Taiwan | National Taiwan Univ Hosp ChuDong Branch, Yunlin<br />
County, Taiwan | E-Da Hosp, Kaohsiung City, Taiwan<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
295<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
296<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP338<br />
C-MIP DOWNREGULATES NF-κB ACTIVITY AND PROMOTES APOPTOSIS<br />
IN PODOCYTES OF PATIENTS WITH IDIOPATHIC NEPHROTIC SYNDROME<br />
Ory Virgine | Fan Qing Feng | Shao-Yu Zhang | Desvaux Dominique | Audard<br />
Vincent | Candelier Marina | Lang Philippe | Guellaen Georges | Andre Pawlak<br />
| Djillali Sahali<br />
INSERM U955 Group 21, Créteil, France | Dept Nephrology, Henri Mondor<br />
Hosp, Créteil, France<br />
SAP339<br />
PHARMACOLOGICAL SUPPRESSION OF PLASMINOGEN ACTIVATOR IN-<br />
HIBITOR-1 (PAI-1) AMELIORATES THE INJURY OF GLOMERULAR PODO-<br />
CYTE IN THE EXPERIMENTAL GLOMERULONEPHRITIS<br />
Sachiko Matsumoto | Atsuhiro Ichimura | Takashi Dan | Takashi Nakamichi |<br />
Tadashi Tsujita | Koji Akahori | Sadayoshi Ito | Tosho Miyata<br />
Tohoku Univ Grad School Medicine, Sendai, Japan | Dept Molecular Medicine<br />
and Therapy, United Centers Advanced Res and Translational Medicine (ART),<br />
Tohoku Univ Grad School Medicine | Div Nephrology, Dept Endocrinology and<br />
Vascular Medicine, Tohoku Univ Grad School of Medicine | Tohoku Univ, Sendai,<br />
Japan<br />
SAP340<br />
PHARMACEUTICAL INHIBITION OF PODOCYTE UPAR EXPRESSION RE-<br />
DUCES PROTEINURIA IN NTX RATS AND LPS MICE<br />
Shaoting Xie | Bin Zhang | Wei Shi | Yun Yang<br />
Guangdong General Hosp, Guangzhou, China<br />
SAP341<br />
KLOTHO PROTEIN REDUCES MOUSE RENAL FIBROSIS AFTER UNILATE-<br />
RAL URET<strong>ERA</strong>L OBSTRUCTION THROUGH INHIBITION OF WNT SIGNA-<br />
LING<br />
Hajime Nagasu | Minoru Satoh | Kengo Kidokoro | Yuko Nishi | Chieko Ihoriya<br />
| Hiroyuki Kadoya | Tamaki Sasaki | Naoki Kashihara<br />
Kawasaki Medical School, Kurashiki, Japan<br />
SAP342<br />
TRANSFORMING GROWTH FACTOR Β STIMULATES PROFIBROTIC EPI-<br />
THELIAL SIGNALING TO ACTIVATE PERICYTE-MYOFIBROBLAST TRAN-<br />
SITION IN OBSTRUCTIVE KIDNEY FIBROSIS<br />
Ching-Fang Wu | Fan-Chi Chang | Yi-Ting Chen | Yu-Hsiang Chou | Jeremy<br />
Duffield | Shuei-Liong Lin<br />
National Taiwan Univ Hosp | Univ Washington | National Taiwan Univ<br />
SAP343<br />
MESENCHYMAL STROMAL CELLS AND LISINOPRIL COMBINATION THE-<br />
RAPY INDUCE RENAL REPAIR MODULATING SCATTER FACTORS IN UNI-<br />
LAT<strong>ERA</strong>L URET<strong>ERA</strong>L OBSTRUCTION EXPERIMENTAL MODEL<br />
Chiara Rocca | Marilena Gregorini | Valeria Corradetti | Teresa Valsania | Giulia<br />
Bedino | Francesca Bosio | Eleonora Francesca Pattonieri | Pasquale Esposito|<br />
Vincenzo Sepe | Carmelo Libetta | Teresa Rampino | Antonio Dal Canton<br />
Unit Nefrology, Dialysis and Transpl, Univ and Fond IRCCS Policlinico San Matteo<br />
SAP344<br />
COMBINATION TH<strong>ERA</strong>PY WITH MESENCHYMAL STROMAL CELLS AND<br />
LISINOPRIL REDUCES RENAL FIBROSIS IN A RAT EXPERIMENTAL MODEL<br />
OF UNILAT<strong>ERA</strong>L URET<strong>ERA</strong>L OBSTRUCTION INHIBITING RENIN ANGIO-<br />
TENSIN SYSTEM<br />
Giulia Bedino | Marilena Gregorini | Valeria Corradetti | Chiara Rocca | Eleonora<br />
Francesca Pattonieri | Teresa Valsania | Francesca Bosio | Pasquale Esposito<br />
| Vincenzo Sepe | Carmelo Libetta | Teresa Rampino | Antonio Dal Canton<br />
Dip Nefrologia, Dialisi e Trapianto, Univ e Policlinico San Matteo, Pavia<br />
SAP345<br />
USE OF XANTHINE OXIDASE INHIBITOR FEBUXOSTAT INHIBITS RENAL<br />
INTERSTITIAL INFLAMMATION AND FIBROSIS IN UNILAT<strong>ERA</strong>L URETE-<br />
RAL OBSTRUCTIVE NEPHROPATHY<br />
Hiroki Omori | Noritaka Kawada | Kazunori Inoue | Yoshiyasu Ueda | Ryohei<br />
Yamamoto | Isao Matsui | Jyunya Kaimori | Yoshitsugu Takabatake | Toshiki<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Moriyama | Yoshitaka Isaka | Hiromi Rakugi<br />
Dept Geriatric Medicine and Nephrology, Osaka Univ Grad School Medicine<br />
SAP346<br />
KIM-1 AND NGAL: NEW MARKERS OF OBSTRUCTIVE NEPHROPATHY<br />
Anna Wasilewska | Katarzyna Taranta-Janusz | Wojciech Dębek | Elżbieta<br />
Kuroczycka-Saniutycz<br />
Dept Pediatrics and Nephrology<br />
SAP347<br />
URET<strong>ERA</strong>L ANGIOGENESIS AND LYMPHANGIOGENESIS AFTER URETE-<br />
RAL OBSTRUCION IN MICE<br />
Ae Sin Lee | Jung Eun Lee | Yu Jin Jung | Kyung Pyo Kang | Sik Lee | Won Kim<br />
Dept Internal Medicine and Inst Medical Sciences, Chonbuk National Univ Medical<br />
School, Jeonju, Korea<br />
SAP348<br />
DELETION OF ENDOTHELIN-1 FROM ENDOTHELIAL CELL IN-VIVO AND<br />
ETAR BLOCKING IN-VITRO ATTENUATE KIDNEY FIBROSIS AND MYOFI-<br />
BROBLAST FORMATION<br />
Nur Arfian | Noriaki Emoto | Keiko Yagi | Kazuhiko Nakayama | Anggoro Budi<br />
Hartopo | Dwi Aris Nugrahaningsih | Masashi Yanagisawa | Ken-ichi Hirata<br />
Cardiovascular Div Internal Dept, Grad School Medicine Kobe Univ | Clinical<br />
Pharmacy Dept, Kobe Pharmaceutical Univ | Howard Hughes Medical Inst,<br />
Univ Texas Southwestern Medical Center, Dallas<br />
SAP349<br />
ALK1 HETEROZYGOUS DISRUPTION INCREASES RENAL FIBROSIS FOL-<br />
LOWING URET<strong>ERA</strong>L OBSTRUCTION<br />
José Manuel Muñoz-Félix | Jose M. Lopez-Novoa | Carlos Martinez-Salgado<br />
Unidad Fisiopatología Renal y Cardiovascular, Inst Reina Sofía Investigación<br />
Nefrológica, Salamanca, Spain | Univ Salamanca, Salamanca, Spain, | Inst Estudios<br />
Ciencias Salud Castilla y León (IECSCYL), Unidad Investigacion, Hosp Univ<br />
Salamanca, Spain<br />
SAP350<br />
L-ENDOGLIN OVEREXPRESSION INCREASES RENAL FIBROSIS AFTER<br />
UNILAT<strong>ERA</strong>L URET<strong>ERA</strong>L OBSTRUCTION<br />
Barbara Oujo | José Manuel Muñoz-Félix | Miguel Arevalo | Carmelo Bernabeu|<br />
Fernando Perez-Barriocanal | Jose M. Lopez-Novoa<br />
Univ Salamanca, Salamanca, Spain | Unidad Fisiopatología Renal y Cardiovascular,<br />
Inst Reina Sofía Investigación Nefrológica, Salamanca, Spain | Centro<br />
Investigaciones Biologicas, CSIC, Madrid, Spain<br />
SAP351<br />
IMPACT OF TWO IMMUNOSUPPRESSIVE DRUGS (CYCLOSPORINE AND<br />
EVEROLIMUS) ON IRI-INDUCED FIBROSIS<br />
Kers Jesper | Vittoz Nathalie | Galichon Pierre | Dubois Xu Yi Chun | Hertig<br />
Alexandre | Rondeau Eric<br />
Dept Pathology | APHP, Hôp Tenon | Inserm U702<br />
SAP352<br />
TH<strong>ERA</strong>PEUTIC EFFECTS OF MESENCHYMAL STEM CELLS IN WISTAR-<br />
KYOTO RATS WITH ANTI-GLOMERULAR BASEMENT MEMBRANE GLO-<br />
MERULONEPHRITIS<br />
Masayuki Iyoda | Takanori Shibata | Kei Matsumoto | Yuki Shindo-Hirai | Yoshihiro<br />
Kuno | Yukihiro Wada | Tadao Akizawa<br />
Div Nephrology, Dept Medicine, Showa Univ School Medicine<br />
SAP353<br />
ATTENUATED GLOMERULAR ARGININE TRANSPORT PREVENTS HYPER-<br />
FILTRATION AND INDUCES HIF-1Α IN THE PREGNANT UREMIC RAT<br />
Idit Schwartz | Doron Schwartz<br />
Tel Aviv Sourasky Medical Center<br />
SAP354<br />
INT<strong>ERA</strong>CTION BETWEEN IgA AND PROXIMAL TUBULAR CELLS DURING<br />
GLOMERULAR DISEASES<br />
Caroline Prot Bertoye | Sara Terryn | Julien Claver | Walid Beghdadi Beghdadi|<br />
Renato Monteiro | Uli Blank | Olivier Devuyst | Eric Daugas<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
297<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
298<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
INSERM U699, Paris France | Div Nephrology- NEFR Unit- Univ Catholique<br />
Louvain Medical School, Brussels, Belgium | Nephrology Dpt Bichat Hosp<br />
APHP, Paris, France<br />
SAP355<br />
COMPARATIVE STUDY OF VALPROIC ACID AND TRICHOSTATIN A IN AN<br />
EXPERIMENTAL MODEL OF FSGS<br />
Katrien Van Beneden | Caroline Geers | Marina Pauwels | Inge Mannaerts |<br />
Christiane Van den Branden | Leo A. van Grunsven<br />
Vrije Univ Brussel, Brussels, Belgium | Univ Ziekenhuis Brussel, Brussels, Belgium<br />
SAP356<br />
TRANSPORT IN PODOCYTES OF ACUTE PUROMYCIN AMINONUCLEOSI-<br />
DE NEPHROSIS (PAN)<br />
Ismail Seckin | Meltem Pekpak | Mumin Uzunalan | Bulent Uruluer | Sibel<br />
Köktürk | Zeynep Öztürk | Hüseyin Sönmez | Elif Yaprak<br />
Istanbul Univ, Cerrahpasa Medical Fac, Dept Histology and Embryology | Lab<br />
Memorial Hosp | Istanbul Univ, Cerrahpasa Med Fac, Biochemistry<br />
SAP357<br />
NOVEL VASCULOPROTECTIVE ROLE OF NITRIC OXIDE SYNTHASE (NOS)<br />
SYSTEM IN MICE: INVOLVEMENT OF NOS SYSTEM IN BONE MARROW-<br />
DERIVED VASCULAR PROGENITOR CELLS<br />
Yumi Furuno | Masato Tsutsui | Tsuyoshi Morishita | Hiroaki Shimokawa |<br />
Yutaka Otsuji | Nobuyuki Yanagihara | Narutoshi Kabashima | Serino Ryota|<br />
Kaori Kanegae | Tetsu Miyamoto | Junichi Nakamata | Nana Ishimatsu | Masahito<br />
Tamura<br />
Second Dept Internal Medicine, Univ Occupational and Environmental Health|<br />
Dept Pharmacology, Grad School Medicine, Univ Ryukyus | Dept Cardiovascular<br />
Medicine, Tohoku Univ Grad School Medicine | Kidney Center, Univ Occupational<br />
and Environmental Health<br />
SAP358<br />
PLATELET-DERIVED GROWTH FACTOR RECEPTOR BETA SIGNAL COULD<br />
CONTRIBUTE TO VULN<strong>ERA</strong>BILITY AND REPAIRABILITY OF GLOMERU-<br />
LAR CAPILLARY STRUCTURE<br />
Taizo Nakagawa | Kumi Ichikawa | Mayumi Miyamoto | Daisuke Takabayashi|<br />
Hidenori Yamazaki | Kouta Kakeshita | Tsutomu Koike | Satoshi Kagitani<br />
| Fumihiro Tomoda | Takeru Hamashima | Yoko Ishii | Hiroshi Inoue|<br />
Masakiyo Sasahara<br />
Second Dept Internal Medicine, Dept Pathology, Univ Toyama, Toyama, Japan<br />
SAP359<br />
SILENCING THE EXPRESSION OF NOTCH3 RECEPTOR PREVENTS THE DE-<br />
VELOPMENT OF GLOMERULONEPHRITIS<br />
Fala El Machhour | Monique Kerroch | Laurent Mesnard | Christos Chatziantoniou<br />
| Jean-Claude Dussaule<br />
INSERM UMR S 702, Paris, France<br />
SAP360<br />
CALPONIN-H2 SUPPRESSES THE DEVELOPMENT OF INTERSTITIAL FI-<br />
BROSIS OF BOTH KIDNEYS AND HEART IN OLD MICE<br />
Kiyoko Inui | Fumihiko Sasai | Yuichi Maruta | Hiroki Nishiwaki | Eri Kawashima<br />
| Yoshihiko Inoue | Ashio Yoshimura<br />
Showa Univ Fujigaoka Hosp Yokohama Japan<br />
SAP361<br />
RECOMBINANT HUMAN SOLUBLE THROMBOMODULIN ATTENUATES<br />
ANTI-GLOMERULAR BASEMENT MEMBRANE GLOMERULONEPHRITIS<br />
IN WISTAR-KYOTO RATS<br />
Kei Matsumoto | Masayuki Iyoda | Takanori Shibata | Yukihiro Wada | Yuki<br />
Shindo-Hirai | Yoshihiro Kuno | Tadao Akizawa<br />
Div Nephrology, Dept Medicine, Showa Univ School Medicine, Tokyo, Japan<br />
SAP362<br />
PROTECTIVE EFFECT OF N-3 FATTY ACIDS AGAINST CYCLOSPORIN A-<br />
ASSOCIATED CYTOTOXICITY IN CULTURED HUMAN MESANGIAL CELLS<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Estella Musacchio | Giovanna Priante | Chiara Valvason | Leonardo Sartori |<br />
Bruno Baggio<br />
Clinica Medica I, Dept Medicine, Univ Padova | Nephrology Unit, Dept Medicine,<br />
Univ Padova<br />
SAP363<br />
INFLUENCE OF CYCLOSPORINE A ON GLOMERULAR GROWTH AND<br />
PROTECTIVE EFFECT OF MIZORIBINE AND LOSARTAN ON CYCLOSPORI-<br />
NE A NEPHROTOXICITY IN RAT<br />
Ji Hong Kim<br />
Ganagnam Severance Hosp, Yonsei Univ College Medicine, Seoul, Korea<br />
SAP364<br />
EVALUATION OF EARLY DIAGNOSTIC MARKERS FOR ALPORT SYNDROME<br />
BEFORE THE ONSET OF MICROALBUMINURIA IN THE COL4A3-KNOCKOUT<br />
ANIMAL MODEL OF CHRONIC PROGRESSIVE RENAL FIBROSIS<br />
Oliver Gross | Rubel Diana | Dihazi Gry H. | Bibi Asimal | Temme Johanna |<br />
Schmidt-Eylers Imke | Weimer Lydia | Müller Gerhard-Anton | Dihazi Hassan<br />
Univ Medicine Goettingen, Goettingen, Germany<br />
SAP365<br />
REGULATION OF THE MOUSE GLOMERULAR FILTRATION BY THE INTE-<br />
GRIN LINKED KINASE (ILK). ROLE OF THE VASODILATORY cGMP PATH-<br />
WAY<br />
Jose Luis Cano | Mercedes Griera | Gemma Olmos | Paloma Martin | Maria<br />
Alicia Cortes | Susana Lopez-Ongil | Diego Rodriguez-Puyol | Sergio De Frutos<br />
Alcala Univ, Alcala de Henares, Spain | Physiology Dept, Alcala Univ, Alcala de<br />
Henares, Madrid, Spain | Univ Alcala, Fac Medicina, Alcala de Henares, Madrid,<br />
Spain | Fund Investigacion Biomedica Hosp Principe Asturias, Alcala de Henares,<br />
Madrid, Spain | Nephrology Section and Res Unit, Hosp Príncipe Asturias,<br />
Alcalá de Henares and IRSIN, Alcala De Henares, Madrid<br />
SAP366<br />
HSP70 INCREASE THE PRODUCTION OF EXTRACELLULAR MATRIX BY<br />
VASCULAR SMOOTH MUSCLE CELLS THROUGH TGFΒ1 UP-REGULATION<br />
Marta Gonzalez | Sergio De Frutos | Jose Luis Cano | Alicia Luengo | Paloma<br />
Martin | Manuel Rodriguez-Puyol | Laura Calleros<br />
Alcala Univ, Alcala de Henares, Spain | Univ Alcala, Fac Medicina, Alcala de<br />
Henares, Madrid, Spain<br />
SAP367<br />
PROTEINURIC EFFECTS OF TANSCRANIAL MAGNETIC STIMULATIONS<br />
Rosaria Lupica | Antonio Lacquaniti | Valentina Donato | Rossella Maggio |<br />
Claudia Mastroeni | Silvia Lucisano | Valeria Cernaro | Maria Rosaria Fazio |<br />
Angelo Quartarone | Michele Buemi<br />
Policlinico Univ G. Martino, Messina, Italy<br />
SAP368<br />
REGULATION OF RENAL FIBROBLAST FUNCTION BY POTASSIUM CHAN-<br />
NELS<br />
Michael Kacik | Sybell Goedicke | Holger Eggert | Joachim Dirk Hoyer<br />
Philipps-Univ, Dept Nephrology, Marburg, Germany | Dept Nephrology, Marburg,<br />
Germany<br />
SAP369<br />
CCR7 DEFICIENCY CAUSES A RENAL PHENOTYPE<br />
Simone Wurm | Andreas Steege | Miriam Banas | Armin Kurtz | Bernhard<br />
Banas<br />
Univ Medical Center Regensburg | Univ Regensburg<br />
SAP370<br />
EFFECTS OF GSK3 INHIBITION ON THE REGEN<strong>ERA</strong>TIVE CAPACITY OF RE-<br />
NAL PROGENITOR CELLS<br />
Laura Lasagni | Elena Lazzeri | Anna Peired | Maria Lucia Angelotti | Elisa<br />
Ronconi | Simone Romoli | Paola Romagnani<br />
Univ Florence, Florence, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
299<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
300<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP371<br />
TYROSINE PHOSPHORYLATION SITES Y4/8/10 OF CD2AP DETERMINE<br />
BINDING TO NEPHRIN<br />
Irini Schaefer | Beina Teng | Kirstin Worthmann | Hermann Haller | Mario<br />
Schiffer<br />
Medical School Hannover, Nephrology | Medical School Hannover, Germany<br />
SAP372<br />
PROTEOMIC PROFILE OF CD24+ CD133+ RENAL MULTIPOTENT PROGE-<br />
NITORS (RMP)<br />
Clelia Prattichizzo | Giuseppe Stefano Netti | Maria Teresa Rocchetti | Luigi<br />
Cormio | Giuseppe Carrieri | Giovanni Stallone | Giuseppe Grandaliano | Elena<br />
Ranieri | Loreto Gesualdo<br />
Nephrology, Dialysis and Transpl Unit, Clinical Pathology Unit, Dept Biomedical<br />
Sciences, Univ Foggia | Univ Foggia, Foggia, Italy | Urology Unit, Dept<br />
Surgical Sciences, Univ Foggia | Nephrology, Dialysis and Transpl Unit, DETO,<br />
Univ Bari<br />
SAP373<br />
THE INFLUENCE OF HIGH PROTEIN SOY BEAN DIET ON BLOOD SERUM<br />
NIITRATE LEVEL IN SPONTANEOUSLY HYPERTENSIVE RATS WITH EXPE-<br />
RIMENTAL RENAL FAILURE<br />
Anatoliy Kucher | Alexey Smirnov | Marina Parastayeva | Olga Beresneva |<br />
Ivan Kayukov | Irina Zubina | Galina Ivanova<br />
Saint-Petersburg State Medical Univ named after I.P. Pavlov | Pavlov Inst Physiology,<br />
Saint-Petersburg, Russia<br />
SAP374<br />
IMPLICATION OF Cx37 IN EXPERIMENTAL NEPHROPATHY<br />
Ahmed Abed | Ludwig Schlekenbach | Bernard Foglia | Christos Chatziantoniou<br />
| Brenda Kwak | Christos Chadjichristos<br />
INSERM U702 | Cardiology Dpt, Geneva Univ Hosp<br />
SAP375<br />
INCREASED ANGIOTENSIN II AND ALDOSTERONE LEVELS INDUCE OXI-<br />
DATIVE STRESS AND DNA DAMAGE IN THE KIDNEY INDEPENDENT OF<br />
THEIR HEMODYNAMIC EFFECTS<br />
Nina Queisser | Nicole Schupp | Susanne Brand<br />
Univ Würzburg, Würzburg, Germany<br />
SAP376<br />
ROLE OF IL-17 IN THE PATHOMECHANISM OF RENAL FIBROSIS<br />
Leonóra Himer | Beáta Szebeni | Erna Sziksz | Shinobu Saijo | Éva Kis | Ágnes<br />
Prókai | Nóra F. Bánki | Andrea Fekete | Tivadar Tulassay | Ádám Vannay<br />
Res Lab Paediatrics and Nephrology, Hungarian Academy of Sciences, Budapest,<br />
Hungary | Center Experimental Medicine, Inst Medical Science, Univ Tokyo, Japan<br />
| First Dept Paediatrics, Semmelweis Univ, Budapest, Hungary<br />
SAP377<br />
SELECTIVE INDUCTION AND MODULATION OF mTORC1 AND mTORC2<br />
SIGNALING DURING OSTEOBLASTIC DIFFERENTIATION AND CALCIFI-<br />
CATION OF MESENCHYMAL STEM CELLS<br />
Björn Hegner | Theres Schaub | Claudia Lange | Duska Dragun<br />
Dept Nephrology and Intensive Care Medicine | Charite, Berlin Germany | Clinic<br />
Stem Cell Transpl<br />
SAP378<br />
CKD IMPAIRS FUNCTIONALITY OF MESENCHYMAL STEM CELLS (MSC)<br />
IN VITRO AND IN VIVO<br />
Barbara Mara Klinkhammer | Kramann Rafael | Mallau Monika | Makowska<br />
Anna | Claudia van Roeyen | Peter Boor | Buecher Eva Bettina | Otten Simon |<br />
Stuettgen Esther | Jürgen Floege | Uta Kunter<br />
Univ Hosp RWTH Aachen, Nephrology and Clinical Immunology, Aachen, Germany<br />
| RWTH Aachen Univ<br />
SAP379<br />
PRO-CALCIFYING CELL FUNCTIONS OF MESENCHYMAL STEM CELLS IS<br />
DIFFERENTIALLY MODULATED BY UREMIC RETENTION SOLUTES – A SY-<br />
STEMATIC ANALYSIS<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Björn Hegner | Daniel Janke | Theres Schaub | Claudia Lange | Joachim Jankowski<br />
| Duska Dragun<br />
Dept Nephrology and Intensive Care Medicine | Charite, Berlin Germany | Clinic<br />
for Stem Cell Transpl | Dept Nephrology<br />
SAP380<br />
LIPOPOLYSACCHARIDE INCREASES CALCIFICATION IN VASCULAR<br />
SMOOTH MUSCLE CELLS BY HIGH INORGANIC PHOSPHATE AND HIGH<br />
CALCIUM CONCENTRATION MEDIA<br />
Matsuhiko Hayashi | Ichiro Takamatsu | Chihiro Horimai | Tadashi Yoshida<br />
Apheresis and Dialysis Center, Keio Univ, School Medicine, Tokyo, Japan<br />
SAP381<br />
HYPERPHOSPHATEMIA DIRECTLY AFFECTS ENDOTHELIAL FUNCTION<br />
BY DOWN-REGULATING ANNEXIN II<br />
Giovanna Seno Di Marco | Maximilian Koenig | Christian Stock | Stephanie<br />
Reiermann | Susanne Amler | Gabriele Koehler | Manfred Fobker | Friedrich<br />
Buck | Hermann Pavenstaedt | Detlef Lang | Marcus Brand<br />
Univ Muenster<br />
SAP382<br />
ANTIOXIDATIVE STRATEGY TO PROTECT THE KIDNEY FROM EXPERI-<br />
MENTAL PYELONEPHRITIS IN VITRO AND IN VIVO<br />
Egor Plotnikov | Maria Morosanova | Irina Pevzner | Ljubava Zorova | Natalya<br />
Pulkova | Dmitry Zorov<br />
Belozersky Inst Physico-Chemical Biology, Moscow State Univ | Fac Bioengineering<br />
and Bioinformatics, Mitoengineering Res Inst, Lomonosov Moscow State<br />
Univ, Moscow, Russia | Mitoengineering Res Inst, Lomonosov Moscow State<br />
Univ, Moscow, Russia<br />
SAP383<br />
RESPONSE OF VEGF TO ACTIVATION OF VIRAL RECEPTORS AND TNFα IN<br />
IMMUNE MEDIATED GLOMERULONEPHRITIS<br />
Markus Wörnle | Andrea Ribeiro | Franziska Belling | Monika Merkle<br />
Medical Policlinic, Univ Munich, Germany<br />
SAP384<br />
ABNORMAL CONFORMATION AND IMPAIRED DEGRADATION OF NEU-<br />
TROPHIL EXTRACELLULAR TRAPS INDUCED BY PROPYLTHIOURACIL<br />
ARE IMPLICATED IN THE PATHOGENESIS OF MPO-ANCA-ASSOCIATED<br />
VASCULITIS<br />
Daigo Nakazawa | Saori Nishio | Sekiya Shibasaki | Utano Tomaru | Ishizu<br />
Akihiro<br />
Hokkaido Univ Hosp, Internal Medicine II | Hokkaido Univ, Internal Medicine<br />
II | Hokkaido Univ, Dept Pathology | Hokkaido Univ, Fac Health Sciences<br />
SAP385<br />
AMELIORATED DUAL ABNORMALITIES OF MEGALIN AND NAPI-IIC EX-<br />
PRESSIONS IN PROXIMAL RENAL TUBULES BY ORAL PREDNISOLONE<br />
TH<strong>ERA</strong>PY IN A CASE OF ANTI-MITOCHONDRIAL ANTIBODIES-M2 POSI-<br />
TIVE TUBULOINTERSTITIAL NEPHRITIS WITH FANCONI SYNDROME<br />
Ikue Kobayashi | Yasuo Imanishi | Masafumi Kurajoh | Yuki Nagata | Masayo<br />
Yamagata | Masanori Emoto | Toshimi Michigami | Eiji Ishimura | Masaaki<br />
Inaba<br />
Osaka City Univ Grad School Medicine, Osaka, Japan | Res Inst, Osaka Medical<br />
Center Maternal and Child Health, Osaka, Japan<br />
SAP386<br />
RALOXIFENE AMELIORATES PROTEINURIA-INDUCED INFLAMMASOME<br />
ACTIVATION AND TUBULAR INJURY<br />
Yuko Nishi | Minoru Satoh | Tamaki Sasaki | Naoki Kashihara<br />
Kawasaki Medical School, Kurashiki, Japan<br />
SAP387<br />
RESV<strong>ERA</strong>TROL ENHANCES ENDOGENOUS HEME OXYGENASE-1 AND<br />
ANTI-COMPLEMENTARY ACTIVITY TO AMELIORATE EXPERIMENTAL<br />
MURINE MEMBRANOUS NEPHROPATHY<br />
Chia-Chao Wu | Kuo-Cheng Lu | Jin-Shuen Chen | Pauling Chu | Yuh-Feng Lin<br />
Div Nephrology, Dept Medicine, Tri-Serv General Hosp, National Defense Me-<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
301<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
302<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
dical Center, Taipei, Taiwan | Dept Medicine, Cardinal Tien Hosp, School Medicine,<br />
Fu Jen Catholic Univ, New Taipei city, Taiwan | Div Nephrology, Dept<br />
Medicine, Shuang-Ho Hosp, Taipei Medical Univ, Taipei, Taiwan<br />
SAP388<br />
LIPOCALIN-2 IS AN ENDOGENOUS INHIBITOR OF INFLAMMATION IN<br />
MURINE NEPHROTOXIC SERUM NEPHRITIS<br />
Kathrin Eller | Andrea Schroll | Miriam Banas | Alexander Kirsch | Julia Huber|<br />
Günter Weiss | Igor Theurl | Alexander R. Rosenkranz<br />
Medical Univ Graz, Graz, Austria | Medical Univ Innsbruck, Innsbruck, Austria|<br />
Medical Univ Regensburg, Regensburg, Germany<br />
SAP389<br />
DEVELOPMENTAL RELATIONSHIP OF HUMAN MONOCYTE SUBSETS<br />
AND THE IMPACT OF IMMUNOSUPPRESSANTS ON MONOCYTE SUBPO-<br />
PULATIONS<br />
Adam Zawada | Kyrill Rogacev | Marina Achenbach | Danilo Fliser | Gerhard<br />
Held | Gunnar Henrik Heine<br />
Dept Internal Medicine IV, Dept Internal Medicine I, Saarland Univ Medical Center,<br />
Homburg, Germany<br />
SAP390<br />
A UREMIC TOXIN, 3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIO-<br />
NATE ACCUMULATES IN PROXIMAL TUBULAR CELLS AND INDUCES<br />
CELL DAMAGE THROUGH INCREASING OXIDATIVE STRESS<br />
Yohei Miyamoto | Yasunori Iwao | Hiroshi Watanabe | Daisuke Kadowaki |<br />
Yu Ishima | Victor Tuan Giam Chuang | Keizo Sato | Masaki Otagiri | Toru<br />
Maruyama<br />
Dept Biopharmaceutics, Grad School Pharmaceutical Sciences, Kumamoto Univ,<br />
Kumamoto, Japan | School Pharmaceutical Sciences, Univ Shizuoka, Shizuoka,<br />
Japan | School Pharmacy, Fac Health Sciences, Curtin Health Innovation Res<br />
Inst, Curtin Univ, Western Australia, Australia | School Pharmacy, Kyushu Univ<br />
Health and Welfare, Nobeoka, Japan | Fac Pharmaceutical Sciences, Sojo Univ,<br />
Kumamoto, Japan<br />
SAP391<br />
THE EFFECT OF INDOXYL SULFATE ON INTESTINAL IMMUNOLOGY IN<br />
CHRONIC KIDNEY DISEASE<br />
Yoshiyasu Ueda | Hirotsugu Iwatani | Yoshitaka Isaka<br />
Osaka Univ, Suita, Japan<br />
SAP392<br />
p-CRESYL SULFATE CAUSES RENAL TUBULAR CELL DAMAGE BY INDU-<br />
CING OXIDATIVE STRESS THROUGH THE ACTIVATION OF NADPH OXI-<br />
DASE<br />
Hiroshi Watanabe | Daisuke Honda | Yohei Miyamoto | Tsuyoshi Noguchi |<br />
Daisuke Kadowaki | Yu Ishima | Motoko Tanaka | Hisae Tanaka | Masafumi<br />
Fukagawa | Masaki Otagiri | Toru Maruyama<br />
Dept Biopharmaceutics, Grad School Pharmaceutical Sciences, Kumamoto Univ,<br />
Kumamoto, Japan | Dept Nephrology, Akebono Clinic, Kumamoto, Japan | Div<br />
Nephrology, Endocrinology and Metabolism, Tokai Univ School Medicine, Kanagawa,<br />
Japan | Fac Pharmaceutical Sciences, Sojo Univ, Kumamoto, Japan<br />
SAP393<br />
IMMUNOMODULATORY EFFECTS OF TUMOR NECROSIS FACTOR ALPHA<br />
AND TNF RECEPTOR SYSTEM: IMPLICATIONS FOR IMMUNE MEDIATED<br />
GLOMERULAR AND VASCULAR DISORDERS AND THEIR TH<strong>ERA</strong>PY WITH<br />
BIOLOGICAL AGENTS<br />
Markus Wörnle | Andrea Ribeiro | Joachim Pircher | Simone Köppel | Hanna<br />
Mannell | Florian Krötz | Monika Merkle<br />
Medical Policlinic, Univ Munich, Germany | Walter-Brendel-Centre Experimental<br />
Medicine, Univ Munich, Germany<br />
SAP394<br />
EFFECT OF CARDIORENAL SYNDROME TYPE 1 PLASMA ON MONOCYTES<br />
APOPTOSIS: A PILOT STUDY<br />
Grazia Maria Virzì | Chiara Bolin | Dinna Cruz | Elisa Scalzotto | Massimo de<br />
Cal | Giorgio Vescovo | Claudio Ronco<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Dept Nephrology, Dialysis and Transpl, St Bortolo Hosp, IRRIV-International<br />
Renal Resarch Inst Vicenza, Italy | Internal Medicine, St Bortolo Hosp , Vicenza,<br />
Italy | San Bortolo Hosp Vicenza | Div Nephrology, Univ Padua, Padua, Italy<br />
SAP395<br />
TYPICAL PLASMA PROFILE IN CARDIORENAL SYNDROME TYPE 1 PA-<br />
TIENTS<br />
Grazia Maria Virzì | Chiara Bolin | Dinna Cruz | Elisa Scalzotto | Massimo de<br />
Cal | Giorgio Vescovo | Claudio Ronco<br />
Dept Nephrology, Dialysis and Transpl, St Bortolo Hosp, IRRIV-International<br />
Renal Resarch Inst Vicenza, Italy | Internal Medicine, St Bortolo Hosp , Vicenza,<br />
Italy | San Bortolo Hosp Vicenza | Div Nephrology, Univ Padua, Padua, Italy<br />
SAP396<br />
INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE M PREVENTS CHRO-<br />
NIC AFTER ACUTE KIDNEY INJURY THROUGH SUPPRESSION OF RENAL<br />
INFLAMMATION<br />
Regina Gröbmayr | Maciej Lech | Mi Ryu | Hans-Joachim Anders<br />
Medizinische Klinik und Poliklinik IV, Univ Munich, Munich, Germany | Renal<br />
Div, Medizinische Klinik und Poliklinik IV, Univ Munich, Munich, Germany |<br />
LMU, Munich, Germany | Nephrological Center, Medical Policlinic, Univ Munich,<br />
Germany<br />
SAP397<br />
VITAMIN D RECEPTOR ACTIVATORS INHIBIT VASCULAR SMOOTH MU-<br />
SCLE CELL MIN<strong>ERA</strong>LIZATION INDUCED BY PHOSPHATE AND TNF-α<br />
Yumie Aoshima | Masahide Mizobuchi | Hiroaki Ogata | Chiaki Kumata | Ai<br />
Nakazawa | Fumiko Kondo | Naoko Ono | Fumihiko Koiwa | Eriko Kinugasa|<br />
Tadao Akizawa<br />
Dept Nephrology, Showa Univ School of Medicine, Tokyo, Japan<br />
SAP398<br />
RENAL AFFERENT NEURONS EXHIBIT AN ALTERED FIRING PATTERN IN<br />
AN IN VITRO MODEL OF KIDNEY INFLAMMATION<br />
Wolfgang Freisinger | Nena Lale | Angelika Lampert | Tilmann Ditting | Sonja<br />
Heinlein | Roland E. Schmieder | Roland Veelken<br />
Med Clinic 4, Inst Physiology and Pathophysiology, Univ Erlangen-Nürnberg,<br />
Germany<br />
SAP399<br />
EFFECT OF CHRONIC ADMA INFUSION IN RATS ON WHITE BLOOD CELL<br />
COUNT, LEUKOCYTE SUBSETS AND TISSUE NK CELLS<br />
Heike Nave | Ronny Perthel | Mayuren Suntharalingam | Stefanie Bode-Böger|<br />
Gernot Beutel | Jan Kielstein<br />
Martin Luther Univ Halle-Wittenberg | Medical School Hannover | Otto-von-<br />
Guericke Universtiy<br />
SAP400<br />
CONNECTIVE TISSUE GROWTH FACTOR INDUCES A SUSTAINED IN-<br />
FLAMMATORY RESPONSE IN THE KIDNEY AND VESSELS VIA LOCAL IN-<br />
TERLEUKIN 17A PRODUCTION<br />
Raquel Rodrigues-Díez | Raul Rodrigues-Diez | Sandra Rayego-Mateos | Carolina<br />
Lavoz | Luiz Guilherme Stark Aroeira | Macarena Orejudo | Matilde Alique|<br />
Alberto Ortiz | Jesus Egido | Marta Ruiz-Ortega<br />
Cellular Biology Renal Diseases Lab Univ Autónoma Madrid, Spain | IDIPAZ,<br />
Madrid, Spain | Dialysis Unit, Fund Jiménez Díaz, Madrid, Spain| IIS-FJD, Madrid,<br />
Spain<br />
SAP401<br />
NON-HLA ANTIBODIES TARGETING G-PROTEIN COUPLED RECEPTORS<br />
INDUCE mTORC1 AND mTORC2 SIGNALLING IN HUMAN MICROVASCU-<br />
LAR ENDOTHELIUM<br />
Wischnewski Oskar | Catar Rusan | Theres Schaub | Björn Hegner | Duska<br />
Dragun<br />
Charité-Univsmedizin Berlin, Germany | Dept Nephrology and Intensive Care<br />
Medicine<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
303<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
304<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP402<br />
ENDOTHELIAL GLYCOCALYX DAMAGE IN CHRONIC KIDNEY DISEASE<br />
COINCIDENCES WITH ENDOTHELIAL DYSFUNCTION<br />
Jan-Sören Padberg | Anne Wiesinger | Marcus Brand | Giovanna Seno Di Marco|<br />
Stefan Reuter | Alexander Grabner | Dominik Kentrup | Alexander Lukasz|<br />
Hans Oberleithner | Hermann Pavenstädt | Philipp Kümpers<br />
Dept Medicine D, Div Internal Medicine, Nephrology, and Rheumatology, Univ<br />
Hosp Münster, Münster, Germany | Dept Nephrology & Hypertension, Hannover<br />
Medical School | Inst Physiology II, Univ Muenster<br />
SAP403<br />
COMPLEMENT REGULATION BY HUMAN FACTOR H-RELATED PROTEIN<br />
2 (CFHR2) IS LINKED TO MPGN I<br />
Hannes U Eberhardt | Christine Skerka | Qian Chen | Teresia Hallstroem |<br />
Andrea Hartmann | Markus J Kemper | Peter F Zipfel<br />
Leibniz Inst Natural Product Res and Infection Biology, Jena, Germany | Univ<br />
Hosp Eppendorf, Hamburg, Germany<br />
SAP404<br />
C-MIP IS A NEGATIVE REGULATOR OF T-LYMPHOCYTE ACTIVATION<br />
AND REPRODUCES IN VIVO SOME T LYMPHOCYTE DISORDERS OBSER-<br />
VED IN ACTIVE MCNS<br />
Kélhia N'Gomé-Sendeyo | Qing-Feng Fan | Shao-Yu Zhang | André Pawlak |<br />
Djillali Sahali<br />
INSERM U955 équipe 21, Créteil, France<br />
SAP405<br />
ROLE OF RECEPTORS OF THE INNATE IMMUNE SYSTEM IN GLOMERU-<br />
LAR FIBRIN DEPOSTIION AND FIBROSIS<br />
Markus Wörnle | Andrea Ribeiro | Monika Merkle<br />
Medical Policlinic, Univ Munich, Germany<br />
SAP406<br />
IRON DEFICIENCY ANAEMIA INCREASES RENAL OXIDATIVE STRESS<br />
AND INFLAMMATION IN SPONTANEOUSLY HYPERTENSIVE STROKE<br />
PRONE RATS TREATED WITH DOXORUBICIN<br />
Jorge Toblli | Gabriel Cao | Jorge Fernando Giani | Fernando Pablo Dominici<br />
Lab Experimental Medicine, Hosp Alemán | School Pharmacy Univ Buenos Aires,<br />
Argentina<br />
SAP407<br />
THE BLOCKING OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM CAN<br />
DECLINE BOTH EPO AND EPO RECEPTOR IN CKD RAT<br />
Jae Seok Kim | Jae Won Yang | Min Keun Kim | Byoung Geun Han | Seung<br />
Ok Choi<br />
Yonsei Univ Wonju College Medicine, Wonju, Korea<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
RENAL HISTOPATHOLOGY<br />
SAP408<br />
COMPLEMENT PATHWAYS ACTIVATION IN PAUCI-IMMUNE NECROTI-<br />
ZING GLOMERULONEPHRITIS WITH ANTINEUTROPHIL CYTOPLASMIC<br />
AUTOANTIBODY<br />
Figuères Marie-Lucile | Noel Laure-Hélène | Chaabouni Yosr | Moreau Anne|<br />
Fakhouri Fadi<br />
Serv Anatomopathologie, Hôp Necker, Paris, France | Serv Néphrologie, Tunis,<br />
Tunisie | Serv Anatomopathologie, CHU Nantes, France | Serv Néphrologie,<br />
CHU Nantes, France<br />
SAP409<br />
COMPUTERIZED INSTERSITIAL FIBROSIS IS THE MOST POWERFUL HI-<br />
STOLOGICAL PREDICTOR OF RENAL OUTCOME IN ANCA-ASSOCIATED<br />
VASCULITIS<br />
Charlene Levi| Vannary Meas-Yedid | Cristina Daniliuc | Alexandre Karras |<br />
Jean Christophe Olivo-Marin | Luc Mouthon | Elsa Guiard | Melanie Roland |<br />
Loic Guillevin | Christian Jacquot | Dominique Nochy | Eric Thervet<br />
Hop Europeen Georges Pompidou | Lab Analyse Images Quantitative, Inst Pasteur<br />
| Hop Cochin<br />
SAP410<br />
THE EUROPEAN MPGN REGISTRY: NOVEL GENETIC- AND AUTOIMMU-<br />
NE- FACTORS ALLOW A DIFFERENTIATION BETWEEN MPGN SUBTYPE I<br />
AND SUBTYPE II<br />
Qian Chen | Barbara Uzonyi | Susann Lindner | Christoph Licht | Bernd Hoppe|<br />
Magdalena Riedl | Michael Kirschfink | Sandra Habbich | Gunter Wolf |<br />
Lisa Strain | Timothy HJ Goodship | Peter F Zipfel<br />
Leibniz Inst Natural Product Res and Infection Biology, Jena Germany | Hosp<br />
Sick Children, Toronto, Canada | Univ Children's Hosp, Cologne, Germany |<br />
Univ Innsbruck, Austria | Univ Heidelberg, Germany | Imoversoty Cjildren's<br />
Hosp Cologne, Germany | Univ Hosp Jena, Germany | Newcastle upon Tyne<br />
Hosp, Newcastle upon Tyne, UK<br />
SAP411<br />
VALIDITY OF OXFORD CLASSIFICATION OF IgA NEPHROPATHY IN ARABS<br />
Hala Kfoury | Abdulkareem Alsuwaida | Khaled Alsaad | Fayez Alhejaili |<br />
Mohammed Alghonaim | Jamal Alwakeel | Sufia Husain | Noura AlOudah<br />
King Saud Univ, Riyadh, Saudi Arabia | King Abdulaziz Medical City, College<br />
Medicine, King Saud bin Abdulaziz Univ Health Sciences, Riyadh, Saudi Arabia|<br />
King Saud Univ, King Khalid Univ Hosp, Dept Medicine, Riyadh, Saudi Arabia |<br />
King Saud Univ, King Khalid Univ Hosp, Dept Pathology, Riyadh, Saudi Arabia<br />
SAP412<br />
LAPAROASSISTED RETROPERITONEAL KIDNEY BIOPSY (LKB) IN PA-<br />
TIENTS WITH CONTRAINDICATIONS TO PERCUTANEOUS KIDNEY BIOP-<br />
SY (PKB)<br />
Luca Besso | Michela Tamagnone | Germana Daidola | Manuel Burdese | Lorenzo<br />
Repetto | Giovanni Pasquale | Loredana Colla | Luigi Biancone | Piero<br />
Stratta | Giuseppe Paolo Segoloni<br />
Nephrology, Molinette Hosp, Turin, Italy | Dept Internal Medicine, Nephrology,<br />
Univ Turin,Turin, Italy | Urology, Molinette Hosp, Turin, Italy | Nephrology,<br />
Piemonte Orientale Univ, Novara, Italy<br />
SAP413<br />
RENAL BIOPSY DATABASE FROM THE DEPT PATHOLOGY DUBRAVA<br />
UNIV HOSP ZAGREB<br />
Jasna Bacalja | Ana Marija Bauer Šegvić | Stela Bulimbašić | Arijana Pačić| Mladen<br />
Knotek | Mirjana Sabljar Matovinović | Krešimir Galešić | Danica Galešić<br />
Ljubanović<br />
Univ Hosp Dubrava Zagreb, Zagreb, Croatia | Dubrava Univ Hosp, Zagreb, Croatia<br />
| Merkur Univ Hosp, Zagreb, Croatia<br />
SAP414<br />
MORPHOLOGICAL CHARACTERISTICS OF KIDNEY INVOLVEMENT IN<br />
NON-HODGKIN LYMPHOMA/LEUKEMIA, LYMPHOPLASMACYTIC LYM-<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
305<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
306<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
PHOMA AND ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA – ONE<br />
CENTER EXPERIENCE<br />
Elena Zakharova | Ekaterina Stolyarevich | Olga Vorobjova<br />
City Hosp n.a. S.P. Botkin, Moscow, Russian Federation | Moscow City Nephrology<br />
Center | Leningrad Regional Patology Bureau<br />
SAP415<br />
ACTIVATION OF MAPK/ERK SIGNALING PATHWAY IN MESANGIAL<br />
CELLS IS ASSOCIATED WITH GLOMERULAR DAMAGE IN IGA NEPHRO-<br />
PATHY<br />
Houda Tamouza | Jonathan Maurice Chemouny | Martin Flamant | Leona Raskova<br />
Kafkova | Marie Demion | Mesnard Laurent | Francine Walker | Bruce<br />
A Julian | Emilie Tissandié | Meetu Kaushik Tiwari | Jan Novak | Niels Olsen<br />
Camara | Marc Benhamou | Francois Vrtovsnik | Renato C Monteiro | Ivan<br />
Cruz Moura<br />
INSERM U699, Paris, France | APHP, Paris, France | Dept Microbiology, Univ<br />
Alabama Birmingham, Birmingham, AL, USA | INSERM U702, Paris, France |<br />
Dept Pathology, Hôp Bichat-Claude Bernard, Paris, France | Transpl Immunobiology<br />
Lab, São Paulo, Brazil | Hôp Bichat, AP-HP<br />
SAP416<br />
CORRELATION OF INFLAMMATORY CELL INFILTRATION AND HISTOLO-<br />
GIC AND CLINICAL MANIFESTATIONS OF LUPUS NEPHRITIS<br />
Shiva Samavat | Pedram Ahmadpoor | Peyman Torbati | Ramin Ghaderi | Fatemeh<br />
Poorrezagholi | Fariba Samadian | Mohsen Nafar<br />
Labbafinejad Hosp, Tehran, Iran<br />
SAP417<br />
GLOMERULAR CAPILLARY INJURY IN THE ENDOCAPILLARY PROLIFE-<br />
RATIVE LESIONS OF VARIOUS GLOMERULONEPHRITIS<br />
Akiko Mii | Akira Shimizu | Tomohiro Kaneko | Fumihiko Yasuda | Megumi<br />
Fukui | Yukinari Masuda | Yasuhiko Iino | Yasuo Katayama<br />
Nippon Medical School, Tokyo, Japan<br />
SAP418<br />
NCAM POSITIVE INTERSTITIAL CELLS INCREASE IN INTERSTITIAL FIBRO-<br />
SIS IN DIFFERENT RENAL DISEASES<br />
Claudia Müller | Jasmina Marković-Lipkovski | Sanja Simić-Ogrizović | Radomir<br />
Naumović | Sanja Ćirović | Dragan Mitrović | Gerhard Müller<br />
Univ Tübingen, ZMF – Zentrum Med Forschung, Tübingen, Germany | Univ<br />
Belgrade, Fac Medicine, Nephrology Clinic, Belgrade, Serbia | Univ Belgrade -<br />
Fac Medicine, Inst Pathology, Belgrade, Serbia | Univsmedizin Göttingen, Zentrum<br />
Innere Medizin, Göttingen, Germany<br />
SAP419<br />
PROGNOSTIC MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL FAC-<br />
TORS IN PATIENTS WITH SCHOENLEIN-HENOCH NEPHROPATHY<br />
Aldona Wozniak | Małgorzata Janicka-Jedyńska | Jakub Żurawski | Elżbieta<br />
Kaczmarek | Jacek Zachwieja<br />
Dept Clinical Pathology, Dept Clinical Pathomorphology, Dept Childhood Cardiology<br />
and Nephrology, Univ Medical Sciences, Poznań, Poland<br />
SAP420<br />
THE CLINICAL PRESENTATION AND COURSE OF IDIOPATHIC RENAL<br />
THROMBOTIC MICROANGIOPATHY (RTMA)<br />
S Khilji | T Dorman | P O'Kelly | L Lampty | KCP Leung | A Shadivan | C<br />
Varghese | JJ Walshe<br />
Beaumont Hosp, Dublin, Ireland<br />
SAP421<br />
IMMUNOHISTOCHEMICAL CHARACTERISTICS OF IGG4-RELATED KID-<br />
NEY DISEASE (IGG4RKD)<br />
Takao Saito | Mitsuhiro Kawano | Takako Saeki | Ichiro Mizushima | Yutaka<br />
Yamaguchi | Naofumi Imai | Hitoshi Nakashima | Hisanori Umehara<br />
Fukuoka Univ School Medicine, Fukuoka, Japan | Kanazawa Univ Hosp, Kanazawa,<br />
Japan | Nagaoka Red Cross Hosp, Nagaoka, Japan | Yamaguchi's Pathology<br />
Lab, Matsudo, Japan | Niigata Univ Grad School Medicine, Hiigata, Japan |<br />
Kanazawa Medical Univ, Ishikawa, Japan<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP422<br />
PAX-2 PROTEIN AS A MARKER OF DEDIFFERENTIATION OF PODOCYTES<br />
IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS (CGN): ASSOCIA-<br />
TION WITH CLINICAL AND MORPHOLOGICAL MARKERS OF GLOMERU-<br />
LAR DEMAGE AND NEPHROSCLEROSIS<br />
Mikhail Shvetsov | Olga Popova | Natalia Chebotareva | Aleksey Ivanov | Irina<br />
Bobkova<br />
I.M. Sechenov First Moscow State Medical Univ, Moscow, Russia<br />
SAP423<br />
CLC-5 AND PROTEINURIC NEPHROPATHY: WHICH HYPOTHESIS SUG-<br />
GEST THE STUDY OF TUBULAR AND GLOMERULAR PROTEIN?<br />
Daniela Cremasco | Monica Ceol | Licia Peruzzi | Gianna Mazzucco | Marra<br />
Giuseppina | Giuseppe Vezzoli | Rosalba Cristofaro | Angela D'Angelo | Franca<br />
Anglani | Dorella Del Prete<br />
Div Nephrology, Dept Medicine Univ Padova | Nephr Dial Traspl, Regina Margherita<br />
Children’s Hosp Torino | Patol Anat Unit, Univ Torino | Nephr Dial<br />
IRCCS Ca’ Grande Milano | Nephr Dial, U, IRCCS Hosp S Raf Milano | Lab<br />
Histomorphology and Molecular Biology Kidney, Div Nephrology, Dept Medicine,<br />
Univ Padua, Italy<br />
SAP424<br />
NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IN GLO-<br />
MERULONEPHRITIDES: AN IMMUNOHYSTOCHEMICAL EXPRESSION<br />
ANALYSIS<br />
Giuseppe Coppolino | Nicola Comi | Davide Bolignano | Valentina Piraina |<br />
Roberta Talarico | Alessandro Colombo | Gaetano Lucisano | Giorgio Fuiano<br />
Azienda Osp-Univ Magna Graecia, Catanzaro, Italy<br />
SAP425<br />
NEPHROTIC SYNDROME IN THE ADULT: DISTRIBUTION OF HISTOLOGI-<br />
CAL TYPES, REFERRING TO RENAL BIOPSIES PERFORMED IN NORTHERN-<br />
EASTERN ITALY FROM 1998 TO 2008<br />
Patrizia Bernich | Antonio Lupo | Triveneto Registry of Renal Biopsies<br />
Dept Nephrology, Verona, Italy<br />
SAP426<br />
INFLAMMATORY INDICES AND PARENCHYMAL CALCIFICATIONS IN<br />
KIDNEY TRANSPL BIOPSIES<br />
Maria Pia Rastaldi | Piergiorgio Messa | Diana Alexandru | Laurentiu Mogoanta<br />
| Ofelia Claudia Jercan<br />
IRCCS Fond Ca' Granda Osp Policlinico, Milan, Italy | Univ Medicine and Pharmacy<br />
Craiova, Romania<br />
SAP427<br />
MORPHOLOGIC MARKERS OF INTRARENAL BLOOD FLOW AND ANGIO-<br />
GENESIS DISORDERS IN CHRONIC GLOMERULONEPHRITIS: ASSOCIA-<br />
TION WITH SYSTEMIC ARTERIAL HYPERTENSION AND DISEASE ACTI-<br />
VITY<br />
Mikhail Shvetsov | Aleksey Ivanov | Veronica Uribe Villegas | Olga Popova<br />
I.M. Sechenov First Moscow State Medical Univ, Moscow, Russia<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
307<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
308<br />
PERITONEAL DIALYSIS<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP428<br />
THE EFFECT AND MECHANISM OF FLUVASTATIN ON THE EXPRESSION<br />
OF FIBRONECTIN IN HUMAN PERITONEAL MESOTHELIAL CELLS INDU-<br />
CED BY HIGH-GLUCOSE PERITONEAL DIALYSATE<br />
Jia Liu | Yanchun Liu | Yaguang Xu | Xiufen Zhao | Jun Qian | Bin Sun |<br />
Changying Xing<br />
First Affiliated Hosp Nanjing Medical Univ, Nanjing, China<br />
« SAP429<br />
EFFECTS OF TRANSPLED MESOTHELIAL CELLS DURING PERITONEAL<br />
REPAIR USING TEMP<strong>ERA</strong>TURE-SENSITIVE SV40 LARGE T ANTIGEN GENE<br />
TRANSGENIC RAT MESOTHELIAL CELLS<br />
Reo Kanda | Chieko Hamada | Takanori Nakano | Keiichi Wakabayashi | Hiroaki<br />
Io | Satoshi Horikoshi | Yasuhiko Tomino<br />
Div Nephrology, Dept Internal Medicine, Juntendo Univ Fac Medicine, Tokyo,<br />
Japan<br />
SAP430<br />
PENTRAXIN 3 EXPRESSION IN A RAT MODEL OF CONTINUOUS PERITO-<br />
NEAL DIALYSIS<br />
Nana Ishimatsu | Tetsu Miyamoto | Hiroyuki Morimoto | Junichi Nakamata |<br />
Ryoko Baba | Kaori Kanegae | Ryota Serino | Narutoshi Kabashima | Yutaka<br />
Otsuji | Yoshiaki Doi | Masahito Tamura<br />
Second Dept Internal Medicine, Dept Anatomy, Kidney Center, Univ Occupational<br />
and Environmental Health, Kitakyusyu, Japan<br />
SAP431<br />
HIGH GLUCOSE PERITONEAL DIALYSATE INDUCES APOPTOSIS THROU-<br />
GH ENDOPLASMIC RETICULUM STRESS IN PERITONEAL MESOTHELIAL<br />
CELLS<br />
Junichi Nakamata | Hiroyuki Morimoto | Ryoko Baba | Nana Ishimatsu | Tetsu<br />
Miyamoto | Kaori Kanegae | Ryota Serino | Narutoshi Kabashima | Yutaka<br />
Otsuji | Yoshiaki Doi | Masahito Tamura<br />
Second Dept Internal Medicine, Dept Anatomy, Kidney Center, Univ Occupational<br />
and Environmental Health, Kitakyushu, Japan<br />
SAP432<br />
ADMINISTRATION OF PIGMENT EPITHELIUM-DERIVED FACTOR AME-<br />
LIORATES CG-INDUCED PERITONEAL INJURY AND FIBROSIS IN MICE<br />
Takuo Kusumoto | Kei Fukami | Sho-ichi Yamagishi | Seiji Ueda | Yusuke Kaida<br />
| Takuma Hazama | Yosuke Nakayama | Ryotaro Ando | Nana Obara |<br />
Seiya Okuda<br />
Div Nephrology, Dept Medicine, Dept Pathophysiology and Therapeutics Diabetic<br />
Vascular Complications, Kurume Univ School Medicine<br />
SAP433<br />
PROTECTIVE EFFECTS OF ICODEXTRIN ON INTER-CELLULAR ADHESION<br />
MOLECULE-1 EXPRESSION VIA PROTEIN KINASE C IN HUMAN ENDO-<br />
THELIAL CELLS<br />
Masahito Tamura | Mika Matsumoto | Tetsu Miyamoto | Kaori Kanegae |<br />
Yumi Furuno | Ryota Serino | Narutoshi Kabashima | Yutaka Otsuji<br />
Univ Occupational and Environmental Health, Kitakyushu, Japan<br />
SAP434<br />
CALCITRIOL AMELIORATES CHLORHEXIDE DIGLUCONATE-INDUCED<br />
LIVER PERITONEAL FIBROSIS IN RATS<br />
Hsu Bang-Gee<br />
Tzu Chi General Hosp, Hualien, Taiwan<br />
SAP435<br />
PULSE PRESSURE IN PD PATIENTS<br />
Luisa Mazzotta | Alberto Rosati | Antonio Carlini<br />
Dept Nephrology, Lucca Hosp<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP436<br />
THE TIME HAS AN EFFECT ON THE DECLINE IN SERUM ALBUMIN CON-<br />
CENTRATIONS IN PATIENTS ON PERITONEAL DIALYSIS INCIDENTS<br />
Viviana Teixeira Henriques | Edson Zangiacomi Martinez | José Carolino Divino-Filho<br />
| Roberto Pecoits-Filho | José Abrão Cardeal da Costa<br />
Univ São Paulo, Ribeirão Preto, Brazil | Baxter Health Care and Social Medicine|<br />
Pontificia Univ Catolica Parana, Curitiba<br />
SAP437<br />
ESTIMATES OF FOOD INTAKE AND ABSORPTION OF CARBOHYDRATES<br />
IN PERITONEAL DIALYSIS (PD) AND LIPID PROFILE<br />
Viviana Teixeira Henriques<br />
Univ São Paulo<br />
SAP438<br />
ASSOCIATION BETWEEN PHYSICAL ACTIVITY MEASURED BY ACCELE-<br />
ROMETRY AND INFLAMMATION, CO-MORBIDITY, AND NUTRITIONAL<br />
STATUS IN PERITONEAL DIALYSIS PATIENTS<br />
Thiane Gama Axelsson | Bengt Lindholm | Juan Jesus Carrero | Olof Heimburger<br />
| Peter Stenvinkel | Abdul Rashid Qureshi<br />
Baxter Novum and Renal Medicine, Karolinska Inst<br />
SAP439<br />
MALNUTRITION AND INFLAMMATION AFFECT THE VIABILITY OF PERI-<br />
TONEAL MESOTHELIAL CELLS IN PERITONEAL DIALYSIS PATIENTS<br />
Masanobu Akazawa | Tomomi Uno | Eiichiro Kanda | Yoshitaka Maeda<br />
Tokyo Koysai Hosp | JA Toride Mecial Center<br />
SAP440<br />
RESIDUAL RENAL FUNCTION PREDICTS NUTRITIONAL STATE IN PERI-<br />
TONEAL DIALYSIS (PD) PATIENTS<br />
Maria Aktsiali | Sofia Antonopoulou | Konstantina Tsiolaki | Neratzoula Bakirtzi<br />
| Alexandra Patrinou | Maria Georgopoulou | Paraskevi Liaveri | Nikolaos<br />
Afentakis | George Tsirpanlis<br />
Dept Nephrology, General Hosp Athens, G. Gennimatas, Athens, Greece<br />
SAP441<br />
LOWER BASELINE PERITONEAL MEMBRANE TRANSPORT STATUS WITH<br />
STRICT PROTEIN RESTRICTION DIET DURING PREDIALYTIC PERIOD IS<br />
ASSOCIATED WITH CONSEQUENT BETTER OUTCOMES AMONG PERITO-<br />
NEAL DIALYSIS PATIENTS<br />
Takeshi Hasegawa | Hiroki Nishiwaki | Makoto Hirose | Daisuke Komukai |<br />
Hironori Tayama | Fumihiko Koiwa | Ashio Yoshimura<br />
Showa Univ Fujigaoka Hosp<br />
SAP442<br />
EFFECT OF BIOCOMPATIBLE PERITONEAL DIALYSIS FLUIDS ON DAILY<br />
URINE VOLUME, SERUM ADIPONECTIN LEVELS, SMALL SOLUTE PER-<br />
MEABILITY AND MESOTHELIAL CELL INTEGRITY SIX MONTHS AFTER<br />
CONVERSION BACK TO CONVENTIONAL PERITONEAL DIALYSIS FLUIDS<br />
Sing Leung Lui | Susan Yung | Colin Tang | Flora Ng | Wai Kei Lo | Tak Mao<br />
Chan<br />
Tung Wah Hosp, Hong Kong SAR, China | Univ Hong Kong, Hong Kong SAR,<br />
China<br />
SAP443<br />
LOW CIRCULATING ADIPONECTIN LEVELS ARE ASSOCIATED WITH IN-<br />
SULIN RESISTANCE IN NON-OBESE PERITONEAL DIALYSIS PATIENTS<br />
Hyang Mo Koo | Fa Mee Doh | Dong Eun Yoo | Hyung Jung Oh | Tae-Hyun<br />
Yoo | Kyu Hun Choi | Shin-Wook Kang | Dae Suk Han | Seung Hyeok Han<br />
College Medicine, Yonsei Univ, Seoul, Korea<br />
SAP444<br />
SURVIVAL OF INCIDENT PERITONEAL DIALYSIS PATIENTS IN BRAZIL<br />
(BRAZPD): IS OVERWEIGHT/OBESITY AN ADVANTAGE?<br />
Natalia Fernandes | Marcus Gomes Bastos | Márcia Regina Gianotti Franco | Alfredo<br />
Chaoubah | Maria da Glória Lima | Roberto Pecoits-Filho | José Carolino<br />
Divino-Filho | Abdul Rashid Qureshi<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
309<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
310<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Interdisciplinary Program Studies, Res, and Treatment Nephrology – Federal<br />
Univ Juiz Fora, Juiz de Fora – MG, Brazil | Clinica GAMEN – Rio de Janeiro |<br />
Dept Statistics – Federal Univ Juiz Fora, Juiz de Fora | Center Health and Biological<br />
Sciences, Pontifícia Univ Católica Paraná, Curitiba | Div Renal Medicine,<br />
CLINTEC, Karolinska Inst | Karolinska Inst<br />
SAP445<br />
GERIATRIC NUTRITIONAL RISK INDEX AS A RISK FACTOR FOR MORTALI-<br />
TY IN PERITONEAL DIALYSIS PATIENTS<br />
Seokhui Kang | Junyoung Do | Kyuhyang Cho | Jongwon Park | Kyungwoo<br />
Yoon<br />
Yeungnam Univ Hosp, Daegu, Korea<br />
SAP446<br />
RELATIONSHIP BETWEEN KT/V UREA VALUES, NUTRITIONAL STATUS,<br />
COMORBIDITY INDEX AND COMPONENTS OF QUALITY OF LIFE IN INCI-<br />
DENT PERITONEAL DIALYSIS PATIENTS<br />
Jin-Bor Chen | Ben-Chung Cheng | Te-Chuan Chen | Yu-Jen Su | Chien-Hsing<br />
Wu<br />
Kaohsiung Chang Gung Memorial Hosp and Chang Gung Univ College Medicine,<br />
Kaohsiung, Taiwan<br />
SAP447<br />
CLINICAL STATUS OF PATIENTS TREATED FOR MORE 10 YEARS WITH<br />
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD)<br />
Yongki Park | Jimin Jeon<br />
Dongrae BongSaeng Hosp<br />
SAP448<br />
UREMIC PRURITUS: PREVALENCE, CLINICAL CHARACTERISTICS AND<br />
IMPACT ON QUALITY OF LIFE IN PATIENTS ON MAINTENANCE PERITO-<br />
NEAL DIALYSIS<br />
Maria Tsikeloudi | Panagiotis Pateinakis | Katerina Patsatsi | Eleni Manou |<br />
Dimitrios Sotiriadis | Dimitrios Tsakiris<br />
Dept Nephrology, Papageorgiou General Hosp, Thessaloniki, Greece | Second<br />
Dept Dermatology, Medical School, Aristotle Univ Thessaloniki, Papageorgiou<br />
General Hosp, Thessaloniki, Greece<br />
SAP449<br />
TIME-DEPENDENT COVARIATES: A PROBLEMATIC IN SURVIVAL ANALY-<br />
SIS TAKING COMPETING RISKS INTO ACCOUNT. AN EXAMPLE IN PERI-<br />
TONEAL DIALYSIS<br />
Laetitia Teixeira | Anabela Rodrigues | M.J. Carvalho | António Cabrita | Denisa<br />
Mendonça<br />
PDMA, ICBAS-UP, Porto, Portugal | Nephrology Unit, CHP – Hosp Santo António,<br />
Porto, Portugal | Populations Studies Dept, ICBAS, Univ Porto, Porto,<br />
Portugal<br />
SAP450<br />
IS THE LOW-GDP SOLUTION RELATED TO CHANGE IN PERITONEAL<br />
MEMBRANE CHARACTERISTICS IN LONG-TERM PERITONEAL DIALYSIS<br />
PATIENTS?<br />
Seokhui Kang | Junyoung Do | Jongwon Park | Kyuhyang Cho | Kyungwoo<br />
Yoon<br />
Yeungnam Univ Hosp, Daegu, Korea<br />
SAP451<br />
THE HIDDEN MESSAGE OF PERITONEAL DIALYSIS EFFLUENT IN PAEDIA-<br />
TRIC PATIENTS<br />
Maurizio Bruschi | Giovanni Candiano | Laura Santucci | Salvatore Luzio |<br />
Rossella Cannavò | Gian Marco Ghiggeri | Enrico Verrina<br />
G. Gaslini<br />
SAP452<br />
ULTRASOUND GUIDED RECTUS SHEATH AND TRANSVERSUS ABDOMI-<br />
NIS PLANE BLOCK (TAP) FOR CONTINUOUS AMBULATORY PERITONEAL<br />
DIALYSIS (CAPD) CATHETERIZATION - OUR EXPERIENCE<br />
Yogesh Varadarajan | Balasubramaniyam Raju<br />
K.G Hosp and PG Medical Inst, Coimbatore, Tamilnadu, India<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP453<br />
CATHETER REVISION FOR THE TREATMENT OF INTRACTABLE EXIT SITE<br />
INFECTION/TUNNEL INFECTION IN PERITONEAL DIALYSIS PATIENTS: A<br />
SINGLE CENTER EXPERIENCE<br />
Kyu-Hyang Cho | Junyoung Do | Seokhui Kang | Jong-Won Park | Kyung-Woo<br />
Yoon | Tae-Woo Kim<br />
Dept Internal Medicine, Yeungnam Univ Hosp, Daegu, Korea | Yeungnam Univ<br />
Hosp, Daegu, Korea | Dept Internal Medicine, Soonchunhyang Univ Gumi<br />
Hosp, Gumi, Korea<br />
SAP454<br />
CHANGING PICTURE IN THE MICROBIOLOGY OF PERITONEAL DIALYSIS<br />
ASSOCIATED PERITONITIS - REPORT OVER ALMOST THREE DECADES<br />
Martin Kimmel | Niko Braun | Jörg Latus | Mark Dominik Alscher<br />
Robert-Bosch Hosp, Stuttgart, Germany<br />
SAP455<br />
32-YEARS EXPERIENCE IN PERITONEAL DIALYSIS-RELATED PERITONITIS<br />
IN ONE ACADEMIC CENTRE: CHANGES IN PERITONITIS RATES, CAUSA-<br />
TIVE ORGANISMS AND OUTCOME, RELATED TO THE IMPLEMENTATION<br />
OF THE DOUBLE-BAG Y-SET DEVICE AND DAILY MUPIROCIN ON THE<br />
EXIT-SITE<br />
Dirk Struijk | Sadie van Esch | Raymond T. Krediet<br />
AMC, Amsterdam, Netherlands<br />
SAP456<br />
THE RELEVANCE OF ANCESTRALLY ADMIXED POPULATION ON SURVI-<br />
VAL IN INCIDENT PERITONEAL DIALYSIS PATIENTS IN BRAZIL<br />
Natalia Fernandes | Tessa van den Beukel | Tiny Hoekstra | Luciana Tirapani|<br />
Kleyton de Andrade Bastos | Roberto Pecoits-Filho | Abdul Rashid Qureshi |<br />
Marcus Bastos | Friedo Dekker | José Carolino Divino-Filho<br />
Interdisciplinary Program Studies, Res, and Treatment Nephrology – Federal<br />
Univ Juiz Fora, Juiz de Fora – MG, Brazil | Leiden Univ Medical Central | Federal<br />
Univ Sergipe | Pontific Univ Paraná | Karolinska Inst | Div Renal Medicine,<br />
CLINTEC, Karolinska Inst, Stockholm, Sweden<br />
SAP457<br />
HYPONATREMIA IN PD PATIENTS; INFLUENCE OF FUROSEMIDE AND EF-<br />
FECT OF VASOPRESSIN RECEPTOR ANTAGONIST<br />
Tamura Yasuhisa | Hidetoshi Kanai | Kenji Harada | Yasuhiro Kawai<br />
Kokura Memorial Hosp<br />
SAP458<br />
PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY OF ADEQUATE<br />
DIALYSIS IN JAPANESE PATIENTS UNDERGOING PERITONEAL DIALYSIS:<br />
PERITONEAL DIALYSIS REGISTRY AND COHORT STUDY (PDR-CS)<br />
Hitoshi Sugiyama | Yasuhiko Ito | Kazuhiko Tsuruya | Hisako Yoshida | Hiroki<br />
Maruyama | Shin Goto | Masaaki Nakayama | Hidetomo Nakamoto | Hiroshi<br />
Morinaga | Seiichi Matsuo | Hirofumi Makino<br />
Okayama Univ Grad School | Nagoya Univ Grad School | Grad School Medical<br />
Sciences, Kyushu Univ | Niigata Univ Grad School | Fukushima Medical Univ|<br />
Saitama Medical School<br />
SAP459<br />
CHANGES IN BODY COMPOSITION USING BIOELECTRICAL IMPEDANCE<br />
IN PATIENTS ON PERITONEAL DIALYSIS (PD) PREVALENT<br />
María Cristina Di Gioia | Paloma Gallar | Nuria Laso | Isabel Rodriguez | Gabriela<br />
Cobo | Aniana Oliet | Julie Hynostroza | Juan Carlos Herrero | Carmen<br />
Mon | Milagros Ortiz | Ana Vigil<br />
Hosp Severo Ochoa, Leganes, Madrid, Spain<br />
SAP460<br />
WATER SOLUBLE VITAMIN E (TMG) PREVENTS GDPS INDUCED PERITO-<br />
NEAL DAMAGE<br />
Tadashi Tomo<br />
Oita Univ<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
311<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
312<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP461<br />
POLYCYSTIC KIDNEY DISEASE SHOULD NOT BE CONSIDERED AS A FOR-<br />
MAL CONTRAINDICATION FOR PERITONEAL DIALYSIS<br />
Jose Portolés | Simona Uta | Ana M Tato | Paula Lopez-Sanchez | Maite Rivera|<br />
Rosely Rodriguez-Pena | Gloria del Peso | Mayra Ortega | Carmen Felipe<br />
Hosp Univ Puerta de Hierro, Majadahonda, Spain | Hosp Univ Fund Alcorcon,<br />
Alcorcon, Spain | Hosp Univ Ramon y Cajal, Madrid, Spain | Hosp Univ La<br />
Paz, Madrid, Spain | Hosp Infanta Leonor, Madrid, Spain | Hosp Nuestra S. de<br />
Sonsoles, Avila, Spain<br />
SAP462<br />
EFFECT OF PERITONEAL DIALYSIS ON LIFE QUALITY IN PATIENTS WITH<br />
REFRACTORY END STAGE CONGESTIVE HEART FAILURE<br />
Eirini Tsampikaki | Georgios Aperis | Aristeides Kaikis | Christos Paliouras |<br />
Nikolaos Karvouniaris | Maria Maragaki | Polichronis Alivanis<br />
General Hosp Rhodes, Greece<br />
SAP463<br />
PERITONEAL DIALYSIS IN A PATIENT WITH SEVERE RECESSIVE DYSTRO-<br />
PHIC EPIDERMOLYSIS BULLOSA<br />
Birgit Kortus-Götze | Thomas Höferhüsch | Joachim Hoyer<br />
Dept Internal Medicine, Div Nephrology, Univ Medical Center, Philipps-Univ<br />
Marburg, Germany<br />
SAP464<br />
THE VARIABILITY OF HYDRATATION STATUS AFFECTS RESIDUAL RE-<br />
NAL FUNCTION IN PERITONEAL DIALYSIS PATIENTS<br />
Francesca Martino | Manish Kaushik | Maria Pia Rodighiero | Carlo Crepaldi|<br />
Claudio Ronco<br />
San Bortolo Hosp, Vicenza, Italy<br />
SAP465<br />
NGAL IN PERITONEAL DIALYSIS REFLECTS THE STATUS OF THE PERITO-<br />
NEUM<br />
Antonio Lacquaniti | Valentina Donato | Maria Rosaria Fazio | Silvia Lucisano |<br />
Valeria Cernaro | Rosaria Lupica | Michele Buemi | Carmela Aloisi<br />
Univ Messina, Messina, Italy<br />
SAP466<br />
CELL POPULATION IN PERITONEAL DIALYSIS EFFLUENT REFLECTS PERI-<br />
TONEAL MEMBRANE DAMAGE<br />
Tomomi Uno | Masanobu Akazawa | Eiichiro Kanda | Yoshitaka Maeda<br />
JA Toride Mecial Center | Tokyo Koysai Hosp<br />
SAP467<br />
QT INTERVAL DISPERSION AMONG CHRONIC AMBULATORY PERITONE-<br />
AL DIALYSIS PATIENTS AND ASSOCIATION WITH IRON STORES<br />
Nuket Bavbek Ruzgaresen | Sema Secilmis | Hakki Yilmaz | Ali Akcay | Murat<br />
Duranay<br />
Fatih Univ Medical School, Dept Nephrology, Ankara, Turkey | Ankara Education<br />
and Res Hosp, Dept Internal Medicine, Ankara, Turkey<br />
SAP468<br />
RELATIONSHIP BETWEEN FIBROBLAST GROWTH FACTOR-23 AND FETU-<br />
IN-A WITH METASTATIC CALCIFICATION AND ATHEROSCLEROSIS IN<br />
PERITONEAL DIALYSIS PATIENTS<br />
Nilgül Akalın | Mehmet Rıza Altıparmak | Sinan Trabulus | Ayşe Serap Yalın |<br />
Rezzan Ataman | Kamil Serdengeçti<br />
Istanbul Univ Cerrahpasa Medical Fac Dept Internal Medicine, Istanbul, Turkey<br />
SAP469<br />
DIALYSIS DOSE ADJUSTED TO RESIDUAL RENAL FUNCTION<br />
Karoly Schneider | Balintné Bator<br />
B.BRAUN Avitum Hungary Zrt. Dialysis Centre No. 11, Győr, Hungary<br />
SAP470<br />
HISTOLOGICAL CRITERIA FOR ENCAPSULATING PERITONEAL SCLERO-<br />
SIS – A STANDARDIZED APPROACH<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Braun Niko | Fritz Peter | Christoph Ulmer | Latus Joerg | Kimmel Martin |<br />
Biegger Dagmar | Ott German | Reimold Fabian | Dippon Juergen | Segerer<br />
Stephan | Alscher Dominik<br />
Robert-Bosch Hosp, Stuttgart | Margarete Fischer–Bosch Inst Clinical Pharmacology<br />
| Beth Israel Deaconess Medical Center, Boston, USA | Dept Mathematics,<br />
Univ Stuttgart, Germany | Div Nephrology, Univ Hosp, Zurich, Switzerland<br />
SAP471<br />
DIFFERENT PHENOTYPES OF ENCAPSULATING PERITONEAL SCLERO-<br />
SIS – MACROSCOPICAL APPEARANCE, HISTOLOGICAL FINDINGS AND<br />
OUTCOME<br />
Joerg Latus | Christoph Ulmer | Peter Fritz | Bianka Rettenmaier | Sandra Hirschburger<br />
| Stephan Segerer | Dagmar Biegger | Thomas Lang | German Ott |<br />
Martin Kimmel | Mark Dominik Alscher | Niko Braun<br />
Robert-Bosch Hosp, Stuttgart, Germany | Margarete-Fischer–Bosch Inst Clinical<br />
Pharmacology, Stuttgart, Germany | Univ Hosp, Zurich, Switzerland<br />
SAP472<br />
ENCAPSULATING PERITONEAL SCLEROSIS MAY EVOLVE WITHOUT SY-<br />
STEMIC INFLAMMATION AND ABSENCE OF RADIOLOGICAL ABNORMA-<br />
LITIES<br />
Meelad Habib | Mario Korte | Martijn Hagen | Frank Dor | Michiel Betjes<br />
Erasmus MC, Univ Medical Center, Rotterdam, Netherlands | Albert Schweizer<br />
Hosp, Dordrecht, Netherlands<br />
SAP473<br />
LOCALIZED ENCAPSULATING PERITONEAL SCLEROSIS (EPS) CONSTRIC-<br />
TING THE TERMINAL ILEUM; AN UNUSUAL APPEARANCE REQUIRING<br />
SURGICAL INTERVENTION<br />
Meelad Habib | Martijn Hagen | Mario Korte | Robert Zietse | Frank Dor |<br />
Michiel Betjes<br />
Erasmus MC, Univ Medical Center, Rotterdam,Netherlands | Albert Schweizer<br />
Hosp, Dordrecht, Netherlands<br />
SAP474<br />
ENCAPSULATING PERITONEAL SCLEROSIS- CLINICAL, RADIOLOGICAL<br />
AND HISTOLOGICAL DATA AND OUTCOME OF 49 PATIENTS<br />
Joerg Latus | Christoph Ulmer | Peter Fritz | Bianka Rettenmaier | Dagmar<br />
Biegger | Thomas Lang | German Ott | Christoph Scharpf | Martin Kimmel |<br />
Mark Dominik Alscher | Niko Braun<br />
Robert-Bosch Hosp, Stuttgart, Germany | Margarete-Fischer–Bosch Inst Clinical<br />
Pharmacology, Stuttgart, Germany<br />
SAP475<br />
CLINICAL FEATURES OF POST-TRANSPL ENCAPSULATING PERITONEAL<br />
SCLEROSIS (EPS); LESS INFLAMMATION, LOWER MORTALITY, AND A DIF-<br />
FERENT SECOND HIT COMPARED TO CLASSICAL EPS<br />
Meelad Habib | Mario Korte | Robert Zietse | Michiel Betjes<br />
Erasmus MC, Univ Medical Center, Rotterdam, Netherlands | Albert Schweizer<br />
Hosp, Dordrecht, Netherlands<br />
« SAP476<br />
THE EFFECT OF HMG-COA REDUCTASE INHIBITOR ON INSULIN RESI-<br />
STANCE IN PATIENTS UNDERGOING PERITONEAL DIALYSIS<br />
Tae Ik Chang | Dong Ho Shin | Hyung Jung Oh | Shin-Wook Kang | Dae-Suk<br />
Han | Tae-Hyun Yoo | Seung Hyeok Han<br />
Dept Internal Medicine, National Health Insurance Corporation Ilsan Hosp, Koyang,<br />
Korea, | Dept Internal Medicine, College Medicine, Yonsei Univ, Seoul,<br />
Korea<br />
SAP477<br />
LONG TERM EFFECT OF CONTINUOUS AMBULATORY PERITONEAL<br />
DIALYSIS FLUIDS WITH NEUTRAL PH AND LOW GLUCOSE DEGRADA-<br />
TION PRODUCT CONCENTRATION; A 5-YEAR RETROSPECTIVE STUDY<br />
Hun Young Choi | Yong Kyu Lee | Beom Suk Kim | Seung Hyeok Han | Tae<br />
Hyun Yoo | Hyeong Cheon Park | Ho Yung Lee<br />
Kangnam Severance Hosp, Seoul, Korea | Severance Hosp, Seoul, Korea<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
313<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
314<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP478<br />
THE SELECTION OF PERITONEAL MESOTHELIAL CELLS IS IMPORTANT<br />
FOR CELL TH<strong>ERA</strong>PY TO AMELIORATE PERITONEAL FIBROSIS<br />
Naoya Horimoto | Kenji Tuji | Shinji Kitamura | Hitoshi Sugiyama | Hirohumi<br />
Makino<br />
Dept Medicine and Clinical Science, Okayama Univ Grad School Medicine, Dentistry<br />
and Pharmaceutical Sciences | Center Chronic Kidney Disease and Peritoneal<br />
Dialysis, Okayama Univ Hosp<br />
SAP479<br />
MILD COGNITIVE IMPAIRMENT (MCI) IS MORE PREVALENT IN PERITO-<br />
NEAL DIALYSIS PATIENTS: NEUROIMAGING BY BRAIN SPECT<br />
Rei Isshiki | Masao Iwagami | Daimu Tsutsumi | Yasuhiro Mochida | Kunihiro<br />
Ishioka | Machiko Oka | Kyoko Maesato | Hidekazu Moriya | Takayasu Ohtake|<br />
Sumi Hidaka | Shuzo Kobayashi<br />
Shonan Kamakura General Hosp, Kamakura, Japan<br />
SAP480<br />
AQUAPORIN-1 AND ANGIOGENESIS IN CAPD PERITONEUM<br />
Chieko Higuchi | Yoko Tanihata | Madoka Ishii | Himiko Sugimoto | Naoyo<br />
Sato | Ai Kyono | Tetsuya Ogawa | Hideki Nishimura | Kuniaki Otsuka<br />
Tokyo Women's Medical Univ Medical Center East, Tokyo, Japan<br />
SAP481<br />
THE EFFECT OF LOW GDP SOLUTION ON PERITONEAL SOLUTE TRAN-<br />
SPORT IN CAPD PATIENTS<br />
Kyu-Hyang Cho | Jun-Young Do | Seokhui Kang | Jong-Won Park | Kyung-<br />
Woo Yoon | Tae-Woo Kim<br />
Dept Internal Medicine, Yeungnam Univ Hosp, Daegu, Korea | Dept Internal<br />
Medicine, Soonchunhyang Univ Gumi Hosp, Gumi, Korea<br />
SAP482<br />
MEDICAL AND NON MEDICAL FACTORS LIMITATING THE DEVELOP-<br />
MENT OF PD: ANALYSIS OF A PREDIALYSIS INFORMATION PROGRAM<br />
Caroline du Halgouët | Azeroual Latifa | Verhoeven Anne Sophie | Dupuis<br />
Emmanuel | Randoux Christine | Vrtovsnik François<br />
Hop Bichat, Paris, France<br />
SAP483<br />
MEMBRANE EFFECT OF PREDNISOLONE - STUDY IN VITRO<br />
Teresa Grzelak | Lucja Czyzewska-Majchrzak | Marta Kramkowska | Henryk<br />
Witmanowski | Krystyna Czyzewska<br />
Poznan Univ Medical Science, Poznan, Poland<br />
SAP484<br />
D/P CREATININE AS AN INDEPENDENT RISK FACTOR FOR TOTAL MOR-<br />
TALITY AND CARDIOVASCULAR MORTALITY IN A POPULATION OF PE-<br />
RITONEAL DIALYSIS PATIENTS<br />
Katarzyna Janda | Marcin Krzanowski | Paulina Dumnicka | Władysław<br />
Sułowicz<br />
Chair and Dept Nephrology, Jagiellonian Univ Collegium Medicum, Cracow,<br />
Poland | Dept Medical Diagnostics, Jagiellonian Univ Collegium Medicum, Cracow<br />
SAP485<br />
IS SERUM ALKALINE PHOSPHATASE A PREDICTOR OF CARDIOVASCU-<br />
LAR CALCIFICATIONS IN PERITONEAL DIALYSIS PATIENTS?<br />
Merita Rroji (Molla) | Saimir Seferi | Myftar Barbullushi | Erjola Likaj | Elizana<br />
Petrela | Nestor Thereska<br />
UHC Mother Teresa, Dept Nephrology-Dialysis-Transpl, Tirana, Albania | UHC<br />
Mother Teresa, Dept Statistic, Tirana, Albania<br />
SAP486<br />
PERITONEAL DIALYSIS IN THE LONG TERM: ELEVEN YEARS’ EXPERIEN-<br />
CE IN A SINGLE SARDINIAN CENTER<br />
Gianfranca Cabiddu | Elena Dessi | Augusta Arceri | Pisano Laura | Eleonora<br />
Manca | Maura Conti | Riccardo Cao | Antonello Pani<br />
Azienda Osp Brotzu Cagliari | Nephrology, Brotzu Hosp<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP487<br />
IMMUNOPHENOTYPING OF PERITONEAL MACROPHAGES AND THEIR<br />
SURFACE MARKERS IN PERITONEAL DIALYSIS PATIENTS<br />
Chia-Te Liao<br />
Cardiff Univ, Cardiff, UK<br />
SAP488<br />
PROGNOSTIC HOSPITALIZATIONS AND SURVIVAL FACTORS IN ELDER-<br />
LY PATIENTS ON RENAL REPLACEMENT TH<strong>ERA</strong>PY IN MEXICO<br />
Olynka Vega Vega | Angeles Mendoza de la Garza | Ricardo Correa-Rotter<br />
National Inst Nutrition, Mexico, Mexico<br />
SAP489<br />
COMBINATION TH<strong>ERA</strong>PY WITH PERITONEAL DIALYSIS AND HEMO-<br />
DIALYSIS FROM THE INITIATION OF RENAL REPLACEMENT TH<strong>ERA</strong>PY<br />
PRESERVE THE RESIDUAL RENAL FUNCTION AND IMPROVE THE PA-<br />
TIENTS’ PROGNOSIS - RETROSPECTIVE COHORT STUDY FOR 24 MONTHS<br />
Atsushi Ueda | Kei Nagai | Madoka Morimoto | Aki Hirayama | Shigeru Owada<br />
| Yukio Tonozuka | Chie Saito | Chie Saito | Kunihiro Yamagata<br />
Namegata District General Hosp | Tsukuba Univ Technology | Asao Clinic |<br />
Baxter Limited<br />
SAP490<br />
CONTRIBUTION OF FLUID STATUS TO PERITONEAL SOLUTE TRANSPORT<br />
IN PERITONEAL DIALYSIS PATIENTS<br />
Akihiko Matsuda | Yousuke Tayama | Tomonari Ogawa | Mizuki Iwanaga |<br />
Chie Noiri | Minoru Hatano | Tota Kiba | Koichi Kanozawa | Hitoshi Katou |<br />
Hajime Hasegawa | Tetsuya Mitarai<br />
Dept Nephrology and Blood Purification, Saitama Medical Center, Saitama Medical<br />
Univ, Kawagoe, Japan<br />
SAP491<br />
INFLUENCE OF RESIDUAL DIURESIS (RD) AND FRACTIONAL SODIUM EX-<br />
CRETION (FENa) AND BLOOD PRESSURE IN PERITONEAL DIALYSIS (PD)<br />
PATIENTS<br />
Silvia Ros-Ruiz | Laura Fuentes-Sanchez | Cristina Jironda-Gallegos | Elena<br />
Gutierrez-Vilches | Patricia Garcia-Frias | Domingo Hernandez-Marrero<br />
Carlos Haya Hosp<br />
SAP492<br />
RAPID DECLINE OF RESIDUAL RENAL FUNCTION IS ASSOCIATED WITH<br />
PARADOXICAL IMPROVEMENT OF NUTRITIONAL STATUS IN PERITONE-<br />
AL DIALYSIS PATIENTS WITH HEAVY PROTEINURIA<br />
Seokhui Kang | Seunghyun Lee | Kyuhyang Cho | Jongwon Park | Kyungwoo<br />
Yoon | Junyoung Do<br />
Yeungnam Univ Hosp, Daegu, Korea | Yeungnam Univ Yeongcheon Hosp, Yeongcheon,<br />
Korea<br />
SAP493<br />
HIGH SCORE IN EPWORTH SLEEPINESS SCALE PREDICT ALL CAUSE<br />
MORTALITY AND CARDIOVASCULAR EVENTS IN PERITONEAL DIALYSIS<br />
PATIENTS<br />
Xueli Lai | Wei Chen | Zhiyong Guo<br />
Dept Nephrology, Changhai Hosp<br />
SAP494<br />
THE PHARMACOLOGICAL EFFECT OF SODIUM CITRATE IN PD FLUID<br />
Magnus Braide<br />
Univ Gothenburg, Gothenburg, Sweden<br />
SAP495<br />
GLUCOSE VARIABILITY MONITORING WITH CGMS IN UREMIC PERITO-<br />
NEAL DIALYSIS PATIENTS WITH TYPE 2 DIABETES MELLITUS<br />
Vaduva Cristina | Simona Georgiana Popa | Mota Maria | Mota Eugen<br />
Haemodialysis Center, Emergency Hosp Craiova, Romania | Clinical Centre<br />
Diabetes, Nutrition, Metabolic Diseases, Nephrology Dept, Univ Medicine and<br />
Pharmacy Craiova, Romania<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
315<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
316<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP496<br />
BONE DENSITY AND VASCULAR CALCIFICATION IN PERITONEAL<br />
DIALYSIS PATIENTS<br />
Francesca Martino | Pierluigi Di Loreto | Claudio Ronco<br />
San Bortolo Hosp, Vicenza, Italy<br />
SAP497<br />
IS RESIDUAL RENAL FUNCTION AN IMPORTANT FACTOR IN CONTROL<br />
OF PHOSPHORUS LEVELS IN CONTINUOUS AMBULATORY PERITONEAL<br />
DIALYSIS PATIENTS<br />
Merita Rroji (Molla) | Saimir Seferi | Myftar Barbullushi | Elizana Petrela | Nereida<br />
Spahia | Erjola Likaj | Nestor Thereska<br />
UHC Mother Teresa, Dept Nephrology-Dialysis-Transpl, Tirana, Albania | Dept<br />
Statistic, Tirana, Albania<br />
SAP498<br />
PERINATAL OUTCOMES OF WOMEN WITH ADVANCE CHRONIC KIDNEY<br />
DISEASE THAT INITIATIED PERITONEAL DIALYSIS DURING PREGNANCY<br />
Lucio O. Sánchez Macías | Karla I. Lares Castellanos | J. Antonio Hernandez<br />
Pacheco | Olynka Vega Vega | Ricardo Correa Rotter<br />
National Medical Science and Nutrition Inst Salvador Zubirán | National Inst<br />
Perinatology Isidro Espinosa de los Reyes | National Inst Nutrition, Mexico,<br />
Mexico<br />
SAP499<br />
ANURIC PATIENTS ARE NOT MORE OVERHYDRATED UNDER ADEQUA-<br />
TE PD PRESCRIPTION: CLINICAL RELEVANCE OF MULTIFREQUENCY BIO-<br />
IMPEDANCE ANALYSIS<br />
Aguiar Pedro Ventura | Santos Olivia | Laetitia Teixeira | Vidinha Joana | Ferrer<br />
Francisco | Carvalho Maria João | Cabrita António | Anabela Soares Rodrigues<br />
Centro Hosp Porto, Hosp Santo Antonio, Porto, Portugal | PDMA, ICBAS-UP,<br />
Porto, Portugal | Hosp São Teotónio, Viseu, Portugal | Centro Hosp Coimbra,<br />
Coimbra, Portugal<br />
SAP500<br />
COMPARISON OF DIURNAL BLOOD PRESSURE PATTERN, RESIDUAL RE-<br />
NAL FUNCTION AND LEFT VENTRICULAR HYPERTROPHY IN PERITONE-<br />
AL DIALYSIS PATIENTS ON DIFFERENT REGIMENS<br />
Nuh Ataş | Yasemin Erten | Kürşad Öneç | Salih Inal | Salih Topal | Ahmet<br />
Akyel | Bülent Çelik | Gülay Ulusal Okyay | Yusuf Tavil<br />
Gazi Univ Medical School, Dept Internal Medicine, Ankara, Turkey | Gazi Univ<br />
Medical School, Dept Nephrology, Ankara, Turkey | Gazi Univ Medical School,<br />
Dept Cardiology, Ankara, Turkey | Gazi Univ Fac Health Sciencel, Dept Statistics,<br />
Ankara, Turkey<br />
SAP501<br />
MEAN PLATELET VOLUME IS RELATED TO D/P CREATININE IN PERITO-<br />
NEAL DIALYSIS<br />
Matthias Zeiler | Tania Monteburini | Rosa Maria Agostinelli | Rita Marinelli|<br />
Stefano Santarelli<br />
Dept Nephrology, Osp Carlo Urbani, Jesi, Italy<br />
SAP502<br />
ASSOCIATION BETWEEN BIOIMPEDANCE ANALYSIS PARAMETERS AND<br />
LEFT VENTRICULAR HYPERTROPHY IN PERITONEAL DIALYSIS PATIENTS<br />
Yasemin Erten | Salih Inal | Kürşad Öneç | Nuh Ataş | Gülay Ulusal Okyay |<br />
Çağrı Yaylacı | Gülşah Şahin | Yusuf Tavil | Galip Güz | Şükrü Sindel<br />
Gazi Univ, Medical School, Dept Nephrology, Ankara, Turkey | Gazi Univ,<br />
Medical School, Dept Internal Medicine, Ankara, Turkey | Gazi Univ, Medical<br />
School, Dept Cardiology, Ankara, Turkey | Gazi Univ Fac Health Sciences, Dept<br />
Nutrition and Dietetics, Ankara, Turkey<br />
SAP503<br />
MORTALITY AND PERITONITIS RISK STRATIFICATION IN PERITONEAL<br />
DIALYSIS PATIENTS: THE RELEVANCE OF C-REACTIVE PROTEIN<br />
Ana Pinho | Ana Cabrita | Anabela Malho Guedes | André Fragoso | Helena<br />
Carreira | Isabel Pinto | Idalecio Bernardo | Pedro Leao<br />
Nephrology Dept Faro Hosp, Faro, Portugal | Inst Public Health Univ Porto<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP504<br />
TRANSFORMING GROWTH FACTOR BETA (TGF-β) AS A RISK FACTOR FOR<br />
CARDIOVASCULAR DISEASE IN A POPULATION OF PERITONEAL DIALY-<br />
SIS PATIENTS<br />
Katarzyna Janda | Marcin Krzanowski | Beata Kuśnierz-Cabala | Paulina<br />
Dumnicka | Andrzej Kraśniak | Eve Chowaniec | Barbara Tabor-Ciepiela |<br />
Władysław Sułowicz<br />
Chair and Dept Nephrology, Dept Medical Diagnostics, Jagiellonian Univ Collegium<br />
Medicum, Cracow, Poland<br />
SAP505<br />
PERI-AORTIC FAT TISSUE THICKNESS IN PERITONEAL DIALYSIS PA-<br />
TIENTS<br />
Kultigin Turkmen | Orhan Ozbek | Mehmet Kayrak | Cigdem Samur | Ibrahim<br />
Guler | Halil Zeki Tonbul<br />
Konya Univ, Meram School Medicine, Konya, Turkey<br />
SAP506<br />
GSK-3BETA INHIBITION: A NOVEL TREATMENT OPTION TO DECREASE<br />
MESOTHELIAL INJURY IN EXPERIMENTAL PERITONEAL DIALYSIS<br />
Krisztina Rusai | Rebecca Herzog | Klaus Kratochwill | Lilian Kuster | Christoph<br />
Aufricht<br />
Medical Univ Vienna<br />
SAP507<br />
APD MAKES HIGH DEMANDS ON CATHETER FUNCTION – NEW SURGI-<br />
CAL PROCEDURE FOR IMPLANTATION OF TENCKHOFF CATHETERS<br />
Clemens-Magnus Meier | Danilo Fliser | Martin K. Schilling | Matthias Klingele<br />
Univsklinikum des Saarlandes, Homburg, Germany<br />
SAP508<br />
THE PREVENTION TECHNIQUE FOR PD CATHETER MALPOSITION<br />
Mizuya Fukasawa | Masayuki Takeda | Manabu Kamiyama<br />
Yamanashi Univ<br />
SAP509<br />
LEFT VENTRICULAR DIASTOLIC DYSFUNCTION AS A PREDICTOR OF RA-<br />
PID DECLINE OF RESIDUAL RENAL FUNCTION IN PATIENTS WITH PERI-<br />
TONEAL DIALYSIS<br />
Young Rim Song | Hyung Jik Kim | Sung Gyun Kim | Jwa-Kyung Kim | Jung<br />
Woo Noh | Young Ki Lee | Jong Woo Yoon | Ja-Ryong Koo<br />
Dept Internal Medicine, Hallym Univ Sacred Heart Hosp | Dept Internal Medicine,<br />
Kangnam Sacred Heart Hosp | Dept Internal Medicine, Chuncheon Sacred<br />
Heart Hosp<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
317<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
318<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
RENAL ANAEMIA - CKD 5D<br />
SAP510<br />
UP-REGULATION OF HEPCIDIN-25 BY EPOETIN-BETA AND METHOXY PO-<br />
LYETHYLENE GLYCOL-EPOETIN-BETA IS DEPENDENT ON SERUM FERR-<br />
TIN LEVEL IN HEMODIALYSIS PATIENTS<br />
Kazuya Takasawa | Chikako Takaeda | Masato Higuchi | Teiryo Maeda | Naohisa<br />
Tomosugi | Norishi Ueda<br />
Pubulic Central Hosp Matto-Ishikawa, Hakusan, Japan | Medical Care Proteomics<br />
Biotechnology Co., Ltd. | Biomarker Society | Div Advanced Medicine,<br />
Medical Res Inst, Kanazawa Medical Univ<br />
SAP511<br />
HEPCIDIN-20 AS PREDICTIVE BIOMARKER FOR HEMOGLOBIN IN HEMO-<br />
DIALYSIS PATIENTS<br />
Yusuke Sasaki | Masaya Ikezoe | Masahiro Hagiwara | Shunichi Furuhata |<br />
Minoru Murakami | Yasushi Shimonaka | Satoshi Yamazaki<br />
Chugai Pharmaceutical Co., Ltd. | Saku Central Hosp<br />
SAP512<br />
LOW HEPCIDIN LEVEL IS ASSOCIATED WITH INCREASED ERYTHROPO-<br />
IESIS IN MAINTENANCE HEMODIALYSIS (MHD) PATIENTS WITH LESS<br />
IRON STORAGE<br />
Sayuri Hamahata | Mai Oue | Takahiro Kuragano | Minoru Furuta | Mana Yahiro<br />
| Aritoshi Kida | Yoshinaga Otaki | Yukiko Hasuike | Hiroshi Nonoguchi|<br />
Takeshi Nakanishi<br />
Hyogo College Medicine<br />
SAP513<br />
THE RELATIONSHIP BETWEEN OBESITY AND HEPCIDIN LEVELS IN HAE-<br />
MODIALYSIS PATIENTS<br />
Pantelis Sarafidis | Adam Rumjon | Daniel Ackland | Helen MacLaughlin |<br />
Sukhvinder S. Bansal | Iain C. Macdougall<br />
King's College Hosp NHS Found Trust, London, UK | Inst Pharmaceutical Sciences,<br />
King's College London, London, UK | Renal Unit, King's College Hosp<br />
SAP514<br />
ON-LINE HEMODIAFILTRATION AND ERYTHROPOIETIN RESISTANCE IN<br />
HEMODIALYTIC PATIENTS: ROLE OF HEPCIDIN. PRELIMINARY RESULTS<br />
FROM REDERT STUDY<br />
Vincenzo Panichi | Alberto Rosati | Erasmo Malagnino | Riccardo Giusti | Aldo<br />
Casani | Giancarlo Betti | Paolo Conti | Giada Bernabini | Giada Bernabini |<br />
Claudio Gabrielli | David Caiani | Alessia Scatena | Massimiliano Migliori |<br />
Francesco Pizzarelli<br />
Versilia's Hosp | Nephrology and Dialysis Unit, Hosp Lucca | Nephrology and<br />
Dialysis Unit, Hosp Massa | Nephrology and Dialysis Unit, Hosp Grosseto |<br />
Nephrology and Dialysis Unit, S.Maria Annunziata Hosp, Firenze | Nephrology<br />
and Dialysis Unit, Versilia Hosp<br />
SAP515<br />
FACTORS PREDICTING THE INCREASE OF RETICULOCYTE HAEMOGLO-<br />
BIN CONTENT (CHr) FOLLOWING INTRAVENOUS IRON ADMINISTRA-<br />
TION IN HAEMODIALYSIS PATIENTS<br />
Efstathios Mitsopoulos | Maria Tsiatsiou | Ilias Minasidis | Varvara Kousoula |<br />
Eleni Intzevidou | Ploumis Passadakis | Vasilis Vargemezis | Dimitrios Tsakiris<br />
Papageorgiou General Hosp, Thessaloniki, Greece | Democritus Univ Thrace,<br />
Alexandroupolis, Greece<br />
SAP516<br />
AN OPEN, RANDOMIZED, PARALLEL GROUP, MULTI-CENTER STUDY<br />
ON THE PROGNOSIS OF HEMODIALYSIS PATIENTS IN ANEMIA TREAT-<br />
MENT BY COMBINATION TH<strong>ERA</strong>PY WITH IRON AND VITAMIN C AND<br />
ERYTHROPOIETIN (ACTIVE STUDY)<br />
Mana Yahiro | Aritoshi Kida | Yoshinaga Otaki | Yukiko Hasuike | Hiroshi<br />
Nonoguchi | Takeshi Nakanishi | Takahiro Kuragano<br />
Hyogo College Medicine<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP517<br />
A 12 MONTH RANDOMISED CONTROLLED TRIAL EXAMINING THE ESA-<br />
SPARING EFFECTS OF A VITAMIN E BONDED DIALYSIS MEMBRANE<br />
Simon W Lines | Angela M Carter | Emma J Dunn | Mark J Wright<br />
St James's Univ Hosp, Leeds, UK | Univ Leeds, Leeds, UK<br />
SAP518<br />
INTRODUCTION OF ANEMIA TREATMENT ALGORITHM USING IRON<br />
AND ESA IMPROVED HB LEVELS WITHIN THE TARGET RANGE IN HEMO-<br />
DIALYSIS PATIENTS<br />
Ryuzi Aoyagi | Takayoshi Miura<br />
Tachikawa General Hosp<br />
SAP519<br />
PREDICTIVE POWER OF ESAs RESPONSIVENESS OF RETICULOCYTIES<br />
AND THEIR SUBTYPES IN NORMORESISTANT HEMODIALYSIS PATIENTS:<br />
A TIME-DEPENDENT COX MODELS APPROACH<br />
Luciano De Paola | Gianmarco Lombardi | Giuseppe Coppolino | Luigi Lombardi<br />
SOC Nefrogy and Dialysis, AO Pugliese-Ciaccio Catanzaro | Azienda Osp-Univ<br />
Magna Graecia, Catanzaro, Italy<br />
SAP520<br />
IRON RESTRICTION WTIH ESA (ERYTHROPOIESIS STIMULATING AGENT)<br />
FOR ESA-HYPORESPONSIVENESS<br />
Yukiko Hasuike | Hiromi Fukumoto | Shoji Kaibe | Masanori Tokuyama | Aritoshi<br />
Kida | Yoshinaga Otaki | Takahiro Kuragano | Hiroshi Nonoguchi| Mana<br />
Hiwasa | Takashi Miyamoto | Haruki Ohue | Akihide Matsumoto | Kazuhiro<br />
Toyoda | Takeshi Nakanishi<br />
Hyogo College Medicine | Hiwasa Clinic, Nishinomiy, Japan | Miyamoto Clinic|<br />
Ohue Clinic | Seiyu Clinic | Meiwa Hosp<br />
SAP521<br />
MANAGEMENT OF ANEMIA IN HEMODIALYSIS PATIENTS: A RETRO-<br />
SPECTIVE STUDY ON THE PRACTICES IN FRENCH CENTERS<br />
Jacques Rottembourg | Corinne Emery | Antoine Lafuma | Jorge Wernli | Lorraine<br />
Zakin | Lamine Mahi<br />
Dialysis Unit Diaverum, Paris, France | Cemka/Eval | Vifor Pharma<br />
SAP522<br />
ANEMIA MANAGEMENT IN CHILDREN ON CHRONIC PD: A STUDY OF<br />
THE INTERNATIONAL PEDIATRIC PERITONEAL DIALYSIS NETWORK<br />
(IPPN)<br />
Dagmara Borzych-Duzalka | Yelda Bilginer | Lars Pape | Il So Ha | Mustafa<br />
Bak | Annabelle Chua | Lesley Rees | S Pesle | Francisco Cano | Agnieszka<br />
Urzykowska | Sevinc Emre | J Russcasso | V Ramela | Nikoleta Printza | Colin<br />
White | Dafina Kuzmanovska | Vogel Andrea | Dirk Müller-Wiefel | Bradley<br />
Warady | Franz Schaefer<br />
Medical Univ Gdansk, Poland | Dept Pediatric Nephrology, Hacettebe Univ,<br />
Turkey | Medizinische Hochschule, Hannover | National Univ Children’s Hosp,<br />
Seoul, South Korea | Dr Behcet Uz Children Res and Education Hosp, Izmir,<br />
Turkey | Texas Children’s Hosp, Houston, USA | Great Ormond Street Hosp<br />
Children NHS Trust, London | Hosp Pediatrico Humberto Notti, Mendoza, Argentina<br />
| Hosp Luis Calvo Mackenna, Santiago, Chile | Children’s Memorial<br />
Hosp, Warsaw, Poland | Istambul Univ, Istambul, Turkey | Serv Nefrología<br />
Hosp Niños Sor María Ludovica, La Plata, Argentina | SENNIAD, Montevideo,<br />
Uruguay | Aristoteles Univ, Thessaloniki, Greece | BC Children’s Hosp, Vancuver,<br />
Canada | Pediatric Clinic, Nephrology Unit, Skopje, Macedonia | Pontificia<br />
Univ Católica Chile, Santiago, Chile | KfH Center Children and Adolescents,<br />
Hamburg, Germany | Children’s Mercy Hosp, Kansas City, USA | Univ Heidelberg,<br />
Heidelberg, Germany<br />
SAP523<br />
THE EFFECT OF INTRAVENOUS ASCORBIC ACID IN CONTINUOUS HEMO-<br />
DIALYSIS PATIENTS WITH ANEMIA<br />
Jong Hoon Chung | Mi Kyung Park | Hyun Lee Kim | Bung Chul Shin<br />
Dept Internal Medicine, Chosun Univ Medical School, GwangJu, Korea | Dept<br />
Nursing, Nambu Univ, GwangJu, South Korea<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
319<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
320<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP524<br />
RESIDUAL STANDARD DEVIATION OF HEMATOCRIT AND THE RELATED<br />
FACTORS IN HEMODIALYSIS PATIENTS<br />
Tetsuya Fujikawa | Tadashi Kuji | Midori Kakimoto | Kazuhiko Shibata | Hidehisa<br />
Satta | Masahiro Nishihara | Seiichi Kawata | Naoaki Koguchi | Yoshiyuki<br />
Toya | Satoshi Umemura<br />
Yokohama City Univ, Yokohama, Japan | Yokohama Minami Clinic | Toshin<br />
Clinic | Yokodai Central Clinic, Yokohama, Japan<br />
SAP525<br />
MANAGEMENT OF ANEMIA WITH C<strong>ERA</strong> IN ROUTINE CLINICAL PRACTI-<br />
CE: RESULTS AT 12 MONTHS OF THE HORTENSIA STUDY IN HEMODIALY-<br />
SIS<br />
Verhelst David | Godin Michel | Hoffmann Maxime | Landais Paul | Kone Sebastien<br />
| Vrtovsnik Francois<br />
Dept Nephrology, Centre Hosp Avignon | CHU Rouen | Polyclinique La Louviere<br />
| Hosp Necker | Roche Lab | Hosp Bichat<br />
SAP526<br />
RELATIONSHIP BETWEEN ERYPTOSIS AND RED BLOOD CELL LIFESPAN<br />
IN HEMODIALYSIS PATIENTS<br />
Viktoriya Kuntsevich | Yanna Dou | Stephan Thijssen | Nathan W Levin | Peter<br />
Kotanko<br />
Beth Israel Medical Center, New York, USA | Renal Res Inst; Beth Israel Medical<br />
Cener, New york, USA<br />
SAP527<br />
IL-6 IS AN INDEPENDENT RISK FACTOR FOR RESISTANCE TO ERYTHRO-<br />
POIESIS-STIMULATING AGENTS IN HEMODIALYSIS PATIENTS WITHOUT<br />
IRON DEFICIENCY<br />
Byung Soo Kim | Won Do Park | Ho Cheol Song | Hyun Gyung Kim | Young-<br />
Ok Kim<br />
Catholic Univ Korea | Sanggye Paik Hosp, Inje Univ | Uijeongbu St. Mary's<br />
Hosp, Catholic Univ Korea<br />
SAP528<br />
BONE MARROW TARGETING CONTRIBUTES TO ERYTHROPOIETIC EQUI-<br />
VALENCE FOLLOWING INTRAVENOUS (IV) AND SUBCUTANEOUS (SC)<br />
PEGINESATIDE ADMINISTRATION IN RATS<br />
Kathryn Woodburn | Kei-Lai Fong | Yuu Moriya | Yoshihiko Tagawa<br />
Affymax Inc, Palo Alto, USA | Accellient Partners LLC, Waltham, USA | Takeda<br />
Pharmaceutical Company Ltd., Osaka, Japan<br />
SAP529<br />
APPROPRIATE FERRITIN LEVELS IN TREATMENT OF RENAL ANEMIA<br />
Teiryo Maeda | Fumiyoshi Kanda | Natumi Morita | Naohisa Tomosugi<br />
Biomarker Society.Co., Ltd. | Keio Univ Fac Nursing and Medical Care | Dept<br />
Advanced Medicine, Medical Res Inst, Kanazawa Medical Univ<br />
SAP530<br />
CHARACTERISTICS OF PATIENTS ENROLLED IN THE EUROPEAN MONI-<br />
TOR-CKD5 PHARMACOEPIDEMIOLOGICAL STUDY OF ANAEMIA MANA-<br />
GEMENT WITH BIOSIMILAR EPOETIN ALFA<br />
Gerard London | Philippe Zaoui | Adrian Covic | Frank Dellanna | David<br />
Goldsmith | Loreto Gesualdo | Johannes Mann | Christian Combe | Matthew<br />
Turner | Michael Meunzberg | Karen MacDonald | Ivo Abraham<br />
Centre Hosp FH Manhes, Fleury-Merogis, France | Centre Hosp Univ Grenoble|<br />
GI Pop Univ Hosp Medicine and Pharmacy | Dialysezentrum | Guy's and St<br />
Thomas' NHS Found Hosp | Univ Studi Bari, Bari, Italy | Schwabing Klinikum<br />
and Friedrich Alexander Univ Erlangen-Nurnburg | Centre Hop Bordeaux |<br />
Sandoz Biopharmaceuticals | Matrix45, LLC<br />
SAP531<br />
RISK-BASED INDIVIDUALISATION OF TARGET HB IN HAEMODIALYSIS<br />
PATIENTS WITH RENAL ANAEMIA IN THE POST-TREAT <strong>ERA</strong>: PHYSICIAN-<br />
REPORTED PRINCIPLES VERSUS SPECIFIED TARGET HB LEVELS (MONI-<br />
TOR-CKD5 STUDY)<br />
Loreto Gesualdo | Christian Combe | Adrian Covic | Frank Dellanna | David<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
Goldsmith | Gerard London | Johannes Mann | Philippe Zaoui | Matthew Turner<br />
| Michael Meunzberg | Karen MacDonald | Ivo Abraham<br />
Dept Emergency and Organ Transpl, Univ Bari, Italy | Centre Hop Bordeaux|<br />
GI Pop Univ Hosp Medicine and Pharmacy | Dialysezentrum | Guy's and St<br />
Thomas' NHS Found Hosp | Centre Hosp FH Manhes, Fleury-Merogis, France |<br />
Schwabing Klinikum and Friedrich Alexander Univ Erlangen-Nurnburg | Centre<br />
Hosp Univ Grenoble | Sandoz Biopharmaceuticals | Matrix 45, LLC<br />
SAP532<br />
IMPROVEMENT OF ANEMIA MANAGEMENT IN HEMODIALYSIS PA-<br />
TIENTS BY SIMULTANEOUS, ONCE EVERY TWO WEEKS ADMINISTRA-<br />
TIONS OF DARBEPOETIN ALFA AND IRON: ANEMIA DAY CONCEPT<br />
Jacques Rottembourg | Alain Guerin | Mirela Diaconita<br />
Dialysis Unit Diaverum, Paris, France<br />
SAP533<br />
RED BLOOD CELL LIFE SPAN VARIABILITY – A NOVEL INDICATOR AND<br />
ITS CLINICAL CORRELATES IN CHRONIC HEMODIALYSIS<br />
Rebecca Apruzzese | Yanna Dou | Stephan Thijssen | Anja Kruse | Georges<br />
Ouellet | Nathan W. Levin | Peter Kotanko<br />
Renal Res Inst, New York, USA<br />
SAP534<br />
A META-ANALYSIS OF FERRIC CITRATE FOR HYPERPHOSPHATEMIA:<br />
THE EFFECTS OF AN ORAL IRON-CONTAINING PHOSPHATE BINDER ON<br />
SERUM FERRITIN AND SATURATED TRANSFERRIN IN HEMODIALYSIS<br />
PATIENTS<br />
Christopher Bond | Donna Jensen | Steven Wang | Elizabeth Pham | Jaime<br />
Rubin | Mohammed Sika | Robert Niecestro<br />
DaVita Inc, Denver, CO, USA | Vanderbilt Univ | Keryx Biopharmaceuticals<br />
SAP535<br />
ERYTHROPOIETIC ACTIVITY, ABSORPTION, DISTRIBUTION, METABOLI-<br />
SM AND EXCRETION (ADME) OF PEGINESATIDE, AN ERYTHROPOIESIS<br />
STIMULATING AGENT, IN THE MONKEY<br />
Kathryn Woodburn | Kei-Lai Fong | Steven Sloneker | Paul Strzemienski | Eric<br />
Solon | Yuu Moriya | Yohihiko Tagawa<br />
Affymax Inc, Palo Alto, USA | Accellient Partners LLC, Waltham, USA | Calvert<br />
Laboratories Inc., Olyphant, USA | QPS, Newark, USA | Takeda Pharmaceutical<br />
Company Ltd., Osaka, Japan<br />
SAP536<br />
UREMIA, ANAEMIA AND MORPHOLOGICAL ABNORMALITIES OF THE<br />
RED BLOOD CELLS IN HAEMODIALYSIS: AN INVESTIGATION WITH THE<br />
ATOMIC FORCE AND SCANNING ELECTRON MICROSCOPES<br />
Dimosthenis Stamopoulos | Nerantzoula Mpakirtzi | Eirini Grapsa | Basiliki<br />
Gogola | Efthymios Manios | Nikolaos Afentakis<br />
Inst Materials Science, National Center Scientific Res Demokritos, Athens, Greece|<br />
Dept Nephrology, National Hosp Athens G. Gennimatas | Dept Nephrology,<br />
General Hosp Athens Aretaieion, Athens, Greece | Dept Nephrology, General<br />
Hosp Athens G. Gennimatas, Athens, Greece<br />
SAP537<br />
A RECENT RESURGENCE OF ANTIBODY-MEDIATED PRCA CASES IN THE<br />
UK<br />
James Ewer | Iain C. Macdougall<br />
Kings College Hosp, London, UK | Renal Unit, King's College Hosp<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
321<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
322<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
MIN<strong>ERA</strong>L AND BONE DISEASE - CKD 5D<br />
SAP538<br />
CLINICAL EVALUATION OF NOVEL PTH(1-84) BIOINTACT ASSAYS IN HE-<br />
MODIALYSIS PATIENTS<br />
Manfred Hecking | Alexander Kainz | Bernhard Bielesz | Max Plischke | Georg<br />
Beilhack | Walter H. Hoerl | Gere Sunder-Plassmann | Christian Bieglmayer<br />
Medical Univ Vienna | Dept Medicine III, Div Nephrology and Dialysis, Medical<br />
Univ Vienna, Vienna, Austria<br />
SAP539<br />
EVALUATION OF INTACT PTH IN HEAMODIALYZED PATIENTS WITH A<br />
THIRD GEN<strong>ERA</strong>TION KIT<br />
Sydney Benchetrit | Janice Green | Jacques Bernheim | Eliezer Golan<br />
Dpt Nephrology and Hypertension, Meir Medical Center | Renal Physiology<br />
Lab, Dept Nephrology and Hypertension, Meir Medical Center<br />
SAP540<br />
PLASMA FATTY ACID COMPOSITION IS ASSOCIATED WITH BONE MINE-<br />
RAL DENSITY IN HAEMODIALYSIS PATIENTS<br />
Nobuyuki Oyake | Keiko Suzuki | Saki Itoh | Kazuaki Tanabe<br />
Otsuka Clinic | Shimane Univ Fac Medicine<br />
SAP541<br />
ASSOCIATION OF SERUM PENTOSIDINE LEVEL WITH THE PREVALENCE<br />
OF FRACTURES IN HEMODIALYSIS PATIENTS<br />
Akira Fujimori | Shioko Okada | Kiyoko Yamamoto | Makoto Sakai | Nozomu<br />
Kamiura<br />
Konan Hosp, Kobe, Japan<br />
SAP542<br />
STRONG RELATIONSHIP BETWEEN BONE MICROARCHITECTURE AND<br />
ADIPONECTIN IN MAINTENANCE HEMODIALYSIS<br />
Pelletier Solenne | Fitsum Guebre-Egziabher | Justine Bacchetta | Jocelyne<br />
Drai| Michel Richard | Roland Chapurlat | Denis Fouque<br />
Hop Edouard Herriot | Hop Femme Mere Enfant | Hop Lyon Sud<br />
SAP543<br />
BONE TOURNOVER ABNORMALITIES IN DIALYSED PATIENTS<br />
Zbigniew Nowak | Kade Grzegorz | Konieczna Maria | Wańkowicz Zofia<br />
Military Inst Medicine, Warsaw, Poland<br />
SAP544<br />
BONE HISTOMORPHOMETRY IN PATIENTS UNDERGOING DIALYSIS<br />
WITH SERIOUS CALCIFICATIONS<br />
Kamil Zamboch | Jana Zahalkova | Zdenka Kosatikova | Petra Skypalova |<br />
Josef Skarda<br />
Dept Internal Medicine III, Univ Hosp and Palacky Univ Olomouc, Czech Republic<br />
| Šternberk Hosp, Dept Hemodialysis, Czech Republic | Dept Pathology,<br />
Univ Hosp and Palacky Univ Olomouc, Czech Republic<br />
SAP545<br />
EFFECT OF HIGH GLUCOSE CONCENTRATION ON THE OSTEOBLAST<br />
FUNCTION<br />
Juliana Cunha | Mirian Boim | Vanessa Ferreira | Marcelo Naves<br />
Federal Univ São Paulo, São Paulo, Brazil<br />
SAP546<br />
A NOVEL AND SIMPLE METHOD FOR EVALUATING THE AMOUNT OF<br />
INTRADIALYTIC PHOSPHATE REMOVAL<br />
Hiroshi Kikuchi | Hisaki Shimada | Yasumi Takimoto | Ryo Karasawa | Masaaki<br />
Shimotori | Kozo Ikarashi | Noriko Saito | Shigeru Miyazaki | Shinji Sakai|<br />
Masashi Suzuki<br />
Toyosaka Hosp, Kita-ku, Niigata city, Niigata pref, Japan | Kidney Center Shinraku-en<br />
Hosp, Niigata, Japan<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP547<br />
EFFECT OF CINACALCET HYDROCHLORIDE (CH) ON BONE MIN<strong>ERA</strong>L<br />
DENSITY IN HEMODIALYSIS (HD) PATIENTS WITH SECONDARY HYPER-<br />
PARATHYROIDISM (SHPT)<br />
Hiroaki Ogata | Akiko Takeshima | Masahiro Yamamoto | Kei Asakura | Tadashi<br />
Kato | Kanji Shishido | Fumihiko Koiwa | Masahide Mizobuchi | Eriko<br />
Kinugasa | Tadao Akizawa<br />
Dept Internal Medicine, Showa Univ Northern Yokohama Hosp Yokohama,<br />
Japan | Internal Medicine, Kawasaki Clinic, Kawasaki, Japan | Dept Internal<br />
Medicine, Showa Univ Fujigaoka Hosp, Yokohama, Japan | Dept Nephrology,<br />
Showa Univ School Medicine, Tokyo, Japan<br />
SAP548<br />
LANTHANUM CARBONATE: A POSTMARKETING OBSERVATIONAL STU-<br />
DY OF EFFICACY AND SAFETY<br />
Francesco Londrino | Valentina Corbani | Michela Ardini | Valeria Falqui | Tito<br />
Zattera | Giuseppe Rombola'<br />
Osp S. Andrea La Spezia Italy<br />
SAP549<br />
LANTHANUM CARBONATE (LC) INTERFERES IN MEASUREMENR OF<br />
LUMBAR BONE MIN<strong>ERA</strong>L DENSITY (BMD) WITH DUAL ENERGY X-RAY<br />
ABSORPTIOMETRY (DEXA) IN PATIENTS ON HEMODIALYSIS (HD)<br />
Hiroaki Ogata | Yui Takeshige | Masahide Mizobuchi | Kantaro Matsuzaka |<br />
Masahiro Yamamoto | Kanji Shishido | Tadao Akizawa | Eriko Kinugasa<br />
Dept Internal Medicine, Showa Univ Northern Yokohama Hosp Yokohama, Japan<br />
| Showa Univ Northern Yokohama Hosp, Yokohama, Japan | Dept Nephrology,<br />
Showa Univ School Medicine, Tokyo, Japan | Internal Medicine, Kawasaki<br />
Clinic, Kawasaki, Japan<br />
SAP550<br />
LANTHANUM PREVENTS HIGH PHOSPHATE-INDUCED VSMCs OSTEO-<br />
BLASTIC DIFFERENTATION<br />
Paola Ciceri | Elisa Volpi | Irene Brenna | Francesca Elli | Elisa Borghi | Diego<br />
Brancaccio | Mario Cozzolino<br />
Lab Experimental Nephrology, DMCO, Univ Milan | Lab Microbiology, DMCO,<br />
Univ Milan | DMCO, Univ Milan, Renal Div, San Paolo Hosp, Milan, Italy<br />
SAP551<br />
ANALYSIS OF SERUM PHOSPHATE CONTROL AND PHOSPHATE BINDER<br />
UTILIZATION IN PATIENTS NEW TO HAEMODIALYSIS<br />
Kimberley Farrand | J. Brian Copley | Jamie Heise | Moshe Fridman | Michael<br />
Keith | Arthur Silverberg<br />
Shire Pharmaceuticals, Wayne, PA, USA | AMF Consulting, Los Angeles, CA, USA<br />
SAP552<br />
LOWER SERUM PHOSPHORUS CAN BE ATTAINED BY INCREASING THE<br />
DOSE OF LANTHANUM CARBONATE<br />
Rosamund Wilson | J. Brian Copley | Lynne Poole<br />
Spica Consultants, Marlborough, UK | Shire Pharmaceuticals, Wayne, PA, USA|<br />
Shire Pharmaceuticals, Basingstoke, UK<br />
SAP553<br />
INCREASED LEVELS OF SERUM PARATHYROID HORMONE AND FIBRO-<br />
BLAST GROWTH FACTOR-23 ARE THE MAIN FACTORS ASSOCIATED<br />
WITH THE PROGRESSION OF VASCULAR CALCIFICATION IN LONG-<br />
HOUR HEMODIALYSIS PATIENTS<br />
Guillaume Jean | Eric Bresson | Charles Chazot<br />
Nephrocare Tassin-Charcot France | Clinique Protestante Caluire France<br />
SAP554<br />
BIOLOGICAL IMPACT OF TARGETED DIALYSATE CALCIUM CHANGES IN<br />
HEMODIALYSIS PATIENTS: THE KEY ROLE OF PARATHYROID HORMONE<br />
Guillaume Jean | Charles Chazot<br />
Nephrocare Tassin-Charcot France<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
323<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
324<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP555<br />
DIALYSATE CALCIUM INDIVIDUALIZATION ADJUSTED BY INTRA-<br />
DIALYTIC CALCIUM BALANCE<br />
Francisco Maduell | Marta Arias | Alexis Sentis | Nestor Rodriguez | Sonia<br />
Jimenez | Belen Alemany | Nuria Perez | Manel Vera | Nestor Fontsere | Montserrat<br />
Carrera | Aleix Cases<br />
Hosp Clinic, Barcelona, Spain | Hosp Dr Peset, Valencia, Spain<br />
SAP556<br />
INTRADIALYTIC CALCIUM BALANCE IN HEMODIALYSIS PATIENTS TRE-<br />
ATED WITH CALCIMIMETICS AND SEVELAMER HYDROCHLORIDE<br />
Makrouhi Sonikian | Theodora Miha | Iakovos Skarakis | Ioannis Karatzas |<br />
Aphroditi Karaitianou<br />
Nephrology Dept, A. Fleming General Hosp, Athens, Greece| Chemistry School,<br />
Kapodistriakon Univ, Athens, Greece | Biochemistry Dept, A. Fleming General<br />
Hosp, Athens, Greece<br />
SAP557<br />
LOW VS STANDARD CALCIUM DIALYSATE IN TREATMENT OF HAEMO-<br />
DIALYSIS PATIENTS WITH DIFFERENT SERUM PARATHYROID HORMONE<br />
LEVELS<br />
Vasilije Tomanoski | Dobrila Petkovic | Ivan Curic | Rajko Hrvacevic<br />
Special Hosp Haemodialysis Fresenius Medical Care, Novi Sad, Serbia | Fresenius<br />
Medical Care Srbija d.o.o., Belgrade, Serbia<br />
SAP558<br />
CINACALCET VS. PARICALCITOL IN HEMODIALYSIS PATIENTS<br />
Nickos Kaperonis | Christine Kourvelou | Aris Sgantzos | Dimitra<br />
Nastou|George Ntatsis | Stavroula Ziakka | Filippos Karakakis | Vasileios Nikolopoulos<br />
| Dimitra Zoubaniotou | Alexandra Koutsovasili |Antonis Zagorianakos<br />
| Vasileios Kolovos | Nikos Papagalanis<br />
Red Cross Hosp, Athens, Greece<br />
SAP559<br />
AN INTEGRATED CARE APPROACH USING ELECTRONIC PILLBOX MONI-<br />
TORING OF CINACALCET TO REACH iPTH TARGETS IN HEMODIALYSIS<br />
PATIENTS: A MULTICENTER, RANDOMIZED TRIAL<br />
Valentina Forni | Menno Pruijm | Eric Tousset | Carole Zweiacker | Isabel Menetrey<br />
| Lorenzo Berwert | Roberto Bullani | Anne Cherpillod | Luca Gabutti |<br />
Thierry Gauthier | Georges Halabi | Claudine Mathieu | Pascal Meier | Olivier<br />
Phan | Silvio Pianca | Carlo Schoenholzer | Daniel Teta | Beat von Albertini |<br />
Bernard Vrijens | Michel Burnier<br />
Univ Hosp Lausanne, Lausanne<br />
SAP560<br />
CONSISTENT USE OF CINACALCET IMPROVES CLINICAL OUTCOMES IN<br />
JAPANESE HAEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARA-<br />
THYROIDISM: MARGINAL STRUCTURAL ANALYSES FROM THE MIN<strong>ERA</strong>L<br />
AND BONE DISORDER OUTCOMES STUDY FOR JAPANESE CKD STAGE 5D<br />
PATIENTS (MBD-5D)<br />
Tadao Akizawa | Noriaki Kurita | Masahide Mizobuchi | Masafumi Fukagawa|<br />
Yoshihiro Onishi | Takuhiro Yamaguchi | Takeshi Hasegawa | Shingo Fukuma<br />
| Kiyoshi Kurokawa | Shunichi Fukuhara<br />
Dept Nephrology, Showa Univ School Medicine, Tokyo, Japan | Kyoto Univ,<br />
Kyoto, Japan | Div Nephrology, Endocrinology and Metabolism, Tokai Univ<br />
School Medicine, Isehara, Japan | Inst Health Outcomes and Process Evaluation<br />
Res | Tohoku Univ, Sendai, Japan | Showa Univ Fujigaoka Hosp | National<br />
Grad Inst Policy Studies<br />
SAP561<br />
IMPROVED CONTROL OF SECONDARY HYPERPARATHYROIDISM (SHPT)<br />
USING CINACALCET WITH LOW DOSES OF VITAMIN D (IF PRESCRIBED)<br />
IN INCIDENT HAEMODIALYSIS SUBJECTS NOT RECEIVING VITAMIN D<br />
AT ENROLMENT<br />
P Urena | I Bridges | C Christiano | S Cournoyer | K Cooper | M Farouk | N<br />
Kopyt | M Rodriguez | D Zehnder | A Covic<br />
Clinique Landy, France | Amgen Ltd, UK | East Carolina Univ, USA | Hôp<br />
Charles LeMoyne, Canada | Amgen Inc., USA | Amgen (Europe) GmbH, Swit-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
zerland | Lehigh Valley Hosp, USA | Hosp Univ Reina Sofia, IMIBIC, Spain |<br />
Warwick Medical School, UK | Parhon Univ Hosp, Gr.T. Popa Univ Medicine<br />
and Pharmacy, Romania<br />
SAP562<br />
CINACALCET HCL INDUCES DIFFICULTY OF PARATHYROIDECTOMY<br />
FOR PATIENTS WITH SECONDARY HYPERPARATHYROIDISM<br />
Yoshihiro Tominaga | Takahisa Hiramitsu | Takayuki Yamamoto | Kouji Nanmoku<br />
| Yoshiko Matsuda | Toyonori Tsuzuki<br />
Nagoya Second Red Cross Hosp, Nagoya Japan<br />
« SAP563<br />
ACTIVATED VITAMIN D ALTERS THE T CELL DIFFERENTIATION IN<br />
CHRONIC HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARA-<br />
THYROIDISM<br />
Cheng-Lin Lang | Kuo-Cheng Lu | Min-Hui Wang | Shin-Yun Liu | Jenq-Wen<br />
Huang | Chih-Kang Chiang | Kuan-Yu Hung<br />
Cardinal Tien Hosp, YongHe Br | Dept Internal Medicine, Cardinal Tien Hosp |<br />
Dept Internal Medicine, National Taiwan Univ Hosp<br />
SAP564<br />
TWO YEARS AFTER THE PUBLICATION OF THE K/DIGO CKD-MBD GUI-<br />
DELINES: WHAT DID CHANGE IN OUR TREATMENT STRATEGIES?<br />
Christos Bantis | Nicoletta-Maria Kouri | Ellada Tsandekidou | Stylianos Frangidis<br />
| Apostolos Tsiandoulas | Eleni Liakou | Gerasimos Bamichas | Maria<br />
Stangou | Aikaterini Papagianni | Georgios Efstratiadis | Taisir Natse | Dimitrios<br />
Memmos<br />
Dept Nephrology, Papanikolaou General Hosp, Thessaloniki, Greece | Dept Nephrology,<br />
Aristotle Univ Thessaloniki, Hippokration Hosp, Thessaloniki, Greece<br />
SAP565<br />
ACHIEVEMENT OF THE NKF/K-DOQI RECOMMENDED TARGET VALUES<br />
FOR BONE AND MIN<strong>ERA</strong>L METABOLISM IN INCIDENT HAEMODIALYSIS<br />
PATIENTS: RESULTS OF THE FARO-2 COHORT<br />
Mario Cozzolino | Piergiorgio Messa | Diego Brancaccio | Giuseppe Cannella|<br />
Sandro Mazzaferro<br />
DMCO, Univ Milan, Renal Div, San Paolo Hosp, Milan, Italy | CROFF, Milan,<br />
Italy | Univ Milan | H S Martino, Genova | Univ La Sapienza, Rome<br />
SAP566<br />
MIN<strong>ERA</strong>L AND BONE DISORDER AMONG PARTICIPANTS IN THE CHINA<br />
DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS): SERUM<br />
BIOMARKERS<br />
X Yu | M Guidinger | B Bieber | X Yang | F Tentori | RL Pisoni | J Qian | N<br />
Chen | Y Yan | M Wang | L Zuo | H Wang | M Wang | J Albert | S Ramirez<br />
First Affiliated Hosp Sun Yat-Sen Univ, Guangzhou, China | Univ Michigan,<br />
Ann Arbor, Michigan, USA | Arbor Res Collaborative for Health, Ann Arbor,<br />
Michigan, USA | Dept Medicine, Renji Hosp, Shanghai, China | Shanghai Ruijin<br />
Hosp, Shanghai, China | Peking Univ First Hosp, Beijing, China<br />
SAP567<br />
MIN<strong>ERA</strong>L METABOLISM IN HEMODIALYSIS PATIENTS BETWEEN GUIDE-<br />
LINES AND CLINICAL PRACTICE: A 3 YEARS RETROSPECTIVE OBSERVA-<br />
TIONAL STUDY<br />
Francesco Caccetta | Maurizio Caroppo | Fernando Musio | Anna Mudoni |<br />
Antonella Accogli | Maria Dolores Zacheo | Vitale Nuzzo<br />
Card. G. Panico Hosp, Tricase - Italy<br />
SAP568<br />
SERUM iPTH, CALCIUM AND PHOSPHATE, AND ALL-CAUSE AND CAR-<br />
DIOVASCULAR MORTALITY IN HEMODYALISIS PATIENTS: A SINGLE -<br />
CENTER 5 YEAR FOLLOW-UP ANALYSIS<br />
Gjulsen Selim | Olivera Stojceva-Taneva | Liljana Tozija | Saso Gelev | Vlatko<br />
Pusevski | Pavlina Dzekova-Vidimliski | Irena Rambabova-Busletic | Aleksandar<br />
Sikole<br />
Univ Clinic Nephrology, Univ Sts. Cyril and Methodius Skopje, R. Macedonia<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
325<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
326<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP569<br />
OBSTACLES TO MIN<strong>ERA</strong>L METABOLISM CONTROL IN HEMODIALYSIS<br />
PATIENTS: FIRST RESULTS FROM THE ITALIAN NATIONAL AUDIT<br />
Pasquale Esposito | Rosanna Coppo | Fabio Malberti | Antonio Dal Canton<br />
Nephrology, Dialysis, Transpl; Fond IRCCS Policlinico San Matteo; Pavia, Italy|<br />
Nephrology, Dialysis, Transpl, Regina Margherita Univ Hosp, Turin, Italy | Dept<br />
Nephrology, Ist Osp, Cremona- Italy<br />
SAP570<br />
COST-EFFECTIVENESS OF 99mTc-MIBI SCINTIGRAPHY FOR HAEMO-<br />
DIALYSIS PATIENTS WITH PERSISTENT OR RECURRENT HYPERPARA-<br />
THYROIDISM IN JAPAN<br />
Kensuke Moriwaki | Hirotaka Komaba | Takatoshi Kakuta | Masafumi Fukagawa<br />
Dept Health Informatics, Niigata Univ Health and Welfare, Niigata, Japan | Div<br />
Nephrology, Endocrinology and Metabolism, Tokai Univ School Medicine, Isehara,<br />
Japan<br />
SAP571<br />
POTENTIAL ROLE OF RELAXIN IN RENAL OSTEODYSTROPHY<br />
Valeria Cernaro | Rosaria Lupica | Valentina Donato | Antonio Lacquaniti |<br />
Maria Rosaria Fazio | Silvia Lucisano | Michele Buemi<br />
Polyclinic Messina, Dept Internal Medicine, Div Nephrology<br />
SAP572<br />
SIGNIFICANT POSITIVE RELATIONSHIP BETWEEN SERUN UNDERCARBO-<br />
XYLATED OSTEOCALCIN AND GLYCEMIC CONTROL IN MAINTENANCE<br />
HEMODIALYSIS PATIENTS<br />
Senji Okuno | Eiji Ishimura | Naoki Tsuboniwa | Kyoko Norimine | Kenjiro<br />
Yamakawa | Tomoyuki Yamakawa | Shigeichi Shoji | Katsuhito Mori | Yoshiki<br />
Nishizawa | Masaaki Inaba<br />
Shigasagi Hosp, Osaka, Japan | Osaka City Univ Grad School Medicine, Osaka,<br />
Japan<br />
SAP573<br />
IS VITAMIN D A CONCERN IN BLACK AFRICAN HEMODIALYSIS PA-<br />
TIENTS?<br />
Mohamed Dahaba | Sidy Seck | Moustapha Cisse<br />
Polyclinic ABC, Dakar, Senegal<br />
SAP574<br />
THE CONTROL OF CORRECTED CALCIUM, PHOSPHORUS AND INTACT-<br />
PTH WITHOUT SEVELAMER HCL FOLLOWING THE 2011 DISASTER IN<br />
JAPAN<br />
Yukinori Jotoku | Yuzuyu Sato<br />
Matsuyama, Ehime<br />
SAP575<br />
A MULTI-CENTRE, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROL-<br />
LED, MULTIPLE FIXED-DOSE STUDY OF COLESTILAN (MCI-196) VERSUS<br />
PLACEBO IN CHRONIC KIDNEY DISEASE STAGE 5 SUBJECTS ON DIALYSIS<br />
(CKD 5D) WITH HYPERPHOSPHATAEMIA AND DYSLIPIDAEMIA (DL): SA-<br />
FETY RESULTS<br />
Nada Dimkovic<br />
Clinical Dept Renal Diseases, Zvezdara Univ Medical Center, Belgrade<br />
SAP576<br />
FGF-23 LEVELS ARE ASSOCIATED WITH VASCULAR CALCIFICATION IN<br />
PERITONEAL DIALYSIS PATIENTS<br />
Ebru Asicioglu | Arzu Kahveci | Hakki Arikan | Mehmet Koc | Serhan Tuglular|<br />
Cetin Ozener<br />
Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, Istanbul, Turkey<br />
SAP577<br />
CONSISTENT MANAGEMENT OF MIN<strong>ERA</strong>L-AND-BONE DISORDER: A CA-<br />
SE-COHORT STUDY OF CAUSES OF DEATH IN HEMODIALYSIS PATIENTS<br />
WITH SECONDARY HYPERPARATHYROIDISM<br />
Masafumi Fukagawa | Ryo Kido | Hirotaka Komaba | Yoshihiro Onishi | Ta-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
kuhiro Yamaguch | Takeshi Hasegawa | Noriaki Kurita | Tadao Akizawa |<br />
Kiyoshi Kurokawa | Shunichi Fukuhara<br />
Div Nephrology, Endocrinology and Metabolism, Tokai Univ School Medicine|<br />
Inst Health Outcomes and Process Evaluation Res (iHope International)| Div Biostatistics<br />
Tohoku Univ Grad School Medicine | Div Nephrology, Dept Internal<br />
Medicine, Showa Univ Fujigaoka Hosp | Dept Epidemiology and Healthcare Res,<br />
Grad School Medicine and Public Health, Kyoto Univ | Div Nephrology, Dept<br />
Medicine, Showa Univ School Medicine | National Grad Inst Policy Studies|<br />
Dept Epidemiology and Healthcare Res, School of Public Health, Univ Kyoto<br />
SAP578<br />
BOTH VASCULAR AND VALVULAR CALCIFICATION ARE STRONG PRE-<br />
DICTORS OF 6-YEARS MORTALITY IN NON-DIABETIC PATIENTS ON<br />
MAINTENANCE HEMODIALYSIS<br />
Andrzej Krasniak | Maciej Drozdz | Grzegorz Chmiel | Piotr Podolec | Mieczyslaw<br />
Pasowicz | Martyna Kowalczyk-Michalek | Wladyslaw Sulowicz<br />
Chair and Dept Nephrology, Jagiellonian Univ, Krakow, Poland | Inst Cardiology,<br />
Krakow, Poland<br />
SAP579<br />
EFFICACY OF THE COMBINATION OF FLEXIBLE DOSES OF PARICALCITOL<br />
AND CINACALCET IN THE TREATMENT OF MOD<strong>ERA</strong>TE TO SEVERE SE-<br />
CONDARY HYPERPARATHYROIDISM IN HEMODIALYSIS PATIENTS<br />
German Perez-Suarez | Eduardo Baamonde | Elvira Bosch | Jose Ignacio Ramirez<br />
| Bilal El Hayek | Maria del Mar Lago | Cesar Garcia | Maria Dolores Checa<br />
Avericum Hemodialysis Center, Las Palmas, Spain | Hosp Univ Insular Gran<br />
Canaria, Las Palmas, Spain<br />
SAP580<br />
CLINICO-HISTOLOGIC EVALUATION OF PATIENTS WITH UREMIC TUMO-<br />
RAL CALCINOSIS RECEIVING HEMODIALYSIS<br />
Rikako Hiramatsu | Yoshifumi Ubara<br />
Toranomon Hosp, Tokyo, Japan<br />
SAP581<br />
EFFICACY, TOL<strong>ERA</strong>BILITY, SAFETY PROFILE AND SATISFACTION DE-<br />
GREE WITH CALCIUM ACETATE AND MAGNESIUM CARBONATE TREAT-<br />
MENT IN HEMODIALYSIS<br />
Karla Salas | Esteve Simo Vicent | Juan Carlos Gonzalez Oliva | Miquel Fulquet<br />
| Veronica Duarte | Monica Pou | Anna Saurina | Javier Macías | Manel<br />
Ramírez de Arellano<br />
Serv Nefrologia, Hosp Terrassa, Consorci Sanitari Terrassa (CST)| Serv Nefrologia,<br />
Hosp Mollet (Barcelona)<br />
SAP582<br />
CALCIUM ACETATE/ MAGNESIUM CARBONATE TH<strong>ERA</strong>PY IS ASSOCIA-<br />
TED WITH LOWER PROGRESSION OF LEFT VENTRICULAR MASS INDEX<br />
AND VALVULAR CALCIFICATIONS IN HAEMODIALYSIS PATIENTS<br />
Patricia Matias | Cristina Jorge | Marco Mendes | Tiago Amaral | Carina Ferreira<br />
| Inês Aires | Célia Gil | Aníbal Ferreira<br />
Nephrocare - Vila Franca de Xira, Portugal<br />
SAP583<br />
CALCIUM ACETATE AND MAGNESIUM CARBONATE ASSOCIATION: A<br />
GOOD ALTERNATIVE OF CALCIUM-BASED PHOSPHATE BINDERS<br />
Francesc Maduell | Nuria Perez | Marta Arias | Nestor Fontsere | Manel Vera|<br />
Montserrat Carrera | Alexis Sentis | Nestor Rodriguez | Carola Arcal | Josep<br />
Maria Campistol<br />
Hosp Clinic, Barcelona, Spain<br />
SAP584<br />
IS THERE ANY CORRELATION BETWEEN CARDIAC VALVE CALCIFICA-<br />
TION AND ABDOMINAL AORTIC CALCIFICATION IN HEMODIALYSIS<br />
PATIENTS?<br />
Saimir Seferi | Merita Rroji | Eriola Likaj | Elizana Petrela | Myftar Barbullushi|<br />
Nereida Zeneli | Suela Mumajesi | Nestor Thereska<br />
Univ Hosp Center Mother Teresa, Dept Nephrology- Dialysis-Transpl, Tirana,<br />
Albania | Univ Hosp Center Mother Teresa, Dept Statistic, Tirana, Albania<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
327<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
328<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP585<br />
HISTOLOGY AMD IMMUNOCHEMISTRY OF PARATHYROID GLANDS IN<br />
HEMODIALYSIS PATIENTS REFRACTORY TO CONVENTIONAL OR CIN-<br />
CALCET TH<strong>ERA</strong>PY<br />
Carlo Vulpio | Maurizio Bossola | Egidio Stigliano | Guido Fadda<br />
Catholic Univ Rome<br />
SAP586<br />
INFLUENCE OF PARATHYROIDECTOMY ON MORTALITY IN HEMO-<br />
DIALYSIS PATIENTS<br />
Ana Paula Santana Gueiros | Joaquim Oliveira Borba Junior | Andrea Bezerra de<br />
Melo da Silveira Lordsllen | José Edevanilson de Barros Gueiros<br />
UFPE, Recife, Brazil<br />
SAP587<br />
ARE THE PARATHYROID HORMONE LEVELS IN JAPANESE HEMODIALY-<br />
SIS PATIENTS UNDERESTIMATED? - SPECULATION FROM A SINGLE CEN-<br />
TER EXPERIENCE<br />
Noritomo Itami | Kazushi Tuneyama | Susumu Uemura | Hiromi Hamada |<br />
Jouji Takada | Kunihiko Takahashi<br />
Kidney Center, Nikko Memorial Hosp-Higasimuroran Satellite Clinic<br />
SAP588<br />
IMPACT OF RENAL TRANSPLANT ON CORONARY ARTERY CALCIFICA-<br />
TION IN HEMODIALYSIS PATIENTS<br />
Konstantinos Adamidis | Christos Pleros | Theodora Oikonomaki | Eirini<br />
Kyratzi | Dimitrios Exarchos | Georgios Metaxatos | Spyros Dracopoulos | Nikoletta<br />
Nikolopoulou | Theophanis Apostolou<br />
Nephrology Dept, Radiology Dept, Renal Transpl unit, Evangelismos General<br />
Hosp, Athens, Greece<br />
SAP589<br />
OBSERVATIONAL PROSPECTIVE STUDY ON INCIDENT HAEMODIALY-<br />
SIS PATIENTS: VDRA USE AND IMPACT ON SURVIVAL: RESULTS OF THE<br />
FARO-2 COHORT<br />
Piergiorgio Messa | Mario Cozzolino | Sandro Mazzaferro | Diego Brancaccio|<br />
Giuseppe Cannella<br />
Fond IRCCS Ca' Granda Policlinico Milan Italy | Osp S. Paolo Milan Italy | Univ<br />
La Sapienza Roma Italy | Osp S. Martino Genova Italy<br />
SAP590<br />
COMPLIANCE OF THE HEMODIALYSIS PATIENT TO THE NATIVE VITA-<br />
MIN D TH<strong>ERA</strong>PY<br />
Pierre Delanaye | Bernard Dubois | Jean-Marie Krzesinski | Etienne Cavalier<br />
Univ Liège<br />
SAP591<br />
REPERCUSSION OF CHOLECALCIFEROL SUPPLEMENTATION ON THE<br />
TREATMENT OF MIN<strong>ERA</strong>L METABOLISM IN HEMODIALYSIS PATIENTS<br />
Vanesa de la Fuente | Maria Teresa Gil | Patricia Gutierrez | Pablo Delgado |<br />
Jorge Ribero | Lola Arenas<br />
Hosp Perpetuo Socorro, Alicante, Spain<br />
SAP592<br />
RELATIONSHIP BETWEEN VITAMIN D ANALOGS AND LEFT VENTRICU-<br />
LAR MASS INDEX IN MAINTANENCE HEMODIALYSIS PATIENTS<br />
Siren Sezer | Emre Tutal | Zeynep Bal | Mehtap Erkmen Uyar | F. Nurhan<br />
Ozdemir Acar<br />
Dept Nephrology, Baskent Univ, Ankara, Turkey | Dept Nephrology, Baskent<br />
Univ, Adana, Turkey | Dept Nephrology, Baskent Univ, Istanbul, Turkey<br />
SAP593<br />
CHRONIC KIDNEY DISEASE - MIN<strong>ERA</strong>L BONE DISORDER EVALUATION<br />
IN PERITONEAL DIALYSIS PATIENTS<br />
Rodrigo Azevedo de Oliveira | Fellype Carvalho Barreto | Monique Mendes |<br />
Luciene Dos Reis | Juliana Cunha Ferreira | Zita Maria Leme Britto | Rosa Maria<br />
Moysés | Vanda Jorgetti<br />
Univ São Paulo, São Paulo, Brasil | CETENE<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP594<br />
TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN MAINTA-<br />
NENCE HEMODIALYSIS PATIENTS: A RANDOMISED CLINICAL TRIAL<br />
COMPARING PARICALCITOL, CALCITRIOL AND SINACALCET<br />
Siren Sezer | Emre Tutal | Zeynep Bal | Ruya Ozelsancak | Bahar Gurlek Demirci<br />
| Dilek Torun | F. Nurhan Ozdemir Acar<br />
Dept Nephrology, Baskent Univ, Ankara, Turkey | Dept Nephrology, Baskent<br />
Univ, Adana, Turkey | Dept Nephrology, Baskent Univ, Adana, Turkey | Dept<br />
Nephrology, Baskent Univ, Istanbul, Turkey<br />
SAP595<br />
FIXED DOSES OF PARICALCITOL AND CINACALCET IN THE TH<strong>ERA</strong>PY OF<br />
SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON MAINTENAN-<br />
CE DIALYSIS – OUR INITIAL EXPERIENCE<br />
Ljubisa Veljancic | Milorad Radojevic | Zoran Paunic | Neven Vavic | Katarina<br />
Obrencevic | Zoran Kovacevic | Janko Pejovic<br />
Clinic Nephrology MMA | Inst Medical Biochemistry MMA<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
329<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
330<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
PATHOPHYSIOLOGY CKD 5D<br />
SAP596<br />
HIGH PREVALENCE OF DEPRESSION IN HAEMODIALYSED PATIENTS<br />
Marcin Adamczak | Andrzej Więcek | Łukasz Nowak<br />
Dept Nephrology, Endocrinology and Metabolic Diseases, Medical Univ Silesia<br />
SAP597<br />
INFLUENCE OF LOW-FAT DIET AND PHYSICAL ACTIVITY ON SERUM<br />
SALUSIN-ALPHA CONCENTRATION IN HEMODIALYSIS PATIENTS<br />
Alicja E. Grzegorzewska | Leszek Niepolski | Dominik Pajzderski<br />
Univ Medical Sciences, Poznań, Poland | B.Braun Avitum Dialysis Centre, Nowy<br />
Tomyśl, Poland | Dept Nephrology, Transpl and Internal Diseases, Univ Medical<br />
Sciences, Poznań, Poland<br />
SAP598<br />
SODIUM THIOSULFATE (STS): A NEW OPTION FOR HEMODIALYSIS PA-<br />
TIENTS WITH UREMIC PRURITUS<br />
Walid Ahmed Abdel Atty Mohamed | Farouk Mohame Khamis Zaki | Wessam<br />
Harby Mohamed Bekhit | Ibrahim Sobhy Sherif<br />
Alexandria Univ Student Hosp, Elshatby, Alexandria, Egypt | Qabbary Specialized<br />
Hosp, Qabbary, Alexandria, Egypt | Abu Keer General Hosp, Abu Keer,<br />
Alexandria, Egypt | Elshefaa Hosp, Sidi Gaber, Alexandria, Egypt<br />
SAP599<br />
SERUM FETUIN A AND ITS RELATIONSHIP WITH HEPATIC STEATOSIS<br />
AND SERUM CHEMERIN LEVEL IN MAINTENANCE HEMODIALYSIS PA-<br />
TIENTS<br />
Chien-Chu Lin | Hung-Yuan Chen | Yen-Lin Chiu | Shih-Ping Hsu | Mei-Fen<br />
Pai | Ju-Yeh Yang | Yu-Sen Peng | Tun-Jun Tsai | Kwan-Dun Wu<br />
Div Gastroenterology and Hepatology, Dept Internal Medicine, Far Eastern Memorial<br />
Hosp, New Taipei City, Taiwan | Div Nephrology, Dept Internal Medicine,<br />
Far Eastern Memorial Hosp, New Taipei City, Taiwan | Div Nephrology,<br />
Dept Internal Medicine, National Taiwan Univ Hosp and National Taiwan Univ<br />
College Medicine, Taipei, Taiwan<br />
SAP600<br />
CAN PAST HISTORY OF VARICELLA INFECTION PREDICT SEROPOSITIVI-<br />
TY FOR VARICELLA ZOSTER VIRUS IN PATIENTS WITH CHRONIC KIDNEY<br />
DISEASE?<br />
Soroush Shojai | Uday Udayaraj | Parastoo Shojai<br />
Southmead Hosp, Bristol, UK | Southmead Hosp, North Bristol NHS Trust, Bristol,<br />
UK<br />
SAP601<br />
IS THE FEELING OF THIRST A PRIMARY CAUSE OF EXCESSIVE WEIGHT<br />
GAIN IN PATIENTS ON MAINTAINING HEMODIALYSIS?<br />
Rafał Zwiech | Agnieszka Bruzda-Zwiech<br />
Dept Kidney Transpl, Dept Paediatric Dentistry, Medical Univ Lodz, Poland<br />
SAP602<br />
HSP27 AS A NEW MARKER OF APOPTOSIS IN CHILDREN ON CHRONIC<br />
DIALYSIS<br />
Kinga Musial | Danuta Zwolinska<br />
Dept Pediatric Nephrology, Wroclaw Medical Univ, Wroclaw, Poland<br />
SAP603<br />
ASSOCIATION OF IL12 POLYMORPHIC VARIANTS WITH DEVELOPMENT<br />
OF ANTIBODIES TO SURFACE ANTIGEN OF HEPATITIS B VIRUS IN HEMO-<br />
DIALYSIS PATIENTS IN RESPONSE TO HEPATITIS B VIRUS VACCINATION<br />
OR INFECTION<br />
Alicja E. Grzegorzewska | Wobszal Piotr M. | Adrianna Mostowska | Paweł P.<br />
Jagodziński<br />
Dept Nephrology, Transpl and Internal Diseases, Dept Biochemistry and Molecular<br />
Biology, Univ Medical Sciences, Poznań<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP604<br />
IMMUNOGENICITY AND SEROCONVERSION AFTER HEPATITIS B VAC-<br />
CINATION IN HAEMODIALYSIS PATIENTS: RESULTS OF TWO DIFFERENT<br />
VACCINATION SCHEDULES<br />
Vittorio Ortalda | Paola Tomei | Tewolde Yabarek | Olga Tobaldini | Concetta<br />
Gangemi | Michele Giuseppe Messa | Antonio Lupo<br />
Div Nephrology A.U.O.I Verona, Italy | Nephrology, ULSS 22, Villafranca Verona,<br />
Italy<br />
SAP605<br />
PRESSURE-VOLUME RELATIONSHIPS IN THE INTERSTITIAL COMPART-<br />
MENT OF PATIENTS WITH RENAL DYSFUNCTION AND OEDEMA; CLINI-<br />
CAL CORRELATES AND IMPLICATIONS FOR VOLUME ASSESSMENT<br />
Leonard Ebah | Milind Nikam | Angela Summers | Idalia Dawidowska | Anuradha<br />
Jayanti | Helge Wiig | Paul Brenchley | Sandip Mitra<br />
Manchester Royal Infirmary, Manchester, UK | Univ Bergen<br />
SAP606<br />
INTRODUCTION OF VILDAGLIPTIN IN HEMODIALYSIS PATIENTS<br />
Satoshi Mikami | Takayuki Hamano | Osamu Iba | Mitsunobu Toki | Hiroshi<br />
Mikami | Yoshihiro Takamitsu | Masamitsu Fujii<br />
Higashikohri Hosp | Clinical Epidemiology Unit, Center Clinical Epidemiology<br />
and Biostatistics, Univ Pennsylvania School Medicine<br />
SAP607<br />
CLINICAL EFECTIVNESS OF VACCINATION AGAINST INFLUENZA IN<br />
DIALYSIS PATIENTS<br />
Pavlina Dzekova-Vidimliski | Aleksandar Sikole | Saso Gelev | Gjulsen Selim|<br />
Lada Trajceska<br />
Univ Clinic Nephrology, Skopje, FYR Macedonia<br />
SAP608<br />
LOW LEVELS OF EICOSAPENTAENOIC ACID (EPA)/ARACHIDONIC ACID<br />
(AA) RATIO IN JAPANESE HEMODIALYSIS PATIENTS<br />
Shouichi Fujimoto | Hiroko Inagaki | Keiichi Fukudome | Fumitaka Ebihara |<br />
Naoto Yokota | Yuji Sato<br />
Univ Miyazaki Hosp | Chiyoda Hosp | Yokota Clinic<br />
SAP609<br />
CHARACTERISTICS OF PATIENTS RECEIVING EXTREMELY LONG TERM<br />
HEMODIALYSIS TH<strong>ERA</strong>PY<br />
Takashi Akiba | Shigeru Otsubo | Kosau Nitta<br />
Dept Blood Purification, Dept Medicine, Kidney Center, Tokyo Women’s Medical<br />
Univ, Tokyo, Japan<br />
SAP610<br />
HEPARIN-FREE (EVODIAL) DIALYSIS DOES NOT ACTIVATE ACTIVIN A<br />
Alicja Rydzewska-Rosolowska | Joanna Gozdzikiewicz | Jacek Borawski | Tomasz<br />
Hryszko | Ewa Koc-Zorawska | Michal Mysliwiec<br />
Dept Nephrology and Transpl, Medical Univ Bialystok, Bialystok, Poland<br />
SAP611<br />
OPTIMIZATION OF 2D-DIGE ANALYSIS IN PLASMA AND ULTRAFILTRATE<br />
FOR IDENTIFICATION OF NEW UREMIC TOXINS<br />
Marta Arias | Elisenda Bañon-Maneus | Amanda Sole | Natalia Hierro-Garcia|<br />
Jordi Rovira | Maria Jose Ramírez-Bajo | Luis Fernado Quintana | Fritz Diekmann<br />
| Daniel Moya-Rull | Francisco Maduell | Josep Maria Campistol<br />
Hosp Clinic, Barcelona, Spain<br />
SAP612<br />
FACTORS INFLUENCING HYPERVISCOSITY IN MAINTENANCE HEMO-<br />
DIALYSIS PATIENTS<br />
Mehtap Erkmen Uyar | Selami Kocak Toprak | Hatice Saglam | Emre Tutal |<br />
Meltem Bay | Osman Ilhan | Siren Sezer<br />
Başkent Univ Hosp, Dept Nephrology, Ankara, Turkey | Dept Hematology, Baskent<br />
Univ, Ankara, Turkey | Dept Internal Medicine, Baskent Univ, Ankara,<br />
Turkey | Dept Hematology, Ankara Univ, Ankara, Turkey<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
331<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
332<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP613<br />
RENALASE, STROKE AND HYPERTENSION IN HEMODIALYZED PATIENTS<br />
Jolanta Malyszko | Jacek Malyszko | Piotr Kozminski | Ewa Koc-Zorawska |<br />
Edyta Zbroch | Michal Mysliwiec<br />
Nephrology Dept | Nephrol Dept, Med Univ, Bialystok, Poland | Dialysis Unit,<br />
Mlawa, Poland<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
TRANSPLANTATION - BASIC<br />
SAP614<br />
EFFECT OF CYCLOSPORINE A ADMINISTRATION IN PREGNANT RATS ON<br />
BLOOD PRESSURE AND GLOMERULI NUMBER IN THEIR OFFSPRING<br />
Marcin Adamczak | Nadezda Koleganova | Jens Randel Nyengaard | Eberhard<br />
Ritz | Andrzej Więcek | Natalia Słabiak Błaż<br />
Dept Nephrology, Endocrinology and Metabolic Diseases, Medical Univ Silesia|<br />
Dept Pathology, Univ Heidelberg, Heidelberg, Germany | Stereology and<br />
Electron Microscopy Res Lab, Inst Clinical Medicine, Aarhus Univ, Aarhus, Denmark|<br />
Dept Internal Medicine, Univ Heidelberg, Germany<br />
SAP615<br />
THE PHENOTYPE OF TUBULAR EPITHELIAL CELLS DOES NOT RECOVER<br />
AFTER A CONVERSION FROM CYCLOSPORINE A TO SIROLIUMUS<br />
Dubois Xu Yi Chun | Hertig Alexandre | Girardot-Seguin Sandrine | Toupance<br />
Olivier | Etienne Isabelle | Legendre Christophe | Touchard Guy | Westeel<br />
Pierre François | Rérolle Jean-Philippe | Lebanchu Yvon | Rondeau Eric<br />
APHP, Hôp Tenon | Inserm U702 | Roche | CHU Reims | CHU Rouen | APHP,<br />
Hôp Necker | CHU Poitiers | CHU Amiens | CHU Limoges | Univ Tours |<br />
APHP, Hôp Tenon<br />
SAP616<br />
IMPACT OF EVEROLIMUS AND SIROLIMUS ON PODOCYTES: A DIRECT<br />
COMPARISON<br />
Sandra Müller-Krebs | Lena Weber | Julia Tsobaneli | Jochen Reiser | Martin<br />
Zeier | Vedat Schwenger<br />
Dept Nephrology, Univ Heidelberg, Heidelberg, Germany | Div Nephrology and<br />
Hypertension, Leonard Miller School Medicine, Univ Miami, Miami, FL, USA<br />
SAP617<br />
EFFECTS OF IMMUNOSUPPRESSIVE DRUGS ON TH17 CELLS DIFFEREN-<br />
TIATION<br />
Claire Tinel | Maxime Samson | Bernard Bonnotte | Christiane Mousson<br />
Dept Nephrology, Univ Hosp, Dijon, France | Inserm U866, Fac Medicine, Dijon,<br />
France<br />
SAP618<br />
EFFECTS OF CYCLOSPORINE A AND RAPAMYCIN ON DENDRITIC CELLS<br />
MATURATION IN VITRO<br />
Maja Machcińska | Katarzyna Bocian | Marcin Wyzgał | Grażyna Korczak-<br />
Kowalska<br />
Dept Immunology, Fac Biology, Univ Warsaw, Poland | Transpl Inst, Medical<br />
Univ Warsaw, Poland<br />
SAP619<br />
MIZORIBINE VERSUS MYCOPHENOLATE MOFETIL IN COMBINATION<br />
WITH TACROLIMUS FOR PRIMARY KIDNEY TRANSPLANTATION: EFFI-<br />
CACY AND SAFETY EVALUATION<br />
Man Ki Ju | Kyu Ha Huh | Kwan Tae Park | Sung Joo KIm | Baik Hwan Cho |<br />
Chan Duck Kim | Byung Jun So | Samuel Leee | Chong Myung Kang | Dong<br />
Jin Joo | Yu Seun Kim<br />
Gangnam Severance Hosp, YUMC, Seoul, Korea | Dept Transpl Surgery, Severance<br />
Hosp, Yonsei Univ Health System, Seoul | Dept Surgery, Korea Univ<br />
College Medicine, Seoul | Dept Surgery, Samsung Medical Center, Seoul | Dept<br />
Surgery, Chonbuk Univ College Medicine, Jeonju | Dept Internal Medicine,<br />
Kyungpook National Univ College Medicine, Daegu | Dept Surgery, Wonkwang<br />
Univ College Medicine, Iksan | Dept Surgery, Hallym Univ College Medicine,<br />
Seoul | Dept Internal Medicine, Hanyang Univ College Medicine, Seoul<br />
SAP620<br />
IMMUNOSUPPRESSIVE AGENTS IMPAIR ANTIGEN UPTAKE OF DENDRI-<br />
TIC-LIKE CELLS<br />
Katarzyna Bocian | Michał Zarzycki | Anna Sobich | Grażyna Korczak-Kowalska<br />
Dept Immunology, Fac Biology Univ Warsaw<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
333<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
334<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
« SAP621<br />
“PROPE TOL<strong>ERA</strong>NCE” THE POSSIBILITY OF DONOR INTERLEUKIN-10-<br />
TRANSDUCTED FOETAL LIVER STEM CELLS IN MICE HEART ALLOGRAFT<br />
Masahide Matsuyama | Taro Hase | Rikio Yoshimura | Katsuhiro Koshino |<br />
Kazuki Sakai | Tomoyuki Suzuki | Syuuji Nobori | Hidetaka Ushigome | Leila<br />
Brikci-Nigassa | Jamel Chargui | Jean-Louis Touraine | Norio Yoshimura<br />
Dept Transpl and Regenerative Surgery, Grad School Medical Science, Kyoto<br />
Prefectural Univ Medicine, Kyoto, Japan | Dept Urology, Osaka City Univ Grad<br />
School Medicine, Osaka, Japan | Dept Transpl and Clinical Immunology, Claude<br />
Bernard Univ Lyon and Lyon Hosp, Lyon, France<br />
SAP622<br />
MACROPHAGE STIMULATING PROTEIN (MSP) PROMOTES TUBULAR RE-<br />
GEN<strong>ERA</strong>TION AND CD133+ RENAL PROGENITOR DIFFERENTIATION AF-<br />
TER KIDNEY ISCHEMIA-REPERFUSION INJURY: POTENTIAL PROTECTIVE<br />
ROLE IN DELAYED KIDNEY GRAFT FUNCTION<br />
Vincenzo Cantaluppi | Davide Medica | Federico Figliolini | Massimilano Migliori<br />
| Claudio Mannari | Sergio Dellepiane | Alessandro Domenico Quercia |<br />
Olga Randone | Michela Tamagnone | Maria Messina | Ana Maria Manzione|<br />
Andrea Ranghino | Luigi Biancone | Giuseppe Paolo Segoloni | Giovanni Camussi<br />
Univ Turin, Turin, Italy | Nephrology and Dialysis Unit, Osp Versilia, Camaiore<br />
(LU), Italy | Dept Neuroscience, Univ Pisa, Italy<br />
SAP623<br />
IMPROVED KIDNEY ISOGRAFT SURVIVAL WITH A NEW HISTIDINE-<br />
TRYPTOPHANE-KETOGLUTARATE (HTK)-BASED COLD PRESERVATION<br />
SOLUTION<br />
Tobias R. Türk | Xunfeng Zou | Ursula Rauen | Herbert de Groot | Kerstin<br />
Amann | Andreas Kribben | Kai-Uwe Eckardt | Wanja M. Bernhardt | Oliver<br />
Witzke<br />
Dept Nephrology and Hypertension, Univ Hosp Erlangen, Friedrich-Alexander<br />
Univ, Erlangen-Nuremberg, Germany | Dept Nephrology, Univ Hosp Essen,<br />
Univ Duisburg-Essen, Essen, Germany | Inst Physiological Chemistry, Univ<br />
Hosp Essen, Univ Duisburg-Essen, Germany | Nephropathology<br />
SAP624<br />
GENOME-WIDE ASSOCIATION STUDY IDENTIFIES 13 LOCI ASSOCIATED<br />
WITH ACUTE T-CELL REJECTION IN CAUCASIAN RENAL TRANSPLANT<br />
PATIENTS<br />
Ghisdal Lidia | Coppieters Wouter | Lebranchu Yvon | Alamartine Eric | Le<br />
Meur Yann | Touchard Guy | Noël Christian | Essig Marie | Merville Pierre|<br />
Ajarchouh Zineb | Dinic Miriana | Massart Annick | Abramowicz Marc | Abramowicz<br />
Daniel<br />
Hôp Erasme-ULB | GIGA, Univ Liège, Liège, Belgium | CHU Tours, Tours,<br />
France | CHU Saint-Etienne | CHU Brest, Brest, France | CHU Poitiers | CHRU<br />
Lille | CHU Limoges | CHU Bordeaux<br />
« SAP625<br />
IMMUNOMODULATORY EFFECTS OF TNFα / TNF RECEPTOR SYSTEM<br />
DEPENDENT ON ACTIVATION OF VIRAL RECEPTORS OF THE INNATE<br />
IMMUNE SYSTEM IN POLYOMAVIRUS BK ASSOCIATED NEPHROPATHY<br />
Markus Wörnle | Andrea Ribeiro | Nasim Motamedi | Hermann Josef Gröne |<br />
Clemens D. Cohen | Detlef Schlöndorff | Holger Schmid<br />
Medical Policlinic, Univ Munich, Germany | Dept Virology, Max v. Pettenkofer-<br />
Inst, Munich, Germany | Dept Cellular and Molecular Pathology, German Cancer<br />
Res Center, Heidelberg, Germany | Div Nephrology and Inst Physiology,<br />
Univ Zurich, Zurich, Switzerland | Dept Medicine, Mount Sinai School Medicine,<br />
New York, NY USA<br />
SAP626<br />
EARLY PHYSICAL EXERCISE DECREASES ASYMMETRIC DIMETHYLARGI-<br />
NE AFTER RENAL TRANSPLANTATION<br />
Vladimir Teplan<br />
Inst Clin Exp Medicine, Prague, Czech Republic<br />
SAP627<br />
BRAIN DEATH CHANGES CHEMOKINE AND FUNCTIONAL TOLL-LIKE<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
RECEPTOR EXPRESSION IN KIDNEYS AND OTHER SOLID ORGANS<br />
Miriam Banas | Bernhard Banas | Andreas Steege | Tobias Bergler | Bernd Krüger<br />
| Peter Schnülle | Benito Yard | Bernhard K Krämer | Simone Höger<br />
Klinik und Poliklinik Innere Medizin II, Uniklinikum Regensburg, Germany | V.<br />
Medizinische Klinik, Univsklinikum Mannheim, Germany<br />
SAP628<br />
GITR/TNFRSF18 IS SIGNIFICANTLY UP-REGULATED IN FINE-NEEDLE<br />
ASPIRATION BIOPSY SAMPLES FROM STABLE AS COMPARED WITH ACU-<br />
TE REJECTION KIDNEY TRANSPLANTS<br />
Maria Paula Xavier | Susana Sampaio-Norton | Sérgio Gaião | Helena Alves |<br />
Gerardo Oliveira<br />
Centro Histocompatibilidade Norte, Porto, Portugal | Serv Nefrologia, Hosp S.<br />
João, Porto, Portugal | CINTESIS, Fac Medicina Porto, Portugal<br />
SAP629<br />
PD-L2 IS SIGNIFICANTLY UP-REGULATED IN FINE-NEEDLE ASPIRATION<br />
BIOPSY SAMPLES FROM STABLE AS COMPARED WITH ACUTE REJECTION<br />
KIDNEY TRANSPLANTS<br />
Maria Paula Xavier | Susana Sampaio-Norton | Sérgio Gaião | Helena Alves |<br />
Gerardo Oliveira<br />
Centro Histocompatibilidade Norte, Porto, Portugal | Serv Nefrologia, Hosp S.<br />
João, Porto, Portugal | GCCT, Hosp S. João, Porto, Portugal<br />
SAP630<br />
ICOS IS SIGNIFICANTLY UP-REGULATED IN FINE-NEEDLE ASPIRATION<br />
BIOPSY SAMPLES FROM ACUTE REJECTION KIDNEY TRANSPLANTS<br />
Maria Paula Xavier | Susana Sampaio-Norton | Sérgio Gaião | Helena Alves |<br />
Gerardo Oliveira<br />
Centro Histocompatibilidade Norte, Porto, Portugal | Serv Nefrologia, Hosp S.<br />
João, Porto, Portugal | GCCT, Hosp S. João, Porto, Portugal<br />
SAP631<br />
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS<br />
OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS<br />
Gianluigi Zaza | Federica Rascio | Paola Pontrelli | Simona Granata | Carlo<br />
Rugiu | Giuseppe Grandaliano | Antonio Lupo<br />
Univ Verona | Renal Unit, Univ Bari, Italy | Renal Unit, Univ Bari, Italy | Renal<br />
Unit Hosp/Univ Verona, Italy<br />
« SAP632<br />
MOLECULAR PREDICTORS OF DELAYED GRAFT FUNCTION OF KIDNEY<br />
ALLOGRAFT<br />
Mariana Wohlfahrtova | Irena Brabcova | Peter Balaz | Libor Janousek | Alena<br />
Lodererova | Eva Honsova | Peter Wohlfahrt | Ondrej Viklicky<br />
Inst Clinical and Experimental Medicine<br />
SAP633<br />
POSITRON EMISSION TOMOGRAPHY WITH EX VIVO 18F-FDG LABELED<br />
HUMAN T-LYMPHOCYTES FOR DIAGNOSIS OF ACUTE REJECTION AFTER<br />
RENAL TRANSPLANTATION IN THE RAT<br />
Alexander Grabner | Dominik Kentrup | Bayram Edemir | Yasemin Sirin | Hermann<br />
Pavenstädt | Otmar Schober | Eberhard Schlatter | Michael Schäfers | Uta<br />
Schnöckel | Stefan Reuter<br />
Dept Internal Medicine D, Experimental Nephrology, Univ Hosp Münster, Münster,<br />
Germany | Dept Nuclear Medicine, Münster, Germany | European Inst<br />
Molecular Imaging, Univ Münster, Münster, Germany<br />
SAP634<br />
CHARACTERIZATION OF THE TRANSCRIPTOMIC PROFILE OF PERIPHE-<br />
RAL LYMPHOMONOCYTES IN RENAL CHRONIC ANTIBODY-MEDIATED<br />
REJECTION (CAMR)<br />
Federica Rascio | Paola Pontrelli | Matteo Accetturo | Margherita Gigante |<br />
Maddalena Gigante | Tiziana Tataranni | Anna Zito | Antonio Schena | Francesco<br />
Paolo Schena | Giovanni Stallone | Loreto Gesualdo | G Grandaliano<br />
Dept Emergency and Organ Transpl, Univ Bari, Italy | DETO, Univ Bari, Italy|<br />
Dept Biomedical Sciences, Univ Foggia, Foggia, Italy | Univ Foggia, Italy |<br />
Nephrology Dialysis and Transpl Unit, Dept Emergency and Organ Transpl<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
335<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
336<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
(D.E.T.O.), Univ Bari, Italy | Dept Biomedical Sciences, Univ Foggia, Italy |<br />
Nephrology, Dialysis and Transpl Unit, Dept Biomedical Sciences, Univ Foggia<br />
SAP635<br />
REMOVING ANTI-HLA ANTIBODIES: WHAT IS THE BEST TECHNIQUE?<br />
Nicolas Maillard | Ingrid Masson | Absi Lena | Mehdi Manolie | Alamartine<br />
Eric | Mariat Christophe<br />
Serv Néphrologie, Dialyse, Transpl Rénale, Saint Etienne, France | Etablissement<br />
Français Sang Auvergne Loire, France<br />
SAP636<br />
METABOLITES FROM THE SUPERFICIAL RENAL GRAFT CORTEX AS MES-<br />
SENGERS OF ORGAN QUALITY – A MICRODIALYSIS STUDY<br />
Casper Kierulf Lassen | Anna Krarup Keller | Ulla Møldrup | Bo Martin Bibby|<br />
Bente Jespersen<br />
Dept Nephrology, Aarhus Univ Hosp, Skejby, Denmark | Inst Clinical Medicine,<br />
Aarhus Univ, Denmark | Dept Urology, Aarhus Univ Hosp, Skejby, Denmark |<br />
Dept Biostatistics, Aarhus Univ, Denmark<br />
SAP637<br />
THE LEVEL OF ARGININE METABOLIC PRODUCTS IN KIDNEY TRAN-<br />
SPLANT PATIENTS<br />
Tatjana Cvetkovic | Radmila Velickovic Radovanovic | Radmila Pavlovic | Vidojko<br />
Djordjevic | Predrag Vlahovic | Nikola Stefanovic | Nikola Sladojevic |<br />
Aleksandra Ignjatovic<br />
Clinic Nephrology, Clinical Centre, Nis, Serbia | Inst Chemistry, Medical Fac<br />
Nis, Serbia | Cathedra Statistic and Informatics, Medical Fac, Nis, Serbia<br />
SAP638<br />
ARGINASE INHIBITION IMPROVES ACUTE KIDNEY INJURY AFTER ISCHE-<br />
MIA REPERFUSION INJURY AND RENAL TRANSPLANTATION IN MICE<br />
Song Rong | Jan Menne | Hermann Haller | Peter Suszdak | Peter Tomczuk |<br />
Faikah Gueler | Shushakova Nelli<br />
Hannover Medical School, Hannover, Germany | Dept Nephrology & Hypertension,<br />
Medical School Hannover, Germany | Corridor Inc.<br />
SAP639<br />
THE PERIOP<strong>ERA</strong>TIVE MANAGEMENT OF DONOR IN KIDNEY TRAN-<br />
SPLANTATION<br />
Dehayni Sara | El Khyat Salma | Mtioui Naoufal | Madad Tarik | Zamd Mohamed<br />
| Medkouri Guislaine | Benghanem Mohamed Gharbi | Ramdani Benyounes<br />
Dept Nephrology Uh Ibn Rochd Casablanca<br />
SAP640<br />
INHIBITION OF CLASSICAL PKC-alpha/beta ATTENUATE HYPOXIA INDU-<br />
CED PROGRESSIVE INTERSTITIAL FIBROSIS AND TUBULAR ATROPHY BY<br />
TGF-beta INHIBITION<br />
Xia Lu | Song Rong | Nelli Shushakova | Jan Menne | Torsten Kirsch | Hermann<br />
Haller | Faikah Gueler<br />
Inst Organ Transpl, Tongji Hosp, Wuhan, China | Hannover Medical School,<br />
Hannover, Germany | Dept Nephrology, Hannover Medical School, Hannover,<br />
Germany<br />
« SAP641<br />
SYSTEMATIC HISTOLOGICAL ANALYSIS OF THROMBOTIC MICROAN-<br />
GIOPATHY IN A PORCINE XENO-KIDNEY-TRANSPLANT-MODEL<br />
Clemens L. Bockmeyer | Wolf Ramackers | Juliane Wittig | Putri A. Agustian|<br />
Johannes Klose | Maximilian E. Dämmrich | Hans Kreipe | Verena Bröcker |<br />
Michael Winkler | Jan U. Becker<br />
Medical School Hannover, Inst Pathology, Hannover, Germany | Medical School<br />
Hannover, Clinic General, Visceral and Transpl Surgery, Hannover, Germany<br />
SAP642<br />
microRNA EXPRESSION PROFILES IN TRANSPLANT ASSOCIATED THROM-<br />
BOTIC MICROANGIOPATHY<br />
Putri A. Agustian | Juliane Wittig | Jan U. Becker | Clemens L. Bockmeyer<br />
Medical School Hannover, Inst Pathology, Hannover, Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
TRANSPLANTATION - CLINICAL II<br />
SAP643<br />
EFFECT OF CONVERSION FROM CYCLOSPORINE A TO TACROLIMUS ON<br />
ENDOTHELIAL PROGENITOR CELLS IN STABLE LONG-TERM KIDNEY<br />
TRANSPLANT RECIPIENTS. A RANDOMIZED CONTROLLED TRIAL<br />
Markus Riegersperger | Max Plischke | Sabine Steiner-Böker | Daniela Seidinger<br />
| Wolfgang Winkelmayer | Gere Sunder-Plassmann<br />
Medical Univ Vienna, Dept Medicine III, Div Nephrology & Dialysis, Austria |<br />
Medical Univ Vienna, Dept Medicine II, Div Angiology, Austria | Stanford Univ,<br />
Palo Alto, USA<br />
SAP644<br />
THE EFFECT OF DIFFERENT CALCINEURIN INHIBITORS ON OXIDATIVE<br />
STRESS PARAMETERS IN RENAL TRANSPLANT RECIPIENTS<br />
Predrag Vlahović | Tatjana Cvetković | Vidojko Djordjević | Radmila Veličković-<br />
Radovanović | Nikola Stefanović | Aleksandra Ignjatović | Nikola Sladojević<br />
Center Medical Biochemistry, Clinical Center, Niš, Serbia | Clinic Nephrology<br />
and Hemodialysis, Clinical Center, Niš, Serbia | Center Statistics and Informatics,<br />
Medical Fac, Niš, Serbia<br />
SAP645<br />
EFFECTS OF TWICE-DAILY VS. ONCE-DAILY SLOW RELEASE TACROLI-<br />
MUS ON THE INSULIN RESISTANCE INDEXES IN KIDNEY TRANSPLANT<br />
PATIENTS<br />
Valeria Cademartori | Fabio Massarino | Emanuele Luigi Parodi | Rodolfo Russo<br />
| Antonella Sofia | Iris Fontana | Giorgio L. Viviani | Giacomo Garibotto<br />
Dept Internal Medicine, Nephrology Section, Genoa Univ, Genoa, Italy | Transpl<br />
Section, Genoa Univ and AOU San Martino, Genoa, Italy<br />
SAP646<br />
IMMUNOSUPPRESSION WITH RAPID STEROID TAPER IN KIDNEY TRAN-<br />
SPLANT USING DONATION AFTER CARDIAC DEATH (DCD) DONORS<br />
Martin Mai | William Mai | Burcin Taner | Hani Wadei | Mary Prendergast |<br />
Thomas Gonwa<br />
Mayo Clinic, Jacksonville, USA | Univ William and Mary, Williamsburg, USA<br />
SAP647<br />
EARLY CONVERSION FROM TWICE DAILY TACROLIMUS TO THE ONCE<br />
DAILY EXTENDED FORMULATION IN RENAL TRANSPLANT PATIENTS<br />
BEFORE HOSPITAL DISCHARGE<br />
Jannot Martin | Sury Aurore | Chabroux Seffert Aline | Maillard Nicolas | Medhi<br />
Manolie | Sauron Catherine | Alamartine Eric | Mariat Christophe<br />
CHU Saint-Etienne<br />
SAP648<br />
EFFECT OF IMMUNOSUPPRESSIVE REGIMEN ON DONOR-SPECIFIC HLA-<br />
ANTIBODY FORMATION AFTER KIDNEY TRANSPLANTATION<br />
Susanne Brakemeier | Lutz Liefeldt | Petra Glander | Johannes Waiser | Nils<br />
Lachmann | Constanze Schönemann | Bianca Zukunft | Patrick Illigens | Danilo<br />
Schmidt | Kaiyin Wu | Birgit Rudolph | Hans-H. Neumayer | Klemens<br />
Budde<br />
Charité, Nephrology, Berlin, Germany | Charité, HLA-Lab, Berlin, Germany |<br />
Charité, Pathology, Berlin, Germany<br />
SAP649<br />
PRETRANSPLANT DONOR-SPECIFIC HLA ANTIBODIES DETECTED BY SIN-<br />
GLE-ANTIGEN BEAD FLOW CYTOMETRY: RISK FACTORS AND OUTCOME<br />
AFTER KIDNEY TRANSPLANTATION<br />
Luis Pallardo Mateu | Asuncion Sancho Calabuig | Josep Crespo Albiach | Sandra<br />
Beltran Catalan | Eva Gavela Martinez | Julia Kanter Berga<br />
Hosp Dr Peset Valencia, Spain<br />
SAP650<br />
ABO INCOMPATIBLE KIDNEY TRANSPLANTATION IN THE ELDERLY<br />
Takaaki Kimura | Takashi Yagisawa | Nobuo Ishikawa | Yasunaru Sakuma |<br />
Takehito Hujiwara | Akinori Nukui | Masahiro Yashi<br />
Jichi Medical Univ | Jichi Medical Univ Hosp<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
337<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
338<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP651<br />
EFFECT OF DONOR GENDER IN KIDNEY GRAFT SURVIVAL IN THE AGE-<br />
MARGINAL DONOR POOL<br />
Jose Duraes | Jorge Malheiro | Isabel Fonseca | Ana Rocha | La Salete Martins|<br />
Manuela Almeida | Leonideo Dias | Antonio Castro-Henriques | António Cabrita<br />
Hosp Santo António | Nephrology Unit, Centro Hosp Porto, Porto, Portugal<br />
SAP652<br />
SUBCLINICAL REJECTION ADVERSELY AFFECTS KIDNEY GRAFT SURVI-<br />
VAL AND FUNCTION<br />
Martin Mai | William Mai | Hani Wadei | Mary Prendergast | Thomas Gonwa<br />
Mayo Clinic, Jacksonville, USA | Univ William and Mary, Williamsburg, USA<br />
SAP653<br />
TRANSURETHRAL RESECTION THE PROSTATE FOR BLADDER OUTLET<br />
OBSTRUCTION DUE TO BENIGN PROSTATIC HYPERPLASIA IN KIDNEY<br />
TRANSPLANT RECIPIENTS: LONG-TERM UROLOGICAL AND RENAL FUN-<br />
CTIONAL OUTCOMES IN A PROSPECTIVE STUDY<br />
Alessandro Volpe | Marco Quaglia | Alberto Menegotto | Roberta Fenoglio |<br />
Cristina Izzo | Andrea Airoldi | Carlo Terrone | Piero Stratta<br />
Amedeo Avogadro Univ, Maggiore della Carità Hosp, Novara, Italy<br />
SAP654<br />
A CASE-CONTROL STUDY OF THE IMPACT OF TICLOPIDINE AND CLOPI-<br />
DOGREL ON SURGICAL RISK IN RENAL TRANSPLANTATION<br />
Benahmed Ahmed | Kianda Mireille | Broeders Nilufer | Massart Annick | Wissing<br />
Karl Martin | Hoang Anh-Dung | Mikhalski Dimitri | Madhoun Philippe |<br />
Racapé Judith | Abramowicz Daniel<br />
Hop Erasme | UZ Brussel<br />
SAP655<br />
DETERMINANTS OF OUTCOME AFTER KTX IN ELDERLY PATIENTS<br />
Lutz Liefeldt | Petra Glander | Yang Lan | Danilo Schmidt | Christoph Heine |<br />
Klemens Budde | Hans-H. Neumayer<br />
Charité, Nephrology, Berlin, Germany<br />
SAP656<br />
DETERMINANTS AND DURATION OF HOSPITALISATIONS AFTER KTX IN<br />
ELDERLY PATIENTS<br />
Danilo Schmidt | Petra Glander | Klemens Budde | Hans-H. Neumayer | Lutz<br />
Liefeldt<br />
Charité, Nephrology, Berlin, Germany<br />
SAP657<br />
ADULT MALE DONOR INTO FEMALE RECIPIENT INCREASES THE RISK<br />
OF KIDNEY GRAFT LOSS ONLY IN YOUNG-FOR-YOUNG RENAL TRAN-<br />
SPLANT<br />
Marco Quaglia | Valentina Capone | Cristina Izzo | Alberto Menegotto | Roberta<br />
Fenoglio | Andrea Airoldi | Piero Stratta<br />
Amedeo Avogadro Univ, Novara, Italy. | Maggiore della Carità Hosp<br />
SAP658<br />
TRANSPLANTATION RATES FOR LIVE-DONOR, BUT NOT DECEASED-<br />
DONOR KIDNEYS VARY WITH SOCIO-ECONOMIC STATUS IN AUSTRALIA<br />
Blair Grace | Philip Clayton | Alan Cass | Stephen McDonald<br />
ANZDATA Registry, Adelaide, Australia | Australia and New Zealand Dialysis<br />
and Transpl Registry | George Inst Global Health<br />
SAP659<br />
LONGITUDINAL OBSERVATION OF RENAL FUNCTIONS FOLLOWING<br />
LIVE KIDNEY TRANSPLANTATION: FEASIBILITY AND LIMITATION TO<br />
USE ELDERLY KIDNEY<br />
Takashi Yagisawa | Masahiro Yashi | Takaaki Kimura | Akinori Nukui | Takehito<br />
Fujiwara | Yasunaru Sakuma | Nobuo Ishikawa | Toshihisa Iwabuchi|<br />
Osamu Muraishi<br />
Jichi Medical Univ Hosp | St. Luke’s International Hosp<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP660<br />
ROLE OF FGF23 IN KIDNEY TRANSPLANT: IS THERE ANY DIFFERENCE<br />
BETWEEN RECIPIENTS OF PREEMPTIVE TRANSPLANTS AND PATIENTS<br />
WHO HAD BEEN ON DIALYSIS?<br />
Vicente Torregrosa | Xoana Barros | Mª Jesús Martinez de Osaba | Raphael Paschoalin<br />
| Josep María Campistol<br />
Hosp Clinic, Barcelona, Spain<br />
SAP661<br />
KIDNEY TRANSPLANTATION AND ITS IMPACT ON FEMALE SEXUAL<br />
FUNCTION<br />
Rashad Hassan | Ahmed El-Hefnawy | Shady Soliman | Ahmed Shokeir<br />
Urology and Nephrology Center, Mansoura, Egypt<br />
SAP662<br />
DETERMINANTS OF CAROTID ATHEROSCLEROSIS CHANGES IN RENAL<br />
TRANSPLANT PATIENTS: THE ROLE OF ASYMMETRIC DIMETHYLARGI-<br />
NINE<br />
Aysegul Cobanoglu Kudu | Ozkan Gungor | Fatih Kircelli | Ekrem Altınel |<br />
Gulay Asci | Suha Sureyya Ozbek | Huseyin Toz | Ercan Ok<br />
Ege Univ School Medicine, Div Nephrology, Izmir, Turkey | Ege Univ School<br />
Medicine, Div Radiology, Izmir, Turkey<br />
SAP663<br />
THE TREATMENT OF ACUTE HUMORAL REJECTION (AHR): A TASK STILL<br />
FAR AT HAND<br />
Silvio Sandrini | Gisella Setti | Francesca Valerio | Stefano Possenti | Irene Torrisi<br />
A.O. Spedali Civili, Brescia, Italy<br />
SAP664<br />
BK VIRUS NEPHROPATHY TREATED WITH mTOR INHIBITORS-BASED IM-<br />
MUNOSUPPRESSION<br />
Natalia Polanco | Laura Garcia-Puente | Esther Gonzalez Monte | Enrique Morales<br />
| Eduardo Gutierrez | Ignacio Bengoa | Ana Hernandez | Jorge Caballero|<br />
Jose Maria Morales | Amado Andres<br />
12 de Octubre Univ Hosp<br />
SAP665<br />
PROSPECTIVE STUDY ON THE CLINICAL AND PROGNOSTIC SIGNIFICAN-<br />
CE OF POLYOMAVIRUS JC INFECTION IN KIDNEY TRANSPLANT<br />
Veronica Sgarlato | Giorgia Comai | Gaetano La Manna | Ilaria Moretti | Valeria<br />
Grandinetti | Davide Martelli | Maria Piera Scolari | Sergio Stefoni<br />
Inst Nephrology, Dialysis and Renal Transpl, Univ Bologna, Bologna, Italy | S.<br />
Orsola Hosp<br />
SAP666<br />
EFFICACY AND APPROPRIATENESS OF HISTOLOGICAL SCORE IN PRE-<br />
DICTION OF THE 3-YEAR OUTCOME OF KIDNEY TRANSPLANTATION<br />
Chiara Valentini | Elisa Persici | Gaetano La Manna | Maria Laura Cappuccilli|<br />
Veronica Sgarlato | Giovanni Liviano D'Arcangelo | Benedetta Fabbrizio | Elisa<br />
Carretta | Giovanni Mosconi | Maria Piera Scolari | Giorgio Feliciangeli | Franco<br />
Walter Grigioni | Sergio Stefoni<br />
Inst Nephrology, Dialysis and Renal Transpl, Univ Bologna, Bologna, Italy | F.<br />
Addarii Inst Oncologic and Transpl Molecular Pathology, Univ Bologna, Bologna,<br />
Italy | Dept Medicine and Public Health, Univ Bologna, Bologna, Italy<br />
« SAP667<br />
SHORT-TERM EFFECTS OF AN ω-3 (n-3) RICH DIET ON METABOLIC AND<br />
INFLAMMATORY MARKERS IN RENAL TRANSPLANT RECIPIENTS<br />
Luca Apicella | Brunella Guida | Sossio Vitale | Gianluca Garofalo | Luigi Russo<br />
| Imma Maresca | Roberta Rossano | Bruno Memoli | Rosa Carrano | Stefano<br />
Federico | Massimo Sabbatini<br />
Univ Napoli Federico II, Napoli, Italy | Dept Neuroscience, Physiology Nutrition<br />
Unit, Nephrology and Renal Transpl, Dept Systematic Pathology, Univ Naples<br />
Federico II, Naples, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
339<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
340<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
SAP668<br />
PRE TRANSPLANT BIOPSY AND 1 YEAR GRAFT OUTCOMES IN MARGI-<br />
NAL KIDNEY. A MONOCENTRIC STUDY<br />
Paolo Carta | Maria Zanazzi | Lorenzo Di Maria | Leonardo Caroti | Anduela<br />
Miejshtri | Aris Tsalouchos | Elisabetta Bertoni<br />
Nephrology Unit, Careggi Univ Hosp, Florence, Italy<br />
SAP669<br />
DETERMINANTS OF LEFT VENTRICULAR MASS INDEX IN RENAL ALLO-<br />
GRAFT RECIPIENTS<br />
Siren Sezer | Mehtap Erkmen Uyar | Turan Colak | Zeynep Bal | Emre Tutal |<br />
Gaye Kalacı | F. Nurhan Ozdemir Acar<br />
Dept Nephrology, Baskent Univ, Ankara, Turkey| Dept Internal Medicine, Baskent<br />
Univ, Ankara, Turkey | Dept Nephrology, Baskent Univ, Istanbul, Turkey<br />
SAP670<br />
MEDICAL FACTORS ASSOCIATED TO THE REGISTRATION ON THE KID-<br />
NEY WAITING LIST IN FRANCE<br />
Christian Jacquelinet | Sahar Bayat<br />
Agence Biomedecine | EHESP<br />
SAP671<br />
LYMPHOCYTE RECONSTITUTION AFTER INDUCTION WITH THYMO-<br />
GLOBULIN IN RENAL TRANSPLANTATION: IMPACT OF THE MODE OF<br />
ADMINISTRATION (DAILY VS INTERMITTENT TREATMENT BASED ON T<br />
LYMPHOCYTE MONITORING)<br />
Vincent Pernin | Pierre Portales | Ilan Szwarc | Valerie Garrigue | Fernando<br />
Vetromile | Sylvie Delmas | Jean Francois Eliaou | Georges Mourad<br />
CHU Lapeyronie Montpellier | CHU St Eloi Montpellier<br />
SAP672<br />
POSTTRANSPLANT HYPOPHOSPHATEMIA IS FREQUENT AND ASSOCIA-<br />
TED WITH BETTER OUTCOMES<br />
Lu Huber | Torsten Slowinski | Marcel Naik | Petra Glander | Lutz Liefeldt |<br />
Danilo Schmidt | Hans-Hellmut Neumayer | Klemens Budde<br />
Charité – Univsmedizin Berlin<br />
SAP673<br />
HYPERPARATHYROIDISM IN KIDNEY TRANSPLANT PATIENTS DISCON-<br />
TINUING CINACALCET AFTER LONG-TERM HEMODIALYSIS<br />
Kentaro Nakai | Hideki Fujii | Keiji Kono | Shunsuke Goto | Takeshi Ishimura|<br />
Masashi Takeda | Masato Fujisawa | Shinichi Nishi<br />
Div Nephrology and Kidney Center, Div Urology, Kobe Univ Grad School Medicine,<br />
Kobe, Japan<br />
SAP674<br />
KIDNEY TRANSPLANT PATIENTS ON CINACALCET BEFORE SURGERY<br />
SHOW LESS GRAFT CALCIFICATION DURING THE FIRST YEAR AFTER<br />
TRANSPLANTATION THAN THE ONES THAT HAVE NEVER RECEIVED IT<br />
Raphael Pereira Paschoalin | Jose Vicente Torregrosa | Xoana Barros Freiria |<br />
Carlos Edoardo Durán Rebolledo | Ana Sanchez Escuredo | Manel Solé | Josep<br />
Maria Campistol<br />
Hosp Clinic - Barcelona, Spain<br />
« SAP675<br />
ANALYSIS OF CHARACTERISTICS AND OUTCOMES OF A SINGLE CENTRE<br />
CLUSTER OF PNEUMOCYSTIS JIROVECII PNEUMONIA IN THE UK<br />
Sajeda Youssouf | Fozia Tabbasm | Ricky Bell | Reem Al-Jayyousi | Graham<br />
Warwick<br />
Univ Hosp Leicester<br />
SAP676<br />
THE NEW SPECTRUM OF PNEUMOCYSTIS JIROVECII PNEUMONIA: A<br />
MULTICENTER STUDY<br />
Anne Grall | Laeticia Treguer | Marie Essig | Caroline Lecaque | Natacha Noël|<br />
Matthias Büchler | Dominique Bertrand | Joseph Rivalan | Laura Braun | Florence<br />
Villemain | Bruno Hurault de Ligny | Anne Totet | Nathalie Pestourie |<br />
Dominique Toubas | Gilles Nevez | Yannick Le Meur<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
CHU, Brest France | CHU, Limoges France | CHU, Amiens France | CHU,<br />
Reims France | CHU, Tours France | CHU, Rouen France | CHU, Rennes France|<br />
CHU, Strasbourg France | CHU, Angers France | CHU, Caen France<br />
SAP677<br />
ORGAN DONATION: OPINION OF DOCTORS<br />
Bassit Nour El Houda | Habiblah Mustapha | Fadili Wafaa | Laouad Inass<br />
CHU Mohammed VI Marrakech<br />
SAP678<br />
USE OF EXPANDED CRITERIA LIVING DONORS: POSSIBLE SOLUTION OF<br />
SEVERE ORGAN SHORTAGE IN THE BALKANS<br />
Irena Rambabova Bushljetikj | Jelka Masin-Spasovska | Goce Spasovski | Zivko<br />
Popov | Aleksandar Sikole | Ninoslav Ivanovski<br />
Univ Clinic Nephrology and Urology , Skopje, R. Macedonia<br />
SAP679<br />
INTERMEDIATE EARLY GRAFT FUNCTION IS A RISK FACTOR FOR GRAFT<br />
LOSS AND WORSE LONG-TERM GRAFT FUNCTION IN KIDNEY TRAN-<br />
SPLANT PATIENTS<br />
Mário Raimundo | José Guerra | Catarina Teixeira | Alice Santana | Sónia Silva|<br />
Clara Mil Homens | António Gomes da Costa<br />
Hosp Santa Maria, Dept Nephrology & Renal Transpl, Lisbon, Portugal<br />
SAP680<br />
RESULTS OF LIVER AND COMBINED LIVER-KIDNEY TRASPLANT WITH<br />
MELD SCORE: WHAT CHANGED AFTER THE INCLUSION OF RENAL FUN-<br />
CTION AS A DETERMINANT OF LIVER ALLOCATION?<br />
Daniela Loredo | Mariana Cleres | Gabriel Gondolesi | Luis Maria Gutierrez |<br />
R. Marcela Fortunato | Valeria Descalzi | Pablo Raffaele<br />
Univ Hosp, Favaloro Fond, Buenos Aires, Argentina<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
341<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
342<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
PAEDIATRIC NEPHROLOGY<br />
SAP681<br />
URINARY HEME OXYGENASE-1 IS A NEW INDICATOR IN HUMAN CON-<br />
GENITAL HYDRONEPHROSIS<br />
Hufeng Shi | Jianguo Wen | Zhenzhen Li<br />
First Affiliated Hosp Zhengzhou Univ, Zhengzhou, China<br />
SAP682<br />
ULTRASOUND IN NEONATAL AND CHILDHOOD HYDRONEPHROSIS: IS<br />
IT A RELIABLE TOOL TO GUIDE THE MANAGEMENT?<br />
Maged Elsayed | Khaled Kamal<br />
Erfan Hosp Sitteen Street Jeddah | Ain Shams Univ Cairo<br />
SAP683<br />
URINARY MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR MA-<br />
TRIX METALLOPROTEINASE-1 IN CHILDREN WITH URETEROPELVIC JUN-<br />
CTION OBSTRUCTION<br />
Zhenzhen Li | Jianguo Wen | Hufeng Shi<br />
First Affiliated Hosp Zhengzhou Univ, Zhengzhou, China<br />
SAP684<br />
MDR-1 GENE POLYMORPHISMS AND CLINICAL COURSE OF NEPHROTIC<br />
SYNDROME IN EGYPTIAN CHILDREN<br />
Amal El Shal | Doaa Youssef<br />
Zagazig Univ, Zagazig, Egypt<br />
SAP685<br />
LC-MS/MS AND ANTIBODY-ARRAY BASED URINARY PROTEOME<br />
ANALYSIS OF OBSTRUCTIVE NEPHROPATHY<br />
Cécile Caubet | Chrystelle Lacroix | Breuil Benjamin | Flavio Bandin | Jean-<br />
Loup Bascands | Bernard Monsarrat | Stéphane Decramer | Joost Schanstra<br />
Inserm U1048 | CNRS, IPBS (Inst Pharmacologie et Biologie Structurale) | CHU<br />
Toulouse, Hôp Enfants, Serv Néphrologie | Inst National Santé et Recherche<br />
Médicale (INSERM), U1048, Inst Cardiovascular and Metabolic Disease<br />
SAP686<br />
DOES RITUXIMAB INDUCE HYPOGAMMAGLOBULINEMIA IN CHILDREN<br />
WITH STEROID DEPENDENT IDIOPATHIC NEPHROTIC SYNDROME?<br />
Delbe-Bertin Laetitia | Tim Ulinski | Bilal Aoun<br />
Armand Trousseau Hosp, APHP, France<br />
SAP687<br />
THE ROLE OF TREG CELLS IN PEDIATRIC PATIENTS WITH IDIOPATHIC<br />
NEPHROTIC SYNDROME<br />
Kadriye Ozdemir | Nida Dincel | Betul Sozeri | Sevgi Mir<br />
Ege Univ Fac Medicine<br />
SAP688<br />
THE RELATIONSHIP BETWEEN GLOMERULOSCLEROSIS AND mRNA EX-<br />
PRESSION OF GENES ENCODING PODOCTYE PROTEINS IN CHILDREN<br />
WITH STEROID RESISTANT NEPHROTIC SYNDROME<br />
Nida Dincel | Afig Berdeli | Sevgi Mir | Fatma Akyiğit<br />
Ege Univ Fac Medicine<br />
SAP689<br />
EFFICACY OF COMBINED TH<strong>ERA</strong>PY WITH CYCLOSPORINE A AND MY-<br />
COPHENOLATE MOPHETIL IN CHILDREN WITH IDIOPATHIC NEPHRO-<br />
TIC SYNDROME<br />
Malgorzata Mizerska-Wasiak | Malgorzata Panczyk-Tomaszewska | Hanna<br />
Szymanik-Grzelak | Maria Roszkowska-Blaim<br />
Dept Pediatrics and Nephrology, Medical Univ Warsaw<br />
SAP690<br />
RITUXIMAB RESTORES EXPRESSION OF TOLL-LIKE RECEPTORS AND NF-<br />
ΚB PATHWAY IN PERIPH<strong>ERA</strong>L BLOOD MONONUCLEAR CELLS OF CHIL-<br />
DREN SUFFERING FROM STEROID SENSITIVE IDIOPATHIC NEPHROTIC<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SYNDROME<br />
Agnes Jamin | Laurene Dehoux | Renato C Monteiro | Georges Deschenes<br />
INSERM U699, Paris, France | Serv Néphrologie Pédiatique, Hôp Robert Debré,<br />
Paris, France<br />
SAP691<br />
PREVENTION OF STEROID INDUCED BONE DISEASE IN CHILDREN WITH<br />
NEPHROTIC SYNDROME: A SYSTEMATIC REVIEW<br />
Antonia Bouts | Jean-Claude Davin | Eiske Dorresteijn | Michiel Schreuder |<br />
Marc Lilien | Michiel Oosterveld | Sharon Kramer | Mariken Gruppen<br />
Emma Children's Hosp, Academic Medical Center, Amsterdam, Netherlands |<br />
Erasmus Medical Center, Rotterdam, Netherlands | Radboud Univ, Nijmegen,<br />
Netherlands | Wilhelmina Children's Hosp, Utrecht, Netherlands | Cochrane<br />
Collaboration Center, Academic Medical Center, Amsterdam, Netherlands<br />
SAP692<br />
RENAL MANIFESTATIONS AND GROWTH IN CHILDREN AND ADOLE-<br />
SCENTS WITH FABRY DISEASE INCLUDED IN THE FABRY OUTCOME SUR-<br />
VEY (FOS)<br />
Guillem Pintos-Morell | Uma Ramaswami | Rossella Parini | Marianne<br />
Rohrbach | Gisela Kalkum | Michael Beck<br />
Univ Hosp Germans Trias i Pujol, Badalona, Spain | Addenbrooke’s Hosp, Cambridge,<br />
UK | San Gerardo Hosp, Monza, Italy | Univ. Children's Hosp Zurich,<br />
Switzerland | Univ. Children’s Hosp, Mainz, Germany | Johannes-Gutenberg-<br />
Univ Mainz<br />
SAP693<br />
A HEALTHCARE MODEL TO LESSEN THE GLOBAL EPIDEMIC OF NON-<br />
COMMUNICABLE DISEASES (NCD) IN LOW AND MIDDLE INCOME<br />
COUNTRIES (LMIC): PERITONEAL DIALYSIS (PD) FOR ACUTE KIDNEY<br />
INJURY (AKI)<br />
Mary Carter | Sampson Antwi | John Callegari | Peter Kotanko | Nathan W Levin<br />
Sustainable Kidney Care Foundation, New York, USA | Kwamw Nkrumah Univ<br />
Science & Technology/Komfo Anokye Teaching Hosp, Kumasi, Ghana | Renal<br />
Res Inst, New York USA<br />
SAP694<br />
HEPCIDIN-25 AND MARKERS OF MIN<strong>ERA</strong>L METABOLISM IN CHILDREN<br />
WITH PRE-DIALYSIS CKD STAGES 3-5<br />
Adam Rumjon | Iain C. Macdougall | Charles Turner | Caroline J. Booth | David<br />
Goldsmith | Manish D. Sinha<br />
King's College Hosp NHS Found Trust, London, UK | Renal Unit, King's College<br />
Hosp | WellChild Lab, Evelina Children's Hosp, Guy's and St. Thomas'<br />
Hosps NHS Found Trust, London, UK | Dept Paediatric Nephrology, Evelina<br />
Children's Hosp, Guy's and St. Thomas' Hosp NHS Found Trust, London, UK |<br />
Guy's and St Thomas' NHS Found Hosp<br />
SAP695<br />
ACTIVATION OF INNATE IMMUNITY IN CHILDREN WITH HENOCH–<br />
SHOENLEIN PURPURA: TOLL-LIKE RECEPTORS IN CIRCULATING MONO-<br />
NUCLEAR CELLS<br />
Roberta Camilla | Elisa Loiacono | Maria Elena Donadio | Margherita Conrieri|<br />
Manuela Bianciotto | Francesca M. Bosetti | Licia Peruzzi | Giovanni Conti |<br />
Alessandra Bitto | Alessandro Amore | Rosannna Coppo<br />
Nephrology, Dialysis and Transpl - R. Margherita Hosp, Turin | Pediatric Emergency<br />
Dept - R. Margherita Hosp, Turin | Pediatric Nephrology - Martino Hosp,<br />
Messina<br />
SAP696<br />
EFFICACY OF TREATMENT HENOCH-SCHÖNLEIN NEPHRITIS BASED ON<br />
CLINICAL AND HISTOLOGICAL MANIFESTATIONS<br />
Malgorzata Mizerska-Wasiak | Maria Roszkowska-Blaim | Jadwiga Maldyk<br />
Dept Pediatrics and Nephrology, Dept Pathology, Medical Univ Warsaw<br />
SAP697<br />
MYCOPHENOLIC ACID TREATMENT IN PAEDIATRIC ONSET LUPUS NE-<br />
PHRITIS<br />
Hsin-Hsu Chou | Yuan-Yow Chiou<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
343<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
344<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Ditmanson Medical Foundation Chia-Yi Christian Hosp, Chiayi, Taiwan | National<br />
Cheng Kung Univ Medical Center<br />
SAP698<br />
METABOLIC PROFILE OF NEPHROLITHIASIS IN CHILDREN AGED 0-2 YE-<br />
ARS- SINGLE CENTER EXPERIENCE<br />
Violetta Bochniewska | Katarzyna Jobs | Anna Jung<br />
Wojskowy Inst Medyczny, Warsaw, Poland<br />
SAP699<br />
UROLITHIASIS IN INFANTS<br />
Mohammad Hossein Fallahzadeh Abarghooei | Javad Zare | Vahid Sedighi<br />
Goorabi | Ali Derakhshan | Mitra Basiratnia | Mohammad Amin Fallahzadeh<br />
Abarghooei | Ghamar Hosseini Al-Hashemi | Fatemeh Fallahzadeh Abarghooei<br />
Shiraz Nephro-Urology Res Center, Shiraz Univ Medical Sciences, Shiraz, Iran<br />
SAP700<br />
NONDIPPING STATUS AS AN EARLY RISK FACTOR FOR THE DIABETIC<br />
COMPLICATIONS IN NORMOTENSIVE PATIENTS WITH T1DM<br />
Agnieszka Kluska-Jozwiak | Jolanta Soltysiak | Katarzyna Lipkowska | Magdalena<br />
Silska | Piotr Fichna | Bogda Skowronska | Witold Stankiewicz | Danuta<br />
Ostalska-Nowicka | Jacek Zachwieja<br />
Dept Pediatric Cardiology and Nephrology, Dept Pediatric Diabetes and Obesity,<br />
Poznan Univ Medical Science, Poznan, Poland<br />
SAP701<br />
KIDNEY DAMAGE IN PRIMARY HYPERTENSION IN CHILDHOOD<br />
İlknur Girişgen | Ferah Sönmez | Çiğdem Yenisey<br />
Pediatric Nephrology Dept, Biochemistry Dept, Adnan Menderes Univ, Aydın,<br />
Turkey<br />
SAP702<br />
MEASUREMENT OF PULSE WAVE VELOCITY IN HEALTHY YOUNGSTERS –<br />
REFERENCE VALUES AND COMPARISON OF THREE DEVICES<br />
Eva Kis | Orsolya Cseprekal | Andrea Kerti | Attila Szabo | Paolo Salvi | Athanase<br />
Benetos | Tivadar Tulassay | George Reusz<br />
SE, 1st Dept Pediatrics, Budapest, Hungary | Dept Internal Medicine and Geriatrics,<br />
INSERM U961, Univ Nancy, France<br />
SAP703<br />
SKIN AUTOFLUORESCENCE (sAF) AS A NEW NONINVASIVE MARKER OF<br />
CARDIOVASCULAR DAMAGE IN CHILDREN WITH CHRONIC KIDNEY DI-<br />
SEASE (CKD)<br />
Irena Makulska | Maria Szczepańska | Dorota Drożdż | Danuta Zwolńska<br />
Dept Pediatric Nephrology Wrocław Medical Univ | Dialysis Unit, Silesian Medical<br />
Univ, Zabrze, Poland | Children’s Hosp, Jagiellonian Univ, Cracow, Poland<br />
SAP704<br />
IN THE FAMILIAL MEDITERRENEAN FEVER PATIENTS, CARDIOVASCU-<br />
LAR RISK ASSESSMENT GENETIC MARKERS AND BIOMARKERS: LIPO-<br />
PROTEIN A AND SERUM AMYLOID A<br />
Betul Sozeri | Afig Berdeli | Sevgi Mir<br />
Ege Univ Fac Medicine<br />
SAP705<br />
PLATELETS VITAL COMPUTER MORPHOMETRY IN CHILDREN WITH HE-<br />
MOLYTIC UREMIC SYNDROME<br />
Evgeniya Tolstova<br />
Mocscow State Medical Dentist Univ, Moscow, Russian Federation<br />
SAP706<br />
E. COLI VIRULENCE PATERN IN URINARY TRACT INFECTION (UTI) WITH<br />
OR WITHOUT URINARY TRACT ANOMALIES – MAY IT HELP TO FURTHER<br />
REDUCE VOIDING CYSTOGRAPHIES IN CHILDREN?<br />
Larakeb Anis | Tim Ulinski | Bensman Alber | Bingen Edouard<br />
Armand Trousseau Hosp, APHP<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP707<br />
PREVALENCE OF ALBUMINURIA IN CHILDREN FOLLOWED FOR HIV<br />
INFECTION IN THE PEDIATRIC UNIVERSITY HOSPITAL (CHUP-CDG) OF<br />
OUAGADOUGOU<br />
Coulibaly Gérard | Kouanda Seni | Tountian/Ouedraogo Dunia Julienne Hadiza<br />
| Sapo Christian | Tiendrébéogo Benoît | Babinet François | Lengani Adama<br />
Serv Nephrologie et Hemodialyse, CHU Yalgado Ouédraogo, Ouagadougou,<br />
Burkina Faso | Inst Recherche Sciences Santé, Ouagadougou | Echo Pôle Sante,<br />
Le Mans, France<br />
SAP708<br />
NEPHRITIS IN NEWLY DIAGNOSED S.L.E. CHILDREN IN AUSTRALIA<br />
Andrew Rosenberg | Jane Munro | Kevin Murray | Brynn Wainstein | John<br />
Ziegler | Davinder Singh-Grewal | Christina Boros | Navid Adib | Elizabeth<br />
Elliot | Rose Fahy | Fiona Mackie | Gad Kainer<br />
Sydney Children's Hosp | Royal Children's Hosp Melbourne | Princess Margaret<br />
Hosp Children | Children's Hosp, Westmead | Univ Adelaide | Children's<br />
Hosp, Brisbane | Australian Paediatric Surveillance Unit | Alice Springs Hosp<br />
SAP709<br />
EFFECT OF HEMODIALYSIS (HD) SESSION ON VENTRICULAR ACTIVA-<br />
TION TIME IN CHILDREN WITH END-STAGE RENAL FAILURE (ESRF)<br />
Dorota Polak-Jonkisz | Krystyna Laszki-Szczachor | Danuta Zwolinska | Anna<br />
Janocha | Leslaw Rusiecki | Malgorzata Sobieszczanska<br />
Wroclaw Medical Univ<br />
« SAP710<br />
CARPEDIEM: CARDIO-RENAL PEDIATRIC DIALYSIS EMERGENCY MACHI-<br />
NE. A NEW HOPE FOR INFANTS<br />
Francesco Garzotto | Zaccaria Ricci | Anna Clementi | Roberto Cena | Jeong<br />
Chul Kim | Monica Zanella | Claudio Ronco<br />
Nephrology Dept, St. Bortolo Hosp, Vicenza, Italy | Dept Cardiology and Cardiac<br />
Surgery, Pediatric Cardiac Intensive Care Unit, Bambino Gesù Children’s<br />
Hosp, Rome, Italy | San Bortolo Hosp | Product Specialist, Bellco, Italy<br />
SAP711<br />
INCREASED CASPASE -3 ACTIVITY IN RED BLOOD CELLS (RBCS) IN CHIL-<br />
DREN WITH CHRONIC KIDNEY DISEASE (CKD) TREATED CONSERVATI-<br />
VELY<br />
Dorota Polak-Jonkisz | Leszek Purzyc | Danuta Zwolinska | Irena Makulska |<br />
Maria Szczepanska<br />
Wroclaw Medical Univ | Medical Univ Silesia<br />
SAP712<br />
RENAL FUNCTIONAL RESERVE IN CHILDREN WITH SOLITARY KIDNEY<br />
AND CHRONIC RENAL FAILURE<br />
Amira Peco-Antic | Jelena Kotur-Stevuljević | Dušan Paripović | Gordana<br />
Šćekić | Gordana Miloševski-Lomić | Dragana Bogićević | Brankica Spasojević-<br />
Dimitrijeva<br />
Medical Fac, Fac Pharmacy, Univ Belgrade, Belgrade, Serbia | Dept Nephrology,<br />
Univ Children's Hosp, Belgrade, Serbia | Children Hosp Zemun, Zemun, Serbia|<br />
Dept Neurology, Univ Children's Hosp, Belgrade, Serbia<br />
SAP713<br />
EFFECT OF GENDER ON HEALTH-RELATED QUALITY OF LIFE IN PEDIA-<br />
TRIC LIVE-DONOR KIDNEY TRANSPLANTATION: A SINGLE-CENTER EX-<br />
PERIENCE<br />
Rashad Hassan | Amr El-Husseini | Mohamed Sobh | Mohamed Ghoneim<br />
Urology and Nephrology Center, Mansoura, Egypt | Univ South Florida<br />
SAP714<br />
ADULT HEIGHT AFTER CHILDHOOD ONSET RENAL REPLACEMENT THE-<br />
RAPY IN EUROPE: AN ESPN/<strong>ERA</strong>-<strong>EDTA</strong> REGISTRY STUDY<br />
Jerome Harambat | Marjolein Bonthuis | Karlijn J. van Stralen | Gema Ariceta |<br />
Nina Battelino | Timo Jahnukainen | Ana R. Sandes | Christian Combe | Kitty<br />
J. Jager | Enrico Verrina | Franz Schaefer<br />
ESPN/<strong>ERA</strong>-<strong>EDTA</strong> Registry, Academic Medical Center, Amsterdam, Netherlands<br />
| Univ Children's Hosp Cruces, Barracaldo, Spain | Univ Children's Hosp,<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
345<br />
SATURDAY, MAY 26
SATURDAY, MAY 26<br />
346<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
P O S T E R S<br />
Ljubljana, Slovenia | Univ Children’s Hosp, Helsinki, Finland | Univ Children's<br />
Hosp Santa Maria, Lisbon, Portugal | Nephrology Dept, Univ Hosp, Bordeaux,<br />
France | Gaslini Children's Hosp, Genoa, Italy | Univ Children's Hosp, Heidelberg,<br />
Germany<br />
SAP715<br />
VESICO-URET<strong>ERA</strong>L REFLUX AS A RISK FACTOR FOR ACUTE PYELONE-<br />
PHRITIS AND RENAL DAMAGE IN CHILDREN WITH UTI: SYSTEMATIC<br />
REVIEW AND META-ANALYSIS<br />
Reynaldo Espindola | Justine Bacchetta | Pierre Cochat | Constantinos Stefanis|<br />
Sandrine Leroy<br />
Inst Pasteur | Hôp Femme Mère Enfant & Univ Lyon | P. and A. Kyriakou’<br />
Children’s Hosp<br />
SAP716<br />
PROCALCITONIN PREDICTS WELL ACUTE PYELONEPHRITIS AND RENAL<br />
SCARS IN CHILDREN WITH URINARY TRACT INFECTION<br />
Sandrine Leroy | Anna Fernandez-Lopez | Roya Nikfar | Carla Romanello |<br />
François Bouissou | Alain Gervaix | Metin Gurgoze | Silvia Bressan | Vladislav<br />
Smolkin | David Tuerlinkx | Constantinos Stefanidis | Georgios Vaos | Pierre<br />
Leblond | Firat Gungor | Dominique Gendrel | Martin Chalumeau<br />
Inst Pasteur | Joan de Deu Hosp | Abuzar Children Medical Center Hosp | Univ<br />
Udine | Children's Hosp, Paul Sabathier Univ, CHU Purpan | Univ Hosp Geneva<br />
| Fırat Univ Medicine Fac | Univ Padova | Medical Center | Cliniques<br />
Univ Mont-Godinne, Univ Catholique Louvain | P. and A. Kyriakou Children’s<br />
Hosp| Democritus Univ Thrace and Univ General Hosp Alexandroupolis | Jeanne<br />
de Flandre Hosp | Akdeniz Univ, School Medicine | Necker Hosp<br />
SAP717<br />
DOES HEPCIDIN-25 CORRELATE WITH LV MASS IN PAEDIATRIC CKD PA-<br />
TIENTS?<br />
Adam Rumjon | Iain C. Macdougall | Charles Turner | Debbie Rawlins | Caroline<br />
J. Booth | John M. Simpson | Manish D. Sinha<br />
King's College Hosp NHS Found Trust, London, UK | Renal Unit, King's College<br />
Hosp | WellChild Lab, Dept Congenital Heart Disease | Dept Paediatric<br />
Nephrology, Evelina Children's Hosp, Guy's and St. Thomas' Hosp NHS Found<br />
Trust, London, UK<br />
SAP718<br />
SUCCESSFUL TREATMENT OF MEMBRANOPROLIF<strong>ERA</strong>TIVE GLOMERU-<br />
LONEPHRITIS TYPE I WITH MONOCLONAL ANTI C5 ANTIBODY (ECULI-<br />
ZUMAB)<br />
Garnier Arnaud | Modesto Anne | Tellier Stéphanie | Bandin Flavio | Fremeaux<br />
Bacchi Veronique | Decramer Stéphane<br />
Hôp Enfants | Hôp Rangueil | Hôp Européen Georges Pompidou<br />
¯ t SAP719<br />
UK PAEDIATRIC RENAL TRANSPLANTATION: A REVIEW OF CHANGING<br />
PRACTICE AND IMPROVED OUTCOMES OVER 20 YEARS<br />
Lisa Mumford | Stephen Marks | Niaz Ahmad | Heather Maxwell | Jane Tizard<br />
NHS Blood and Transpl, Bristol, UK | Great Ormond Street Hosp, London, UK |<br />
Leeds General Infirmary, Leeds, UK | Royal Hosp Sick Children, Glasgow, UK |<br />
Bristol Royal Hosp Children, Bristol, UK<br />
SAP720<br />
NEAR-INFRARED SPECTROSCOPY AS A CONTINUOUS REAL-TIME MONI-<br />
TORING FOR KIDNEY GRAFT PERFUSION<br />
Enrico Vidal | Angela Amigoni | Mariacristina Varagnolo | Elisa Benetti | Giulia<br />
Ghirardo | Valentina Brugnolaro | Luisa Murer<br />
Dept Pediatrics, Univ Padova, Italy | Lab Medicine, Padova Hosp, Italy | Paediatric<br />
Nephrology, Dialysis and Transpl Unit, Dept Paediatrics, Univ Padova,<br />
Padova, Italy<br />
SAP721<br />
SUCCESSFUL LIVER-KIDNEY TRANSPLANTATION IN A PATIENT WITH<br />
ESRD DUE TO HOMOZYGOUS FACTOR H MUTATION<br />
Bilal Aoun | Grapin Christine | Bensman Alber | Tim Ulinski<br />
Armand Trousseau Hosp, APHP, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
P O S T E R S<br />
SAP722<br />
PROTOCOL BIOPSIES IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS<br />
ON CYCLOSPORINE VERSUS TACROLIMUS<br />
Bilal Aoun | Stéphane Decramer | Flavio Bandin | Tim Ulinski<br />
Armand Trousseau Hosp, APHP, France | Pediatrics, CHU Toulouse<br />
SAP723<br />
AMBULATORY ARTERIAL STIFFNESS INDEX IN RENAL TRANSPLANT<br />
CHILDREN – CROSS SECTIONAL STUDY<br />
Arianna Dégi | Andrea Kerti | Éva Kis | Orsolya Cseprekál | Attila J. Szabó |<br />
György S. Reusz<br />
First Dept Pediatrics, Semmelweis Univ, Budapest, Hungary<br />
SAP724<br />
TRANSPLANT RENAL ARTERY STENOSIS IN PEDIATRIC KIDNEY TRAN-<br />
SPLANTATION: INCIDENCE, RISK FACTORS, EFFICACY AND SAFETY OF<br />
ENDOSCOPIC TREATMENT<br />
Giulia Ghirardo | Alessandro Vidoni | Enrico Vidal | Elisa Benetti | Gaetano<br />
Ramondo | Diego Miotto | Luisa Murer<br />
Paediatric Nephrology, Dialysis and Transpl Unit, Dept Paediatrics, Univ Padova,<br />
Padova, Italy | Dept Medical Diagnostic Sciences and Special Therapies, Univ<br />
Padova, Italy | Dept Pediatrics, Univ Padova, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
347<br />
SATURDAY, MAY 26
348<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
DAY AT A GLANCE<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
page<br />
08:00 - 09:30 Symposia<br />
Diabetic nephropathy 350<br />
Anaemia management 351<br />
Complications after transplantation 352<br />
Hyponatremia 353<br />
Albuminuria and other biomarkers 354<br />
Free Communications + Mini Lectures<br />
Cardiovascular complications in CKD 5D 355<br />
Autoimmune systemic diseases 357<br />
Clinical studies in CKD 359<br />
09:45 - 10:30 Plenary Lecture R. Bindels 361<br />
10.30 - 11.30 <strong>ERA</strong>-<strong>EDTA</strong> General Assembly 362<br />
(for <strong>ERA</strong>-<strong>EDTA</strong> members only)<br />
11:30 - 13:00 Symposia<br />
IgA nephropathy 363<br />
Reappraisal of European Guidelines 364<br />
Renal cancer and the kidney in cancer 365<br />
Stem cells 366<br />
Prevention of AKI<br />
and delayed graft function 367<br />
Free Communications + Mini Lectures<br />
Transplantation clinical 368<br />
CKD 5D epidemiology and outcomes 370<br />
349<br />
SUNDAY, MAY 27
SUNDAY, MAY 27<br />
350<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
GRAND AMPHITHEATRE 08:00 - 09:30<br />
Symposium 37<br />
Diabetic nephropathy<br />
Chair: Hermann Haller, Hanover, Germany<br />
Detlef Schlöndorff, New York, USA<br />
New insights into the pathogenesis of diabetic nephropathy<br />
Katalin Susztak, New York, USA<br />
Models of diabetic nephropathy: in search of the holy<br />
grail<br />
Charles Alpers, Seattle, USA<br />
Paradigm shifts and optimal treatment of diabetic nephropathy<br />
Carl Erik Mogensen, Aarhus, Denmark<br />
Therapeutic approaches to diabetic nephropathy beyond<br />
the RAS (including SOCS; suppressors of cytokines)<br />
Jesus Egido, Madrid, Spain<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 1 08:00 - 09:30<br />
Symposium 38<br />
Anaemia management<br />
Chair: Kai-Uwe Eckardt, Erlangen, Germany<br />
Pierre-Yves Martin, Geneva, Switzerland<br />
How important is transfusion avoidance in <strong>2012</strong><br />
Iain C. Macdougall, London, UK<br />
Can we predict the risk for adverse events?<br />
Andrzej Wiecek, Katowice, Poland<br />
Anaemia management: the KDIGO recommendations<br />
Patrick S. Parfrey, St. John’s, Canada<br />
Anaemia management: how and why does ERBP differ<br />
from KDIGO<br />
Francesco Locatelli, Lecco, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
351<br />
SUNDAY, MAY 27
SUNDAY, MAY 27<br />
352<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BLEU 08:00 - 09:30<br />
Symposium 39<br />
Complications after transplantation<br />
Chair: Claudio Ponticelli, Milan, Italy<br />
Lionel Rostaing, Toulouse, France<br />
Prevention of renal progression in renal transplantation<br />
Anke Schwarz, Hanover, Germany<br />
Posttransplant recurrence of primary glomerulonephritis<br />
Claudio Ponticelli, Milan, Italy<br />
Metabolic syndrome, insulin resistance, and chronic allograft<br />
dysfunction<br />
Esteban Porrini, La Laguna, Spain<br />
Risk factors for NODAT. Influence of immunosuppressive<br />
therapy<br />
Marian Klinger, Wroclaw, Poland<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BORDEAUX 08:00 - 09:30<br />
Symposium 40<br />
Hyponatremia<br />
Chair: Gabriel Choukroun, Amiens, France<br />
Robert Unwin, London, UK<br />
The pathophysiology and symptoms of hyponatremia<br />
Peter Gross, Dresden, Germany<br />
Diagnostic approach to hyponatremia: the ERBP point of<br />
view<br />
Robert Zietse*, Rotterdam, Netherlands<br />
Treatment of hyponatremia<br />
Michael Joannidis*, Innsbruck, Austria<br />
* ERBP Workgroup on Hyponatremia Guidelines<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
353<br />
SUNDAY, MAY 27
SUNDAY, MAY 27<br />
354<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 2 08:00 - 09:30<br />
Symposium 41<br />
Albuminuria and other biomarkers<br />
Chair: Ron T. Gansevoort, Groningen, Netherlands<br />
Gert Mayer, Innsbruck, Austria<br />
Albuminuria as predictor of poor renal and CV outcome<br />
Paul de Jong, Groningen, Netherlands<br />
Albuminuria - a limb of the new KDIGO CKD tripod<br />
Christopher G. Winearls, Oxford, UK<br />
Finding protein biomarkers in urinary exosomes: application<br />
of principles from systems biology<br />
Mark A. Knepper, Bethesda, USA<br />
Transcriptional networks in glomerular failure<br />
Matthias Kretzler, Ann Arbor, USA<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE HAVANE 08:00 - 09:30<br />
Free Communication Session 24<br />
Cardiovascular complications in CKD 5D<br />
Chair: Bengt Fellström, Uppsala, Sweden<br />
Fatih Kircelli, Yozgat, Turkey<br />
FREE COMMUNICATIONS<br />
SUO001<br />
SERUM SALUSIN-ALPHA AND CD36 ARE POSITIVELY<br />
CORRELATED IN HEMODIALYSIS PATIENTS<br />
Alicja E. Grzegorzewska | Leszek Niepolski | Jan Sikora |<br />
Paweł P. Jagodziński | Dominik Pajzderski<br />
Univ Medical Sciences, Poznań, Poland | B.Braun Avitum<br />
Dialysis Centre, Nowy Tomyśl | Dept Clinical Immunology,<br />
Univ Medical Sciences, Poznań | Dept Biochemistry and Molecular<br />
Biology, Univ Medical Sciences, Poznań | Dept Nephrology,<br />
Transplantology and Internal Diseases, Univ Medical Sciences,<br />
Poznań, Poland<br />
SUO002<br />
DYSFUNCTIONAL HIGH DENSITY LIPOPROTEIN (HDL)<br />
FROM PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD)<br />
INCREASES ARTERIAL BLOOD PRESSURE: ROLE OF EN-<br />
DOTHELIAL NITRIC OXIDE (NO) SYNTHASE<br />
Timo Speer | Lucia Rohrer | Nicolle Kränkel | Kira Kuschnerus<br />
| Zewinger Stephen | Alexander Akhmedov | Yi Shi |<br />
Andreas Jung | Gabriel Wernicke | Arnold von Eckardstein |<br />
Thomas F. Lüscher | Danilo Fliser | Ulf Landmesser | Ferdinand<br />
Bahlmann<br />
Univ Hosp Zurich, Dept Clinical Chemistry, Zurich, Switzerland<br />
| Univ Hosp Zurich, Cardiovascular Center, Zurich,<br />
Switzerland | Saarland Univ Hosp, Dept Internal Medicine IV,<br />
Homburg/Saar, Germany<br />
SUO003<br />
PREDIALYSIS BLOOD PRESSURE AND CARDIOVASCULAR<br />
OUTCOMES AMONG HEMODIALYSIS PATIENTS: RESULTS<br />
FROM THE DOPPS<br />
Bruce Robinson | Angelo Karaboyas | Christian Combe |<br />
Martin Gallagher | Patricia De Sequera | Hiroyasu Yamamoto|<br />
Hal Morgenstern | Douglas Schaubel | David Goodkin |<br />
Nathan Levin | Rajiv Saran | Friedrich Port<br />
Arbor Research Collaborative for Health, Ann Arbor, USA |<br />
Centre Hosp Univ Bordeaux, France | Renal Unit, Concord Repatriation<br />
& General Hosp, Sydney, Australia | Seccion Nefrologia,<br />
Hosp Infanta Leonor, Madrid, Spain | Div Kidney and<br />
Hypertension, Jikei Univ School Medicine, Tokyo, Japan | Univ<br />
Michigan, Ann Arbor, USA | Renal Research Inst, New York,<br />
USA<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
355<br />
SUNDAY, MAY 27
SUNDAY, MAY 27<br />
356<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
SUO004<br />
PREDICTING ACUTE SUDDEN CARDIAC DEATH<br />
Benjamin Goldstein | Wolfgang Winkelmayer | Themistocles<br />
Assimes<br />
Stanford Univ, Palo Alto, USA<br />
SUO005<br />
ALDOSTERONE AND CORTISOL AFFECT THE RISK OF<br />
SUDDEN CARDIAC DEATH IN HAEMODIALYSIS PA-<br />
TIENTS<br />
Christiane Drechsler | Eberhard Ritz | Andreas Tomaschitz|<br />
Stefan Pilz | Stephan Schönfeld | Katja Blouin | Martin Bidlingmaier<br />
| Fabian Hammer | Vera Krane | Winfried März |<br />
Bruno Allolio | Martin Fassnacht | Christoph Wanner<br />
Univ Würzburg, Germany | Univ Heidelberg, Germany | Univ<br />
Graz, Austria | LMU Munich, Germany| Synlab Lab, Heidelberg,<br />
Germany<br />
SUO006<br />
RISK STRATIFICATION OF CARDIAC DEATH IN HEMO-<br />
DIALYSIS PATIENTS WITHOUT CORONARY ARTERY DISE-<br />
ASE BY MYOCARDIAL FATTY ACID IMAGING<br />
Masato Nishimura | Yu Okamoto | Toshiko Tokoro | Masashi<br />
Nishida | Nodoka Sato | Tetsuya Hashimoto | Noriyuki Iwamoto<br />
| Toshihiko Ono<br />
Toujinkai Hosp, Kyoto, Japan<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 352AB 08:00 - 09:30<br />
Free Communication Session 25 + Mini Lecture<br />
Autoimmune systemic diseases<br />
Chair: Mohamed Daha, Leiden, Netherlands<br />
Ralph Kettritz, Berlin, Germany<br />
Mini Lecture<br />
Modulators of positive and negative costimulation<br />
Bernard Vanhove, Nantes, France<br />
FREE COMMUNICATIONS<br />
SUO007<br />
COSTIMULATION BLOCKADE WITH SYSTEMIC siRNA<br />
ANTI CD40 AMELIORATES EXPERIMENTAL LUPUS NE-<br />
PHRITIS IN A DOSE DEPENDENT MANNER<br />
Elia Ripoll | Montse Goma | Nuria Bolaños | Immaculada<br />
Herrero | Oriol Bestard | Josep M Cruzado | Josep M Grinyó|<br />
Juan Torras<br />
HUB-IDIBELL, Barcelona, Spain<br />
SUO008<br />
ANTIPHOSPHOLIPID SYNDROME NEPHROPATHY IN LU-<br />
PUS EXPOSES TO MORE ANTIPHOSPHOLIPID ANTIBODY<br />
SYNDROME – RELATED EVENTS BUT NOT TO WORSE RE-<br />
NAL FUNCTION DURING LONG TERM FOLLOW-UP<br />
Marion Venot | Dominique Nochy | Valérie Caudwell | Christian<br />
Jacquot | Gary Hill | Jean-Charles Piette | Eric Daugas<br />
Nephrology Dpt Bichat Hosp APHP, Paris, France | Pathology<br />
Dpt HEGP APHP, Paris France | Nephrology Dpt Hôp Sud<br />
Francilien, Evry, France | Nephrology Dpt HEGP APHP, Paris<br />
France | Internal Medicine Dpt GH Pitié Salpêtrière APHP, Paris,<br />
France<br />
SUO009<br />
IL-10 PRODUCING REGULATORY B-CELLS ARE DIMINI-<br />
SHED IN ANCA-ASSOCIATED VASCULITIS<br />
Benjamin Wilde | Marielle Thewissen | Pieter van Paassen |<br />
Marc Hilhorst | Jan Damoiseaux | Oliver Witzke | Jan Willem<br />
Cohen Tervaert<br />
Maastricht Univ, Dept Internal Medicine, Div Clinical and Experimental<br />
Immunology, Maastricht, Netherlands | Univ Duisburg-Essen,<br />
Dept Nephrology, Essen, Germany<br />
SUO010<br />
A RANDOMIZED CONTROLLED TRIAL OF MYCOPHE-<br />
NOLATE MOFETIL VERSUS CYCLOPHOSPHAMIDE FOR<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
357<br />
SUNDAY, MAY 27
SUNDAY, MAY 27<br />
358<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
INDUCTION TH<strong>ERA</strong>PY IN ANCA ASSOCIATED SYSTEMIC<br />
VASCULITIS WITH RENAL INVOLVEMENT<br />
Nan Chen | Xin Li | Wen Zhang | Pingyan Shen | Haijing Yu|<br />
Yongxi Chen | Hong Ren | Liyan Ni<br />
Dept Nephrology, Ruijin Hosp, Shanghai Jiao Tong Univ School<br />
of Medicine, Shanghai. China<br />
SUO011<br />
SCLERODERMA RENAL CRISIS: A RETROSPECTIVE MUL-<br />
TICENTRE STUDY ON 91 PATIENTS AND 427 CONTROLS<br />
Céline Lebas | Loïc Guillevin | Alice Bérezné | Raphaèle Seror|<br />
Luis Teixeira | Jacques Pourrat | Alfred Mahr | Eric Hachulla<br />
| Christian Agard | Jean Cabane | Philippe Vanhille|<br />
Jean-Robert Harle | Isabelle Deleveaux | Luc Mouthon<br />
Dept Nephrology and Internal Medicine, Centre Hosp, Valenciennes,<br />
France | Dept Internal Medicine, Hôp Cochin, Paris,<br />
France | Dept Nephrology and Clinical Immunology, Hôp<br />
Rangueil, Toulouse, France | Dept Internal Medicine, Hôp Huriez,<br />
Lille, France | Dept Internal Medicine, Hôtel Dieu, Nantes,<br />
France | Dept Internal Medicine, Hôp Saint Antoine, Paris,<br />
France | Dept Internal Medicine, Hôp Conception, Marseille,<br />
France | Dept Internal Medicine, Hôp Gabriel-Montpied, Clermont-Ferrand,<br />
France<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 342AB 08:00 - 09:30<br />
Free Communication Session 26 + Mini Lecture<br />
Clinical studies in CKD<br />
Chair: Peter Barany, Stockholm, Sweden<br />
Adeera Levin, Vancouver, Canada<br />
FREE COMMUNICATIONS<br />
SUO012<br />
CANADIAN STUDY OF PREDICTION OF DEATH, DIALYSIS<br />
AND INTERIM CARDIOVASCULAR EVENTS: CANPRED-<br />
DICT: BIOMARKERS IMPROVE PREDICTION OF ONE YEAR<br />
OUTCOMES IN CHRONIC KIDNEY COHORT<br />
Adeera Levin | Claudio Rigatto | Brendan Barrett | François<br />
Madore | Norman Muirhead | Daniel Holmes | Catherine Clase<br />
| Mila Tang | Ognjenka Djurdjev | on behalf of the CAN-<br />
PREDDICT investigators<br />
Univ British Columbia | Univ Manitoba | Memorial Univ Newfoundland<br />
| Univ Montréal | London Health Science Center |<br />
St. Paul’s Hosp | McMaster Univ | BC Renal Agency, Vancouver,<br />
Canada<br />
SUO013<br />
SERUM METABOLITES ASSOCIATE WITH KIDNEY FUN-<br />
CTION DECLINE AND INCIDENT CHRONIC KIDNEY DISE-<br />
ASE IN THE GEN<strong>ERA</strong>L POPULATION<br />
Oemer-Necmi Goek | Angela Döring | Christian Gieger |<br />
Margit Heier | Wolfgang Koenig | Cornelia Prehn | Werner<br />
Römisch-Margl | Rui Wang-Sattler | Thomas Illig | Karsten<br />
Suhre | Peggy Sekula | Jerzy Adamski | Anna Köttgen | Christa<br />
Meisinger<br />
Div Nephrology, Univ Medical Center Freiburg, Freiburg, Germany<br />
| Inst Epidemiology I, Inst Genetic Epidemiology, Helmholtz<br />
Zentrum München, German Research Center Environmental<br />
Health, Neuherberg, Germany|Dept Internal Medicine<br />
II - Cardiology, Univ Ulm Medical Center, Ulm, Germany | Inst<br />
Experimental Genetics, Genome Analysis Center, Inst Bioinformatics<br />
and Systems Biology, Research Unit Molecular Epidemiology,<br />
Inst Bioinformatics and Systems Biology, Helmholtz<br />
Zentrum München, German Research Center Environmental<br />
Health, Neuherberg, Germany | Inst Medical Biometry and<br />
Medical Informatics, Univ Medical Center Freiburg, Freiburg,<br />
Germany<br />
SUO014<br />
FETUINURIA PREDICTS ADVERSE OUTCOME IN CKD 3&4<br />
Edward Smith | Martin Ford | Laurie Tomlinson | Lawrence<br />
McMahon | Chakravarthi Rajkumar | Stephen Holt<br />
Monash Univ | Brighton and Sussex Medical School | Dept<br />
Clinical Pharmacology, Addenbrooke’s Hosp, Cambridge, UK<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
359<br />
SUNDAY, MAY 27
SUNDAY, MAY 27<br />
360<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
SUO015<br />
EFFECTS OF N-3 FATTY ACIDS ON DECLINE OF KIDNEY<br />
FUNCTION AFTER MYOCARDIAL INFARCTION: ALPHA<br />
OMEGA TRIAL<br />
Ellen Hoogeveen | Eugenie Gemen | Marianne Geleijnse |<br />
Ron Kusters | Daan Kromhout | Erik Giltay<br />
Jeroen Bosch Hosp, Den Bosch, Netherlands | Wageningen<br />
Univ, Wageningen, Netherlands | Leiden Univ Medical Center,<br />
Leiden, Netherlands<br />
Mini Lecture<br />
Is AKI a risk factor for CKD and ESRD?<br />
Norbert Lameire, Ghent, Belgium<br />
FREE COMMUNICATION<br />
SUO016<br />
A MULTIFACTORIAL INTERVENTION WITH THE AID OF<br />
NURSE PRACTITIONERS IMPROVES RENAL OUTCOME IN<br />
PATIENTS WITH CHRONIC KIDNEY DISEASE: RESULTS OF<br />
THE MASTERPLAN STUDY<br />
MJ Peeters | AD van Zuilen | AJG van den Brand | ML Bots |<br />
PJ Blankestijn | JFM Wetzels<br />
Radboud University Nijmegen Medical Center | University<br />
Medical Center Utrecht, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
GRAND AMPHITHEATRE 09:45 - 10:30<br />
Plenary Lecture 3<br />
Chair: Markus Ketteler, Coburg, Germany<br />
Cengiz Utas, Kayseri, Turkey<br />
Novel insights into the renal handling of calcium<br />
and magnesium<br />
René Bindels, Nijmegen, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
361<br />
SUNDAY, MAY 27
SUNDAY, MAY 27<br />
362<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
Registered Charity No. 1060134<br />
<strong>ERA</strong>-<strong>EDTA</strong> GEN<strong>ERA</strong>L ASSEMBLY<br />
AMPHITHEATRE HAVANE 10:30 - 11:30<br />
The admission to the General Assembly is strictly reserved<br />
to <strong>ERA</strong>-<strong>EDTA</strong> Members only.<br />
Members should have their <strong>ERA</strong>-<strong>EDTA</strong> membership<br />
cards to show in order to enter the room for the General<br />
Assembly.<br />
All <strong>ERA</strong>-<strong>EDTA</strong> Members (Full and Associate) can participate<br />
with voice during the meeting, however vote is<br />
only possible for Full Members.<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
GRAND AMPHITHEATRE 11:30 - 13:00<br />
Symposium 42<br />
IgA Nephropathy<br />
Chair: Nan Chen, Shanghai, China<br />
Renato Monteiro, Paris, France<br />
Pathogenesis of IgA Nephropathy: new insights<br />
John Feehally, Leicester, UK<br />
VALIGA: the largest clinical and pathological database<br />
for IgA nephropathy in Europe<br />
Rosanna Coppo, Turin, Italy<br />
IgAN - a mucosal immune disease?<br />
Bengt Fellström, Uppsala, Sweden<br />
KDIGO Guidelines: Indications for immunosuppressive<br />
therapy in IgA Nephropathy<br />
Jürgen Floege, Aachen, Germany<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
363<br />
SUNDAY, MAY 27
SUNDAY, MAY 27<br />
364<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 1 11:30 - 13:00<br />
Symposium 43<br />
Reappraisal of European Guidelines<br />
Chair: Ali Basci, Izmir, Turkey<br />
Wim Van Biesen, Ghent, Belgium<br />
How to assess target organ damage – blood vessels vs.<br />
kidney?<br />
Sadayoshi Ito, Sendai, Japan<br />
Blood pressue control in CKD 4-5 patients with diabetes:<br />
the ERBP guideline<br />
Hermann Haller, Hanover, Germany<br />
Antihypertensive treatment in dialysis patients<br />
Rajiv Agarwal, Indianapolis, USA<br />
Novel antihypertensive agents<br />
Mustafa Arici, Ankara, Turkey<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BLEU 11:30 - 13:00<br />
Symposium 44<br />
Renal cancer and the kidney in cancer<br />
Chair: Jean-Pierre Grünfeld, Paris, France<br />
Martin Zeier, Heidelberg, Germany<br />
The role of miRNA in RCC<br />
Elena Ranieri, Foggia, Italy<br />
VHL tumor suppressor protein and longevity<br />
Roman-Ulrich Müller, Cologne, Germany<br />
The dilemma of early treatment of angiomyolipomas<br />
John Bissler, Cincinnati, USA<br />
FREE COMMUNICATIONS<br />
¯ SUO017<br />
ANGIOMYOLIPOMA RESPONSE TO EVEROLIMUS TREAT-<br />
MENT IN PATIENTS WITH TUBEROUS SCLEROSIS COM-<br />
PLEX OR SPORADIC LYMPHANGIOLEIOMYOMATOSIS:<br />
RESULTS FROM EXIST-2<br />
Bernard Zonnenberg|Klemens Budde | Chris Kingswood|<br />
Michael Frost | Elena Belousova | Elzbieta Radzikowska |<br />
Matthias Sauter| Norio Nonomura | Susanne Brakemeier | Petrus<br />
de Vries | Judith Klimovsky | Gaurav Shah | Sara Miao|<br />
Jeremie Lincy | John Bissler<br />
Univ Medical Center Utrect, Utrecht, Netherlands|Charite-<br />
Universitätsmedizin Berlin, Berlin, Germany|Royal Sussex<br />
County Hosp, Brighton, UK|Minnesota Epilepsy Group, St.<br />
Paul, MN, USA|Moscow Research Inst Pediatrics & Pediatric<br />
Surgery, Moscow, Russia|National Tuberculosis and Lung Diseases<br />
Research Inst, Warsaw, Poland|Medizinische Klinik und<br />
Poliklinik IV, Klinikum der Ludwig-Maximilians Univ, Munich,<br />
Germany|Osaka Univ Hosp, Suita, Osaka, Japan| Charite-Universitätsmedizin<br />
Berlin, Berlin, Germany|Div Child &<br />
Adolescent Psychiatry, Univ Cape Town, South Africa| Novartis<br />
Pharmaceuticals Corporation, Florham Park, NJ, USA|<br />
Novartis Pharma AG, Basel, Switzerland|Div Nephrology, Cincinnati<br />
Children’s Hosp Medical Center, Cincinnati, OH, USA<br />
SUO018<br />
SOLID RENAL TUMORS OF COLLECTING DUCT ORIGIN IN<br />
PATIENTS WITH CHRONIC LITHIUM NEPHROPATHY<br />
Boer Walther | Goldschmeding Roel | Rookmaaker Maarten<br />
Dept Nephrology, Dept Pathology, Univ Medical Center,<br />
Utrecht, Netherlands<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
365<br />
SUNDAY, MAY 27
SUNDAY, MAY 27<br />
366<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
AMPHITHEATRE BORDEAUX 11:30 - 13:00<br />
Symposium 45<br />
Stem cells<br />
Chair: Duska Dragun, Berlin, Germany<br />
Shoichi Maruyama, Nagoya, Japan<br />
Stem cells and renal repair<br />
Ariela Benigni, Bergamo, Italy<br />
Endogenous stem cells of the kidney<br />
Paola Romagnani, Florence, Italy<br />
Stem cell function in the uremic milieu<br />
Uta Kunter, Aachen, Germany<br />
FREE COMMUNICATION<br />
SUO019<br />
ADULT RENAL STEM/PROGENITOR CELLS REPAIR ACU-<br />
TE RENAL TUBULAR CELL INJURY BY MEANS OF SPECI-<br />
FIC TLR2-DRIVEN PARACRINE FACTORS<br />
Fabio Sallustio | Vincenzo Costantino | Sharon Natasha Cox |<br />
Antonia Loverre | Marco Rizzi | Francesco Paolo Schena<br />
Dept Emergency and Organ Transpl, Univ Bari, Bari, Italy | Nephrology<br />
Dialysis and Transpl Unit, Bari, Italy<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM CONCORDE 2 11:30 - 13:00<br />
Symposium 46<br />
Prevention of AKI and delayed graft function<br />
Chair: Giuseppe Grandaliano, Foggia, Italy<br />
Patrick Maxwell, London, UK<br />
Abnormal oxygen metabolism in uremia<br />
Masaomi Nangaku, Tokyo, Japan<br />
Prevention of renal injury through upregulation of HIF<br />
Kai-Uwe Eckardt, Erlangen, Germany<br />
Ischemic preconditioning<br />
Mohammad Magdi Yaqoob, London, UK<br />
Machine-perfusion of kidney allografts<br />
Rutger J. Ploeg, Oxford, UK<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
367<br />
SUNDAY, MAY 27
SUNDAY, MAY 27<br />
368<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 352AB 11:30 - 13:00<br />
Free Communication Session 27 + Mini Lecture<br />
Transplantation clinical<br />
Chair: Marian Klinger, Wroclaw, Poland<br />
Bruno Watschinger, Vienna, Austria<br />
FREE COMMUNICATIONS<br />
SUO020<br />
CIRCULATING PRO-INFLAMMATORY CD4+CD28NULL<br />
T CELLS INCREASE THE RISK FOR A CARDIOVASCULAR<br />
EVENT SHORTLY AFTER KIDNEY TRANSPLANTATION<br />
Michiel Betjes | Willem Weimar | Nicolle Litjens<br />
Erasmus MC, Univ Medical Center, Rotterdam, Netherlands<br />
SUO021<br />
HCMV-SPECIFIC CELLULAR IMMUNE RESPONSE IN KID-<br />
NEY TRANSPLANT RECIPIENTS<br />
Cristina Costa | Alda Saldan | Franca Sinesi | Francesca Sidoti|<br />
Samantha Mantovani | Salvatore Simeone | Cinzia Balloco|<br />
Elsa Piasentin Alessio | Andrea Piceghello | Alessia Di Nauta|<br />
Andrea Ranghino | Giuseppe Segoloni | Rossana Cavallo<br />
Univ Hosp San Giovanni Battista Torino, Turin, Italy<br />
SUO022<br />
LONG-TERM IMPACT OF EARLY CYTOMEGALOVIRUS IN-<br />
FECTION AFTER KIDNEY TRANSPLANTATION<br />
Yuliya V Smedbraaten | Anders Hartmann | Halvor Rollag |<br />
Torbjoern Leivestad | Aksel Foss | Haavard Viko | Ingrid Os|<br />
Solbjørg Sagedal<br />
Dept Nephrology, Oslo Univ Hosp Ullevaal, Oslo, Norway |<br />
Sect Nephrology, Div Specialised Medicine and Surgery, Inst<br />
Medical Microbiology, Oslo Univ Hosp RiksHosp and Univ<br />
Oslo, Oslo, Norway<br />
t SUO023<br />
ECULIZUMAB FOR AHUS RECURRENCE IN RENAL TRAN-<br />
SPLANTATION<br />
Julien Zuber | Krid Saoussen | Le Quintrec Moglie | Noel Laure-Hélène<br />
| Gueutin victor | Chatelet Valérie | Salomon Rémi|<br />
Lahoche Annie | Deschênes Georges | Hourmant Maryvonne |<br />
Frémeaux-Bacchi Véronique | Niaudet Patrick | Rondeau Eric|<br />
Legendre Christophe | Loirat Chantal<br />
Univ Paris Descartes, Paris, France | Necker Néphrologie<br />
pédiatrique, Paris, France | Hôp Foch, Paris, France | Hôp<br />
Pitié-Salpétrière, Paris, France | CHU Caen | CHU Lille | Hôp<br />
Robert Debré, Paris, France | CHU Nantes | HEGP | Hôp Tenon,<br />
Paris, France<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
« SUO024<br />
UK STUDY OF LIVING KIDNEY DONOR-RECIPIENT RELA-<br />
TIONSHIPS: GENDER AND ETHNIC VARIATIONS<br />
Rishi Pruthi | Rommel Ravanan | Anna Casula | Paul Roderick<br />
UK Renal Registry, Bristol, England | Southmead Hosp, Bristol,<br />
UK | Univ Southampton, Southampton, UK<br />
Mini Lecture<br />
Weight changes before and after kidney transplantation<br />
- is it relevant?<br />
Magdalena Durlik, Warsaw, Poland<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
369<br />
SUNDAY, MAY 27
SUNDAY, MAY 27<br />
370<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
ROOM 342AB 11:30 - 13:00<br />
Free Communication Session 28<br />
CKD 5D epidemiology and outcomes<br />
Chair: Friedo Dekker, Leiden, Netherlands<br />
Patrick S. Parfrey, St. John’s, Canada<br />
FREE COMMUNICATIONS<br />
« SUO025<br />
EVIDENCE FOR A CAUSAL RELATIONSHIP BETWEEN<br />
NERVE DYSFUNCTION AND HYPERKALAEMIA IN END-<br />
STAGE KIDNEY DISEASE<br />
Ria Arnold | Bruce A. Pussell | Virginija Grinius | Matthew C.<br />
Kiernan | Cindy S-Y. Lin | Arun V. Krishnan<br />
School Medical Sciences, Univ New South Wales, Sydney,<br />
Australia | Dept Nephrology, Prince Wales Hosp Randwick,<br />
Sydney, Australia | Neuroscience Research Australia, Sydney,<br />
Australia<br />
SUO026<br />
PATIENTS IN CHRONIC HEMODIALYSIS PRESENT INCRE-<br />
ASED INDOLEAMINE 2,3-DIOXYGENASE (IDO) ACTIVITY:<br />
A CLUE FOR UREMIC IMMUNODEFICIENCY<br />
Davide Defedele | Elisa Loiacono | M. Paola Puccinelli | Licia<br />
Peruzzi | Stefano Maffei | Roberta Camilla | Rachele Gallo<br />
| Giorgio Triolo | Daniela Bergamo | Elena Palazzo | Luca<br />
Vergano | Federica Campolo | Alessandro Amore | Rosannna<br />
Coppo<br />
Diagnostics Dept, Nephrology, Dialysis, Transpl - Regina Margherita<br />
Hosp, Turin | Nephrology and Dialysis, CTO - M. Adelaide<br />
Hosp, Turin, Italy | Diagnostic Serv, Diagnostic Dept, R.<br />
Margherita Hosp, Turin, Italy<br />
« SUO027<br />
PREDICTING ERYTHROPOIETIN RESISTANCE IN HEMO-<br />
DIALYSIS PATIENTS: POST HOC ANALYSES FROM THE 4D<br />
STUDY<br />
Andreas Schneider | Markus P. Schneider | Alan G. Jardine |<br />
Christoph Wanner | Christiane Drechsler<br />
Univ Hosp Wuerzburg, Wuerzburg, Germany | Univ Hosp Erlangen,<br />
Erlangen, Germany | Univ Glasgow, Glasgow, UK<br />
SUO028<br />
DIALYSATE SODIUM PRESCRIPTION, BLOOD PRESSURE,<br />
AND OUTCOMES IN HEMODIALYSIS PATIENTS<br />
Manfred Hecking | Angelo Karaboyas | Hugh Rayner | Rajiv<br />
Saran | Ananda Sen | Masaaki Inaba | Jurgen Bommer |<br />
Walter Horl | Ronald Pisoni | Bruce Robinson | Gere Sunder-<br />
Plassmann | Friedrich Port<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
S C I E N T I F I C P R O G R A M M E<br />
Medical Univ Vienna, Austria | Arbor Research Collaborative<br />
for Health, Ann Arbor, USA | Birmingham Heartlands Hosp,<br />
UK | Univ Michigan, Ann Arbor, USA | Osaka City Univ Graduate<br />
School Medicine, Japan | Univ Heidelberg, Germany<br />
« SUO029<br />
PATTERNS OF SYSTOLIC BLOOD PRESSURE, ALBUMIN,<br />
AND INTERDIALYTIC WEIGHT GAIN IN CHRONIC HEMO-<br />
DIALYSIS PATIENTS BEFORE HOSP ADMISSION<br />
Len A Usvyat | Stephan Thijssen | Peter Kotanko | Nathan<br />
W Levin<br />
Renal Research Inst, New York, USA<br />
« SUO030<br />
RENAL CENTRE CHARACTERISTICS AND PRACTICE PAT-<br />
TERNS ASSOCIATED WITH RRT INCIDENCE IN THE UK<br />
Clare Castledine | Julie Gilg | Chris Rogers | Yoav Ben-Shlomo<br />
| Fergus Caskey<br />
UK Renal Registry, Bristol, UK | UK Renal Registry | Univ<br />
Bristol | School Social and Community Medicine, Bristol Univ,<br />
UK| NHS North Bristol, Bristol, UK<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
371<br />
SUNDAY, MAY 27
SUNDAY, MAY 27<br />
372<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
S C I E N T I F I C P R O G R A M M E<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
INDUSTRY SPONSORED SYMPOSIA<br />
Friday, May 25<br />
13:15 – 15:15<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
page<br />
Grand Amphitheatre Roche 374<br />
Room Concorde 1 Gambro 375<br />
Amphitheatre Bleu Fresenius Medical Care 376<br />
Amphitheatre Bordeaux Sanofi 377<br />
Room Concorde 2 Otsuka Pharmaceutical Europe 378<br />
Room 252 AB Alexion Pharma International 379<br />
Amphitheatre Havane Takeda Pharmaceuticals Europe 380<br />
Room 352 AB B.Braun 381<br />
Saturday, May 26<br />
13:15 – 15:15<br />
page<br />
Room Concorde 1 Abbott 382<br />
Amphitheatre Bleu Amgen 383<br />
Amphitheatre Bordeaux Shire Pharmaceuticals 384<br />
Room Concorde 2 Baxter Healthcare 385<br />
Room 252 AB Vifor Pharma<br />
and Fresenius Medical Care 386<br />
Amphitheatre Havane DV Care 387<br />
Room 342 AB Nipro Europe 388<br />
Room 352 AB Toray 389<br />
373<br />
INDUSTRY SPONSORED SYMPOSIA
INDUSTRY SPONSORED SYMPOSIA<br />
374<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Friday, May 25 13:15 - 15:15<br />
Grand Amphitheatre<br />
Offering stability in the fluctuating world<br />
of renal anaemia<br />
Chair: Philippe Lang, Paris, France<br />
Welcome & Introduction<br />
Philippe Lang, Paris, France<br />
New targets, new standards: The key messages from<br />
KDIGO<br />
Kai-Uwe Eckardt, Erlangen, Germany<br />
New vs. old world: Implications of an individualised<br />
treatment approach to renal anaemia<br />
Angel Luis Martín de Francisco, Santander, Spain<br />
Case in point: The potential effect of KDIGO on European<br />
chronic renal anaemia care<br />
Sean Fenwick, Sunderland, UK<br />
Discussion<br />
Summary & Conclusions<br />
organised by ROCHE<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Friday, May 25 13:15 - 15:15<br />
Room Concorde 1<br />
Reflections and experience from 30 years in the files of<br />
dialysis<br />
Chair: Claudio Ronco, Vicenza, Italy<br />
Introduction<br />
Ingrid Ledebo, Lund, Sweden<br />
Panel discussion with the participation of<br />
Anders Christensson, Malmö, Sweeden<br />
Ingrid Ledebo, Lund, Sweden<br />
Raymond Vanholder, Ghent, Belgium<br />
Richard Ward, Louisville, USA<br />
- How physiological is contemporary dialysis?<br />
- Which components of a dialysis treatment can still be<br />
considered unphysiological?<br />
- Can and should we strive to make dialysis therapy<br />
more physiological?<br />
- If so, which are the most important steps to take?<br />
- What impact could this have on outcome?<br />
organised by GAMBRO<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
375<br />
INDUSTRY SPONSORED SYMPOSIA
INDUSTRY SPONSORED SYMPOSIA<br />
376<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Friday, May 25 13:15 - 15:15<br />
Amphitheatre Bleu<br />
Meeting cardiovascular challenges in haemodialysis<br />
Chair: David Wheeler, London, UK<br />
High-volume online HDF: maximizing convection for<br />
better outcomes<br />
Bernard Canaud, Montpellier, France<br />
Potassium control in CKD: can we do better?<br />
James Heaf, Herlev, Denmark<br />
Modern phosphate binding therapy involving magnesium<br />
Markus Ketteler, Coburg, Germany<br />
organised by FRESENIUS MEDICAL CARE<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Friday, May 25 13:15 - 15:15<br />
Amphitheatre Bordeaux<br />
New insights in markers of CKD-MBD; how can we<br />
improve patient outcomes?<br />
Chair: Tilman Drueke, Amiens, France<br />
The rise of FGF23 from mendelian obscurity<br />
to mainstream cardiovascular notoriety<br />
Myles Wolf, Miami, USA<br />
The reappraisal of calcium balance in chronic kidney<br />
disease<br />
David Spiegel, Denver, USA<br />
Prevention of cardiovascular calcification in CKD<br />
patients, should this be key priority?<br />
Chris McIntyre, Derby, UK<br />
organised by SANOFI<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
377<br />
INDUSTRY SPONSORED SYMPOSIA
INDUSTRY SPONSORED SYMPOSIA<br />
378<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Friday, May 25 13:15 - 15:15<br />
Room Concorde 2<br />
Taking a closer look at hyponatraemia<br />
Chair: Maurice Laville, Lyon, France<br />
Welcome and introduction:<br />
The hyponatraemia mind-set and environment<br />
Maurice Laville, Lyon, France<br />
Under the microscope:<br />
Hyponatraemia from a fluid balance perspective<br />
Søren Nielsen, Aarhus, Denmark<br />
Robert W. Schrier, Denver, USA<br />
Investigating the optimal treatment of hyponatraemia:<br />
Practical case studies<br />
Volker Burst, Köln, Germany<br />
Questions and answers<br />
Chair close<br />
organised by<br />
OTSUKA PHARMACEUTICAL EUROPE<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Friday, May 25 13:15 - 15:15<br />
Room 252 AB<br />
aHUS: A complement-Mediated Thrombotic<br />
Microangiopathy<br />
Chair: Christophe Legendre, Paris, France<br />
The role of complement in complement mediated diseases<br />
Peter Zipfel, Jena, Germany<br />
aHUS disease and diagnosis: key learnings<br />
Franz Schaefer, Heidelberg, Germany<br />
Improving patient outcomes in aHUS<br />
Chantal Loirat, Paris, France<br />
organised by<br />
ALEXION PHARMA INTERNATIONAL<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
379<br />
INDUSTRY SPONSORED SYMPOSIA
INDUSTRY SPONSORED SYMPOSIA<br />
380<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Friday, May 25 13:15 - 15:15<br />
Amphitheatre Havane<br />
Chemin de fer: following the right track in anaemia<br />
management<br />
Chair: Iain Macdougall, London, UK<br />
Chairman’s introduction<br />
Iain Macdougall, London, UK<br />
Planning the route ahead:<br />
Meeting the challenges of disease progression in renal<br />
anaemia<br />
Simon Roger, Gosford, Australia<br />
Future therapeutic options:<br />
Following the right track in anaemia management in<br />
CKD<br />
Francesco Locatelli, Lecco, Italy<br />
Signalling change:<br />
Hepcidin as a novel biomarker for CKD<br />
Tomas Ganz, Los Angeles, USA<br />
All aboard!<br />
Open forum discussion<br />
Iain Macdougall, London, UK<br />
organised by<br />
TAKEDA PHARMACEUTICALS EUROPE<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Friday, May 25 13:15 - 15:15<br />
Room 352 AB<br />
Ensuring good dialysis quality in times of cost pressure<br />
Chairs: Ziad A. Massy, Amiens, France<br />
Philippe Nicoud, Sallanches, France<br />
What counts? Efficiency and efficacy of interventions to<br />
ensure good dialysis quality<br />
John Moran, Los Angeles, USA<br />
High flux dialysis changing medical practice - an update<br />
James Tattersall, Leeds, UK<br />
Water quality and needs for good dialysis: the impact of<br />
dialysate flow rate on delivered Kt/V<br />
Nicholas Hoenich, Newcastle, UK<br />
organised by B. BRAUN AVITUM<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
381<br />
INDUSTRY SPONSORED SYMPOSIA
INDUSTRY SPONSORED SYMPOSIA<br />
382<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Saturday, May 26 13:15 - 15:15<br />
Room Concorde 1<br />
Mitigation of declining kidney function:<br />
how pathophysiological mechanisms inform new<br />
treatment options<br />
Chair: Dick de Zeeuw, Groningen, Netherlands<br />
Introduction and opening remarks<br />
Dick de Zeeuw, Groningen, Netherlands<br />
Progression of kidney disease: processes and variability<br />
Adeera Levin, Vancouver, Canada<br />
How do oxidative stress and inflammation contribute to<br />
declining kidney function?<br />
Ziad Massy, Amiens, France<br />
KEAP1-Nrf2 as a therapeutic target<br />
Christoph Wanner, Würzburg, Germany<br />
Panel discussion<br />
organised by ABBOTT<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Saturday, May 26 13:15 - 15:15<br />
Amphitheatre Bleu<br />
Evolving our understanding of CKD management<br />
through outcome trials<br />
Chair: Eberhard Ritz, Heidelberg, Germany<br />
Chair’s welcome and introduction: the role of evidence<br />
based medicine in clinical decision taking<br />
Eberhard Ritz, Heidelberg, Germany<br />
Improving outcomes in CKD-MBD patients with<br />
calcimimetics: the potential of EVOLVE<br />
David Wheeler, London, UK<br />
Management of anaemia in chronic kidney disease:<br />
Recent learnings<br />
Robert Toto, Dallas, USA<br />
organised by AMGEN<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
383<br />
INDUSTRY SPONSORED SYMPOSIA
INDUSTRY SPONSORED SYMPOSIA<br />
384<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Saturday, May 26 13:15 - 15:15<br />
Amphitheatre Bordeaux<br />
Clinical challenges in balancing nutritional intake and<br />
phosphate metabolism in dialysis patients<br />
Chair: Denis Fouque, Lyon, France<br />
Chair’s Introduction<br />
Denis Fouque, Lyon, France<br />
Protein intake and phosphate control<br />
Kamyar Kalantar-Zadeh, Los Angeles, USA<br />
Enabling adequate protein intake: the critical role of<br />
phosphate binders<br />
Mario Cozzolino, Milan, Italy<br />
The challenge of non-adherence<br />
Rob Horne, London, UK<br />
Questions to the panel<br />
Meeting close<br />
organised by SHIRE PHARMACEUTICALS<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Saturday, May 26 13:15 - 15:15<br />
Room Concorde 2<br />
Delivering high dose haemodialysis in the home:<br />
physician and patient perspectives<br />
Chair: Gérard M. London, Fleury-Mérogis, France<br />
Providing patients an option for high dose haemodialysis<br />
- balancing patient benefits, risks and lifestyle<br />
Deborah Zimmerman, Ottawa, Canada<br />
Hurdles to establish and maintain a successful home<br />
haemodialysis programme<br />
Eero Honkanen, Helsinki, Finland<br />
Leaving the centre behind - a patient’s perspective<br />
Ian Hazel, Chesterfield, UK<br />
Q & A Session<br />
Summary and Conclusions<br />
organised by BAXTER HEALTHCARE<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
385<br />
INDUSTRY SPONSORED SYMPOSIA
INDUSTRY SPONSORED SYMPOSIA<br />
386<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Saturday, May 26 13:15 - 15:15<br />
Room 252 AB<br />
The new KDIGO Anaemia Guidelines – Targeting better<br />
patient outcomes<br />
Chair: Walter Hörl, Vienna, Austria<br />
Introduction<br />
Walter Hörl, Vienna, Austria<br />
The new KDIGO Anaemia Guidelines on the use of iron<br />
in clinical practice:<br />
What do we know and what do we not know?<br />
Patrick Parfrey, St. John’s, Canada<br />
Achieving a balance in anaemia management:<br />
What is the role of IV iron?<br />
Gilbert Deray, Paris, France<br />
IV iron therapy:<br />
How do we maximize benefit and minimize risk?<br />
Iain Macdougall, London, United Kingdom<br />
Panel discussion<br />
organised by<br />
VIFOR PHARMA and FRESENIUS MEDICAL CARE<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Saturday, May 26 13:15 - 15:15<br />
Amphitheatre Havane<br />
Bringing quality to life for dialysis patients: how can we<br />
improve the patient experience?<br />
Chairs: David Van Wyck, Denver, USA<br />
Kai-Uwe Eckardt, Erlangen, Germany<br />
Treatment around the world: how are we doing?<br />
David Van Wyck, Denver, USA<br />
Kai-Uwe Eckardt, Erlangen, Germany<br />
Patient-based medicine in dialysis: what is the spectrum<br />
of alternatives?<br />
Claudio Ronco, Vicenza, Italy<br />
Population-based medicine in dialysis: is it applicable in<br />
all patients?<br />
Wim Van Biesen, Ghent, Belgium<br />
Continuous improvement in patient management:<br />
how can we apply the learning healthcare paradigm to<br />
dialysis?<br />
Mahesh Krishnan, Minneapolis, USA<br />
organised by DV CARE<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
387<br />
INDUSTRY SPONSORED SYMPOSIA
INDUSTRY SPONSORED SYMPOSIA<br />
388<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Saturday, May 26 13:15 - 15:15<br />
Room 342 AB<br />
Health & safety in dialysis<br />
Chair: Lucile Mercadal, Paris, France<br />
Bisphenol A (BPA) exposure from dialysis equipment:<br />
implications for adverse health effects in patients with<br />
impaired kidney function<br />
Frederick Vom Saal, Columbia, USA<br />
Buttonhole needling of hemodialysis arterio-venous<br />
fistulae results in less complications and interventions<br />
compared to the rope-ladder technique<br />
Madga van Loon, Maastricht, Netherlands<br />
organised by NIPRO EUROPE<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
I N D U S T R Y S P O N S O R E D S Y M P O S I A<br />
Saturday, May 26 13:15 - 15:15<br />
Room 352 AB<br />
Clinical potentials of adsorptive dialysis membrane<br />
Chair: Thierry Hannedouche, Strasbourg, France<br />
Immune deficiency in ESRD patients; the role of the<br />
dialysis membrane<br />
Marie-Noëlle Peraldi, Paris, France<br />
Removal of albumin-bound uremic toxins by hemodialysis<br />
Toshimitsu Niwa, Nagoya, Japan<br />
Clinical experience with enhanced adsorption dialysis<br />
for FLCs removal in patients with multiple myeloma<br />
Antonio Santoro, Bologna, Italy<br />
organised by TORAY<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
389<br />
INDUSTRY SPONSORED SYMPOSIA
EXHIBITORS<br />
390<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
INDUSTRY EXHIBITION<br />
THURSDAY, MAY 24, <strong>2012</strong><br />
17:00-21:00 Exhibition Open<br />
19:30-21:00 Welcome Reception in the Exhibition<br />
FRIDAY, MAY 25, <strong>2012</strong><br />
09:00-17:30 Exhibition Open<br />
09:30-10:45 Poster Viewing and Exhibition Visit<br />
11:30-11:45 Coffee Break and Exhibition Visit<br />
16:45-17:00 Coffee Break and Exhibition Visit<br />
SATURDAY, MAY 26, <strong>2012</strong><br />
09:00-17:30 Exhibition Open<br />
09:30-10:45 Poster Viewing and Exhibition Visit<br />
11:30-11:45 Coffee Break and Exhibition Visit<br />
16:45-17:00 Coffee Break and Exhibition Visit<br />
SUNDAY, MAY 27, <strong>2012</strong><br />
09:00-12:00 Exhibition Open<br />
09:30-09:45 Coffee Break and Exhibition Visit<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
391<br />
EXHIBITORS
EXHIBITORS<br />
EXHIBITORS LIST A-Z<br />
392<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
COMPANY .............................................................Booth No.<br />
Abbott ............................................................ 2.03+2.90+2.88<br />
Actual Way Medical Devices - Via Actual .................. 2.21<br />
Alam Medical ...............................................................1.64A<br />
Alere International.......................................................... 1.93<br />
Alexion Pharma International............................1.26+1.116<br />
Allmed Medical............................................................... 2.27<br />
Amgen Europe ................................................................ 2.48<br />
ARBOR Research............................................................ 1.G7<br />
Asahi Kasei Medical Europe ................................1.42+1.47<br />
Atcor Medical ............................................................... 1.G23<br />
Atlantic Biomedical......................................................... 2.04<br />
Awak Technologies......................................................... 1.68<br />
B.Braun Avitum............................................................... 2.12<br />
Bain Medical Equipment................................................ 1.22<br />
Baxter Healthcare............................................................ 2.39<br />
Bellco...................................................................Hall Maillot<br />
Binding Site (the)............................................................. 1.05<br />
Bionic Medizintechnik.................................................. 1.103<br />
BioPorto Diagnostics ................................................... 1.G21<br />
Bodystat........................................................................... 1.G6<br />
Culligan ............................................................................ 1.94<br />
Covidien ........................................................................... 1.16<br />
Cybernius Medical.......................................................... 1.37<br />
Debiotech.......................................................................... 1.91<br />
Diaverum.......................................................................... 2.19<br />
Dirinco .............................................................................. 1.32<br />
Dustri Verlag....................................................................1.P1<br />
DV Care ............................................................................ 1.29<br />
DWA ................................................................................. 2.81<br />
E.D.P. La Traccia .......................................................... 1.G22<br />
EffeEmme ......................................................................... 2.44<br />
EG Medical Systems ....................................................... 1.62<br />
Elsevier Masson...............................................................1.P4<br />
Emodial............................................................................. 2.42<br />
<strong>ERA</strong>-<strong>EDTA</strong> 2013 <strong>Congress</strong> Istanbul.......................... 1.G14<br />
Etropal .............................................................................. 1.11<br />
Euroclinic......................................................................... 1.G5<br />
FedAirg............................................................................ 1.G9<br />
French Society of Dialysis........................................... 1.G11<br />
French Society of Nephrology...................................... 1.G8<br />
Fresenius Kabi ................................................................. 2.68<br />
Fresenius Medical Care.................................................. 2.68<br />
Gambro............................................................................. 2.46<br />
Gardhen Bilance ........................................................... 1.98C<br />
HemoSapiens................................................................ 1.G24<br />
Herco Wassertechnik...................................................... 2.64<br />
Hospira UK ...................................................................... 2.83<br />
IFKF - International Federation<br />
of Kidney Foundation ................................................... 1.G4<br />
Immundiagnostik......................................................... 1.G19<br />
Infomed ............................................................................ 1.45<br />
Innovative Blood Purification ....................................... 1.50<br />
Intermedt Medizin & Technik....................................... 1.97<br />
ISN International Society of Nephrology ................... 1.G3<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
COMPANY ..............................................................Booth No<br />
Janssen .............................................................................. 2.37<br />
JiHua Medical Apparatus and Instruments............. 1.G17<br />
Joline ................................................................................. 1.34<br />
Karger ...............................................................................1.P6<br />
Kawasumi......................................................................... 2.05<br />
Kimal................................................................................. 1.01<br />
Labor Limbach.............................................................. 1.G20<br />
Lauer ................................................................................. 2.12<br />
Likamed............................................................................ 2.66<br />
Medcomp.......................................................................... 1.71<br />
Medica Italia .................................................................. 1.100<br />
Medikit.............................................................................. 1.35<br />
Meditechlab & Suisse Med Technologies.................... 1.92<br />
MediTheque Bookshop ..................................................1.P5<br />
Medvision....................................................................... 1.115<br />
MedXL ........................................................................... 1.G10<br />
Membrana ........................................................................ 2.20<br />
Miltenyi Biotec................................................................. 2.40<br />
Mitsubishi Pharma Europe............................................ 1.10<br />
Nature PG.........................................................................1.P2<br />
NDT-ERBP-NDT-Educational..................................... 1.102<br />
Nephrokit ......................................................................... 1.28<br />
Nikkiso Europe............................................................... 2.75<br />
Ningbo Tianyi Medical Appliance ............................ 1.G15<br />
Nipro Europe................................................................... 2.14<br />
NKF USA.......................................................................... 2.26<br />
Novartis Pharmaceuticals - Oncology ......................... 1.31<br />
NxStage Medical ............................................................. 1.02<br />
Otsuka Pharmaceuticals Europe................................... 1.60<br />
OUP Oxford University Press ....................................... 1.72<br />
PakuMed .......................................................................... 1.36<br />
Pharmacosmos................................................................. 2.13<br />
Physidia ............................................................................ 1.65<br />
PosterSessionOnLine - Poster Virtual Gallery............ 1.24<br />
Pronefro............................................................................ 1.96<br />
Roche................................................................................. 2.52<br />
Sandoz .............................................................................. 2.73<br />
Sanofi Aventis Groupe ................................................... 2.79<br />
Savient Pharmaceuticals ................................................ 1.14<br />
Serumwerk Bernburg ..................................................... 1.61<br />
Shire Pharmaceuticals .................................................... 2.01<br />
Sined.................................................................................. 1.57<br />
Soludia Maghreb............................................................. 2.65<br />
Takeda Pharmaceuticals Europe...........................P01+P02<br />
TauroPharm ..................................................................... 1.43<br />
Terumo BCT...................................................................1.98B<br />
Thermo Fisher Scientific............................................... 1.113<br />
Tianjin Denny Tech Co.................................................1.63B<br />
Toray ................................................................................. 1.49<br />
Turkish Society of Nephrology.................................. 1.G12<br />
Vifor Fresenius Medical Care Renal Pharma.....2.22+2.23<br />
Wichtig Editore.................................................................1P3<br />
Wisepress ...................................................................... 1.G18<br />
WS Far Ir Medical ........................................................1.63A<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
393<br />
EXHIBITORS
EXHIBITORS<br />
394<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
LIST OF EXHIBITORS<br />
IN ALPHABETICAL ORDER<br />
Companies are totally responsible for the description below<br />
Abbott .............................................Booth 2.03+2.90+2.88<br />
Abbott is a global, broad-based health care company<br />
devoted to the discovery, development, manufacture<br />
and marketing of pharmaceuticals and medical products,<br />
including nutritionals, devices and diagnostics.<br />
Our commitment to kidney care and kidney patients<br />
stretches back more than two decades and extends<br />
across our pharmaceutical, nutritional, diagnostic and<br />
vascular divisions. We produce and market a wide<br />
range of products that benefit kidney disease patients<br />
in more than 130 countries around the world today,<br />
and have an industry-leading pipeline focused on<br />
brining continued innovation to patients tomorrow.<br />
Abbott information is available on the company’s<br />
websites at www.abbott.com<br />
Actual Way Medical Devices -<br />
Via Actual ........................................................ Booth 2.21<br />
We are ActualWay ® , a Portuguese manufacturer of<br />
care treatment medical equipment such as Therapy,<br />
Sampling/Blood Donation, Gynaecological, Multifunctional<br />
Chairs, Couches and many accessories.<br />
We have been increasing our distribution all over the<br />
world thanks to big efforts in promoting our products.<br />
Our sales strategy is based on building a long term relationship<br />
with all our partners providing quality and<br />
service. The best way to take care is to get our partners´<br />
and patients´ satisfaction meeting their needs.<br />
We produce reliable, strong and comfortable products<br />
because we do care. Come and join us so that we can<br />
expand business together!<br />
www.actualway.pt<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
Alam Medical ............................................... Booth 1.64A<br />
Alam Medical, a French company, develops, manufactures<br />
and markets high-tech medical products with<br />
particular focus on cardiovascular diagnosis with the<br />
Compliorr device. Complior AnalyseR measures aortic<br />
stiffness with the reference methodology: simultaneous<br />
carotid-femoral pulse wave velocity (PWV).<br />
Compliorr is the device used in most epidemiological<br />
studies which made PWV a recognized measurement<br />
of organ damage in the ESH guidelines. The latest distance<br />
methodology and the international PWV reference<br />
values are included in Compliorr Analyse for a<br />
rapid and easy interpretation of the results. With the<br />
Compliorr Analyse, it is possible to assess central pressure<br />
from a carotidogram. The measurement is handsfree<br />
and done during the PWV measurement with no<br />
additional time. With Compliorr Analyse, you have<br />
the reference gold standard PWV and carotid central<br />
pressure analysis in a single acquisition.<br />
www.complior.com<br />
Alere International ......................................... Booth 1.93<br />
By developing new capabilities in near-patient diagnosis,<br />
monitoring and health management, Alere Inc.<br />
(formerly Inverness Medical Innovations, Inc.) enables<br />
individuals to take charge of improving their health<br />
and quality of life. Alere’s global leading products<br />
and services, as well as its new product development<br />
efforts, focus on infectious disease, cardiology, oncology,<br />
drugs of abuse and women’s health. For more information<br />
about Alere, please visit at www.alere.com<br />
Alexion Pharma International ........ Booths 1.26+1.116<br />
Alexion Pharmaceuticals is a global biopharmaceutical<br />
company focused on serving patients with severe and<br />
ultra-rare disorders through the innovation, development<br />
and commercialization of life-transforming therapeutic<br />
products. Alexion is the global leader in complement<br />
inhibition, and has developed and markets<br />
Soliris ® (eculizumab) as a treatment for patients with<br />
PNH and aHUS. Alexion is evaluating other potential<br />
indications for Soliris and is developing four other<br />
highly innovative biotechnology product candidates.<br />
www.alxn.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
395<br />
EXHIBITORS
EXHIBITORS<br />
396<br />
49th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X HPI OB IS T OE R S<br />
Allmed Medical ............................................. Booth 2.27<br />
Allmed Medical GmbH is a vertically integrated manufacturer,<br />
providing the latest world-class standards<br />
in dialysis products. Allmed’s leading dialyzer brand,<br />
Polypurer incorporates a new proprietary Polysulfone<br />
membrane, with outstanding performances in both efficiency<br />
and biocompatibility aspects. The membrane<br />
is unique for its unprecedented Micro-Undulation<br />
Technology. Allmed and its partners are committed<br />
to offer customised solutions to professionals and patients<br />
in Hemodialysis. Capitalizing on its long experience<br />
in the field of hemodialysis, Allmed is able to give<br />
personalised service and assistance to its customers.<br />
www.allmedgrp.com<br />
Amgen Europe .................................................. Booth 2.48<br />
Amgen discovers, develops and delivers innovative<br />
human therapeutics. A biotechnology pioneer since<br />
1980 and the originator of recombinant ESAs, Amgen<br />
was one of the first companies to realize the new science’s<br />
promise by bringing novel medicines from lab,<br />
to manufacturing plant, to patient. Amgen therapeutics<br />
have changed the practice of medicine, helping millions<br />
of people in the fight against cancer, kidney disease,<br />
rheumatoid arthritis and other serious illnesses. With<br />
a broad and deep pipeline of potential new medicines,<br />
Amgen remains committed to advancing<br />
science to dramatically improve people’s lives. June<br />
2011 marks 10 years since the launch of Aranesp ® (darbepoetin<br />
alfa) and 5 years since the introduction of the<br />
world’s firstgen. calcimimetic, Mimpara ® . We invite<br />
you to come and celebrate with us on booth 2.02, level 2.<br />
www.amgen.com<br />
Arbor Research .............................................. Booth 1.G7<br />
Arbor Research is a not-for-profit research organization<br />
based in Ann Arbor, Michigan, USA, conducting<br />
large studies in epidemiology and public health. With<br />
particular expertise in biostatistical analysis, clinical<br />
practice, the management and integration of large data<br />
sets, economics, and public policy, Arbor Research engages<br />
in health outcomes research on chronic disease<br />
and end-stage organ failure, currently including the<br />
international Dialysis Outcomes and Practice Patterns<br />
Study. www.dopps.org<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
Asahi Kasei Medical Europe ............. Booths 1.42+1.47<br />
Asahi Kasei Medical is a world leader in research, development,<br />
and production of devices and systems for<br />
blood treatment and purification based on advanced<br />
membrane separation and adsorption technologies. It<br />
serves the global market with haemodialysis, therapeutic<br />
apheresis, and blood transfusion products. Information<br />
about Asahi’s membranes, adsorbents and<br />
full range of products can be found on our website at:<br />
www.asahikasei-medical.com<br />
Atcor Medical ............................................... Booth 1.G23<br />
AtCor Medical’s SphygmoCor ® systems, featured in<br />
over 2000 published studies, are the global gold standard<br />
for noninvasive central blood pressure/arterial<br />
stiffness assessment. Major studies have found:<br />
-- Elevated central pressure is a superior independent<br />
predictor of CV risk<br />
-- 70% of patients with high normal blood pressure<br />
had central pressures equivalent with those of patients<br />
with Stage 1 Hypertension<br />
--Patients with central pulse pressure ≥ 50mmHg are<br />
at significantly higher risk for cardiovascular events.<br />
Visit us for a complementary central pressures assessment.<br />
www.atcormedical.com<br />
Atlantic Biomedical ....................................... Booth 2.04<br />
Atlantic Biomedical P. Ltd. is an overriding organization<br />
incorporated in the year 2008 by the joint efforts<br />
of Mr. Ravi Vazirani & Mr. Sunil Vazirani in the domain<br />
of dialysis related products and services. Atlantic<br />
Biomedical P. Ltd. is engaged in the manufacturing of<br />
medical equipments whereas Atlantic Pharmaceuticals<br />
(incorporated in the year 1987) is engaged in the<br />
manufacturing and marketing of licensed drug products.<br />
Ours is an ISO 13485-2003 certified company and<br />
have distinction of being the first manufactures of<br />
Dialyzer Reprocessing Machine RENACLEAN ® , Cold<br />
Sterilant RENACLEAN ® , Hot Disinfectant RENAS-<br />
TERIL ® , Acid Concentrate CITRACON ® , Calcium Acetate<br />
LOW-PHOS ® tablets in India. Apart from what<br />
we are one of the leading Dialysis Fluid Manufacturers<br />
in the country like Bicarbonate, Acetic, Na, K, Calcium<br />
Free & Citric Acid Concentrate.<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
397<br />
EXHIBITORS
EXHIBITORS<br />
398<br />
49th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Awak Technologies ....................................... Booth 1.68<br />
Awak is developing the world’s first wearable dialysis<br />
machine targeting ESRD patients. Our Vision is to create<br />
a new paradigm in renal dialysis. It is different from<br />
current dialysis machines in the market, as it provides<br />
patients with freedom during their treatment. With<br />
Awak weighing only 1kg and the ability to regenerate<br />
spent dialysate, it now substitutes the major functions<br />
of a kidney by constantly removing toxins and waste<br />
materials, and excessive fluid from the patient’s body.<br />
This new technology not only have and sustain ESRD<br />
patients, but also enhances their lives, bringing them<br />
comfort and convenience. www.awak.com<br />
B.Braun Avitum .............................................. Booth 2.12<br />
Always with Passion.<br />
B. Braun Avitum is a leading provider of dialysis care<br />
products. The B. Braun Avitum product range includes<br />
dialysis machines and dialysis consumables for<br />
chronic and acute dialysis as well as a comprehensive<br />
product portfolio for special blood cleansing processes<br />
to treat conditions such as lipid metabolic disorders. B.<br />
Braun Avitum manufactures top quality dialysis machines,<br />
dialyzers (e.g. xevonta) and disposables.<br />
www.bbraun.com<br />
Bain Medical Equipment ............................. Booth 1.22<br />
Bain Medical Equipment (Guangzhou) Co., Ltd. was<br />
established in 2003 specialized in researching, developing,<br />
manufacturing and distributing of medical<br />
equipment and medical macromolecule products.<br />
We have strong technical strength, comprising an experienced<br />
team with expertise and high technologies<br />
from Europe and Japan. Having introduced advanced<br />
manufacturing and inspecting facilities, we are able to<br />
perform dynamic monitoring covering full process of<br />
materials purchase, production and finished products.<br />
Presently Bain specializes in manufacturing and distributing<br />
hemodialyzer, tubing sets for hemodialysis,<br />
disposable AV fistula needle sets, and tubing disposables<br />
for hemodialysis, all with leading technologies in<br />
the industry. ISO9001, ISO13485, CE and CCC certification<br />
passed. www.bainmedical.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
Baxter Healthcare ........................................... Booth 2.39<br />
Baxter International Inc’s Renal franchise is a leader in<br />
renal home therapies through its products for Peritoneal<br />
Dialysis (PD), providing PD solutions including<br />
Low Glucose, devices, related supplies and services<br />
to help end-stage kidney disease patients perform dialysis<br />
treatment in the home. Baxter also distributes<br />
products and provides support services for Continuous<br />
Renal Replacement Therapy (CRRT), an acute,<br />
hospital-based therapy, and distributes products for<br />
In-Center Hemodialysis (HD). Baxter, in partnership<br />
with DEKA Research and Development Corporation,<br />
is developing innovative technologies aimed at<br />
employing a compact design and convenient use for<br />
patients, such as a new automated PD cycler and High<br />
Dose HD technology platform. www.baxter.com<br />
Bellco .............................................................Hall Maillot<br />
Bellco, with over 40 years’ experience, operates worldwide<br />
offering therapies and systems for blood purification<br />
in Dialysis, Intensive Care and Cardiology,<br />
with increased focus on personalized treatments for<br />
critical patients. Bellco stands out for the Collaborative<br />
Research in the treatment of renal failure, multiple organ<br />
failure, sepsis and congestive heart failure, with<br />
the goal of sharing know-how and innovation with the<br />
scientific and medical communities. Upon these premises,<br />
Bellco provides its contribution to the Collaborative<br />
Research Club. Biocompatibility, cardiovascular<br />
stability, nutritional state and clearance efficiency are<br />
the leading challenges for Bellco’s Therapeutic Dialysis:<br />
constant research and innovation for personalised<br />
solutions. Complex clinical conditions, such as those<br />
of patients in Intensive Care, undergoing surgery,<br />
with multiple traumas, sepsis, multi-organ failure,<br />
cardiopathy, affected by immune pathologies and intoxication,<br />
require integrated therapeutic approaches<br />
capable of assuring versatility, functionality and effectiveness.<br />
The Bellco’s all-embracing offer for all these<br />
pathologies provides a completely new outlook on<br />
Acute patients. www.bellco.net<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
399<br />
EXHIBITORS
EXHIBITORS<br />
400<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Binding Site ..................................................... Booth 1.05<br />
Visit stand 1.05 to learn more about polyclonal Freelite<br />
® serum free light chain (FLC) measurement in<br />
Acute Kidney Injury: “Clonal serum FLC can be measured<br />
with high sensitivity and specificity and used to<br />
rapidly screen for cast nephropathy. A sustained decrease<br />
in serum FLC levels within 3 weeks of starting<br />
treatment is associated with renal recovery”- Cockwell<br />
2010. Collect your copy of this paper and the Kidney<br />
in plasma cell dyscrasias book International Myeloma<br />
Working Group and NCCN ® guidelines recommend<br />
use of serum free light chain assays in the initial diagnostic<br />
workup of Multiple Myeloma and related disorders.<br />
www.bindingsite.co.uk<br />
Bionic Medizintechnik ............................... Booth 1.103<br />
Bionic Medizintechnik with HQ in Friedrichsdorf near<br />
Frankfurt, Germany, is a specialised manufacturer of<br />
products for dialysis since 30 years. Our product range<br />
includes a large selection of dialysis fistula needles, dialysis<br />
catheters, therapy chairs and beds. Bionic dialysis<br />
fistula needles are leading in Europe and are setting<br />
new standards in quality and puncture characteristics.<br />
Bionic therapy chairs and beds are leading in performance<br />
and ergonomics. www.bionic-jms.com<br />
BioPorto Diagnostics .................................. Booth 1.G21<br />
The ability to diagnose acute kidney injury (AKI) at an<br />
early time point is essential for improving the management<br />
and outcome of patients at risk of AKI. The novel<br />
biomarker NGAL has been shown to outperform current<br />
kidney status markers such as serum creatinine<br />
and cystatin C because it responds much earlier and<br />
shows a proportionate response to injury. With The<br />
NGAL Test your hospital lab can measure NGAL<br />
in both plasma and urine samples on fully automated<br />
analyzers. www.bioporto.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
Bodystat........................................................... Booth 1.G6<br />
BODYSTAT ® are established as one of the global leaders<br />
in body composition analysis using Bioelectrical<br />
Impedance Analysis (BIA) technology. Complex<br />
changes occur in body composition and fluid status<br />
during illness, renal failure and haemodialysis. Bodystat’s<br />
Multi-Frequency BIA technology can be used to<br />
assist in achieving Dry Weight, quickly, conveniently,<br />
without significant training or education.<br />
See validation paper: Calf Bioimpedance Ratio Improves<br />
Dry Weight Assessment and Blood Pressure<br />
Control in Hemodialysis Patients. (Yi-Lun Zhou et al)<br />
Am J Nephrol 2010;32:109-116.<br />
www.bodystat.com<br />
Covidien ........................................................... Booth 1.37<br />
Covidien Vascular Therapies delivers a broad range<br />
of innovative non-invasive and endovascular devices<br />
for the treatment of vascular disease worldwide. Covidien<br />
currently offers clinically proven solutions for<br />
the prevention and treatment of deep vein thrombosis<br />
(DVT), chronic venous insufficiency, dialysis access,<br />
peripheral vascular disease, and neurovascular disease.<br />
Covidien develops new technologies, products<br />
and programs focused on improved patient outcomes<br />
and safer, more efficient healthcare practices throughout<br />
the continuum of care, across the globe.<br />
www.covidien.com<br />
Cybernius Medical ......................................... Booth 1.16<br />
Cybernius Medical Ltd. is committed to the effective<br />
utilization of proven leading edge technology in the<br />
Health Care Industry. CML focuses its resources on<br />
the development, sale, deployment and support of the<br />
cyberREN ® Renal Patient Care Management System<br />
for Nephrology. cyberREN ® is a comprehensive Electronic<br />
Medical Record (EMR), Clinical Data Analysis,<br />
and Reporting System for Nephrology. cyberREN ® is<br />
marketed and serviced by a team of dedicated clinicians<br />
and information technologists. Also Available:<br />
cyberREN OFFICE, (Nephrologist Private Practice<br />
System) and cyberFUNDS (Billing for Nephrology)<br />
To contact a representative in your area call:<br />
1.800.276.8128 or visit our website at<br />
www.cyberren.com - email: info@cyberren.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
401<br />
EXHIBITORS
EXHIBITORS<br />
402<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Culligan ............................................................ Booth 1.94<br />
Culligan International is one of the longest-established,<br />
best-known companies in the water treatment sector,<br />
founded in Chicago in 1936. Culligan is a worldwide<br />
organization whose mission is water quality improvement.<br />
We have an extensive licensee distribution system<br />
in over 100 countries. Culligan manufactures a<br />
complete line of systems for drinking water, as well as<br />
for many demanding industrial applications: ultrafiltration,<br />
electro-deionisation, pharmaceutical industry,<br />
haemodialysis, food and beverage industry, electronics<br />
industry, which requires the highest purity water<br />
possible. www.culligan.it<br />
Debiotech ......................................................... Booth 1.91<br />
Debiotech is a Swiss, independent, high-tech medical<br />
device development company founded in 1989.<br />
Its core competence lies in the identification of breakthrough<br />
technologies and their development to market<br />
approval. These devices are then licensed to major<br />
international pharmaceutical and medical device companies.<br />
DialEase TM is the lightest and smallest APD<br />
Cycler ever conceived for Homecare Peritoneal Dialysis,<br />
with an innovative approach to offer more Quality<br />
and Safety for Patients, with full remote control by<br />
Nephrologists, while simplifying daily use and transportation.<br />
www.debiotech.com<br />
Diaverum ......................................................... Booth 2.19<br />
At Diaverum, our mission is to improve the quality of<br />
life for renal patients by revitalising them both physically<br />
and emotionally. Being one of the world’s leading<br />
renal care providers, Diaverum offers a holistic<br />
approach, from preventive and early stage renal care<br />
to all renal replacement therapies. As a product independent<br />
provider – the largest in Europe - we are able<br />
to focus soley on caring for the individual needs of<br />
our patients. Our experience in renal care dates back<br />
20 years, when the first dialysis clinic was established,<br />
previously under our former name Gambro Healthcare.<br />
Today, 6,800 employees care for more than 20,000<br />
patients in 17 countries in Europe, Latin America,<br />
Middle East and Australia. The corporate office of Diaverum<br />
is located in Munich, Germany, the head office<br />
is in Lund, Sweden. For more information visit<br />
www.diaverum.com.<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
Dirinco .............................................................. Booth 1.32<br />
The Dirinco Group is a Dutch and Swiss based company,<br />
with innovations mainly in the field of vascular<br />
access, hemotology, oncology and nephrology. Citra-<br />
Lock - catheter lock solution, anti-clotting and antimicrobial<br />
is one of the innovations from Dirinco. The<br />
products are in a vial or prefilled syringe and is based<br />
on tri-sodium citrate and can be safely used in all catheters!<br />
Please find the different catheter lock solutions<br />
like Citra-lock and CitraFlow by Dirinco on<br />
www.citra-lock.com<br />
Dustri Verlag ...................................................Booth 1.P1<br />
Clinical Nephrology – Dustri Verlag<br />
For almost 40 years, Clinical Nephrology, a Dustri-<br />
Verlag publication, has been one of the leading journals<br />
in its field. Under the editorship of H.H. Malluche<br />
(Lexington, KT, USA) – supported by 18 Section Editors<br />
– the editorial quality has improved significantly<br />
due to a remarkable increase of manuscript submissions.<br />
Also ask for our special fellowship program.<br />
The book program of Dustri-Verlag was extended by<br />
“Seyffart’s Directory of Drug Dosage in Kidney Disease”<br />
in 2011<br />
www.clinnephrol.com - www.dustri.com<br />
DV Care ............................................................ Booth 1.29<br />
DV Care., a wholly owned subsidiary of a United States<br />
based FORTUNE 500 ® company that is a leading provider<br />
of kidney care in the United States, delivering dialysis<br />
services to patients with chronic kidney failure and end<br />
stage renal disease. As of December 31, 2011, the organization<br />
operated or provided administrative services<br />
at 1,809 dialysis facilities in the United States, serving<br />
approximately 142,000 patients. The company also operated<br />
11 outpatient dialysis centers located in three countries<br />
outside the United States. In line with the overall<br />
corporate mission, DV Care strives to improve patients’<br />
quality of life by innovating clinical care, and by offering<br />
integrated treatment plans, personalized care teams<br />
and convenient health-management services. The organization<br />
also supports numerous programs dedicated<br />
to creating positive, sustainable change in communities<br />
around the world. The company’s leadership development<br />
initiatives and social responsibility efforts have<br />
been recognized by Fortune, Modern Healthcare, Newsweek<br />
and WorldBlu. For inquiries dial +310 536 2478 or<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
403<br />
EXHIBITORS
EXHIBITORS<br />
404<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
send an email to global@davita.com.<br />
DWA ................................................................. Booth 2.81<br />
DWA - The Dialysis Water Specialists<br />
DWA has specialised in innovative solutions for the<br />
supply of high purity water to dialysis centres - worldwide.<br />
DWA develops systems for production of ultrapure<br />
permeate and its distribution right to the dialysis<br />
machine. Our expertise in water treatment covers all<br />
aspects from the pre-treatment stages, through reverse<br />
osmosis, ultrafiltration and hot cleaning systems, right<br />
up to the supply connection through to the dialysis<br />
machine. In addition, DWA offers systems for production<br />
and distribution of acid and bicarbonate concentrates.<br />
DWA is partner for dialysis centres - worldwide!<br />
www.dwa-online.com<br />
E.D.P. La Traccia .......................................... Booth 1.G22<br />
Cooperativa Edp La Traccia is:<br />
- a Research Laboratory for the ICT and Robotic sectors;<br />
- certified ISO 9001:2000 for the design, development,<br />
maintenance, assistance and sale of software and<br />
hardware products; designing and implementation<br />
of professional training projects;<br />
- certified ISO 27001 for specialized consultancy and<br />
expert technical assistance of software and hardware<br />
products, management of LAN networks and<br />
internal infrastructures;<br />
- a recognized Training Centre by the Basilicata Region.<br />
La Traccia, thanks to state-of-the-art technology and<br />
the large number of solutions in place with customers<br />
distributed all over Italy, is the Italian market leader<br />
for the supply of:<br />
- software applications for Nephrology and Dialysis<br />
hospital wards (installed in over 210 Italian hospitals);<br />
- software products for the Management of Organ<br />
Transplant Waiting Lists (installed in 9 Italian Regions);<br />
- software application to manage the Regional Dialysis<br />
and Organ Transplant Register (installed in 8 Italian<br />
Regions);<br />
- software application for the management of “Register<br />
of Medical and Dental Surgeons (installed in 20<br />
Italian Provincial Orders);<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
The company has furthermore:<br />
- maturated significant experience in the computerization<br />
of Hospital Patient Records, with vertical integration<br />
for the various specializations;<br />
- carried out research projects: the most important<br />
of which was relative to Theme 7 of the National<br />
Research Project of Telemedicine funded by the<br />
M.I.U.R. (Monitoring of Dialysis and Perinatal Outpatients).<br />
www.latraccia.it<br />
EffeEmme ........................................................ Booth 2.44<br />
We have been producing bloodlines and accessories<br />
for haemodialysis treatments for 30 years. Our company<br />
structure, always evolving, allows us to promptly<br />
react to the increasing requirements of the market. Our<br />
customers have confidence in us as a reliable partner<br />
with a track record of long lasting cooperation. On<br />
time delivery and service are our standard.<br />
www.effeemme.it<br />
EG Medical Systems ...................................... Booth 1.62<br />
EG-Medical Systems manufactures and supplies regionally<br />
a rich span of medical disposables and devices<br />
including Medical, Surgical & Dialysis disposables<br />
e.g. Blood Lines & Fistula Needles, Urine & Drainage<br />
bags, Infusion & Transfusion sets, CVP, at top quality<br />
level since year 2000. The company has been merited<br />
ISO 9001, ISO 13485, CE 0120 www.eggroup-eg.com<br />
Elsevier Masson ..............................................Booth 1.P4<br />
Elsevier Masson is the first French speaking medical<br />
and paramedical publisher. Its three mains activities<br />
are the publishing of books for initial or continuing<br />
education, of EMC treaties, and the publication<br />
of medical and paramedical journals. The university<br />
books, written by the best teachers, form all the profession<br />
of health for two centuries. The books of continuous<br />
medical education, written by the best experts<br />
hospitalo-university and intended for the professionals<br />
of health, the general practitioner, the specialists,<br />
the pharmacists, the dental surgeons, the veterinarians<br />
and in the all paramedical, insure the permanent update<br />
of their practical knowledge. www.elsevier.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
405<br />
EXHIBITORS
EXHIBITORS<br />
406<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Emodial ............................................................ Booth 2.42<br />
Emodial Srl was established in 1982 in Ferrara, Italy,<br />
and since that time has been operating in the field of<br />
haemodialysis providing a complete range of products<br />
for dressings and becoming one the leading companies<br />
in the field. Our products have been designed on the basis<br />
of the suggestions and co-operation offered by various<br />
Dialysis Centres of relevant Care Units, which felt<br />
the need for new products suitable for the medications<br />
and absorption of wound exudates, to be used as an alternative<br />
to the traditional cotton or non-woven pads.<br />
Our main products can be referable to the following<br />
typologies:<br />
-pads, plasters and bandages for fistula;<br />
-start-stop kits for haemodialysis, catheterism and<br />
peritoneal dialysis<br />
-devices for the disposal of used fistula needles;<br />
We have also recently developed a new range of patented<br />
products based on silver which helps to control<br />
the risk of infections of the vascular access.<br />
www.emodial.it<br />
<strong>ERA</strong>-<strong>EDTA</strong> 2013 <strong>Congress</strong> Istanbul ........ Booth 1.G14<br />
The <strong>ERA</strong>-<strong>EDTA</strong> congress that will be held in Istanbul<br />
in 2013 (May 18-21) will be the 50 th annual congress of<br />
this association. In order to mark this important anniversary<br />
the scientific programme will be richer than<br />
usual, with more pathways and more courses. The<br />
venue for this event will be the recently built Istanbul<br />
<strong>Congress</strong> Center, completed in September 2009 and<br />
situated in Harbiye, on a hilltop overlooking the Bosphorus.<br />
Information will be available at the booth and<br />
in the website www.era-edta2013.org<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
Etropal .............................................................. Booth 1.11<br />
Etropal is a company with over thirty years of experience<br />
in research, development and manufacturing of<br />
medical devices for single use, meeting all the requirements<br />
of a contemporary medicine in this field. The<br />
company offers an extensive product line that spans<br />
medical devices for haemodialysis-dialysers, blood<br />
lines, fistula needles and other medical devices. The<br />
company operates a fully integrated ‘quality assurance<br />
system’ according to ISO 9001 and ISO 13485.<br />
www.etropal.eu<br />
M E D I C A L E Q U I P M E N T<br />
Euroclinic ........................................................ Booth 1.G5<br />
Euroclinic SpA is a leading manufacturing company<br />
specialized in the production of high-tech Medical<br />
Equipments presently distributed and appreciated in<br />
more than 27 foreign countries mainly for the elegant<br />
design and the technical reliability. The continuous<br />
Research and Development activity is focused on<br />
state-of-art lines of Units and Chairs for ENT, Podiatry,<br />
Gynaecology, Diagnostic & Imaging fields. A new<br />
product for Dialysis/Oncology has been developed in<br />
the last year thanks to a highly experienced team of<br />
engineers. www.euroclinic.it<br />
FedAirg ............................................................ Booth 1.G9<br />
Federg is an initiative aimed at establishing a European<br />
federation of patients with renal genetic diseases<br />
(RGD). Federg will gather European associations devoted<br />
to RGD, thus providing enough voice and room<br />
to the smallest ones and given them more empowerment<br />
within the European community: better inform,<br />
help and advocate, support research, better represent<br />
patients and foster the development of national associations.<br />
AIRG-France, a French association, focussing<br />
on Renal Genetic Diseases (RGD), has taken the initiative<br />
of FEDERG and was promptly joined by other<br />
AIRGs in Europe (Belgium, Switzerland and Spain)<br />
and other RGD associations. It has received the support<br />
of <strong>ERA</strong>-<strong>EDTA</strong>, ESPN and Eurordis. The project<br />
will be developed in <strong>2012</strong>, information can be found<br />
on the following sites:<br />
www.federg<strong>2012</strong>.wordpress.com - www.airg-france.fr<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
407<br />
EXHIBITORS
EXHIBITORS<br />
408<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
French Society of Dialysis ......................... Booth 1.G11<br />
The Société de Francophone de Dialyse (SFD) is a<br />
French speaking association of nephrologists founded<br />
in 1993, currently having about 800 members throughout<br />
the French speaking countries. The French speaking<br />
Society of Dialysis aims to improve formation and<br />
collaborative work in dialysis through an annual Joint<br />
Meeting with the Société de Néphrologie, and by organizing<br />
annually two or more specific CME courses in<br />
collaboration with the Moroccan Society of Nephrology<br />
and the Tunisian Society of Nephrology. SFD contributes<br />
further to research on dialysis and end stage<br />
renal disease by funding clinical and fundamental research<br />
programmes. Publication media are the journal<br />
«Néphrologie & Thérapeutique», the e-learning website<br />
www.rein-eform.org and the society own website<br />
www.sfdial.org. Please visit the booth to learn more<br />
on SFD and join us.<br />
French Society of Nephrology .................... Booth 1.G8<br />
The Société de Néphrologie (SN) is a French speaking<br />
association of nephrologists founded in 1961, currently<br />
having about 1500 members. Its publication is<br />
Néphrologie & Thérapeutique. SN contributes to the<br />
dissemination of knowledge by its annual Joint Meeting<br />
with the Société Francophone de Dialyse, and by<br />
organizing annually a specific CME course. SN contributes<br />
to research in nephrology directly by funding<br />
research projects both for laboratories and individual<br />
researchers as post-doctoral trainings. Visit the booth<br />
to learn about the next annual Joint Meeting: Geneva,<br />
October 2-5, <strong>2012</strong>. More information at:<br />
www.soc-nephrologie.org<br />
Fresenius Kabi ................................................ Booth 2.68<br />
Fresenius Kabi is dedicated to the therapy and care of<br />
critically and chronically ill patients inside and outside<br />
the hospital by providing intravenously administered<br />
drugs, infusion therapies, clinical nutrition and related<br />
medical devices. The company applies its long-standing<br />
expertise in pharmaceuticals and medical devices<br />
to support clinical staff and care professionals in the<br />
best therapy of patients. For more information about<br />
Fresenius Kabi, visit the company’s Web site at<br />
www.fresenius-kabi.com.<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
Fresenius Medical Care ................................. Booth 2.68<br />
Fresenius Medical Care is the world’s largest integrated<br />
provider of products and services for individuals<br />
undergoing dialysis because of chronic kidney failure,<br />
a condition that affects more than 2.1 million individuals<br />
worldwide. Through its network of more than<br />
2,890 dialysis clinics in North America, Europe, Latin<br />
America, Asia-Pacific and Africa, Fresenius Medical<br />
Care provides dialysis treatment to more than 233,100<br />
patients around the globe. Fresenius Medical Care is<br />
also the world’s leading provider of dialysis products<br />
such as hemodialysis machines, dialyzers and related<br />
disposable products. With the new business unit Renal<br />
Pharma Fresenius Medical Care is now complementing<br />
its leading dialysis technologies, products and<br />
services with renal pharmaceuticals. We will continuously<br />
build up and provide a comprehensive range of<br />
drugs and drive their integration into innovative treatment<br />
platforms to achieve improved therapeutic outcomes<br />
in dialysis patients. www.fmc-ag.de<br />
Gambro ............................................................ Booth 2.46<br />
Gambro has been pioneering solutions for patients in<br />
Chronic and Acute Therapies for more than 47 years.<br />
With you and your patients as our inspiration, we are<br />
constantly seeking ways to advance the science of dialysis.<br />
The result is innovative products & therapies<br />
that will support your success. Gambro - Your home of<br />
INNOVATION - You inspire, We innovate.<br />
www.gambro.com<br />
Gardhen Bilance ...........................................Booth 1.98C<br />
Gardhen bilance is a company presents in most parts<br />
of the world thanks to its exclusive distributors and to<br />
high quality of the products. The beds and chairs with<br />
or without scales are presents in all privates dialysis<br />
centers and dialysis hospital departments. Gardhen bilance<br />
manufactures medical devices and weighing systems<br />
in conformity to ISO 9001:2008, ISO 13485:2003,<br />
93/42/CEE. Design, comfort, robust construction is<br />
our mission www.gardhenbilance.it<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
409<br />
EXHIBITORS
EXHIBITORS<br />
410<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
HemoSapiens ............................................... Booth 1.G24<br />
Hemo Sapiens ® Inc is a high-tech medical company<br />
specialized in the development of non-invasive medical<br />
devices designed for the real-time assessment,<br />
monitoring and management of complete hemodynamics.<br />
Hemo Sapiens ® ® flagship product is Hotman ®<br />
- a PC-based system for automatic, noninvasive and<br />
hands-free acquisition of a patient’s blood flow and<br />
left-ventricular parameters using Company’s proprietary<br />
very-low current TEB (Thoracic Electrical Bioimpedance)<br />
providing the unique Integrated Hemodynamic<br />
Management solution.<br />
www.hemosapiens.net<br />
Herco Wassertechnik ..................................... Booth 2.64<br />
Herco developed and offers complete water treatment<br />
solutions for dialysis applications. Products are: Water<br />
softeners, filters, reverse osmosis, ring main, bed<br />
head media panels, central concentrate distribution.<br />
Reverse osmosis units for haemodialysis purposes according<br />
to MDD, TÜV approved. www.herco-wt.de<br />
Hospira UK ...................................................... Booth 2.83<br />
Hospira is a global speciality pharmaceutical and<br />
medication delivery company dedicated to Advancing<br />
Wellness. As a world expert in speciality generic<br />
injectable pharmaceuticals, Hospira offers one of the<br />
broadest portfolios of generic acute-care and oncology<br />
injectables, as well as integrated infusion therapy<br />
and medication management solutions. Through its<br />
products, Hospira helps improve the safety, cost and<br />
productivity of patient care. The company is headquartered<br />
in Lake Forest, Illinois, United States and<br />
has more than 14,000 employees. The head office for<br />
Hospira in Europe, Middle East and Africa is in Royal<br />
Leamington Spa, UK. Learn more about Hospira at<br />
www.hospira.com.<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
IFKF - International Federation<br />
of Kidney Foundation .................................. Booth 1.G4<br />
Improving Kidney Health Worldwide<br />
Our Long Term Commitment:<br />
Improvement in prevention, quality of life and health<br />
for all people with or at risk of kidney disease, regardless<br />
of race, color, creed, gender, sexual orientation or<br />
social class.<br />
Our Mission:<br />
To foster creation, growth, and international collaboration<br />
between local kidney foundations and to enable<br />
and help empower member organizations to attain our<br />
goals. To represent at the international level the needs<br />
of people with, or at risk of kidney disease. Our worldwide<br />
community of kidney foundations constitutes a<br />
unique and potent force to bring a global instrument<br />
for the prevention, detection and treatment of kidney<br />
disease.<br />
Our Tools:<br />
Annual meeting, regional meetings, Kidney Foundations<br />
Partnership Program KFPP, educational programs<br />
and seminars for health care workers on nutrition<br />
and other topics. SeeKD ® program for detection<br />
and prevention of CKD. Joel D Kopple Award for<br />
outstanding performance, IFKF Innovation Challenge<br />
for innovative ideas for compliance with medicine use.<br />
World Kidney Day, in cooperation with ISN.<br />
www.ikfk.net<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
411<br />
EXHIBITORS
EXHIBITORS<br />
412<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Immundiagnostik ....................................... Booth 1.G19<br />
Closing the Gaps in Laboratory Diagnostics<br />
Immundiagnostik AG, founded in 1986, is a globally<br />
operating diagnostics company represented in over 30<br />
countries. We focus on the development and production<br />
of innovative immunoassays (ELISA, EIA) and<br />
other analytical detection methods (e.g. HPLC, LC-<br />
MS/MS and PCR) for medical routine and research.<br />
Our mission is to provide effective tools for prevention,<br />
differential diagnosis and therapy monitoring in<br />
the areas of gastroenterology, cardiovascular diseases,<br />
disorders of the skeletal system and oxidative stress.<br />
The product portfolio is completed by a broad range<br />
of antibodies and antigens. Our business relations include<br />
contract analyses for diagnostic laboratories and<br />
academic research institutions, esp. in context with<br />
clinical trials. Multiple cooperations with the pharmaceutical<br />
industry and a tight network with scientific<br />
organisations are the basis for a successful product<br />
development. Securing progress: Our comprehensive<br />
range of products is continuously refuelled by a rich<br />
pipeline of proprietary developments. With a headcount<br />
of more than 60 employees, Immundiagnostik’s<br />
headquarter is located in Bensheim, south-western<br />
Germany. www.immundiagnostik.com<br />
Infomed ............................................................ Booth 1.45<br />
With 20 years of experiences around the world, Infomed<br />
has comforted its leadership as a provider of<br />
extracorporeal blood purification devices offering<br />
complete solutions with many advanced medical<br />
treatments such as: Continuous hemofiltration and hemodiafiltration,<br />
plasma exchange, cascade filtration,<br />
double filtration plasmapheresis (DFPP), blood and<br />
plasma perfusion and CPFA (Coupled Plasma Filtration<br />
Adsorption). Infomed provides a complete range<br />
of machines and all associated disposables such as<br />
pre-assembled kits, filters and adsorption cartridges.<br />
www.infomed.biz<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
Innovative Blood Purification...................... Booth 1.50<br />
We are an integrated provider of hemodialysis medical<br />
disposables products, such as Dialyzers, Bloodline<br />
Sets & AV Fistula Needle Sets and Dialysate Solution,<br />
for individuals undergoing dialysis due to chronic<br />
kidney failure. We manufacture and distribute our<br />
hemodialysis medical disposables to dialysis clinics<br />
all over Eastern Europe, Middle East and Asia Pacific.<br />
Through our jointly-owned German subsidiary, International<br />
Dialysers Technologies GmbH (“IDT”) that<br />
own and manage a dialyzer assembly plant in Germany,<br />
we were able to develop our Dialyzer under our<br />
own brand name “Innovative”, we also manufactured<br />
our products via our OEM Partners. All our products<br />
are certified with CE and ISO 13485.<br />
www.innovative-bp.com<br />
Intermedt Medizin & Technik .................... Booth 1.97<br />
Intermedt was founded in 1997 and is a specialist for<br />
dialysis concentrate production systems.<br />
The fully automatic dry concentrate system ECOMix<br />
in combination with ECOCart allows the production<br />
of concentrate in your own dialysis center. We<br />
don’t transport any Water only the dry salts in large<br />
cartridges. The “ECOCart” is a reusable cartridge and<br />
contains all raw materials in dry form for the production<br />
of 750l acid concentrate. www.intermedt.de<br />
ISN International Society of Nephrology Booth 1.G3<br />
The International Society of Nephrology (ISN) is a<br />
global not-for-profit society dedicated to its philanthropic<br />
mission of advancing the diagnosis, treatment,<br />
and prevention of kidney diseases in the developing<br />
and developed world. Since its foundation in 1960,<br />
ISN has pursued the worldwide advancement of education,<br />
science and patient care in nephrology. The<br />
Society represents a wide international network and<br />
provides an efficient platform for timely scientific exchange,<br />
debate and dissemination between healthcare<br />
professionals around the world. ISN has over 9,000<br />
professional members from more than 126 countries.<br />
In addition, ISN closely collaborates with over 70 national<br />
and regional nephrology societies around the<br />
world, representing about 20,000 professionals.<br />
www.theisn.org<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
413<br />
EXHIBITORS
EXHIBITORS<br />
414<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Janssen .............................................................. Booth 2.37<br />
Janssen Pharmaceutical Companies of Johnson &<br />
Johnson are dedicated to addressing and solving the<br />
most important unmet medical needs of our time, including<br />
oncology (e.g. multiple myeloma and prostate<br />
cancer), immunology (e.g. psoriasis), neuroscience<br />
(e.g. schizophrenia, dementia and pain), infectious<br />
disease (e.g. HIV/AIDS, Hepatitis C and tuberculosis),<br />
and cardiovascular and metabolic diseases (e.g.<br />
diabetes). Driven by our commitment to patients, we<br />
develop sustainable, integrated healthcare solutions<br />
by working side-by-side with healthcare stakeholders,<br />
based on partnerships of trust and transparency. More<br />
information can be found at www.janssen-emea.com<br />
JiHua Medical Apparatus and Instruments .Booth 1.G17<br />
Jihua Medical Apparatus and Instruments Co.,LTD<br />
GuangZhou (Jihua Company), established in 2000. We<br />
are specialized to research, produce and sell hemodialysis<br />
equipment and some relative blood purification<br />
devices such as electric dialysis chair, RO water<br />
unit, dialyzer reprocessing machine, hemoperfusion<br />
machine, blood pump, dialysate powder stirring machine<br />
ect. Our dialysis equipments have gained the CE<br />
mark and company are certified with ISO 9001&ISO<br />
13485 in 2007. So far, Jihua products are selling in the<br />
whole provinces in china and successfully exported<br />
to more than 60 countries in Asia, South America, Europe<br />
and Africa countries. Our vision is to contribute<br />
to the growth of international blood purification career<br />
and to be the leadership on nephrology with the most<br />
professional and sustainable development ability and<br />
outstanding corporate culture. www.ji-hua.com<br />
Joline ................................................................. Booth 1.34<br />
Joline GmbH & Co. KG is an internationally operating<br />
company in southern Germany with a strong focus<br />
on quality standards and innovative, medical technologies.<br />
Since our foundation in 1999 it has been our<br />
intent to develop and produce high-quality products<br />
in the field of Vascular Access. All our FlowFamily-<br />
Products are CE marked and exclusively “Made in<br />
Germany”. www.joline.net<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
Karger ...............................................................Booth 1.P6<br />
S. Karger Medical Publishers is a publishing house<br />
whose publications in the field of nephrology include<br />
6 scientific journals, e.g. ‘Nephron’, and the renowned<br />
book series ‘Contributions to Nephrology’. New releases<br />
presented include the titles Hepatitis C in Renal<br />
Disease, Hemodialysis and Transplantation’, ‘On-Line<br />
Hemodiafiltration: The Journey and the Vision’ and<br />
‘Controversies in Acute Kidney Injury’. Publications<br />
are accessible online, with full-text search of articles,<br />
pay-per-view options and many other services. Founded<br />
122 years ago, this Swiss-based family-owned publishing<br />
house combines highly sophisticated production<br />
technology with customized services for its authors,<br />
editors and readers.<br />
www.karger.com/nephrology<br />
Kawasumi ........................................................ Booth 2.05<br />
Since 1957, Kawasumi Laboratories has been providing<br />
nephrologists worldwide dialyzers, blood tubing<br />
lines, and AV fistula sets. We are renowned for our<br />
consistently high quality. Kawasumi is a leading supplier<br />
of advanced dialyzers. The RENAK PS dialyzer<br />
will delight you with its high performance. Blood<br />
tubing lines and AV fistula sets are among the best<br />
known and most trusted in the world. Kawasumi also<br />
provides a wide variety of therapeutic plasmapheresis<br />
products. Visit the Kawasumi booth and see how we<br />
can help you provide excellent therapy!<br />
www.kawasumi.jp<br />
Kimal ................................................................ Booth 1.01<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
415<br />
EXHIBITORS
EXHIBITORS<br />
416<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Labor Limbach ............................................. Booth 1.G20<br />
Limbach Laboratory is the market leader in medical<br />
laboratory testing in Germany as well as the largest<br />
provider of diagnostic services to nephrology<br />
departments, dialysis units and nephrologists in private<br />
practices. It was founded 1979 in Heidelberg by<br />
Dr.med. Hans-Jakob Limbach. A central focus of its<br />
activity was the determination of parathyroid hormone<br />
and other special hormone testing. Today, Limbach<br />
Laboratories Group covers all diagnostic fields of<br />
laboratory medicine within 29 affiliated laboratories<br />
countrywide. Furthermore, it has built up a network<br />
of laboratory services throughout Europe. Last but not<br />
least, Limbach Laboratory has an active R&D program<br />
in the field of test development, particularly for markers<br />
of bone metabolism. www.labor-limbach.de<br />
Lauer ................................................................. Booth 2.12<br />
LMW/Aquaboss ® stands for innovation, quality and<br />
cost efficiency. Since 1989 Lauer is developing, manufacturing<br />
and marketing RO systems, accessory equipment<br />
for dead space free supply of purified water and<br />
other liquid media used in dialysis. During the years<br />
Lauer has introduced several patented technologies<br />
inrenal market, e.g. impulse backwashing and secondary<br />
ring mains.<br />
www.aquaboss.com<br />
Likamed ........................................................... Booth 2.66<br />
We are an expert for therapy and treatment chairs<br />
and beds in the medical field and we are more than 30<br />
years successful in the market. Our long lasting experience<br />
und strict quality check, guarantee that the label<br />
“Made by Likamed” stands always for highest quality.<br />
Our products and our company are certificated for<br />
DIN EN ISO 13485. www.likamed.de<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
Medcomp ......................................................... Booth 1.71<br />
Medcomp, well known for its wide range of cuffed<br />
and uncuffed venous access catheters will be offering<br />
new information on:<br />
1. Videos on new dialysis catheter implantation technique<br />
2. Catheter Locking Solutions<br />
3. Long Term Dialysis Catheters<br />
4. Acute Access Blood Purification Catheters<br />
www.medcompnet.com<br />
Medica Italia ................................................. Booth 1.100<br />
Mdica S.p.A. is located inside the biomedical district of<br />
Mirandola near Modena Italy. Medica was established<br />
in 1985, and since then it has been operating in the<br />
manufacturing and sales of medical devices specifically<br />
in the field of blood purification and recently also<br />
in water purification, providing an extensive range of<br />
products. Blood lines, Dialysers, Electro medical machines<br />
and associated disposables and Infusion disposables<br />
are at the core of Medica manufacturing. Since<br />
the early 90’s Medica continues to work on developing<br />
and manufacturing of hollow fiber membranes for<br />
both medical and water purification applications. The<br />
development and manufacturing of these technologies<br />
is primarily in house. www.medica.it<br />
Medikit ............................................................. Booth 1.35<br />
Medikit is a leading manufacturer of vascular access<br />
medical devices based in Tokyo, Japan. Supercath<br />
brand hemodialysis fistula catheter, upgrade replacement<br />
of steel fistula needle, can reduce risk of damage<br />
with cannulation on AV fistulas and AV Grafts. Catheters<br />
with safety mechanism preventing accidental<br />
needle-stick injuries are also available. Come and visit<br />
us at stand 1.35. www.medikit.co.jp<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
417<br />
EXHIBITORS
EXHIBITORS<br />
418<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Meditechlab & Suisse Med Technologies .... Booth 1.92<br />
Suisse Med Technologies is a market leader in providing<br />
synthetic hollow fiber spinning lines and dialyser<br />
assembly lines. Our technology is designed to deliver<br />
optimal cost of goods while ensuring worldwide quality<br />
standards. We support our customers achieve their<br />
financial goals by offering a wide range of additional<br />
services such as go-to-market strategies, regulatory<br />
compliance, ISO-10993 compliant devices and qualified<br />
raw materials. Our subsidiary, Meditechlab, is a<br />
supplier of quality dialysis products that meet all international<br />
norms: ISO 9001 v-2000, ISO 13485 v-2003<br />
and the European Medical Device Directive 93/42/<br />
EEC (CE-mark).<br />
www.meditechlab.com www.SuisseMT.com<br />
MediTheque Bookshop ................................Booth 1.P5<br />
Medvision ...................................................... Booth 1.115<br />
As an international developer of professional medical<br />
information systems, we are providing efficient and<br />
economical solutions for the treatment and care of sick<br />
people for over twenty years now. Our medical information<br />
systems are used in many doctor’s practices,<br />
outpatient clinics, hospitals, dialysis units, and medical<br />
care centres. Especially in the field of dialysis, we<br />
have made a name for ourselves with a market share<br />
of well over 60 % in Germany and a large number of<br />
customers in Europe and Asia. Our international OEM<br />
cooperation partners are the world leaders in dialysis.<br />
www.medvision.de<br />
MedXL ........................................................... Booth 1.G10<br />
MedXL designs and manufactures quality healthcare<br />
products since 1992 and is a leader in setting the standards<br />
for safe, secure and efficacious prefilled syringe<br />
products. Our prefilled CitraFlow syringes containing<br />
4% sodium citrate are currently used in many<br />
countries as an alternative to heparin for locking catheters.<br />
CitraFlow is a natural way to safely and effectively<br />
lock indwelling catheters. www.medxl.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
Membrana........................................................ Booth 2.20<br />
Membrana is the largest independent membrane producer<br />
worldwide. Membrana is part of Polypore International<br />
Inc., a global high technology company<br />
specializing in microporous membranes. Membrana<br />
offers a wide range of capillary and flat sheet membranes,<br />
particularly for haemodialysis, blood oxygenation<br />
and plasmapheresis. Products include the<br />
haemodialysis membrane families of DIAPES ® and<br />
PUREMA ® . Membrana also manufactures a variety<br />
of membranes used for filtration in various industries<br />
and applications and the Liqui-Cel ® contactors for gas<br />
transfer as well as the Liqui-Flux ® modules for membrane<br />
filtration. www.membrana.com<br />
Miltenyi Biotec ............................................... Booth 2.40<br />
Miltenyi Biotec, a diversified biotechnology and medical<br />
device company, offers the CliniMACS ® Cell Selection<br />
System. Based on MACS ® Technology, it can be<br />
used for clinical-scale magnetic enrichment of cells.<br />
Another exemplary clinical application represents TheraSorb<br />
Therapeutic Apheresis, which selectively<br />
removes pathogenic substances from the blood by immunoadsorption.<br />
www.miltenyibiotec.com<br />
Mitsubishi Pharma Europe .......................... Booth 1.10<br />
Mitsubishi Pharma Europe is the European Headquarters<br />
of one of Japan’s largest pharmaceutical companies,<br />
Mitsubishi Tanabe Pharma Corporation. Based in<br />
London, Mitsubishi Pharma Europe is engaged in the<br />
clinical development of new drugs for the European<br />
markets. Mitsubishi Pharma Europe is conducting trials<br />
in Europe in the following therapy areas; cardiovascular,<br />
diabetes, CNS and renal conditions. The staff<br />
include regulatory, QA, clinical, biostatistics, medical<br />
information, pharmacovigilance, pharmaceutical technology<br />
and marketing. www.mitsubishi-pharma.eu<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
419<br />
EXHIBITORS
EXHIBITORS<br />
420<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Nature PG ........................................................Booth 1.P2<br />
Nature Publishing Group (NPG) brings you leading<br />
scientific and medical research. Our portfolio combines<br />
the continued excellence of Nature, its associated<br />
research and review journals, and over 50 leading<br />
academic and society journals in the life, physical<br />
and clinical sciences. Open access options are offered<br />
through the academic and society journals. NPG also<br />
provides timely news content and, through Naturejobs,<br />
scientific career information. Visit the NPG stand<br />
P02 to pick up your free sample copies of Kidney International,<br />
Nature Reviews Nephrology and other<br />
NPG journals, subscribe at the conference rate, or find<br />
out about advertising opportunities in any NPG title.<br />
www.nature.pg<br />
NDT-ERBP-NDT-Educational ................... Booth 1.102<br />
Visit the <strong>ERA</strong>-<strong>EDTA</strong> booth to find information about<br />
the current activities, especially with regard to educational<br />
initiatives and to the European Renal Best Practice.<br />
ERBP’s main purpose is to help increasing the<br />
implementation of European nephrology recommendations<br />
and guidance and to enhance the quality of<br />
European and worldwide nephrology practice. ERBP<br />
has also created a set of patient information documents,<br />
in the belief that joint decisions, made together<br />
by physicians and well-informed patients, are fundamental<br />
to obtain the best treatment for each individual<br />
renal patient.<br />
At the booth you can also collect a printed copy of this<br />
congress’s Book of Abstracts, if you wish to have a paper<br />
version of it in addition to the one on CD.<br />
www.eraedta.org<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
Nephrokit ........................................................ Booth 1.28<br />
Nephtrokit was founded on December 2007, by Dr<br />
Mokhtar Chawki, skilled French Nephrologist on dialysis<br />
vascular access field. Based on the west suburb of<br />
Paris. Nephrokit is an innovative start-up who detains<br />
4 validated patents for improving techniques of securing<br />
dialysis needle and reducing post dialysis time to<br />
clot of vascular access puncture sites. Nephrokit creates<br />
a breakthrough with new compressive device<br />
named “IRIS” ® for dialysis access puncture sites. Non<br />
exclusive agreement for IRIS distribution was signed<br />
with Bellco France and Belgium, Gambro France. The<br />
device is also sold in dialysis kits by Mölnylcke in Europe.<br />
Nephrokit is also seeking to introduce Iris ® in the domain<br />
of blood transfusion and is looking for partners<br />
in this field. www.nephrokit.com<br />
Nikkiso Europe .............................................. Booth 2.75<br />
The Nikkiso group has been providing technologies<br />
and products in order to meet demands of our customer,<br />
the society and the times we live in for more<br />
than half a century. The Nikkiso Europe GmbH is our<br />
European entity based in Hanover/Germany and responsible<br />
for production and distribution of our excellent<br />
technologies to the EMEA (Europe, Middle East,<br />
Africa) region. Beyond production and distribution<br />
Nikkiso Europe is able to develop extracorporeal technologies<br />
in our Research and Development department.<br />
Overall the Nikkiso Europe GmbH is our clear<br />
commitment to Europe and our customers there. Nikkiso<br />
Europe GmbH – Our flexibility is your efficiency.<br />
www.nikkiso-europe.eu<br />
TYH<br />
R<br />
Ningbo Tianyi Medical Appliance .......... Booth 1.G15<br />
Established in 1998, Ningbo Tianyi Medical is specialized<br />
in producing hemodialysis blood line, blood<br />
tubing sets for Continuous Renal Replacement Treatment<br />
(CRRT), Arterial venous fistula (AVF) needle,<br />
infusion set, blood transfusion set ect. The company<br />
has achieved ISO 13485 certification. Products are under<br />
CE and CCC certificates. “Quality first, scientific<br />
management, sincere and creditable service, customeroriented”<br />
is our business concept. www.tianyinb.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
421<br />
EXHIBITORS
EXHIBITORS<br />
422<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Nipro Europe................................................... Booth 2.14<br />
Nipro Europe has built its reputation on consistent<br />
high levels of quality and service in Europe. With its<br />
5 Business Units, we distribute products for hemodialysis<br />
(Renal Care), hospital consumables (Hospital<br />
Products), blood glucose diagnostics (Diabetes Care),<br />
oxygenators and accessories (Cardiopulmonary) and<br />
medical glass products (Pharmaceutical Solutions).<br />
Our priority is building long-term partnerships with<br />
each customer. This is accomplished by providing superior<br />
quality and value throughout the business in<br />
addition to listening to customer needs and translating<br />
those needs into specific products and services. We<br />
constantly thrive to create and offer safe, high-quality<br />
products ensuring a better quality of life.<br />
www.nipro-europe.com<br />
NKF USA ......................................................... Booth 2.26<br />
NKF USA offers the nephrology community the latest<br />
science and practical tools through our clinical practice<br />
guidelines, our free kidney screening programs,<br />
and our professional memberships. Learn more about<br />
KDOQI (T), KEEP (T), and our scientific journals:<br />
AJKD, ACKD and JRN. Find out about the new KDI-<br />
GO (R) Guidelines that are being published this year<br />
including AKI, GN, Hypertension and Anemia.<br />
www.kidney.org<br />
Novartis Pharmaceuticals - Oncology ........ Booth 1.31<br />
Novartis is a global leader in oncology through strong<br />
research and development efforts and a broad portfolio<br />
of marketed products. Novartis Oncology discovers<br />
and develops innovative therapies including Glivec ®<br />
(imatinib), Tasigna ® (nilotinib), Afinitor ® (everolimus),<br />
Zometa ® (zoledronic acid), Femara ® (letrozole), Sandostatin<br />
® LAR ® (octreotide acetate for injectable suspension)<br />
and Exjade ® (deferasirox). Novartis Oncology<br />
has one of the broadest and most comprehensive<br />
pipelines in the industry, currently with more than<br />
20 novel medicines in development that target many<br />
therapeutically important proteins to help address the<br />
unmet needs of patients. www.novartis.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
NxStage Medical ............................................ Booth 1.02<br />
NxStage is leading a movement to transform renal<br />
care. To make it simpler. To make it portable. To expand<br />
treatment options for clinicians by overcoming<br />
traditional barriers. NxStage is finding itself at the<br />
forefront of dramatically improved renal care, thanks<br />
to innovative yet simple therapeutic solutions that<br />
benefit patients, caregivers, and society. For more information<br />
visit www.nxstage.com<br />
Otsuka Pharmaceuticals Europe ................. Booth 1.60<br />
Otsuka Pharmaceutical is a global healthcare company<br />
with the corporate philosophy: ‘Otsuka-people<br />
creating new products for better health worldwide.’<br />
The Otsuka Group is comprised of 151 companies and<br />
employs approximately 40,000 people in 23 countries<br />
and regions worldwide. Otsuka is committed to focusing<br />
its research and development on innovative products<br />
and medical devices that address unmet medical<br />
needs, particularly in our specialist areas of renal, endocrine,<br />
gastro-intestinal and central nervous system<br />
disorders. Come and visit Otsuka Europe at Stand 1.60<br />
on Level 1 at the Palais des Congrès de Paris, to learn<br />
more about Otsuka’s commitment to innovation and<br />
education in nephrology. www.otsuka-europe.com<br />
OUP Oxford University Press ...................... Booth 1.72<br />
Oxford University Press publishes some of most respected<br />
medical books and journals in the world including<br />
the Oxford Clinical Nephrology Series, and on<br />
behalf of the <strong>ERA</strong>-<strong>EDTA</strong> we publish the leading European<br />
journal Nephrology Dialysis Transplantation as<br />
well as CKJ (Clinical Kidney Journal). Visit our stand<br />
to browse books and to pick up free copies of the journals.<br />
www.oxfordjournals.org and www.oup.com.<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
423<br />
EXHIBITORS
EXHIBITORS<br />
424<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
PakuMed .......................................................... Booth 1.36<br />
PakuMed medical products gmbh is a German company<br />
founded in 1990 specialized in the development,<br />
manufacture and worldwide distribution of special<br />
medical products. Highly qualified medical competence,<br />
flexibility and close cooperation with our customers<br />
as well as best service are our strong points.<br />
Our product quality meets highest international standard<br />
with reasonable prices. Besides port catheter systems<br />
and accessories, innovative products for Hemodialysis<br />
and Apheresis are designed to meet the needs<br />
of our clients and complete our product range.<br />
www.pakumed.de<br />
Pharmacosmos ................................................ Booth 2.13<br />
PHARMACOSMOS develops and markets medicines<br />
for the treatment of iron deficiency. An independent<br />
pharmaceutical company with an ongoing R&D programme,<br />
Pharmacosmos’ goal is to improve treatment<br />
options for healthcare professionals and patients,<br />
by offering innovative treatments - Pharmacosmos<br />
works with exclusive partners in more than 50 countries<br />
worldwide. Pharmacosmos holds the marketing<br />
authorisation for Monofer ® (iron isomaltoside 1000),<br />
a treatment for iron deficiency anaemia that offers<br />
patients with various iron needs the convenience of<br />
high dose iron in one visit. Seventy million doses of<br />
its second parenteral iron preparation CosmoFer ® (low<br />
molecular weight iron dextran) have already been administered<br />
worldwide. www.pharmacosmos.com<br />
Physidia ............................................................ Booth 1.65<br />
Physidia is a French start-up. Its mission is the development<br />
and marketing of a daily hemodialysis system<br />
suitable for home use. The project was initiated in<br />
Lyon. In 2002-2005, the first tests systems were developed,<br />
which passed clinical trials. The S³ system will<br />
be marketed in 2013 in France. Main features are: premix<br />
dialysate; disposable lines and pumps; simplified<br />
operations; truly portable; versatile modalities: SDHD<br />
and HDF, practice inspired by peritoneal dialysis.<br />
www.physidia.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
PosterSessionOnLine -<br />
Poster Virtual Gallery ................................... Booth 1.24<br />
PosterSessionOnline is the world’s largest free-access<br />
medical poster resource - browse posters from <strong>ERA</strong>-<br />
<strong>EDTA</strong> and more than 50 other congresses online at<br />
your leisure. Log on to the exciting new <strong>ERA</strong>-<strong>EDTA</strong><br />
ONLINE POSTER FORUM to ask questions to the presenters,<br />
exchange ideas and network with colleagues.<br />
PosterSessionOnline has also provided all poster presenters<br />
with the opportunity to have their posters<br />
printed and delivered free of charge to the congress<br />
venue, picking them up from the Takeda Hospitality<br />
Suite during the meeting.<br />
Log in and join the debate in the Era-Edta online poster<br />
forum! www.postersessiononline.com<br />
Pronefro............................................................ Booth 1.96<br />
Pronefro, Produtos Nefrológicos, S.A. company was<br />
founded in 1983 and has its headquarters in Maia,<br />
located around 10km Porto in north of Portugal. We<br />
have a large experience has manufacture since we<br />
have been working with medical devices and more<br />
specifically on dialysis products for over 25 years. We<br />
have in our range of products, bloodlines, AV fistulas<br />
needles, dialysers, catheters, therapy chairs, tubes for<br />
esthetical use, diabetics shoes and others accessories.<br />
We work mostly with distributors, our product quality<br />
meets highest international standards; the company is<br />
certified according to EN ISO 9001 and EN ISO 13845.<br />
For more information please see our website<br />
www.pronefro.pt<br />
Roche ................................................................ Booth 2.52<br />
Headquartered in Basel, Switzerland, Roche is a<br />
leader in research-focused healthcare with combined<br />
strengths in pharmaceuticals and diagnostics. Roche<br />
is the world’s largest biotech company with truly differentiated<br />
medicines in oncology, virology, inflammation,<br />
metabolism and CNS. Roche is also the world<br />
leader in in-vitro diagnostics, tissue-based cancer<br />
diagnostics and a pioneer in diabetes management.<br />
Roche’s personalized healthcare strategy aims at providing<br />
medicines and diagnostic tools that enable tangible<br />
improvements in the health, quality of life and<br />
survival of patients. For more information:<br />
www.roche.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
425<br />
EXHIBITORS
EXHIBITORS<br />
426<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Sandoz .............................................................. Booth 2.73<br />
Sandoz is a Novartis company with a reputation for<br />
quality going back to the 19 th century. Present in 130<br />
countries, our broad portfolio of affordable, high-quality<br />
medicines is available to 90% of the world’s population.<br />
Sandoz Biopharmaceuticals, a specialized business<br />
within Sandoz and Novartis, develops, produces<br />
and markets biopharmaceutical medicines and active<br />
ingredients worldwide, and enjoys close synergies<br />
across the value chain with other parts of the Novartis<br />
Group. Our decades of experience and significant<br />
investments have helped to position us as the pioneer<br />
and global leader in biosimilars. Our vision is to<br />
dramatically increase patient access to essential highquality<br />
biopharmaceuticals, by consistently advancing<br />
this global leadership position. www.sandoz.com<br />
Sanofi Aventis Groupe .................................. Booth 2.79<br />
Sanofi a diversified global healthcare leader, focused<br />
on patients’ needs<br />
Sanofi has core strengths in the field of healthcare<br />
with growth platforms: emerging markets, human<br />
vaccines, consumer healthcare, diabetes, innovative<br />
products and animal health. Through the acquisition<br />
of Genzyme, Sanofi has reinforced its footprint in biotechnology<br />
and rare diseases.<br />
Sanofi’ strategy is based on three key principles in order<br />
to deliver long-term sustainable growth: increasing<br />
innovation in Research & Development, seizing<br />
external growth opportunities, adapt to future challenges<br />
and opportunities.<br />
Sanofi:<br />
- More than 110,000 employees in 100 countries<br />
- 2011 net sales: €33.4 billion<br />
For more information: http://en.sanofi.com/home.asp<br />
Savient Pharmaceuticals ............................... Booth 1.23<br />
Savient Pharma Ireland Limited, a wholly-owned subsidiary<br />
of Savient Pharmaceuticals, is a specialty biopharmaceutical<br />
company seeking regulatory approval<br />
for KRYSTEXXA ® in the European Union for the treatment<br />
of refractory chronic gout. KRYSTEXXA is available<br />
in the European Union through a Named Patient<br />
<strong>Programme</strong> and is currently the only FDA approved<br />
product for this indication in the United States.<br />
www.savient.com<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
Serumwerk Bernburg .................................... Booth 1.61<br />
The Serumwerk Bernburg Group is an internationally<br />
- renowned producer and supplier of medicinal<br />
products and medical devices for human and veterinary<br />
use, based in Germany. The dialysis division is<br />
successfully active since 1998 in Europe, Middle East,<br />
Asia and North Africa. It offers a wide range of medical<br />
disposables for hemodialysis, e.g. VitaPES dialyzers,<br />
DiaCart & DiaBox bicarbonate cartridges, bloodlines<br />
and IV solutions. The company is focused on<br />
offering “Made in Germany” products to their worldwide<br />
clients. www.serumwerk.de<br />
Shire Pharmaceuticals ................................... Booth 2.01<br />
Shire shares the vision of nephrology practitioners to<br />
place the best interest of patients at the heart of everything<br />
we do. The commitment of Shire is to enable<br />
people with life-altering conditions to lead better lives.<br />
In the field of nephrology, Shire supports research<br />
which improves understanding of renal science, kidney<br />
health awareness and education in renal units<br />
Products include Fosrenol ® , a non-calcium, non-resin<br />
phosphate binder for the management of hyperphosphataemia.<br />
www.shire.com<br />
Sined ................................................................. Booth 1.57<br />
Sined is an international medical computer solutions<br />
specialist, focused exclusively on the design, manufacture,<br />
installation and maintenance of remote monitoring,<br />
clinical record and data collection systems. Sined<br />
not only offers leading expertise as a pioneer of IT in<br />
nephrology, but is uniquely customer focused, committed<br />
to multi-brand compatibility that protects existing<br />
investments while providing fully-customised, scalable<br />
solutions that meet all a customer’s needs cost-effectively.<br />
Renowned for close customer service, Sined works<br />
with medical, IT and administrative staff to increase<br />
efficiency and reduce risks, simultaneously improving<br />
stock and finance management to achieve substantial<br />
savings and reliable revenue. www.sined.it<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
427<br />
EXHIBITORS
EXHIBITORS<br />
428<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Soludia Maghreb ............................................ Booth 2.65<br />
Based in Morocco since 1998, Soludia Maghreb pharmaceutical<br />
laboratory is the leading manufacturer<br />
specialized in producing haemodialysis solution and<br />
powder products with a French licence. We provide<br />
excellent service to our customers. Our company is<br />
certified ISO 9001, ISO 13485, CE 120 labelled products,<br />
ISO 17025 in progress<br />
Our range of products :<br />
- Bicarbonate liquid, Bicarbonate powder for Gambro<br />
generator, for Fresenius generator and for Bellco generator.<br />
- 5 liters acid bag, acetate free acid, acid central with<br />
1000 liters Tank.<br />
- water analysis for haemodialysis<br />
We have the big part of the Moroccan market shares.<br />
We have been exporting our products to West Africa.<br />
We started exporting our products to Europe.<br />
For additional information on our company and products,<br />
please log on our website www.soludia.ma<br />
Takeda Pharmaceuticals Europe ......... Booth P01+P02<br />
Takeda is a research-based global pharmaceutical<br />
company committed to striving towards better health<br />
for patients worldwide through leading innovations<br />
in medicine. Takeda is renowned for its expertise and<br />
is dedicated to building on its success as a leader and<br />
preferred partner in the pharmaceutical industry.<br />
Takeda’s vision is to embody worldwide pharmaceutical<br />
leadership through innovation, culture and growth,<br />
guided by an unwavering commitment to significantly<br />
improve the lives of patients. www.takeda.eu<br />
TauroPharm ..................................................... Booth 1.43<br />
TauroPharm GmbH is a life science company specialized<br />
in antimicrobial medical devices. One of the<br />
company’s core interests is to offer a safe and effective<br />
technology for locking central venous access devices<br />
(catheters and ports). TauroLock, a non-antibiotic<br />
lock solution, which is capable of dramatically reducing<br />
catheter related blood stream infections (CRBSI) is<br />
free of side effects. TauroLock is highly effective in<br />
eradicating bacteria and fungi and has been successfully<br />
tested on more than five hundred organisms, including<br />
multiresistant forms such as MRSA and VRE.<br />
It is to be used in dialysis, oncology, intensive care and<br />
parenteral nutrition. To improve catheter patency Tau-<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
roLock products contain 4% citrate and/or heparin<br />
(TauroLock, TauroLock-Hep100, TauroLock-<br />
Hep500) and/or urokinase (TauroLock-U25.000).<br />
www.tauropharm.de<br />
Terumo BCT ..................................................Booth 1.98B<br />
CaridianBCT and Terumo Transfusion have united to<br />
become Terumo BCT, a global leader in blood component<br />
and cellular technologies. We believe in the potential<br />
of blood and cell therapies to do even more for<br />
the world than they do today. As we strive to make<br />
even safer, higher-quality transfusions available, we<br />
can help our customers bring even more treatment options<br />
to patients with advanced blood therapies and<br />
we can help researchers develop cell therapies that<br />
may fundamentally improve health care.<br />
www.terumobct.com<br />
BRAHMS GmbH,<br />
Part of Thermo Fisher Scientific ................ Booth 1.113<br />
Thermo Fisher Scientific specialises in innovative<br />
products that facilitate earlier diagnosis of diseases<br />
and better control of therapy, thus enabling doctors to<br />
provide more efficient and economic patient care.<br />
Major fields of activity are diagnosis of infectious and<br />
thyroid diseases, cardiology and pneumology as well<br />
as sepsis, tumors, and Down’s syndrome.<br />
www.thermoscientific.com/brahms<br />
Tianjin Denny Tech Co. ..............................Booth 1.63B<br />
We are professional manufacturer of dialysis product,<br />
We hold 1000 m2 clean room and completed foundation<br />
complementation. We possess advanced injection<br />
machine, extruding machine, high frequency heat<br />
sealing machine, ETO sterilization equipment, semiproduct<br />
automatic assembling machine, large-scale<br />
central air conditioning system and cooling unit. The<br />
composition delivers the totally enclosed production<br />
process from raw material investment to the end product.The<br />
blood tubing and arterial venous fistula needle<br />
was sales in world wide and we have passed CE and<br />
ISO13485 quality certification.<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
429<br />
EXHIBITORS
EXHIBITORS<br />
430<br />
49 th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
E X H I B I T O R S<br />
Toray ................................................................ Booth 1.49<br />
Toray is a leading manufacturer of synthetic fibers and<br />
dedicated to the development of dialysis products under<br />
its corporate slogan, “Innovation by Chemistry”.<br />
Toray supports high quality and advanced medical<br />
care with our biocompatible polymethylmethacrylate<br />
dialyzer, FILTRYZER, high flux polysulfone dialyzer,<br />
TORAYSULFONE & TORAYLIGHT, and dialysis machine,<br />
TR-8000.<br />
www.toray-medical.com/en/index.html<br />
Turkish Society of Nephrology ................ Booth 1.G12<br />
When the Turkish Society of Nephrology (TSN) was<br />
founded in Istanbul forty one years ago in 1970, it coincided<br />
with that of many of the Western European<br />
Nephrology Societies. Currently, TSN has 411 active<br />
members and 11 working groups also 8 branches with<br />
their own separate memberships in Istanbul, Izmir,<br />
Kayseri, Antalya, Bursa, Konya, Adana and Ankara.<br />
Turkish membership has actually reached 273 in ISN<br />
& 294 in <strong>ERA</strong>-<strong>EDTA</strong> (6th largest membership). TSN<br />
has increased its patient awareness activities this year<br />
and on the Kidney Day, TSN Activities consisted of<br />
a large variety from Banners in Football Matches to<br />
Newspaper Advertisements, TV Ads, Stands in Shopping<br />
Malls, Press Briefings School Visits and handouts<br />
in Nephrology Centers. www.tsn.org.tr/en/<br />
Vifor Fresenius Medical Care<br />
Renal Pharma .........................................Booth 2.22+2.23<br />
Vifor Fresenius Medical Care Renal Pharma Ltd. is a<br />
strategic partnership between Vifor Pharma and Fresenius<br />
Medical Care. The nephrology company develops<br />
and commercialises innovative and high-quality<br />
products to improve the lives of patients suffering<br />
from chronic kidney disease worldwide. The products<br />
include Venofer ® and Ferinject ® in the field of dialysis<br />
and pre-dialysis (CKD stage III – V) as well as PA21, a<br />
novel iron-based phosphate binder.<br />
www.viforpharma.com/en/About-Vifor/businesses.<br />
php<br />
w w w . e r a e d t a 2 0 1 2 . o r g
MAY 24-27, <strong>2012</strong> PARIS, France<br />
E X H I B I T O R S<br />
W I C H T I G E D I T O R E<br />
MEDICAL PUBLISHER<br />
Wichtig Editore ................................................Booth 1P3<br />
Wichtig Editore Medical publisher began its activity<br />
in 1977, dedicating passion and competence to the<br />
publication of widely appreciated scientific journals -<br />
focusing on nephrology, dialysis and transplantation<br />
– mostly indexed in important bibliographic databases.<br />
The Editorial Board of these outstanding journals<br />
acknowledge well-known leading scientists and, it is<br />
also thanks to their contributions, that Wichtig Editore’s<br />
titles are increasingly appreciated worldwide.<br />
Also, to be up-to-date, Wichtig Editore Medical Publisher<br />
is working to make its publications available as<br />
e-pubs for tablets and smartphones<br />
Websites: www.artificial-organs.com - www.<br />
jnephrol.com - www.vascular-access.info - www.<br />
wichtig-publisher.com/gin<br />
Wisepress ...................................................... Booth 1.G18<br />
Wisepress.com, Europe’s leading conference bookseller,<br />
has a complete range of relevant books and journals<br />
which can be purchased at the stand or, if you would<br />
rather not carry them, posted to you - Wisepress will<br />
deliver worldwide. We also have a comprehensive<br />
medical and scientific online bookshop with great offers.<br />
www.wisepress.com<br />
WS Far Ir Medical ....................................... Booth 1.63A<br />
We are the pioneer in Far-Infrared medical equipment<br />
industry, and have been manufacturing the FIR Therapy<br />
Unit for 20 years; our product WS Far-Infrared<br />
Therapy Unit is an essential tool for vascular access<br />
care in the hemodialysis centers all across Taiwan. In<br />
March 2007, the clinical evidence, “Far Infrared Therapy:<br />
a Novel Treatment Improving Access Blood Flow<br />
and Unassisted Patency of Arteriovenous Fistula in<br />
Hemodialysis Patients” was published in the Journal<br />
of American Society of Nephrology shows that Far-<br />
Infrared Therapy can effectively improve the access<br />
blood flow and unassisted patency of AV Fistula in<br />
hemodialysis patients. www.far-infrared.com.tw<br />
w w w . e r a e d t a 2 0 1 2 . o r g<br />
431<br />
EXHIBITORS
<strong>Programme</strong> at a glance<br />
49th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
MAY 24-27, <strong>2012</strong> PARIS, France<br />
Thursday, May 24th, <strong>2012</strong><br />
Grand Amphitheatre Room 252AB Room 253 Room 351 Room 352AB Room Concorde 2<br />
08:30 - 12:30 CME 1<br />
CME 2<br />
Rheumatology for nephrologists<br />
Peritoneal Dialysis<br />
10:15 - 11:45 EURECA-m Working Group<br />
12:00 - 13:30 EUTox Working Group<br />
13:00 - 17:00 CME 3<br />
CME 4<br />
Clinical questions for managing Nephrolithiasis Renal Pathology<br />
13:45 - 15:15 Working Group<br />
Immunonephrology<br />
on Inherited Kidney Disorders<br />
Working Group<br />
15:00 - 17:00 Drug-induced renal injury: the<br />
quest for sensitive biomarkers (IMI)<br />
15:30 - 17:00 EuDial Working Group The Soft-Skill Masterclass<br />
18:00 - 19:30 Opening Ceremony<br />
Fluid and electrolytes, tubular transport, physiology Hereditary disorders, development, pregnancy, paediatric nephrology<br />
Exhibition Level 1 and 2<br />
Glomerular diseases and general clinical nephrology Acute kidney injury and intensive care nephrology<br />
19:30 - 21:00 Welcome Reception<br />
CKD - epidemiology, prevention, progression, pathophysiology Hypertension, diabetes, vascular disease<br />
LEGENDA<br />
End stage renal disease, dialysis Transplantation
<strong>Programme</strong> at a glance<br />
49th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
MAY 24-27, <strong>2012</strong> PARIS, France<br />
Friday, May 25th, <strong>2012</strong><br />
Grand Amphitheatre Room Concorde 1 Amphitheatre Bleu Amphitheatre Bordeaux Amphitheatre Havane Room 352AB Room 342AB Room Concorde 2 Room 252 AB<br />
08:00 - 09:30 S 1<br />
S 2<br />
S 3<br />
S 4<br />
S 5<br />
FC 1<br />
FC 2<br />
FC 3<br />
Late breaking clinical trials <strong>ERA</strong>-<strong>EDTA</strong> Registry Current aspects of CKD- Diagnostic approaches Advances in understanding AKI and stem cells Renal physiology IgA Nephropathy and<br />
mineral bone disorders to the tranplant kidney the renin-angiotensin system<br />
urinary proteomics<br />
Alexion Pharma<br />
International<br />
09:30 - 10:45 Poster session, coffee break and exhibition visit<br />
10:45 - 11:30 Plenary Lecture 1<br />
G. Karsenty: The novel<br />
endocrinology of bone<br />
11:30 - 11:45 Coffee break and exhibition visit<br />
11:45 - 13:15 S 6<br />
S 7<br />
S 8<br />
S 9<br />
S 10<br />
FC 4<br />
FC 5<br />
FC 6<br />
Sepsis and AKI<br />
What is “good Polycystic kidney Bone and mineral metabolism Leukocytes and pro-infl ammatory Mechanisms and targets of HUS and diabetic Paediatric nephrology<br />
dialysis”?<br />
disease: clinical studies after transplantation mediators in renal injury<br />
glomerular damage nephropathy<br />
13:15 - 15:15 Roche Gambro Fresenius Medical Sanofi Takeda Pharmaceuticals B.Braun Otsuka Pharmaceutical<br />
Care<br />
Europe<br />
Europe<br />
15:15 - 16:45 S 11<br />
S 12<br />
S 13<br />
S 14<br />
FC 7<br />
FC 8<br />
FC 9<br />
S 15<br />
Thrombotic microangiopathies The prehypertensive Calcium sensing and Peritoneal dialysis Vascular damage and access Clinical epidemiology AKI clinical studies Renal fi brosis<br />
and complement disorders kidney<br />
PTH secretion<br />
in CKD<br />
and CKD 1-5<br />
16:45 - 17:00 Coffee break and exhibition visit<br />
17:00 - 18:30 S 16<br />
S 17<br />
LU 1<br />
LU 2<br />
S 18<br />
FC 10<br />
FC 11<br />
FC 12<br />
DOPPS<br />
Vascular<br />
Clinical nephrology Transplantation<br />
Paraneoplastic GN, monoclonal- Genetic studies in Hypertension Anaemia<br />
calcifi cations in CKD<br />
IgG related disorders and amyloid renal diseases
<strong>Programme</strong> at a glance<br />
49th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
MAY 24-27, <strong>2012</strong> PARIS, France<br />
Saturday, May 26th, <strong>2012</strong><br />
Grand Amphitheatre Room Concorde 1 Amphitheatre Bleu Amphitheatre Bordeaux Amphitheatre Havane Room 352AB Room 342AB Room Concorde 2 Room 252 AB<br />
08:00 - 09:30 S 19<br />
S 20<br />
S 21<br />
S 22<br />
S 23<br />
FC 13<br />
FC 14<br />
FC 15<br />
Salt and volume<br />
Highlights of the 2011 New advances in the<br />
Markers of renal Advances in<br />
The EU and glomerular Diabetes basic Bone and mineral<br />
management in dialysis ESOT congress pathophysiology of AKI progression - New understanding tubular diseases<br />
research<br />
diseases 1<br />
patients<br />
approaches and studies function<br />
09:30 - 10:45 Poster session, coffee break and exhibition visit<br />
10:45 - 11:30 Plenary Lecture 2<br />
R. Johnson: Fructose, metabolic<br />
syndrome and kidney disease<br />
11:30 - 11:45 Coffee break and exhibition visit<br />
11:45 - 13:15 S 24<br />
S 25<br />
S 26<br />
S 27<br />
FC 16<br />
FC 17<br />
FC 18<br />
Atherosclerotic and cardiac Ciliopathies and polycystic Novel invasive strategies in antihyper- Minimal change Transplantation basic Peritoneal dialysis<br />
Renal fi brosis<br />
disease in CKD<br />
kidney diseases (basic and tensive treatment - Renal sympathetic diseases/FSGS<br />
translational)<br />
denervation, barorefl ex stimulation<br />
13:15 - 15:15 Abbott Amgen Shire<br />
DV Care Toray Nipro Europe Baxter Healthcare Vifor Pharma and<br />
Pharmaceuticals<br />
Fresenius Medical Care<br />
15:15 - 16:45 S 28<br />
S 29<br />
S 30<br />
S 31<br />
FC 19<br />
FC 20<br />
FC 21<br />
S 32<br />
Progression of CKD and associated Membranous The elderly patient with CKD or Genetic diseases of the Genetic diseases Dialysis techniques and Mineral homeostasis Outcomes after<br />
cardiovascular complications nephropathy on dialysis<br />
glomerular barrier<br />
adequacy<br />
and nephrolithiasis transplantation<br />
16:45 - 17:00 Coffee break and exhibition visit<br />
17:00 - 18:30 S 33<br />
S 34<br />
LU 3<br />
S 35<br />
FC 22<br />
FC 23<br />
S 36<br />
Management issues in Vasculitis and lupus CKD and dialysis<br />
Glomerular permeability and Bone and mineral Diabetes clinical studies<br />
Tolerance and predictors<br />
patients with CKD<br />
permeability-inducing factors diseases 2<br />
of transplant outcome
<strong>Programme</strong> at a glance<br />
49th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
MAY 24-27, <strong>2012</strong> PARIS, France<br />
Amphitheatre Havane Room 352AB Room 342AB Room Concorde 2<br />
Sunday, May 27th, <strong>2012</strong><br />
Grand Amphitheatre Room Concorde 1 Amphitheatre Bleu Amphitheatre<br />
S 41<br />
Albuminuria and other<br />
biomarkers<br />
FC 26<br />
Clinical studies in CKD<br />
FC 25<br />
Autoimmune systemic<br />
diseases<br />
FC 24<br />
Cardiovascular<br />
complications in CKD 5D<br />
Bordeaux<br />
S 40<br />
Hyponatremia<br />
S 39<br />
Complications after<br />
transplantation<br />
S 38<br />
Anaemia management<br />
08:00 - 09:30 S37<br />
Diabetic nephropathy<br />
09:30 - 09:45 Coffee break and exhibition visit<br />
09:45 - 10:30 Plenary Lecture 3<br />
R. Bindels:<br />
Novel insights into the<br />
renal handling of calcium<br />
and magnesium<br />
10:30 - 11:30 <strong>ERA</strong>-<strong>EDTA</strong><br />
General<br />
Assembly<br />
S 46<br />
Prevention of AKI and<br />
delayed graft function<br />
FC 28<br />
CKD 5D epidemiology<br />
and outcomes<br />
FC 27<br />
Transplantation clinical<br />
S 45<br />
Stem cells<br />
S 44<br />
Renal cancer and the<br />
kidney in cancer<br />
S 43<br />
Reappraisal of<br />
European Guidelines<br />
11:30 - 13:00 S 42<br />
IgA nephropathy
An OtsukA sPOnsORED InDustRY sAtEllItE<br />
sYmPOsIum hElD DuRIng thE EuROPEAn REnAl<br />
AssOcIAtIOn – EuROPEAn DIAlYsIs AnD tRAnsPlAnt<br />
AssOcIAtIOn cOngREss, PARIs <strong>2012</strong><br />
Taking a closer look<br />
at hyponatraemia<br />
Friday 25th May <strong>2012</strong>, 13:15–14:30<br />
Concorde 2, Level 4, Neuilly Side<br />
Le Palais des Congres de Paris, Paris<br />
13:15 Lunch<br />
13:30 Welcome and introduction:<br />
The hyponatraemia mind-set<br />
and environment<br />
Maurice Laville (Chair)<br />
13:35 Under the microscope:<br />
Hyponatraemia from a fluid balance<br />
perspective<br />
Robert Schrier and Søren Nielsen<br />
14:00 Investigating the optimal treatment<br />
of hyponatraemia:<br />
Practical case studies<br />
Volker Burst<br />
14:20 Questions and answers<br />
All<br />
14:30 Chair close<br />
Maurice Laville<br />
For more information please visit stand 1.60<br />
to find out more visit<br />
www.hyponatraemia.com<br />
Date of preparation: March <strong>2012</strong><br />
OPEL/0212/SAM/1098
49th 4 <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
MAY M 24-27, <strong>2012</strong> PARIS, France<br />
Level 0
49th 4 <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
MAY M 24-27, <strong>2012</strong> PARIS, France<br />
COMPANY .................. BOOTH NO.<br />
Takeda Pharmaceuticals<br />
Europe ..................................P01+P02<br />
Kimal ........................................... 1.01<br />
NxStage Medical ......................... 1.02<br />
Binding Site (the) ....................... 1.05<br />
Mitsubishi Pharma Europe ......... 1.10<br />
Etropal ........................................ 1.11<br />
Bain Medical Equipment ............ 1.22<br />
Poster Session On Line -<br />
Poster Virtual Gallery ................. 1.24<br />
Alexion Pharma International ... 1.26<br />
Nephrokit .................................... 1.28<br />
DV Care ....................................... 1.29<br />
Novartis Pharmaceuticals -<br />
Oncology ..................................... 1.31<br />
Dirinco ......................................... 1.32<br />
Joline ........................................... 1.34<br />
Medikit ........................................ 1.35<br />
PakuMed ..................................... 1.36<br />
Covidien ...................................... 1.37<br />
Asahi Kasei Medical Europe ...... 1.42<br />
TauroPharm ................................ 1.43<br />
Infomed ...................................... 1.45<br />
Asahi Kasei Medical Europe ...... 1.47<br />
Toray ........................................... 1.49<br />
Innovative Blood Purifi cation .... 1.50<br />
Sined ........................................... 1.57<br />
Otsuka Pharmaceuticals Europe 1.60<br />
Serumwerk Bernburg ................. 1.61<br />
EG Medical Systems .................... 1.62<br />
WS Far Ir Medical .....................1.63A<br />
Tianjin Denny Tech Co. .............1.63B<br />
Alam Medical ............................1.64A<br />
Physidia ....................................... 1.65<br />
Awak Technologies .................... 1.68<br />
Medcomp .................................... 1.71<br />
OUP Oxford University Press ...... 1.72<br />
Debiotech ................................... 1.91<br />
Meditechlab & Suisse Med<br />
Technologies ............................... 1.92<br />
Alere International ..................... 1.93<br />
Culligan ....................................... 1.94<br />
Pronefro ...................................... 1.96<br />
Intermedt Medizin & Technik .... 1.97<br />
Terumo BCT ..............................1.98B<br />
Gardhen Bilance .......................1.98C<br />
Savient Pharmaceuticals ............ 1.14<br />
Cybernius Medical ...................... 1.16<br />
Thermo Fisher Scientifi c ........... 1.113<br />
Medica Italia ............................. 1.100<br />
NDT-ERBP-NDT-Educational ..... 1.102<br />
Bionic Medizintechnik ............. 1.103<br />
Medvision ................................. 1.115<br />
Alexion Pharma International . 1.116<br />
Sandoz - Novartis Group ............1.G1<br />
ISN International Society<br />
of Nephrology ............................1.G3<br />
IFKF - International Federation<br />
of Kidney Foundation ................1.G4<br />
Euroclinic ....................................1.G5<br />
Bodystat ......................................1.G6<br />
ARBOR Research .........................1.G7<br />
French Society of Nephrology ...1.G8<br />
Fedairg ........................................1.G9<br />
COMPANY .................. BOOTH NO.<br />
MedXL .......................................1.G10<br />
French Society of Dialysis .........1.G11<br />
Turkish Society of Nephrology 1.G12<br />
<strong>ERA</strong>-<strong>EDTA</strong> 2013<br />
<strong>Congress</strong> Istanbul .....................1.G14<br />
Ningbo Tianyi Medical<br />
Appliance ..................................1.G15<br />
JiHua Medical Apparatus<br />
and Instruments .......................1.G17<br />
Wisepress ..................................1.G18<br />
Immundiagnostik .....................1.G19<br />
Labor Limbach ..........................1.G20<br />
BioPorto Diagnostics ................1.G21<br />
E.D.P. La Traccia ........................1.G22<br />
Atcor Medical ...........................1.G23<br />
HemoSapiens ............................1.G24<br />
Dustri ........................................... 1.P1<br />
Nature PG ................................... 1.P2<br />
Elsevier Masson .......................... 1.P4<br />
MediTheque Bookshop .............. 1.P5<br />
Karger ......................................... 1.P6<br />
Wichtig Editore ........................... 1P3<br />
Poster Help Desks ...........PD01+PD02<br />
Gielissen Exhibition<br />
Service Desk ..............................1.64B<br />
Catering Areas ..................C11+C11D<br />
Sitting Areas ......C11abc+1.14+1.53+<br />
1.108+1.111<br />
Level 1
49th 4 <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
MAY M 24-27, <strong>2012</strong> PARIS, France<br />
COMPANY ........................... BOOTH NO.<br />
Shire Pharmaceuticals .......................... 2.01<br />
Abbott ................................................... 2.03<br />
Atlantic Biomedical .............................. 2.04<br />
Kawasumi ............................................. 2.05<br />
B.Braun Avitum .................................... 2.12<br />
Lauer ..................................................... 2.12<br />
Pharmacosmos ...................................... 2.13<br />
Nipro Europe ........................................ 2.14<br />
Diaverum .............................................. 2.19<br />
Membrana ............................................ 2.20<br />
Actual Way Medical Devices -<br />
Via Actual ............................................. 2.21<br />
Vifor Fresenius Medical Care<br />
Renal Pharma .............................. 2.22+2.23<br />
NKF USA ................................................ 2.26<br />
Allmed Medical .................................... 2.27<br />
Janssen .................................................. 2.37<br />
Baxter Healthcare ................................. 2.39<br />
Miltenyi Biotec ..................................... 2.40<br />
Emodial ................................................. 2.42<br />
EffeEmme ............................................. 2.44<br />
Gambro ................................................. 2.46<br />
Amgen Europe ..................................... 2.48<br />
Roche .................................................... 2.52<br />
Fresenius Medical Care<br />
Therapy Forum ....... 2.54+2.55+2.60+2.60A<br />
Herco Wassertechnik ............................ 2.64<br />
Soludia Maghreb .................................. 2.65<br />
Likamed ................................................ 2.66<br />
Fresenius Kabi ....................................... 2.68<br />
Fresenius Medical Care ........................ 2.68<br />
Sandoz - Novartis Group ...................... 2.73<br />
Nikkiso Europe ..................................... 2.75<br />
Sanofi Aventis Groupe ......................... 2.79<br />
DWA ...................................................... 2.81<br />
Hospira UK ............................................ 2.83<br />
Abbott .......................................... 2.90+2.88<br />
Bellco .........................................Hall Maillot<br />
Catering Areas .............. C20+C21+C23+C24<br />
Level 2
49th 4 <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
MAY M 24-27, <strong>2012</strong> PARIS, France<br />
Level 3
49th 4 <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
MAY M 24-27, <strong>2012</strong> PARIS, France<br />
Level 4
CKJ<br />
CLINICAL KIDNEY JOURNAL<br />
an academic journal of the <strong>ERA</strong>-<strong>EDTA</strong><br />
<strong>ERA</strong>-<strong>EDTA</strong><br />
is a medical association<br />
active in encouraging<br />
intercultural communication<br />
and knowledge<br />
What can <strong>ERA</strong>-<strong>EDTA</strong><br />
do for you?<br />
ISSN 0931-0500 (Print) ISSN 1480-2385 (Online)<br />
Volume 1 Number 1 7 Jan <strong>2012</strong><br />
Official Publication of the European Renal Association -<br />
European Dialysis and Transplant Association<br />
www.ndt.oxfordjournals.org<br />
Official Publication of the European<br />
Renal Association -European Dialysis<br />
and Transplant Association<br />
49th <strong>ERA</strong>-<strong>EDTA</strong> CONGRESS<br />
MAY 24-27, <strong>2012</strong><br />
www.ndt.oxfordjournals.org<br />
PARIS, France<br />
www. eraedta20<br />
ISSN 0931-0500 (Print) ISSN 1480-2385 (Online)<br />
Volume 1 Number 1 7 Jan <strong>2012</strong><br />
ndt<br />
NEPHROLOGY DIALYSIS TRANSPLANTATION<br />
12.org<br />
Basic and clinical renal science<br />
Stanley Shaldon,<br />
<strong>ERA</strong>-<strong>EDTA</strong> award,<br />
PRAGUE, 23 JUNE 2011<br />
<strong>EDTA</strong> <strong>2012</strong> Paris man70x100.indd 1 31-03-2011 8:09:01<br />
<strong>ERA</strong>-<strong>EDTA</strong> members are entitled<br />
to EXCLUSIVE benefi ts:<br />
Free subscription to NDT and CKJ<br />
and access to NDT archive<br />
Exclusive access to scientifi c and<br />
educational contents<br />
Very special low registration fee<br />
at the <strong>ERA</strong>-<strong>EDTA</strong> <strong>Congress</strong><br />
Special access to the <strong>ERA</strong>-<strong>EDTA</strong><br />
restricted libraries on the web-site<br />
Special Discounts to<br />
Oxford University Press Medical<br />
publications<br />
What can you do<br />
for <strong>ERA</strong>-<strong>EDTA</strong>?<br />
Become a member<br />
and start to network now!<br />
www.era-edta.org
The new 5008 CorDiax<br />
Beyond your expectations<br />
Cardioprotective Haemodialysis<br />
The new 5008 CorDiax<br />
Cardioprotective Haemodialysis with<br />
advanced safety for reduced cardiovascular<br />
complications and mortality:<br />
� AutoSub plus maximising patients’ substitution<br />
volumes with minimum efforts for<br />
the full benefi ts of advanced ONLINE HDF<br />
� Sophisticated safety features setting<br />
new benchmarks in venous access<br />
monitoring<br />
5008 CorDiax – The essential element<br />
of the CorDiax product line.<br />
Fresenius Medical Care Deutschland GmbH<br />
61346 Bad Homburg · Germany · www.fmc-ag.com<br />
Visit us<br />
at booth<br />
2.68<br />
Level 2<br />
SP T
Change language